data_2la6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2la6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 112.452 0.538 . . . . 61.149999999999999 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.2 m -130.83 128.63 41.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.884 0.474 . . . . 71.319999999999993 110.099 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.4 pt -115.39 147.31 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.423 . . . . 71.439999999999998 111.551 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -105.71 108.86 20.6 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.256 0.622 . . . . 74.230000000000004 110.045 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG11 HG23 ' A' ' 95' ' ' VAL . 17.5 t -101.19 138.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.064 0.946 . . . . 73.140000000000001 110.09 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 23.4 mt-30 -119.44 155.11 32.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.728 0.811 . . . . 55.229999999999997 111.34 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.04 44.74 76.41 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.511 0.965 . . . . 52.340000000000003 115.511 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.426 HD23 HG21 ' A' ' 93' ' ' ILE . 49.3 mt -81.22 -30.75 34.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.462 1.105 . . . . 65.519999999999996 110.781 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.07 160.53 11.39 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 113.815 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.55 -23.01 64.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.492 0.717 . . . . 73.420000000000002 110.364 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -107.15 88.44 2.74 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.646 0.778 . . . . 60.340000000000003 108.995 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.37 136.7 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.888 0.875 . . . . 75.519999999999996 111.038 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.38 161.81 20.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.689 . . . . 75.439999999999998 110.43 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.557 HG21 ' HB ' ' A' ' 51' ' ' ILE . 76.1 mt -50.85 -47.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.173 0.989 . . . . 64.209999999999994 111.32 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -75.99 -23.99 55.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.333 0.653 . . . . 74.129999999999995 111.823 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -67.94 -46.4 71.56 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.658 0.383 . . . . 63.140000000000001 110.541 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 30.8 t -64.6 -42.73 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.092 0.473 . . . . 71.209999999999994 110.27 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.62 96.16 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.542 -0.754 . . . . 74.209999999999994 112.637 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.19 -22.07 55.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.96 0.504 . . . . 71.329999999999998 111.449 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -79.58 -44.95 20.1 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.236 0.614 . . . . 75.239999999999995 111.364 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -83.14 -13.71 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.852 1.056 . . . . 75.230000000000004 113.852 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.71 -30.08 60.53 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.009 1.114 . . . . 71.549999999999997 114.009 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.28 -24.41 67.27 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.623 0.769 . . . . 74.430000000000007 112.606 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 79' ' ' ALA . 19.5 mm -82.41 -44.37 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.836 0.854 . . . . 72.530000000000001 111.372 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.88 179.64 48.66 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 116.406 -0.361 . . . . 63.43 113.67 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.64 125.09 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.497 0.719 . . . . 74.230000000000004 111.549 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.7 mt -94.0 138.38 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 70.420000000000002 108.781 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.584 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 27.1 mtpp -57.73 155.02 10.73 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.068 0.547 . . . . 71.519999999999996 111.73 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.8 m -145.5 125.38 13.5 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.273 0.629 . . . . 73.200000000000003 111.155 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.33 125.85 30.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.778 -0.823 . . . . 62.130000000000003 108.778 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.3 -21.66 25.62 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.643 0.608 . . . . 74.439999999999998 112.643 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.26 -43.21 95.56 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.305 0.642 . . . . 74.430000000000007 111.713 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -82.72 -42.93 17.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.576 0.75 . . . . 72.519999999999996 110.117 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.51 56.02 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.392 -0.822 . . . . 71.319999999999993 111.893 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -110.44 147.09 35.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.105 0.962 . . . . 74.319999999999993 111.63 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 33.7 Cg_endo -64.99 142.19 73.82 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.594 2.196 . . . . 73.129999999999995 110.835 173.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.584 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 61.3 mtt -72.79 94.31 1.78 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.716 0.77 . . . . 71.439999999999998 110.34 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.557 ' HB ' HG21 ' A' ' 27' ' ' ILE . 66.4 mt -144.93 119.81 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.042 1.337 . . . . 72.400000000000006 108.264 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 24.5 m-80 -102.7 110.77 22.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.114 -0.699 . . . . 74.129999999999995 109.114 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.69 124.35 28.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.903 0.881 . . . . 74.230000000000004 109.92 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.428 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.2 m-85 -80.33 110.43 15.76 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.647 0.779 . . . . 72.230000000000004 110.814 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -96.86 143.02 28.16 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 71.219999999999999 109.864 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.08 144.44 40.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 74.430000000000007 111.266 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.87 -46.47 30.04 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.447 0.699 . . . . 74.230000000000004 112.175 -171.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.11 -42.69 15.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.539 0.57 . . . . 74.25 112.539 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.5 p -81.95 -30.03 31.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.207 0.447 . . . . 73.450000000000003 112.207 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.06 84.57 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 114.015 0.366 . . . . 55.210000000000001 114.015 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -99.19 164.89 11.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.014 0.926 . . . . 74.239999999999995 110.531 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.02 131.47 45.11 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.973 0.509 . . . . 72.329999999999998 111.622 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -75.66 -21.71 57.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.194 0.598 . . . . 72.310000000000002 111.82 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.77 26.66 31.46 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 116.073 -0.512 . . . . 70.219999999999999 112.902 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 3.6 mp0 -116.72 154.47 30.56 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.543 -0.975 . . . . 75.340000000000003 109.755 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -160.14 146.94 16.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.877 0.471 . . . . 74.239999999999995 111.513 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.9 p -104.16 117.89 35.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.973 -0.38 . . . . 63.409999999999997 109.973 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.93 108.08 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.621 0.769 . . . . 74.409999999999997 110.36 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 m -85.18 104.19 14.83 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.889 0.476 . . . . 72.439999999999998 110.821 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.4 m-85 -79.67 158.2 27.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.49 0.716 . . . . 74.120000000000005 110.788 169.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.64 -31.23 63.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.065 0.546 . . . . 74.430000000000007 111.349 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -118.73 134.17 23.56 Favored Pre-proline 0 N--CA 1.48 1.067 0 C-N-CA 123.053 0.541 . . . . 64.340000000000003 111.564 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.2 -34.9 99.02 Favored 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 122.523 2.149 . . . . 74.129999999999995 116.197 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.72 -29.35 77.19 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 122.867 2.059 . . . . 65.530000000000001 113.079 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -74.68 -40.85 61.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.223 0.609 . . . . 63.240000000000002 110.396 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.86 84.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.541 -0.754 . . . . 72.049999999999997 111.098 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.34 -44.85 90.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.109999999999999 111.296 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.891 0.476 . . . . 61.109999999999999 111.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.49 ' HA ' HG13 ' A' ' 37' ' ' ILE . . . -60.76 -34.21 74.11 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.407 0.683 . . . . 64.120000000000005 112.232 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.497 HG12 HG12 ' A' ' 95' ' ' VAL . 71.9 mt -69.19 -54.98 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.831 0.452 . . . . 74.040000000000006 110.49 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.42 -33.1 69.3 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.768 0.827 . . . . 73.310000000000002 111.921 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -80.57 -56.46 4.15 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.691 0.796 . . . . 75.219999999999999 112.17 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HB3' HD11 ' A' ' 93' ' ' ILE . 61.7 m-85 -86.65 -11.64 50.73 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 114.457 1.28 . . . . 74.400000000000006 114.457 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -63.87 116.12 5.5 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.578 0.626 . . . . 75.519999999999996 110.322 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.73 5.55 74.23 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 114.871 0.708 . . . . 75.450000000000003 114.871 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.84 159.59 14.9 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 117.949 0.874 . . . . 73.099999999999994 111.767 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.41 115.79 27.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.64 0.376 . . . . 72.319999999999993 111.651 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.404 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 91.2 t80 -70.28 -56.34 7.0 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.997 0.919 . . . . 73.420000000000002 110.925 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -147.18 63.01 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.908 0.861 . . . . 62.43 109.151 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.37 0.28 66.25 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 115.093 -0.958 . . . . 75.400000000000006 113.692 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.13 121.28 36.9 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.010000000000005 110.7 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.8 98.98 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.736 2.291 . . . . 72.439999999999998 112.666 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.0 pt -71.22 148.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.591 0.96 . . . . 74.129999999999995 113.591 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -115.39 104.94 12.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.67 1.188 . . . . 72.140000000000001 108.416 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.543 HG23 HG11 ' A' ' 18' ' ' VAL . 15.1 t -102.16 131.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.671 0.388 . . . . 75.510000000000005 110.137 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.3 p -136.55 178.65 6.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.503 1.121 . . . . 71.340000000000003 109.779 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.9 145.13 31.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.681 0.392 . . . . 74.409999999999997 110.076 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.19 7.7 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.031 0.443 . . . . 74.340000000000003 109.983 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.573 1.84 0 C-N-CA 123.733 0.813 . . . . 75.319999999999993 110.835 -178.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 111.767 0.284 . . . . 62.520000000000003 111.767 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -101.25 130.18 47.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 73.530000000000001 109.917 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 43.4 pt -110.71 153.07 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.517 0.727 . . . . 74.420000000000002 110.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -111.08 128.46 55.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.147 0.579 . . . . 71.540000000000006 109.49 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 95' ' ' VAL . 10.7 t -121.11 141.34 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.775 0.83 . . . . 72.109999999999999 110.324 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -123.8 155.42 38.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.413 1.085 . . . . 74.030000000000001 110.169 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 23.19 63.23 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 114.713 0.645 . . . . 74.340000000000003 114.713 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD22 HG23 ' A' ' 93' ' ' ILE . 77.1 mt -64.52 -34.56 78.52 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.169 0.988 . . . . 73.150000000000006 111.885 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.25 21.9 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.154 -0.93 . . . . 53.310000000000002 111.119 -168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.92 -4.78 56.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 117.827 0.814 . . . . 75.239999999999995 112.636 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -94.01 17.56 12.14 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.233 0.613 . . . . 72.329999999999998 110.711 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.83 140.49 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 124.159 0.984 . . . . 73.120000000000005 112.272 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 30' ' ' VAL . 50.1 p -125.05 158.46 33.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.357 0.663 . . . . 73.239999999999995 110.214 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' HB ' ' A' ' 51' ' ' ILE . 70.2 mt -59.57 -35.09 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.834 0.454 . . . . 72.120000000000005 110.777 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.27 -46.78 88.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.605 0.762 . . . . 73.340000000000003 111.388 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -61.83 -43.28 99.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.581 0.752 . . . . 74.129999999999995 111.767 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 26' ' ' THR . 48.1 t -66.13 -45.68 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 121.047 0.451 . . . . 75.25 110.64 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -64.65 -33.98 77.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.677 -0.692 . . . . 71.030000000000001 111.996 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.23 -33.77 59.21 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.292 0.637 . . . . 71.530000000000001 111.644 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -74.56 -53.33 9.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 74.340000000000003 111.424 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 48.3 m-85 -78.68 -17.56 55.74 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 113.729 1.011 . . . . 73.340000000000003 113.729 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 64.9 pttt -58.29 -28.71 65.24 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.528 0.936 . . . . 74.420000000000002 113.528 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.35 -22.88 63.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.552 0.741 . . . . 75.209999999999994 112.357 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mm -81.38 -41.13 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.097 0.959 . . . . 74.450000000000003 111.094 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.28 -171.64 44.75 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.014 -0.539 . . . . 71.519999999999996 113.184 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.97 127.11 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.063 0.545 . . . . 74.120000000000005 110.257 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.2 mt -94.56 137.02 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.148 0.979 . . . . 64.420000000000002 108.954 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.4 mtpt -59.03 146.37 38.57 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.548 0.69 . . . . 74.319999999999993 111.707 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 50.5 m -129.29 125.27 36.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.728 -1.124 . . . . 74.519999999999996 109.583 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -57.22 107.51 0.43 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 109.082 -0.71 . . . . 74.519999999999996 109.082 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.64 -19.4 65.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.018 0.927 . . . . 74.230000000000004 112.827 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -78.59 -48.6 14.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.449 0.699 . . . . 74.329999999999998 111.65 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -85.13 -38.54 18.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.229 0.612 . . . . 75.140000000000001 111.821 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.77 2.67 61.19 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 115.927 -0.579 . . . . 50.119999999999997 112.636 -172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -99.1 144.2 27.79 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.053 0.941 . . . . 65.409999999999997 111.777 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 38.2 Cg_endo -66.11 139.64 56.53 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.852 2.368 . . . . 65.519999999999996 111.811 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.45 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.0 mtt -72.73 93.37 1.65 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.669 0.747 . . . . 73.25 109.586 -175.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.539 ' HB ' HG22 ' A' ' 27' ' ' ILE . 81.9 mt -147.0 120.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.948 1.299 . . . . 74.510000000000005 108.602 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.55 110.55 22.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 110.027 -0.36 . . . . 71.219999999999999 110.027 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.34 129.22 34.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.854 0.862 . . . . 72.540000000000006 109.835 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 92.6 m-85 -89.13 117.32 28.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.487 0.715 . . . . 72.010000000000005 110.244 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 m -99.14 150.62 21.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.17 0.988 . . . . 74.340000000000003 110.196 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.25 132.27 35.82 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.585 0.754 . . . . 72.219999999999999 109.842 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -70.17 -32.67 70.73 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.662 0.785 . . . . 72.230000000000004 112.249 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.8 -52.68 5.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.64 0.776 . . . . 74.010000000000005 111.557 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 p -82.11 -30.31 31.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.53 0.732 . . . . 75.120000000000005 112.323 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.76 89.43 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.501 -0.318 . . . . 71.140000000000001 113.498 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 61' ' ' LYS . 9.5 mtmp? -102.17 155.7 18.04 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.767 0.827 . . . . 73.099999999999994 109.808 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.42 136.57 57.97 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.914 0.486 . . . . 73.420000000000002 111.776 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -72.09 -15.28 62.0 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.278 0.631 . . . . 70.409999999999997 112.284 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.77 31.06 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.689 -0.564 . . . . 73.239999999999995 111.689 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 52.0 mt-10 -130.9 149.13 52.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.064 0.946 . . . . 75.329999999999998 109.566 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.71 154.25 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.748 0.647 . . . . 70.420000000000002 112.748 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 25.1 p -109.43 116.12 31.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.851 -0.613 . . . . 73.310000000000002 111.007 173.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.66 109.71 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.466 0.706 . . . . 75.5 110.113 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 69.2 m -83.52 102.84 12.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.693 0.397 . . . . 65.120000000000005 110.772 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 56.3 m-85 -78.89 153.78 30.26 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.903 0.481 . . . . 72.209999999999994 110.842 170.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.05 -34.38 61.84 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.828 -0.624 . . . . 65.549999999999997 111.143 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -111.91 130.2 23.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.054 0.542 . . . . 75.109999999999999 111.032 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -49.84 -38.11 46.82 Favored 'Trans proline' 0 CA--C 1.583 2.936 0 C-N-CA 123.334 2.69 . . . . 72.5 116.305 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.37 -28.68 78.62 Favored 'Trans proline' 0 C--N 1.403 3.434 0 CA-C-N 122.477 1.92 . . . . 64.420000000000002 113.934 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 m -73.42 -39.45 65.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 74.340000000000003 110.038 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.87 79.94 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.474 0.71 . . . . 72.109999999999999 111.052 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -59.96 -51.42 69.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.242 1.017 . . . . 70.420000000000002 111.149 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.75 90.7 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.005 -0.543 . . . . 64.239999999999995 112.156 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.24 72.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.45 0.7 . . . . 72.439999999999998 112.506 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.431 HG12 HG11 ' A' ' 95' ' ' VAL . 70.2 mt -63.29 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.03 0.532 . . . . 74.5 111.05 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.34 -30.05 69.28 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.347 -0.842 . . . . 75.129999999999995 111.985 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -79.06 -59.53 2.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.954 0.501 . . . . 73.040000000000006 111.675 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 93' ' ' ILE . 27.4 m-85 -80.78 -10.55 59.72 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.965 1.098 . . . . 75.129999999999995 113.965 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -65.76 111.19 3.11 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.548 0.613 . . . . 72.099999999999994 109.992 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.27 1.4 60.95 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.794 -0.639 . . . . 64.219999999999999 114.307 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.7 mmtt -96.37 149.29 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.261 0.624 . . . . 74.319999999999993 111.036 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -87.52 128.06 35.24 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.083 -0.386 . . . . 74.209999999999994 111.376 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.75 -73.63 0.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.399 0.68 . . . . 74.099999999999994 110.603 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 t -119.96 53.11 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.75 0.786 . . . . 65.109999999999999 109.814 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.73 90.11 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 115.37 -0.832 . . . . 74.120000000000005 113.322 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -122.57 126.73 26.06 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.048 0.939 . . . . 72.430000000000007 109.895 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 132.04 25.65 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.089 2.526 . . . . 62.109999999999999 112.52 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.3 pt -107.56 153.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.219 0.608 . . . . 73.219999999999999 111.857 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -121.8 126.82 49.69 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.003 0.921 . . . . 63.009999999999998 108.575 172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.562 HG13 HG23 ' A' ' 18' ' ' VAL . 16.2 t -114.55 143.89 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 122.943 0.497 . . . . 75.239999999999995 111.156 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 m -147.12 -177.08 5.48 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.807 1.643 . . . . 73.140000000000001 109.057 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 53.7 m-85 -87.38 147.82 25.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.699 0.681 . . . . 65.530000000000001 110.603 168.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.92 85.69 6.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.584 0.753 . . . . 73.209999999999994 109.752 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 123.658 0.783 . . . . 73.25 111.405 -175.015 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 111.641 0.237 . . . . 70.420000000000002 111.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -95.45 125.18 39.89 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.989 0.516 . . . . 74.450000000000003 109.944 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.4 pt -120.95 140.61 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.156 0.583 . . . . 75.430000000000007 112.23 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -95.32 127.62 41.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.132 0.491 . . . . 75.120000000000005 110.554 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 95' ' ' VAL . 14.9 t -120.57 137.26 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.458 1.103 . . . . 71.109999999999999 109.985 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.42 156.26 31.79 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.046 0.938 . . . . 74.319999999999993 110.778 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 2.28 82.98 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 114.468 0.547 . . . . 64.530000000000001 114.468 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 25' ' ' VAL . 96.0 mt -57.21 -20.87 29.65 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.834 1.05 . . . . 70.109999999999999 113.834 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.32 162.0 35.15 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.055 0.382 . . . . 75.019999999999996 114.055 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.21 -21.34 61.42 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.211 0.604 . . . . 75.439999999999998 111.787 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -92.45 2.58 56.58 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.004 0.922 . . . . 74.430000000000007 111.18 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 21' ' ' LEU . 11.1 p -66.54 147.53 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.53 0.732 . . . . 74.340000000000003 112.242 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.6 p -128.19 157.4 40.93 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.381 0.672 . . . . 74.549999999999997 110.367 172.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG23 ' HB ' ' A' ' 51' ' ' ILE . 71.5 mt -54.14 -41.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.156 0.982 . . . . 75.319999999999993 111.381 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.95 -29.27 62.96 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.367 0.667 . . . . 74.519999999999996 112.28 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 m -70.94 -43.56 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.567 0.347 . . . . 75.209999999999994 111.199 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.07 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 120.946 0.403 . . . . 70.25 110.022 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.08 96.36 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.498 0.719 . . . . 70.329999999999998 112.254 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -34.5 75.12 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.63 0.772 . . . . 72.409999999999997 111.071 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.13 -51.86 19.43 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.524 0.73 . . . . 74.109999999999999 110.882 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -80.9 -14.61 57.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.86 1.059 . . . . 75.120000000000005 113.86 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -54.89 -33.34 61.91 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.8 0.666 . . . . 74.439999999999998 112.8 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.97 -23.34 66.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.88 0.872 . . . . 74.5 112.67 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.31 -50.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.712 0.805 . . . . 75.230000000000004 111.277 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.35 -178.73 43.54 Favored Glycine 0 C--O 1.24 0.514 0 CA-C-N 115.35 -0.841 . . . . 61.200000000000003 113.012 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.3 mt -69.29 122.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 123.332 0.653 . . . . 75.439999999999998 110.317 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.1 mt -92.81 135.42 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.809 0.844 . . . . 71.120000000000005 108.835 171.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 29.3 mtpp -56.26 154.47 8.02 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.96 0.504 . . . . 64.340000000000003 111.591 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.0 m -138.64 122.35 17.53 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.169 0.588 . . . . 75.140000000000001 111.007 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -65.93 112.25 3.71 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.25 -1.019 . . . . 63.409999999999997 108.25 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -82.8 -12.23 57.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.942 0.497 . . . . 73.129999999999995 112.289 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -74.6 -47.77 30.47 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.605 0.762 . . . . 74.420000000000002 110.514 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -83.3 -39.37 20.9 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.63 0.772 . . . . 73.409999999999997 111.127 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.7 16.13 52.85 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.305 -0.861 . . . . 63.520000000000003 112.742 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -114.75 149.88 43.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.051 0.94 . . . . 75.239999999999995 111.299 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.49 151.32 85.54 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.584 2.189 . . . . 74.140000000000001 112.74 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.5 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.1 mtt -78.3 93.1 4.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.666 0.745 . . . . 74.310000000000002 109.147 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.539 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.0 mt -141.42 114.35 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.576 -1.268 . . . . 74.409999999999997 107.576 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.426 HD21 ' N ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -99.86 109.57 21.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.398 -0.593 . . . . 73.319999999999993 109.398 -170.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.11 125.16 29.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.538 0.735 . . . . 73.430000000000007 110.324 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 9.6 m-85 -78.12 126.31 30.62 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 72.549999999999997 110.429 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -116.91 143.45 45.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.847 0.859 . . . . 75.409999999999997 110.061 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -71.14 112.16 7.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.319 0.648 . . . . 74.230000000000004 109.971 168.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.926 0.49 . . . . 74.140000000000001 111.819 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 59' ' ' THR . 12.9 pt-20 -73.71 -43.82 58.14 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.871 0.868 . . . . 75.430000000000007 111.907 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -99.39 -50.08 4.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.466 0.706 . . . . 71.239999999999995 111.612 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.1 -1.37 28.4 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.521 -0.763 . . . . 73.400000000000006 112.652 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -98.12 160.06 14.54 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.635 0.774 . . . . 74.140000000000001 111.271 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.69 136.58 51.22 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.203 0.601 . . . . 71.319999999999993 111.901 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 7.8 mtpm? -66.85 -17.99 65.16 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.729 0.812 . . . . 74.409999999999997 112.398 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.38 33.86 21.59 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 121.318 0.399 . . . . 52.310000000000002 112.446 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.8 mt-10 -135.16 155.9 49.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.169 0.988 . . . . 72.109999999999999 109.948 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.03 152.56 13.27 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 112.14 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 21.7 p -104.59 123.95 48.45 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.576 -0.738 . . . . 72.230000000000004 110.186 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 t -104.6 109.16 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.709 0.804 . . . . 70.140000000000001 109.816 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.1 m -86.76 100.47 12.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.53 0.332 . . . . 64.409999999999997 110.816 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 56.2 m-85 -75.55 160.57 30.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.372 0.669 . . . . 73.219999999999999 111.134 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.0 -30.31 39.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.514 0.726 . . . . 72.319999999999993 111.188 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -114.49 132.76 22.68 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.381 0.672 . . . . 63.149999999999999 110.866 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.98 -36.14 95.47 Favored 'Trans proline' 0 CA--C 1.586 3.116 0 C-N-CA 122.547 2.165 . . . . 73.030000000000001 115.956 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.1 -28.0 65.35 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 122.701 2.0 . . . . 73.109999999999999 113.356 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -69.77 -39.85 76.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.573 0.701 . . . . 73.319999999999993 110.211 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.86 -49.27 76.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.865 -1.061 . . . . 75.329999999999998 111.413 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -60.24 -45.44 93.22 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.208 1.003 . . . . 74.219999999999999 111.17 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.42 97.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.838 -0.619 . . . . 71.510000000000005 111.797 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.88 72.25 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.203 0.601 . . . . 74.430000000000007 112.482 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.34 -63.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.047 0.539 . . . . 74.540000000000006 110.684 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.12 -31.19 66.92 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.747 0.819 . . . . 73.420000000000002 112.105 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -78.75 -59.76 2.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.656 0.783 . . . . 74.140000000000001 111.668 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.492 ' HB2' HG22 ' A' ' 95' ' ' VAL . 39.2 m-85 -87.45 -11.48 48.93 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.449 1.277 . . . . 73.420000000000002 114.449 -170.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.28 119.48 10.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.289 -0.634 . . . . 63.409999999999997 109.289 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.44 87.74 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.977 0.751 . . . . 64.340000000000003 114.977 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.9 150.14 21.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.714 0.806 . . . . 74.409999999999997 112.061 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.11 123.87 27.37 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.054 0.761 . . . . 72.030000000000001 113.054 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -125.13 133.04 52.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 75.219999999999999 108.373 167.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 t 62.58 11.43 4.75 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.531 1.132 . . . . 74.430000000000007 113.362 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.62 20.03 10.55 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 114.94 0.736 . . . . 73.25 114.94 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -154.04 146.33 17.3 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 118.22 1.01 . . . . 73.450000000000003 111.193 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.82 104.06 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.332 2.021 . . . . 74.219999999999999 112.733 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.31 165.21 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.356 0.662 . . . . 75.5 112.418 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -121.01 117.72 27.99 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.28 1.032 . . . . 70.150000000000006 109.79 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 18' ' ' VAL . 21.9 t -114.53 136.71 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.062 0.545 . . . . 71.439999999999998 110.546 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -153.6 175.68 12.94 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.538 1.135 . . . . 75.150000000000006 109.997 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.62 146.14 54.15 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 118.562 0.619 . . . . 74.349999999999994 111.828 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.72 97.22 5.09 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.514 -0.551 . . . . 63.229999999999997 109.514 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 CA--C 1.556 1.182 0 C-N-CA 124.112 0.965 . . . . 73.439999999999998 110.869 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.524 0.202 . . . . 73.340000000000003 111.512 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -99.47 125.93 45.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.007 0.523 . . . . 73.129999999999995 110.765 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 76' ' ' ALA . 42.0 pt -110.11 152.27 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.847 0.859 . . . . 72.230000000000004 110.983 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -107.31 130.51 54.76 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 123.431 0.693 . . . . 75.120000000000005 109.827 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG22 HG13 ' A' ' 95' ' ' VAL . 14.7 t -122.6 140.82 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.228 1.011 . . . . 72.120000000000005 110.259 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -118.66 164.35 15.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.925 1.29 . . . . 75.439999999999998 110.217 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.48 79.24 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 114.639 0.616 . . . . 72.209999999999994 114.639 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.1 -17.97 60.87 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.496 1.119 . . . . 73.230000000000004 112.705 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.95 173.03 48.7 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.151 0.42 . . . . 44.509999999999998 114.151 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.32 -19.67 61.62 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.594 0.757 . . . . 75.349999999999994 112.604 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.64 10.58 36.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.639 0.607 . . . . 74.310000000000002 112.639 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.32 128.92 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 122.997 0.519 . . . . 63.240000000000002 111.803 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 30' ' ' VAL . 7.6 p -122.72 150.77 42.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.857 -0.527 . . . . 73.219999999999999 109.657 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.6 mt -54.38 -42.38 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.145 0.978 . . . . 75.409999999999997 111.706 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -39.42 80.58 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.181 0.592 . . . . 74.510000000000005 112.333 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.3 m -64.26 -41.7 96.82 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.914 0.486 . . . . 73.329999999999998 111.396 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 26' ' ' THR . 63.5 t -65.49 -43.27 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.022 0.529 . . . . 64.439999999999998 110.723 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.0 96.46 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.831 -0.622 . . . . 73.209999999999994 112.186 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.93 -30.72 62.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.371 0.669 . . . . 64.200000000000003 111.46 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -74.17 -53.86 8.98 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.693 0.797 . . . . 74.209999999999994 112.007 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 62.1 m-85 -77.46 -14.51 59.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.983 1.105 . . . . 64.209999999999994 113.983 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.14 -30.84 62.72 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.767 1.025 . . . . 73.140000000000001 113.767 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.58 -25.02 65.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.691 0.797 . . . . 74.510000000000005 113.037 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.2 mm -83.9 -52.76 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.461 0.704 . . . . 73.430000000000007 110.59 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.51 167.79 35.81 Favored Glycine 0 C--O 1.241 0.568 0 CA-C-N 116.08 -0.509 . . . . 64.340000000000003 113.391 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.18 128.04 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 75.420000000000002 109.538 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 83.3 mt -97.12 136.61 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.501 0.721 . . . . 75.120000000000005 109.09 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.5 mtpt -57.15 142.27 43.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.254 0.622 . . . . 74.430000000000007 111.951 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 75.3 m -132.73 127.16 34.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.696 0.798 . . . . 75.430000000000007 110.489 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -70.81 118.33 13.45 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.699 0.8 . . . . 74.310000000000002 109.154 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -77.06 -23.01 52.01 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.517 0.727 . . . . 74.040000000000006 111.796 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.95 -51.57 53.59 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.336 0.654 . . . . 74.109999999999999 110.72 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -84.74 -37.11 21.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.153 0.581 . . . . 71.319999999999993 111.838 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.11 -2.86 59.9 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 116.025 -0.534 . . . . 72.109999999999999 113.076 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -99.74 147.77 33.86 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.262 1.025 . . . . 75.349999999999994 112.355 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 39.7 Cg_endo -67.6 149.27 79.42 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.655 2.236 . . . . 71.030000000000001 112.775 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 53.1 mtt -78.33 94.74 4.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 64.010000000000005 109.973 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.543 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.96 123.86 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.992 1.317 . . . . 70.510000000000005 108.027 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -106.4 108.66 20.28 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.577 -0.527 . . . . 75.239999999999995 109.577 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.8 mt -83.08 117.71 23.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.239 0.616 . . . . 74.439999999999998 109.677 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -70.29 105.36 2.96 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.089 0.556 . . . . 74.319999999999993 111.106 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -89.82 147.37 23.83 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.596 -0.729 . . . . 71.239999999999995 109.233 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.85 125.89 30.28 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.54 0.736 . . . . 73.109999999999999 109.907 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -70.15 -21.8 63.04 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.976 0.732 . . . . 72.200000000000003 112.976 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.71 -57.94 2.42 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.28 0.632 . . . . 75.120000000000005 111.128 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.2 p -82.67 -20.25 36.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.048 0.539 . . . . 74.319999999999993 112.279 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.75 -1.19 74.29 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 114.937 0.735 . . . . 70.120000000000005 114.937 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -101.81 160.73 14.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.26 0.624 . . . . 73.209999999999994 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.78 126.37 28.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.792 0.437 . . . . 75.409999999999997 111.133 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.89 -16.52 64.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.07 0.948 . . . . 75.230000000000004 112.242 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.33 25.23 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 111.991 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -133.24 150.54 51.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.09 0.956 . . . . 73.200000000000003 109.164 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.76 157.38 18.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.58 0.585 . . . . 75.120000000000005 112.58 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 p -117.24 117.2 28.89 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.093 0.557 . . . . 73.319999999999993 111.074 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.47 111.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.32 1.048 . . . . 75.409999999999997 110.353 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m -85.85 103.18 14.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.509 0.323 . . . . 53.299999999999997 111.004 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 33.5 m-85 -76.4 164.55 25.89 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.024 0.53 . . . . 74.019999999999996 110.499 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.73 -40.4 61.3 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.023 0.529 . . . . 75.120000000000005 109.934 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.89 129.39 24.22 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.49 0.716 . . . . 74.340000000000003 110.916 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.17 -37.65 87.62 Favored 'Trans proline' 0 CA--C 1.587 3.144 0 C-N-CA 122.669 2.246 . . . . 75.140000000000001 115.471 165.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.51 -27.62 61.96 Favored 'Trans proline' 0 C--N 1.406 3.59 0 CA-C-N 122.386 1.888 . . . . 72.209999999999994 113.426 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.9 m -72.84 -39.0 66.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.284 0.564 . . . . 73.450000000000003 110.363 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 16' ' ' ILE . . . -59.43 -52.14 66.89 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.227 -0.897 . . . . 60.420000000000002 110.898 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.26 -42.55 96.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.77 0.828 . . . . 75.109999999999999 111.841 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.17 96.7 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.698 0.399 . . . . 74.019999999999996 111.68 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.53 71.64 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.397 0.679 . . . . 64.209999999999994 112.257 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -62.26 -61.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 122.684 0.394 . . . . 74.209999999999994 110.282 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 -33.8 67.63 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.742 0.817 . . . . 75.420000000000002 112.299 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -77.91 -54.55 6.19 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.722 0.809 . . . . 75.140000000000001 112.151 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.62 -12.78 30.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.246 1.202 . . . . 75.209999999999994 114.246 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.41 126.87 29.19 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.739 0.7 . . . . 72.239999999999995 110.452 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.29 1.71 90.45 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.044 0.778 . . . . 75.319999999999993 115.044 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.0 -167.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.91 0.855 . . . . 74.439999999999998 111.775 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.17 125.86 44.33 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.138 0.575 . . . . 72.239999999999995 112.104 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.461 ' HB2' HG23 ' A' ' 93' ' ' ILE . 66.6 t80 -77.32 -69.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.244 0.618 . . . . 74.140000000000001 111.455 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 m -133.83 75.29 1.59 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.666 0.786 . . . . 70.540000000000006 109.486 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.4 0.04 44.14 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 115.379 -0.828 . . . . 61.049999999999997 114.638 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.2 135.06 26.95 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.081 0.953 . . . . 70.299999999999997 111.895 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.85 140.06 49.53 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.109 2.539 . . . . 75.420000000000002 113.357 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.461 HG23 ' HB2' ' A' ' 88' ' ' PHE . 37.7 pt -123.36 151.83 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.32 1.048 . . . . 75.019999999999996 112.068 -173.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -118.72 122.48 42.59 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.086 -1.079 . . . . 74.319999999999993 108.086 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 18' ' ' VAL . 18.9 t -112.29 141.17 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.506 . . . . 73.019999999999996 110.655 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.0 p -152.3 -179.78 7.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.289 1.436 . . . . 71.530000000000001 109.041 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -73.81 150.42 41.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.772 0.714 . . . . 71.329999999999998 110.944 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.68 88.87 7.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.026 0.53 . . . . 65.510000000000005 110.293 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.498 0 C-N-CA 123.953 0.901 . . . . 75.409999999999997 110.945 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 111.747 0.277 . . . . 74.439999999999998 111.747 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.8 m -138.16 125.83 22.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.788 -0.449 . . . . 74.299999999999997 109.788 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' A' ' 76' ' ' ALA . 29.0 pt -109.6 143.12 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 122.779 0.432 . . . . 72.209999999999994 112.101 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -96.8 110.66 23.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.468 -0.567 . . . . 75.120000000000005 109.468 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 95' ' ' VAL . 5.9 t -104.96 138.37 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.611 0.764 . . . . 75.010000000000005 110.103 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -120.71 166.48 13.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.282 1.033 . . . . 74.450000000000003 110.218 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.15 31.72 72.22 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 114.519 0.568 . . . . 73.200000000000003 114.519 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -81.91 -17.11 48.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.205 1.002 . . . . 74.329999999999998 112.355 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.99 168.61 40.69 Favored Glycine 0 N--CA 1.475 1.271 0 N-CA-C 114.133 0.413 . . . . 53.450000000000003 114.133 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -74.69 -13.38 60.61 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.426 0.69 . . . . 75.230000000000004 112.599 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.61 -3.55 58.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.621 0.768 . . . . 73.239999999999995 111.895 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.72 127.53 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 N-CA-C 113.161 0.801 . . . . 74.519999999999996 113.161 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 30' ' ' VAL . 43.6 p -122.93 154.22 38.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.385 0.674 . . . . 74.430000000000007 110.042 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.7 mt -57.25 -42.72 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.533 0.733 . . . . 74.409999999999997 111.736 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.35 -40.39 95.77 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.634 0.774 . . . . 74.299999999999997 111.463 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.2 t -65.82 -45.02 83.82 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.88 0.472 . . . . 74.239999999999995 111.282 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 26' ' ' THR . 60.2 t -62.83 -42.08 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.27 0.557 . . . . 75.310000000000002 110.278 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.519 -0.764 . . . . 74.519999999999996 112.172 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.79 -35.7 80.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.758 0.823 . . . . 71.099999999999994 111.271 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -71.92 -55.98 6.51 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.93 0.892 . . . . 74.219999999999999 111.031 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.0 m-85 -79.71 -16.59 55.38 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.147 1.166 . . . . 71.430000000000007 114.147 -172.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.71 -24.17 66.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.729 1.011 . . . . 75.129999999999995 113.729 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.96 -23.94 65.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.335 0.654 . . . . 75.430000000000007 112.686 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.7 mm -86.86 -45.99 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 63.409999999999997 111.812 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.63 174.67 45.72 Favored Glycine 0 C--O 1.24 0.505 0 CA-C-N 115.709 -0.678 . . . . 64.040000000000006 113.123 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.0 mt -67.54 123.62 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.499 0.72 . . . . 74.140000000000001 111.339 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 74.2 mt -94.08 130.8 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.446 1.098 . . . . 72.219999999999999 108.41 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.8 mtpp -54.64 146.57 16.35 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.498 0.719 . . . . 64.430000000000007 112.193 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 99.6 m -126.93 138.53 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.196 0.998 . . . . 73.310000000000002 109.352 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -78.27 128.68 34.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.651 0.781 . . . . 55.539999999999999 109.68 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -67.48 -40.13 85.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.789 0.836 . . . . 73.239999999999995 111.856 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.93 -49.6 75.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.718 0.807 . . . . 75.450000000000003 112.029 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -87.11 -47.04 9.23 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.158 0.583 . . . . 73.420000000000002 111.753 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.6 14.6 49.65 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 116.276 -0.42 . . . . 74.129999999999995 112.624 -171.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -117.56 151.92 48.92 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 124.338 1.055 . . . . 73.329999999999998 111.447 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.0 Cg_endo -67.22 146.65 76.71 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.743 2.295 . . . . 73.430000000000007 112.633 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.528 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.2 mtt -77.95 96.57 5.07 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.319 0.58 . . . . 74.120000000000005 110.014 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 27' ' ' ILE . 83.4 mt -143.07 118.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.61 1.164 . . . . 74.230000000000004 108.363 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.5 m-20 -98.7 108.27 20.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.285 -0.635 . . . . 73.109999999999999 109.285 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -80.04 130.15 35.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.524 -0.547 . . . . 72.209999999999994 109.524 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 84.1 m-85 -89.78 121.85 32.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.994 0.518 . . . . 63.450000000000003 110.438 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -115.56 145.95 42.18 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.381 1.072 . . . . 75.109999999999999 110.167 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.53 104.81 1.66 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.95 0.5 . . . . 73.420000000000002 110.063 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -64.15 -22.65 67.02 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.72 0.808 . . . . 74.329999999999998 111.648 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.99 -56.09 5.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.561 0.744 . . . . 73.129999999999995 111.633 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -86.66 -49.02 7.8 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.287 0.635 . . . . 74.519999999999996 111.486 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.49 -3.16 27.88 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.858 -0.61 . . . . 74.030000000000001 113.453 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.09 153.12 23.94 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.297 0.639 . . . . 74.340000000000003 111.044 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.01 135.61 52.58 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.006 0.522 . . . . 74.099999999999994 110.502 174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD3' ' HB3' ' A' ' 54' ' ' TYR . 50.2 mtpt -68.26 -26.16 65.54 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.069 0.548 . . . . 73.400000000000006 112.092 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.41 38.72 8.78 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.598 -0.601 . . . . 73.310000000000002 111.598 -168.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.1 mt-10 -134.8 158.02 45.27 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.735 0.814 . . . . 74.430000000000007 110.245 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.69 160.33 28.43 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 54.329999999999998 112.017 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 p -117.41 114.31 23.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.939 0.496 . . . . 73.409999999999997 110.296 167.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.29 104.56 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.966 0.906 . . . . 74.540000000000006 109.757 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.0 m -82.65 102.59 11.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.68 0.392 . . . . 71.120000000000005 111.708 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 57.9 m-85 -80.22 160.07 25.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.807 0.843 . . . . 74.420000000000002 109.736 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.53 -31.24 47.42 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.24 -0.436 . . . . 73.209999999999994 110.485 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -110.38 130.16 23.18 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.768 0.827 . . . . 72.510000000000005 110.719 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.08 -40.46 81.45 Favored 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.181 1.921 . . . . 74.120000000000005 115.164 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.58 -31.5 87.16 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 122.406 1.895 . . . . 62.340000000000003 113.973 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m -69.49 -43.12 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.167 0.587 . . . . 72.120000000000005 109.963 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB3' HG21 ' A' ' 16' ' ' ILE . . . -62.5 -49.34 75.76 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.983 -1.008 . . . . 75.209999999999994 111.107 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -60.21 -48.43 81.77 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.708 1.203 . . . . 73.530000000000001 111.19 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.09 -35.59 80.91 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.139 0.576 . . . . 73.340000000000003 112.192 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.42 -32.12 69.89 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.824 0.45 . . . . 63.100000000000001 111.913 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.496 HG12 HG13 ' A' ' 95' ' ' VAL . 59.8 mt -64.45 -59.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.787 0.435 . . . . 75.329999999999998 110.102 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -55.83 -32.43 63.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.791 0.837 . . . . 75.25 112.924 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -78.47 -59.91 2.59 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.351 0.66 . . . . 73.510000000000005 111.173 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 93' ' ' ILE . 69.6 m-85 -84.41 -15.29 46.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.639 1.348 . . . . 74.549999999999997 114.639 -169.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.55 115.69 4.92 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 118.574 0.625 . . . . 75.049999999999997 110.444 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.45 58.34 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.768 -0.462 . . . . 62.039999999999999 114.193 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.1 mmtt -93.46 147.17 23.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.818 0.847 . . . . 73.209999999999994 110.674 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.09 124.4 31.07 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 122.232 -0.292 . . . . 75.439999999999998 111.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -84.35 -81.24 0.18 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.139 -0.689 . . . . 75.129999999999995 109.139 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.0 m -106.18 70.41 0.84 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.325 -0.62 . . . . 72.120000000000005 109.325 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.93 -3.76 34.69 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.963 0.745 . . . . 73.319999999999993 114.963 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -121.31 130.15 24.94 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 123.579 0.752 . . . . 75.530000000000001 110.89 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.62 120.01 7.09 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.868 2.379 . . . . 71.140000000000001 111.76 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.4 pt -88.57 146.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.232 0.539 . . . . 73.409999999999997 112.352 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -109.6 110.44 21.51 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.069 -1.086 . . . . 74.540000000000006 108.069 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 HG23 ' A' ' 18' ' ' VAL . 7.0 t -101.66 132.07 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.426 -0.583 . . . . 70.120000000000005 109.426 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -138.29 172.64 12.61 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.176 0.99 . . . . 62.530000000000001 109.438 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -71.97 142.95 49.38 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.146 0.43 . . . . 75.5 110.03 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 66.51 8.67 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.999 0.904 . . . . 73.420000000000002 110.659 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.557 1.244 0 CA-C-N 114.842 -1.072 . . . . 63.340000000000003 110.862 179.463 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.725 0.298 . . . . 73.109999999999999 111.556 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.4 m -97.58 126.05 42.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.819 0.448 . . . . 74.430000000000007 110.155 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.417 HG21 ' HB1' ' A' ' 76' ' ' ALA . 34.7 pt -103.42 151.24 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.15 0.58 . . . . 74.230000000000004 111.202 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -110.06 119.78 40.36 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 74.439999999999998 109.508 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG22 HG13 ' A' ' 95' ' ' VAL . 13.7 t -114.23 136.91 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.889 0.875 . . . . 75.439999999999998 110.44 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -117.48 162.18 18.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.265 1.026 . . . . 75.109999999999999 110.199 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.32 26.52 74.51 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 114.35 0.5 . . . . 73.120000000000005 114.35 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 HG21 ' A' ' 93' ' ' ILE . 55.1 mt -71.7 -24.46 61.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.496 1.119 . . . . 73.129999999999995 111.981 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.36 161.42 36.57 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.447 -0.342 . . . . 44.149999999999999 112.811 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.69 -7.78 55.99 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.372 0.586 . . . . 70.340000000000003 111.595 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.19 11.94 17.29 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.001 0.921 . . . . 62.100000000000001 111.571 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.83 133.95 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 123.928 0.891 . . . . 63.530000000000001 112.476 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 p -133.73 155.2 50.18 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.671 0.788 . . . . 71.25 110.23 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.25 -39.54 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.217 0.607 . . . . 75.200000000000003 111.253 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.93 -49.91 74.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.834 0.854 . . . . 75.109999999999999 111.744 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 m -65.34 -43.44 90.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.088 0.555 . . . . 75.349999999999994 112.126 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.24 -40.84 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 122.901 0.48 . . . . 65.400000000000006 110.812 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.65 84.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.053 -0.521 . . . . 70.5 111.371 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.96 -27.94 67.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 70.409999999999997 111.92 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -77.18 -54.87 5.96 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.844 0.857 . . . . 74.409999999999997 111.978 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.402 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 61.9 m-85 -77.85 -18.95 55.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.199 1.185 . . . . 72.430000000000007 114.199 -174.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -57.24 -27.91 62.47 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 113.728 1.01 . . . . 74.25 113.728 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -58.2 -26.2 62.52 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.593 0.757 . . . . 74.349999999999994 112.758 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.24 -51.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 74.299999999999997 111.076 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.32 -177.01 46.72 Favored Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.861 -0.609 . . . . 70.530000000000001 113.259 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.04 118.31 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.253 0.621 . . . . 71.430000000000007 111.151 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.9 mt -87.95 123.08 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.177 -1.046 . . . . 63.0 108.177 169.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 54.3 mtpt -46.27 118.14 1.82 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.426 0.69 . . . . 72.120000000000005 112.423 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 80.7 m -103.96 115.56 30.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.335 0.654 . . . . 64.239999999999995 110.273 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -56.63 122.13 11.34 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.364 1.066 . . . . 74.099999999999994 110.592 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.7 mmmp? -80.75 -14.79 57.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.449 1.1 . . . . 74.319999999999993 112.583 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 10.0 mmpt? -84.83 -43.01 14.56 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 111.249 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.8 p -85.98 -40.4 15.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.612 0.765 . . . . 75.219999999999999 111.553 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.76 64.92 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.086 -0.506 . . . . 70.510000000000005 112.025 -170.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -114.66 156.69 44.46 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 125.22 1.408 . . . . 62.130000000000003 110.824 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 65.2 Cg_endo -72.56 153.53 54.8 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.403 2.069 . . . . 72.209999999999994 112.852 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.513 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.5 mtt -83.7 95.73 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.99 0.916 . . . . 75.420000000000002 109.35 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -137.61 122.87 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 75.239999999999995 108.535 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -106.07 108.67 20.31 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.375 -0.602 . . . . 71.329999999999998 109.375 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.0 mt -89.37 129.52 35.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.728 0.811 . . . . 72.430000000000007 109.076 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.19 124.44 34.36 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.574 0.35 . . . . 73.450000000000003 111.097 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.6 m -108.83 137.81 46.16 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.663 0.785 . . . . 73.329999999999998 110.201 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.54 136.05 47.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.777 0.831 . . . . 62.100000000000001 110.831 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -76.42 -24.3 53.98 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.13 0.789 . . . . 74.400000000000006 113.13 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -92.41 -55.4 3.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.842 0.457 . . . . 65.0 111.348 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -73.95 -30.63 62.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.771 0.828 . . . . 74.109999999999999 111.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.88 6.34 88.64 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.997 -0.547 . . . . 75.430000000000007 113.441 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -100.83 158.54 15.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.282 0.633 . . . . 74.25 111.511 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.62 130.91 44.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.168 0.587 . . . . 75.239999999999995 111.582 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.43 -16.78 64.37 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.345 1.058 . . . . 74.439999999999998 112.697 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 29.07 56.22 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.267 -0.333 . . . . 64.239999999999995 112.267 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.67 146.23 52.07 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.416 1.086 . . . . 71.239999999999995 108.536 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.36 169.58 21.74 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.483 0.549 . . . . 62.520000000000003 112.483 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 p -123.56 130.82 53.24 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.982 -0.554 . . . . 54.109999999999999 111.089 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -110.1 109.52 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.669 0.788 . . . . 73.420000000000002 109.746 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -79.53 104.11 9.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.338 0.255 . . . . 64.030000000000001 111.143 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 48.9 m-85 -82.69 163.07 21.58 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 120.842 0.353 . . . . 74.430000000000007 110.187 169.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.31 -40.19 52.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.319 0.647 . . . . 74.430000000000007 110.836 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 11.7 m-20 -112.61 133.81 21.78 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.156 0.582 . . . . 75.310000000000002 111.706 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.17 -41.09 59.3 Favored 'Trans proline' 0 CA--C 1.584 3.015 0 C-N-CA 122.842 2.362 . . . . 73.129999999999995 116.028 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 69.8 Cg_endo -71.08 -20.92 28.12 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 122.526 1.938 . . . . 74.209999999999994 113.204 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 t -75.77 -39.5 56.92 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.574 0.702 . . . . 75.150000000000006 109.451 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 16' ' ' ILE . . . -61.15 -45.17 95.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.056 -0.975 . . . . 70.340000000000003 110.623 173.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.1 -46.4 89.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.494 1.118 . . . . 73.340000000000003 110.882 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.79 97.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.172 0.589 . . . . 71.349999999999994 112.008 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.48 77.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 75.040000000000006 112.143 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 HG11 ' A' ' 95' ' ' VAL . 83.7 mt -64.71 -57.91 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.216 0.607 . . . . 75.430000000000007 110.823 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.94 -32.92 68.28 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.11 0.964 . . . . 72.510000000000005 111.884 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.78 -54.45 5.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.236 0.615 . . . . 73.109999999999999 112.446 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.491 ' HB2' HG21 ' A' ' 95' ' ' VAL . 58.8 m-85 -89.34 -6.52 56.61 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.872 1.064 . . . . 75.109999999999999 113.872 -171.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.6 124.45 22.39 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.266 0.485 . . . . 75.230000000000004 110.085 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.53 -0.84 89.22 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.041 -0.527 . . . . 73.409999999999997 114.017 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -97.57 170.5 8.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.537 0.735 . . . . 71.200000000000003 110.914 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.08 137.9 50.73 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.114 0.565 . . . . 70.109999999999999 111.78 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -129.29 131.62 47.0 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.813 1.245 . . . . 75.25 108.526 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t 63.33 25.85 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.362 1.065 . . . . 71.219999999999999 111.537 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.01 88.1 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-N 116.049 -0.523 . . . . 43.119999999999997 113.706 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -115.02 117.24 41.88 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.341 1.056 . . . . 70.540000000000006 110.495 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.92 100.74 0.17 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.627 2.218 . . . . 62.43 113.066 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.441 HG21 HD23 ' A' ' 21' ' ' LEU . 40.3 pt -82.64 153.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.92 0.888 . . . . 74.140000000000001 113.368 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -114.91 110.25 19.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.076 1.351 . . . . 75.530000000000001 109.169 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 18' ' ' VAL . 23.8 t -103.87 131.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 122.151 -0.343 . . . . 71.540000000000006 110.096 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.1 p -142.79 179.29 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.608 1.163 . . . . 55.119999999999997 109.748 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -77.06 150.07 35.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.487 0.585 . . . . 72.099999999999994 110.772 169.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.82 87.94 7.48 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.094 0.473 . . . . 72.319999999999993 110.936 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.471 1.108 . . . . 74.019999999999996 110.822 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 28.0 p-10 . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.972 0.415 . . . . 75.329999999999998 111.26 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -100.96 128.95 46.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 70.109999999999999 110.218 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.1 pt -110.85 151.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.423 0.689 . . . . 75.010000000000005 110.892 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -108.0 116.19 31.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.158 0.583 . . . . 72.340000000000003 109.724 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG12 HG23 ' A' ' 95' ' ' VAL . 11.3 t -107.76 142.1 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.251 1.02 . . . . 73.239999999999995 110.16 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -122.07 158.88 28.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.851 1.26 . . . . 74.319999999999993 110.171 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.55 38.98 95.29 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 114.509 0.563 . . . . 74.219999999999999 114.509 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.86 -31.86 27.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.648 1.179 . . . . 74.209999999999994 111.691 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.0 159.6 11.98 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 122.748 0.213 . . . . 63.509999999999998 113.489 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.71 -14.73 57.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.219 0.608 . . . . 75.409999999999997 111.302 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -88.92 3.89 49.87 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.728 0.811 . . . . 74.140000000000001 110.995 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.05 136.25 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.631 0.772 . . . . 72.349999999999994 111.585 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -129.05 151.92 49.21 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.945 -0.472 . . . . 62.0 110.194 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.555 HG22 ' HB ' ' A' ' 51' ' ' ILE . 75.9 mt -52.8 -45.01 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.239 1.015 . . . . 74.349999999999994 112.032 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.82 -31.73 68.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.427 0.691 . . . . 71.430000000000007 112.528 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -75.37 -36.77 60.87 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.57 0.348 . . . . 64.239999999999995 111.684 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.88 -39.85 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.427 0.632 . . . . 72.109999999999999 109.599 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.92 99.52 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.913 -1.039 . . . . 75.439999999999998 111.65 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.84 -34.86 69.62 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.309 0.644 . . . . 73.340000000000003 111.679 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.27 -54.15 9.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.775 0.83 . . . . 75.230000000000004 111.508 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 38.6 m-85 -77.29 -18.28 57.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.635 1.346 . . . . 74.150000000000006 114.635 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.79 -21.47 64.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.511 1.3 . . . . 73.299999999999997 114.511 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -57.64 -26.09 61.11 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.413 0.685 . . . . 72.129999999999995 112.388 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 mm -85.65 -45.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 75.430000000000007 111.214 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.83 44.3 Favored Glycine 0 C--O 1.241 0.576 0 CA-C-N 116.077 -0.51 . . . . 61.210000000000001 113.302 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 122.84 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.555 0.742 . . . . 75.230000000000004 110.185 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.8 mt -92.51 124.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.071 -1.085 . . . . 71.109999999999999 108.071 173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -50.62 154.81 1.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.068 0.947 . . . . 75.0 112.902 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 87.2 m -137.5 127.25 25.42 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.559 -0.746 . . . . 75.129999999999995 110.824 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.34 113.94 4.42 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.686 -0.688 . . . . 65.519999999999996 109.417 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -78.01 -13.29 59.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 112.172 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -80.67 -29.38 36.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.039 0.535 . . . . 75.409999999999997 112.289 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -103.21 -50.83 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.131 0.573 . . . . 64.299999999999997 110.893 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.58 10.64 28.6 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.563 -0.744 . . . . 73.519999999999996 112.364 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.63 145.31 30.38 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 75.109999999999999 111.637 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.27 145.74 93.31 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.842 2.361 . . . . 73.310000000000002 112.47 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 52.3 mtt -73.65 94.0 2.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.799 0.809 . . . . 73.219999999999999 109.739 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.555 ' HB ' HG22 ' A' ' 27' ' ' ILE . 84.7 mt -145.78 120.93 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.507 -1.224 . . . . 71.219999999999999 108.369 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -101.29 110.33 22.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.496 -0.557 . . . . 71.519999999999996 109.496 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -78.71 136.09 37.33 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.098 -0.704 . . . . 75.549999999999997 109.098 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.2 111.03 22.72 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.253 0.621 . . . . 75.030000000000001 110.144 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -86.65 151.65 23.25 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.037 0.535 . . . . 74.340000000000003 110.087 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.98 142.19 28.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.914 0.886 . . . . 72.549999999999997 110.896 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -37.62 59.71 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.485 -0.779 . . . . 74.209999999999994 112.672 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -94.24 -43.85 8.25 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.705 0.402 . . . . 72.200000000000003 111.713 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -81.92 -33.71 30.25 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 118.008 0.367 . . . . 75.310000000000002 111.864 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.59 13.17 83.21 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 116.239 -0.437 . . . . 74.400000000000006 114.167 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -104.1 173.57 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.598 0.759 . . . . 75.129999999999995 110.286 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.28 123.31 22.71 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.792 0.33 . . . . 74.420000000000002 110.226 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.564 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 7.8 mtpm? -63.63 -21.68 66.5 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.125 0.97 . . . . 74.219999999999999 113.18 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 23.26 35.66 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 123.178 0.299 . . . . 71.239999999999995 112.412 -171.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -121.34 151.05 40.55 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.043 -0.681 . . . . 74.439999999999998 109.692 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.78 154.85 24.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 64.319999999999993 111.713 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.9 p -109.86 120.59 42.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.62 0.368 . . . . 65.209999999999994 110.08 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.67 111.65 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.696 0.798 . . . . 71.219999999999999 110.449 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 70.7 m -85.55 105.12 15.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.682 0.393 . . . . 75.200000000000003 111.166 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.431 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 52.1 m-85 -81.25 153.45 27.13 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.261 0.624 . . . . 74.230000000000004 110.074 168.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.29 -28.79 62.29 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.138 0.575 . . . . 74.439999999999998 111.233 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.61 127.97 26.35 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 111.194 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 9.9 Cg_endo -54.92 -34.31 85.63 Favored 'Trans proline' 0 CA--C 1.583 2.973 0 C-N-CA 123.008 2.472 . . . . 75.109999999999999 116.277 170.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.48 -28.06 62.14 Favored 'Trans proline' 0 C--N 1.4 3.284 0 CA-C-N 122.62 1.972 . . . . 64.140000000000001 113.39 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 m -75.1 -35.04 61.78 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.114 0.566 . . . . 62.149999999999999 110.004 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.33 -53.64 54.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.679 -0.691 . . . . 74.329999999999998 111.121 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -59.37 -44.43 92.74 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.936 0.895 . . . . 73.109999999999999 110.77 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.88 90.89 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.002 -0.545 . . . . 74.400000000000006 111.775 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.42 72.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.245 0.618 . . . . 74.319999999999993 112.327 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 95' ' ' VAL . 83.0 mt -66.0 -58.37 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.992 0.517 . . . . 73.209999999999994 110.398 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.1 -26.21 68.44 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 115.327 -0.851 . . . . 71.530000000000001 111.919 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -81.0 -60.42 2.3 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.931 0.492 . . . . 75.239999999999995 111.754 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.52 -6.72 58.61 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.87 1.063 . . . . 72.439999999999998 113.87 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.39 106.27 0.73 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 118.118 0.417 . . . . 74.230000000000004 110.374 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.05 55.33 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.055 0.782 . . . . 72.510000000000005 115.055 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.41 -174.35 4.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.03 0.915 . . . . 71.209999999999994 110.616 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.6 127.42 37.04 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 122.922 0.489 . . . . 74.120000000000005 111.3 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -92.46 -87.91 0.21 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.861 0.464 . . . . 64.409999999999997 110.146 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.1 m -89.64 50.58 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.389 0.614 . . . . 72.010000000000005 109.907 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.17 4.9 69.64 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.883 -0.599 . . . . 63.530000000000001 113.915 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.68 134.09 21.01 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.725 0.81 . . . . 70.540000000000006 110.679 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.91 107.07 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.658 2.905 . . . . 62.030000000000001 112.672 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.73 143.53 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 N-CA-C 113.164 0.802 . . . . 74.209999999999994 113.164 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -118.65 114.86 23.4 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.951 1.301 . . . . 74.310000000000002 108.681 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 18' ' ' VAL . 15.0 t -107.92 141.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.639 0.376 . . . . 64.109999999999999 110.584 -174.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 t -148.68 -178.21 6.22 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.329 1.051 . . . . 72.530000000000001 110.0 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -76.25 140.62 41.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.849 0.46 . . . . 74.150000000000006 110.252 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.24 5.25 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.173 0.511 . . . . 63.210000000000001 109.737 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 124.497 1.119 . . . . 71.209999999999994 110.857 -171.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.081 0.467 . . . . 63.219999999999999 109.924 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -98.64 129.87 45.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.584 0.753 . . . . 72.420000000000002 110.463 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.0 pt -110.33 151.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.6 0.76 . . . . 74.299999999999997 111.123 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -106.37 119.32 38.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.253 0.621 . . . . 73.310000000000002 109.67 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 95' ' ' VAL . 11.2 t -112.61 140.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.249 1.02 . . . . 72.239999999999995 110.606 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.38 157.06 30.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.362 1.065 . . . . 72.040000000000006 110.486 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.64 34.88 42.63 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 115.135 0.814 . . . . 65.450000000000003 115.135 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.53 -21.69 28.47 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.269 1.028 . . . . 74.530000000000001 112.129 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.25 158.86 30.09 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 116.816 -0.174 . . . . 44.439999999999998 112.885 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.158 0.583 . . . . 74.310000000000002 112.297 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.96 11.8 23.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.95 0.5 . . . . 64.219999999999999 111.491 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.98 138.58 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 123.788 0.835 . . . . 73.540000000000006 112.414 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 30' ' ' VAL . 39.0 p -124.91 153.86 42.01 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.213 0.605 . . . . 74.140000000000001 110.461 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.523 HG22 ' HB ' ' A' ' 51' ' ' ILE . 79.8 mt -55.67 -42.84 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.741 0.817 . . . . 63.229999999999997 111.598 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -33.1 72.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.379 0.672 . . . . 74.420000000000002 112.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.3 t -69.9 -42.22 73.68 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.387 0.275 . . . . 62.149999999999999 111.025 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 26' ' ' THR . 59.8 t -63.89 -42.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.326 0.584 . . . . 72.530000000000001 110.072 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.32 82.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.13 -0.941 . . . . 73.329999999999998 111.895 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.88 -38.71 92.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 74.310000000000002 111.299 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -67.89 -56.36 9.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.356 1.063 . . . . 72.239999999999995 111.515 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 85.2 m-85 -78.87 -20.46 49.46 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.212 1.19 . . . . 74.120000000000005 114.212 -174.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.77 -23.24 67.28 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.824 1.046 . . . . 75.540000000000006 113.824 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -60.49 -24.91 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.181 0.592 . . . . 72.209999999999994 112.291 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 mm -82.85 -43.65 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.102 0.961 . . . . 73.549999999999997 111.018 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.79 169.17 42.29 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.793 -0.639 . . . . 73.239999999999995 112.612 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.39 131.52 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.045 0.538 . . . . 75.140000000000001 110.9 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.4 mt -97.69 131.09 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.814 0.846 . . . . 72.439999999999998 108.804 173.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 60.1 mtpt -53.65 151.2 6.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.288 0.635 . . . . 65.349999999999994 112.194 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.0 m -142.48 127.6 18.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.728 0.811 . . . . 71.209999999999994 110.262 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.78 127.8 34.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.711 0.804 . . . . 74.329999999999998 110.384 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -31.54 56.64 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.432 0.693 . . . . 74.010000000000005 112.287 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -51.45 43.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.966 0.506 . . . . 72.340000000000003 111.806 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -82.28 -51.37 7.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.569 0.748 . . . . 74.230000000000004 110.899 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.14 10.6 29.58 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.872 -0.603 . . . . 64.409999999999997 113.822 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -109.2 147.74 36.58 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 117.724 0.762 . . . . 54.119999999999997 112.721 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.7 Cg_endo -68.64 142.72 54.07 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.947 2.431 . . . . 75.099999999999994 112.371 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.517 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.1 mtt -74.08 95.25 2.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.595 0.712 . . . . 75.310000000000002 110.257 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.523 ' HB ' HG22 ' A' ' 27' ' ' ILE . 81.9 mt -143.91 120.09 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.687 1.195 . . . . 74.239999999999995 108.902 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.74 111.28 23.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.146 0.578 . . . . 74.219999999999999 110.005 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.0 mt -86.5 114.37 23.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.643 0.777 . . . . 65.109999999999999 110.072 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.9 126.72 31.55 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.528 0.731 . . . . 72.140000000000001 111.433 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -99.72 145.3 27.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.604 0.762 . . . . 70.219999999999999 110.561 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.67 138.91 36.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.417 0.687 . . . . 74.439999999999998 112.334 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 11.4 ptp180 -64.94 -35.86 82.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.25 1.02 . . . . 75.439999999999998 112.64 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 19.5 mm-40 -87.86 -57.02 3.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.263 0.625 . . . . 63.140000000000001 111.462 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 p -73.11 -28.54 62.33 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.248 0.833 . . . . 74.030000000000001 113.248 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.0 73.32 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 123.358 0.411 . . . . 62.329999999999998 113.084 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -122.27 159.42 27.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.921 1.288 . . . . 72.420000000000002 109.167 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.52 133.07 55.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.645 0.378 . . . . 70.010000000000005 111.736 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -67.12 -14.19 62.66 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.853 0.861 . . . . 74.420000000000002 113.048 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.67 35.14 32.98 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.103 -0.799 . . . . 73.219999999999999 111.103 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -139.36 138.46 36.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.089 0.956 . . . . 75.540000000000006 109.016 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.58 159.11 40.68 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.02 0.438 . . . . 74.209999999999994 112.143 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 24.3 p -111.46 123.69 50.74 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.267 -0.424 . . . . 74.299999999999997 110.698 172.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.0 110.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.68 0.792 . . . . 74.040000000000006 110.371 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 m -88.6 102.27 14.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.852 0.461 . . . . 64.299999999999997 111.276 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 70.5 m-85 -79.3 158.25 27.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.217 0.607 . . . . 75.049999999999997 111.363 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.56 -32.08 70.66 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.853 0.861 . . . . 71.140000000000001 111.048 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.99 136.77 26.55 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.667 0.787 . . . . 72.150000000000006 112.006 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.0 -36.33 95.83 Favored 'Trans proline' 0 CA--C 1.58 2.795 0 C-N-CA 122.768 2.312 . . . . 75.329999999999998 116.208 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.09 -26.72 65.43 Favored 'Trans proline' 0 C--N 1.393 2.912 0 CA-C-N 122.816 2.041 . . . . 73.120000000000005 113.403 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -71.53 -40.45 70.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 62.229999999999997 109.712 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -61.49 -53.62 53.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.125 -0.943 . . . . 72.040000000000006 111.296 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.46 -46.51 88.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.752 1.221 . . . . 74.329999999999998 111.166 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.74 99.27 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.804 -0.634 . . . . 71.519999999999996 111.691 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.57 74.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.923 0.489 . . . . 73.030000000000001 112.183 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.475 HG12 HG11 ' A' ' 95' ' ' VAL . 86.8 mt -62.12 -62.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.892 0.477 . . . . 71.329999999999998 110.449 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.59 -31.59 70.73 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.877 0.871 . . . . 74.209999999999994 112.578 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -77.54 -53.23 7.85 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 111.964 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.561 ' HB3' HD13 ' A' ' 93' ' ' ILE . 64.7 m-85 -88.41 -7.66 56.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.838 1.051 . . . . 72.239999999999995 113.838 -172.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.21 115.35 4.07 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.126 0.421 . . . . 64.540000000000006 110.519 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.68 10.7 72.47 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.592 0.597 . . . . 73.049999999999997 114.592 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -101.52 153.43 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.701 0.75 . . . . 75.319999999999993 111.698 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.35 127.04 34.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.088 0.555 . . . . 75.319999999999993 112.163 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -92.47 -52.75 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.189 0.595 . . . . 73.030000000000001 110.852 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -126.01 40.65 3.69 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.963 0.905 . . . . 73.420000000000002 110.015 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.6 15.85 80.89 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 115.815 -0.63 . . . . 60.32 112.8 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -136.7 129.28 17.34 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.304 1.042 . . . . 75.010000000000005 110.758 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.33 135.26 36.16 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.185 2.59 . . . . 74.010000000000005 113.243 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 83' ' ' PHE . 27.1 pt -104.7 150.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 74.209999999999994 112.215 -173.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -114.76 109.9 18.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.764 0.826 . . . . 74.109999999999999 108.807 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 18' ' ' VAL . 7.8 t -108.64 137.59 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 122.813 0.445 . . . . 74.439999999999998 110.432 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.9 m -146.07 179.55 7.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.325 1.05 . . . . 73.200000000000003 109.458 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -74.62 143.05 44.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.725 -0.472 . . . . 73.010000000000005 109.725 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.33 91.89 1.37 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.37 0.605 . . . . 74.019999999999996 111.175 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 124.165 0.986 . . . . 74.430000000000007 111.102 178.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 111.808 0.299 . . . . 74.430000000000007 111.808 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.3 m -97.88 125.6 42.85 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.295 0.638 . . . . 73.209999999999994 109.819 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.69 140.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.066 0.547 . . . . 74.319999999999993 111.175 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -94.79 125.36 39.4 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.939 -0.393 . . . . 72.299999999999997 109.939 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG11 HG22 ' A' ' 95' ' ' VAL . 23.0 t -118.05 139.64 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.099 0.959 . . . . 73.530000000000001 109.82 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -127.58 162.06 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.97 0.908 . . . . 74.140000000000001 110.973 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.75 66.93 Favored Glycine 0 N--CA 1.479 1.502 0 O-C-N 123.46 0.475 . . . . 62.009999999999998 114.192 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.492 HD23 HG21 ' A' ' 93' ' ' ILE . 34.3 mt -75.46 -26.5 58.29 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.098 0.959 . . . . 72.450000000000003 111.789 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.16 152.15 21.11 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.964 -0.454 . . . . 63.130000000000003 111.964 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.99 -3.45 35.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.355 0.872 . . . . 74.129999999999995 113.355 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -101.43 18.85 19.07 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.393 0.677 . . . . 73.150000000000006 110.522 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 HD11 ' A' ' 21' ' ' LEU . 11.2 p -71.51 135.59 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 123.264 0.626 . . . . 73.109999999999999 112.135 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -127.28 150.73 49.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.573 -0.705 . . . . 74.140000000000001 110.901 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' HB ' ' A' ' 51' ' ' ILE . 85.1 mt -52.93 -45.83 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.456 1.102 . . . . 75.200000000000003 111.978 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.62 -31.14 67.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.655 0.782 . . . . 73.329999999999998 111.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.5 m -71.54 -40.11 70.27 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.759 0.424 . . . . 73.209999999999994 111.606 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 26' ' ' THR . 52.3 t -66.45 -36.94 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.896 0.478 . . . . 73.120000000000005 110.151 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.27 75.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.605 -0.725 . . . . 72.329999999999998 111.344 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.44 -30.97 71.82 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.601 0.76 . . . . 72.109999999999999 111.68 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -74.18 -56.46 4.87 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.528 0.731 . . . . 74.340000000000003 111.195 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 23.0 m-85 -77.17 -18.55 57.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.404 1.261 . . . . 74.439999999999998 114.404 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -63.42 -20.57 65.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 113.89 1.07 . . . . 71.450000000000003 113.89 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.21 -25.32 65.51 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.23 0.612 . . . . 74.25 112.138 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.4 mm -88.36 -48.45 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.241 1.016 . . . . 74.310000000000002 111.367 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.0 169.7 39.0 Favored Glycine 0 C--O 1.238 0.353 0 C-N-CA 121.435 -0.412 . . . . 73.540000000000006 113.414 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.32 117.21 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.492 0.717 . . . . 74.310000000000002 110.329 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.7 mt -86.22 127.86 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.828 -0.804 . . . . 72.450000000000003 108.828 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -53.26 154.54 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.059 0.944 . . . . 72.150000000000006 112.833 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.3 m -132.01 127.0 35.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.953 0.901 . . . . 73.129999999999995 110.334 -175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -64.0 119.99 11.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.727 0.811 . . . . 65.319999999999993 109.986 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.72 -21.23 64.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.338 1.055 . . . . 74.25 112.529 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -86.53 -43.36 12.79 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.447 0.699 . . . . 75.120000000000005 112.037 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 p -89.46 -36.27 15.52 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.924 0.713 . . . . 44.340000000000003 112.924 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.43 77.09 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 112.712 -0.155 . . . . 51.439999999999998 112.712 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -99.46 151.18 37.34 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.631 1.172 . . . . 74.420000000000002 110.919 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.4 145.22 76.62 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.571 2.181 . . . . 74.109999999999999 111.436 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.432 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 59.3 mtt -74.47 92.26 2.34 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.234 -0.654 . . . . 73.510000000000005 109.234 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.605 ' HB ' HG22 ' A' ' 27' ' ' ILE . 79.9 mt -145.72 117.66 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.781 1.232 . . . . 73.439999999999998 108.172 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 30.4 m-80 -104.5 111.58 24.3 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 109.94 -0.393 . . . . 75.230000000000004 109.94 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -80.37 128.65 33.81 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.413 0.685 . . . . 74.439999999999998 110.053 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.571 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 70.4 m-85 -86.1 136.09 33.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.183 0.593 . . . . 74.329999999999998 110.708 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -128.82 138.73 52.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.516 1.126 . . . . 73.030000000000001 109.614 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.09 110.55 3.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.695 -0.854 . . . . 65.400000000000006 108.695 170.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -67.64 -22.52 65.32 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.986 0.515 . . . . 74.409999999999997 111.695 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.522 ' HG3' HG22 ' A' ' 59' ' ' THR . 8.9 pt-20 -75.85 -48.43 21.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.614 0.766 . . . . 73.150000000000006 112.17 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.522 HG22 ' HG3' ' A' ' 58' ' ' GLU . 60.5 p -91.61 -33.42 15.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.226 0.61 . . . . 74.510000000000005 112.075 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.26 3.1 76.09 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.728 -0.669 . . . . 64.230000000000004 113.54 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -93.01 161.28 14.51 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.436 0.618 . . . . 64.099999999999994 111.17 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.64 141.51 39.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.139 0.576 . . . . 55.530000000000001 111.217 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -78.45 -14.31 59.43 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.230000000000004 112.134 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.86 37.96 28.36 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.177 -0.369 . . . . 72.230000000000004 112.177 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 48.5 mt-10 -130.7 151.37 51.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.896 0.878 . . . . 70.310000000000002 109.627 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 141.76 14.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.915 0.486 . . . . 72.340000000000003 112.02 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.3 p -101.62 112.92 25.64 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.438 0.295 . . . . 73.340000000000003 110.836 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -103.5 110.52 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.014 0.926 . . . . 64.099999999999994 110.038 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 47.3 m -87.86 107.08 18.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.843 0.457 . . . . 61.32 111.012 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.406 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 46.1 m-85 -83.12 157.11 22.94 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.217 0.532 . . . . 74.519999999999996 110.352 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.68 -34.43 75.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.78 0.832 . . . . 74.310000000000002 110.684 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -118.51 134.12 23.49 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.399 0.68 . . . . 73.230000000000004 111.033 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.62 -36.56 89.79 Favored 'Trans proline' 0 CA--C 1.582 2.888 0 C-N-CA 122.517 2.144 . . . . 70.329999999999998 116.225 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.85 -32.81 77.2 Favored 'Trans proline' 0 C--N 1.397 3.125 0 CA-C-N 122.8 2.036 . . . . 74.140000000000001 114.107 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.7 p -78.13 -33.25 50.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.09 0.556 . . . . 73.400000000000006 110.394 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.27 74.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.171 0.588 . . . . 63.329999999999998 111.205 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -61.87 -40.52 95.64 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.287 1.035 . . . . 73.010000000000005 110.796 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.97 94.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.776 -0.647 . . . . 72.519999999999996 111.872 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.06 -27.11 68.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.133 0.573 . . . . 55.450000000000003 112.408 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.1 mt -64.36 -63.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.519 0.328 . . . . 75.549999999999997 110.615 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.0 -28.16 66.11 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.672 0.789 . . . . 63.420000000000002 112.005 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.52 -61.01 2.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.117 0.567 . . . . 74.200000000000003 111.63 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 93' ' ' ILE . 72.8 m-85 -82.72 -10.83 58.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.162 1.171 . . . . 74.239999999999995 114.162 -169.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.53 94.13 0.27 Allowed 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 109.025 -0.732 . . . . 71.430000000000007 109.025 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.76 -12.65 11.85 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.195 -0.911 . . . . 55.310000000000002 114.444 -174.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 93' ' ' ILE . 49.0 mmtm -81.56 140.54 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.941 0.871 . . . . 73.120000000000005 110.612 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.9 121.19 31.01 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.148 -0.345 . . . . 74.310000000000002 111.842 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -83.95 -80.96 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.109 0.564 . . . . 72.120000000000005 109.719 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -104.33 57.03 0.71 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.501 0.667 . . . . 60.32 110.126 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 9.29 84.88 Favored Glycine 0 N--CA 1.48 1.62 0 CA-C-N 115.682 -0.69 . . . . 72.129999999999995 114.201 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -126.03 126.47 24.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 123.984 0.914 . . . . 72.450000000000003 110.534 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.15 108.62 1.37 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.796 2.33 . . . . 73.040000000000006 112.018 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 83' ' ' PHE . 11.3 pt -77.89 152.51 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.411 0.685 . . . . 75.310000000000002 111.872 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -116.87 120.49 38.65 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.811 -0.811 . . . . 75.129999999999995 108.811 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.563 HG22 HG11 ' A' ' 18' ' ' VAL . 21.6 t -116.0 136.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 122.751 0.42 . . . . 74.420000000000002 110.955 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 t -147.29 176.63 9.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.469 1.508 . . . . 73.340000000000003 108.703 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -71.98 145.54 48.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.389 0.54 . . . . 75.329999999999998 111.094 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.63 76.32 10.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 75.129999999999995 109.9 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.635 0.774 . . . . 75.230000000000004 111.317 -178.125 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.284 0.476 . . . . 74.030000000000001 112.284 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -95.28 137.89 33.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.054 0.541 . . . . 74.439999999999998 109.947 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 pt -113.89 148.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.842 -0.536 . . . . 73.230000000000004 111.184 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.5 113.95 27.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.614 -0.513 . . . . 72.319999999999993 109.614 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 95' ' ' VAL . 11.0 t -105.63 132.78 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.037 0.935 . . . . 73.150000000000006 109.639 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.58 162.39 18.07 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.855 0.862 . . . . 73.540000000000006 109.824 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.71 68.44 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 114.424 0.53 . . . . 74.219999999999999 114.424 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 18' ' ' VAL . 32.3 mt -80.24 -17.55 51.95 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.857 1.263 . . . . 74.549999999999997 112.459 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.65 173.5 46.93 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.967 0.747 . . . . 65.530000000000001 114.967 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.98 -13.4 60.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.28 1.032 . . . . 74.129999999999995 112.723 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -93.19 11.32 28.28 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.922 0.889 . . . . 73.409999999999997 111.545 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.07 129.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 O-C-N 121.429 -0.794 . . . . 61.43 112.801 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -132.87 158.86 41.49 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.326 0.65 . . . . 70.209999999999994 110.475 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -51.88 -51.21 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.967 0.907 . . . . 75.340000000000003 111.593 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.06 -32.13 68.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.598 0.759 . . . . 74.329999999999998 112.891 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -72.06 -42.25 66.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.109 0.163 . . . . 74.430000000000007 111.004 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.86 -43.08 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 120.853 0.358 . . . . 74.310000000000002 110.445 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.71 87.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.891 -0.595 . . . . 75.200000000000003 112.242 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.06 -27.69 66.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.753 0.421 . . . . 63.229999999999997 111.282 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.38 -50.36 27.13 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 64.129999999999995 110.43 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 18.7 m-85 -82.81 -19.68 37.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.339 1.236 . . . . 72.299999999999997 114.339 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -67.1 -18.31 65.26 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 113.385 0.883 . . . . 74.239999999999995 113.385 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.78 -25.97 65.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.538 0.735 . . . . 74.219999999999999 111.799 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.5 mm -83.2 -38.7 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.376 1.07 . . . . 73.230000000000004 111.381 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.12 -179.81 48.24 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 113.156 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.7 120.13 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.178 0.591 . . . . 75.299999999999997 110.878 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 79.3 mt -93.85 123.78 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.362 0.665 . . . . 74.430000000000007 109.692 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 48.3 mtpt -48.61 146.85 2.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.157 0.983 . . . . 75.5 112.446 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 89.5 m -140.0 123.55 17.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.546 0.738 . . . . 74.439999999999998 110.717 -170.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -63.25 126.06 26.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.677 0.791 . . . . 75.319999999999993 109.719 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.36 -37.54 37.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.283 0.633 . . . . 74.439999999999998 111.973 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.32 -50.16 71.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.183 0.593 . . . . 75.129999999999995 111.29 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.7 p -79.43 -37.21 37.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.736 0.415 . . . . 75.519999999999996 111.344 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.58 63.91 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 116.379 -0.373 . . . . 64.049999999999997 112.464 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -111.15 144.31 30.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 123.93 0.892 . . . . 74.439999999999998 112.173 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 21.6 Cg_endo -61.35 139.17 81.26 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.81 2.34 . . . . 71.140000000000001 112.291 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 48.6 mtt -71.75 96.4 1.61 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.238 0.542 . . . . 74.120000000000005 110.112 -170.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' THR . 60.7 mt -141.12 126.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.434 1.093 . . . . 65.129999999999995 109.173 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.0 m-20 -103.1 110.43 22.37 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.994 -0.743 . . . . 73.099999999999994 108.994 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -89.24 116.68 27.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 72.319999999999993 110.287 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -82.68 118.54 23.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.532 0.733 . . . . 65.340000000000003 110.744 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -106.65 148.92 27.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.368 1.067 . . . . 72.549999999999997 110.479 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.57 136.72 35.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.121 0.568 . . . . 74.439999999999998 110.949 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -72.66 -29.81 63.75 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.75 0.82 . . . . 63.140000000000001 112.627 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -84.89 -61.15 1.85 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.052 0.541 . . . . 74.219999999999999 111.023 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 p -76.77 -31.23 56.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.747 0.819 . . . . 71.109999999999999 112.092 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.58 2.03 90.58 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 116.376 -0.375 . . . . 74.099999999999994 113.458 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -84.75 151.78 24.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.696 0.799 . . . . 74.120000000000005 111.025 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 mt -67.2 129.86 41.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.92 -0.582 . . . . 71.019999999999996 109.679 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -72.78 -9.39 58.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.301 0.64 . . . . 75.019999999999996 112.281 -173.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.35 40.97 31.95 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.268 -0.733 . . . . 63.520000000000003 111.268 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -142.54 138.13 30.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.866 0.866 . . . . 64.109999999999999 109.099 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.0 152.62 24.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.846 0.458 . . . . 74.430000000000007 111.657 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -111.97 120.56 42.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 111.185 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.08 111.16 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.651 1.181 . . . . 65.319999999999993 110.295 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.3 t -83.96 108.94 17.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.462 0.305 . . . . 73.340000000000003 110.9 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 44.3 m-85 -85.5 160.04 19.78 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.131 0.491 . . . . 73.230000000000004 110.501 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.23 -37.87 57.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.291 0.636 . . . . 72.519999999999996 110.485 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -116.38 129.81 24.96 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.518 0.727 . . . . 64.439999999999998 110.606 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.55 -35.45 56.23 Favored 'Trans proline' 0 CA--C 1.579 2.765 0 C-N-CA 123.09 2.527 . . . . 73.239999999999995 116.668 169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.5 -32.94 97.08 Favored 'Trans proline' 0 C--N 1.395 3.017 0 CA-C-N 122.843 2.051 . . . . 72.019999999999996 113.313 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -71.84 -38.55 70.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.215 0.606 . . . . 65.430000000000007 110.297 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.77 53.82 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.391 -0.822 . . . . 71.329999999999998 110.969 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.46 -40.48 97.24 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.474 1.11 . . . . 65.200000000000003 111.717 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.91 97.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 62.310000000000002 112.041 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.67 71.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.253 0.621 . . . . 74.25 111.993 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 HG13 ' A' ' 95' ' ' VAL . 75.2 mt -63.43 -62.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.969 0.508 . . . . 71.109999999999999 110.464 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.65 -32.07 66.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.672 0.789 . . . . 73.409999999999997 112.321 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -77.77 -55.3 5.45 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.033 0.533 . . . . 74.040000000000006 112.228 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.458 ' HB3' HD11 ' A' ' 93' ' ' ILE . 73.9 m-85 -88.57 -15.67 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.133 1.16 . . . . 74.239999999999995 114.133 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.47 118.45 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.347 0.521 . . . . 73.099999999999994 110.271 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.09 -1.79 78.04 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.824 0.69 . . . . 75.409999999999997 114.824 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.97 173.57 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.45 0.625 . . . . 74.400000000000006 111.139 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -107.61 106.74 17.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.088 0.555 . . . . 75.230000000000004 111.268 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -86.0 113.57 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.235 -1.024 . . . . 72.140000000000001 108.235 168.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t 61.01 24.5 14.6 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.303 0.641 . . . . 73.140000000000001 111.872 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.19 76.89 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 123.169 0.414 . . . . 70.540000000000006 113.969 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.51 126.01 45.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.84 0.856 . . . . 75.349999999999994 111.024 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.81 100.95 1.4 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.411 2.074 . . . . 74.450000000000003 112.226 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.5 pt -85.49 154.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 113.557 0.947 . . . . 72.319999999999993 113.557 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -126.13 113.83 17.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.746 1.218 . . . . 72.329999999999998 109.075 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.564 HG21 HG11 ' A' ' 18' ' ' VAL . 15.5 t -104.53 138.88 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.571 0.348 . . . . 71.209999999999994 110.615 -172.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.4 m -144.25 -178.7 6.09 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 74.109999999999999 109.48 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.52 147.88 37.47 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.436 0.562 . . . . 75.109999999999999 110.734 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.11 83.63 4.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.022 -0.732 . . . . 70.540000000000006 109.022 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.527 0 C-N-CA 124.001 0.92 . . . . 74.230000000000004 111.563 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.717 0.294 . . . . 71.219999999999999 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 m -104.01 127.77 51.58 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.696 0.798 . . . . 62.409999999999997 109.698 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 76' ' ' ALA . 32.1 pt -109.43 154.26 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.775 0.83 . . . . 74.219999999999999 111.279 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -109.08 121.97 46.27 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.858 0.863 . . . . 71.349999999999994 109.954 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 95' ' ' VAL . 19.8 t -118.03 140.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.535 1.134 . . . . 73.0 110.253 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.01 158.03 34.69 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.983 0.913 . . . . 73.109999999999999 110.525 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.17 35.43 43.48 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 114.602 0.601 . . . . 44.100000000000001 114.602 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 93' ' ' ILE . 65.3 mt -80.57 -34.16 35.55 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.074 0.95 . . . . 73.530000000000001 112.321 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 153.06 8.58 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.087 -0.405 . . . . 73.519999999999996 112.087 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.33 -1.93 43.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.989 0.737 . . . . 71.0 112.989 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -120.82 29.93 7.14 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.332 0.653 . . . . 74.329999999999998 110.142 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.41 136.95 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 123.44 0.696 . . . . 62.219999999999999 111.682 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 30' ' ' VAL . 42.7 p -122.48 151.13 41.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 74.340000000000003 110.521 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.551 HG21 ' HB ' ' A' ' 51' ' ' ILE . 70.7 mt -53.43 -41.16 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.663 0.785 . . . . 75.409999999999997 111.091 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.42 -40.42 93.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.341 0.656 . . . . 74.099999999999994 112.404 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.5 p -72.31 -38.27 68.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.288 0.235 . . . . 71.010000000000005 111.52 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 41.3 t -65.41 -40.52 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.163 0.506 . . . . 74.209999999999994 110.195 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.273 -0.876 . . . . 74.219999999999999 112.371 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.78 -32.25 72.7 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.374 0.669 . . . . 61.25 111.207 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -76.65 -49.83 15.23 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.013 -0.54 . . . . 73.150000000000006 111.158 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 18.4 m-85 -80.48 -17.91 50.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.147 1.166 . . . . 71.040000000000006 114.147 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.99 -21.69 66.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.269 0.841 . . . . 74.430000000000007 113.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.22 -28.72 59.36 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.581 0.752 . . . . 74.420000000000002 112.153 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -82.32 -42.67 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 74.099999999999994 111.445 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.94 -178.92 47.06 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.392 -0.367 . . . . 70.349999999999994 113.326 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.49 119.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.068 0.547 . . . . 63.25 110.747 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.5 mt -87.2 125.29 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.888 -0.782 . . . . 73.409999999999997 108.888 173.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.417 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 53.7 mtpt -48.41 131.9 16.83 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.661 0.784 . . . . 71.209999999999994 112.184 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 53.5 m -116.17 123.17 47.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 74.109999999999999 110.709 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -63.68 119.0 9.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.72 0.808 . . . . 75.310000000000002 109.132 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -76.37 -27.16 56.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 73.140000000000001 111.586 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -72.97 -43.44 62.25 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.427 0.691 . . . . 73.349999999999994 111.615 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -84.52 -36.54 22.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.019 0.527 . . . . 74.150000000000006 111.411 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.6 66.41 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 115.799 -0.637 . . . . 73.109999999999999 112.415 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.05 157.74 47.89 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.41 1.084 . . . . 74.5 111.665 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 60.6 Cg_endo -69.83 155.33 65.97 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.489 2.126 . . . . 74.200000000000003 113.002 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.417 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 54.1 mtt -83.41 94.85 8.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.718 0.807 . . . . 75.409999999999997 109.186 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' HB ' HG21 ' A' ' 27' ' ' ILE . 89.3 mt -142.18 117.95 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.765 -1.107 . . . . 74.129999999999995 108.799 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.425 HD21 ' N ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -97.12 107.5 20.04 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.758 -0.83 . . . . 75.040000000000006 108.758 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.1 mt -77.03 150.29 35.8 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.914 -0.772 . . . . 75.25 108.914 172.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.83 128.61 55.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.805 0.442 . . . . 71.409999999999997 110.654 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -115.08 139.63 49.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.252 1.021 . . . . 74.430000000000007 110.259 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -66.45 128.19 35.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.767 0.827 . . . . 71.140000000000001 110.798 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -62.98 -34.66 77.99 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.52 0.328 . . . . 73.140000000000001 110.744 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -76.72 -58.08 3.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.454 0.702 . . . . 72.209999999999994 111.809 -172.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.4 p -81.37 -29.24 34.09 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.498 0.555 . . . . 64.5 112.498 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.39 5.96 86.09 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 116.57 -0.286 . . . . 73.120000000000005 113.208 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -96.77 167.9 10.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.109 0.963 . . . . 70.129999999999995 109.721 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.1 mt -75.3 137.7 41.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.71 0.291 . . . . 71.310000000000002 110.512 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 6.6 mtpm? -67.82 -28.37 67.51 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.807 -0.633 . . . . 74.510000000000005 112.269 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.0 23.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.919 -0.582 . . . . 74.510000000000005 113.736 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -116.98 156.38 27.56 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.734 0.767 . . . . 74.230000000000004 110.228 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -162.14 149.81 14.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.429 0.692 . . . . 73.030000000000001 111.489 174.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 39.4 p -106.71 126.04 51.78 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.866 0.466 . . . . 53.530000000000001 110.498 172.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.56 110.99 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.526 0.73 . . . . 74.319999999999993 110.428 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 25.2 m -85.41 103.23 14.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.338 0.255 . . . . 73.129999999999995 111.071 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 63.7 m-85 -82.69 162.15 21.9 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.099999999999994 110.742 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.1 -40.19 62.88 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.62 -0.718 . . . . 75.230000000000004 110.929 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 26.7 m-20 -109.92 134.37 20.69 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.923 0.489 . . . . 75.239999999999995 112.049 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.09 -42.75 51.8 Favored 'Trans proline' 0 CA--C 1.581 2.837 0 C-N-CA 122.932 2.421 . . . . 72.230000000000004 116.199 168.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 59.6 Cg_endo -68.38 -24.12 37.33 Favored 'Trans proline' 0 C--N 1.398 3.157 0 CA-C-N 122.237 1.835 . . . . 73.239999999999995 112.713 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -71.3 -43.27 67.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.487 0.66 . . . . 62.030000000000001 109.787 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 16' ' ' ILE . . . -65.93 -42.37 90.19 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.334 -0.848 . . . . 72.430000000000007 111.342 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -62.82 -43.36 99.0 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.78 0.832 . . . . 74.230000000000004 110.707 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.99 89.43 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.847 -0.615 . . . . 73.099999999999994 111.492 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.45 70.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.075 0.55 . . . . 73.510000000000005 112.003 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.522 HG12 HG13 ' A' ' 95' ' ' VAL . 62.4 mt -68.4 -60.07 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.207 0.203 . . . . 73.219999999999999 110.478 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.37 -25.95 64.69 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.198 0.599 . . . . 73.510000000000005 111.871 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -82.68 -62.48 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.567 0.347 . . . . 74.409999999999997 111.811 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.517 ' HB2' HG22 ' A' ' 95' ' ' VAL . 79.0 m-85 -80.52 -15.52 56.48 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.955 1.095 . . . . 75.450000000000003 113.955 -168.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.14 106.72 3.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.48 -0.563 . . . . 74.530000000000001 109.48 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.56 35.39 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 115.338 -0.847 . . . . 73.420000000000002 114.218 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -83.29 -177.04 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.466 0.633 . . . . 72.409999999999997 111.743 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -121.03 120.44 35.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.857 . . . . 73.430000000000007 109.843 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' HB2' HG22 ' A' ' 93' ' ' ILE . 86.2 t80 -68.52 -69.5 0.32 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.097 0.559 . . . . 74.519999999999996 111.082 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.9 t -133.62 69.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.939 0.896 . . . . 71.519999999999996 109.167 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.87 -2.95 38.95 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.122 -0.945 . . . . 51.350000000000001 114.193 -172.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -115.87 125.89 28.22 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 124.262 1.025 . . . . 74.439999999999998 111.03 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.4 130.18 29.3 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.096 2.531 . . . . 74.450000000000003 112.742 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.474 HG22 ' HB2' ' A' ' 88' ' ' PHE . 30.5 pt -116.4 144.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 121.908 0.861 . . . . 75.450000000000003 112.702 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -114.2 121.36 43.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.947 -1.501 . . . . 73.450000000000003 106.947 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 80' ' ' ILE . 25.8 t -113.85 138.71 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.258 0.551 . . . . 71.510000000000005 110.692 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.5 p -148.88 179.41 7.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.03 1.332 . . . . 64.049999999999997 109.481 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -78.37 145.1 35.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 118.526 0.603 . . . . 75.349999999999994 111.592 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.37 113.48 24.79 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.315 -0.624 . . . . 74.430000000000007 109.315 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.563 1.467 0 C-N-CA 123.153 0.581 . . . . 75.209999999999994 111.724 -176.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 120.713 0.292 . . . . 73.019999999999996 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -102.98 130.51 50.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.391 0.676 . . . . 64.409999999999997 109.509 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' THR . 34.9 pt -117.22 138.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.23 0.612 . . . . 74.430000000000007 111.958 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -94.56 117.21 29.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.106 0.479 . . . . 75.030000000000001 110.469 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG12 HG21 ' A' ' 95' ' ' VAL . 12.5 t -113.39 138.81 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.466 1.106 . . . . 75.299999999999997 110.279 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.95 162.57 22.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.343 1.057 . . . . 72.319999999999993 110.11 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.14 65.51 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 114.506 0.562 . . . . 70.230000000000004 114.506 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD12 HG23 ' A' ' 25' ' ' VAL . 81.9 mt -72.34 -36.03 68.72 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.067 0.947 . . . . 73.430000000000007 111.879 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.27 158.07 11.68 Favored Glycine 0 N--CA 1.476 1.352 0 C-N-CA 123.219 0.438 . . . . 73.239999999999995 112.556 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.86 -19.43 61.96 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.015 0.908 . . . . 75.120000000000005 112.719 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -89.53 7.29 37.03 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.029 0.932 . . . . 75.430000000000007 111.323 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG23 HD12 ' A' ' 21' ' ' LEU . 9.9 p -69.72 134.32 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.354 0.662 . . . . 74.209999999999994 112.444 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' HG21 ' A' ' 30' ' ' VAL . 15.0 p -120.4 163.05 18.48 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.016 -0.427 . . . . 72.299999999999997 110.007 171.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 51' ' ' ILE . 80.5 mt -57.83 -42.4 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 123.917 0.887 . . . . 74.540000000000006 111.5 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.41 -30.04 65.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.474 0.71 . . . . 74.409999999999997 111.776 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -45.85 81.53 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.783 0.433 . . . . 75.439999999999998 110.877 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 26' ' ' THR . 21.5 t -64.88 -40.84 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 121.19 0.519 . . . . 72.200000000000003 110.225 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.58 88.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.34 -0.846 . . . . 63.140000000000001 111.744 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.88 -40.33 97.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.027 0.931 . . . . 71.219999999999999 111.582 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.31 -48.19 44.03 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.379 -0.828 . . . . 75.099999999999994 110.89 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.38 -19.57 35.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.548 1.314 . . . . 72.519999999999996 114.548 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.44 -16.61 63.81 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.835 1.05 . . . . 72.340000000000003 113.835 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -61.41 -29.18 69.77 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.089 0.555 . . . . 74.439999999999998 111.772 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.17 -42.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.057 0.943 . . . . 74.319999999999993 111.189 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.62 171.67 42.81 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 116.358 -0.383 . . . . 45.450000000000003 113.04 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.84 123.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.826 -0.435 . . . . 73.25 109.826 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.4 mt -93.97 129.76 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.99 0.916 . . . . 73.120000000000005 108.796 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.0 mtpt -51.04 140.51 15.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.319999999999993 112.311 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 56.0 m -128.45 121.81 29.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.181 -0.918 . . . . 72.400000000000006 109.829 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -57.63 119.57 6.83 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.208 1.003 . . . . 65.439999999999998 110.565 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -76.09 -16.94 59.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.704 0.802 . . . . 73.530000000000001 112.839 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -82.08 -52.29 7.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.649 0.379 . . . . 74.430000000000007 110.803 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -80.46 -46.62 15.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.25 0.62 . . . . 64.519999999999996 111.587 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.31 15.65 40.44 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.979 -0.555 . . . . 72.140000000000001 112.633 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -107.87 148.84 38.16 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.24 1.016 . . . . 72.450000000000003 111.827 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -67.75 149.88 78.82 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.409 2.073 . . . . 73.519999999999996 112.182 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.498 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 49.4 mtt -81.94 94.34 7.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.619 0.723 . . . . 75.430000000000007 109.67 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.606 ' HB ' HG22 ' A' ' 27' ' ' ILE . 78.7 mt -145.88 117.56 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.501 1.121 . . . . 75.349999999999994 108.693 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 78.9 m-20 -96.88 109.38 22.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.67 -0.493 . . . . 73.430000000000007 109.67 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.01 150.19 39.04 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.554 0.534 . . . . 74.219999999999999 109.856 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 46.9 m-85 -107.65 132.28 53.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.275 0.63 . . . . 75.140000000000001 109.952 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -133.99 142.88 47.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.725 0.81 . . . . 73.209999999999994 110.042 -174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -76.67 114.83 15.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.798 0.439 . . . . 74.140000000000001 109.827 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -71.72 -8.03 51.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.293 0.637 . . . . 75.329999999999998 112.471 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.35 -56.27 4.46 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.392 0.677 . . . . 74.140000000000001 110.888 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 p -96.93 -21.13 17.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.733 0.813 . . . . 61.310000000000002 112.556 -173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 12.64 83.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 120.056 -0.302 . . . . 71.329999999999998 113.751 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -97.22 147.89 23.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.47 0.708 . . . . 75.409999999999997 111.588 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.81 138.32 56.05 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.103 0.561 . . . . 70.340000000000003 111.541 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -77.47 -17.23 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.342 0.657 . . . . 73.430000000000007 111.579 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.08 24.34 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.333 0.396 . . . . 62.210000000000001 112.33 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 46.8 mt-10 -135.25 153.05 52.05 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.916 0.886 . . . . 54.530000000000001 109.74 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.33 156.27 23.69 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.471 0.545 . . . . 55.009999999999998 112.471 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 69.5 p -113.87 118.57 34.57 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 122.745 0.418 . . . . 61.43 110.676 171.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.52 107.96 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.888 0.875 . . . . 75.109999999999999 111.025 -170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -83.82 102.65 12.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.716 0.407 . . . . 75.310000000000002 111.521 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 53.3 m-85 -79.81 149.86 30.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.403 0.681 . . . . 71.519999999999996 110.686 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.03 -32.75 57.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.395 0.678 . . . . 73.209999999999994 110.573 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.77 127.39 37.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.15 0.58 . . . . 72.310000000000002 110.473 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.31 -48.36 18.92 Favored 'Trans proline' 0 CA--C 1.581 2.874 0 C-N-CA 122.602 2.201 . . . . 73.120000000000005 115.532 170.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.85 -19.32 27.34 Favored 'Trans proline' 0 C--N 1.398 3.149 0 CA-C-N 122.2 1.821 . . . . 75.310000000000002 113.609 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -69.37 -33.67 73.41 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.222 0.609 . . . . 75.299999999999997 111.211 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.29 56.01 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.925 -0.579 . . . . 64.329999999999998 111.466 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.585 0.754 . . . . 71.310000000000002 111.092 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.78 94.21 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.102 0.561 . . . . 71.200000000000003 111.796 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.53 67.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 74.099999999999994 112.699 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 95' ' ' VAL . 82.2 mt -66.86 -58.38 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 120.899 0.381 . . . . 74.25 110.054 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.99 -27.79 69.11 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.434 -0.803 . . . . 72.400000000000006 112.166 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -81.5 -62.3 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.612 0.365 . . . . 71.420000000000002 111.344 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' HB3' HD11 ' A' ' 93' ' ' ILE . 66.8 m-85 -79.51 -11.73 59.89 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.282 1.215 . . . . 74.329999999999998 114.282 -168.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.42 111.06 1.86 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 118.508 0.595 . . . . 74.319999999999993 110.362 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.57 60.0 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 115.128 0.811 . . . . 54.450000000000003 115.128 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.74 161.56 18.33 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 118.43 1.115 . . . . 75.140000000000001 111.105 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -99.23 119.92 38.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 75.239999999999995 111.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -84.21 -77.69 0.26 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.903 0.481 . . . . 73.040000000000006 110.222 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -118.13 75.48 1.01 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.46 0.704 . . . . 75.549999999999997 110.078 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.21 1.03 59.21 Favored Glycine 0 CA--C 1.54 1.652 0 N-CA-C 115.061 0.784 . . . . 75.209999999999994 115.061 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -132.9 138.01 30.92 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.483 0.713 . . . . 74.510000000000005 110.983 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.96 140.6 55.33 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.695 2.264 . . . . 74.230000000000004 111.975 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 83' ' ' PHE . 19.6 pt -110.38 152.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.223 0.609 . . . . 72.340000000000003 111.707 -171.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -118.18 114.76 23.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.461 0.704 . . . . 74.329999999999998 109.567 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.515 HG21 HG12 ' A' ' 18' ' ' VAL . 15.9 t -109.22 133.45 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.606 0.362 . . . . 75.200000000000003 110.244 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.2 t -145.42 -178.67 6.2 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.455 1.102 . . . . 72.319999999999993 109.494 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.84 134.9 38.91 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.858 -0.526 . . . . 73.430000000000007 110.815 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 86.53 6.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.852 0.461 . . . . 72.120000000000005 110.548 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.221 1.008 . . . . 74.510000000000005 110.951 -178.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.533 0.568 . . . . 72.0 112.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -93.87 132.08 38.64 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.051 0.54 . . . . 71.439999999999998 110.774 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 29.1 pt -113.23 147.92 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.64 . . . . 73.510000000000005 111.263 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -108.84 115.63 30.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.56 0.744 . . . . 75.540000000000006 110.426 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 95' ' ' VAL . 4.2 t -111.75 143.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.831 0.852 . . . . 71.239999999999995 110.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.79 155.11 47.24 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.011 0.925 . . . . 72.409999999999997 111.484 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.72 24.64 37.93 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 114.367 0.507 . . . . 53.229999999999997 114.367 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.7 -16.28 51.75 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.934 0.894 . . . . 74.200000000000003 112.837 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.99 158.65 29.35 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 120.947 0.193 . . . . 73.040000000000006 113.444 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.91 -5.25 55.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.482 0.713 . . . . 74.209999999999994 112.857 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.18 18.74 19.05 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.818 0.847 . . . . 74.329999999999998 111.257 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.24 144.61 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.276 0.631 . . . . 71.25 112.318 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -124.09 154.62 39.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.196 0.598 . . . . 75.450000000000003 111.103 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.565 HG21 ' HB ' ' A' ' 51' ' ' ILE . 73.3 mt -55.45 -39.26 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.893 0.877 . . . . 75.319999999999993 110.881 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.055 0.942 . . . . 74.0 111.843 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -72.22 -40.91 67.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.513 0.325 . . . . 73.230000000000004 111.223 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.07 -42.08 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 110.171 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.47 91.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.521 0.729 . . . . 73.319999999999993 111.808 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.96 -33.03 74.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.5 0.72 . . . . 72.349999999999994 110.764 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -71.04 -55.48 8.18 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.052 0.941 . . . . 75.120000000000005 111.085 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -81.51 -19.3 42.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.477 1.288 . . . . 74.450000000000003 114.477 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -61.35 -26.21 67.66 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.695 0.998 . . . . 74.120000000000005 113.695 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -61.72 -24.34 66.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.374 0.669 . . . . 72.010000000000005 112.323 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.9 mm -83.13 -50.95 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.992 0.917 . . . . 75.150000000000006 111.344 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 75' ' ' SER . . . -161.73 168.61 36.93 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.683 -0.69 . . . . 60.32 113.674 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.65 110.41 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.384 0.674 . . . . 74.549999999999997 110.669 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.1 mt -80.9 131.84 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 108.444 -0.947 . . . . 75.519999999999996 108.444 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.46 124.96 14.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.261 0.624 . . . . 73.409999999999997 111.085 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 30.6 m -113.43 120.15 40.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.643 -0.708 . . . . 74.439999999999998 110.487 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -60.93 108.77 0.91 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.551 -0.907 . . . . 74.109999999999999 108.551 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.59 -27.59 62.27 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.398 0.679 . . . . 71.329999999999998 111.994 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -62.16 -50.17 72.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.716 0.806 . . . . 72.209999999999994 111.48 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -86.51 -40.27 15.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.383 0.673 . . . . 74.329999999999998 111.077 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 1.62 50.12 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.861 -0.609 . . . . 65.430000000000007 112.718 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -104.89 151.52 39.42 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 124.134 0.974 . . . . 64.319999999999993 112.444 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 72.9 Cg_endo -72.18 155.48 56.46 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.761 2.307 . . . . 74.519999999999996 112.712 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.7 mtt -83.77 95.17 8.34 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.47 0.652 . . . . 74.299999999999997 109.962 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.565 ' HB ' HG21 ' A' ' 27' ' ' ILE . 75.6 mt -142.59 124.49 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.442 1.097 . . . . 74.530000000000001 109.117 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 15.3 m120 -106.18 109.84 21.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.883 0.473 . . . . 74.510000000000005 110.085 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.63 124.92 31.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.684 0.794 . . . . 75.230000000000004 109.601 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 94.0 m-85 -83.02 125.77 31.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.917 0.487 . . . . 75.230000000000004 111.149 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 9.9 m -112.23 142.16 45.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.783 0.833 . . . . 75.420000000000002 109.845 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.7 129.7 37.52 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.924 0.489 . . . . 75.310000000000002 110.454 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -70.59 -27.86 64.43 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.3 1.04 . . . . 75.120000000000005 112.384 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -85.86 -50.57 7.02 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.318 0.647 . . . . 72.340000000000003 112.025 -175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.5 p -83.16 -30.8 27.54 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.566 0.746 . . . . 72.400000000000006 112.111 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.28 9.69 85.66 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 116.229 -0.441 . . . . 70.120000000000005 113.872 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -109.41 154.75 22.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.224 0.61 . . . . 74.019999999999996 110.966 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 mt -62.18 136.47 57.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.421 0.688 . . . . 73.510000000000005 111.921 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -73.34 -12.74 60.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.797 0.839 . . . . 74.299999999999997 111.918 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.65 42.44 21.58 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.827 -0.509 . . . . 61.219999999999999 111.827 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 50.6 mt-10 -131.81 147.93 52.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.915 0.886 . . . . 75.420000000000002 109.722 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -153.18 139.46 18.48 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.196 0.443 . . . . 75.310000000000002 112.196 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.8 p -101.25 119.5 38.85 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.844 -0.428 . . . . 75.239999999999995 109.844 169.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.3 t -109.24 108.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.631 0.772 . . . . 75.349999999999994 110.383 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.2 m -81.02 104.93 11.85 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.6 0.36 . . . . 73.150000000000006 111.117 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -82.1 157.56 24.04 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.94 0.496 . . . . 73.329999999999998 110.463 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.44 -37.66 60.21 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.999 0.52 . . . . 75.400000000000006 110.027 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -111.91 122.25 37.49 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.918 0.887 . . . . 63.450000000000003 110.261 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.53 -34.63 73.34 Favored 'Trans proline' 0 CA--C 1.583 2.939 0 C-N-CA 122.554 2.17 . . . . 75.310000000000002 116.565 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.61 -30.41 79.06 Favored 'Trans proline' 0 C--N 1.397 3.114 0 CA-C-N 122.687 1.995 . . . . 74.019999999999996 113.209 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 36.7 m -73.77 -35.74 65.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.038 0.446 . . . . 64.319999999999993 110.503 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.29 -50.09 74.42 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.434 -0.803 . . . . 62.020000000000003 111.285 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.25 -40.94 98.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.503 0.721 . . . . 74.120000000000005 111.161 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.34 98.99 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.965 -0.562 . . . . 64.239999999999995 111.813 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.44 75.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.447 0.699 . . . . 75.310000000000002 112.145 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.525 HG12 HG12 ' A' ' 95' ' ' VAL . 69.7 mt -66.81 -56.95 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.822 -0.626 . . . . 73.310000000000002 110.599 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.44 -31.01 67.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.644 0.778 . . . . 73.129999999999995 111.876 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -80.55 -58.21 3.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.78 0.832 . . . . 72.450000000000003 111.993 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -85.24 -10.19 56.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.382 1.253 . . . . 73.230000000000004 114.382 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.08 119.28 11.75 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 118.575 0.625 . . . . 75.200000000000003 110.45 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.02 1.85 84.34 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.456 -0.793 . . . . 54.210000000000001 114.45 -175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.94 173.26 8.59 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 117.623 0.711 . . . . 73.200000000000003 110.793 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.33 122.95 48.03 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.105 -0.372 . . . . 71.219999999999999 111.718 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -92.99 -67.44 0.86 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.621 0.769 . . . . 74.329999999999998 110.028 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -112.95 50.09 0.9 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.695 0.798 . . . . 63.030000000000001 109.886 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 115.456 -0.793 . . . . 73.209999999999994 113.678 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -122.32 130.23 24.77 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.355 1.062 . . . . 65.239999999999995 110.387 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.2 94.0 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.53 2.153 . . . . 74.219999999999999 111.804 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.2 pt -71.33 155.34 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.977 0.911 . . . . 75.329999999999998 112.506 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -118.82 122.16 41.73 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.188 -1.042 . . . . 74.230000000000004 108.188 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 18' ' ' VAL . 11.2 t -109.29 133.08 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.196 0.522 . . . . 73.450000000000003 110.002 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -133.05 -178.03 4.78 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.148 1.379 . . . . 44.0 109.019 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 32.7 m-85 -90.67 151.2 21.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 122.097 -0.377 . . . . 73.209999999999994 110.736 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.18 82.87 2.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.554 0.741 . . . . 73.329999999999998 109.216 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 115.695 -0.684 . . . . 53.340000000000003 112.34 -172.188 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 CA--C 1.551 0.988 0 CA-C-O 120.508 0.194 . . . . 72.340000000000003 111.229 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -108.65 126.21 52.73 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.615 0.766 . . . . 73.329999999999998 110.142 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.8 pt -105.5 157.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.681 0.792 . . . . 74.510000000000005 110.842 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -116.72 115.11 25.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.447 0.699 . . . . 74.430000000000007 110.095 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.532 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -104.98 145.02 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 124.401 1.08 . . . . 75.019999999999996 110.184 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.44 157.57 36.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.361 1.064 . . . . 73.349999999999994 110.056 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.12 41.7 92.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 115.233 0.853 . . . . 74.319999999999993 115.233 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 93' ' ' ILE . 41.4 mt -81.82 -32.51 31.21 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.162 0.985 . . . . 73.430000000000007 111.639 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.76 161.26 11.7 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-N 116.182 -0.463 . . . . 65.540000000000006 112.619 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.48 -5.86 57.98 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.296 0.638 . . . . 73.200000000000003 112.064 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -94.54 14.0 22.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.506 0.723 . . . . 70.310000000000002 111.381 173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 p -75.42 138.53 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.421 0.688 . . . . 74.530000000000001 112.444 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 30' ' ' VAL . 60.6 p -131.33 148.76 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.531 0.732 . . . . 54.439999999999998 110.947 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG23 ' HB ' ' A' ' 51' ' ' ILE . 69.7 mt -51.66 -49.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.942 1.297 . . . . 73.510000000000005 112.893 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.91 -32.27 73.68 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 122.904 0.482 . . . . 75.340000000000003 111.935 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -74.37 -39.13 62.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.413 0.685 . . . . 74.219999999999999 111.536 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 26' ' ' THR . 42.7 t -63.97 -43.04 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 74.010000000000005 109.86 173.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.9 95.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.874 -1.057 . . . . 54.409999999999997 111.616 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 -34.17 77.67 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.634 0.773 . . . . 74.439999999999998 111.883 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.16 -53.51 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.881 0.472 . . . . 73.010000000000005 111.189 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 35.7 m-85 -77.87 -16.19 58.45 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.222 1.193 . . . . 75.299999999999997 114.222 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.19 -18.64 65.48 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.054 1.131 . . . . 74.530000000000001 114.054 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.02 -30.99 68.42 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.324 0.65 . . . . 75.219999999999999 111.914 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.59 -48.78 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.022 0.929 . . . . 70.420000000000002 110.896 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.7 173.18 40.59 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.426 -0.806 . . . . 71.450000000000003 112.695 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.88 127.83 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 122.989 0.516 . . . . 64.510000000000005 110.735 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.0 mt -97.54 134.79 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.637 0.775 . . . . 73.349999999999994 109.089 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 59.2 mtpt -62.22 155.64 24.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.457 0.703 . . . . 73.120000000000005 112.02 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 84.8 m -137.15 122.12 18.94 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.328 -0.851 . . . . 72.540000000000006 110.467 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -61.21 114.7 3.3 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.575 1.15 . . . . 62.039999999999999 109.47 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.26 -11.24 59.8 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.835 0.854 . . . . 74.099999999999994 112.878 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -83.4 -52.2 6.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.103 0.561 . . . . 74.230000000000004 110.598 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -79.67 -31.88 41.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.443 0.697 . . . . 71.219999999999999 111.691 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.2 81.58 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 116.008 -0.542 . . . . 71.140000000000001 112.964 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -104.92 149.86 38.04 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.42 1.088 . . . . 71.409999999999997 111.304 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.0 Cg_endo -63.65 146.73 92.72 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.369 2.046 . . . . 75.25 111.534 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 61.0 mtt -75.65 94.0 3.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.54 0.686 . . . . 72.239999999999995 109.471 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.592 ' HB ' HG23 ' A' ' 27' ' ' ILE . 77.7 mt -144.08 127.89 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.85 1.26 . . . . 74.25 108.533 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 19.2 m120 -108.02 110.31 21.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.715 -0.476 . . . . 72.099999999999994 109.715 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.951 0.782 . . . . 63.240000000000002 109.343 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HE1' HG23 ' A' ' 67' ' ' THR . 79.7 m-85 -74.99 120.44 20.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.232 0.613 . . . . 73.400000000000006 111.134 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 m -100.57 140.02 35.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.693 0.797 . . . . 75.209999999999994 108.956 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.59 124.36 23.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.593 0.757 . . . . 71.400000000000006 110.848 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -64.72 -24.9 67.71 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.633 0.773 . . . . 73.129999999999995 112.978 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.44 -53.65 3.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.404 0.682 . . . . 74.200000000000003 111.604 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.1 p -84.18 -22.86 30.8 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.366 0.667 . . . . 74.420000000000002 112.65 -173.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 8.12 74.1 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.262 0.465 . . . . 72.239999999999995 114.262 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.61 149.53 21.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.073 0.949 . . . . 72.129999999999995 111.233 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.25 125.72 24.44 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 117.94 0.336 . . . . 75.140000000000001 110.485 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -72.51 -21.97 61.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.994 0.518 . . . . 71.450000000000003 112.31 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 22.05 66.54 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.183 -0.367 . . . . 74.439999999999998 112.183 -170.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -115.08 143.13 45.68 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.24 -1.022 . . . . 74.049999999999997 108.24 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -151.73 159.3 44.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.705 0.402 . . . . 64.109999999999999 111.915 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 p -114.65 120.72 41.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.606 0.362 . . . . 64.420000000000002 111.24 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.29 111.84 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.099 0.559 . . . . 71.420000000000002 110.534 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.9 m -88.86 105.62 17.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.413 0.685 . . . . 75.120000000000005 111.413 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 51.5 m-85 -80.81 161.14 24.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.863 0.865 . . . . 74.030000000000001 110.765 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.32 -33.93 65.41 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.592 0.757 . . . . 75.530000000000001 110.943 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.18 132.07 22.92 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.776 0.83 . . . . 74.230000000000004 111.189 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.46 -43.29 45.29 Favored 'Trans proline' 0 CA--C 1.584 2.991 0 C-N-CA 122.779 2.319 . . . . 74.230000000000004 115.288 165.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.99 -27.72 66.2 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 122.311 1.861 . . . . 71.219999999999999 113.563 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 m -69.57 -38.72 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.545 0.688 . . . . 74.010000000000005 109.838 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -60.03 -54.78 41.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.628 -1.169 . . . . 65.299999999999997 110.861 175.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -59.22 -45.39 91.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.836 0.854 . . . . 75.400000000000006 111.404 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.94 99.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.946 -0.57 . . . . 75.409999999999997 111.686 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.05 -32.82 73.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.539 0.525 . . . . 72.230000000000004 111.992 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 76' ' ' ALA . 79.0 mt -65.33 -62.21 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.545 0.338 . . . . 65.209999999999994 111.049 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.65 -25.09 66.06 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 112.443 0.534 . . . . 75.310000000000002 112.443 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -78.26 -59.04 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.729 0.412 . . . . 74.120000000000005 110.945 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -86.62 -9.34 56.26 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.602 1.334 . . . . 71.319999999999993 114.602 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.87 106.28 1.85 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.732 0.696 . . . . 74.120000000000005 110.39 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.45 56.29 Favored Glycine 0 CA--C 1.546 1.985 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 114.232 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -80.71 175.9 10.27 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 123.761 0.824 . . . . 74.239999999999995 112.219 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.64 115.8 26.36 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.654 0.382 . . . . 74.299999999999997 111.383 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -82.55 -75.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.186 0.595 . . . . 75.209999999999994 111.042 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 t -98.93 37.31 1.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.324 0.65 . . . . 73.530000000000001 110.03 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.64 11.66 85.09 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 115.986 -0.552 . . . . 73.420000000000002 112.139 -164.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.1 121.6 41.24 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.433 1.093 . . . . 72.439999999999998 110.608 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.21 96.2 0.33 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.937 2.425 . . . . 75.25 112.561 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.418 HG21 HD21 ' A' ' 21' ' ' LEU . 29.5 pt -74.86 153.58 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.181 0.992 . . . . 74.430000000000007 113.32 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -119.75 114.77 22.66 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.965 -1.124 . . . . 74.109999999999999 107.965 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 18' ' ' VAL . 19.2 t -109.39 137.28 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 120.974 0.416 . . . . 72.420000000000002 110.297 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -142.51 -174.52 4.16 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.336 1.454 . . . . 61.299999999999997 109.042 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -79.96 146.4 32.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.907 -0.495 . . . . 70.140000000000001 110.69 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.4 107.97 18.26 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.939 -0.393 . . . . 74.129999999999995 109.939 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.489 1.486 0 C-N-CA 123.385 0.674 . . . . 75.409999999999997 112.068 -176.744 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 120.475 0.179 . . . . 74.340000000000003 110.681 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 m -97.83 126.59 43.28 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.277 0.56 . . . . 71.349999999999994 110.059 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.2 pt -105.72 153.93 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.789 0.836 . . . . 73.329999999999998 111.13 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -109.41 125.19 52.14 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.144 0.578 . . . . 74.120000000000005 109.903 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 HG21 ' A' ' 95' ' ' VAL . 18.7 t -121.31 141.75 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.081 0.952 . . . . 73.439999999999998 109.901 -175.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -127.87 159.87 33.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.902 0.881 . . . . 74.239999999999995 110.539 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.5 32.12 35.1 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 114.303 0.481 . . . . 53.340000000000003 114.303 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.81 -28.38 24.53 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.888 0.875 . . . . 73.420000000000002 112.225 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.96 161.49 18.71 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 123.068 0.366 . . . . 70.010000000000005 113.496 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -83.78 -2.0 55.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.712 1.004 . . . . 61.420000000000002 113.712 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -121.19 21.6 11.15 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.395 0.678 . . . . 63.340000000000003 111.902 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.77 142.77 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.291 0.636 . . . . 70.129999999999995 111.528 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.0 p -122.62 153.83 38.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.451 -0.78 . . . . 74.549999999999997 110.618 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG21 ' HB ' ' A' ' 51' ' ' ILE . 93.4 mt -53.46 -40.29 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.146 0.978 . . . . 70.109999999999999 111.43 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.29 -44.18 95.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.787 0.835 . . . . 71.439999999999998 111.53 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -68.94 -41.26 78.31 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.182 0.593 . . . . 72.310000000000002 111.844 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.6 -43.42 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.119 0.568 . . . . 75.420000000000002 110.021 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.95 88.75 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.368 -0.833 . . . . 75.120000000000005 111.753 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.42 -30.46 70.22 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.268 0.627 . . . . 72.120000000000005 111.6 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -72.61 -55.07 7.43 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.792 0.837 . . . . 74.510000000000005 111.64 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 77.2 m-85 -81.1 -20.01 42.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.413 1.264 . . . . 75.140000000000001 114.413 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -58.0 -29.93 65.66 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.659 0.985 . . . . 75.219999999999999 113.659 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.01 -26.49 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.815 0.846 . . . . 74.209999999999994 112.598 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 mm -79.27 -47.6 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.751 0.821 . . . . 55.32 110.758 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 173.99 43.03 Favored Glycine 0 N--CA 1.463 0.497 0 CA-C-N 116.211 -0.449 . . . . 62.520000000000003 113.295 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.28 124.3 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.379 0.671 . . . . 62.240000000000002 110.837 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 65.3 mt -94.37 131.86 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.062 0.945 . . . . 73.420000000000002 109.625 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.1 mtpt -54.91 144.99 21.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.464 0.706 . . . . 75.109999999999999 111.743 173.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.4 m -126.19 128.21 46.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.265 -0.879 . . . . 72.120000000000005 109.794 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -69.56 114.36 7.71 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.797 0.839 . . . . 74.310000000000002 108.942 172.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.96 -15.27 60.19 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.42 0.688 . . . . 74.209999999999994 112.254 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.73 -36.19 65.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.985 0.514 . . . . 74.219999999999999 111.371 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -98.67 -41.77 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.485 0.714 . . . . 73.099999999999994 111.761 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.58 8.07 54.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 115.754 -0.657 . . . . 55.109999999999999 112.812 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.9 150.16 52.43 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 123.931 0.892 . . . . 72.200000000000003 112.377 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.4 Cg_endo -61.48 145.03 98.34 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.434 2.756 . . . . 73.219999999999999 112.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.516 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 60.8 mtt -74.81 97.11 3.21 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.384 0.612 . . . . 75.140000000000001 109.789 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.548 ' HB ' HG21 ' A' ' 27' ' ' ILE . 99.2 mt -142.0 124.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.545 1.138 . . . . 75.340000000000003 109.043 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.9 m-20 -101.85 107.43 18.61 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.031 -0.729 . . . . 74.230000000000004 109.031 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.22 134.93 36.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.722 -0.844 . . . . 63.43 108.722 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -100.01 122.15 42.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.008 0.523 . . . . 71.200000000000003 110.379 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 m -102.54 141.44 35.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.261 1.024 . . . . 74.400000000000006 110.218 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.8 133.82 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.165 0.586 . . . . 74.349999999999994 109.584 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -87.31 -24.86 24.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.554 0.742 . . . . 75.409999999999997 112.798 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.09 -34.98 14.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.271 0.471 . . . . 74.209999999999994 112.271 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -90.75 -53.52 4.37 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.074 0.398 . . . . 71.430000000000007 112.074 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.63 -0.88 34.33 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 116.025 -0.534 . . . . 72.510000000000005 113.587 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.06 152.93 19.72 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.451 0.7 . . . . 73.319999999999993 109.75 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 84.3 mt -62.66 140.55 58.7 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.097 0.475 . . . . 72.230000000000004 111.788 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -74.11 -13.08 60.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.969 0.908 . . . . 65.430000000000007 112.186 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 29.53 39.69 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.453 -0.34 . . . . 74.219999999999999 112.531 -174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.5 145.07 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.971 0.909 . . . . 73.219999999999999 109.631 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 147.0 18.41 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.963 0.411 . . . . 73.120000000000005 111.919 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 75.0 p -102.01 133.6 46.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.9 -0.591 . . . . 64.430000000000007 110.159 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -115.1 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 123.139 0.576 . . . . 72.129999999999995 110.339 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 43.9 m -85.14 102.3 13.16 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.849 0.46 . . . . 64.530000000000001 110.961 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.7 m-85 -79.45 155.51 28.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.116 0.566 . . . . 72.230000000000004 110.747 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.71 -35.76 72.89 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.216 0.606 . . . . 74.239999999999995 110.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -114.38 129.01 25.27 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.379 0.671 . . . . 61.020000000000003 111.337 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.51 -37.99 83.02 Favored 'Trans proline' 0 CA--C 1.587 3.15 0 C-N-CA 123.108 2.538 . . . . 75.319999999999993 116.42 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.64 -24.87 40.98 Favored 'Trans proline' 0 C--N 1.396 3.047 0 CA-C-N 122.611 1.968 . . . . 74.219999999999999 112.857 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -74.59 -38.12 62.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.647 0.779 . . . . 63.200000000000003 110.21 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.42 -51.34 70.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.779 -1.1 . . . . 50.520000000000003 110.692 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' HA ' HD13 ' A' ' 80' ' ' ILE . 1.3 tmtp? -65.17 -39.15 92.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.32 -0.854 . . . . 75.150000000000006 111.299 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.0 94.71 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.396 0.278 . . . . 74.239999999999995 111.285 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.404 0.682 . . . . 74.109999999999999 112.222 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 77' ' ' LYS . 89.6 mt -65.61 -63.46 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.018 0.527 . . . . 70.349999999999994 110.674 173.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.05 -25.59 67.77 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.403 -0.817 . . . . 74.140000000000001 111.698 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -82.12 -60.23 2.29 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.871 0.469 . . . . 74.329999999999998 111.691 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.728 1.381 . . . . 73.340000000000003 114.728 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.33 119.87 12.31 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.678 0.672 . . . . 73.340000000000003 109.74 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 5.35 75.97 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 114.86 0.704 . . . . 73.230000000000004 114.86 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.29 -167.8 2.0 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 117.939 0.869 . . . . 75.219999999999999 111.525 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.13 118.06 23.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.098 0.959 . . . . 72.239999999999995 109.981 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HB2' HG21 ' A' ' 93' ' ' ILE . 67.9 t80 -78.8 -75.11 0.25 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.67 0.271 . . . . 72.439999999999998 110.578 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.4 t -122.84 61.21 1.01 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.778 0.799 . . . . 73.049999999999997 110.077 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.41 2.49 84.39 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.011 -0.995 . . . . 73.040000000000006 114.076 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -117.18 136.51 23.41 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.998 0.919 . . . . 74.310000000000002 110.186 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.07 116.7 4.81 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.555 2.17 . . . . 74.409999999999997 112.153 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' A' ' 88' ' ' PHE . 41.1 pt -92.56 153.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.574 0.749 . . . . 73.530000000000001 113.005 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HZ1' ' HB3' ' A' ' 94' ' ' LYS . 2.6 mmmp? -123.95 119.09 28.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.215 1.006 . . . . 74.299999999999997 108.869 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.527 HG21 HG13 ' A' ' 18' ' ' VAL . 32.6 t -112.85 134.12 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.598 0.759 . . . . 72.329999999999998 110.136 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.7 p -146.42 -176.33 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.742 1.217 . . . . 72.430000000000007 109.182 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -76.46 145.33 39.31 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.01 0.823 . . . . 75.219999999999999 110.778 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.25 93.28 8.16 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.04 0.448 . . . . 54.200000000000003 110.793 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 124.036 0.935 . . . . 70.049999999999997 111.261 178.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.552 1.027 0 CA-C-O 121.025 0.44 . . . . 72.120000000000005 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -96.44 132.48 41.94 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.579 0.752 . . . . 75.109999999999999 110.625 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.415 HG21 ' HB1' ' A' ' 76' ' ' ALA . 35.7 pt -114.96 152.87 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.879 0.872 . . . . 73.230000000000004 111.061 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -107.7 116.45 31.96 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.158 0.583 . . . . 72.409999999999997 110.175 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.551 HG23 HG11 ' A' ' 95' ' ' VAL . 19.1 t -109.6 134.15 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.212 1.005 . . . . 75.329999999999998 110.436 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -120.12 157.19 29.53 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.063 0.945 . . . . 72.040000000000006 110.562 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.88 29.55 28.58 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-O 121.241 0.356 . . . . 73.120000000000005 113.941 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.28 -13.46 46.62 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.153 0.981 . . . . 73.430000000000007 112.957 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.0 54.25 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 114.878 0.711 . . . . 71.209999999999994 114.878 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.88 -24.61 48.43 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.813 0.845 . . . . 71.5 112.34 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.67 20.02 9.16 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.416 0.686 . . . . 72.430000000000007 111.787 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.14 131.73 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.056 0.543 . . . . 72.019999999999996 112.0 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.4 p -129.39 154.67 46.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.406 0.682 . . . . 75.140000000000001 110.292 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.566 HG21 ' HB ' ' A' ' 51' ' ' ILE . 90.4 mt -50.24 -52.51 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 124.283 1.033 . . . . 75.219999999999999 111.815 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.42 -37.03 84.28 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.568 -0.742 . . . . 73.310000000000002 111.462 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -69.9 -36.89 75.77 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.107 0.41 . . . . 74.5 112.107 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.5 -37.9 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 120.977 0.417 . . . . 71.310000000000002 110.052 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.74 66.06 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.924 0.49 . . . . 74.209999999999994 111.594 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.34 -32.52 58.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.101 0.96 . . . . 74.310000000000002 111.434 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.14 -49.69 41.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.659 0.784 . . . . 74.010000000000005 110.392 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 14.2 m-85 -82.89 -16.96 45.45 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.556 1.317 . . . . 75.030000000000001 114.556 -173.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -66.98 -17.36 64.88 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.471 0.915 . . . . 73.439999999999998 113.471 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.55 -24.75 63.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.039 0.536 . . . . 73.420000000000002 111.99 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.06 -41.08 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.304 1.042 . . . . 75.019999999999996 111.375 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.11 176.45 47.19 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.454 -0.403 . . . . 74.230000000000004 113.993 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.4 126.18 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.899 0.479 . . . . 72.439999999999998 109.911 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 81.0 mt -94.64 141.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.712 0.805 . . . . 75.420000000000002 109.038 173.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.533 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 26.4 mtpp -59.78 144.67 47.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.366 0.666 . . . . 74.200000000000003 111.658 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.3 m -128.4 120.27 26.62 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.489 -0.778 . . . . 71.530000000000001 109.569 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.16 114.72 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.017 -0.734 . . . . 73.219999999999999 109.017 171.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.35 -28.28 66.08 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.277 1.031 . . . . 73.420000000000002 111.777 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 11.5 mmpt? -71.61 -45.87 60.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.29 0.636 . . . . 75.239999999999995 111.74 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 p -82.98 -35.17 26.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.134 0.574 . . . . 74.150000000000006 111.453 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.17 17.79 64.15 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.78 -0.645 . . . . 72.219999999999999 112.404 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -120.98 152.07 55.94 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.407 1.083 . . . . 74.439999999999998 111.79 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HG2' HG22 ' A' ' 27' ' ' ILE . 18.8 Cg_endo -61.42 146.77 96.83 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.739 2.292 . . . . 74.219999999999999 113.141 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.533 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 52.7 mtt -82.75 97.1 8.41 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.016 0.526 . . . . 73.230000000000004 110.646 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.566 ' HB ' HG21 ' A' ' 27' ' ' ILE . 70.2 mt -144.27 117.48 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.183 0.993 . . . . 75.299999999999997 109.132 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.56 110.37 22.19 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.589 -0.523 . . . . 75.530000000000001 109.589 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.7 mt -82.31 115.35 21.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.46 0.704 . . . . 74.409999999999997 110.196 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -69.89 117.33 11.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.061 0.545 . . . . 61.130000000000003 110.247 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 m -122.39 139.13 54.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.02 0.928 . . . . 62.43 109.59 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -73.32 135.63 44.38 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.175 0.59 . . . . 70.219999999999999 111.62 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 15.4 ptm180 -64.64 -38.33 90.65 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.459 1.103 . . . . 75.219999999999999 112.674 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 45.4 mt-10 -80.77 -55.52 4.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.252 0.621 . . . . 75.209999999999994 111.839 -171.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.2 p -84.07 -31.19 25.47 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.3 0.64 . . . . 71.230000000000004 111.794 -174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 8.71 86.26 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 116.438 -0.346 . . . . 72.109999999999999 113.22 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -92.8 152.32 19.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.213 0.605 . . . . 75.209999999999994 111.937 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.76 126.46 28.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.767 0.827 . . . . 61.509999999999998 110.784 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -71.27 -12.97 61.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.051 0.94 . . . . 62.240000000000002 112.201 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.97 37.73 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 112.014 -0.435 . . . . 72.239999999999995 112.014 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.47 149.27 49.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.998 . . . . 73.219999999999999 109.552 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.32 159.13 25.1 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.492 0.553 . . . . 72.109999999999999 112.492 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.5 p -115.24 114.08 24.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.132 0.573 . . . . 71.420000000000002 111.323 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 51' ' ' ILE . 21.6 t -99.81 108.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.432 1.093 . . . . 75.510000000000005 110.608 -173.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.2 m -84.98 101.76 12.63 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.686 0.394 . . . . 75.239999999999995 111.28 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 38.0 m-85 -77.37 156.13 31.44 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.097 0.559 . . . . 73.209999999999994 111.18 171.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.08 -27.41 54.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.298 0.639 . . . . 71.219999999999999 111.296 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 22.8 m-20 -120.0 131.38 24.43 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 122.942 0.497 . . . . 70.439999999999998 111.743 171.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.37 -38.3 82.37 Favored 'Trans proline' 0 CA--C 1.583 2.93 0 C-N-CA 122.879 2.386 . . . . 64.129999999999995 115.68 168.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 37.7 Cg_endo -64.98 -25.42 59.35 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 123.03 2.118 . . . . 62.039999999999999 113.404 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.9 m -76.17 -37.24 58.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.072 0.549 . . . . 73.010000000000005 110.19 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HB1' HG21 ' A' ' 16' ' ' ILE . . . -61.69 -48.29 81.46 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.324 0.649 . . . . 72.019999999999996 111.015 174.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.42 -47.5 85.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.279 1.032 . . . . 75.430000000000007 110.799 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.34 93.88 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.604 -0.725 . . . . 73.329999999999998 111.738 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -31.76 73.07 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.321 0.648 . . . . 71.25 112.507 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 95' ' ' VAL . 72.5 mt -63.62 -61.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.264 0.226 . . . . 74.450000000000003 110.599 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.19 -24.7 65.0 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.421 0.688 . . . . 63.109999999999999 112.643 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -80.21 -59.38 2.73 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.44 0.696 . . . . 74.150000000000006 111.617 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 93' ' ' ILE . 77.1 m-85 -85.84 -10.83 54.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.194 1.183 . . . . 74.120000000000005 114.194 -170.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.68 115.14 4.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.376 0.534 . . . . 73.329999999999998 110.258 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.53 68.58 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 114.921 0.728 . . . . 71.150000000000006 114.921 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.5 mmtt -94.08 141.46 28.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.111 0.956 . . . . 73.329999999999998 111.935 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.04 116.13 19.14 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.599 0.759 . . . . 74.319999999999993 112.179 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -90.9 -78.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.582 0.753 . . . . 73.099999999999994 110.949 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -109.26 54.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.968 0.889 . . . . 73.510000000000005 110.248 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.64 8.48 87.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.983 -1.008 . . . . 74.209999999999994 113.83 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -133.59 136.82 27.54 Favored Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 123.811 0.845 . . . . 74.010000000000005 109.878 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.73 116.55 4.76 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.739 2.293 . . . . 75.530000000000001 110.893 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 83' ' ' PHE . 16.0 pt -80.45 154.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.735 0.642 . . . . 74.010000000000005 112.735 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -119.22 112.3 19.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.369 -0.975 . . . . 72.540000000000006 108.369 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.551 HG11 HG23 ' A' ' 18' ' ' VAL . 14.2 t -107.0 137.02 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.019 0.528 . . . . 75.349999999999994 110.876 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.6 m -141.51 179.86 6.56 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.997 1.319 . . . . 70.219999999999999 109.207 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.31 149.59 31.72 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.807 0.731 . . . . 73.230000000000004 110.399 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.89 85.92 7.03 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.024 0.44 . . . . 73.420000000000002 110.117 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.571 1.752 0 C-N-CA 123.209 0.604 . . . . 71.430000000000007 112.135 -176.114 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.461 0.172 . . . . 62.049999999999997 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -106.18 125.67 51.28 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.843 0.857 . . . . 74.010000000000005 110.747 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 76' ' ' ALA . 30.3 pt -114.9 148.28 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.906 0.882 . . . . 71.439999999999998 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -102.14 120.05 39.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.433 0.693 . . . . 73.510000000000005 109.607 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG23 HG11 ' A' ' 95' ' ' VAL . 14.4 t -114.9 136.13 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.186 0.994 . . . . 72.230000000000004 110.388 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -124.37 162.69 23.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.131 0.973 . . . . 74.230000000000004 110.234 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.92 25.93 61.33 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 114.203 0.441 . . . . 61.039999999999999 114.203 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 93' ' ' ILE . 77.0 mt -79.03 -22.38 45.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.352 1.061 . . . . 71.150000000000006 112.013 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.87 167.66 42.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.083 0.373 . . . . 63.219999999999999 113.227 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.62 -19.56 59.13 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 112.84 0.682 . . . . 72.439999999999998 112.84 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -86.91 6.93 29.51 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.145 0.578 . . . . 74.519999999999996 111.934 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.2 138.03 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 124.198 0.999 . . . . 73.329999999999998 112.242 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -129.44 151.15 50.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.756 -0.59 . . . . 73.400000000000006 110.061 171.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 51' ' ' ILE . 67.9 mt -49.19 -51.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.631 1.172 . . . . 64.439999999999998 112.773 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.68 -21.1 55.85 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.788 0.662 . . . . 72.530000000000001 112.788 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -73.85 -37.55 64.75 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 117.962 0.346 . . . . 65.530000000000001 111.099 171.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.23 -41.48 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 121.309 0.576 . . . . 70.430000000000007 109.7 171.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.5 92.42 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.341 -0.845 . . . . 75.200000000000003 111.596 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.93 -38.11 89.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.273 0.629 . . . . 72.239999999999995 111.047 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -67.27 -55.9 12.06 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.816 0.846 . . . . 63.439999999999998 111.385 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.446 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 49.0 m-85 -77.94 -21.64 50.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.584 1.327 . . . . 70.150000000000006 114.584 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.87 -20.04 66.09 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.983 1.105 . . . . 74.510000000000005 113.983 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -60.56 -22.28 63.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 122.985 0.514 . . . . 73.219999999999999 112.15 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.08 -42.45 14.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 124.507 1.123 . . . . 73.140000000000001 111.424 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 172.67 45.12 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.981 -0.554 . . . . 73.299999999999997 113.229 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.96 125.47 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.557 0.743 . . . . 74.349999999999994 110.719 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 73.2 mt -95.56 130.5 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.943 0.897 . . . . 70.430000000000007 109.388 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.591 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.5 mtpt -51.04 153.99 1.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.743 0.817 . . . . 75.219999999999999 112.91 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 52.4 m -140.07 125.46 18.97 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.613 0.765 . . . . 71.230000000000004 110.508 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -64.13 123.87 20.19 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.448 0.699 . . . . 74.310000000000002 111.038 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -71.78 -24.02 61.67 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.109 0.563 . . . . 74.420000000000002 112.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.8 -54.36 13.99 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.807 0.443 . . . . 65.099999999999994 111.577 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -84.57 -45.3 12.7 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.196 0.598 . . . . 74.439999999999998 111.668 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.97 37.8 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.973 -0.558 . . . . 74.439999999999998 112.523 -170.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -106.13 148.94 37.52 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.128 0.971 . . . . 75.530000000000001 111.28 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 51.0 Cg_endo -68.14 145.97 68.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.598 2.198 . . . . 72.140000000000001 111.922 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.591 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 58.2 mtt -77.16 94.79 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.563 0.697 . . . . 71.200000000000003 110.026 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.575 ' HB ' HG23 ' A' ' 27' ' ' ILE . 86.7 mt -144.54 116.44 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.053 1.341 . . . . 74.510000000000005 108.49 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 14.5 m120 -99.03 109.43 22.18 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.155 -0.683 . . . . 71.510000000000005 109.155 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.84 120.8 26.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.138 0.575 . . . . 73.109999999999999 110.06 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 57.0 m-85 -73.12 104.35 4.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.011 0.524 . . . . 74.340000000000003 110.994 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -86.76 160.0 18.95 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.953 0.901 . . . . 62.32 110.065 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -93.45 155.1 17.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.953 0.901 . . . . 73.349999999999994 111.962 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.16 -35.64 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.658 0.783 . . . . 75.510000000000005 112.834 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.97 -37.99 14.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.93 -0.482 . . . . 75.239999999999995 111.952 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.401 ' HB ' ' HZ3' ' A' ' 61' ' ' LYS . 31.5 p -94.01 -33.38 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 112.522 0.564 . . . . 73.420000000000002 112.522 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.86 6.26 89.16 Favored Glycine 0 CA--C 1.541 1.656 0 N-CA-C 114.223 0.449 . . . . 41.420000000000002 114.223 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HZ3' ' HB ' ' A' ' 59' ' ' THR . 38.6 mtmm -102.1 171.72 7.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.689 0.796 . . . . 73.209999999999994 110.78 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.37 130.26 39.33 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.972 -0.455 . . . . 72.25 111.71 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -74.78 -18.96 60.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.432 0.693 . . . . 75.239999999999995 112.548 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 35.1 12.61 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 116.362 -0.381 . . . . 65.310000000000002 113.064 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 41.3 mt-10 -127.94 154.06 45.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.2 1.0 . . . . 73.530000000000001 109.042 173.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -163.57 164.08 24.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.093 0.557 . . . . 71.140000000000001 111.822 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.0 p -120.26 128.92 53.77 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.998 -0.546 . . . . 71.400000000000006 109.98 168.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.42 111.8 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.575 0.75 . . . . 63.439999999999998 110.809 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 m -89.21 102.71 15.37 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.936 0.494 . . . . 72.030000000000001 111.724 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 34.7 m-85 -78.09 156.85 29.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.707 0.803 . . . . 75.129999999999995 110.625 168.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.1 -32.31 44.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.045 0.538 . . . . 74.049999999999997 110.434 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 4.0 m-20 -106.08 122.58 41.82 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.59 0.756 . . . . 62.229999999999997 110.453 174.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 72' ' ' ASP . 5.3 Cg_endo -49.94 -42.45 44.97 Favored 'Trans proline' 0 CA--C 1.586 3.108 0 C-N-CA 122.918 2.412 . . . . 61.530000000000001 115.789 167.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.32 -25.5 71.57 Favored 'Trans proline' 0 C--N 1.406 3.564 0 CA-C-N 122.602 1.965 . . . . 73.439999999999998 113.117 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.8 m -76.59 -37.22 56.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.436 0.694 . . . . 73.140000000000001 110.917 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 16' ' ' ILE . . . -65.07 -47.21 78.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.082 0.553 . . . . 64.219999999999999 111.151 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.58 -42.96 95.29 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.562 0.745 . . . . 75.209999999999994 111.282 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.42 89.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.285 -0.416 . . . . 71.409999999999997 111.847 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.65 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.398 0.679 . . . . 73.349999999999994 112.385 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 95' ' ' VAL . 72.4 mt -64.24 -63.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.528 0.331 . . . . 74.549999999999997 110.326 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.3 -31.76 63.97 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.556 0.742 . . . . 74.140000000000001 112.45 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -78.49 -56.98 4.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.499 0.72 . . . . 74.209999999999994 111.921 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 93' ' ' ILE . 62.7 m-85 -88.13 -4.1 58.8 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.242 1.201 . . . . 73.140000000000001 114.242 -171.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.7 110.81 1.4 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.634 0.374 . . . . 62.119999999999997 111.097 173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.33 80.16 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.049 0.779 . . . . 71.329999999999998 115.049 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.44 144.01 26.64 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 117.811 0.805 . . . . 71.030000000000001 112.023 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.64 116.91 19.33 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.983 0.513 . . . . 74.219999999999999 112.335 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.11 -66.88 0.82 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.485 0.714 . . . . 75.430000000000007 109.996 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.3 t -107.44 38.76 2.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.295 1.038 . . . . 74.439999999999998 110.001 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.56 23.86 74.22 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.003 -0.544 . . . . 74.219999999999999 113.253 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 28.0 p-10 -138.71 123.69 11.9 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 124.06 0.944 . . . . 74.549999999999997 110.53 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 21.9 Cg_exo -64.31 112.52 1.93 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.156 2.571 . . . . 74.109999999999999 112.771 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.454 HG21 HD21 ' A' ' 21' ' ' LEU . 18.6 pt -83.55 161.24 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 72.349999999999994 112.031 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -113.85 123.06 48.88 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.259 1.023 . . . . 74.25 108.298 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 18' ' ' VAL . 14.6 t -115.06 134.72 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 121.042 0.449 . . . . 75.519999999999996 110.508 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -142.72 179.77 6.8 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.173 1.389 . . . . 70.510000000000005 109.227 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -76.79 151.9 35.78 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.206 0.457 . . . . 73.519999999999996 110.488 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.72 95.89 8.62 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.69 0.396 . . . . 64.510000000000005 110.2 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 123.49 0.716 . . . . 72.439999999999998 111.275 -178.271 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 112.195 0.442 . . . . 74.340000000000003 112.195 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.7 m -126.82 129.56 48.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.889 0.876 . . . . 71.430000000000007 109.647 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 29.7 pt -116.21 146.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.823 0.849 . . . . 74.549999999999997 111.335 -175.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -102.28 123.92 46.94 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.457 0.703 . . . . 74.219999999999999 109.871 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG11 HG22 ' A' ' 95' ' ' VAL . 21.6 t -119.12 138.85 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.667 1.187 . . . . 71.400000000000006 110.073 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -126.1 155.41 41.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.03 0.932 . . . . 72.299999999999997 110.808 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.84 1.36 70.68 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 114.184 0.434 . . . . 74.310000000000002 114.184 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.422 HD22 HG23 ' A' ' 93' ' ' ILE . 85.3 mt -61.36 -12.32 13.6 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.123 1.157 . . . . 74.420000000000002 114.123 -178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.25 173.28 49.57 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.389 0.515 . . . . 61.25 114.389 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 8.3 pt-20 -71.68 -22.46 61.66 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.286 -0.538 . . . . 74.329999999999998 111.27 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.52 8.93 22.76 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.714 0.806 . . . . 71.209999999999994 112.305 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.72 137.1 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.275 0 C-N-CA 122.722 0.409 . . . . 75.299999999999997 111.965 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 30' ' ' VAL . 57.9 p -131.22 148.01 52.66 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.428 0.691 . . . . 75.5 109.81 171.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.644 HG21 ' HB ' ' A' ' 51' ' ' ILE . 83.7 mt -51.5 -47.08 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.463 1.105 . . . . 75.510000000000005 112.983 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -69.7 -29.31 66.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.18 0.592 . . . . 73.450000000000003 111.916 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -74.1 -36.11 64.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.688 0.395 . . . . 73.140000000000001 111.369 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' THR . 44.4 t -65.36 -40.68 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.366 0.603 . . . . 74.129999999999995 109.663 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.98 85.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.017 -0.992 . . . . 63.119999999999997 111.735 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.74 -26.39 63.35 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.073 0.549 . . . . 75.329999999999998 111.664 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -75.29 -57.08 4.11 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.399 0.68 . . . . 72.439999999999998 111.578 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 30.9 m-85 -75.25 -19.47 59.71 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.593 1.331 . . . . 73.340000000000003 114.593 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.73 -21.51 66.44 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.69 0.996 . . . . 75.420000000000002 113.69 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -57.26 -25.03 58.54 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.112 0.565 . . . . 73.349999999999994 112.353 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.8 mm -84.57 -56.33 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.945 0.898 . . . . 71.030000000000001 110.72 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.33 166.99 33.87 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 116.024 -0.535 . . . . 73.209999999999994 113.38 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.23 114.16 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.019 0.528 . . . . 73.319999999999993 110.051 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 76.5 mt -79.7 136.31 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 109.186 -0.672 . . . . 60.439999999999998 109.186 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.6 mtpt -53.51 142.11 23.29 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.151 0.58 . . . . 72.099999999999994 112.0 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.7 m -132.88 119.84 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.629 -0.714 . . . . 72.230000000000004 110.079 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.73 123.33 16.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.335 1.054 . . . . 75.010000000000005 110.222 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -73.94 -30.75 62.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.656 0.782 . . . . 72.439999999999998 111.791 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.53 -51.54 49.67 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.151 0.581 . . . . 71.129999999999995 111.546 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 p -83.67 -45.67 13.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.469 0.708 . . . . 72.420000000000002 111.359 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.21 17.04 35.74 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 115.623 -0.717 . . . . 70.120000000000005 112.421 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -104.9 156.9 35.31 Favored Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 124.235 1.014 . . . . 74.400000000000006 112.801 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.78 142.2 19.98 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.956 2.437 . . . . 72.409999999999997 112.8 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.609 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.0 mtt -79.04 94.32 5.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.263 0.554 . . . . 75.120000000000005 110.305 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.644 ' HB ' HG21 ' A' ' 27' ' ' ILE . 72.1 mt -146.77 115.88 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.525 1.13 . . . . 65.219999999999999 108.906 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.17 111.15 23.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 74.450000000000003 110.116 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.61 143.36 34.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.147 0.579 . . . . 72.129999999999995 110.164 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -100.38 126.09 46.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 73.340000000000003 109.848 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -115.2 142.45 46.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.065 0.946 . . . . 74.150000000000006 110.276 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -67.7 96.55 0.56 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.06 -0.718 . . . . 75.310000000000002 109.06 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -61.88 -24.1 66.72 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.593 0.757 . . . . 74.040000000000006 112.065 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' A' ' 59' ' ' THR . 10.9 pt-20 -71.69 -39.49 70.18 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.461 0.705 . . . . 71.109999999999999 111.903 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -103.49 -62.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.308 0.643 . . . . 75.239999999999995 111.478 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 -7.84 5.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.37 -0.377 . . . . 65.420000000000002 113.701 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -90.19 161.88 15.51 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.546 0.673 . . . . 74.049999999999997 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 59.6 mt -76.49 138.46 40.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.254 0.622 . . . . 74.319999999999993 111.649 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -73.32 -20.15 60.87 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.744 0.818 . . . . 74.450000000000003 111.787 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.79 33.85 20.4 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.739 -0.664 . . . . 71.299999999999997 112.719 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.88 148.97 52.29 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.917 0.887 . . . . 63.549999999999997 109.74 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.11 159.57 31.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.567 0.58 . . . . 72.439999999999998 112.567 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.6 p -114.9 117.57 31.05 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.068 0.547 . . . . 63.25 110.629 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.36 109.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.68 0.792 . . . . 74.420000000000002 110.385 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -86.94 101.61 13.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.021 0.528 . . . . 70.310000000000002 111.116 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 58.3 m-85 -77.59 157.28 30.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.722 0.809 . . . . 74.420000000000002 110.76 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.38 -35.99 58.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.225 0.61 . . . . 73.510000000000005 110.579 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -106.49 128.01 27.07 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.541 0.737 . . . . 73.030000000000001 110.821 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -52.29 -39.94 71.31 Favored 'Trans proline' 0 CA--C 1.582 2.883 0 C-N-CA 122.697 2.265 . . . . 61.229999999999997 115.764 166.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.25 -24.01 65.69 Favored 'Trans proline' 0 C--N 1.401 3.317 0 CA-C-N 122.297 1.856 . . . . 73.219999999999999 113.715 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.8 m -77.12 -38.06 52.88 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.109 0.564 . . . . 71.439999999999998 110.782 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 16' ' ' ILE . . . -64.55 -43.8 92.81 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.428 0.632 . . . . 70.25 110.318 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -60.64 -48.02 83.64 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.146 1.378 . . . . 72.420000000000002 111.37 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.16 94.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.81 -0.632 . . . . 60.140000000000001 112.479 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.482 0.713 . . . . 74.230000000000004 112.387 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG12 HG11 ' A' ' 95' ' ' VAL . 92.2 mt -63.9 -60.53 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.115 0.566 . . . . 70.450000000000003 110.574 172.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.48 -31.68 66.23 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.409 -0.814 . . . . 75.439999999999998 111.576 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -80.06 -61.87 1.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.809 0.444 . . . . 70.219999999999999 111.933 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB2' HG23 ' A' ' 95' ' ' VAL . 71.3 m-85 -80.02 -10.46 59.77 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.618 0.97 . . . . 75.219999999999999 113.618 -170.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.4 104.26 2.23 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 109.541 -0.54 . . . . 72.010000000000005 109.541 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.55 42.41 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 115.546 -0.752 . . . . 62.32 114.017 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -82.69 152.1 25.95 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.882 0.841 . . . . 75.010000000000005 110.073 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.95 124.1 35.81 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.429 0.529 . . . . 64.140000000000001 112.429 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -126.83 136.32 52.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.253 -1.018 . . . . 74.439999999999998 108.253 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 t 61.49 30.32 18.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.189 0.996 . . . . 74.540000000000006 111.609 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.26 29.0 54.83 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.478 -0.783 . . . . 53.0 115.041 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -161.41 145.29 9.8 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 117.305 0.553 . . . . 72.129999999999995 111.383 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.64 110.67 1.93 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.018 2.479 . . . . 75.150000000000006 113.438 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG23 HD22 ' A' ' 21' ' ' LEU . 34.4 pt -78.88 160.6 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.861 0.865 . . . . 74.209999999999994 112.223 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -118.18 128.19 54.47 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.463 1.105 . . . . 73.319999999999993 109.457 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.54 HG22 HG11 ' A' ' 18' ' ' VAL . 23.6 t -121.91 135.34 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 74.329999999999998 111.107 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.5 p -146.4 179.36 7.58 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.708 1.203 . . . . 64.430000000000007 109.022 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 45.8 m-85 -75.27 154.4 37.47 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.969 0.804 . . . . 74.409999999999997 111.713 174.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.12 88.3 6.46 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.241 -0.652 . . . . 71.319999999999993 109.241 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.57 1.715 0 C-N-CA 123.451 0.7 . . . . 72.549999999999997 111.551 -174.712 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 CA--C 1.554 1.117 0 N-CA-C 111.88 0.326 . . . . 75.200000000000003 111.88 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -94.77 126.75 40.29 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.915 0.486 . . . . 74.430000000000007 110.187 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.5 pt -113.36 156.0 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.584 0.754 . . . . 73.129999999999995 111.291 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -116.3 125.42 52.13 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.329 0.651 . . . . 72.420000000000002 110.146 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG11 HG23 ' A' ' 95' ' ' VAL . 18.5 t -117.41 146.33 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.191 0.996 . . . . 74.140000000000001 110.363 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 27.6 mt-30 -124.7 163.62 21.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.684 1.193 . . . . 74.0 110.184 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.97 23.57 74.29 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 114.953 0.741 . . . . 61.520000000000003 114.953 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.19 -17.92 59.31 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.328 1.051 . . . . 75.319999999999993 111.958 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 177.29 49.54 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 114.71 0.644 . . . . 74.140000000000001 114.71 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 34.0 mt-10 -75.29 -14.66 60.52 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.664 0.786 . . . . 75.049999999999997 112.797 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -84.09 -8.97 58.96 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.336 0.654 . . . . 60.439999999999998 112.191 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.7 128.36 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 113.716 1.006 . . . . 74.120000000000005 113.716 -169.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 30' ' ' VAL . 43.3 p -125.61 152.86 44.57 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.517 0.727 . . . . 72.519999999999996 110.289 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 51' ' ' ILE . 88.0 mt -52.91 -45.55 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.379 0.672 . . . . 75.329999999999998 111.593 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.64 -38.74 92.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.58 0.752 . . . . 74.519999999999996 111.777 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.3 t -71.5 -39.46 70.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.756 0.422 . . . . 72.340000000000003 111.707 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 26' ' ' THR . 61.9 t -65.32 -40.4 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.256 0.55 . . . . 71.430000000000007 110.014 176.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -63.22 -42.63 99.29 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.141 -0.936 . . . . 72.239999999999995 111.286 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.52 -30.65 67.46 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.143 0.577 . . . . 74.5 111.379 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.43 -53.7 7.76 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.692 0.797 . . . . 73.230000000000004 111.418 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.2 m-85 -79.04 -16.26 57.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.784 1.031 . . . . 75.140000000000001 113.784 -174.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 63.6 pttt -59.07 -29.77 67.57 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 113.09 0.774 . . . . 74.299999999999997 113.09 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -58.85 -25.09 62.94 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.796 0.838 . . . . 52.439999999999998 112.275 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.35 -45.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.253 1.021 . . . . 74.540000000000006 111.649 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -178.7 45.62 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 116.343 -0.39 . . . . 72.409999999999997 113.315 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.92 126.97 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.7 0.4 . . . . 73.319999999999993 110.123 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 80.4 mt -95.06 143.2 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.785 0.834 . . . . 71.209999999999994 108.852 170.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.7 mtpt -62.42 145.62 53.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.092 0.557 . . . . 74.120000000000005 111.504 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 41.5 m -125.67 123.91 39.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.106 0.962 . . . . 73.310000000000002 108.809 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -71.69 123.74 23.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.071 0.549 . . . . 71.209999999999994 109.664 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -18.28 45.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.209 0.604 . . . . 72.439999999999998 111.722 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.26 -52.73 44.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.932 0.493 . . . . 72.25 110.801 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -83.38 -41.53 18.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.388 0.675 . . . . 70.420000000000002 111.022 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.63 16.0 44.27 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 115.881 -0.599 . . . . 70.409999999999997 112.512 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -121.91 153.33 60.48 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.184 0.994 . . . . 73.099999999999994 111.972 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 41.1 Cg_endo -64.22 140.92 73.43 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.256 2.637 . . . . 75.549999999999997 112.855 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.604 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.8 mtt -73.98 95.51 2.51 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.359 0.6 . . . . 74.019999999999996 109.809 -174.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' A' ' 27' ' ' ILE . 80.4 mt -144.67 120.73 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.833 1.253 . . . . 73.519999999999996 108.614 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 m120 -101.45 110.15 22.1 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.902 -0.407 . . . . 71.409999999999997 109.902 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.86 141.52 32.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.524 0.73 . . . . 74.519999999999996 109.748 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.49 112.41 25.31 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.474 0.71 . . . . 75.299999999999997 110.267 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -97.52 141.61 30.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.614 0.766 . . . . 75.540000000000006 110.17 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.41 123.63 25.02 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.69 1.196 . . . . 73.329999999999998 109.995 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.38 -20.05 59.19 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.307 1.225 . . . . 73.409999999999997 114.307 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.1 pt-20 -93.76 -44.5 8.11 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.946 0.793 . . . . 60.130000000000003 112.199 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 58' ' ' GLU . 46.1 p -92.22 -35.35 13.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.896 0.478 . . . . 74.420000000000002 112.124 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.89 0.94 68.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 113.945 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.5 162.31 27.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.39 0.595 . . . . 74.409999999999997 110.532 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 78.3 mt -81.08 132.67 35.38 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.811 -0.555 . . . . 73.510000000000005 111.053 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.21 -19.35 64.75 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.799 0.84 . . . . 74.200000000000003 111.866 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.57 21.49 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.007 -0.542 . . . . 63.43 112.147 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.45 145.11 46.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.789 0.835 . . . . 74.209999999999994 109.405 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.22 150.63 22.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.783 0.66 . . . . 71.209999999999994 112.783 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 35.6 p -108.19 114.46 28.36 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.828 0.451 . . . . 74.439999999999998 111.045 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -102.66 108.96 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.953 0.901 . . . . 74.209999999999994 109.853 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.1 m -85.47 105.29 15.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.615 0.366 . . . . 73.409999999999997 110.52 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 49.4 m-85 -79.26 156.63 28.02 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.357 0.663 . . . . 73.030000000000001 111.161 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.04 57.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.36 0.664 . . . . 71.209999999999994 110.737 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.27 129.52 23.81 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.276 0.63 . . . . 61.200000000000003 110.712 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.59 -42.02 43.57 Favored 'Trans proline' 0 CA--C 1.58 2.778 0 C-N-CA 123.005 2.47 . . . . 65.540000000000006 116.55 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.63 -21.17 52.52 Favored 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 122.301 1.857 . . . . 74.549999999999997 113.362 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 m -72.64 -38.17 67.78 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.309 0.644 . . . . 72.510000000000005 109.669 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.48 -53.24 57.66 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 55.210000000000001 111.276 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.99 -41.75 98.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.64 0.776 . . . . 71.340000000000003 111.151 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.49 98.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.892 0.477 . . . . 72.200000000000003 111.778 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.151 0.58 . . . . 63.210000000000001 112.457 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.64 -56.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.074 0.55 . . . . 70.439999999999998 110.928 174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.5 -27.33 69.2 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.524 0.729 . . . . 64.140000000000001 112.043 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -82.36 -60.39 2.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.057 0.543 . . . . 74.329999999999998 111.553 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -82.69 -13.57 56.16 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.23 1.196 . . . . 74.239999999999995 114.23 -168.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.57 104.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 119.194 0.906 . . . . 73.430000000000007 110.203 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.05 6.04 49.24 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.514 -0.766 . . . . 62.350000000000001 114.56 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.25 -176.45 5.11 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 117.856 0.828 . . . . 75.5 111.556 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.81 122.36 42.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.121 0.569 . . . . 61.219999999999999 110.664 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -75.32 -70.9 0.39 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.842 -0.429 . . . . 71.219999999999999 109.842 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.8 t -115.17 50.06 1.01 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.783 0.833 . . . . 74.510000000000005 109.391 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.53 73.59 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 115.408 -0.815 . . . . 64.5 113.501 -174.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -131.37 128.76 22.1 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.904 0.881 . . . . 72.430000000000007 111.806 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 113.82 2.3 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.369 2.713 . . . . 74.530000000000001 113.551 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.1 pt -97.19 151.86 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.552 0.741 . . . . 73.5 112.777 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 75.1 mmtt -113.6 112.09 22.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.326 1.05 . . . . 75.150000000000006 109.384 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.544 HG23 HG11 ' A' ' 18' ' ' VAL . 21.7 t -112.5 128.3 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.99 -0.444 . . . . 74.439999999999998 110.809 -174.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.0 m -140.48 -179.66 6.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.161 1.384 . . . . 73.420000000000002 109.495 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -73.87 151.49 40.46 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.179 0.445 . . . . 73.439999999999998 110.63 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 91.1 6.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.214 0.531 . . . . 64.140000000000001 109.939 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.567 1.611 0 C-N-CA 123.931 0.892 . . . . 75.209999999999994 110.782 -177.283 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 70' ' ' PHE . 35.5 p30 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 112.274 0.472 . . . . 73.329999999999998 112.274 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -103.19 130.0 50.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.282 0.633 . . . . 72.219999999999999 110.672 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.9 pt -119.26 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.64 0.776 . . . . 74.310000000000002 112.13 -176.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -95.81 119.63 34.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.25 0.548 . . . . 73.400000000000006 110.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG11 HG23 ' A' ' 95' ' ' VAL . 17.6 t -112.83 141.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.782 1.233 . . . . 75.409999999999997 109.814 -177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -126.44 155.22 42.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.229 1.011 . . . . 63.140000000000001 110.439 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.88 32.3 50.24 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.222 0.849 . . . . 75.450000000000003 115.222 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 HD23 HG21 ' A' ' 93' ' ' ILE . 69.8 mt -74.89 -33.33 62.03 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.214 1.006 . . . . 74.109999999999999 112.114 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.64 153.86 10.34 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-N 116.185 -0.461 . . . . 72.400000000000006 112.868 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.43 -8.36 54.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.992 0.917 . . . . 75.310000000000002 112.191 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -117.22 81.8 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.032 0.933 . . . . 75.140000000000001 109.302 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.17 131.75 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.2 1.0 . . . . 75.329999999999998 110.525 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' HG21 ' A' ' 30' ' ' VAL . 12.8 p -116.26 155.71 27.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.655 -0.653 . . . . 73.049999999999997 109.992 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.568 HG21 ' HB ' ' A' ' 51' ' ' ILE . 68.1 mt -52.19 -47.67 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.118 0.967 . . . . 74.340000000000003 112.187 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.88 -21.45 54.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.995 0.518 . . . . 74.200000000000003 112.374 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -68.83 -44.34 73.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.842 0.457 . . . . 74.420000000000002 110.144 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 26' ' ' THR . 24.6 t -67.14 -38.97 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 115.912 -0.586 . . . . 72.040000000000006 110.364 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.71 79.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.756 -0.656 . . . . 72.540000000000006 111.738 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.55 -31.57 72.84 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.222 0.609 . . . . 63.219999999999999 111.358 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -73.58 -54.29 8.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.035 0.534 . . . . 74.430000000000007 111.152 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 40.2 m-85 -78.02 -22.92 48.5 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.087 1.143 . . . . 74.439999999999998 114.087 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.52 -22.61 66.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.055 0.761 . . . . 72.420000000000002 113.055 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.46 -27.32 65.98 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.796 0.438 . . . . 73.209999999999994 111.628 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.06 -45.07 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 75.519999999999996 110.988 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.22 44.3 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 116.094 -0.503 . . . . 62.420000000000002 113.625 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.23 127.39 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.71 0.804 . . . . 74.530000000000001 110.683 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.3 mt -98.85 132.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 73.409999999999997 109.904 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.03 142.75 29.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 75.230000000000004 111.501 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 67.7 m -139.85 131.32 26.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.811 -0.632 . . . . 74.530000000000001 111.07 -176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -68.86 114.68 7.4 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.261 1.025 . . . . 73.299999999999997 109.357 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -74.37 -21.57 59.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.391 0.676 . . . . 73.219999999999999 112.184 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -73.52 -49.13 28.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.653 0.381 . . . . 74.530000000000001 111.499 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -86.16 -45.19 11.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.039 0.536 . . . . 65.209999999999994 111.867 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.84 -4.34 39.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.893 -0.594 . . . . 73.150000000000006 112.802 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -93.19 140.15 23.22 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 112.471 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 53.8 Cg_endo -70.44 149.67 62.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.745 2.297 . . . . 55.450000000000003 111.842 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.6 mtt -75.57 94.35 3.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.351 0.596 . . . . 71.109999999999999 109.52 -176.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.568 ' HB ' HG21 ' A' ' 27' ' ' ILE . 75.1 mt -145.06 121.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 74.319999999999993 107.713 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.7 m-80 -104.57 107.85 19.0 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 110.019 -0.363 . . . . 73.329999999999998 110.019 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.7 mt -81.04 126.17 31.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.057 0.943 . . . . 74.109999999999999 110.002 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 96.4 m-85 -86.43 134.73 33.67 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.251 0.62 . . . . 74.530000000000001 111.085 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -129.78 144.91 51.53 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.64 1.176 . . . . 72.200000000000003 109.746 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -68.97 113.02 5.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.116 0.566 . . . . 72.040000000000006 110.12 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -65.88 -24.61 66.9 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.994 0.917 . . . . 73.329999999999998 111.44 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' A' ' 59' ' ' THR . 11.6 pt-20 -77.37 -45.34 26.3 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.546 0.738 . . . . 64.430000000000007 112.011 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.501 HG21 ' HG3' ' A' ' 58' ' ' GLU . 37.4 p -94.28 -56.74 2.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.068 0.461 . . . . 73.329999999999998 111.698 -176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.24 4.7 23.67 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-N 116.053 -0.521 . . . . 41.340000000000003 113.574 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HB2' ' HZ1' ' A' ' 61' ' ' LYS . 10.1 mtmp? -97.87 151.38 20.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.293 0.637 . . . . 73.120000000000005 111.577 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.76 135.2 52.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.452 0.701 . . . . 75.430000000000007 111.158 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.67 -16.17 60.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.374 0.67 . . . . 75.400000000000006 111.708 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.62 39.65 24.79 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.766 -0.534 . . . . 75.230000000000004 111.766 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 57.9 mt-10 -133.56 148.97 51.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.427 0.691 . . . . 72.450000000000003 109.33 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -157.86 151.53 23.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.791 0.436 . . . . 72.310000000000002 111.688 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -112.44 113.43 25.61 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.649 0.38 . . . . 74.230000000000004 110.65 172.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.0 t -101.5 110.62 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.571 1.148 . . . . 71.239999999999995 110.174 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 20.0 m -89.95 101.39 14.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 111.216 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 41.9 m-85 -76.56 157.42 32.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.383 0.673 . . . . 71.239999999999995 110.557 170.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.06 -32.37 67.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.777 0.431 . . . . 72.019999999999996 110.017 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -113.79 123.67 32.5 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.548 0.739 . . . . 73.439999999999998 111.474 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.74 -33.53 80.86 Favored 'Trans proline' 0 CA--C 1.583 2.941 0 C-N-CA 122.841 2.36 . . . . 63.240000000000002 116.497 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.2 -26.41 42.32 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 122.871 2.061 . . . . 71.420000000000002 113.209 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.5 m -77.69 -35.44 52.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.531 0.733 . . . . 71.219999999999999 110.485 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 16' ' ' ILE . . . -62.63 -49.89 73.4 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 121.4 0.619 . . . . 71.329999999999998 110.594 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -65.58 -37.52 86.88 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.676 1.191 . . . . 72.340000000000003 111.426 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.82 90.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.1 0.56 . . . . 73.329999999999998 112.045 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.64 68.46 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.303 0.641 . . . . 75.25 112.444 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.4 mt -64.47 -64.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.883 0.473 . . . . 71.239999999999995 110.464 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.06 -25.01 65.02 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.355 0.662 . . . . 75.230000000000004 112.389 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -82.32 -62.14 1.7 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.993 0.517 . . . . 75.319999999999993 111.67 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.12 -9.76 59.42 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.032 1.123 . . . . 74.219999999999999 114.032 -170.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -66.13 118.13 9.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 120.943 0.401 . . . . 61.32 110.389 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.88 79.66 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.335 -0.703 . . . . 75.450000000000003 114.511 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -93.95 167.89 11.31 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 118.44 1.12 . . . . 74.230000000000004 111.386 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -96.89 118.92 34.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.214 0.605 . . . . 70.219999999999999 111.487 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 89.7 t80 -72.47 -74.17 0.17 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.001 0.521 . . . . 64.5 110.414 172.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -116.95 60.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.039 0.936 . . . . 73.450000000000003 108.847 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.22 13.27 67.11 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 115.272 -0.876 . . . . 61.25 113.46 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -118.19 120.48 32.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.247 1.019 . . . . 65.209999999999994 111.017 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.28 96.0 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.953 2.435 . . . . 73.140000000000001 113.158 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.485 HG21 HD23 ' A' ' 21' ' ' LEU . 28.1 pt -76.04 156.07 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.78 0.832 . . . . 73.219999999999999 113.225 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -122.98 116.56 23.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.366 1.066 . . . . 74.5 108.942 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG23 HG11 ' A' ' 18' ' ' VAL . 20.0 t -110.92 136.36 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.67 0.388 . . . . 74.430000000000007 110.731 -174.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.8 p -148.67 -176.52 5.36 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.982 1.313 . . . . 75.420000000000002 109.657 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -76.6 146.67 38.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.741 0.701 . . . . 72.439999999999998 111.758 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.84 100.15 11.5 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.984 0.514 . . . . 64.120000000000005 110.242 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.811 0.844 . . . . 61.399999999999999 111.416 -174.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.409 0.147 . . . . 73.030000000000001 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.94 -171.31 27.88 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 116.614 -0.267 . . . . 74.120000000000005 113.242 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -68.4 -40.58 81.25 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.659 0.784 . . . . 73.340000000000003 111.462 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -100.45 135.75 41.41 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.838 0.855 . . . . 73.329999999999998 109.487 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -117.35 140.32 49.72 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.654 0.782 . . . . 73.099999999999994 110.665 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -69.88 -41.01 75.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.541 0.736 . . . . 74.030000000000001 112.683 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -80.52 77.07 7.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.285 -0.635 . . . . 74.109999999999999 109.285 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.06 -31.08 71.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.956 0.902 . . . . 71.299999999999997 112.153 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -64.47 144.14 57.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.57 0.348 . . . . 73.530000000000001 110.535 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -84.98 121.37 27.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 122.573 0.349 . . . . 73.120000000000005 110.644 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.7 t -79.63 91.91 5.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.319 0.648 . . . . 71.120000000000005 111.009 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.4 98.81 6.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.782 -0.644 . . . . 74.239999999999995 109.467 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.427 HD22 ' HB3' ' A' ' 97' ' ' PHE . 8.5 p30 -90.28 174.35 7.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.909 0.484 . . . . 74.439999999999998 111.146 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -99.46 12.35 36.63 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.452 0.538 . . . . 61.149999999999999 112.452 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.2 m -130.83 128.63 41.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.884 0.474 . . . . 71.319999999999993 110.099 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.4 pt -115.39 147.31 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.423 . . . . 71.439999999999998 111.551 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -105.71 108.86 20.6 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.256 0.622 . . . . 74.230000000000004 110.045 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG11 HG23 ' A' ' 95' ' ' VAL . 17.5 t -101.19 138.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.064 0.946 . . . . 73.140000000000001 110.09 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 23.4 mt-30 -119.44 155.11 32.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.728 0.811 . . . . 55.229999999999997 111.34 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.04 44.74 76.41 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.511 0.965 . . . . 52.340000000000003 115.511 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.426 HD23 HG21 ' A' ' 93' ' ' ILE . 49.3 mt -81.22 -30.75 34.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.462 1.105 . . . . 65.519999999999996 110.781 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.07 160.53 11.39 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 113.815 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.55 -23.01 64.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.492 0.717 . . . . 73.420000000000002 110.364 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -107.15 88.44 2.74 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.646 0.778 . . . . 60.340000000000003 108.995 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.37 136.7 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.888 0.875 . . . . 75.519999999999996 111.038 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.38 161.81 20.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.689 . . . . 75.439999999999998 110.43 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.557 HG21 ' HB ' ' A' ' 51' ' ' ILE . 76.1 mt -50.85 -47.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.173 0.989 . . . . 64.209999999999994 111.32 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -75.99 -23.99 55.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.333 0.653 . . . . 74.129999999999995 111.823 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -67.94 -46.4 71.56 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.658 0.383 . . . . 63.140000000000001 110.541 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 30.8 t -64.6 -42.73 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.092 0.473 . . . . 71.209999999999994 110.27 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.62 96.16 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.542 -0.754 . . . . 74.209999999999994 112.637 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.19 -22.07 55.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.96 0.504 . . . . 71.329999999999998 111.449 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -79.58 -44.95 20.1 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.236 0.614 . . . . 75.239999999999995 111.364 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -83.14 -13.71 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.852 1.056 . . . . 75.230000000000004 113.852 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.71 -30.08 60.53 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.009 1.114 . . . . 71.549999999999997 114.009 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.28 -24.41 67.27 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.623 0.769 . . . . 74.430000000000007 112.606 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 79' ' ' ALA . 19.5 mm -82.41 -44.37 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.836 0.854 . . . . 72.530000000000001 111.372 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.88 179.64 48.66 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 116.406 -0.361 . . . . 63.43 113.67 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.64 125.09 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.497 0.719 . . . . 74.230000000000004 111.549 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.7 mt -94.0 138.38 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 70.420000000000002 108.781 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.584 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 27.1 mtpp -57.73 155.02 10.73 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.068 0.547 . . . . 71.519999999999996 111.73 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.8 m -145.5 125.38 13.5 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.273 0.629 . . . . 73.200000000000003 111.155 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.33 125.85 30.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.778 -0.823 . . . . 62.130000000000003 108.778 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.3 -21.66 25.62 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.643 0.608 . . . . 74.439999999999998 112.643 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.26 -43.21 95.56 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.305 0.642 . . . . 74.430000000000007 111.713 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -82.72 -42.93 17.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.576 0.75 . . . . 72.519999999999996 110.117 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.51 56.02 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.392 -0.822 . . . . 71.319999999999993 111.893 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -110.44 147.09 35.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.105 0.962 . . . . 74.319999999999993 111.63 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 33.7 Cg_endo -64.99 142.19 73.82 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.594 2.196 . . . . 73.129999999999995 110.835 173.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.584 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 61.3 mtt -72.79 94.31 1.78 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.716 0.77 . . . . 71.439999999999998 110.34 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.557 ' HB ' HG21 ' A' ' 27' ' ' ILE . 66.4 mt -144.93 119.81 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.042 1.337 . . . . 72.400000000000006 108.264 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 24.5 m-80 -102.7 110.77 22.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.114 -0.699 . . . . 74.129999999999995 109.114 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.69 124.35 28.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.903 0.881 . . . . 74.230000000000004 109.92 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.428 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.2 m-85 -80.33 110.43 15.76 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.647 0.779 . . . . 72.230000000000004 110.814 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -96.86 143.02 28.16 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 71.219999999999999 109.864 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.08 144.44 40.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 74.430000000000007 111.266 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.87 -46.47 30.04 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.447 0.699 . . . . 74.230000000000004 112.175 -171.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.11 -42.69 15.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.539 0.57 . . . . 74.25 112.539 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.5 p -81.95 -30.03 31.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.207 0.447 . . . . 73.450000000000003 112.207 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.06 84.57 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 114.015 0.366 . . . . 55.210000000000001 114.015 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -99.19 164.89 11.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.014 0.926 . . . . 74.239999999999995 110.531 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.02 131.47 45.11 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.973 0.509 . . . . 72.329999999999998 111.622 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -75.66 -21.71 57.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.194 0.598 . . . . 72.310000000000002 111.82 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.77 26.66 31.46 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 116.073 -0.512 . . . . 70.219999999999999 112.902 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 3.6 mp0 -116.72 154.47 30.56 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.543 -0.975 . . . . 75.340000000000003 109.755 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -160.14 146.94 16.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.877 0.471 . . . . 74.239999999999995 111.513 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.9 p -104.16 117.89 35.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.973 -0.38 . . . . 63.409999999999997 109.973 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.93 108.08 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.621 0.769 . . . . 74.409999999999997 110.36 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 m -85.18 104.19 14.83 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.889 0.476 . . . . 72.439999999999998 110.821 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.4 m-85 -79.67 158.2 27.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.49 0.716 . . . . 74.120000000000005 110.788 169.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.64 -31.23 63.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.065 0.546 . . . . 74.430000000000007 111.349 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -118.73 134.17 23.56 Favored Pre-proline 0 N--CA 1.48 1.067 0 C-N-CA 123.053 0.541 . . . . 64.340000000000003 111.564 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.2 -34.9 99.02 Favored 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 122.523 2.149 . . . . 74.129999999999995 116.197 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.72 -29.35 77.19 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 122.867 2.059 . . . . 65.530000000000001 113.079 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -74.68 -40.85 61.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.223 0.609 . . . . 63.240000000000002 110.396 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.86 84.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.541 -0.754 . . . . 72.049999999999997 111.098 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.34 -44.85 90.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.109999999999999 111.296 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.891 0.476 . . . . 61.109999999999999 111.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.49 ' HA ' HG13 ' A' ' 37' ' ' ILE . . . -60.76 -34.21 74.11 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.407 0.683 . . . . 64.120000000000005 112.232 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.497 HG12 HG12 ' A' ' 95' ' ' VAL . 71.9 mt -69.19 -54.98 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.831 0.452 . . . . 74.040000000000006 110.49 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.42 -33.1 69.3 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.768 0.827 . . . . 73.310000000000002 111.921 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -80.57 -56.46 4.15 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.691 0.796 . . . . 75.219999999999999 112.17 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HB3' HD11 ' A' ' 93' ' ' ILE . 61.7 m-85 -86.65 -11.64 50.73 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 114.457 1.28 . . . . 74.400000000000006 114.457 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -63.87 116.12 5.5 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.578 0.626 . . . . 75.519999999999996 110.322 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.73 5.55 74.23 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 114.871 0.708 . . . . 75.450000000000003 114.871 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.84 159.59 14.9 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 117.949 0.874 . . . . 73.099999999999994 111.767 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.41 115.79 27.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.64 0.376 . . . . 72.319999999999993 111.651 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.404 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 91.2 t80 -70.28 -56.34 7.0 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.997 0.919 . . . . 73.420000000000002 110.925 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -147.18 63.01 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.908 0.861 . . . . 62.43 109.151 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.37 0.28 66.25 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 115.093 -0.958 . . . . 75.400000000000006 113.692 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.13 121.28 36.9 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.010000000000005 110.7 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.8 98.98 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.736 2.291 . . . . 72.439999999999998 112.666 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.0 pt -71.22 148.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.591 0.96 . . . . 74.129999999999995 113.591 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -115.39 104.94 12.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.67 1.188 . . . . 72.140000000000001 108.416 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.543 HG23 HG11 ' A' ' 18' ' ' VAL . 15.1 t -102.16 131.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.671 0.388 . . . . 75.510000000000005 110.137 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.3 p -136.55 178.65 6.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.503 1.121 . . . . 71.340000000000003 109.779 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 13' ' ' ASN . 78.1 m-85 -80.9 145.13 31.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.681 0.392 . . . . 74.409999999999997 110.076 169.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.19 7.7 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.031 0.443 . . . . 74.340000000000003 109.983 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.573 1.84 0 C-N-CA 123.733 0.813 . . . . 75.319999999999993 110.835 -178.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 111.433 0.16 . . . . 63.0 111.433 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.58 76.01 0.53 Allowed Glycine 0 C--N 1.354 1.58 0 C-N-CA 122.895 0.283 . . . . 63.140000000000001 113.142 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -81.0 131.17 35.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.149 0.98 . . . . 74.409999999999997 111.383 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.15 -27.77 65.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.622 0.601 . . . . 74.340000000000003 112.622 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -73.89 141.73 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.38 0.511 . . . . 74.049999999999997 112.38 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -81.0 -19.7 43.42 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.568 0.747 . . . . 73.25 111.486 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -145.02 140.52 28.21 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 75.340000000000003 110.334 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -84.26 83.51 7.95 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.289 0.636 . . . . 63.340000000000003 110.785 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -89.49 130.94 35.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.739 0.816 . . . . 73.140000000000001 111.176 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.37 -33.82 76.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.748 0.419 . . . . 74.239999999999995 111.583 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 p -76.64 91.97 3.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.357 0.663 . . . . 64.25 110.869 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.42 110.46 4.15 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.045 -0.724 . . . . 75.120000000000005 109.045 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 97' ' ' PHE . 57.0 t30 -58.86 121.85 12.15 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.455 0.702 . . . . 72.019999999999996 112.31 -170.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -97.17 -6.67 34.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.592 0.757 . . . . 62.520000000000003 111.767 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -101.25 130.18 47.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 73.530000000000001 109.917 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 43.4 pt -110.71 153.07 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.517 0.727 . . . . 74.420000000000002 110.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -111.08 128.46 55.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.147 0.579 . . . . 71.540000000000006 109.49 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 95' ' ' VAL . 10.7 t -121.11 141.34 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.775 0.83 . . . . 72.109999999999999 110.324 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -123.8 155.42 38.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.413 1.085 . . . . 74.030000000000001 110.169 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 23.19 63.23 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 114.713 0.645 . . . . 74.340000000000003 114.713 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD22 HG23 ' A' ' 93' ' ' ILE . 77.1 mt -64.52 -34.56 78.52 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.169 0.988 . . . . 73.150000000000006 111.885 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.25 21.9 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.154 -0.93 . . . . 53.310000000000002 111.119 -168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.92 -4.78 56.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 117.827 0.814 . . . . 75.239999999999995 112.636 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -94.01 17.56 12.14 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.233 0.613 . . . . 72.329999999999998 110.711 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.83 140.49 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 124.159 0.984 . . . . 73.120000000000005 112.272 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 30' ' ' VAL . 50.1 p -125.05 158.46 33.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.357 0.663 . . . . 73.239999999999995 110.214 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' HB ' ' A' ' 51' ' ' ILE . 70.2 mt -59.57 -35.09 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.834 0.454 . . . . 72.120000000000005 110.777 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.27 -46.78 88.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.605 0.762 . . . . 73.340000000000003 111.388 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -61.83 -43.28 99.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.581 0.752 . . . . 74.129999999999995 111.767 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 26' ' ' THR . 48.1 t -66.13 -45.68 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 121.047 0.451 . . . . 75.25 110.64 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -64.65 -33.98 77.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.677 -0.692 . . . . 71.030000000000001 111.996 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.23 -33.77 59.21 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.292 0.637 . . . . 71.530000000000001 111.644 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -74.56 -53.33 9.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 74.340000000000003 111.424 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 48.3 m-85 -78.68 -17.56 55.74 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 113.729 1.011 . . . . 73.340000000000003 113.729 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 64.9 pttt -58.29 -28.71 65.24 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.528 0.936 . . . . 74.420000000000002 113.528 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.35 -22.88 63.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.552 0.741 . . . . 75.209999999999994 112.357 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mm -81.38 -41.13 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.097 0.959 . . . . 74.450000000000003 111.094 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.28 -171.64 44.75 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.014 -0.539 . . . . 71.519999999999996 113.184 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.97 127.11 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.063 0.545 . . . . 74.120000000000005 110.257 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.2 mt -94.56 137.02 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.148 0.979 . . . . 64.420000000000002 108.954 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.4 mtpt -59.03 146.37 38.57 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.548 0.69 . . . . 74.319999999999993 111.707 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 50.5 m -129.29 125.27 36.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.728 -1.124 . . . . 74.519999999999996 109.583 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -57.22 107.51 0.43 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 109.082 -0.71 . . . . 74.519999999999996 109.082 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.64 -19.4 65.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.018 0.927 . . . . 74.230000000000004 112.827 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -78.59 -48.6 14.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.449 0.699 . . . . 74.329999999999998 111.65 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -85.13 -38.54 18.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.229 0.612 . . . . 75.140000000000001 111.821 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.77 2.67 61.19 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 115.927 -0.579 . . . . 50.119999999999997 112.636 -172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -99.1 144.2 27.79 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.053 0.941 . . . . 65.409999999999997 111.777 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 38.2 Cg_endo -66.11 139.64 56.53 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.852 2.368 . . . . 65.519999999999996 111.811 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.45 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.0 mtt -72.73 93.37 1.65 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.669 0.747 . . . . 73.25 109.586 -175.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.539 ' HB ' HG22 ' A' ' 27' ' ' ILE . 81.9 mt -147.0 120.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.948 1.299 . . . . 74.510000000000005 108.602 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.55 110.55 22.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 110.027 -0.36 . . . . 71.219999999999999 110.027 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.34 129.22 34.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.854 0.862 . . . . 72.540000000000006 109.835 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 92.6 m-85 -89.13 117.32 28.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.487 0.715 . . . . 72.010000000000005 110.244 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 m -99.14 150.62 21.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.17 0.988 . . . . 74.340000000000003 110.196 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.25 132.27 35.82 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.585 0.754 . . . . 72.219999999999999 109.842 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -70.17 -32.67 70.73 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.662 0.785 . . . . 72.230000000000004 112.249 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.8 -52.68 5.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.64 0.776 . . . . 74.010000000000005 111.557 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 p -82.11 -30.31 31.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.53 0.732 . . . . 75.120000000000005 112.323 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.76 89.43 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.501 -0.318 . . . . 71.140000000000001 113.498 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 61' ' ' LYS . 9.5 mtmp? -102.17 155.7 18.04 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.767 0.827 . . . . 73.099999999999994 109.808 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.42 136.57 57.97 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.914 0.486 . . . . 73.420000000000002 111.776 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -72.09 -15.28 62.0 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.278 0.631 . . . . 70.409999999999997 112.284 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.77 31.06 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.689 -0.564 . . . . 73.239999999999995 111.689 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 52.0 mt-10 -130.9 149.13 52.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.064 0.946 . . . . 75.329999999999998 109.566 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.71 154.25 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.748 0.647 . . . . 70.420000000000002 112.748 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 25.1 p -109.43 116.12 31.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.851 -0.613 . . . . 73.310000000000002 111.007 173.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.66 109.71 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.466 0.706 . . . . 75.5 110.113 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 69.2 m -83.52 102.84 12.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.693 0.397 . . . . 65.120000000000005 110.772 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 56.3 m-85 -78.89 153.78 30.26 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.903 0.481 . . . . 72.209999999999994 110.842 170.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.05 -34.38 61.84 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.828 -0.624 . . . . 65.549999999999997 111.143 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -111.91 130.2 23.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.054 0.542 . . . . 75.109999999999999 111.032 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -49.84 -38.11 46.82 Favored 'Trans proline' 0 CA--C 1.583 2.936 0 C-N-CA 123.334 2.69 . . . . 72.5 116.305 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.37 -28.68 78.62 Favored 'Trans proline' 0 C--N 1.403 3.434 0 CA-C-N 122.477 1.92 . . . . 64.420000000000002 113.934 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 m -73.42 -39.45 65.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 74.340000000000003 110.038 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.87 79.94 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.474 0.71 . . . . 72.109999999999999 111.052 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -59.96 -51.42 69.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.242 1.017 . . . . 70.420000000000002 111.149 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.75 90.7 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.005 -0.543 . . . . 64.239999999999995 112.156 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.24 72.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.45 0.7 . . . . 72.439999999999998 112.506 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.431 HG12 HG11 ' A' ' 95' ' ' VAL . 70.2 mt -63.29 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.03 0.532 . . . . 74.5 111.05 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.34 -30.05 69.28 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.347 -0.842 . . . . 75.129999999999995 111.985 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -79.06 -59.53 2.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.954 0.501 . . . . 73.040000000000006 111.675 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 93' ' ' ILE . 27.4 m-85 -80.78 -10.55 59.72 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.965 1.098 . . . . 75.129999999999995 113.965 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -65.76 111.19 3.11 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.548 0.613 . . . . 72.099999999999994 109.992 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.27 1.4 60.95 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.794 -0.639 . . . . 64.219999999999999 114.307 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.7 mmtt -96.37 149.29 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.261 0.624 . . . . 74.319999999999993 111.036 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -87.52 128.06 35.24 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.083 -0.386 . . . . 74.209999999999994 111.376 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.75 -73.63 0.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.399 0.68 . . . . 74.099999999999994 110.603 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 t -119.96 53.11 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.75 0.786 . . . . 65.109999999999999 109.814 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.73 90.11 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 115.37 -0.832 . . . . 74.120000000000005 113.322 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -122.57 126.73 26.06 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.048 0.939 . . . . 72.430000000000007 109.895 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 132.04 25.65 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.089 2.526 . . . . 62.109999999999999 112.52 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.3 pt -107.56 153.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.219 0.608 . . . . 73.219999999999999 111.857 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -121.8 126.82 49.69 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.003 0.921 . . . . 63.009999999999998 108.575 172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.562 HG13 HG23 ' A' ' 18' ' ' VAL . 16.2 t -114.55 143.89 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 122.943 0.497 . . . . 75.239999999999995 111.156 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 m -147.12 -177.08 5.48 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.807 1.643 . . . . 73.140000000000001 109.057 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 53.7 m-85 -87.38 147.82 25.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.699 0.681 . . . . 65.530000000000001 110.603 168.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.92 85.69 6.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.584 0.753 . . . . 73.209999999999994 109.752 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 123.658 0.783 . . . . 73.25 111.405 -175.015 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.568 -0.16 . . . . 75.0 110.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.6 -77.15 0.28 Allowed Glycine 0 C--N 1.344 1.01 0 O-C-N 122.375 -0.203 . . . . 72.010000000000005 112.636 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -73.32 162.26 29.55 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.245 0.618 . . . . 73.109999999999999 111.178 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 59.7 27.27 16.49 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.271 1.029 . . . . 74.409999999999997 112.562 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -76.25 129.82 37.25 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.036 0.534 . . . . 73.209999999999994 111.372 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -81.17 136.68 35.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.363 0.505 . . . . 74.040000000000006 112.363 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -46.28 109.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.879 1.272 . . . . 73.530000000000001 112.919 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -73.72 -29.14 62.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.612 0.597 . . . . 75.230000000000004 112.612 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -109.34 152.34 25.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.47 0.708 . . . . 64.230000000000004 112.197 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -121.81 16.0 10.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.378 1.071 . . . . 72.349999999999994 111.458 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -146.94 -49.21 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.574 0.75 . . . . 71.329999999999998 110.055 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.55 84.75 2.61 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.791 0.805 . . . . 74.540000000000006 110.377 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -159.75 131.57 6.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.606 1.162 . . . . 73.310000000000002 108.305 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -97.05 -24.12 15.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.974 0.51 . . . . 70.420000000000002 111.641 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -95.45 125.18 39.89 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.989 0.516 . . . . 74.450000000000003 109.944 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.4 pt -120.95 140.61 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.156 0.583 . . . . 75.430000000000007 112.23 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -95.32 127.62 41.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.132 0.491 . . . . 75.120000000000005 110.554 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 95' ' ' VAL . 14.9 t -120.57 137.26 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.458 1.103 . . . . 71.109999999999999 109.985 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.42 156.26 31.79 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.046 0.938 . . . . 74.319999999999993 110.778 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 2.28 82.98 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 114.468 0.547 . . . . 64.530000000000001 114.468 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 25' ' ' VAL . 96.0 mt -57.21 -20.87 29.65 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.834 1.05 . . . . 70.109999999999999 113.834 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.32 162.0 35.15 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.055 0.382 . . . . 75.019999999999996 114.055 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.21 -21.34 61.42 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.211 0.604 . . . . 75.439999999999998 111.787 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -92.45 2.58 56.58 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.004 0.922 . . . . 74.430000000000007 111.18 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 21' ' ' LEU . 11.1 p -66.54 147.53 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.53 0.732 . . . . 74.340000000000003 112.242 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.6 p -128.19 157.4 40.93 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.381 0.672 . . . . 74.549999999999997 110.367 172.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG23 ' HB ' ' A' ' 51' ' ' ILE . 71.5 mt -54.14 -41.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.156 0.982 . . . . 75.319999999999993 111.381 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.95 -29.27 62.96 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.367 0.667 . . . . 74.519999999999996 112.28 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 m -70.94 -43.56 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.567 0.347 . . . . 75.209999999999994 111.199 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.07 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 120.946 0.403 . . . . 70.25 110.022 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.08 96.36 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.498 0.719 . . . . 70.329999999999998 112.254 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -34.5 75.12 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.63 0.772 . . . . 72.409999999999997 111.071 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.13 -51.86 19.43 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.524 0.73 . . . . 74.109999999999999 110.882 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -80.9 -14.61 57.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.86 1.059 . . . . 75.120000000000005 113.86 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -54.89 -33.34 61.91 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.8 0.666 . . . . 74.439999999999998 112.8 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.97 -23.34 66.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.88 0.872 . . . . 74.5 112.67 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.31 -50.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.712 0.805 . . . . 75.230000000000004 111.277 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.35 -178.73 43.54 Favored Glycine 0 C--O 1.24 0.514 0 CA-C-N 115.35 -0.841 . . . . 61.200000000000003 113.012 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.3 mt -69.29 122.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 123.332 0.653 . . . . 75.439999999999998 110.317 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.1 mt -92.81 135.42 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.809 0.844 . . . . 71.120000000000005 108.835 171.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 29.3 mtpp -56.26 154.47 8.02 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.96 0.504 . . . . 64.340000000000003 111.591 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.0 m -138.64 122.35 17.53 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.169 0.588 . . . . 75.140000000000001 111.007 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -65.93 112.25 3.71 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.25 -1.019 . . . . 63.409999999999997 108.25 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -82.8 -12.23 57.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.942 0.497 . . . . 73.129999999999995 112.289 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -74.6 -47.77 30.47 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.605 0.762 . . . . 74.420000000000002 110.514 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -83.3 -39.37 20.9 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.63 0.772 . . . . 73.409999999999997 111.127 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.7 16.13 52.85 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.305 -0.861 . . . . 63.520000000000003 112.742 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -114.75 149.88 43.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.051 0.94 . . . . 75.239999999999995 111.299 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.49 151.32 85.54 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.584 2.189 . . . . 74.140000000000001 112.74 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.5 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.1 mtt -78.3 93.1 4.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.666 0.745 . . . . 74.310000000000002 109.147 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.539 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.0 mt -141.42 114.35 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.576 -1.268 . . . . 74.409999999999997 107.576 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.426 HD21 ' N ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -99.86 109.57 21.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.398 -0.593 . . . . 73.319999999999993 109.398 -170.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -79.11 125.16 29.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.538 0.735 . . . . 73.430000000000007 110.324 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 9.6 m-85 -78.12 126.31 30.62 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 72.549999999999997 110.429 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -116.91 143.45 45.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.847 0.859 . . . . 75.409999999999997 110.061 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -71.14 112.16 7.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.319 0.648 . . . . 74.230000000000004 109.971 168.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.926 0.49 . . . . 74.140000000000001 111.819 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.53 ' HG3' HG22 ' A' ' 59' ' ' THR . 12.9 pt-20 -73.71 -43.82 58.14 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.871 0.868 . . . . 75.430000000000007 111.907 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.53 HG22 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -99.39 -50.08 4.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.466 0.706 . . . . 71.239999999999995 111.612 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.1 -1.37 28.4 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.521 -0.763 . . . . 73.400000000000006 112.652 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -98.12 160.06 14.54 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.635 0.774 . . . . 74.140000000000001 111.271 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.69 136.58 51.22 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.203 0.601 . . . . 71.319999999999993 111.901 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 7.8 mtpm? -66.85 -17.99 65.16 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.729 0.812 . . . . 74.409999999999997 112.398 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.38 33.86 21.59 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 121.318 0.399 . . . . 52.310000000000002 112.446 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.8 mt-10 -135.16 155.9 49.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.169 0.988 . . . . 72.109999999999999 109.948 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.03 152.56 13.27 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 112.14 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 21.7 p -104.59 123.95 48.45 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.576 -0.738 . . . . 72.230000000000004 110.186 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 t -104.6 109.16 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.709 0.804 . . . . 70.140000000000001 109.816 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.1 m -86.76 100.47 12.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.53 0.332 . . . . 64.409999999999997 110.816 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 56.2 m-85 -75.55 160.57 30.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.372 0.669 . . . . 73.219999999999999 111.134 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.0 -30.31 39.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.514 0.726 . . . . 72.319999999999993 111.188 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -114.49 132.76 22.68 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.381 0.672 . . . . 63.149999999999999 110.866 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.98 -36.14 95.47 Favored 'Trans proline' 0 CA--C 1.586 3.116 0 C-N-CA 122.547 2.165 . . . . 73.030000000000001 115.956 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.1 -28.0 65.35 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 122.701 2.0 . . . . 73.109999999999999 113.356 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -69.77 -39.85 76.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.573 0.701 . . . . 73.319999999999993 110.211 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.86 -49.27 76.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.865 -1.061 . . . . 75.329999999999998 111.413 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -60.24 -45.44 93.22 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.208 1.003 . . . . 74.219999999999999 111.17 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.42 97.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.838 -0.619 . . . . 71.510000000000005 111.797 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.88 72.25 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.203 0.601 . . . . 74.430000000000007 112.482 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.34 -63.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.047 0.539 . . . . 74.540000000000006 110.684 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.12 -31.19 66.92 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.747 0.819 . . . . 73.420000000000002 112.105 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -78.75 -59.76 2.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.656 0.783 . . . . 74.140000000000001 111.668 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.492 ' HB2' HG22 ' A' ' 95' ' ' VAL . 39.2 m-85 -87.45 -11.48 48.93 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.449 1.277 . . . . 73.420000000000002 114.449 -170.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.28 119.48 10.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.289 -0.634 . . . . 63.409999999999997 109.289 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.44 87.74 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.977 0.751 . . . . 64.340000000000003 114.977 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.9 150.14 21.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.714 0.806 . . . . 74.409999999999997 112.061 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.11 123.87 27.37 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.054 0.761 . . . . 72.030000000000001 113.054 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -125.13 133.04 52.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 75.219999999999999 108.373 167.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 t 62.58 11.43 4.75 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.531 1.132 . . . . 74.430000000000007 113.362 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.62 20.03 10.55 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 114.94 0.736 . . . . 73.25 114.94 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -154.04 146.33 17.3 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 118.22 1.01 . . . . 73.450000000000003 111.193 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.82 104.06 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.332 2.021 . . . . 74.219999999999999 112.733 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.31 165.21 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.356 0.662 . . . . 75.5 112.418 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -121.01 117.72 27.99 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.28 1.032 . . . . 70.150000000000006 109.79 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 18' ' ' VAL . 21.9 t -114.53 136.71 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.062 0.545 . . . . 71.439999999999998 110.546 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -153.6 175.68 12.94 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.538 1.135 . . . . 75.150000000000006 109.997 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.62 146.14 54.15 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 118.562 0.619 . . . . 74.349999999999994 111.828 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.72 97.22 5.09 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.514 -0.551 . . . . 63.229999999999997 109.514 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 CA--C 1.556 1.182 0 C-N-CA 124.112 0.965 . . . . 73.439999999999998 110.869 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.342 -0.244 . . . . 74.329999999999998 110.342 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.53 100.92 1.29 Allowed Glycine 0 C--N 1.354 1.564 0 N-CA-C 111.904 -0.479 . . . . 73.439999999999998 111.904 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -62.26 -55.06 32.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.622 0.769 . . . . 73.129999999999995 111.482 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -98.41 78.24 2.41 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.829 0.452 . . . . 71.010000000000005 110.118 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -92.26 103.48 15.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.937 0.495 . . . . 71.109999999999999 110.009 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -126.48 145.16 50.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.206 1.002 . . . . 74.540000000000006 111.218 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -84.87 79.41 9.64 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.587 0.755 . . . . 73.540000000000006 110.768 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -89.95 137.51 32.28 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.118 -0.697 . . . . 72.430000000000007 109.118 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -75.97 140.01 41.82 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.411 0.684 . . . . 73.0 111.903 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -73.34 -26.56 61.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.161 0.584 . . . . 74.510000000000005 111.846 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -97.7 153.64 18.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.79 0.836 . . . . 71.239999999999995 111.168 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.28 176.72 7.1 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.442 0.697 . . . . 74.109999999999999 110.905 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -141.55 115.02 8.92 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.084 0.469 . . . . 74.530000000000001 110.633 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -101.18 -4.83 26.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.208 1.003 . . . . 73.340000000000003 111.512 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -99.47 125.93 45.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.007 0.523 . . . . 73.129999999999995 110.765 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 76' ' ' ALA . 42.0 pt -110.11 152.27 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.847 0.859 . . . . 72.230000000000004 110.983 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -107.31 130.51 54.76 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 123.431 0.693 . . . . 75.120000000000005 109.827 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG22 HG13 ' A' ' 95' ' ' VAL . 14.7 t -122.6 140.82 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.228 1.011 . . . . 72.120000000000005 110.259 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -118.66 164.35 15.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.925 1.29 . . . . 75.439999999999998 110.217 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.48 79.24 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 114.639 0.616 . . . . 72.209999999999994 114.639 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.1 -17.97 60.87 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.496 1.119 . . . . 73.230000000000004 112.705 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.95 173.03 48.7 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.151 0.42 . . . . 44.509999999999998 114.151 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.32 -19.67 61.62 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.594 0.757 . . . . 75.349999999999994 112.604 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.64 10.58 36.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.639 0.607 . . . . 74.310000000000002 112.639 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.32 128.92 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 122.997 0.519 . . . . 63.240000000000002 111.803 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 30' ' ' VAL . 7.6 p -122.72 150.77 42.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.857 -0.527 . . . . 73.219999999999999 109.657 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.6 mt -54.38 -42.38 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.145 0.978 . . . . 75.409999999999997 111.706 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -39.42 80.58 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.181 0.592 . . . . 74.510000000000005 112.333 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.3 m -64.26 -41.7 96.82 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.914 0.486 . . . . 73.329999999999998 111.396 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 26' ' ' THR . 63.5 t -65.49 -43.27 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.022 0.529 . . . . 64.439999999999998 110.723 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.0 96.46 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.831 -0.622 . . . . 73.209999999999994 112.186 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.93 -30.72 62.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.371 0.669 . . . . 64.200000000000003 111.46 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -74.17 -53.86 8.98 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.693 0.797 . . . . 74.209999999999994 112.007 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 62.1 m-85 -77.46 -14.51 59.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.983 1.105 . . . . 64.209999999999994 113.983 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.14 -30.84 62.72 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.767 1.025 . . . . 73.140000000000001 113.767 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.58 -25.02 65.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.691 0.797 . . . . 74.510000000000005 113.037 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.2 mm -83.9 -52.76 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.461 0.704 . . . . 73.430000000000007 110.59 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.51 167.79 35.81 Favored Glycine 0 C--O 1.241 0.568 0 CA-C-N 116.08 -0.509 . . . . 64.340000000000003 113.391 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.18 128.04 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 75.420000000000002 109.538 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 83.3 mt -97.12 136.61 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.501 0.721 . . . . 75.120000000000005 109.09 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.5 mtpt -57.15 142.27 43.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.254 0.622 . . . . 74.430000000000007 111.951 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 75.3 m -132.73 127.16 34.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.696 0.798 . . . . 75.430000000000007 110.489 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -70.81 118.33 13.45 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.699 0.8 . . . . 74.310000000000002 109.154 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -77.06 -23.01 52.01 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.517 0.727 . . . . 74.040000000000006 111.796 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.95 -51.57 53.59 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.336 0.654 . . . . 74.109999999999999 110.72 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -84.74 -37.11 21.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.153 0.581 . . . . 71.319999999999993 111.838 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.11 -2.86 59.9 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 116.025 -0.534 . . . . 72.109999999999999 113.076 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -99.74 147.77 33.86 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.262 1.025 . . . . 75.349999999999994 112.355 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 39.7 Cg_endo -67.6 149.27 79.42 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.655 2.236 . . . . 71.030000000000001 112.775 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 53.1 mtt -78.33 94.74 4.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 64.010000000000005 109.973 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.543 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.96 123.86 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.992 1.317 . . . . 70.510000000000005 108.027 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -106.4 108.66 20.28 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.577 -0.527 . . . . 75.239999999999995 109.577 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.8 mt -83.08 117.71 23.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.239 0.616 . . . . 74.439999999999998 109.677 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -70.29 105.36 2.96 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.089 0.556 . . . . 74.319999999999993 111.106 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -89.82 147.37 23.83 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.596 -0.729 . . . . 71.239999999999995 109.233 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.85 125.89 30.28 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.54 0.736 . . . . 73.109999999999999 109.907 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -70.15 -21.8 63.04 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.976 0.732 . . . . 72.200000000000003 112.976 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.71 -57.94 2.42 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.28 0.632 . . . . 75.120000000000005 111.128 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.2 p -82.67 -20.25 36.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.048 0.539 . . . . 74.319999999999993 112.279 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.75 -1.19 74.29 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 114.937 0.735 . . . . 70.120000000000005 114.937 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -101.81 160.73 14.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.26 0.624 . . . . 73.209999999999994 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.78 126.37 28.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.792 0.437 . . . . 75.409999999999997 111.133 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.89 -16.52 64.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.07 0.948 . . . . 75.230000000000004 112.242 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.33 25.23 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 111.991 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -133.24 150.54 51.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.09 0.956 . . . . 73.200000000000003 109.164 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.76 157.38 18.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.58 0.585 . . . . 75.120000000000005 112.58 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 p -117.24 117.2 28.89 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.093 0.557 . . . . 73.319999999999993 111.074 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.47 111.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.32 1.048 . . . . 75.409999999999997 110.353 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m -85.85 103.18 14.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.509 0.323 . . . . 53.299999999999997 111.004 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 33.5 m-85 -76.4 164.55 25.89 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.024 0.53 . . . . 74.019999999999996 110.499 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.73 -40.4 61.3 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.023 0.529 . . . . 75.120000000000005 109.934 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.89 129.39 24.22 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.49 0.716 . . . . 74.340000000000003 110.916 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.17 -37.65 87.62 Favored 'Trans proline' 0 CA--C 1.587 3.144 0 C-N-CA 122.669 2.246 . . . . 75.140000000000001 115.471 165.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.51 -27.62 61.96 Favored 'Trans proline' 0 C--N 1.406 3.59 0 CA-C-N 122.386 1.888 . . . . 72.209999999999994 113.426 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.9 m -72.84 -39.0 66.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.284 0.564 . . . . 73.450000000000003 110.363 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 16' ' ' ILE . . . -59.43 -52.14 66.89 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.227 -0.897 . . . . 60.420000000000002 110.898 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.26 -42.55 96.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.77 0.828 . . . . 75.109999999999999 111.841 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.17 96.7 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.698 0.399 . . . . 74.019999999999996 111.68 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.53 71.64 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.397 0.679 . . . . 64.209999999999994 112.257 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -62.26 -61.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 122.684 0.394 . . . . 74.209999999999994 110.282 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 -33.8 67.63 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.742 0.817 . . . . 75.420000000000002 112.299 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -77.91 -54.55 6.19 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.722 0.809 . . . . 75.140000000000001 112.151 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.62 -12.78 30.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.246 1.202 . . . . 75.209999999999994 114.246 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.41 126.87 29.19 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.739 0.7 . . . . 72.239999999999995 110.452 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.29 1.71 90.45 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.044 0.778 . . . . 75.319999999999993 115.044 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.0 -167.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.91 0.855 . . . . 74.439999999999998 111.775 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.17 125.86 44.33 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.138 0.575 . . . . 72.239999999999995 112.104 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.461 ' HB2' HG23 ' A' ' 93' ' ' ILE . 66.6 t80 -77.32 -69.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.244 0.618 . . . . 74.140000000000001 111.455 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 m -133.83 75.29 1.59 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.666 0.786 . . . . 70.540000000000006 109.486 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.4 0.04 44.14 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 115.379 -0.828 . . . . 61.049999999999997 114.638 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.2 135.06 26.95 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.081 0.953 . . . . 70.299999999999997 111.895 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.85 140.06 49.53 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.109 2.539 . . . . 75.420000000000002 113.357 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.461 HG23 ' HB2' ' A' ' 88' ' ' PHE . 37.7 pt -123.36 151.83 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.32 1.048 . . . . 75.019999999999996 112.068 -173.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -118.72 122.48 42.59 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.086 -1.079 . . . . 74.319999999999993 108.086 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 18' ' ' VAL . 18.9 t -112.29 141.17 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.506 . . . . 73.019999999999996 110.655 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.0 p -152.3 -179.78 7.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.289 1.436 . . . . 71.530000000000001 109.041 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -73.81 150.42 41.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.772 0.714 . . . . 71.329999999999998 110.944 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.68 88.87 7.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.026 0.53 . . . . 65.510000000000005 110.293 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.498 0 C-N-CA 123.953 0.901 . . . . 75.409999999999997 110.945 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 110.21 -0.293 . . . . 65.25 110.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.77 -146.07 50.16 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 122.893 0.282 . . . . 70.329999999999998 113.392 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -107.98 -20.61 13.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.668 . . . . 74.409999999999997 111.503 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -156.39 84.37 0.98 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-O 121.856 0.836 . . . . 73.239999999999995 111.455 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -132.07 120.22 22.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.548 0.739 . . . . 74.510000000000005 110.139 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -153.28 153.42 32.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 73.239999999999995 109.966 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.65 122.14 30.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.18 0.592 . . . . 74.299999999999997 110.481 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -70.67 112.85 7.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.669 0.388 . . . . 72.010000000000005 110.092 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -122.53 125.58 46.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.173 0.589 . . . . 73.030000000000001 111.826 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -78.57 70.61 4.95 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.812 0.815 . . . . 74.019999999999996 109.087 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.1 m -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.157 0.983 . . . . 54.539999999999999 112.079 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.47 80.1 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.374 1.07 . . . . 75.230000000000004 111.063 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -94.57 168.42 10.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.197 0.599 . . . . 74.409999999999997 110.393 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -95.18 11.75 31.24 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 111.747 0.277 . . . . 74.439999999999998 111.747 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.8 m -138.16 125.83 22.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.788 -0.449 . . . . 74.299999999999997 109.788 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' A' ' 76' ' ' ALA . 29.0 pt -109.6 143.12 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 122.779 0.432 . . . . 72.209999999999994 112.101 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -96.8 110.66 23.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.468 -0.567 . . . . 75.120000000000005 109.468 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 95' ' ' VAL . 5.9 t -104.96 138.37 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.611 0.764 . . . . 75.010000000000005 110.103 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -120.71 166.48 13.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.282 1.033 . . . . 74.450000000000003 110.218 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.15 31.72 72.22 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 114.519 0.568 . . . . 73.200000000000003 114.519 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -81.91 -17.11 48.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.205 1.002 . . . . 74.329999999999998 112.355 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.99 168.61 40.69 Favored Glycine 0 N--CA 1.475 1.271 0 N-CA-C 114.133 0.413 . . . . 53.450000000000003 114.133 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -74.69 -13.38 60.61 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.426 0.69 . . . . 75.230000000000004 112.599 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.61 -3.55 58.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.621 0.768 . . . . 73.239999999999995 111.895 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.72 127.53 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 N-CA-C 113.161 0.801 . . . . 74.519999999999996 113.161 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 30' ' ' VAL . 43.6 p -122.93 154.22 38.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.385 0.674 . . . . 74.430000000000007 110.042 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.7 mt -57.25 -42.72 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.533 0.733 . . . . 74.409999999999997 111.736 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.35 -40.39 95.77 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.634 0.774 . . . . 74.299999999999997 111.463 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.2 t -65.82 -45.02 83.82 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.88 0.472 . . . . 74.239999999999995 111.282 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 26' ' ' THR . 60.2 t -62.83 -42.08 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.27 0.557 . . . . 75.310000000000002 110.278 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.519 -0.764 . . . . 74.519999999999996 112.172 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.79 -35.7 80.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.758 0.823 . . . . 71.099999999999994 111.271 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -71.92 -55.98 6.51 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.93 0.892 . . . . 74.219999999999999 111.031 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.0 m-85 -79.71 -16.59 55.38 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.147 1.166 . . . . 71.430000000000007 114.147 -172.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.71 -24.17 66.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.729 1.011 . . . . 75.129999999999995 113.729 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.96 -23.94 65.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.335 0.654 . . . . 75.430000000000007 112.686 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.7 mm -86.86 -45.99 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 63.409999999999997 111.812 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.63 174.67 45.72 Favored Glycine 0 C--O 1.24 0.505 0 CA-C-N 115.709 -0.678 . . . . 64.040000000000006 113.123 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.0 mt -67.54 123.62 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.499 0.72 . . . . 74.140000000000001 111.339 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 74.2 mt -94.08 130.8 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.446 1.098 . . . . 72.219999999999999 108.41 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.8 mtpp -54.64 146.57 16.35 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.498 0.719 . . . . 64.430000000000007 112.193 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 99.6 m -126.93 138.53 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.196 0.998 . . . . 73.310000000000002 109.352 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -78.27 128.68 34.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.651 0.781 . . . . 55.539999999999999 109.68 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -67.48 -40.13 85.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.789 0.836 . . . . 73.239999999999995 111.856 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.93 -49.6 75.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.718 0.807 . . . . 75.450000000000003 112.029 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -87.11 -47.04 9.23 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.158 0.583 . . . . 73.420000000000002 111.753 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.6 14.6 49.65 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 116.276 -0.42 . . . . 74.129999999999995 112.624 -171.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -117.56 151.92 48.92 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 124.338 1.055 . . . . 73.329999999999998 111.447 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.0 Cg_endo -67.22 146.65 76.71 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.743 2.295 . . . . 73.430000000000007 112.633 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.528 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.2 mtt -77.95 96.57 5.07 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.319 0.58 . . . . 74.120000000000005 110.014 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 27' ' ' ILE . 83.4 mt -143.07 118.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.61 1.164 . . . . 74.230000000000004 108.363 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.5 m-20 -98.7 108.27 20.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.285 -0.635 . . . . 73.109999999999999 109.285 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -80.04 130.15 35.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.524 -0.547 . . . . 72.209999999999994 109.524 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 84.1 m-85 -89.78 121.85 32.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.994 0.518 . . . . 63.450000000000003 110.438 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -115.56 145.95 42.18 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.381 1.072 . . . . 75.109999999999999 110.167 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.53 104.81 1.66 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.95 0.5 . . . . 73.420000000000002 110.063 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -64.15 -22.65 67.02 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.72 0.808 . . . . 74.329999999999998 111.648 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.99 -56.09 5.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.561 0.744 . . . . 73.129999999999995 111.633 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -86.66 -49.02 7.8 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.287 0.635 . . . . 74.519999999999996 111.486 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.49 -3.16 27.88 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.858 -0.61 . . . . 74.030000000000001 113.453 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.09 153.12 23.94 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.297 0.639 . . . . 74.340000000000003 111.044 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.01 135.61 52.58 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.006 0.522 . . . . 74.099999999999994 110.502 174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD3' ' HB3' ' A' ' 54' ' ' TYR . 50.2 mtpt -68.26 -26.16 65.54 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.069 0.548 . . . . 73.400000000000006 112.092 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.41 38.72 8.78 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.598 -0.601 . . . . 73.310000000000002 111.598 -168.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.1 mt-10 -134.8 158.02 45.27 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.735 0.814 . . . . 74.430000000000007 110.245 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.69 160.33 28.43 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 54.329999999999998 112.017 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 p -117.41 114.31 23.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.939 0.496 . . . . 73.409999999999997 110.296 167.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.29 104.56 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.966 0.906 . . . . 74.540000000000006 109.757 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.0 m -82.65 102.59 11.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.68 0.392 . . . . 71.120000000000005 111.708 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 57.9 m-85 -80.22 160.07 25.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.807 0.843 . . . . 74.420000000000002 109.736 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.53 -31.24 47.42 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.24 -0.436 . . . . 73.209999999999994 110.485 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -110.38 130.16 23.18 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.768 0.827 . . . . 72.510000000000005 110.719 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.08 -40.46 81.45 Favored 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.181 1.921 . . . . 74.120000000000005 115.164 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.58 -31.5 87.16 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 122.406 1.895 . . . . 62.340000000000003 113.973 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m -69.49 -43.12 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.167 0.587 . . . . 72.120000000000005 109.963 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB3' HG21 ' A' ' 16' ' ' ILE . . . -62.5 -49.34 75.76 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.983 -1.008 . . . . 75.209999999999994 111.107 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -60.21 -48.43 81.77 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.708 1.203 . . . . 73.530000000000001 111.19 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.09 -35.59 80.91 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.139 0.576 . . . . 73.340000000000003 112.192 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.42 -32.12 69.89 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.824 0.45 . . . . 63.100000000000001 111.913 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.496 HG12 HG13 ' A' ' 95' ' ' VAL . 59.8 mt -64.45 -59.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.787 0.435 . . . . 75.329999999999998 110.102 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -55.83 -32.43 63.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.791 0.837 . . . . 75.25 112.924 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -78.47 -59.91 2.59 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.351 0.66 . . . . 73.510000000000005 111.173 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 93' ' ' ILE . 69.6 m-85 -84.41 -15.29 46.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.639 1.348 . . . . 74.549999999999997 114.639 -169.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.55 115.69 4.92 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 118.574 0.625 . . . . 75.049999999999997 110.444 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.45 58.34 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.768 -0.462 . . . . 62.039999999999999 114.193 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.1 mmtt -93.46 147.17 23.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.818 0.847 . . . . 73.209999999999994 110.674 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.09 124.4 31.07 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 122.232 -0.292 . . . . 75.439999999999998 111.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -84.35 -81.24 0.18 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.139 -0.689 . . . . 75.129999999999995 109.139 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.0 m -106.18 70.41 0.84 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.325 -0.62 . . . . 72.120000000000005 109.325 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.93 -3.76 34.69 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.963 0.745 . . . . 73.319999999999993 114.963 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -121.31 130.15 24.94 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 123.579 0.752 . . . . 75.530000000000001 110.89 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.62 120.01 7.09 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.868 2.379 . . . . 71.140000000000001 111.76 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.4 pt -88.57 146.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.232 0.539 . . . . 73.409999999999997 112.352 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -109.6 110.44 21.51 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.069 -1.086 . . . . 74.540000000000006 108.069 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 HG23 ' A' ' 18' ' ' VAL . 7.0 t -101.66 132.07 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.426 -0.583 . . . . 70.120000000000005 109.426 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -138.29 172.64 12.61 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.176 0.99 . . . . 62.530000000000001 109.438 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -71.97 142.95 49.38 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.146 0.43 . . . . 75.5 110.03 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 66.51 8.67 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.999 0.904 . . . . 73.420000000000002 110.659 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.557 1.244 0 CA-C-N 114.842 -1.072 . . . . 63.340000000000003 110.862 179.463 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.752 0.31 . . . . 73.310000000000002 110.65 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.02 -53.65 4.86 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 116.182 -0.463 . . . . 70.010000000000005 113.72 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -80.25 129.07 34.24 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.374 0.67 . . . . 72.230000000000004 110.967 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -63.8 137.54 58.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.402 0.681 . . . . 62.530000000000001 111.058 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -72.19 102.29 3.02 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 120.66 0.267 . . . . 62.119999999999997 111.408 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -62.69 -42.39 99.61 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.063 0.459 . . . . 61.409999999999997 110.353 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -73.08 130.03 39.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.352 0.661 . . . . 74.200000000000003 109.315 170.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -89.39 133.4 34.53 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.026 0.53 . . . . 74.319999999999993 111.355 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m -79.92 74.9 6.66 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.367 -0.975 . . . . 74.030000000000001 108.367 164.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -136.37 112.52 9.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.404 -0.816 . . . . 75.430000000000007 110.343 -168.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -140.55 97.32 3.18 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.377 -0.972 . . . . 74.129999999999995 108.377 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -54.38 125.84 20.97 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.066 1.135 . . . . 72.530000000000001 114.066 -167.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 97' ' ' PHE . 47.7 t30 -136.18 132.41 35.91 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.944 0.898 . . . . 75.340000000000003 110.188 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -93.15 -23.57 18.54 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.685 0.794 . . . . 73.109999999999999 111.556 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.4 m -97.58 126.05 42.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.819 0.448 . . . . 74.430000000000007 110.155 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.417 HG21 ' HB1' ' A' ' 76' ' ' ALA . 34.7 pt -103.42 151.24 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.15 0.58 . . . . 74.230000000000004 111.202 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -110.06 119.78 40.36 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 74.439999999999998 109.508 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG22 HG13 ' A' ' 95' ' ' VAL . 13.7 t -114.23 136.91 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.889 0.875 . . . . 75.439999999999998 110.44 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -117.48 162.18 18.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.265 1.026 . . . . 75.109999999999999 110.199 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.32 26.52 74.51 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 114.35 0.5 . . . . 73.120000000000005 114.35 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 HG21 ' A' ' 93' ' ' ILE . 55.1 mt -71.7 -24.46 61.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.496 1.119 . . . . 73.129999999999995 111.981 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.36 161.42 36.57 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.447 -0.342 . . . . 44.149999999999999 112.811 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.69 -7.78 55.99 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.372 0.586 . . . . 70.340000000000003 111.595 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.19 11.94 17.29 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.001 0.921 . . . . 62.100000000000001 111.571 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.83 133.95 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 123.928 0.891 . . . . 63.530000000000001 112.476 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 p -133.73 155.2 50.18 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.671 0.788 . . . . 71.25 110.23 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.25 -39.54 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.217 0.607 . . . . 75.200000000000003 111.253 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.93 -49.91 74.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.834 0.854 . . . . 75.109999999999999 111.744 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 m -65.34 -43.44 90.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.088 0.555 . . . . 75.349999999999994 112.126 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.24 -40.84 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 122.901 0.48 . . . . 65.400000000000006 110.812 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.65 84.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.053 -0.521 . . . . 70.5 111.371 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.96 -27.94 67.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 70.409999999999997 111.92 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -77.18 -54.87 5.96 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.844 0.857 . . . . 74.409999999999997 111.978 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.402 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 61.9 m-85 -77.85 -18.95 55.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.199 1.185 . . . . 72.430000000000007 114.199 -174.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -57.24 -27.91 62.47 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 113.728 1.01 . . . . 74.25 113.728 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -58.2 -26.2 62.52 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.593 0.757 . . . . 74.349999999999994 112.758 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.24 -51.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 74.299999999999997 111.076 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.32 -177.01 46.72 Favored Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.861 -0.609 . . . . 70.530000000000001 113.259 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.04 118.31 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.253 0.621 . . . . 71.430000000000007 111.151 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.9 mt -87.95 123.08 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.177 -1.046 . . . . 63.0 108.177 169.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 54.3 mtpt -46.27 118.14 1.82 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.426 0.69 . . . . 72.120000000000005 112.423 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 80.7 m -103.96 115.56 30.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.335 0.654 . . . . 64.239999999999995 110.273 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -56.63 122.13 11.34 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.364 1.066 . . . . 74.099999999999994 110.592 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.7 mmmp? -80.75 -14.79 57.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.449 1.1 . . . . 74.319999999999993 112.583 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 10.0 mmpt? -84.83 -43.01 14.56 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 111.249 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.8 p -85.98 -40.4 15.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.612 0.765 . . . . 75.219999999999999 111.553 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.76 64.92 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.086 -0.506 . . . . 70.510000000000005 112.025 -170.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -114.66 156.69 44.46 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 125.22 1.408 . . . . 62.130000000000003 110.824 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 65.2 Cg_endo -72.56 153.53 54.8 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.403 2.069 . . . . 72.209999999999994 112.852 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.513 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.5 mtt -83.7 95.73 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.99 0.916 . . . . 75.420000000000002 109.35 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -137.61 122.87 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 75.239999999999995 108.535 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -106.07 108.67 20.31 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.375 -0.602 . . . . 71.329999999999998 109.375 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.0 mt -89.37 129.52 35.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.728 0.811 . . . . 72.430000000000007 109.076 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.19 124.44 34.36 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.574 0.35 . . . . 73.450000000000003 111.097 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.6 m -108.83 137.81 46.16 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.663 0.785 . . . . 73.329999999999998 110.201 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.54 136.05 47.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.777 0.831 . . . . 62.100000000000001 110.831 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -76.42 -24.3 53.98 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.13 0.789 . . . . 74.400000000000006 113.13 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -92.41 -55.4 3.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.842 0.457 . . . . 65.0 111.348 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -73.95 -30.63 62.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.771 0.828 . . . . 74.109999999999999 111.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.88 6.34 88.64 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.997 -0.547 . . . . 75.430000000000007 113.441 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -100.83 158.54 15.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.282 0.633 . . . . 74.25 111.511 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.62 130.91 44.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.168 0.587 . . . . 75.239999999999995 111.582 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.43 -16.78 64.37 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.345 1.058 . . . . 74.439999999999998 112.697 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 29.07 56.22 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.267 -0.333 . . . . 64.239999999999995 112.267 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.67 146.23 52.07 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.416 1.086 . . . . 71.239999999999995 108.536 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.36 169.58 21.74 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.483 0.549 . . . . 62.520000000000003 112.483 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 p -123.56 130.82 53.24 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.982 -0.554 . . . . 54.109999999999999 111.089 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -110.1 109.52 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.669 0.788 . . . . 73.420000000000002 109.746 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -79.53 104.11 9.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.338 0.255 . . . . 64.030000000000001 111.143 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 48.9 m-85 -82.69 163.07 21.58 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 120.842 0.353 . . . . 74.430000000000007 110.187 169.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.31 -40.19 52.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.319 0.647 . . . . 74.430000000000007 110.836 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 11.7 m-20 -112.61 133.81 21.78 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.156 0.582 . . . . 75.310000000000002 111.706 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.17 -41.09 59.3 Favored 'Trans proline' 0 CA--C 1.584 3.015 0 C-N-CA 122.842 2.362 . . . . 73.129999999999995 116.028 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 69.8 Cg_endo -71.08 -20.92 28.12 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 122.526 1.938 . . . . 74.209999999999994 113.204 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 t -75.77 -39.5 56.92 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.574 0.702 . . . . 75.150000000000006 109.451 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 16' ' ' ILE . . . -61.15 -45.17 95.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.056 -0.975 . . . . 70.340000000000003 110.623 173.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.1 -46.4 89.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.494 1.118 . . . . 73.340000000000003 110.882 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.79 97.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.172 0.589 . . . . 71.349999999999994 112.008 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.48 77.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 75.040000000000006 112.143 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 HG11 ' A' ' 95' ' ' VAL . 83.7 mt -64.71 -57.91 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.216 0.607 . . . . 75.430000000000007 110.823 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.94 -32.92 68.28 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.11 0.964 . . . . 72.510000000000005 111.884 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.78 -54.45 5.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.236 0.615 . . . . 73.109999999999999 112.446 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' HB2' HG21 ' A' ' 95' ' ' VAL . 58.8 m-85 -89.34 -6.52 56.61 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.872 1.064 . . . . 75.109999999999999 113.872 -171.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.6 124.45 22.39 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.266 0.485 . . . . 75.230000000000004 110.085 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.53 -0.84 89.22 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.041 -0.527 . . . . 73.409999999999997 114.017 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -97.57 170.5 8.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.537 0.735 . . . . 71.200000000000003 110.914 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.08 137.9 50.73 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.114 0.565 . . . . 70.109999999999999 111.78 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -129.29 131.62 47.0 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.813 1.245 . . . . 75.25 108.526 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t 63.33 25.85 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.362 1.065 . . . . 71.219999999999999 111.537 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.01 88.1 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-N 116.049 -0.523 . . . . 43.119999999999997 113.706 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -115.02 117.24 41.88 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.341 1.056 . . . . 70.540000000000006 110.495 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.92 100.74 0.17 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.627 2.218 . . . . 62.43 113.066 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.441 HG21 HD23 ' A' ' 21' ' ' LEU . 40.3 pt -82.64 153.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.92 0.888 . . . . 74.140000000000001 113.368 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -114.91 110.25 19.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.076 1.351 . . . . 75.530000000000001 109.169 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 18' ' ' VAL . 23.8 t -103.87 131.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 122.151 -0.343 . . . . 71.540000000000006 110.096 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.1 p -142.79 179.29 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.608 1.163 . . . . 55.119999999999997 109.748 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.422 ' HB3' HD21 ' A' ' 13' ' ' ASN . 63.6 m-85 -77.06 150.07 35.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.487 0.585 . . . . 72.099999999999994 110.772 169.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.82 87.94 7.48 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.094 0.473 . . . . 72.319999999999993 110.936 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.471 1.108 . . . . 74.019999999999996 110.822 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.65 0.262 . . . . 75.109999999999999 111.65 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.28 -60.21 0.24 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.313 -0.403 . . . . 74.400000000000006 112.754 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -81.65 99.77 9.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.945 0.498 . . . . 71.310000000000002 111.0 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -79.74 95.34 5.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.309 0.643 . . . . 70.219999999999999 110.543 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -139.87 116.93 11.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.89 0.876 . . . . 75.120000000000005 110.57 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -74.39 112.43 10.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.117 0.567 . . . . 74.540000000000006 109.693 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -75.95 122.53 24.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.88 0.472 . . . . 60.210000000000001 110.932 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -71.71 105.43 3.71 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.524 0.678 . . . . 75.400000000000006 110.796 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -154.41 28.35 0.45 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.442 0.697 . . . . 75.230000000000004 110.697 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -65.32 -60.55 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.848 -0.797 . . . . 75.219999999999999 108.848 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.3 t -85.97 124.04 31.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.423 0.689 . . . . 75.109999999999999 109.835 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.4 103.82 2.11 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.818 0.847 . . . . 71.299999999999997 111.087 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -90.13 122.72 33.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.639 0.376 . . . . 73.319999999999993 110.882 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 28.0 p-10 -94.45 -13.14 26.5 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.773 0.829 . . . . 75.329999999999998 111.26 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -100.96 128.95 46.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 70.109999999999999 110.218 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.1 pt -110.85 151.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.423 0.689 . . . . 75.010000000000005 110.892 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -108.0 116.19 31.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.158 0.583 . . . . 72.340000000000003 109.724 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG12 HG23 ' A' ' 95' ' ' VAL . 11.3 t -107.76 142.1 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.251 1.02 . . . . 73.239999999999995 110.16 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -122.07 158.88 28.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.851 1.26 . . . . 74.319999999999993 110.171 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.55 38.98 95.29 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 114.509 0.563 . . . . 74.219999999999999 114.509 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.86 -31.86 27.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.648 1.179 . . . . 74.209999999999994 111.691 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.0 159.6 11.98 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 122.748 0.213 . . . . 63.509999999999998 113.489 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.71 -14.73 57.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.219 0.608 . . . . 75.409999999999997 111.302 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -88.92 3.89 49.87 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.728 0.811 . . . . 74.140000000000001 110.995 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.05 136.25 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.631 0.772 . . . . 72.349999999999994 111.585 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -129.05 151.92 49.21 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.945 -0.472 . . . . 62.0 110.194 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.555 HG22 ' HB ' ' A' ' 51' ' ' ILE . 75.9 mt -52.8 -45.01 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.239 1.015 . . . . 74.349999999999994 112.032 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.82 -31.73 68.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.427 0.691 . . . . 71.430000000000007 112.528 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -75.37 -36.77 60.87 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.57 0.348 . . . . 64.239999999999995 111.684 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.88 -39.85 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.427 0.632 . . . . 72.109999999999999 109.599 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.92 99.52 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.913 -1.039 . . . . 75.439999999999998 111.65 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.84 -34.86 69.62 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.309 0.644 . . . . 73.340000000000003 111.679 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.27 -54.15 9.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.775 0.83 . . . . 75.230000000000004 111.508 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 38.6 m-85 -77.29 -18.28 57.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.635 1.346 . . . . 74.150000000000006 114.635 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.79 -21.47 64.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.511 1.3 . . . . 73.299999999999997 114.511 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -57.64 -26.09 61.11 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.413 0.685 . . . . 72.129999999999995 112.388 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 mm -85.65 -45.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 75.430000000000007 111.214 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.83 44.3 Favored Glycine 0 C--O 1.241 0.576 0 CA-C-N 116.077 -0.51 . . . . 61.210000000000001 113.302 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 122.84 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.555 0.742 . . . . 75.230000000000004 110.185 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.8 mt -92.51 124.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.071 -1.085 . . . . 71.109999999999999 108.071 173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -50.62 154.81 1.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.068 0.947 . . . . 75.0 112.902 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 87.2 m -137.5 127.25 25.42 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.559 -0.746 . . . . 75.129999999999995 110.824 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.34 113.94 4.42 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.686 -0.688 . . . . 65.519999999999996 109.417 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -78.01 -13.29 59.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.932 0.893 . . . . 73.349999999999994 112.172 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -80.67 -29.38 36.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.039 0.535 . . . . 75.409999999999997 112.289 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -103.21 -50.83 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.131 0.573 . . . . 64.299999999999997 110.893 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.58 10.64 28.6 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.563 -0.744 . . . . 73.519999999999996 112.364 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.63 145.31 30.38 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 75.109999999999999 111.637 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.27 145.74 93.31 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.842 2.361 . . . . 73.310000000000002 112.47 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 52.3 mtt -73.65 94.0 2.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.799 0.809 . . . . 73.219999999999999 109.739 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.555 ' HB ' HG22 ' A' ' 27' ' ' ILE . 84.7 mt -145.78 120.93 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.507 -1.224 . . . . 71.219999999999999 108.369 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -101.29 110.33 22.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.496 -0.557 . . . . 71.519999999999996 109.496 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -78.71 136.09 37.33 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.098 -0.704 . . . . 75.549999999999997 109.098 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.2 111.03 22.72 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.253 0.621 . . . . 75.030000000000001 110.144 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -86.65 151.65 23.25 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.037 0.535 . . . . 74.340000000000003 110.087 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.98 142.19 28.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.914 0.886 . . . . 72.549999999999997 110.896 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -37.62 59.71 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.485 -0.779 . . . . 74.209999999999994 112.672 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -94.24 -43.85 8.25 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.705 0.402 . . . . 72.200000000000003 111.713 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -81.92 -33.71 30.25 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 118.008 0.367 . . . . 75.310000000000002 111.864 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.59 13.17 83.21 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 116.239 -0.437 . . . . 74.400000000000006 114.167 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -104.1 173.57 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.598 0.759 . . . . 75.129999999999995 110.286 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.28 123.31 22.71 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.792 0.33 . . . . 74.420000000000002 110.226 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.564 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 7.8 mtpm? -63.63 -21.68 66.5 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.125 0.97 . . . . 74.219999999999999 113.18 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 23.26 35.66 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 123.178 0.299 . . . . 71.239999999999995 112.412 -171.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -121.34 151.05 40.55 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.043 -0.681 . . . . 74.439999999999998 109.692 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.78 154.85 24.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 64.319999999999993 111.713 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.9 p -109.86 120.59 42.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.62 0.368 . . . . 65.209999999999994 110.08 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.67 111.65 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.696 0.798 . . . . 71.219999999999999 110.449 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 70.7 m -85.55 105.12 15.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.682 0.393 . . . . 75.200000000000003 111.166 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.431 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 52.1 m-85 -81.25 153.45 27.13 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.261 0.624 . . . . 74.230000000000004 110.074 168.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.29 -28.79 62.29 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.138 0.575 . . . . 74.439999999999998 111.233 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.61 127.97 26.35 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 111.194 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 9.9 Cg_endo -54.92 -34.31 85.63 Favored 'Trans proline' 0 CA--C 1.583 2.973 0 C-N-CA 123.008 2.472 . . . . 75.109999999999999 116.277 170.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.48 -28.06 62.14 Favored 'Trans proline' 0 C--N 1.4 3.284 0 CA-C-N 122.62 1.972 . . . . 64.140000000000001 113.39 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 m -75.1 -35.04 61.78 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.114 0.566 . . . . 62.149999999999999 110.004 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.33 -53.64 54.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.679 -0.691 . . . . 74.329999999999998 111.121 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -59.37 -44.43 92.74 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.936 0.895 . . . . 73.109999999999999 110.77 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.88 90.89 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.002 -0.545 . . . . 74.400000000000006 111.775 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.42 72.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.245 0.618 . . . . 74.319999999999993 112.327 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 95' ' ' VAL . 83.0 mt -66.0 -58.37 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.992 0.517 . . . . 73.209999999999994 110.398 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.1 -26.21 68.44 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 115.327 -0.851 . . . . 71.530000000000001 111.919 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -81.0 -60.42 2.3 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.931 0.492 . . . . 75.239999999999995 111.754 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.52 -6.72 58.61 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.87 1.063 . . . . 72.439999999999998 113.87 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.39 106.27 0.73 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 118.118 0.417 . . . . 74.230000000000004 110.374 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.05 55.33 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.055 0.782 . . . . 72.510000000000005 115.055 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.41 -174.35 4.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.03 0.915 . . . . 71.209999999999994 110.616 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.6 127.42 37.04 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 122.922 0.489 . . . . 74.120000000000005 111.3 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -92.46 -87.91 0.21 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.861 0.464 . . . . 64.409999999999997 110.146 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.1 m -89.64 50.58 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.389 0.614 . . . . 72.010000000000005 109.907 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.17 4.9 69.64 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.883 -0.599 . . . . 63.530000000000001 113.915 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.68 134.09 21.01 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.725 0.81 . . . . 70.540000000000006 110.679 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.91 107.07 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.658 2.905 . . . . 62.030000000000001 112.672 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.73 143.53 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 N-CA-C 113.164 0.802 . . . . 74.209999999999994 113.164 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -118.65 114.86 23.4 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.951 1.301 . . . . 74.310000000000002 108.681 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 18' ' ' VAL . 15.0 t -107.92 141.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.639 0.376 . . . . 64.109999999999999 110.584 -174.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 t -148.68 -178.21 6.22 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.329 1.051 . . . . 72.530000000000001 110.0 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -76.25 140.62 41.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.849 0.46 . . . . 74.150000000000006 110.252 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.24 5.25 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.173 0.511 . . . . 63.210000000000001 109.737 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 124.497 1.119 . . . . 71.209999999999994 110.857 -171.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 110.053 -0.351 . . . . 74.049999999999997 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 112.19 3.65 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.019 -0.323 . . . . 74.120000000000005 113.083 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -76.97 127.11 32.11 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.318 0.559 . . . . 75.530000000000001 110.989 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -161.62 114.46 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.22 0.608 . . . . 75.510000000000005 110.293 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -127.85 124.98 38.84 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.982 0.513 . . . . 75.540000000000006 110.264 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -95.2 137.24 34.52 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.503 0.321 . . . . 75.540000000000006 110.622 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -65.13 116.42 6.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.709 0.804 . . . . 72.430000000000007 110.921 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -74.93 123.76 25.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.785 0.834 . . . . 73.329999999999998 110.744 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.0 t -95.99 97.02 9.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.259 0.624 . . . . 73.340000000000003 111.613 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -82.89 3.69 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.353 0.661 . . . . 73.319999999999993 111.946 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 t -138.11 131.58 30.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.121 0.969 . . . . 74.420000000000002 109.906 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.1 79.44 5.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.761 0.791 . . . . 73.099999999999994 111.023 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.07 129.17 35.7 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.345 -0.847 . . . . 72.239999999999995 110.442 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -90.4 -19.35 24.05 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.081 0.467 . . . . 63.219999999999999 109.924 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -98.64 129.87 45.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.584 0.753 . . . . 72.420000000000002 110.463 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.0 pt -110.33 151.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.6 0.76 . . . . 74.299999999999997 111.123 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -106.37 119.32 38.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.253 0.621 . . . . 73.310000000000002 109.67 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 95' ' ' VAL . 11.2 t -112.61 140.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.249 1.02 . . . . 72.239999999999995 110.606 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.38 157.06 30.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.362 1.065 . . . . 72.040000000000006 110.486 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.64 34.88 42.63 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 115.135 0.814 . . . . 65.450000000000003 115.135 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.53 -21.69 28.47 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.269 1.028 . . . . 74.530000000000001 112.129 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.25 158.86 30.09 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 116.816 -0.174 . . . . 44.439999999999998 112.885 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.158 0.583 . . . . 74.310000000000002 112.297 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.96 11.8 23.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.95 0.5 . . . . 64.219999999999999 111.491 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.98 138.58 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 123.788 0.835 . . . . 73.540000000000006 112.414 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 30' ' ' VAL . 39.0 p -124.91 153.86 42.01 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.213 0.605 . . . . 74.140000000000001 110.461 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.523 HG22 ' HB ' ' A' ' 51' ' ' ILE . 79.8 mt -55.67 -42.84 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.741 0.817 . . . . 63.229999999999997 111.598 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -33.1 72.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.379 0.672 . . . . 74.420000000000002 112.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.3 t -69.9 -42.22 73.68 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.387 0.275 . . . . 62.149999999999999 111.025 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 26' ' ' THR . 59.8 t -63.89 -42.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.326 0.584 . . . . 72.530000000000001 110.072 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.32 82.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.13 -0.941 . . . . 73.329999999999998 111.895 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.88 -38.71 92.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 74.310000000000002 111.299 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -67.89 -56.36 9.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.356 1.063 . . . . 72.239999999999995 111.515 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 85.2 m-85 -78.87 -20.46 49.46 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.212 1.19 . . . . 74.120000000000005 114.212 -174.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.77 -23.24 67.28 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.824 1.046 . . . . 75.540000000000006 113.824 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -60.49 -24.91 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.181 0.592 . . . . 72.209999999999994 112.291 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 mm -82.85 -43.65 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.102 0.961 . . . . 73.549999999999997 111.018 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.79 169.17 42.29 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.793 -0.639 . . . . 73.239999999999995 112.612 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.39 131.52 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.045 0.538 . . . . 75.140000000000001 110.9 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.4 mt -97.69 131.09 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.814 0.846 . . . . 72.439999999999998 108.804 173.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 60.1 mtpt -53.65 151.2 6.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.288 0.635 . . . . 65.349999999999994 112.194 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.0 m -142.48 127.6 18.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.728 0.811 . . . . 71.209999999999994 110.262 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.78 127.8 34.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.711 0.804 . . . . 74.329999999999998 110.384 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -31.54 56.64 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.432 0.693 . . . . 74.010000000000005 112.287 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -51.45 43.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.966 0.506 . . . . 72.340000000000003 111.806 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -82.28 -51.37 7.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.569 0.748 . . . . 74.230000000000004 110.899 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.14 10.6 29.58 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.872 -0.603 . . . . 64.409999999999997 113.822 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -109.2 147.74 36.58 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 117.724 0.762 . . . . 54.119999999999997 112.721 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.7 Cg_endo -68.64 142.72 54.07 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.947 2.431 . . . . 75.099999999999994 112.371 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.517 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.1 mtt -74.08 95.25 2.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.595 0.712 . . . . 75.310000000000002 110.257 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.523 ' HB ' HG22 ' A' ' 27' ' ' ILE . 81.9 mt -143.91 120.09 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.687 1.195 . . . . 74.239999999999995 108.902 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.74 111.28 23.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.146 0.578 . . . . 74.219999999999999 110.005 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.0 mt -86.5 114.37 23.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.643 0.777 . . . . 65.109999999999999 110.072 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.9 126.72 31.55 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.528 0.731 . . . . 72.140000000000001 111.433 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -99.72 145.3 27.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.604 0.762 . . . . 70.219999999999999 110.561 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.67 138.91 36.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.417 0.687 . . . . 74.439999999999998 112.334 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 11.4 ptp180 -64.94 -35.86 82.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.25 1.02 . . . . 75.439999999999998 112.64 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 19.5 mm-40 -87.86 -57.02 3.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.263 0.625 . . . . 63.140000000000001 111.462 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 p -73.11 -28.54 62.33 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.248 0.833 . . . . 74.030000000000001 113.248 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.0 73.32 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 123.358 0.411 . . . . 62.329999999999998 113.084 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -122.27 159.42 27.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.921 1.288 . . . . 72.420000000000002 109.167 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.52 133.07 55.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.645 0.378 . . . . 70.010000000000005 111.736 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -67.12 -14.19 62.66 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.853 0.861 . . . . 74.420000000000002 113.048 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.67 35.14 32.98 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.103 -0.799 . . . . 73.219999999999999 111.103 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -139.36 138.46 36.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.089 0.956 . . . . 75.540000000000006 109.016 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.58 159.11 40.68 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.02 0.438 . . . . 74.209999999999994 112.143 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 24.3 p -111.46 123.69 50.74 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.267 -0.424 . . . . 74.299999999999997 110.698 172.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.0 110.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.68 0.792 . . . . 74.040000000000006 110.371 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 m -88.6 102.27 14.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.852 0.461 . . . . 64.299999999999997 111.276 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 70.5 m-85 -79.3 158.25 27.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.217 0.607 . . . . 75.049999999999997 111.363 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.56 -32.08 70.66 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.853 0.861 . . . . 71.140000000000001 111.048 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.99 136.77 26.55 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.667 0.787 . . . . 72.150000000000006 112.006 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.0 -36.33 95.83 Favored 'Trans proline' 0 CA--C 1.58 2.795 0 C-N-CA 122.768 2.312 . . . . 75.329999999999998 116.208 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.09 -26.72 65.43 Favored 'Trans proline' 0 C--N 1.393 2.912 0 CA-C-N 122.816 2.041 . . . . 73.120000000000005 113.403 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -71.53 -40.45 70.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 62.229999999999997 109.712 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -61.49 -53.62 53.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.125 -0.943 . . . . 72.040000000000006 111.296 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.46 -46.51 88.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.752 1.221 . . . . 74.329999999999998 111.166 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.74 99.27 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.804 -0.634 . . . . 71.519999999999996 111.691 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.57 74.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.923 0.489 . . . . 73.030000000000001 112.183 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.475 HG12 HG11 ' A' ' 95' ' ' VAL . 86.8 mt -62.12 -62.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.892 0.477 . . . . 71.329999999999998 110.449 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.59 -31.59 70.73 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.877 0.871 . . . . 74.209999999999994 112.578 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -77.54 -53.23 7.85 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.231 0.612 . . . . 71.310000000000002 111.964 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.561 ' HB3' HD13 ' A' ' 93' ' ' ILE . 64.7 m-85 -88.41 -7.66 56.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.838 1.051 . . . . 72.239999999999995 113.838 -172.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.21 115.35 4.07 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.126 0.421 . . . . 64.540000000000006 110.519 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.68 10.7 72.47 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.592 0.597 . . . . 73.049999999999997 114.592 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -101.52 153.43 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.701 0.75 . . . . 75.319999999999993 111.698 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.35 127.04 34.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.088 0.555 . . . . 75.319999999999993 112.163 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -92.47 -52.75 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.189 0.595 . . . . 73.030000000000001 110.852 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -126.01 40.65 3.69 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.963 0.905 . . . . 73.420000000000002 110.015 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.6 15.85 80.89 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 115.815 -0.63 . . . . 60.32 112.8 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -136.7 129.28 17.34 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.304 1.042 . . . . 75.010000000000005 110.758 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.33 135.26 36.16 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.185 2.59 . . . . 74.010000000000005 113.243 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 83' ' ' PHE . 27.1 pt -104.7 150.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 74.209999999999994 112.215 -173.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -114.76 109.9 18.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.764 0.826 . . . . 74.109999999999999 108.807 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 18' ' ' VAL . 7.8 t -108.64 137.59 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 122.813 0.445 . . . . 74.439999999999998 110.432 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.9 m -146.07 179.55 7.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.325 1.05 . . . . 73.200000000000003 109.458 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -74.62 143.05 44.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.725 -0.472 . . . . 73.010000000000005 109.725 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.33 91.89 1.37 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.37 0.605 . . . . 74.019999999999996 111.175 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 124.165 0.986 . . . . 74.430000000000007 111.102 178.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.529 0.204 . . . . 73.209999999999994 110.784 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.13 133.53 13.04 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 119.754 -0.47 . . . . 70.150000000000006 112.99 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -59.34 127.67 33.25 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.801 0.84 . . . . 70.510000000000005 111.616 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -68.5 90.48 0.38 Allowed 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.249 0.833 . . . . 60.140000000000001 113.249 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 t60 61.46 111.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.491 1.516 . . . . 74.430000000000007 112.975 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.01 137.73 55.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.848 0.459 . . . . 74.530000000000001 111.461 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -120.15 -173.92 2.66 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.442 1.097 . . . . 72.319999999999993 110.771 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.39 147.6 30.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.083 0.553 . . . . 75.129999999999995 110.819 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.1 t -60.23 110.59 1.27 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.851 0.46 . . . . 74.340000000000003 111.772 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -157.47 152.51 25.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.436 1.094 . . . . 72.519999999999996 109.792 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t 62.31 15.12 7.35 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.981 0.913 . . . . 70.310000000000002 113.291 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.32 150.38 41.93 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.712 0.805 . . . . 73.120000000000005 111.79 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.441 HD21 ' HB3' ' A' ' 97' ' ' PHE . 48.1 t30 -83.61 129.44 34.96 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.41 0.684 . . . . 70.329999999999998 110.562 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -102.26 -11.05 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.284 0.633 . . . . 74.430000000000007 111.808 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.3 m -97.88 125.6 42.85 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.295 0.638 . . . . 73.209999999999994 109.819 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.69 140.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.066 0.547 . . . . 74.319999999999993 111.175 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -94.79 125.36 39.4 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.939 -0.393 . . . . 72.299999999999997 109.939 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG11 HG22 ' A' ' 95' ' ' VAL . 23.0 t -118.05 139.64 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.099 0.959 . . . . 73.530000000000001 109.82 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -127.58 162.06 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.97 0.908 . . . . 74.140000000000001 110.973 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.75 66.93 Favored Glycine 0 N--CA 1.479 1.502 0 O-C-N 123.46 0.475 . . . . 62.009999999999998 114.192 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.492 HD23 HG21 ' A' ' 93' ' ' ILE . 34.3 mt -75.46 -26.5 58.29 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.098 0.959 . . . . 72.450000000000003 111.789 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.16 152.15 21.11 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.964 -0.454 . . . . 63.130000000000003 111.964 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.99 -3.45 35.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.355 0.872 . . . . 74.129999999999995 113.355 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -101.43 18.85 19.07 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.393 0.677 . . . . 73.150000000000006 110.522 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 HD11 ' A' ' 21' ' ' LEU . 11.2 p -71.51 135.59 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 123.264 0.626 . . . . 73.109999999999999 112.135 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -127.28 150.73 49.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.573 -0.705 . . . . 74.140000000000001 110.901 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' HB ' ' A' ' 51' ' ' ILE . 85.1 mt -52.93 -45.83 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.456 1.102 . . . . 75.200000000000003 111.978 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.62 -31.14 67.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.655 0.782 . . . . 73.329999999999998 111.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.5 m -71.54 -40.11 70.27 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.759 0.424 . . . . 73.209999999999994 111.606 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 26' ' ' THR . 52.3 t -66.45 -36.94 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.896 0.478 . . . . 73.120000000000005 110.151 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.27 75.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.605 -0.725 . . . . 72.329999999999998 111.344 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.44 -30.97 71.82 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.601 0.76 . . . . 72.109999999999999 111.68 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -74.18 -56.46 4.87 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.528 0.731 . . . . 74.340000000000003 111.195 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 23.0 m-85 -77.17 -18.55 57.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.404 1.261 . . . . 74.439999999999998 114.404 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -63.42 -20.57 65.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 113.89 1.07 . . . . 71.450000000000003 113.89 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.21 -25.32 65.51 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.23 0.612 . . . . 74.25 112.138 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.4 mm -88.36 -48.45 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.241 1.016 . . . . 74.310000000000002 111.367 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.0 169.7 39.0 Favored Glycine 0 C--O 1.238 0.353 0 C-N-CA 121.435 -0.412 . . . . 73.540000000000006 113.414 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.32 117.21 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.492 0.717 . . . . 74.310000000000002 110.329 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.7 mt -86.22 127.86 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.828 -0.804 . . . . 72.450000000000003 108.828 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -53.26 154.54 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.059 0.944 . . . . 72.150000000000006 112.833 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.3 m -132.01 127.0 35.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.953 0.901 . . . . 73.129999999999995 110.334 -175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -64.0 119.99 11.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.727 0.811 . . . . 65.319999999999993 109.986 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.72 -21.23 64.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.338 1.055 . . . . 74.25 112.529 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -86.53 -43.36 12.79 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.447 0.699 . . . . 75.120000000000005 112.037 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 p -89.46 -36.27 15.52 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.924 0.713 . . . . 44.340000000000003 112.924 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.43 77.09 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 112.712 -0.155 . . . . 51.439999999999998 112.712 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -99.46 151.18 37.34 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.631 1.172 . . . . 74.420000000000002 110.919 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.4 145.22 76.62 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.571 2.181 . . . . 74.109999999999999 111.436 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.432 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 59.3 mtt -74.47 92.26 2.34 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.234 -0.654 . . . . 73.510000000000005 109.234 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.605 ' HB ' HG22 ' A' ' 27' ' ' ILE . 79.9 mt -145.72 117.66 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.781 1.232 . . . . 73.439999999999998 108.172 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 30.4 m-80 -104.5 111.58 24.3 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 109.94 -0.393 . . . . 75.230000000000004 109.94 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -80.37 128.65 33.81 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.413 0.685 . . . . 74.439999999999998 110.053 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.571 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 70.4 m-85 -86.1 136.09 33.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.183 0.593 . . . . 74.329999999999998 110.708 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -128.82 138.73 52.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.516 1.126 . . . . 73.030000000000001 109.614 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.09 110.55 3.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.695 -0.854 . . . . 65.400000000000006 108.695 170.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -67.64 -22.52 65.32 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.986 0.515 . . . . 74.409999999999997 111.695 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.522 ' HG3' HG22 ' A' ' 59' ' ' THR . 8.9 pt-20 -75.85 -48.43 21.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.614 0.766 . . . . 73.150000000000006 112.17 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.522 HG22 ' HG3' ' A' ' 58' ' ' GLU . 60.5 p -91.61 -33.42 15.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.226 0.61 . . . . 74.510000000000005 112.075 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.26 3.1 76.09 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.728 -0.669 . . . . 64.230000000000004 113.54 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -93.01 161.28 14.51 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.436 0.618 . . . . 64.099999999999994 111.17 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.64 141.51 39.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.139 0.576 . . . . 55.530000000000001 111.217 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -78.45 -14.31 59.43 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.230000000000004 112.134 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.86 37.96 28.36 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.177 -0.369 . . . . 72.230000000000004 112.177 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 48.5 mt-10 -130.7 151.37 51.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.896 0.878 . . . . 70.310000000000002 109.627 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 141.76 14.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.915 0.486 . . . . 72.340000000000003 112.02 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.3 p -101.62 112.92 25.64 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.438 0.295 . . . . 73.340000000000003 110.836 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -103.5 110.52 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.014 0.926 . . . . 64.099999999999994 110.038 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 47.3 m -87.86 107.08 18.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.843 0.457 . . . . 61.32 111.012 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.406 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 46.1 m-85 -83.12 157.11 22.94 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.217 0.532 . . . . 74.519999999999996 110.352 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.68 -34.43 75.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.78 0.832 . . . . 74.310000000000002 110.684 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -118.51 134.12 23.49 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.399 0.68 . . . . 73.230000000000004 111.033 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.62 -36.56 89.79 Favored 'Trans proline' 0 CA--C 1.582 2.888 0 C-N-CA 122.517 2.144 . . . . 70.329999999999998 116.225 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.85 -32.81 77.2 Favored 'Trans proline' 0 C--N 1.397 3.125 0 CA-C-N 122.8 2.036 . . . . 74.140000000000001 114.107 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.7 p -78.13 -33.25 50.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.09 0.556 . . . . 73.400000000000006 110.394 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.27 74.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.171 0.588 . . . . 63.329999999999998 111.205 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -61.87 -40.52 95.64 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.287 1.035 . . . . 73.010000000000005 110.796 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.97 94.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.776 -0.647 . . . . 72.519999999999996 111.872 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.06 -27.11 68.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.133 0.573 . . . . 55.450000000000003 112.408 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.1 mt -64.36 -63.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.519 0.328 . . . . 75.549999999999997 110.615 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.0 -28.16 66.11 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.672 0.789 . . . . 63.420000000000002 112.005 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.52 -61.01 2.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.117 0.567 . . . . 74.200000000000003 111.63 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 93' ' ' ILE . 72.8 m-85 -82.72 -10.83 58.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.162 1.171 . . . . 74.239999999999995 114.162 -169.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.53 94.13 0.27 Allowed 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 109.025 -0.732 . . . . 71.430000000000007 109.025 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.76 -12.65 11.85 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.195 -0.911 . . . . 55.310000000000002 114.444 -174.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 93' ' ' ILE . 49.0 mmtm -81.56 140.54 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.941 0.871 . . . . 73.120000000000005 110.612 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.9 121.19 31.01 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.148 -0.345 . . . . 74.310000000000002 111.842 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -83.95 -80.96 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.109 0.564 . . . . 72.120000000000005 109.719 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -104.33 57.03 0.71 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.501 0.667 . . . . 60.32 110.126 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 9.29 84.88 Favored Glycine 0 N--CA 1.48 1.62 0 CA-C-N 115.682 -0.69 . . . . 72.129999999999995 114.201 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -126.03 126.47 24.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 123.984 0.914 . . . . 72.450000000000003 110.534 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.15 108.62 1.37 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.796 2.33 . . . . 73.040000000000006 112.018 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 83' ' ' PHE . 11.3 pt -77.89 152.51 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.411 0.685 . . . . 75.310000000000002 111.872 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -116.87 120.49 38.65 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.811 -0.811 . . . . 75.129999999999995 108.811 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.563 HG22 HG11 ' A' ' 18' ' ' VAL . 21.6 t -116.0 136.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 122.751 0.42 . . . . 74.420000000000002 110.955 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 t -147.29 176.63 9.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.469 1.508 . . . . 73.340000000000003 108.703 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.441 ' HB3' HD21 ' A' ' 13' ' ' ASN . 39.9 m-85 -71.98 145.54 48.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.389 0.54 . . . . 75.329999999999998 111.094 169.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.63 76.32 10.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 75.129999999999995 109.9 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.635 0.774 . . . . 75.230000000000004 111.317 -178.125 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.137 -0.32 . . . . 73.329999999999998 110.137 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.48 -14.7 15.82 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.398 0.919 . . . . 74.019999999999996 115.398 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -86.15 98.88 11.14 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 117.574 0.687 . . . . 74.549999999999997 111.474 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -170.07 142.91 2.39 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.537 1.135 . . . . 74.340000000000003 109.175 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -62.18 111.28 1.9 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.979 0.511 . . . . 74.439999999999998 111.541 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -76.72 -30.75 56.77 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.7 0.8 . . . . 71.25 111.241 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -76.22 134.99 39.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.733 0.813 . . . . 74.319999999999993 110.16 173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -64.84 123.97 20.78 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.198 0.599 . . . . 72.299999999999997 111.393 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.8 t -170.17 130.91 0.96 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.908 0.883 . . . . 75.209999999999994 110.815 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -79.01 -0.18 30.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 122.833 0.453 . . . . 72.25 111.178 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t 60.47 64.01 1.27 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.531 1.133 . . . . 73.430000000000007 110.709 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.8 27.0 1.64 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.773 -1.103 . . . . 74.329999999999998 112.121 -172.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 115.24 15.23 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.873 0.869 . . . . 75.140000000000001 109.806 176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -86.9 -17.47 33.17 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.915 0.486 . . . . 74.030000000000001 112.284 -168.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -95.28 137.89 33.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.054 0.541 . . . . 74.439999999999998 109.947 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 pt -113.89 148.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.842 -0.536 . . . . 73.230000000000004 111.184 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.5 113.95 27.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.614 -0.513 . . . . 72.319999999999993 109.614 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 95' ' ' VAL . 11.0 t -105.63 132.78 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.037 0.935 . . . . 73.150000000000006 109.639 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.58 162.39 18.07 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.855 0.862 . . . . 73.540000000000006 109.824 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.71 68.44 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 114.424 0.53 . . . . 74.219999999999999 114.424 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 18' ' ' VAL . 32.3 mt -80.24 -17.55 51.95 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.857 1.263 . . . . 74.549999999999997 112.459 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.65 173.5 46.93 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.967 0.747 . . . . 65.530000000000001 114.967 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.98 -13.4 60.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.28 1.032 . . . . 74.129999999999995 112.723 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -93.19 11.32 28.28 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.922 0.889 . . . . 73.409999999999997 111.545 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.07 129.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 O-C-N 121.429 -0.794 . . . . 61.43 112.801 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -132.87 158.86 41.49 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.326 0.65 . . . . 70.209999999999994 110.475 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -51.88 -51.21 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.967 0.907 . . . . 75.340000000000003 111.593 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.06 -32.13 68.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.598 0.759 . . . . 74.329999999999998 112.891 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -72.06 -42.25 66.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.109 0.163 . . . . 74.430000000000007 111.004 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.86 -43.08 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 120.853 0.358 . . . . 74.310000000000002 110.445 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.71 87.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.891 -0.595 . . . . 75.200000000000003 112.242 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.06 -27.69 66.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.753 0.421 . . . . 63.229999999999997 111.282 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.38 -50.36 27.13 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 64.129999999999995 110.43 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 18.7 m-85 -82.81 -19.68 37.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.339 1.236 . . . . 72.299999999999997 114.339 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -67.1 -18.31 65.26 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 113.385 0.883 . . . . 74.239999999999995 113.385 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.78 -25.97 65.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.538 0.735 . . . . 74.219999999999999 111.799 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.5 mm -83.2 -38.7 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.376 1.07 . . . . 73.230000000000004 111.381 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.12 -179.81 48.24 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 113.156 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.7 120.13 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.178 0.591 . . . . 75.299999999999997 110.878 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 79.3 mt -93.85 123.78 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.362 0.665 . . . . 74.430000000000007 109.692 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 48.3 mtpt -48.61 146.85 2.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.157 0.983 . . . . 75.5 112.446 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 89.5 m -140.0 123.55 17.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.546 0.738 . . . . 74.439999999999998 110.717 -170.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -63.25 126.06 26.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.677 0.791 . . . . 75.319999999999993 109.719 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.36 -37.54 37.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.283 0.633 . . . . 74.439999999999998 111.973 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.32 -50.16 71.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.183 0.593 . . . . 75.129999999999995 111.29 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.7 p -79.43 -37.21 37.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.736 0.415 . . . . 75.519999999999996 111.344 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.58 63.91 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 116.379 -0.373 . . . . 64.049999999999997 112.464 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -111.15 144.31 30.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 123.93 0.892 . . . . 74.439999999999998 112.173 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 21.6 Cg_endo -61.35 139.17 81.26 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.81 2.34 . . . . 71.140000000000001 112.291 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 48.6 mtt -71.75 96.4 1.61 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.238 0.542 . . . . 74.120000000000005 110.112 -170.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' THR . 60.7 mt -141.12 126.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.434 1.093 . . . . 65.129999999999995 109.173 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.0 m-20 -103.1 110.43 22.37 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.994 -0.743 . . . . 73.099999999999994 108.994 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -89.24 116.68 27.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 72.319999999999993 110.287 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -82.68 118.54 23.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.532 0.733 . . . . 65.340000000000003 110.744 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -106.65 148.92 27.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.368 1.067 . . . . 72.549999999999997 110.479 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.57 136.72 35.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.121 0.568 . . . . 74.439999999999998 110.949 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -72.66 -29.81 63.75 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.75 0.82 . . . . 63.140000000000001 112.627 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -84.89 -61.15 1.85 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.052 0.541 . . . . 74.219999999999999 111.023 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 p -76.77 -31.23 56.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.747 0.819 . . . . 71.109999999999999 112.092 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.58 2.03 90.58 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 116.376 -0.375 . . . . 74.099999999999994 113.458 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -84.75 151.78 24.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.696 0.799 . . . . 74.120000000000005 111.025 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 mt -67.2 129.86 41.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.92 -0.582 . . . . 71.019999999999996 109.679 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -72.78 -9.39 58.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.301 0.64 . . . . 75.019999999999996 112.281 -173.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.35 40.97 31.95 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.268 -0.733 . . . . 63.520000000000003 111.268 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -142.54 138.13 30.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.866 0.866 . . . . 64.109999999999999 109.099 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.0 152.62 24.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.846 0.458 . . . . 74.430000000000007 111.657 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -111.97 120.56 42.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 111.185 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.08 111.16 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.651 1.181 . . . . 65.319999999999993 110.295 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.3 t -83.96 108.94 17.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.462 0.305 . . . . 73.340000000000003 110.9 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 44.3 m-85 -85.5 160.04 19.78 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.131 0.491 . . . . 73.230000000000004 110.501 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.23 -37.87 57.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.291 0.636 . . . . 72.519999999999996 110.485 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -116.38 129.81 24.96 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.518 0.727 . . . . 64.439999999999998 110.606 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.55 -35.45 56.23 Favored 'Trans proline' 0 CA--C 1.579 2.765 0 C-N-CA 123.09 2.527 . . . . 73.239999999999995 116.668 169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.5 -32.94 97.08 Favored 'Trans proline' 0 C--N 1.395 3.017 0 CA-C-N 122.843 2.051 . . . . 72.019999999999996 113.313 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -71.84 -38.55 70.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.215 0.606 . . . . 65.430000000000007 110.297 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.77 53.82 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.391 -0.822 . . . . 71.329999999999998 110.969 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.46 -40.48 97.24 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.474 1.11 . . . . 65.200000000000003 111.717 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.91 97.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 62.310000000000002 112.041 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.67 71.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.253 0.621 . . . . 74.25 111.993 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 HG13 ' A' ' 95' ' ' VAL . 75.2 mt -63.43 -62.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.969 0.508 . . . . 71.109999999999999 110.464 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.65 -32.07 66.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.672 0.789 . . . . 73.409999999999997 112.321 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -77.77 -55.3 5.45 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.033 0.533 . . . . 74.040000000000006 112.228 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.458 ' HB3' HD11 ' A' ' 93' ' ' ILE . 73.9 m-85 -88.57 -15.67 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.133 1.16 . . . . 74.239999999999995 114.133 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.47 118.45 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.347 0.521 . . . . 73.099999999999994 110.271 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.09 -1.79 78.04 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.824 0.69 . . . . 75.409999999999997 114.824 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.97 173.57 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.45 0.625 . . . . 74.400000000000006 111.139 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -107.61 106.74 17.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.088 0.555 . . . . 75.230000000000004 111.268 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -86.0 113.57 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.235 -1.024 . . . . 72.140000000000001 108.235 168.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t 61.01 24.5 14.6 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.303 0.641 . . . . 73.140000000000001 111.872 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.19 76.89 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 123.169 0.414 . . . . 70.540000000000006 113.969 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.51 126.01 45.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.84 0.856 . . . . 75.349999999999994 111.024 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.81 100.95 1.4 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.411 2.074 . . . . 74.450000000000003 112.226 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.5 pt -85.49 154.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 113.557 0.947 . . . . 72.319999999999993 113.557 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -126.13 113.83 17.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.746 1.218 . . . . 72.329999999999998 109.075 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.564 HG21 HG11 ' A' ' 18' ' ' VAL . 15.5 t -104.53 138.88 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.571 0.348 . . . . 71.209999999999994 110.615 -172.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.4 m -144.25 -178.7 6.09 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 74.109999999999999 109.48 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.52 147.88 37.47 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.436 0.562 . . . . 75.109999999999999 110.734 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.11 83.63 4.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.022 -0.732 . . . . 70.540000000000006 109.022 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.527 0 C-N-CA 124.001 0.92 . . . . 74.230000000000004 111.563 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mmm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 110.179 -0.304 . . . . 74.219999999999999 110.179 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.86 47.9 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 113.524 0.17 . . . . 55.030000000000001 113.524 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -70.25 93.43 0.84 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.606 0.762 . . . . 73.5 110.207 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -90.6 -31.61 16.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.263 0.625 . . . . 74.439999999999998 111.97 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -120.62 130.15 54.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.223 0.609 . . . . 75.519999999999996 110.883 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -77.39 -40.97 41.9 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.124 0.569 . . . . 74.239999999999995 111.915 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -138.6 122.73 18.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.023 0.929 . . . . 75.109999999999999 110.429 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -87.86 -52.67 5.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.709 0.804 . . . . 71.150000000000006 111.378 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -76.07 105.19 6.98 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.144 0.578 . . . . 74.430000000000007 111.46 -175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -78.51 100.01 6.72 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.075 0.55 . . . . 75.420000000000002 110.025 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p -122.28 117.12 25.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.229 0.612 . . . . 70.5 109.869 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -79.48 -170.92 2.53 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.068 0.947 . . . . 64.040000000000006 111.895 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 2.2 m-20 -77.04 135.56 38.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.24 -0.652 . . . . 75.25 109.24 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.59 -19.86 30.41 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.758 0.423 . . . . 71.219999999999999 110.323 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 m -104.01 127.77 51.58 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.696 0.798 . . . . 62.409999999999997 109.698 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 76' ' ' ALA . 32.1 pt -109.43 154.26 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.775 0.83 . . . . 74.219999999999999 111.279 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -109.08 121.97 46.27 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.858 0.863 . . . . 71.349999999999994 109.954 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 95' ' ' VAL . 19.8 t -118.03 140.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.535 1.134 . . . . 73.0 110.253 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.01 158.03 34.69 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.983 0.913 . . . . 73.109999999999999 110.525 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.17 35.43 43.48 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 114.602 0.601 . . . . 44.100000000000001 114.602 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 93' ' ' ILE . 65.3 mt -80.57 -34.16 35.55 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.074 0.95 . . . . 73.530000000000001 112.321 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 153.06 8.58 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.087 -0.405 . . . . 73.519999999999996 112.087 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.33 -1.93 43.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.989 0.737 . . . . 71.0 112.989 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -120.82 29.93 7.14 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.332 0.653 . . . . 74.329999999999998 110.142 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.41 136.95 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 123.44 0.696 . . . . 62.219999999999999 111.682 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 30' ' ' VAL . 42.7 p -122.48 151.13 41.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 74.340000000000003 110.521 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.551 HG21 ' HB ' ' A' ' 51' ' ' ILE . 70.7 mt -53.43 -41.16 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.663 0.785 . . . . 75.409999999999997 111.091 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.42 -40.42 93.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.341 0.656 . . . . 74.099999999999994 112.404 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.5 p -72.31 -38.27 68.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.288 0.235 . . . . 71.010000000000005 111.52 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 41.3 t -65.41 -40.52 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.163 0.506 . . . . 74.209999999999994 110.195 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.273 -0.876 . . . . 74.219999999999999 112.371 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.78 -32.25 72.7 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.374 0.669 . . . . 61.25 111.207 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -76.65 -49.83 15.23 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.013 -0.54 . . . . 73.150000000000006 111.158 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 18.4 m-85 -80.48 -17.91 50.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.147 1.166 . . . . 71.040000000000006 114.147 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.99 -21.69 66.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.269 0.841 . . . . 74.430000000000007 113.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.22 -28.72 59.36 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.581 0.752 . . . . 74.420000000000002 112.153 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -82.32 -42.67 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 74.099999999999994 111.445 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.94 -178.92 47.06 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.392 -0.367 . . . . 70.349999999999994 113.326 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.49 119.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.068 0.547 . . . . 63.25 110.747 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.5 mt -87.2 125.29 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.888 -0.782 . . . . 73.409999999999997 108.888 173.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.417 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 53.7 mtpt -48.41 131.9 16.83 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.661 0.784 . . . . 71.209999999999994 112.184 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 53.5 m -116.17 123.17 47.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 74.109999999999999 110.709 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -63.68 119.0 9.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.72 0.808 . . . . 75.310000000000002 109.132 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -76.37 -27.16 56.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 73.140000000000001 111.586 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -72.97 -43.44 62.25 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.427 0.691 . . . . 73.349999999999994 111.615 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -84.52 -36.54 22.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.019 0.527 . . . . 74.150000000000006 111.411 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.6 66.41 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 115.799 -0.637 . . . . 73.109999999999999 112.415 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.05 157.74 47.89 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.41 1.084 . . . . 74.5 111.665 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 60.6 Cg_endo -69.83 155.33 65.97 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.489 2.126 . . . . 74.200000000000003 113.002 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.417 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 54.1 mtt -83.41 94.85 8.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.718 0.807 . . . . 75.409999999999997 109.186 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' HB ' HG21 ' A' ' 27' ' ' ILE . 89.3 mt -142.18 117.95 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.765 -1.107 . . . . 74.129999999999995 108.799 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.425 HD21 ' N ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -97.12 107.5 20.04 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.758 -0.83 . . . . 75.040000000000006 108.758 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.1 mt -77.03 150.29 35.8 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.914 -0.772 . . . . 75.25 108.914 172.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.83 128.61 55.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.805 0.442 . . . . 71.409999999999997 110.654 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -115.08 139.63 49.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.252 1.021 . . . . 74.430000000000007 110.259 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -66.45 128.19 35.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.767 0.827 . . . . 71.140000000000001 110.798 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -62.98 -34.66 77.99 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.52 0.328 . . . . 73.140000000000001 110.744 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -76.72 -58.08 3.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.454 0.702 . . . . 72.209999999999994 111.809 -172.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.4 p -81.37 -29.24 34.09 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.498 0.555 . . . . 64.5 112.498 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.39 5.96 86.09 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 116.57 -0.286 . . . . 73.120000000000005 113.208 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -96.77 167.9 10.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.109 0.963 . . . . 70.129999999999995 109.721 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.1 mt -75.3 137.7 41.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.71 0.291 . . . . 71.310000000000002 110.512 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 6.6 mtpm? -67.82 -28.37 67.51 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.807 -0.633 . . . . 74.510000000000005 112.269 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.0 23.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.919 -0.582 . . . . 74.510000000000005 113.736 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -116.98 156.38 27.56 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.734 0.767 . . . . 74.230000000000004 110.228 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -162.14 149.81 14.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.429 0.692 . . . . 73.030000000000001 111.489 174.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 39.4 p -106.71 126.04 51.78 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.866 0.466 . . . . 53.530000000000001 110.498 172.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.56 110.99 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.526 0.73 . . . . 74.319999999999993 110.428 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 25.2 m -85.41 103.23 14.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.338 0.255 . . . . 73.129999999999995 111.071 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 63.7 m-85 -82.69 162.15 21.9 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.099999999999994 110.742 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.1 -40.19 62.88 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.62 -0.718 . . . . 75.230000000000004 110.929 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 26.7 m-20 -109.92 134.37 20.69 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.923 0.489 . . . . 75.239999999999995 112.049 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.09 -42.75 51.8 Favored 'Trans proline' 0 CA--C 1.581 2.837 0 C-N-CA 122.932 2.421 . . . . 72.230000000000004 116.199 168.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 59.6 Cg_endo -68.38 -24.12 37.33 Favored 'Trans proline' 0 C--N 1.398 3.157 0 CA-C-N 122.237 1.835 . . . . 73.239999999999995 112.713 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -71.3 -43.27 67.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.487 0.66 . . . . 62.030000000000001 109.787 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 16' ' ' ILE . . . -65.93 -42.37 90.19 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.334 -0.848 . . . . 72.430000000000007 111.342 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -62.82 -43.36 99.0 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.78 0.832 . . . . 74.230000000000004 110.707 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.99 89.43 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.847 -0.615 . . . . 73.099999999999994 111.492 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.45 70.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.075 0.55 . . . . 73.510000000000005 112.003 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG12 HG13 ' A' ' 95' ' ' VAL . 62.4 mt -68.4 -60.07 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.207 0.203 . . . . 73.219999999999999 110.478 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.37 -25.95 64.69 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.198 0.599 . . . . 73.510000000000005 111.871 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -82.68 -62.48 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.567 0.347 . . . . 74.409999999999997 111.811 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.517 ' HB2' HG22 ' A' ' 95' ' ' VAL . 79.0 m-85 -80.52 -15.52 56.48 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.955 1.095 . . . . 75.450000000000003 113.955 -168.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.14 106.72 3.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.48 -0.563 . . . . 74.530000000000001 109.48 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.56 35.39 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 115.338 -0.847 . . . . 73.420000000000002 114.218 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -83.29 -177.04 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.466 0.633 . . . . 72.409999999999997 111.743 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -121.03 120.44 35.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.857 . . . . 73.430000000000007 109.843 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' HB2' HG22 ' A' ' 93' ' ' ILE . 86.2 t80 -68.52 -69.5 0.32 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.097 0.559 . . . . 74.519999999999996 111.082 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.9 t -133.62 69.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.939 0.896 . . . . 71.519999999999996 109.167 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.87 -2.95 38.95 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.122 -0.945 . . . . 51.350000000000001 114.193 -172.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -115.87 125.89 28.22 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 124.262 1.025 . . . . 74.439999999999998 111.03 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.4 130.18 29.3 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.096 2.531 . . . . 74.450000000000003 112.742 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.474 HG22 ' HB2' ' A' ' 88' ' ' PHE . 30.5 pt -116.4 144.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 121.908 0.861 . . . . 75.450000000000003 112.702 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -114.2 121.36 43.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.947 -1.501 . . . . 73.450000000000003 106.947 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 80' ' ' ILE . 25.8 t -113.85 138.71 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.258 0.551 . . . . 71.510000000000005 110.692 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.5 p -148.88 179.41 7.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.03 1.332 . . . . 64.049999999999997 109.481 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 13' ' ' ASN . 51.7 m-85 -78.37 145.1 35.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 118.526 0.603 . . . . 75.349999999999994 111.592 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.37 113.48 24.79 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.315 -0.624 . . . . 74.430000000000007 109.315 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.563 1.467 0 C-N-CA 123.153 0.581 . . . . 75.209999999999994 111.724 -176.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.556 1.192 0 CA-C-O 120.724 0.297 . . . . 75.0 111.168 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.54 2.16 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 114.603 0.601 . . . . 65.310000000000002 114.603 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -79.16 -13.95 59.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.597 0.759 . . . . 74.120000000000005 111.873 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.51 94.17 7.22 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.269 0.628 . . . . 73.549999999999997 109.959 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -66.57 -30.34 70.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.921 0.489 . . . . 75.430000000000007 110.619 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -96.85 137.75 35.45 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.142 0.977 . . . . 73.120000000000005 110.004 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -66.52 -47.75 71.94 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.254 0.622 . . . . 75.120000000000005 111.119 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -92.83 110.84 22.3 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.224 -0.658 . . . . 64.430000000000007 109.224 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.3 t -69.76 141.27 53.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.948 0.499 . . . . 74.420000000000002 111.103 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -98.7 -7.77 27.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.038 0.535 . . . . 73.510000000000005 111.677 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.6 p -145.52 114.64 7.01 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.159 0.584 . . . . 74.219999999999999 110.812 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -130.69 113.07 13.7 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.769 0.828 . . . . 72.310000000000002 108.845 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.445 HD21 ' HB3' ' A' ' 97' ' ' PHE . 49.9 t30 -64.28 108.97 1.74 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.213 0.605 . . . . 71.450000000000003 111.187 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -98.74 1.58 46.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.867 0.867 . . . . 73.019999999999996 111.334 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -102.98 130.51 50.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.391 0.676 . . . . 64.409999999999997 109.509 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' THR . 34.9 pt -117.22 138.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.23 0.612 . . . . 74.430000000000007 111.958 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -94.56 117.21 29.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.106 0.479 . . . . 75.030000000000001 110.469 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG12 HG21 ' A' ' 95' ' ' VAL . 12.5 t -113.39 138.81 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.466 1.106 . . . . 75.299999999999997 110.279 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.95 162.57 22.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.343 1.057 . . . . 72.319999999999993 110.11 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.14 65.51 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 114.506 0.562 . . . . 70.230000000000004 114.506 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD12 HG23 ' A' ' 25' ' ' VAL . 81.9 mt -72.34 -36.03 68.72 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.067 0.947 . . . . 73.430000000000007 111.879 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.27 158.07 11.68 Favored Glycine 0 N--CA 1.476 1.352 0 C-N-CA 123.219 0.438 . . . . 73.239999999999995 112.556 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.86 -19.43 61.96 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.015 0.908 . . . . 75.120000000000005 112.719 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -89.53 7.29 37.03 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.029 0.932 . . . . 75.430000000000007 111.323 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG23 HD12 ' A' ' 21' ' ' LEU . 9.9 p -69.72 134.32 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.354 0.662 . . . . 74.209999999999994 112.444 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' HG21 ' A' ' 30' ' ' VAL . 15.0 p -120.4 163.05 18.48 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.016 -0.427 . . . . 72.299999999999997 110.007 171.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 51' ' ' ILE . 80.5 mt -57.83 -42.4 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 123.917 0.887 . . . . 74.540000000000006 111.5 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.41 -30.04 65.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.474 0.71 . . . . 74.409999999999997 111.776 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -45.85 81.53 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.783 0.433 . . . . 75.439999999999998 110.877 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 26' ' ' THR . 21.5 t -64.88 -40.84 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 121.19 0.519 . . . . 72.200000000000003 110.225 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.58 88.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.34 -0.846 . . . . 63.140000000000001 111.744 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.88 -40.33 97.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.027 0.931 . . . . 71.219999999999999 111.582 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.31 -48.19 44.03 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.379 -0.828 . . . . 75.099999999999994 110.89 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.38 -19.57 35.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.548 1.314 . . . . 72.519999999999996 114.548 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.44 -16.61 63.81 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.835 1.05 . . . . 72.340000000000003 113.835 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -61.41 -29.18 69.77 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.089 0.555 . . . . 74.439999999999998 111.772 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.17 -42.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.057 0.943 . . . . 74.319999999999993 111.189 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.62 171.67 42.81 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 116.358 -0.383 . . . . 45.450000000000003 113.04 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.84 123.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.826 -0.435 . . . . 73.25 109.826 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.4 mt -93.97 129.76 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.99 0.916 . . . . 73.120000000000005 108.796 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.0 mtpt -51.04 140.51 15.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.319999999999993 112.311 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 56.0 m -128.45 121.81 29.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.181 -0.918 . . . . 72.400000000000006 109.829 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -57.63 119.57 6.83 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.208 1.003 . . . . 65.439999999999998 110.565 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -76.09 -16.94 59.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.704 0.802 . . . . 73.530000000000001 112.839 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -82.08 -52.29 7.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.649 0.379 . . . . 74.430000000000007 110.803 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -80.46 -46.62 15.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.25 0.62 . . . . 64.519999999999996 111.587 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.31 15.65 40.44 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.979 -0.555 . . . . 72.140000000000001 112.633 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -107.87 148.84 38.16 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.24 1.016 . . . . 72.450000000000003 111.827 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -67.75 149.88 78.82 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.409 2.073 . . . . 73.519999999999996 112.182 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.498 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 49.4 mtt -81.94 94.34 7.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.619 0.723 . . . . 75.430000000000007 109.67 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.606 ' HB ' HG22 ' A' ' 27' ' ' ILE . 78.7 mt -145.88 117.56 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.501 1.121 . . . . 75.349999999999994 108.693 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 78.9 m-20 -96.88 109.38 22.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.67 -0.493 . . . . 73.430000000000007 109.67 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.01 150.19 39.04 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.554 0.534 . . . . 74.219999999999999 109.856 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 46.9 m-85 -107.65 132.28 53.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.275 0.63 . . . . 75.140000000000001 109.952 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -133.99 142.88 47.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.725 0.81 . . . . 73.209999999999994 110.042 -174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -76.67 114.83 15.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.798 0.439 . . . . 74.140000000000001 109.827 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -71.72 -8.03 51.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.293 0.637 . . . . 75.329999999999998 112.471 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.35 -56.27 4.46 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.392 0.677 . . . . 74.140000000000001 110.888 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 p -96.93 -21.13 17.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.733 0.813 . . . . 61.310000000000002 112.556 -173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 12.64 83.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 120.056 -0.302 . . . . 71.329999999999998 113.751 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -97.22 147.89 23.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.47 0.708 . . . . 75.409999999999997 111.588 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.81 138.32 56.05 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.103 0.561 . . . . 70.340000000000003 111.541 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -77.47 -17.23 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.342 0.657 . . . . 73.430000000000007 111.579 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.08 24.34 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.333 0.396 . . . . 62.210000000000001 112.33 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 46.8 mt-10 -135.25 153.05 52.05 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.916 0.886 . . . . 54.530000000000001 109.74 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.33 156.27 23.69 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.471 0.545 . . . . 55.009999999999998 112.471 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 69.5 p -113.87 118.57 34.57 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 122.745 0.418 . . . . 61.43 110.676 171.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.52 107.96 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.888 0.875 . . . . 75.109999999999999 111.025 -170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -83.82 102.65 12.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.716 0.407 . . . . 75.310000000000002 111.521 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 53.3 m-85 -79.81 149.86 30.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.403 0.681 . . . . 71.519999999999996 110.686 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.03 -32.75 57.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.395 0.678 . . . . 73.209999999999994 110.573 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.77 127.39 37.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.15 0.58 . . . . 72.310000000000002 110.473 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.31 -48.36 18.92 Favored 'Trans proline' 0 CA--C 1.581 2.874 0 C-N-CA 122.602 2.201 . . . . 73.120000000000005 115.532 170.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.85 -19.32 27.34 Favored 'Trans proline' 0 C--N 1.398 3.149 0 CA-C-N 122.2 1.821 . . . . 75.310000000000002 113.609 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -69.37 -33.67 73.41 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.222 0.609 . . . . 75.299999999999997 111.211 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.29 56.01 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.925 -0.579 . . . . 64.329999999999998 111.466 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.585 0.754 . . . . 71.310000000000002 111.092 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.78 94.21 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.102 0.561 . . . . 71.200000000000003 111.796 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.53 67.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 74.099999999999994 112.699 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 95' ' ' VAL . 82.2 mt -66.86 -58.38 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 120.899 0.381 . . . . 74.25 110.054 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.99 -27.79 69.11 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.434 -0.803 . . . . 72.400000000000006 112.166 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -81.5 -62.3 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.612 0.365 . . . . 71.420000000000002 111.344 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.472 ' HB3' HD11 ' A' ' 93' ' ' ILE . 66.8 m-85 -79.51 -11.73 59.89 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.282 1.215 . . . . 74.329999999999998 114.282 -168.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.42 111.06 1.86 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 118.508 0.595 . . . . 74.319999999999993 110.362 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.57 60.0 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 115.128 0.811 . . . . 54.450000000000003 115.128 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.74 161.56 18.33 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 118.43 1.115 . . . . 75.140000000000001 111.105 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -99.23 119.92 38.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 75.239999999999995 111.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -84.21 -77.69 0.26 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.903 0.481 . . . . 73.040000000000006 110.222 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -118.13 75.48 1.01 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.46 0.704 . . . . 75.549999999999997 110.078 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.21 1.03 59.21 Favored Glycine 0 CA--C 1.54 1.652 0 N-CA-C 115.061 0.784 . . . . 75.209999999999994 115.061 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -132.9 138.01 30.92 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.483 0.713 . . . . 74.510000000000005 110.983 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.96 140.6 55.33 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.695 2.264 . . . . 74.230000000000004 111.975 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 83' ' ' PHE . 19.6 pt -110.38 152.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.223 0.609 . . . . 72.340000000000003 111.707 -171.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -118.18 114.76 23.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.461 0.704 . . . . 74.329999999999998 109.567 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.515 HG21 HG12 ' A' ' 18' ' ' VAL . 15.9 t -109.22 133.45 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.606 0.362 . . . . 75.200000000000003 110.244 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.2 t -145.42 -178.67 6.2 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.455 1.102 . . . . 72.319999999999993 109.494 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HB3' HD21 ' A' ' 13' ' ' ASN . 97.7 m-85 -76.84 134.9 38.91 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.858 -0.526 . . . . 73.430000000000007 110.815 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 86.53 6.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.852 0.461 . . . . 72.120000000000005 110.548 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.221 1.008 . . . . 74.510000000000005 110.951 -178.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.61 0.243 . . . . 73.450000000000003 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.04 -157.0 33.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.678 -0.237 . . . . 51.219999999999999 113.609 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.5 140.36 29.94 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.927 0.891 . . . . 73.519999999999996 110.373 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -60.01 117.93 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.41 0.684 . . . . 74.340000000000003 111.527 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -53.87 -67.64 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.497 1.119 . . . . 74.420000000000002 113.005 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -82.54 123.81 29.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.024 0.44 . . . . 74.439999999999998 110.055 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -149.12 130.47 14.7 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.585 0.754 . . . . 72.329999999999998 110.392 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -95.79 28.73 2.94 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.484 0.714 . . . . 74.200000000000003 110.201 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 63.1 p -70.53 83.38 0.59 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.153 0.981 . . . . 74.409999999999997 113.097 -171.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.17 -68.17 0.92 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.804 -1.184 . . . . 75.25 107.804 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -65.89 -29.49 69.93 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 122.597 0.359 . . . . 71.310000000000002 111.013 168.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.568 ' HB3' ' HA ' ' A' ' 9' ' ' SER . 38.9 t70 -81.31 2.05 29.87 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.838 0.855 . . . . 63.329999999999998 112.1 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.425 HD21 ' HB3' ' A' ' 97' ' ' PHE . 41.6 t30 -80.23 135.29 36.23 Favored 'General case' 0 CA--C 1.556 1.187 0 O-C-N 121.107 -0.996 . . . . 71.299999999999997 110.076 168.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -92.0 -26.74 18.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.533 0.568 . . . . 72.0 112.533 -175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -93.87 132.08 38.64 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.051 0.54 . . . . 71.439999999999998 110.774 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 29.1 pt -113.23 147.92 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.64 . . . . 73.510000000000005 111.263 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -108.84 115.63 30.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.56 0.744 . . . . 75.540000000000006 110.426 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 95' ' ' VAL . 4.2 t -111.75 143.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.831 0.852 . . . . 71.239999999999995 110.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.79 155.11 47.24 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.011 0.925 . . . . 72.409999999999997 111.484 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.72 24.64 37.93 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 114.367 0.507 . . . . 53.229999999999997 114.367 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.7 -16.28 51.75 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.934 0.894 . . . . 74.200000000000003 112.837 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.99 158.65 29.35 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 120.947 0.193 . . . . 73.040000000000006 113.444 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.91 -5.25 55.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.482 0.713 . . . . 74.209999999999994 112.857 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.18 18.74 19.05 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.818 0.847 . . . . 74.329999999999998 111.257 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.24 144.61 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.276 0.631 . . . . 71.25 112.318 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -124.09 154.62 39.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.196 0.598 . . . . 75.450000000000003 111.103 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.565 HG21 ' HB ' ' A' ' 51' ' ' ILE . 73.3 mt -55.45 -39.26 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.893 0.877 . . . . 75.319999999999993 110.881 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.055 0.942 . . . . 74.0 111.843 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -72.22 -40.91 67.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.513 0.325 . . . . 73.230000000000004 111.223 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.07 -42.08 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 110.171 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.47 91.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.521 0.729 . . . . 73.319999999999993 111.808 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.96 -33.03 74.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.5 0.72 . . . . 72.349999999999994 110.764 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -71.04 -55.48 8.18 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.052 0.941 . . . . 75.120000000000005 111.085 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -81.51 -19.3 42.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.477 1.288 . . . . 74.450000000000003 114.477 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -61.35 -26.21 67.66 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.695 0.998 . . . . 74.120000000000005 113.695 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -61.72 -24.34 66.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.374 0.669 . . . . 72.010000000000005 112.323 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.9 mm -83.13 -50.95 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.992 0.917 . . . . 75.150000000000006 111.344 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 75' ' ' SER . . . -161.73 168.61 36.93 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.683 -0.69 . . . . 60.32 113.674 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.65 110.41 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.384 0.674 . . . . 74.549999999999997 110.669 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.1 mt -80.9 131.84 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 108.444 -0.947 . . . . 75.519999999999996 108.444 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.46 124.96 14.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.261 0.624 . . . . 73.409999999999997 111.085 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 30.6 m -113.43 120.15 40.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.643 -0.708 . . . . 74.439999999999998 110.487 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -60.93 108.77 0.91 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.551 -0.907 . . . . 74.109999999999999 108.551 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.59 -27.59 62.27 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.398 0.679 . . . . 71.329999999999998 111.994 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -62.16 -50.17 72.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.716 0.806 . . . . 72.209999999999994 111.48 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -86.51 -40.27 15.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.383 0.673 . . . . 74.329999999999998 111.077 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 1.62 50.12 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.861 -0.609 . . . . 65.430000000000007 112.718 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -104.89 151.52 39.42 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 124.134 0.974 . . . . 64.319999999999993 112.444 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 72.9 Cg_endo -72.18 155.48 56.46 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.761 2.307 . . . . 74.519999999999996 112.712 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.7 mtt -83.77 95.17 8.34 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.47 0.652 . . . . 74.299999999999997 109.962 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.565 ' HB ' HG21 ' A' ' 27' ' ' ILE . 75.6 mt -142.59 124.49 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.442 1.097 . . . . 74.530000000000001 109.117 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 15.3 m120 -106.18 109.84 21.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.883 0.473 . . . . 74.510000000000005 110.085 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.63 124.92 31.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.684 0.794 . . . . 75.230000000000004 109.601 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 94.0 m-85 -83.02 125.77 31.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.917 0.487 . . . . 75.230000000000004 111.149 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 9.9 m -112.23 142.16 45.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.783 0.833 . . . . 75.420000000000002 109.845 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.7 129.7 37.52 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.924 0.489 . . . . 75.310000000000002 110.454 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -70.59 -27.86 64.43 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.3 1.04 . . . . 75.120000000000005 112.384 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -85.86 -50.57 7.02 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.318 0.647 . . . . 72.340000000000003 112.025 -175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.5 p -83.16 -30.8 27.54 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.566 0.746 . . . . 72.400000000000006 112.111 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.28 9.69 85.66 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 116.229 -0.441 . . . . 70.120000000000005 113.872 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -109.41 154.75 22.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.224 0.61 . . . . 74.019999999999996 110.966 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 mt -62.18 136.47 57.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.421 0.688 . . . . 73.510000000000005 111.921 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -73.34 -12.74 60.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.797 0.839 . . . . 74.299999999999997 111.918 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.65 42.44 21.58 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.827 -0.509 . . . . 61.219999999999999 111.827 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 50.6 mt-10 -131.81 147.93 52.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.915 0.886 . . . . 75.420000000000002 109.722 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -153.18 139.46 18.48 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.196 0.443 . . . . 75.310000000000002 112.196 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.8 p -101.25 119.5 38.85 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.844 -0.428 . . . . 75.239999999999995 109.844 169.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.3 t -109.24 108.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.631 0.772 . . . . 75.349999999999994 110.383 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.2 m -81.02 104.93 11.85 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.6 0.36 . . . . 73.150000000000006 111.117 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -82.1 157.56 24.04 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.94 0.496 . . . . 73.329999999999998 110.463 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.44 -37.66 60.21 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.999 0.52 . . . . 75.400000000000006 110.027 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -111.91 122.25 37.49 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.918 0.887 . . . . 63.450000000000003 110.261 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.53 -34.63 73.34 Favored 'Trans proline' 0 CA--C 1.583 2.939 0 C-N-CA 122.554 2.17 . . . . 75.310000000000002 116.565 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.61 -30.41 79.06 Favored 'Trans proline' 0 C--N 1.397 3.114 0 CA-C-N 122.687 1.995 . . . . 74.019999999999996 113.209 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 36.7 m -73.77 -35.74 65.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.038 0.446 . . . . 64.319999999999993 110.503 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.29 -50.09 74.42 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.434 -0.803 . . . . 62.020000000000003 111.285 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.25 -40.94 98.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.503 0.721 . . . . 74.120000000000005 111.161 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.34 98.99 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.965 -0.562 . . . . 64.239999999999995 111.813 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.44 75.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.447 0.699 . . . . 75.310000000000002 112.145 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.525 HG12 HG12 ' A' ' 95' ' ' VAL . 69.7 mt -66.81 -56.95 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.822 -0.626 . . . . 73.310000000000002 110.599 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.44 -31.01 67.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.644 0.778 . . . . 73.129999999999995 111.876 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -80.55 -58.21 3.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.78 0.832 . . . . 72.450000000000003 111.993 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -85.24 -10.19 56.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.382 1.253 . . . . 73.230000000000004 114.382 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.08 119.28 11.75 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 118.575 0.625 . . . . 75.200000000000003 110.45 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.02 1.85 84.34 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.456 -0.793 . . . . 54.210000000000001 114.45 -175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.94 173.26 8.59 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 117.623 0.711 . . . . 73.200000000000003 110.793 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.33 122.95 48.03 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.105 -0.372 . . . . 71.219999999999999 111.718 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -92.99 -67.44 0.86 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.621 0.769 . . . . 74.329999999999998 110.028 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -112.95 50.09 0.9 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.695 0.798 . . . . 63.030000000000001 109.886 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 115.456 -0.793 . . . . 73.209999999999994 113.678 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -122.32 130.23 24.77 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.355 1.062 . . . . 65.239999999999995 110.387 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.2 94.0 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.53 2.153 . . . . 74.219999999999999 111.804 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.2 pt -71.33 155.34 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.977 0.911 . . . . 75.329999999999998 112.506 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -118.82 122.16 41.73 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.188 -1.042 . . . . 74.230000000000004 108.188 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 18' ' ' VAL . 11.2 t -109.29 133.08 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.196 0.522 . . . . 73.450000000000003 110.002 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -133.05 -178.03 4.78 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.148 1.379 . . . . 44.0 109.019 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 32.7 m-85 -90.67 151.2 21.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 122.097 -0.377 . . . . 73.209999999999994 110.736 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.18 82.87 2.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.554 0.741 . . . . 73.329999999999998 109.216 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 115.695 -0.684 . . . . 53.340000000000003 112.34 -172.188 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.64 0.257 . . . . 73.010000000000005 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.72 -65.57 3.52 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 114.31 0.484 . . . . 71.109999999999999 114.31 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -70.08 89.74 0.63 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.321 0.649 . . . . 73.340000000000003 112.248 -175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -156.96 104.15 2.09 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 74.150000000000006 109.842 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -65.72 125.95 26.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.515 0.726 . . . . 74.450000000000003 110.522 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -75.06 81.05 2.23 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 120.923 0.392 . . . . 75.420000000000002 111.167 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -151.91 130.13 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 72.200000000000003 109.742 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -96.97 121.18 38.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.145 -0.687 . . . . 72.120000000000005 109.145 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -52.1 -46.5 65.29 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.497 1.119 . . . . 73.319999999999993 113.081 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -102.77 110.86 22.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.945 0.498 . . . . 73.200000000000003 110.03 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 t -127.13 109.62 12.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.384 0.674 . . . . 62.420000000000002 109.351 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.74 172.69 10.26 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.699 0.8 . . . . 75.420000000000002 110.443 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -51.31 107.05 0.16 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.17 0.988 . . . . 75.310000000000002 112.742 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -100.28 6.68 44.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.538 0.735 . . . . 72.340000000000003 111.229 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -108.65 126.21 52.73 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.615 0.766 . . . . 73.329999999999998 110.142 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.8 pt -105.5 157.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.681 0.792 . . . . 74.510000000000005 110.842 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -116.72 115.11 25.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.447 0.699 . . . . 74.430000000000007 110.095 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.532 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -104.98 145.02 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 124.401 1.08 . . . . 75.019999999999996 110.184 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.44 157.57 36.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.361 1.064 . . . . 73.349999999999994 110.056 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.12 41.7 92.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 115.233 0.853 . . . . 74.319999999999993 115.233 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 93' ' ' ILE . 41.4 mt -81.82 -32.51 31.21 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.162 0.985 . . . . 73.430000000000007 111.639 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.76 161.26 11.7 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-N 116.182 -0.463 . . . . 65.540000000000006 112.619 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.48 -5.86 57.98 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.296 0.638 . . . . 73.200000000000003 112.064 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -94.54 14.0 22.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.506 0.723 . . . . 70.310000000000002 111.381 173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 p -75.42 138.53 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.421 0.688 . . . . 74.530000000000001 112.444 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 30' ' ' VAL . 60.6 p -131.33 148.76 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.531 0.732 . . . . 54.439999999999998 110.947 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG23 ' HB ' ' A' ' 51' ' ' ILE . 69.7 mt -51.66 -49.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.942 1.297 . . . . 73.510000000000005 112.893 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.91 -32.27 73.68 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 122.904 0.482 . . . . 75.340000000000003 111.935 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -74.37 -39.13 62.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.413 0.685 . . . . 74.219999999999999 111.536 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 26' ' ' THR . 42.7 t -63.97 -43.04 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 74.010000000000005 109.86 173.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.9 95.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.874 -1.057 . . . . 54.409999999999997 111.616 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 -34.17 77.67 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.634 0.773 . . . . 74.439999999999998 111.883 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.16 -53.51 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.881 0.472 . . . . 73.010000000000005 111.189 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 35.7 m-85 -77.87 -16.19 58.45 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.222 1.193 . . . . 75.299999999999997 114.222 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.19 -18.64 65.48 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.054 1.131 . . . . 74.530000000000001 114.054 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.02 -30.99 68.42 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.324 0.65 . . . . 75.219999999999999 111.914 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.59 -48.78 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.022 0.929 . . . . 70.420000000000002 110.896 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.7 173.18 40.59 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.426 -0.806 . . . . 71.450000000000003 112.695 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.88 127.83 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 122.989 0.516 . . . . 64.510000000000005 110.735 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.0 mt -97.54 134.79 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.637 0.775 . . . . 73.349999999999994 109.089 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 59.2 mtpt -62.22 155.64 24.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.457 0.703 . . . . 73.120000000000005 112.02 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 84.8 m -137.15 122.12 18.94 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.328 -0.851 . . . . 72.540000000000006 110.467 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -61.21 114.7 3.3 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.575 1.15 . . . . 62.039999999999999 109.47 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.26 -11.24 59.8 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.835 0.854 . . . . 74.099999999999994 112.878 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -83.4 -52.2 6.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.103 0.561 . . . . 74.230000000000004 110.598 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -79.67 -31.88 41.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.443 0.697 . . . . 71.219999999999999 111.691 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.2 81.58 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 116.008 -0.542 . . . . 71.140000000000001 112.964 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -104.92 149.86 38.04 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.42 1.088 . . . . 71.409999999999997 111.304 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.0 Cg_endo -63.65 146.73 92.72 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.369 2.046 . . . . 75.25 111.534 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 61.0 mtt -75.65 94.0 3.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.54 0.686 . . . . 72.239999999999995 109.471 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.592 ' HB ' HG23 ' A' ' 27' ' ' ILE . 77.7 mt -144.08 127.89 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.85 1.26 . . . . 74.25 108.533 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 19.2 m120 -108.02 110.31 21.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.715 -0.476 . . . . 72.099999999999994 109.715 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.951 0.782 . . . . 63.240000000000002 109.343 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HE1' HG23 ' A' ' 67' ' ' THR . 79.7 m-85 -74.99 120.44 20.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.232 0.613 . . . . 73.400000000000006 111.134 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 m -100.57 140.02 35.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.693 0.797 . . . . 75.209999999999994 108.956 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.59 124.36 23.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.593 0.757 . . . . 71.400000000000006 110.848 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -64.72 -24.9 67.71 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.633 0.773 . . . . 73.129999999999995 112.978 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.44 -53.65 3.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.404 0.682 . . . . 74.200000000000003 111.604 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.1 p -84.18 -22.86 30.8 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.366 0.667 . . . . 74.420000000000002 112.65 -173.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 8.12 74.1 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.262 0.465 . . . . 72.239999999999995 114.262 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.61 149.53 21.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.073 0.949 . . . . 72.129999999999995 111.233 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.25 125.72 24.44 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 117.94 0.336 . . . . 75.140000000000001 110.485 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -72.51 -21.97 61.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.994 0.518 . . . . 71.450000000000003 112.31 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 22.05 66.54 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.183 -0.367 . . . . 74.439999999999998 112.183 -170.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -115.08 143.13 45.68 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.24 -1.022 . . . . 74.049999999999997 108.24 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -151.73 159.3 44.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.705 0.402 . . . . 64.109999999999999 111.915 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 p -114.65 120.72 41.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.606 0.362 . . . . 64.420000000000002 111.24 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.29 111.84 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.099 0.559 . . . . 71.420000000000002 110.534 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.9 m -88.86 105.62 17.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.413 0.685 . . . . 75.120000000000005 111.413 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 51.5 m-85 -80.81 161.14 24.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.863 0.865 . . . . 74.030000000000001 110.765 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.32 -33.93 65.41 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.592 0.757 . . . . 75.530000000000001 110.943 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.18 132.07 22.92 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.776 0.83 . . . . 74.230000000000004 111.189 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.46 -43.29 45.29 Favored 'Trans proline' 0 CA--C 1.584 2.991 0 C-N-CA 122.779 2.319 . . . . 74.230000000000004 115.288 165.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.99 -27.72 66.2 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 122.311 1.861 . . . . 71.219999999999999 113.563 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 m -69.57 -38.72 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.545 0.688 . . . . 74.010000000000005 109.838 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -60.03 -54.78 41.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.628 -1.169 . . . . 65.299999999999997 110.861 175.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -59.22 -45.39 91.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.836 0.854 . . . . 75.400000000000006 111.404 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.94 99.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.946 -0.57 . . . . 75.409999999999997 111.686 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.05 -32.82 73.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.539 0.525 . . . . 72.230000000000004 111.992 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 76' ' ' ALA . 79.0 mt -65.33 -62.21 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.545 0.338 . . . . 65.209999999999994 111.049 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.65 -25.09 66.06 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 112.443 0.534 . . . . 75.310000000000002 112.443 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -78.26 -59.04 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.729 0.412 . . . . 74.120000000000005 110.945 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -86.62 -9.34 56.26 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.602 1.334 . . . . 71.319999999999993 114.602 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.87 106.28 1.85 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.732 0.696 . . . . 74.120000000000005 110.39 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.45 56.29 Favored Glycine 0 CA--C 1.546 1.985 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 114.232 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -80.71 175.9 10.27 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 123.761 0.824 . . . . 74.239999999999995 112.219 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.64 115.8 26.36 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.654 0.382 . . . . 74.299999999999997 111.383 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -82.55 -75.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.186 0.595 . . . . 75.209999999999994 111.042 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 t -98.93 37.31 1.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.324 0.65 . . . . 73.530000000000001 110.03 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.64 11.66 85.09 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 115.986 -0.552 . . . . 73.420000000000002 112.139 -164.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.1 121.6 41.24 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.433 1.093 . . . . 72.439999999999998 110.608 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.21 96.2 0.33 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.937 2.425 . . . . 75.25 112.561 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.418 HG21 HD21 ' A' ' 21' ' ' LEU . 29.5 pt -74.86 153.58 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.181 0.992 . . . . 74.430000000000007 113.32 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -119.75 114.77 22.66 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.965 -1.124 . . . . 74.109999999999999 107.965 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 18' ' ' VAL . 19.2 t -109.39 137.28 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 120.974 0.416 . . . . 72.420000000000002 110.297 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -142.51 -174.52 4.16 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.336 1.454 . . . . 61.299999999999997 109.042 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -79.96 146.4 32.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.907 -0.495 . . . . 70.140000000000001 110.69 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.4 107.97 18.26 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.939 -0.393 . . . . 74.129999999999995 109.939 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.489 1.486 0 C-N-CA 123.385 0.674 . . . . 75.409999999999997 112.068 -176.744 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 110.311 -0.255 . . . . 71.519999999999996 110.311 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.03 118.62 13.71 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 123.091 0.377 . . . . 33.409999999999997 113.508 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -77.2 101.19 6.08 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.657 0.783 . . . . 73.400000000000006 110.474 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -104.49 92.82 4.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.526 0.731 . . . . 62.119999999999997 112.167 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.74 117.71 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.934 1.294 . . . . 74.430000000000007 108.531 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -73.28 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.103 -0.373 . . . . 74.150000000000006 111.882 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 57.04 29.78 17.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.351 1.061 . . . . 63.420000000000002 111.006 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -94.93 103.37 15.23 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.665 0.786 . . . . 74.209999999999994 110.46 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -153.69 116.14 4.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.364 0.666 . . . . 71.310000000000002 110.24 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -67.17 -43.47 82.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.689 0.795 . . . . 70.109999999999999 110.573 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -101.52 82.11 2.26 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.95 0.9 . . . . 75.400000000000006 109.692 170.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.27 90.51 7.14 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.648 0.737 . . . . 71.239999999999995 109.18 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.17 138.34 56.93 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.779 0.831 . . . . 72.030000000000001 113.127 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -98.13 -17.34 19.1 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.348 -0.842 . . . . 74.340000000000003 110.681 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 m -97.83 126.59 43.28 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.277 0.56 . . . . 71.349999999999994 110.059 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.2 pt -105.72 153.93 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.789 0.836 . . . . 73.329999999999998 111.13 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -109.41 125.19 52.14 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.144 0.578 . . . . 74.120000000000005 109.903 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 HG21 ' A' ' 95' ' ' VAL . 18.7 t -121.31 141.75 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.081 0.952 . . . . 73.439999999999998 109.901 -175.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -127.87 159.87 33.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.902 0.881 . . . . 74.239999999999995 110.539 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.5 32.12 35.1 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 114.303 0.481 . . . . 53.340000000000003 114.303 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.81 -28.38 24.53 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.888 0.875 . . . . 73.420000000000002 112.225 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.96 161.49 18.71 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 123.068 0.366 . . . . 70.010000000000005 113.496 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -83.78 -2.0 55.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.712 1.004 . . . . 61.420000000000002 113.712 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -121.19 21.6 11.15 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.395 0.678 . . . . 63.340000000000003 111.902 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.77 142.77 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.291 0.636 . . . . 70.129999999999995 111.528 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.0 p -122.62 153.83 38.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.451 -0.78 . . . . 74.549999999999997 110.618 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG21 ' HB ' ' A' ' 51' ' ' ILE . 93.4 mt -53.46 -40.29 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.146 0.978 . . . . 70.109999999999999 111.43 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.29 -44.18 95.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.787 0.835 . . . . 71.439999999999998 111.53 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -68.94 -41.26 78.31 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.182 0.593 . . . . 72.310000000000002 111.844 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -64.6 -43.42 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.119 0.568 . . . . 75.420000000000002 110.021 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.95 88.75 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.368 -0.833 . . . . 75.120000000000005 111.753 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.42 -30.46 70.22 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.268 0.627 . . . . 72.120000000000005 111.6 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -72.61 -55.07 7.43 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.792 0.837 . . . . 74.510000000000005 111.64 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 77.2 m-85 -81.1 -20.01 42.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.413 1.264 . . . . 75.140000000000001 114.413 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -58.0 -29.93 65.66 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.659 0.985 . . . . 75.219999999999999 113.659 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.01 -26.49 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.815 0.846 . . . . 74.209999999999994 112.598 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 mm -79.27 -47.6 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.751 0.821 . . . . 55.32 110.758 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 173.99 43.03 Favored Glycine 0 N--CA 1.463 0.497 0 CA-C-N 116.211 -0.449 . . . . 62.520000000000003 113.295 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.28 124.3 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.379 0.671 . . . . 62.240000000000002 110.837 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 65.3 mt -94.37 131.86 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.062 0.945 . . . . 73.420000000000002 109.625 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.1 mtpt -54.91 144.99 21.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.464 0.706 . . . . 75.109999999999999 111.743 173.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.4 m -126.19 128.21 46.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.265 -0.879 . . . . 72.120000000000005 109.794 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -69.56 114.36 7.71 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.797 0.839 . . . . 74.310000000000002 108.942 172.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.96 -15.27 60.19 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.42 0.688 . . . . 74.209999999999994 112.254 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.73 -36.19 65.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.985 0.514 . . . . 74.219999999999999 111.371 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -98.67 -41.77 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.485 0.714 . . . . 73.099999999999994 111.761 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.58 8.07 54.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 115.754 -0.657 . . . . 55.109999999999999 112.812 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.9 150.16 52.43 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 123.931 0.892 . . . . 72.200000000000003 112.377 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.4 Cg_endo -61.48 145.03 98.34 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.434 2.756 . . . . 73.219999999999999 112.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.516 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 60.8 mtt -74.81 97.11 3.21 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.384 0.612 . . . . 75.140000000000001 109.789 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.548 ' HB ' HG21 ' A' ' 27' ' ' ILE . 99.2 mt -142.0 124.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.545 1.138 . . . . 75.340000000000003 109.043 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.9 m-20 -101.85 107.43 18.61 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.031 -0.729 . . . . 74.230000000000004 109.031 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.22 134.93 36.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.722 -0.844 . . . . 63.43 108.722 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -100.01 122.15 42.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.008 0.523 . . . . 71.200000000000003 110.379 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 m -102.54 141.44 35.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.261 1.024 . . . . 74.400000000000006 110.218 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.8 133.82 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.165 0.586 . . . . 74.349999999999994 109.584 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -87.31 -24.86 24.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.554 0.742 . . . . 75.409999999999997 112.798 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.09 -34.98 14.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.271 0.471 . . . . 74.209999999999994 112.271 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -90.75 -53.52 4.37 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.074 0.398 . . . . 71.430000000000007 112.074 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.63 -0.88 34.33 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 116.025 -0.534 . . . . 72.510000000000005 113.587 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.06 152.93 19.72 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.451 0.7 . . . . 73.319999999999993 109.75 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 84.3 mt -62.66 140.55 58.7 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.097 0.475 . . . . 72.230000000000004 111.788 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -74.11 -13.08 60.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.969 0.908 . . . . 65.430000000000007 112.186 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 29.53 39.69 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.453 -0.34 . . . . 74.219999999999999 112.531 -174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.5 145.07 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.971 0.909 . . . . 73.219999999999999 109.631 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 147.0 18.41 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.963 0.411 . . . . 73.120000000000005 111.919 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 75.0 p -102.01 133.6 46.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.9 -0.591 . . . . 64.430000000000007 110.159 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -115.1 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 123.139 0.576 . . . . 72.129999999999995 110.339 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 43.9 m -85.14 102.3 13.16 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.849 0.46 . . . . 64.530000000000001 110.961 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.7 m-85 -79.45 155.51 28.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.116 0.566 . . . . 72.230000000000004 110.747 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.71 -35.76 72.89 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.216 0.606 . . . . 74.239999999999995 110.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -114.38 129.01 25.27 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.379 0.671 . . . . 61.020000000000003 111.337 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.51 -37.99 83.02 Favored 'Trans proline' 0 CA--C 1.587 3.15 0 C-N-CA 123.108 2.538 . . . . 75.319999999999993 116.42 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.64 -24.87 40.98 Favored 'Trans proline' 0 C--N 1.396 3.047 0 CA-C-N 122.611 1.968 . . . . 74.219999999999999 112.857 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -74.59 -38.12 62.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.647 0.779 . . . . 63.200000000000003 110.21 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.42 -51.34 70.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.779 -1.1 . . . . 50.520000000000003 110.692 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' HA ' HD13 ' A' ' 80' ' ' ILE . 1.3 tmtp? -65.17 -39.15 92.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.32 -0.854 . . . . 75.150000000000006 111.299 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.0 94.71 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.396 0.278 . . . . 74.239999999999995 111.285 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.404 0.682 . . . . 74.109999999999999 112.222 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 77' ' ' LYS . 89.6 mt -65.61 -63.46 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.018 0.527 . . . . 70.349999999999994 110.674 173.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.05 -25.59 67.77 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.403 -0.817 . . . . 74.140000000000001 111.698 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -82.12 -60.23 2.29 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.871 0.469 . . . . 74.329999999999998 111.691 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.728 1.381 . . . . 73.340000000000003 114.728 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.33 119.87 12.31 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.678 0.672 . . . . 73.340000000000003 109.74 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 5.35 75.97 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 114.86 0.704 . . . . 73.230000000000004 114.86 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.29 -167.8 2.0 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 117.939 0.869 . . . . 75.219999999999999 111.525 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.13 118.06 23.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.098 0.959 . . . . 72.239999999999995 109.981 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HB2' HG21 ' A' ' 93' ' ' ILE . 67.9 t80 -78.8 -75.11 0.25 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.67 0.271 . . . . 72.439999999999998 110.578 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.4 t -122.84 61.21 1.01 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.778 0.799 . . . . 73.049999999999997 110.077 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.41 2.49 84.39 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.011 -0.995 . . . . 73.040000000000006 114.076 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -117.18 136.51 23.41 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.998 0.919 . . . . 74.310000000000002 110.186 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.07 116.7 4.81 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.555 2.17 . . . . 74.409999999999997 112.153 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' A' ' 88' ' ' PHE . 41.1 pt -92.56 153.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.574 0.749 . . . . 73.530000000000001 113.005 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HZ1' ' HB3' ' A' ' 94' ' ' LYS . 2.6 mmmp? -123.95 119.09 28.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.215 1.006 . . . . 74.299999999999997 108.869 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.527 HG21 HG13 ' A' ' 18' ' ' VAL . 32.6 t -112.85 134.12 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.598 0.759 . . . . 72.329999999999998 110.136 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.7 p -146.42 -176.33 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.742 1.217 . . . . 72.430000000000007 109.182 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -76.46 145.33 39.31 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.01 0.823 . . . . 75.219999999999999 110.778 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.25 93.28 8.16 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.04 0.448 . . . . 54.200000000000003 110.793 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 124.036 0.935 . . . . 70.049999999999997 111.261 178.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.112 0.006 . . . . 75.209999999999994 111.007 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.61 23.8 69.08 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 115.23 0.852 . . . . 74.25 115.23 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -86.43 -48.55 8.34 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.055 0.542 . . . . 74.040000000000006 111.164 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -90.66 92.25 8.75 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.031 -0.729 . . . . 73.099999999999994 109.031 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -72.08 74.79 0.94 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.968 0.907 . . . . 75.349999999999994 111.734 -172.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 58.25 21.02 7.7 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.596 1.158 . . . . 75.420000000000002 112.622 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -86.6 -29.92 22.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.106 0.562 . . . . 64.420000000000002 109.638 173.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.53 113.12 22.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.964 -0.754 . . . . 74.329999999999998 108.964 168.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -72.7 111.2 7.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.614 0.366 . . . . 65.310000000000002 111.539 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -69.24 -55.77 9.57 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.398 0.679 . . . . 72.049999999999997 109.309 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -179.34 50.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.929 1.292 . . . . 75.439999999999998 108.149 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.96 25.8 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.02 1.489 . . . . 74.310000000000002 115.02 -163.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -65.49 129.76 40.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.78 0.432 . . . . 74.010000000000005 110.735 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -87.44 -22.03 25.21 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.146 -0.479 . . . . 72.120000000000005 110.328 174.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -96.44 132.48 41.94 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.579 0.752 . . . . 75.109999999999999 110.625 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG21 ' HB1' ' A' ' 76' ' ' ALA . 35.7 pt -114.96 152.87 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.879 0.872 . . . . 73.230000000000004 111.061 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -107.7 116.45 31.96 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.158 0.583 . . . . 72.409999999999997 110.175 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.551 HG23 HG11 ' A' ' 95' ' ' VAL . 19.1 t -109.6 134.15 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.212 1.005 . . . . 75.329999999999998 110.436 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -120.12 157.19 29.53 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.063 0.945 . . . . 72.040000000000006 110.562 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.88 29.55 28.58 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-O 121.241 0.356 . . . . 73.120000000000005 113.941 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.28 -13.46 46.62 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.153 0.981 . . . . 73.430000000000007 112.957 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.0 54.25 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 114.878 0.711 . . . . 71.209999999999994 114.878 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.88 -24.61 48.43 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.813 0.845 . . . . 71.5 112.34 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.67 20.02 9.16 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.416 0.686 . . . . 72.430000000000007 111.787 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.14 131.73 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.056 0.543 . . . . 72.019999999999996 112.0 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.4 p -129.39 154.67 46.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.406 0.682 . . . . 75.140000000000001 110.292 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.566 HG21 ' HB ' ' A' ' 51' ' ' ILE . 90.4 mt -50.24 -52.51 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 124.283 1.033 . . . . 75.219999999999999 111.815 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.42 -37.03 84.28 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.568 -0.742 . . . . 73.310000000000002 111.462 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -69.9 -36.89 75.77 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.107 0.41 . . . . 74.5 112.107 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.5 -37.9 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 120.977 0.417 . . . . 71.310000000000002 110.052 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.74 66.06 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.924 0.49 . . . . 74.209999999999994 111.594 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.34 -32.52 58.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.101 0.96 . . . . 74.310000000000002 111.434 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.14 -49.69 41.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.659 0.784 . . . . 74.010000000000005 110.392 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 14.2 m-85 -82.89 -16.96 45.45 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.556 1.317 . . . . 75.030000000000001 114.556 -173.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -66.98 -17.36 64.88 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.471 0.915 . . . . 73.439999999999998 113.471 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.55 -24.75 63.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.039 0.536 . . . . 73.420000000000002 111.99 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.06 -41.08 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.304 1.042 . . . . 75.019999999999996 111.375 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.11 176.45 47.19 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.454 -0.403 . . . . 74.230000000000004 113.993 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.4 126.18 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.899 0.479 . . . . 72.439999999999998 109.911 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 81.0 mt -94.64 141.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.712 0.805 . . . . 75.420000000000002 109.038 173.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.533 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 26.4 mtpp -59.78 144.67 47.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.366 0.666 . . . . 74.200000000000003 111.658 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.3 m -128.4 120.27 26.62 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.489 -0.778 . . . . 71.530000000000001 109.569 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.16 114.72 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.017 -0.734 . . . . 73.219999999999999 109.017 171.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.35 -28.28 66.08 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.277 1.031 . . . . 73.420000000000002 111.777 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 11.5 mmpt? -71.61 -45.87 60.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.29 0.636 . . . . 75.239999999999995 111.74 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 p -82.98 -35.17 26.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.134 0.574 . . . . 74.150000000000006 111.453 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.17 17.79 64.15 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.78 -0.645 . . . . 72.219999999999999 112.404 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -120.98 152.07 55.94 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.407 1.083 . . . . 74.439999999999998 111.79 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HG2' HG22 ' A' ' 27' ' ' ILE . 18.8 Cg_endo -61.42 146.77 96.83 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.739 2.292 . . . . 74.219999999999999 113.141 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.533 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 52.7 mtt -82.75 97.1 8.41 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.016 0.526 . . . . 73.230000000000004 110.646 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.566 ' HB ' HG21 ' A' ' 27' ' ' ILE . 70.2 mt -144.27 117.48 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.183 0.993 . . . . 75.299999999999997 109.132 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.56 110.37 22.19 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.589 -0.523 . . . . 75.530000000000001 109.589 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.7 mt -82.31 115.35 21.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.46 0.704 . . . . 74.409999999999997 110.196 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -69.89 117.33 11.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.061 0.545 . . . . 61.130000000000003 110.247 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 m -122.39 139.13 54.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.02 0.928 . . . . 62.43 109.59 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -73.32 135.63 44.38 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.175 0.59 . . . . 70.219999999999999 111.62 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 15.4 ptm180 -64.64 -38.33 90.65 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.459 1.103 . . . . 75.219999999999999 112.674 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 45.4 mt-10 -80.77 -55.52 4.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.252 0.621 . . . . 75.209999999999994 111.839 -171.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.2 p -84.07 -31.19 25.47 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.3 0.64 . . . . 71.230000000000004 111.794 -174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 8.71 86.26 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 116.438 -0.346 . . . . 72.109999999999999 113.22 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -92.8 152.32 19.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.213 0.605 . . . . 75.209999999999994 111.937 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.76 126.46 28.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.767 0.827 . . . . 61.509999999999998 110.784 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -71.27 -12.97 61.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.051 0.94 . . . . 62.240000000000002 112.201 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.97 37.73 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 112.014 -0.435 . . . . 72.239999999999995 112.014 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.47 149.27 49.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.998 . . . . 73.219999999999999 109.552 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.32 159.13 25.1 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.492 0.553 . . . . 72.109999999999999 112.492 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.5 p -115.24 114.08 24.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.132 0.573 . . . . 71.420000000000002 111.323 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 51' ' ' ILE . 21.6 t -99.81 108.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.432 1.093 . . . . 75.510000000000005 110.608 -173.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.2 m -84.98 101.76 12.63 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.686 0.394 . . . . 75.239999999999995 111.28 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 38.0 m-85 -77.37 156.13 31.44 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.097 0.559 . . . . 73.209999999999994 111.18 171.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.08 -27.41 54.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.298 0.639 . . . . 71.219999999999999 111.296 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 22.8 m-20 -120.0 131.38 24.43 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 122.942 0.497 . . . . 70.439999999999998 111.743 171.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.37 -38.3 82.37 Favored 'Trans proline' 0 CA--C 1.583 2.93 0 C-N-CA 122.879 2.386 . . . . 64.129999999999995 115.68 168.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 37.7 Cg_endo -64.98 -25.42 59.35 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 123.03 2.118 . . . . 62.039999999999999 113.404 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.9 m -76.17 -37.24 58.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.072 0.549 . . . . 73.010000000000005 110.19 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HB1' HG21 ' A' ' 16' ' ' ILE . . . -61.69 -48.29 81.46 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.324 0.649 . . . . 72.019999999999996 111.015 174.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.42 -47.5 85.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.279 1.032 . . . . 75.430000000000007 110.799 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.34 93.88 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.604 -0.725 . . . . 73.329999999999998 111.738 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -31.76 73.07 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.321 0.648 . . . . 71.25 112.507 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 95' ' ' VAL . 72.5 mt -63.62 -61.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.264 0.226 . . . . 74.450000000000003 110.599 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.19 -24.7 65.0 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.421 0.688 . . . . 63.109999999999999 112.643 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -80.21 -59.38 2.73 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.44 0.696 . . . . 74.150000000000006 111.617 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 93' ' ' ILE . 77.1 m-85 -85.84 -10.83 54.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.194 1.183 . . . . 74.120000000000005 114.194 -170.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.68 115.14 4.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.376 0.534 . . . . 73.329999999999998 110.258 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.53 68.58 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 114.921 0.728 . . . . 71.150000000000006 114.921 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.5 mmtt -94.08 141.46 28.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.111 0.956 . . . . 73.329999999999998 111.935 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.04 116.13 19.14 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.599 0.759 . . . . 74.319999999999993 112.179 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -90.9 -78.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.582 0.753 . . . . 73.099999999999994 110.949 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -109.26 54.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.968 0.889 . . . . 73.510000000000005 110.248 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.64 8.48 87.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.983 -1.008 . . . . 74.209999999999994 113.83 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -133.59 136.82 27.54 Favored Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 123.811 0.845 . . . . 74.010000000000005 109.878 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.73 116.55 4.76 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.739 2.293 . . . . 75.530000000000001 110.893 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 83' ' ' PHE . 16.0 pt -80.45 154.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.735 0.642 . . . . 74.010000000000005 112.735 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -119.22 112.3 19.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.369 -0.975 . . . . 72.540000000000006 108.369 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.551 HG11 HG23 ' A' ' 18' ' ' VAL . 14.2 t -107.0 137.02 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.019 0.528 . . . . 75.349999999999994 110.876 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.6 m -141.51 179.86 6.56 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.997 1.319 . . . . 70.219999999999999 109.207 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.31 149.59 31.72 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.807 0.731 . . . . 73.230000000000004 110.399 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.89 85.92 7.03 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.024 0.44 . . . . 73.420000000000002 110.117 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.571 1.752 0 C-N-CA 123.209 0.604 . . . . 71.430000000000007 112.135 -176.114 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 111.642 0.238 . . . . 73.329999999999998 111.642 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.5 -158.01 28.81 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.356 -0.383 . . . . 73.319999999999993 113.106 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -101.33 85.9 2.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.887 0.875 . . . . 74.329999999999998 111.918 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 64.44 -2.75 0.59 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.841 1.793 . . . . 65.349999999999994 115.841 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -91.04 -7.73 51.03 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.059 0.845 . . . . 73.120000000000005 111.832 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -114.03 125.71 54.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.681 0.793 . . . . 75.349999999999994 109.703 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -76.1 127.63 33.34 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 72.319999999999993 111.361 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -89.36 40.54 0.99 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.29 0.567 . . . . 74.510000000000005 111.826 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -62.72 156.62 23.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.655 0.782 . . . . 75.019999999999996 111.712 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 62.12 74.08 0.45 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.206 1.002 . . . . 72.219999999999999 111.596 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.7 t -100.8 -11.64 19.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.754 0.822 . . . . 75.209999999999994 111.737 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -78.95 102.0 8.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.964 0.506 . . . . 70.129999999999995 111.931 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 14.5 m120 -105.8 138.78 41.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.689 0.795 . . . . 74.109999999999999 110.39 173.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -93.43 -22.84 18.66 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.976 0.511 . . . . 62.049999999999997 111.067 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -106.18 125.67 51.28 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.843 0.857 . . . . 74.010000000000005 110.747 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 76' ' ' ALA . 30.3 pt -114.9 148.28 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.906 0.882 . . . . 71.439999999999998 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -102.14 120.05 39.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.433 0.693 . . . . 73.510000000000005 109.607 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG23 HG11 ' A' ' 95' ' ' VAL . 14.4 t -114.9 136.13 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.186 0.994 . . . . 72.230000000000004 110.388 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -124.37 162.69 23.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.131 0.973 . . . . 74.230000000000004 110.234 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.92 25.93 61.33 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 114.203 0.441 . . . . 61.039999999999999 114.203 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 93' ' ' ILE . 77.0 mt -79.03 -22.38 45.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.352 1.061 . . . . 71.150000000000006 112.013 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.87 167.66 42.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.083 0.373 . . . . 63.219999999999999 113.227 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.62 -19.56 59.13 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 112.84 0.682 . . . . 72.439999999999998 112.84 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -86.91 6.93 29.51 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.145 0.578 . . . . 74.519999999999996 111.934 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.2 138.03 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 124.198 0.999 . . . . 73.329999999999998 112.242 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -129.44 151.15 50.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.756 -0.59 . . . . 73.400000000000006 110.061 171.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 51' ' ' ILE . 67.9 mt -49.19 -51.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.631 1.172 . . . . 64.439999999999998 112.773 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.68 -21.1 55.85 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.788 0.662 . . . . 72.530000000000001 112.788 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -73.85 -37.55 64.75 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 117.962 0.346 . . . . 65.530000000000001 111.099 171.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.23 -41.48 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 121.309 0.576 . . . . 70.430000000000007 109.7 171.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.5 92.42 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.341 -0.845 . . . . 75.200000000000003 111.596 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.93 -38.11 89.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.273 0.629 . . . . 72.239999999999995 111.047 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -67.27 -55.9 12.06 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.816 0.846 . . . . 63.439999999999998 111.385 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.446 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 49.0 m-85 -77.94 -21.64 50.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.584 1.327 . . . . 70.150000000000006 114.584 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.87 -20.04 66.09 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.983 1.105 . . . . 74.510000000000005 113.983 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -60.56 -22.28 63.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 122.985 0.514 . . . . 73.219999999999999 112.15 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.08 -42.45 14.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 124.507 1.123 . . . . 73.140000000000001 111.424 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 172.67 45.12 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.981 -0.554 . . . . 73.299999999999997 113.229 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.96 125.47 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.557 0.743 . . . . 74.349999999999994 110.719 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 73.2 mt -95.56 130.5 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.943 0.897 . . . . 70.430000000000007 109.388 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.591 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.5 mtpt -51.04 153.99 1.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.743 0.817 . . . . 75.219999999999999 112.91 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 52.4 m -140.07 125.46 18.97 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.613 0.765 . . . . 71.230000000000004 110.508 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -64.13 123.87 20.19 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.448 0.699 . . . . 74.310000000000002 111.038 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -71.78 -24.02 61.67 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.109 0.563 . . . . 74.420000000000002 112.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.8 -54.36 13.99 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.807 0.443 . . . . 65.099999999999994 111.577 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -84.57 -45.3 12.7 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.196 0.598 . . . . 74.439999999999998 111.668 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.97 37.8 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.973 -0.558 . . . . 74.439999999999998 112.523 -170.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -106.13 148.94 37.52 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.128 0.971 . . . . 75.530000000000001 111.28 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 51.0 Cg_endo -68.14 145.97 68.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.598 2.198 . . . . 72.140000000000001 111.922 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.591 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 58.2 mtt -77.16 94.79 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.563 0.697 . . . . 71.200000000000003 110.026 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.575 ' HB ' HG23 ' A' ' 27' ' ' ILE . 86.7 mt -144.54 116.44 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.053 1.341 . . . . 74.510000000000005 108.49 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 14.5 m120 -99.03 109.43 22.18 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.155 -0.683 . . . . 71.510000000000005 109.155 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.84 120.8 26.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.138 0.575 . . . . 73.109999999999999 110.06 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 57.0 m-85 -73.12 104.35 4.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.011 0.524 . . . . 74.340000000000003 110.994 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -86.76 160.0 18.95 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.953 0.901 . . . . 62.32 110.065 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -93.45 155.1 17.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.953 0.901 . . . . 73.349999999999994 111.962 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.16 -35.64 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.658 0.783 . . . . 75.510000000000005 112.834 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.97 -37.99 14.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.93 -0.482 . . . . 75.239999999999995 111.952 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.401 ' HB ' ' HZ3' ' A' ' 61' ' ' LYS . 31.5 p -94.01 -33.38 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 112.522 0.564 . . . . 73.420000000000002 112.522 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.86 6.26 89.16 Favored Glycine 0 CA--C 1.541 1.656 0 N-CA-C 114.223 0.449 . . . . 41.420000000000002 114.223 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HZ3' ' HB ' ' A' ' 59' ' ' THR . 38.6 mtmm -102.1 171.72 7.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.689 0.796 . . . . 73.209999999999994 110.78 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.37 130.26 39.33 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.972 -0.455 . . . . 72.25 111.71 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -74.78 -18.96 60.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.432 0.693 . . . . 75.239999999999995 112.548 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 35.1 12.61 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 116.362 -0.381 . . . . 65.310000000000002 113.064 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 41.3 mt-10 -127.94 154.06 45.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.2 1.0 . . . . 73.530000000000001 109.042 173.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -163.57 164.08 24.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.093 0.557 . . . . 71.140000000000001 111.822 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.0 p -120.26 128.92 53.77 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.998 -0.546 . . . . 71.400000000000006 109.98 168.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.42 111.8 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.575 0.75 . . . . 63.439999999999998 110.809 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 m -89.21 102.71 15.37 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.936 0.494 . . . . 72.030000000000001 111.724 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 34.7 m-85 -78.09 156.85 29.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.707 0.803 . . . . 75.129999999999995 110.625 168.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.1 -32.31 44.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.045 0.538 . . . . 74.049999999999997 110.434 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 4.0 m-20 -106.08 122.58 41.82 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.59 0.756 . . . . 62.229999999999997 110.453 174.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 72' ' ' ASP . 5.3 Cg_endo -49.94 -42.45 44.97 Favored 'Trans proline' 0 CA--C 1.586 3.108 0 C-N-CA 122.918 2.412 . . . . 61.530000000000001 115.789 167.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.32 -25.5 71.57 Favored 'Trans proline' 0 C--N 1.406 3.564 0 CA-C-N 122.602 1.965 . . . . 73.439999999999998 113.117 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.8 m -76.59 -37.22 56.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.436 0.694 . . . . 73.140000000000001 110.917 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 16' ' ' ILE . . . -65.07 -47.21 78.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.082 0.553 . . . . 64.219999999999999 111.151 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.58 -42.96 95.29 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.562 0.745 . . . . 75.209999999999994 111.282 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.42 89.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.285 -0.416 . . . . 71.409999999999997 111.847 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.65 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.398 0.679 . . . . 73.349999999999994 112.385 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 95' ' ' VAL . 72.4 mt -64.24 -63.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.528 0.331 . . . . 74.549999999999997 110.326 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.3 -31.76 63.97 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.556 0.742 . . . . 74.140000000000001 112.45 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -78.49 -56.98 4.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.499 0.72 . . . . 74.209999999999994 111.921 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 93' ' ' ILE . 62.7 m-85 -88.13 -4.1 58.8 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.242 1.201 . . . . 73.140000000000001 114.242 -171.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.7 110.81 1.4 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.634 0.374 . . . . 62.119999999999997 111.097 173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.33 80.16 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.049 0.779 . . . . 71.329999999999998 115.049 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.44 144.01 26.64 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 117.811 0.805 . . . . 71.030000000000001 112.023 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.64 116.91 19.33 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.983 0.513 . . . . 74.219999999999999 112.335 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.11 -66.88 0.82 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.485 0.714 . . . . 75.430000000000007 109.996 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.3 t -107.44 38.76 2.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.295 1.038 . . . . 74.439999999999998 110.001 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.56 23.86 74.22 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.003 -0.544 . . . . 74.219999999999999 113.253 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 28.0 p-10 -138.71 123.69 11.9 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 124.06 0.944 . . . . 74.549999999999997 110.53 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 21.9 Cg_exo -64.31 112.52 1.93 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.156 2.571 . . . . 74.109999999999999 112.771 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.454 HG21 HD21 ' A' ' 21' ' ' LEU . 18.6 pt -83.55 161.24 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 72.349999999999994 112.031 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -113.85 123.06 48.88 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.259 1.023 . . . . 74.25 108.298 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG11 HG23 ' A' ' 18' ' ' VAL . 14.6 t -115.06 134.72 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 121.042 0.449 . . . . 75.519999999999996 110.508 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -142.72 179.77 6.8 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.173 1.389 . . . . 70.510000000000005 109.227 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 13' ' ' ASN . 94.5 m-85 -76.79 151.9 35.78 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.206 0.457 . . . . 73.519999999999996 110.488 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.72 95.89 8.62 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.69 0.396 . . . . 64.510000000000005 110.2 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 123.49 0.716 . . . . 72.439999999999998 111.275 -178.271 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.917 0.389 . . . . 74.040000000000006 111.483 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.4 -121.94 5.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.147 -0.479 . . . . 71.510000000000005 111.937 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -84.9 108.09 17.37 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.119 0.568 . . . . 64.430000000000007 110.612 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.9 114.42 26.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.491 0.716 . . . . 73.219999999999999 110.813 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -71.42 93.73 1.19 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.518 0.727 . . . . 74.310000000000002 109.826 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -74.93 85.68 2.26 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.834 0.826 . . . . 75.540000000000006 112.825 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -132.97 -69.72 0.56 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.081 0.953 . . . . 73.450000000000003 108.795 170.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.88 -42.33 11.92 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.426 -0.583 . . . . 73.319999999999993 109.426 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 m -68.32 91.99 0.41 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.565 -0.743 . . . . 74.420000000000002 110.626 176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -119.76 165.99 13.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.615 0.766 . . . . 74.310000000000002 111.349 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 p -92.88 107.13 18.98 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.348 0.659 . . . . 72.540000000000006 111.491 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -109.99 10.42 24.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.814 0.846 . . . . 72.099999999999994 112.264 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -75.45 131.83 40.41 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.212 0.605 . . . . 65.019999999999996 109.986 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.25 11.04 25.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.05 0.54 . . . . 74.340000000000003 112.195 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.7 m -126.82 129.56 48.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.889 0.876 . . . . 71.430000000000007 109.647 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 29.7 pt -116.21 146.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.823 0.849 . . . . 74.549999999999997 111.335 -175.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -102.28 123.92 46.94 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.457 0.703 . . . . 74.219999999999999 109.871 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG11 HG22 ' A' ' 95' ' ' VAL . 21.6 t -119.12 138.85 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.667 1.187 . . . . 71.400000000000006 110.073 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -126.1 155.41 41.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.03 0.932 . . . . 72.299999999999997 110.808 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.84 1.36 70.68 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 114.184 0.434 . . . . 74.310000000000002 114.184 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.422 HD22 HG23 ' A' ' 93' ' ' ILE . 85.3 mt -61.36 -12.32 13.6 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.123 1.157 . . . . 74.420000000000002 114.123 -178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.25 173.28 49.57 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.389 0.515 . . . . 61.25 114.389 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 8.3 pt-20 -71.68 -22.46 61.66 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.286 -0.538 . . . . 74.329999999999998 111.27 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.52 8.93 22.76 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.714 0.806 . . . . 71.209999999999994 112.305 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.72 137.1 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.275 0 C-N-CA 122.722 0.409 . . . . 75.299999999999997 111.965 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 30' ' ' VAL . 57.9 p -131.22 148.01 52.66 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.428 0.691 . . . . 75.5 109.81 171.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.644 HG21 ' HB ' ' A' ' 51' ' ' ILE . 83.7 mt -51.5 -47.08 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.463 1.105 . . . . 75.510000000000005 112.983 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -69.7 -29.31 66.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.18 0.592 . . . . 73.450000000000003 111.916 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -74.1 -36.11 64.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.688 0.395 . . . . 73.140000000000001 111.369 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' THR . 44.4 t -65.36 -40.68 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.366 0.603 . . . . 74.129999999999995 109.663 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.98 85.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.017 -0.992 . . . . 63.119999999999997 111.735 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.74 -26.39 63.35 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.073 0.549 . . . . 75.329999999999998 111.664 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -75.29 -57.08 4.11 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.399 0.68 . . . . 72.439999999999998 111.578 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 30.9 m-85 -75.25 -19.47 59.71 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.593 1.331 . . . . 73.340000000000003 114.593 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.73 -21.51 66.44 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.69 0.996 . . . . 75.420000000000002 113.69 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -57.26 -25.03 58.54 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.112 0.565 . . . . 73.349999999999994 112.353 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.8 mm -84.57 -56.33 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.945 0.898 . . . . 71.030000000000001 110.72 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.33 166.99 33.87 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 116.024 -0.535 . . . . 73.209999999999994 113.38 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.23 114.16 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.019 0.528 . . . . 73.319999999999993 110.051 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 76.5 mt -79.7 136.31 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 109.186 -0.672 . . . . 60.439999999999998 109.186 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.6 mtpt -53.51 142.11 23.29 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.151 0.58 . . . . 72.099999999999994 112.0 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.7 m -132.88 119.84 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.629 -0.714 . . . . 72.230000000000004 110.079 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.73 123.33 16.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.335 1.054 . . . . 75.010000000000005 110.222 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -73.94 -30.75 62.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.656 0.782 . . . . 72.439999999999998 111.791 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.53 -51.54 49.67 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.151 0.581 . . . . 71.129999999999995 111.546 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 p -83.67 -45.67 13.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.469 0.708 . . . . 72.420000000000002 111.359 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.21 17.04 35.74 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 115.623 -0.717 . . . . 70.120000000000005 112.421 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -104.9 156.9 35.31 Favored Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 124.235 1.014 . . . . 74.400000000000006 112.801 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.78 142.2 19.98 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.956 2.437 . . . . 72.409999999999997 112.8 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.609 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.0 mtt -79.04 94.32 5.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.263 0.554 . . . . 75.120000000000005 110.305 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.644 ' HB ' HG21 ' A' ' 27' ' ' ILE . 72.1 mt -146.77 115.88 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.525 1.13 . . . . 65.219999999999999 108.906 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.17 111.15 23.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 74.450000000000003 110.116 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.61 143.36 34.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.147 0.579 . . . . 72.129999999999995 110.164 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -100.38 126.09 46.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 73.340000000000003 109.848 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -115.2 142.45 46.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.065 0.946 . . . . 74.150000000000006 110.276 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -67.7 96.55 0.56 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.06 -0.718 . . . . 75.310000000000002 109.06 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -61.88 -24.1 66.72 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.593 0.757 . . . . 74.040000000000006 112.065 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' A' ' 59' ' ' THR . 10.9 pt-20 -71.69 -39.49 70.18 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.461 0.705 . . . . 71.109999999999999 111.903 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -103.49 -62.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.308 0.643 . . . . 75.239999999999995 111.478 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 -7.84 5.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.37 -0.377 . . . . 65.420000000000002 113.701 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -90.19 161.88 15.51 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.546 0.673 . . . . 74.049999999999997 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 59.6 mt -76.49 138.46 40.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.254 0.622 . . . . 74.319999999999993 111.649 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -73.32 -20.15 60.87 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.744 0.818 . . . . 74.450000000000003 111.787 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.79 33.85 20.4 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.739 -0.664 . . . . 71.299999999999997 112.719 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.88 148.97 52.29 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.917 0.887 . . . . 63.549999999999997 109.74 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.11 159.57 31.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.567 0.58 . . . . 72.439999999999998 112.567 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.6 p -114.9 117.57 31.05 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.068 0.547 . . . . 63.25 110.629 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.36 109.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.68 0.792 . . . . 74.420000000000002 110.385 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -86.94 101.61 13.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.021 0.528 . . . . 70.310000000000002 111.116 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 58.3 m-85 -77.59 157.28 30.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.722 0.809 . . . . 74.420000000000002 110.76 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.38 -35.99 58.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.225 0.61 . . . . 73.510000000000005 110.579 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -106.49 128.01 27.07 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.541 0.737 . . . . 73.030000000000001 110.821 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -52.29 -39.94 71.31 Favored 'Trans proline' 0 CA--C 1.582 2.883 0 C-N-CA 122.697 2.265 . . . . 61.229999999999997 115.764 166.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.25 -24.01 65.69 Favored 'Trans proline' 0 C--N 1.401 3.317 0 CA-C-N 122.297 1.856 . . . . 73.219999999999999 113.715 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.8 m -77.12 -38.06 52.88 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.109 0.564 . . . . 71.439999999999998 110.782 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 16' ' ' ILE . . . -64.55 -43.8 92.81 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.428 0.632 . . . . 70.25 110.318 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -60.64 -48.02 83.64 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.146 1.378 . . . . 72.420000000000002 111.37 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.16 94.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.81 -0.632 . . . . 60.140000000000001 112.479 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.482 0.713 . . . . 74.230000000000004 112.387 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG12 HG11 ' A' ' 95' ' ' VAL . 92.2 mt -63.9 -60.53 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.115 0.566 . . . . 70.450000000000003 110.574 172.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.48 -31.68 66.23 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.409 -0.814 . . . . 75.439999999999998 111.576 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -80.06 -61.87 1.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.809 0.444 . . . . 70.219999999999999 111.933 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB2' HG23 ' A' ' 95' ' ' VAL . 71.3 m-85 -80.02 -10.46 59.77 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.618 0.97 . . . . 75.219999999999999 113.618 -170.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.4 104.26 2.23 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 109.541 -0.54 . . . . 72.010000000000005 109.541 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.55 42.41 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 115.546 -0.752 . . . . 62.32 114.017 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -82.69 152.1 25.95 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.882 0.841 . . . . 75.010000000000005 110.073 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.95 124.1 35.81 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.429 0.529 . . . . 64.140000000000001 112.429 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -126.83 136.32 52.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.253 -1.018 . . . . 74.439999999999998 108.253 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 t 61.49 30.32 18.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.189 0.996 . . . . 74.540000000000006 111.609 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.26 29.0 54.83 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.478 -0.783 . . . . 53.0 115.041 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -161.41 145.29 9.8 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 117.305 0.553 . . . . 72.129999999999995 111.383 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.64 110.67 1.93 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.018 2.479 . . . . 75.150000000000006 113.438 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG23 HD22 ' A' ' 21' ' ' LEU . 34.4 pt -78.88 160.6 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.861 0.865 . . . . 74.209999999999994 112.223 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -118.18 128.19 54.47 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.463 1.105 . . . . 73.319999999999993 109.457 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.54 HG22 HG11 ' A' ' 18' ' ' VAL . 23.6 t -121.91 135.34 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 74.329999999999998 111.107 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.5 p -146.4 179.36 7.58 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.708 1.203 . . . . 64.430000000000007 109.022 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 45.8 m-85 -75.27 154.4 37.47 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.969 0.804 . . . . 74.409999999999997 111.713 174.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.12 88.3 6.46 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.241 -0.652 . . . . 71.319999999999993 109.241 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.57 1.715 0 C-N-CA 123.451 0.7 . . . . 72.549999999999997 111.551 -174.712 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.339 0.114 . . . . 71.310000000000002 111.172 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.27 138.72 28.22 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 114.195 0.438 . . . . 53.039999999999999 114.195 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -75.26 88.75 2.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.897 0.855 . . . . 73.519999999999996 110.981 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.41 -29.54 70.81 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.368 -1.287 . . . . 72.310000000000002 112.716 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -67.88 135.69 52.89 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.203 0.601 . . . . 73.209999999999994 110.067 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -76.16 158.33 31.82 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.185 0.594 . . . . 75.230000000000004 112.026 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -104.62 6.67 34.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.678 0.791 . . . . 73.120000000000005 111.842 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -71.51 87.55 0.9 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.319 0.648 . . . . 64.299999999999997 111.06 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -158.46 -174.86 5.0 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.873 0.869 . . . . 74.530000000000001 110.654 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -66.64 99.96 0.64 Allowed 'General case' 0 CA--C 1.562 1.433 0 CA-C-O 121.488 0.661 . . . . 72.340000000000003 112.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.3 t -99.79 171.69 7.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.168 0.587 . . . . 72.319999999999993 110.239 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.44 35.21 0.49 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.542 0.737 . . . . 74.040000000000006 111.506 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -80.39 137.9 36.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.132 0.973 . . . . 71.120000000000005 110.575 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -98.64 -20.4 17.01 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.615 0.766 . . . . 75.200000000000003 111.88 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -94.77 126.75 40.29 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.915 0.486 . . . . 74.430000000000007 110.187 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.5 pt -113.36 156.0 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.584 0.754 . . . . 73.129999999999995 111.291 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -116.3 125.42 52.13 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.329 0.651 . . . . 72.420000000000002 110.146 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG11 HG23 ' A' ' 95' ' ' VAL . 18.5 t -117.41 146.33 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.191 0.996 . . . . 74.140000000000001 110.363 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 27.6 mt-30 -124.7 163.62 21.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.684 1.193 . . . . 74.0 110.184 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.97 23.57 74.29 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 114.953 0.741 . . . . 61.520000000000003 114.953 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.19 -17.92 59.31 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.328 1.051 . . . . 75.319999999999993 111.958 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 177.29 49.54 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 114.71 0.644 . . . . 74.140000000000001 114.71 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 34.0 mt-10 -75.29 -14.66 60.52 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.664 0.786 . . . . 75.049999999999997 112.797 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -84.09 -8.97 58.96 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.336 0.654 . . . . 60.439999999999998 112.191 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.7 128.36 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 113.716 1.006 . . . . 74.120000000000005 113.716 -169.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 30' ' ' VAL . 43.3 p -125.61 152.86 44.57 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.517 0.727 . . . . 72.519999999999996 110.289 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 51' ' ' ILE . 88.0 mt -52.91 -45.55 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.379 0.672 . . . . 75.329999999999998 111.593 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.64 -38.74 92.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.58 0.752 . . . . 74.519999999999996 111.777 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.3 t -71.5 -39.46 70.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.756 0.422 . . . . 72.340000000000003 111.707 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 26' ' ' THR . 61.9 t -65.32 -40.4 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.256 0.55 . . . . 71.430000000000007 110.014 176.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -63.22 -42.63 99.29 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.141 -0.936 . . . . 72.239999999999995 111.286 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.52 -30.65 67.46 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.143 0.577 . . . . 74.5 111.379 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.43 -53.7 7.76 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.692 0.797 . . . . 73.230000000000004 111.418 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.2 m-85 -79.04 -16.26 57.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.784 1.031 . . . . 75.140000000000001 113.784 -174.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 63.6 pttt -59.07 -29.77 67.57 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 113.09 0.774 . . . . 74.299999999999997 113.09 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -58.85 -25.09 62.94 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.796 0.838 . . . . 52.439999999999998 112.275 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.35 -45.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.253 1.021 . . . . 74.540000000000006 111.649 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -178.7 45.62 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 116.343 -0.39 . . . . 72.409999999999997 113.315 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.92 126.97 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.7 0.4 . . . . 73.319999999999993 110.123 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 80.4 mt -95.06 143.2 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.785 0.834 . . . . 71.209999999999994 108.852 170.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.7 mtpt -62.42 145.62 53.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.092 0.557 . . . . 74.120000000000005 111.504 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 41.5 m -125.67 123.91 39.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.106 0.962 . . . . 73.310000000000002 108.809 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -71.69 123.74 23.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.071 0.549 . . . . 71.209999999999994 109.664 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -18.28 45.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.209 0.604 . . . . 72.439999999999998 111.722 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.26 -52.73 44.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.932 0.493 . . . . 72.25 110.801 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -83.38 -41.53 18.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.388 0.675 . . . . 70.420000000000002 111.022 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.63 16.0 44.27 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 115.881 -0.599 . . . . 70.409999999999997 112.512 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -121.91 153.33 60.48 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.184 0.994 . . . . 73.099999999999994 111.972 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 41.1 Cg_endo -64.22 140.92 73.43 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.256 2.637 . . . . 75.549999999999997 112.855 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.604 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.8 mtt -73.98 95.51 2.51 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.359 0.6 . . . . 74.019999999999996 109.809 -174.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' A' ' 27' ' ' ILE . 80.4 mt -144.67 120.73 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.833 1.253 . . . . 73.519999999999996 108.614 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 m120 -101.45 110.15 22.1 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.902 -0.407 . . . . 71.409999999999997 109.902 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.86 141.52 32.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.524 0.73 . . . . 74.519999999999996 109.748 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.49 112.41 25.31 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.474 0.71 . . . . 75.299999999999997 110.267 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -97.52 141.61 30.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.614 0.766 . . . . 75.540000000000006 110.17 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.41 123.63 25.02 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.69 1.196 . . . . 73.329999999999998 109.995 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.38 -20.05 59.19 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.307 1.225 . . . . 73.409999999999997 114.307 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.1 pt-20 -93.76 -44.5 8.11 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.946 0.793 . . . . 60.130000000000003 112.199 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 58' ' ' GLU . 46.1 p -92.22 -35.35 13.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.896 0.478 . . . . 74.420000000000002 112.124 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.89 0.94 68.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 113.945 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.5 162.31 27.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.39 0.595 . . . . 74.409999999999997 110.532 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 78.3 mt -81.08 132.67 35.38 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.811 -0.555 . . . . 73.510000000000005 111.053 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.21 -19.35 64.75 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.799 0.84 . . . . 74.200000000000003 111.866 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.57 21.49 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.007 -0.542 . . . . 63.43 112.147 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.45 145.11 46.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.789 0.835 . . . . 74.209999999999994 109.405 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.22 150.63 22.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.783 0.66 . . . . 71.209999999999994 112.783 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 35.6 p -108.19 114.46 28.36 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.828 0.451 . . . . 74.439999999999998 111.045 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -102.66 108.96 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.953 0.901 . . . . 74.209999999999994 109.853 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.1 m -85.47 105.29 15.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.615 0.366 . . . . 73.409999999999997 110.52 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 49.4 m-85 -79.26 156.63 28.02 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.357 0.663 . . . . 73.030000000000001 111.161 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.04 57.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.36 0.664 . . . . 71.209999999999994 110.737 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.27 129.52 23.81 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.276 0.63 . . . . 61.200000000000003 110.712 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.59 -42.02 43.57 Favored 'Trans proline' 0 CA--C 1.58 2.778 0 C-N-CA 123.005 2.47 . . . . 65.540000000000006 116.55 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.63 -21.17 52.52 Favored 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 122.301 1.857 . . . . 74.549999999999997 113.362 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 m -72.64 -38.17 67.78 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.309 0.644 . . . . 72.510000000000005 109.669 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.48 -53.24 57.66 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 55.210000000000001 111.276 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.99 -41.75 98.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.64 0.776 . . . . 71.340000000000003 111.151 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.49 98.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.892 0.477 . . . . 72.200000000000003 111.778 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.151 0.58 . . . . 63.210000000000001 112.457 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.64 -56.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.074 0.55 . . . . 70.439999999999998 110.928 174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.5 -27.33 69.2 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.524 0.729 . . . . 64.140000000000001 112.043 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -82.36 -60.39 2.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.057 0.543 . . . . 74.329999999999998 111.553 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -82.69 -13.57 56.16 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.23 1.196 . . . . 74.239999999999995 114.23 -168.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.57 104.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 119.194 0.906 . . . . 73.430000000000007 110.203 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.05 6.04 49.24 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.514 -0.766 . . . . 62.350000000000001 114.56 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.25 -176.45 5.11 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 117.856 0.828 . . . . 75.5 111.556 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.81 122.36 42.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.121 0.569 . . . . 61.219999999999999 110.664 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -75.32 -70.9 0.39 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.842 -0.429 . . . . 71.219999999999999 109.842 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.8 t -115.17 50.06 1.01 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.783 0.833 . . . . 74.510000000000005 109.391 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.53 73.59 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 115.408 -0.815 . . . . 64.5 113.501 -174.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -131.37 128.76 22.1 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.904 0.881 . . . . 72.430000000000007 111.806 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 113.82 2.3 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.369 2.713 . . . . 74.530000000000001 113.551 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.1 pt -97.19 151.86 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.552 0.741 . . . . 73.5 112.777 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 75.1 mmtt -113.6 112.09 22.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.326 1.05 . . . . 75.150000000000006 109.384 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG23 HG11 ' A' ' 18' ' ' VAL . 21.7 t -112.5 128.3 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.99 -0.444 . . . . 74.439999999999998 110.809 -174.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.0 m -140.48 -179.66 6.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.161 1.384 . . . . 73.420000000000002 109.495 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -73.87 151.49 40.46 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.179 0.445 . . . . 73.439999999999998 110.63 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 91.1 6.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.214 0.531 . . . . 64.140000000000001 109.939 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.567 1.611 0 C-N-CA 123.931 0.892 . . . . 75.209999999999994 110.782 -177.283 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HB3' ' HB3' ' A' ' 4' ' ' HIS . 56.8 mtt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 110.742 -0.096 . . . . 75.329999999999998 110.742 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.84 -88.68 0.3 Allowed Glycine 0 C--N 1.355 1.626 0 O-C-N 123.335 0.397 . . . . 74.219999999999999 113.609 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -65.06 -32.24 73.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.679 0.792 . . . . 75.140000000000001 112.103 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 39.6 t-80 -91.79 86.35 5.9 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.36 0.6 . . . . 75.030000000000001 110.087 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -78.41 106.29 10.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.845 -0.616 . . . . 75.420000000000002 111.369 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.24 18.99 1.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.562 0.745 . . . . 75.209999999999994 112.635 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -117.74 155.59 29.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.657 0.783 . . . . 74.510000000000005 110.463 169.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -148.51 123.0 9.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.715 0.806 . . . . 74.25 109.605 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 t -83.16 138.47 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.921 0.488 . . . . 72.519999999999996 110.792 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -67.18 125.13 25.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.447 0.699 . . . . 75.140000000000001 111.383 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.7 t -70.64 121.06 17.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.876 0.87 . . . . 70.129999999999995 111.577 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.51 133.94 52.33 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 120.994 0.426 . . . . 75.409999999999997 111.102 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -124.55 120.35 31.69 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 75.219999999999999 109.787 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 70' ' ' PHE . 35.5 p30 -92.46 -12.06 33.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.323 0.649 . . . . 73.329999999999998 112.274 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -103.19 130.0 50.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.282 0.633 . . . . 72.219999999999999 110.672 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.9 pt -119.26 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.64 0.776 . . . . 74.310000000000002 112.13 -176.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -95.81 119.63 34.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.25 0.548 . . . . 73.400000000000006 110.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG11 HG23 ' A' ' 95' ' ' VAL . 17.6 t -112.83 141.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.782 1.233 . . . . 75.409999999999997 109.814 -177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -126.44 155.22 42.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.229 1.011 . . . . 63.140000000000001 110.439 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.88 32.3 50.24 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.222 0.849 . . . . 75.450000000000003 115.222 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 HD23 HG21 ' A' ' 93' ' ' ILE . 69.8 mt -74.89 -33.33 62.03 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.214 1.006 . . . . 74.109999999999999 112.114 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.64 153.86 10.34 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-N 116.185 -0.461 . . . . 72.400000000000006 112.868 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.43 -8.36 54.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.992 0.917 . . . . 75.310000000000002 112.191 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -117.22 81.8 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.032 0.933 . . . . 75.140000000000001 109.302 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.17 131.75 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.2 1.0 . . . . 75.329999999999998 110.525 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' HG21 ' A' ' 30' ' ' VAL . 12.8 p -116.26 155.71 27.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.655 -0.653 . . . . 73.049999999999997 109.992 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.568 HG21 ' HB ' ' A' ' 51' ' ' ILE . 68.1 mt -52.19 -47.67 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.118 0.967 . . . . 74.340000000000003 112.187 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.88 -21.45 54.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.995 0.518 . . . . 74.200000000000003 112.374 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -68.83 -44.34 73.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.842 0.457 . . . . 74.420000000000002 110.144 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 26' ' ' THR . 24.6 t -67.14 -38.97 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 115.912 -0.586 . . . . 72.040000000000006 110.364 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.71 79.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.756 -0.656 . . . . 72.540000000000006 111.738 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.55 -31.57 72.84 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.222 0.609 . . . . 63.219999999999999 111.358 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -73.58 -54.29 8.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.035 0.534 . . . . 74.430000000000007 111.152 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 40.2 m-85 -78.02 -22.92 48.5 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.087 1.143 . . . . 74.439999999999998 114.087 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.52 -22.61 66.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.055 0.761 . . . . 72.420000000000002 113.055 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.46 -27.32 65.98 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.796 0.438 . . . . 73.209999999999994 111.628 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.06 -45.07 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 75.519999999999996 110.988 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.22 44.3 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 116.094 -0.503 . . . . 62.420000000000002 113.625 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.23 127.39 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.71 0.804 . . . . 74.530000000000001 110.683 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.3 mt -98.85 132.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 73.409999999999997 109.904 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.03 142.75 29.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 75.230000000000004 111.501 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 67.7 m -139.85 131.32 26.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.811 -0.632 . . . . 74.530000000000001 111.07 -176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -68.86 114.68 7.4 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.261 1.025 . . . . 73.299999999999997 109.357 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -74.37 -21.57 59.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.391 0.676 . . . . 73.219999999999999 112.184 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -73.52 -49.13 28.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.653 0.381 . . . . 74.530000000000001 111.499 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -86.16 -45.19 11.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.039 0.536 . . . . 65.209999999999994 111.867 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.84 -4.34 39.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.893 -0.594 . . . . 73.150000000000006 112.802 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -93.19 140.15 23.22 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 112.471 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 53.8 Cg_endo -70.44 149.67 62.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.745 2.297 . . . . 55.450000000000003 111.842 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.6 mtt -75.57 94.35 3.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.351 0.596 . . . . 71.109999999999999 109.52 -176.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.568 ' HB ' HG21 ' A' ' 27' ' ' ILE . 75.1 mt -145.06 121.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 74.319999999999993 107.713 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.7 m-80 -104.57 107.85 19.0 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 110.019 -0.363 . . . . 73.329999999999998 110.019 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.7 mt -81.04 126.17 31.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.057 0.943 . . . . 74.109999999999999 110.002 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 96.4 m-85 -86.43 134.73 33.67 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.251 0.62 . . . . 74.530000000000001 111.085 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -129.78 144.91 51.53 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.64 1.176 . . . . 72.200000000000003 109.746 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -68.97 113.02 5.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.116 0.566 . . . . 72.040000000000006 110.12 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -65.88 -24.61 66.9 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.994 0.917 . . . . 73.329999999999998 111.44 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' A' ' 59' ' ' THR . 11.6 pt-20 -77.37 -45.34 26.3 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.546 0.738 . . . . 64.430000000000007 112.011 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.501 HG21 ' HG3' ' A' ' 58' ' ' GLU . 37.4 p -94.28 -56.74 2.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.068 0.461 . . . . 73.329999999999998 111.698 -176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.24 4.7 23.67 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-N 116.053 -0.521 . . . . 41.340000000000003 113.574 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HB2' ' HZ1' ' A' ' 61' ' ' LYS . 10.1 mtmp? -97.87 151.38 20.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.293 0.637 . . . . 73.120000000000005 111.577 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.76 135.2 52.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.452 0.701 . . . . 75.430000000000007 111.158 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.67 -16.17 60.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.374 0.67 . . . . 75.400000000000006 111.708 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.62 39.65 24.79 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.766 -0.534 . . . . 75.230000000000004 111.766 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 57.9 mt-10 -133.56 148.97 51.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.427 0.691 . . . . 72.450000000000003 109.33 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -157.86 151.53 23.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.791 0.436 . . . . 72.310000000000002 111.688 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -112.44 113.43 25.61 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.649 0.38 . . . . 74.230000000000004 110.65 172.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.0 t -101.5 110.62 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.571 1.148 . . . . 71.239999999999995 110.174 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 20.0 m -89.95 101.39 14.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 111.216 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 41.9 m-85 -76.56 157.42 32.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.383 0.673 . . . . 71.239999999999995 110.557 170.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.06 -32.37 67.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.777 0.431 . . . . 72.019999999999996 110.017 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -113.79 123.67 32.5 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.548 0.739 . . . . 73.439999999999998 111.474 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.74 -33.53 80.86 Favored 'Trans proline' 0 CA--C 1.583 2.941 0 C-N-CA 122.841 2.36 . . . . 63.240000000000002 116.497 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.2 -26.41 42.32 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 122.871 2.061 . . . . 71.420000000000002 113.209 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.5 m -77.69 -35.44 52.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.531 0.733 . . . . 71.219999999999999 110.485 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 16' ' ' ILE . . . -62.63 -49.89 73.4 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 121.4 0.619 . . . . 71.329999999999998 110.594 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -65.58 -37.52 86.88 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.676 1.191 . . . . 72.340000000000003 111.426 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.82 90.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.1 0.56 . . . . 73.329999999999998 112.045 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.64 68.46 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.303 0.641 . . . . 75.25 112.444 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.4 mt -64.47 -64.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.883 0.473 . . . . 71.239999999999995 110.464 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.06 -25.01 65.02 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.355 0.662 . . . . 75.230000000000004 112.389 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -82.32 -62.14 1.7 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.993 0.517 . . . . 75.319999999999993 111.67 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.12 -9.76 59.42 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.032 1.123 . . . . 74.219999999999999 114.032 -170.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -66.13 118.13 9.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 120.943 0.401 . . . . 61.32 110.389 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.88 79.66 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.335 -0.703 . . . . 75.450000000000003 114.511 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -93.95 167.89 11.31 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 118.44 1.12 . . . . 74.230000000000004 111.386 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -96.89 118.92 34.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.214 0.605 . . . . 70.219999999999999 111.487 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 89.7 t80 -72.47 -74.17 0.17 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.001 0.521 . . . . 64.5 110.414 172.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -116.95 60.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.039 0.936 . . . . 73.450000000000003 108.847 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.22 13.27 67.11 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 115.272 -0.876 . . . . 61.25 113.46 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -118.19 120.48 32.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.247 1.019 . . . . 65.209999999999994 111.017 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.28 96.0 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.953 2.435 . . . . 73.140000000000001 113.158 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.485 HG21 HD23 ' A' ' 21' ' ' LEU . 28.1 pt -76.04 156.07 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.78 0.832 . . . . 73.219999999999999 113.225 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -122.98 116.56 23.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.366 1.066 . . . . 74.5 108.942 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG23 HG11 ' A' ' 18' ' ' VAL . 20.0 t -110.92 136.36 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.67 0.388 . . . . 74.430000000000007 110.731 -174.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.8 p -148.67 -176.52 5.36 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.982 1.313 . . . . 75.420000000000002 109.657 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -76.6 146.67 38.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.741 0.701 . . . . 72.439999999999998 111.758 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.84 100.15 11.5 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.984 0.514 . . . . 64.120000000000005 110.242 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.811 0.844 . . . . 61.399999999999999 111.416 -174.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 112.452 0.538 . . . . 53.23 112.452 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.2 m -130.83 128.63 41.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.884 0.474 . . . . 62.12 110.099 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 80' ' ' ILE . 22.4 pt -115.39 147.31 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.423 . . . . 71.44 111.551 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -105.71 108.86 20.6 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.256 0.622 . . . . 73.54 110.045 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 95' ' ' VAL . 17.5 t -101.19 138.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.064 0.946 . . . . 73.14 110.09 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 74.4 mt-30 -119.44 155.11 32.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.728 0.811 . . . . 55.23 111.34 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.04 44.74 76.41 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.511 0.965 . . . . 52.34 115.511 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 93' ' ' ILE . 49.3 mt -81.22 -30.75 34.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.462 1.105 . . . . 65.52 110.781 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.07 160.53 11.39 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.138 -0.483 . . . . 44.41 113.815 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.55 -23.01 64.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.492 0.717 . . . . 73.42 110.364 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -107.15 88.44 2.74 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.646 0.778 . . . . 52.34 108.995 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.37 136.7 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.888 0.875 . . . . 75.52 111.038 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.38 161.81 20.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.689 . . . . 64.35 110.43 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.57 HG23 ' HB ' ' A' ' 51' ' ' ILE . 76.1 mt -50.85 -47.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.173 0.989 . . . . 55.32 111.32 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -75.99 -23.99 55.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.333 0.653 . . . . 72.22 111.823 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -67.94 -46.4 71.56 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.658 0.383 . . . . 44.21 110.541 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 30.8 t -64.6 -42.73 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.092 0.473 . . . . 54.31 110.27 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.62 96.16 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.542 -0.754 . . . . 74.21 112.637 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.19 -22.07 55.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.96 0.504 . . . . 71.33 111.449 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -79.58 -44.95 20.1 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.236 0.614 . . . . 75.24 111.364 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -83.14 -13.71 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.852 1.056 . . . . 64.43 113.852 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.71 -30.08 60.53 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.009 1.114 . . . . 65.01 114.009 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.28 -24.41 67.27 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.623 0.769 . . . . 63.51 112.606 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 79' ' ' ALA . 19.5 mm -82.41 -44.37 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.836 0.854 . . . . 72.53 111.372 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.88 179.64 48.66 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 116.406 -0.361 . . . . 63.43 113.67 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.64 125.09 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.497 0.719 . . . . 74.23 111.549 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.7 mt -94.0 138.38 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 70.13 108.781 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.591 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 27.1 mtpp -57.73 155.02 10.73 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.068 0.547 . . . . 41.22 111.73 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.8 m -145.5 125.38 13.5 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.273 0.629 . . . . 70.02 111.155 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.33 125.85 30.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.778 -0.823 . . . . 62.13 108.778 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.3 -21.66 25.62 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.643 0.608 . . . . 74.44 112.643 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.26 -43.21 95.56 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.305 0.642 . . . . 74.3 111.713 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -82.72 -42.93 17.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.576 0.75 . . . . 70.04 110.117 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.51 56.02 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.392 -0.822 . . . . 71.32 111.893 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -110.44 147.09 35.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.105 0.962 . . . . 62.33 111.63 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 33.7 Cg_endo -64.99 142.19 73.82 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.594 2.196 . . . . 73.13 110.835 173.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.591 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 61.3 mtt -72.79 94.31 1.78 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.716 0.77 . . . . 71.44 110.34 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 27' ' ' ILE . 66.4 mt -144.93 119.81 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.042 1.337 . . . . 72.1 108.264 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 24.5 m-80 -102.7 110.77 22.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.114 -0.699 . . . . 74.13 109.114 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.69 124.35 28.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.903 0.881 . . . . 74.23 109.92 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.2 m-85 -80.33 110.43 15.76 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.647 0.779 . . . . 72.23 110.814 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -96.86 143.02 28.16 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 43.3 109.864 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.08 144.44 40.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 73.45 111.266 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.87 -46.47 30.04 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.447 0.699 . . . . 74.23 112.175 -171.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.11 -42.69 15.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.539 0.57 . . . . 74.25 112.539 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.5 p -81.95 -30.03 31.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.06 84.57 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 114.015 0.366 . . . . 55.21 114.015 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -99.19 164.89 11.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.014 0.926 . . . . 74.14 110.531 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.02 131.47 45.11 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.973 0.509 . . . . 72.33 111.622 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -75.66 -21.71 57.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.194 0.598 . . . . 52.25 111.82 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.77 26.66 31.46 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 116.073 -0.512 . . . . 60.31 112.902 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 3.6 mp0 -116.72 154.47 30.56 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.543 -0.975 . . . . 75.34 109.755 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -160.14 146.94 16.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.877 0.471 . . . . 61.15 111.513 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.9 p -104.16 117.89 35.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.973 -0.38 . . . . 63.41 109.973 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.93 108.08 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.621 0.769 . . . . 74.31 110.36 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 m -85.18 104.19 14.83 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.889 0.476 . . . . 72.12 110.821 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.4 m-85 -79.67 158.2 27.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.49 0.716 . . . . 74.12 110.788 169.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.64 -31.23 63.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.065 0.546 . . . . 71.35 111.349 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -118.73 134.17 23.56 Favored Pre-proline 0 N--CA 1.48 1.067 0 C-N-CA 123.053 0.541 . . . . 64.34 111.564 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.2 -34.9 99.02 Favored 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 122.523 2.149 . . . . 74.13 116.197 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.72 -29.35 77.19 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 122.867 2.059 . . . . 53.55 113.079 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -74.68 -40.85 61.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.223 0.609 . . . . 52.4 110.396 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.86 84.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.541 -0.754 . . . . 72.05 111.098 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.34 -44.85 90.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.11 111.296 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.891 0.476 . . . . 61.11 111.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 37' ' ' ILE . . . -60.76 -34.21 74.11 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.407 0.683 . . . . 53.35 112.232 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 95' ' ' VAL . 71.9 mt -69.19 -54.98 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.831 0.452 . . . . 74.04 110.49 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.42 -33.1 69.3 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.768 0.827 . . . . 63.12 111.921 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -80.57 -56.46 4.15 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.691 0.796 . . . . 64.23 112.17 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' ILE . 61.7 m-85 -86.65 -11.64 50.73 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 114.457 1.28 . . . . 74.34 114.457 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -63.87 116.12 5.5 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.578 0.626 . . . . 72.33 110.322 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.73 5.55 74.23 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 114.871 0.708 . . . . 50.04 114.871 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.84 159.59 14.9 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 117.949 0.874 . . . . 70.5 111.767 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.41 115.79 27.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.64 0.376 . . . . 62.03 111.651 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 91.2 t80 -70.28 -56.34 7.0 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.997 0.919 . . . . 73.32 110.925 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -147.18 63.01 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.908 0.861 . . . . 62.43 109.151 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.37 0.28 66.25 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 115.093 -0.958 . . . . 75.4 113.692 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.13 121.28 36.9 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 51.42 110.7 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.8 98.98 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.736 2.291 . . . . 70.11 112.666 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.438 HG21 HD23 ' A' ' 21' ' ' LEU . 28.0 pt -71.22 148.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.591 0.96 . . . . 70.23 113.591 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -115.39 104.94 12.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.67 1.188 . . . . 54.32 108.416 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 18' ' ' VAL . 15.1 t -102.16 131.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.671 0.388 . . . . 73.13 110.137 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.3 p -136.55 178.65 6.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.503 1.121 . . . . 40.23 109.779 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.9 145.13 31.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.681 0.392 . . . . 65.22 110.076 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.19 7.7 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.031 0.443 . . . . 74.34 109.983 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.573 1.84 0 C-N-CA 123.733 0.813 . . . . 65.34 110.835 -178.785 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 111.767 0.284 . . . . 53.34 111.767 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -101.25 130.18 47.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 64.55 109.917 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 43.4 pt -110.71 153.07 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.517 0.727 . . . . 70.22 110.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -111.08 128.46 55.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.147 0.579 . . . . 71.54 109.49 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 95' ' ' VAL . 10.7 t -121.11 141.34 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.775 0.83 . . . . 54.33 110.324 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -123.8 155.42 38.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.413 1.085 . . . . 73.21 110.169 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 23.19 63.23 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 114.713 0.645 . . . . 74.34 114.713 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 93' ' ' ILE . 77.1 mt -64.52 -34.56 78.52 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.169 0.988 . . . . 73.04 111.885 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.25 21.9 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.154 -0.93 . . . . 53.31 111.119 -168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.92 -4.78 56.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 117.827 0.814 . . . . 75.22 112.636 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -94.01 17.56 12.14 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.233 0.613 . . . . 72.33 110.711 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 88' ' ' PHE . 8.2 p -75.83 140.49 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 124.159 0.984 . . . . 73.12 112.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' VAL . 50.1 p -125.05 158.46 33.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.357 0.663 . . . . 72.34 110.214 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.2 mt -59.57 -35.09 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.834 0.454 . . . . 72.12 110.777 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.27 -46.78 88.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.605 0.762 . . . . 73.34 111.388 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -61.83 -43.28 99.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.581 0.752 . . . . 62.02 111.767 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' THR . 48.1 t -66.13 -45.68 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 121.047 0.451 . . . . 75.25 110.64 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -64.65 -33.98 77.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.677 -0.692 . . . . 43.05 111.996 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.23 -33.77 59.21 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.292 0.637 . . . . 71.53 111.644 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -74.56 -53.33 9.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 74.34 111.424 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 48.3 m-85 -78.68 -17.56 55.74 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 113.729 1.011 . . . . 72.31 113.729 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 64.9 pttt -58.29 -28.71 65.24 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.528 0.936 . . . . 74.42 113.528 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.35 -22.88 63.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.552 0.741 . . . . 63.23 112.357 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mm -81.38 -41.13 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.097 0.959 . . . . 73.25 111.094 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.28 -171.64 44.75 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.014 -0.539 . . . . 71.52 113.184 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.97 127.11 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.063 0.545 . . . . 44.53 110.257 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.2 mt -94.56 137.02 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.148 0.979 . . . . 61.32 108.954 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.4 mtpt -59.03 146.37 38.57 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.548 0.69 . . . . 70.11 111.707 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 50.5 m -129.29 125.27 36.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.728 -1.124 . . . . 74.52 109.583 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -57.22 107.51 0.43 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 109.082 -0.71 . . . . 53.34 109.082 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.64 -19.4 65.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.018 0.927 . . . . 73.52 112.827 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -78.59 -48.6 14.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.449 0.699 . . . . 74.33 111.65 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -85.13 -38.54 18.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.229 0.612 . . . . 75.14 111.821 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.77 2.67 61.19 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 115.927 -0.579 . . . . 42.11 112.636 -172.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -99.1 144.2 27.79 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.053 0.941 . . . . 65.41 111.777 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 38.2 Cg_endo -66.11 139.64 56.53 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.852 2.368 . . . . 65.52 111.811 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.0 mtt -72.73 93.37 1.65 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.669 0.747 . . . . 73.25 109.586 -175.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.555 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -147.0 120.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.948 1.299 . . . . 74.51 108.602 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.55 110.55 22.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 110.027 -0.36 . . . . 71.22 110.027 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.34 129.22 34.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.854 0.862 . . . . 65.32 109.835 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 92.6 m-85 -89.13 117.32 28.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.487 0.715 . . . . 72.01 110.244 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 m -99.14 150.62 21.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.17 0.988 . . . . 74.34 110.196 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.25 132.27 35.82 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.585 0.754 . . . . 64.24 109.842 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -70.17 -32.67 70.73 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.662 0.785 . . . . 71.41 112.249 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.8 -52.68 5.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.64 0.776 . . . . 71.34 111.557 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 p -82.11 -30.31 31.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.53 0.732 . . . . 72.21 112.323 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.76 89.43 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.501 -0.318 . . . . 71.14 113.498 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -102.17 155.7 18.04 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.767 0.827 . . . . 72.1 109.808 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.42 136.57 57.97 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.914 0.486 . . . . 72.11 111.776 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -72.09 -15.28 62.0 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.278 0.631 . . . . 55.1 112.284 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.77 31.06 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.689 -0.564 . . . . 73.24 111.689 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 52.0 mt-10 -130.9 149.13 52.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.064 0.946 . . . . 75.33 109.566 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.71 154.25 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.748 0.647 . . . . 65.21 112.748 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 25.1 p -109.43 116.12 31.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.851 -0.613 . . . . 71.24 111.007 173.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.66 109.71 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.466 0.706 . . . . 75.5 110.113 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 69.2 m -83.52 102.84 12.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.693 0.397 . . . . 65.12 110.772 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 56.3 m-85 -78.89 153.78 30.26 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.903 0.481 . . . . 72.04 110.842 170.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.05 -34.38 61.84 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.828 -0.624 . . . . 65.55 111.143 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -111.91 130.2 23.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.054 0.542 . . . . 63.31 111.032 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -49.84 -38.11 46.82 Favored 'Trans proline' 0 CA--C 1.583 2.936 0 C-N-CA 123.334 2.69 . . . . 72.5 116.305 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.37 -28.68 78.62 Favored 'Trans proline' 0 C--N 1.403 3.434 0 CA-C-N 122.477 1.92 . . . . 33.45 113.934 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 m -73.42 -39.45 65.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 74.34 110.038 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.87 79.94 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.474 0.71 . . . . 62.5 111.052 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -59.96 -51.42 69.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.242 1.017 . . . . 62.35 111.149 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.75 90.7 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.005 -0.543 . . . . 61.54 112.156 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.24 72.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.45 0.7 . . . . 61.32 112.506 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 95' ' ' VAL . 70.2 mt -63.29 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.03 0.532 . . . . 74.5 111.05 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.34 -30.05 69.28 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.347 -0.842 . . . . 65.44 111.985 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -79.06 -59.53 2.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.954 0.501 . . . . 73.04 111.675 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.606 ' HB3' HD11 ' A' ' 93' ' ' ILE . 27.4 m-85 -80.78 -10.55 59.72 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.965 1.098 . . . . 75.13 113.965 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -65.76 111.19 3.11 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.548 0.613 . . . . 72.1 109.992 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.27 1.4 60.95 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.794 -0.639 . . . . 63.21 114.307 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.7 mmtt -96.37 149.29 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.261 0.624 . . . . 74.32 111.036 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -87.52 128.06 35.24 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.083 -0.386 . . . . 71.1 111.376 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' HG21 ' A' ' 93' ' ' ILE . 53.8 t80 -81.75 -73.63 0.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.399 0.68 . . . . 60.12 110.603 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 t -119.96 53.11 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.75 0.786 . . . . 65.11 109.814 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.73 90.11 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 115.37 -0.832 . . . . 50.35 113.322 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -122.57 126.73 26.06 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.048 0.939 . . . . 62.4 109.895 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 132.04 25.65 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.089 2.526 . . . . 62.11 112.52 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.3 pt -107.56 153.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.219 0.608 . . . . 73.22 111.857 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -121.8 126.82 49.69 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.003 0.921 . . . . 44.31 108.575 172.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 18' ' ' VAL . 16.2 t -114.55 143.89 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 122.943 0.497 . . . . 63.54 111.156 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 m -147.12 -177.08 5.48 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.807 1.643 . . . . 73.14 109.057 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 53.7 m-85 -87.38 147.82 25.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.699 0.681 . . . . 65.53 110.603 168.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.92 85.69 6.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.584 0.753 . . . . 73.21 109.752 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 123.658 0.783 . . . . 73.25 111.405 -175.015 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.487 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 111.641 0.237 . . . . 51.33 111.641 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -95.45 125.18 39.89 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.989 0.516 . . . . 72.31 109.944 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.531 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.4 pt -120.95 140.61 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.156 0.583 . . . . 75.43 112.23 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -95.32 127.62 41.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.132 0.491 . . . . 75.12 110.554 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 95' ' ' VAL . 14.9 t -120.57 137.26 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.458 1.103 . . . . 64.25 109.985 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.42 156.26 31.79 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.046 0.938 . . . . 74.32 110.778 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 2.28 82.98 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 114.468 0.547 . . . . 64.53 114.468 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB3' HG21 ' A' ' 25' ' ' VAL . 96.0 mt -57.21 -20.87 29.65 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.834 1.05 . . . . 61.22 113.834 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.32 162.0 35.15 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.055 0.382 . . . . 73.11 114.055 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.21 -21.34 61.42 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.211 0.604 . . . . 75.44 111.787 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -92.45 2.58 56.58 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.004 0.922 . . . . 74.43 111.18 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 21' ' ' LEU . 11.1 p -66.54 147.53 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.53 0.732 . . . . 74.34 112.242 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.6 p -128.19 157.4 40.93 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.381 0.672 . . . . 72.44 110.367 172.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' A' ' 51' ' ' ILE . 71.5 mt -54.14 -41.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.156 0.982 . . . . 74.32 111.381 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.95 -29.27 62.96 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.367 0.667 . . . . 74.52 112.28 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 m -70.94 -43.56 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.567 0.347 . . . . 73.01 111.199 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.07 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 120.946 0.403 . . . . 63.54 110.022 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.08 96.36 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.498 0.719 . . . . 64.43 112.254 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -34.5 75.12 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.63 0.772 . . . . 72.41 111.071 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.13 -51.86 19.43 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.524 0.73 . . . . 74.11 110.882 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -80.9 -14.61 57.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.86 1.059 . . . . 73.01 113.86 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -54.89 -33.34 61.91 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.8 0.666 . . . . 63.44 112.8 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.97 -23.34 66.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.88 0.872 . . . . 73.42 112.67 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.31 -50.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.712 0.805 . . . . 53.22 111.277 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.35 -178.73 43.54 Favored Glycine 0 C--O 1.24 0.514 0 CA-C-N 115.35 -0.841 . . . . 53.41 113.012 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.3 mt -69.29 122.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 123.332 0.653 . . . . 74.22 110.317 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.1 mt -92.81 135.42 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.809 0.844 . . . . 51.41 108.835 171.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 29.3 mtpp -56.26 154.47 8.02 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.96 0.504 . . . . 64.24 111.591 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.0 m -138.64 122.35 17.53 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.169 0.588 . . . . 62.33 111.007 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -65.93 112.25 3.71 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.25 -1.019 . . . . 63.41 108.25 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -82.8 -12.23 57.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.942 0.497 . . . . 73.13 112.289 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -74.6 -47.77 30.47 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.605 0.762 . . . . 74.41 110.514 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -83.3 -39.37 20.9 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.63 0.772 . . . . 73.41 111.127 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.7 16.13 52.85 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.305 -0.861 . . . . 63.52 112.742 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -114.75 149.88 43.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.051 0.94 . . . . 61.52 111.299 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.49 151.32 85.54 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.584 2.189 . . . . 70.22 112.74 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.508 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.1 mtt -78.3 93.1 4.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.666 0.745 . . . . 63.3 109.147 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.0 mt -141.42 114.35 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.576 -1.268 . . . . 74.41 107.576 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 109.57 21.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.398 -0.593 . . . . 73.32 109.398 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 66' ' ' ALA . 87.6 mt -79.11 125.16 29.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.538 0.735 . . . . 73.43 110.324 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 9.6 m-85 -78.12 126.31 30.62 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 72.55 110.429 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -116.91 143.45 45.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.847 0.859 . . . . 75.41 110.061 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -71.14 112.16 7.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.319 0.648 . . . . 63.35 109.971 168.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.926 0.49 . . . . 74.14 111.819 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 59' ' ' THR . 12.9 pt-20 -73.71 -43.82 58.14 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.871 0.868 . . . . 71.52 111.907 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.56 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -99.39 -50.08 4.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.466 0.706 . . . . 71.24 111.612 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.1 -1.37 28.4 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.521 -0.763 . . . . 53.42 112.652 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -98.12 160.06 14.54 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.635 0.774 . . . . 72.01 111.271 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.69 136.58 51.22 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.203 0.601 . . . . 65.33 111.901 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.85 -17.99 65.16 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.729 0.812 . . . . 61.22 112.398 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.38 33.86 21.59 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 121.318 0.399 . . . . 52.31 112.446 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.8 mt-10 -135.16 155.9 49.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.169 0.988 . . . . 70.22 109.948 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -164.03 152.56 13.27 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.219 0.533 . . . . 73.31 112.14 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 21.7 p -104.59 123.95 48.45 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.576 -0.738 . . . . 72.23 110.186 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 t -104.6 109.16 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.709 0.804 . . . . 70.14 109.816 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.1 m -86.76 100.47 12.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.53 0.332 . . . . 64.41 110.816 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 56.2 m-85 -75.55 160.57 30.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.372 0.669 . . . . 55.25 111.134 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.0 -30.31 39.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.514 0.726 . . . . 72.32 111.188 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -114.49 132.76 22.68 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.381 0.672 . . . . 63.15 110.866 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.98 -36.14 95.47 Favored 'Trans proline' 0 CA--C 1.586 3.116 0 C-N-CA 122.547 2.165 . . . . 72.14 115.956 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.1 -28.0 65.35 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 122.701 2.0 . . . . 73.11 113.356 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -69.77 -39.85 76.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.573 0.701 . . . . 22.24 110.211 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.86 -49.27 76.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.865 -1.061 . . . . 63.4 111.413 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -60.24 -45.44 93.22 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.208 1.003 . . . . 62.43 111.17 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.42 97.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.838 -0.619 . . . . 64.53 111.797 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.88 72.25 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.203 0.601 . . . . 74.43 112.482 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.34 -63.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.047 0.539 . . . . 73.32 110.684 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.12 -31.19 66.92 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.747 0.819 . . . . 73.42 112.105 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -78.75 -59.76 2.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.656 0.783 . . . . 74.14 111.668 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 95' ' ' VAL . 39.2 m-85 -87.45 -11.48 48.93 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.449 1.277 . . . . 71.32 114.449 -170.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.28 119.48 10.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.289 -0.634 . . . . 63.41 109.289 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.44 87.74 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.977 0.751 . . . . 64.34 114.977 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.9 150.14 21.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.714 0.806 . . . . 74.41 112.061 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.11 123.87 27.37 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.054 0.761 . . . . 72.03 113.054 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -125.13 133.04 52.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 74.33 108.373 167.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 t 62.58 11.43 4.75 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.531 1.132 . . . . 74.43 113.362 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.62 20.03 10.55 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 114.94 0.736 . . . . 61.32 114.94 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -154.04 146.33 17.3 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 118.22 1.01 . . . . 71.23 111.193 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.82 104.06 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.332 2.021 . . . . 74.22 112.733 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.31 165.21 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.356 0.662 . . . . 71.43 112.418 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 94' ' ' LYS . 9.3 mmpt? -121.01 117.72 27.99 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.28 1.032 . . . . 62.13 109.79 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 18' ' ' VAL . 21.9 t -114.53 136.71 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.062 0.545 . . . . 71.43 110.546 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -153.6 175.68 12.94 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.538 1.135 . . . . 75.15 109.997 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.62 146.14 54.15 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 118.562 0.619 . . . . 73.11 111.828 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.72 97.22 5.09 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.514 -0.551 . . . . 63.23 109.514 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 CA--C 1.556 1.182 0 C-N-CA 124.112 0.965 . . . . 73.44 110.869 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.524 0.202 . . . . 71.24 111.512 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -99.47 125.93 45.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.007 0.523 . . . . 65.43 110.765 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.433 HG23 ' HB1' ' A' ' 76' ' ' ALA . 42.0 pt -110.11 152.27 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.847 0.859 . . . . 72.23 110.983 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -107.31 130.51 54.76 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 123.431 0.693 . . . . 75.12 109.827 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 95' ' ' VAL . 14.7 t -122.6 140.82 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.228 1.011 . . . . 43.43 110.259 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -118.66 164.35 15.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.925 1.29 . . . . 64.43 110.217 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.48 79.24 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 114.639 0.616 . . . . 72.21 114.639 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.1 -17.97 60.87 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.496 1.119 . . . . 65.24 112.705 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.95 173.03 48.7 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.151 0.42 . . . . 43.14 114.151 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.32 -19.67 61.62 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.594 0.757 . . . . 75.35 112.604 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.64 10.58 36.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.639 0.607 . . . . 71.01 112.639 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.32 128.92 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 122.997 0.519 . . . . 60.4 111.803 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 7.6 p -122.72 150.77 42.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.857 -0.527 . . . . 73.22 109.657 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.6 mt -54.38 -42.38 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.145 0.978 . . . . 72.3 111.706 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -39.42 80.58 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.181 0.592 . . . . 74.34 112.333 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.3 m -64.26 -41.7 96.82 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.914 0.486 . . . . 73.33 111.396 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' THR . 63.5 t -65.49 -43.27 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.022 0.529 . . . . 64.44 110.723 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.0 96.46 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.831 -0.622 . . . . 73.21 112.186 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.93 -30.72 62.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.371 0.669 . . . . 60.14 111.46 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -74.17 -53.86 8.98 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.693 0.797 . . . . 74.21 112.007 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 62.1 m-85 -77.46 -14.51 59.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.983 1.105 . . . . 62.34 113.983 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.14 -30.84 62.72 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.767 1.025 . . . . 71.31 113.767 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.58 -25.02 65.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.691 0.797 . . . . 43.12 113.037 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.2 mm -83.9 -52.76 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.461 0.704 . . . . 71.25 110.59 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.51 167.79 35.81 Favored Glycine 0 C--O 1.241 0.568 0 CA-C-N 116.08 -0.509 . . . . 64.15 113.391 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.18 128.04 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 51.4 109.538 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 83.3 mt -97.12 136.61 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.501 0.721 . . . . 54.44 109.09 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.5 mtpt -57.15 142.27 43.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.254 0.622 . . . . 74.43 111.951 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 75.3 m -132.73 127.16 34.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.696 0.798 . . . . 75.43 110.489 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -70.81 118.33 13.45 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.699 0.8 . . . . 70.12 109.154 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -77.06 -23.01 52.01 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.517 0.727 . . . . 71.23 111.796 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.95 -51.57 53.59 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.336 0.654 . . . . 73.42 110.72 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -84.74 -37.11 21.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.153 0.581 . . . . 71.32 111.838 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.11 -2.86 59.9 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 116.025 -0.534 . . . . 72.11 113.076 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -99.74 147.77 33.86 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.262 1.025 . . . . 75.35 112.355 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 39.7 Cg_endo -67.6 149.27 79.42 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.655 2.236 . . . . 71.03 112.775 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 53.1 mtt -78.33 94.74 4.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 64.01 109.973 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.96 123.86 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.992 1.317 . . . . 61.31 108.027 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -106.4 108.66 20.28 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.577 -0.527 . . . . 74.33 109.577 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.8 mt -83.08 117.71 23.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.239 0.616 . . . . 74.44 109.677 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HE1' HG23 ' A' ' 67' ' ' THR . 30.5 m-85 -70.29 105.36 2.96 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.089 0.556 . . . . 74.32 111.106 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -89.82 147.37 23.83 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.596 -0.729 . . . . 53.54 109.233 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.85 125.89 30.28 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.54 0.736 . . . . 62.02 109.907 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -70.15 -21.8 63.04 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.976 0.732 . . . . 70.35 112.976 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.71 -57.94 2.42 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.28 0.632 . . . . 71.14 111.128 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.2 p -82.67 -20.25 36.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.048 0.539 . . . . 72.05 112.279 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.75 -1.19 74.29 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 114.937 0.735 . . . . 63.32 114.937 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -101.81 160.73 14.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.26 0.624 . . . . 73.21 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.78 126.37 28.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.792 0.437 . . . . 40.55 111.133 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.89 -16.52 64.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.07 0.948 . . . . 71.43 112.242 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.33 25.23 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.991 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -133.24 150.54 51.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.09 0.956 . . . . 73.2 109.164 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.76 157.38 18.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.58 0.585 . . . . 74.34 112.58 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.404 HG23 ' HE1' ' A' ' 54' ' ' TYR . 27.2 p -117.24 117.2 28.89 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.093 0.557 . . . . 73.32 111.074 173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.47 111.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.32 1.048 . . . . 75.41 110.353 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m -85.85 103.18 14.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.509 0.323 . . . . 53.3 111.004 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 33.5 m-85 -76.4 164.55 25.89 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.024 0.53 . . . . 74.02 110.499 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.73 -40.4 61.3 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.023 0.529 . . . . 75.12 109.934 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.89 129.39 24.22 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.49 0.716 . . . . 62.21 110.916 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.17 -37.65 87.62 Favored 'Trans proline' 0 CA--C 1.587 3.144 0 C-N-CA 122.669 2.246 . . . . 65.31 115.471 165.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.51 -27.62 61.96 Favored 'Trans proline' 0 C--N 1.406 3.59 0 CA-C-N 122.386 1.888 . . . . 71.0 113.426 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.9 m -72.84 -39.0 66.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.284 0.564 . . . . 73.45 110.363 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -59.43 -52.14 66.89 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.227 -0.897 . . . . 60.42 110.898 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tmtp? -64.26 -42.55 96.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.77 0.828 . . . . 72.03 111.841 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.17 96.7 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.698 0.399 . . . . 70.33 111.68 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.53 71.64 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.397 0.679 . . . . 43.43 112.257 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 77' ' ' LYS . 81.6 mt -62.26 -61.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 122.684 0.394 . . . . 73.4 110.282 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 -33.8 67.63 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.742 0.817 . . . . 72.2 112.299 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -77.91 -54.55 6.19 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.722 0.809 . . . . 75.14 112.151 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.62 -12.78 30.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.246 1.202 . . . . 75.21 114.246 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.41 126.87 29.19 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.739 0.7 . . . . 72.24 110.452 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.29 1.71 90.45 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.044 0.778 . . . . 63.35 115.044 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 75.3 mmtt -92.0 -167.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.91 0.855 . . . . 74.44 111.775 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.17 125.86 44.33 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.138 0.575 . . . . 71.25 112.104 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 93' ' ' ILE . 66.6 t80 -77.32 -69.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.244 0.618 . . . . 53.11 111.455 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 m -133.83 75.29 1.59 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.666 0.786 . . . . 62.13 109.486 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.4 0.04 44.14 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 115.379 -0.828 . . . . 51.33 114.638 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.2 135.06 26.95 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.081 0.953 . . . . 54.12 111.895 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.4 Cg_exo -67.85 140.06 49.53 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.109 2.539 . . . . 72.23 113.357 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 88' ' ' PHE . 37.7 pt -123.36 151.83 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.32 1.048 . . . . 74.43 112.068 -173.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -118.72 122.48 42.59 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.086 -1.079 . . . . 74.31 108.086 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 18' ' ' VAL . 18.9 t -112.29 141.17 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.506 . . . . 73.02 110.655 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.0 p -152.3 -179.78 7.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.289 1.436 . . . . 70.13 109.041 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -73.81 150.42 41.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.772 0.714 . . . . 62.33 110.944 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.68 88.87 7.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.026 0.53 . . . . 54.43 110.293 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.498 0 C-N-CA 123.953 0.901 . . . . 75.41 110.945 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 111.747 0.277 . . . . 74.44 111.747 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.8 m -138.16 125.83 22.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.788 -0.449 . . . . 74.3 109.788 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.0 pt -109.6 143.12 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 122.779 0.432 . . . . 60.01 112.101 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -96.8 110.66 23.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.468 -0.567 . . . . 75.12 109.468 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 5.9 t -104.96 138.37 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.611 0.764 . . . . 71.45 110.103 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -120.71 166.48 13.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.282 1.033 . . . . 74.45 110.218 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.15 31.72 72.22 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 114.519 0.568 . . . . 73.2 114.519 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -81.91 -17.11 48.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.205 1.002 . . . . 74.33 112.355 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.99 168.61 40.69 Favored Glycine 0 N--CA 1.475 1.271 0 N-CA-C 114.133 0.413 . . . . 53.45 114.133 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 62' ' ' LEU . 13.5 pt-20 -74.69 -13.38 60.61 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.426 0.69 . . . . 75.23 112.599 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.61 -3.55 58.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.621 0.768 . . . . 73.24 111.895 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.72 127.53 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 N-CA-C 113.161 0.801 . . . . 73.24 113.161 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -122.93 154.22 38.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.385 0.674 . . . . 74.43 110.042 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.7 mt -57.25 -42.72 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.533 0.733 . . . . 74.41 111.736 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.35 -40.39 95.77 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.634 0.774 . . . . 74.3 111.463 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.2 t -65.82 -45.02 83.82 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.88 0.472 . . . . 74.24 111.282 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 26' ' ' THR . 60.2 t -62.83 -42.08 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.27 0.557 . . . . 62.4 110.278 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.519 -0.764 . . . . 74.52 112.172 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.79 -35.7 80.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.758 0.823 . . . . 55.34 111.271 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -71.92 -55.98 6.51 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.93 0.892 . . . . 73.45 111.031 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.0 m-85 -79.71 -16.59 55.38 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.147 1.166 . . . . 71.43 114.147 -172.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.71 -24.17 66.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.729 1.011 . . . . 75.13 113.729 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.96 -23.94 65.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.335 0.654 . . . . 64.23 112.686 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.7 mm -86.86 -45.99 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 51.52 111.812 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.63 174.67 45.72 Favored Glycine 0 C--O 1.24 0.505 0 CA-C-N 115.709 -0.678 . . . . 64.04 113.123 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.0 mt -67.54 123.62 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.499 0.72 . . . . 74.14 111.339 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 74.2 mt -94.08 130.8 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.446 1.098 . . . . 64.33 108.41 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.8 mtpp -54.64 146.57 16.35 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.498 0.719 . . . . 60.04 112.193 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 99.6 m -126.93 138.53 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.196 0.998 . . . . 73.31 109.352 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -78.27 128.68 34.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.651 0.781 . . . . 55.54 109.68 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -67.48 -40.13 85.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.789 0.836 . . . . 73.24 111.856 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.93 -49.6 75.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.718 0.807 . . . . 63.3 112.029 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -87.11 -47.04 9.23 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.158 0.583 . . . . 73.42 111.753 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.6 14.6 49.65 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 116.276 -0.42 . . . . 74.13 112.624 -171.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -117.56 151.92 48.92 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 124.338 1.055 . . . . 73.33 111.447 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.0 Cg_endo -67.22 146.65 76.71 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.743 2.295 . . . . 73.43 112.633 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.537 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.2 mtt -77.95 96.57 5.07 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.319 0.58 . . . . 71.34 110.014 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' A' ' 27' ' ' ILE . 83.4 mt -143.07 118.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.61 1.164 . . . . 74.23 108.363 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.5 m-20 -98.7 108.27 20.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.285 -0.635 . . . . 71.1 109.285 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -80.04 130.15 35.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.524 -0.547 . . . . 65.15 109.524 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 84.1 m-85 -89.78 121.85 32.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.994 0.518 . . . . 63.45 110.438 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -115.56 145.95 42.18 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.381 1.072 . . . . 72.33 110.167 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.53 104.81 1.66 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.95 0.5 . . . . 73.42 110.063 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -64.15 -22.65 67.02 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.72 0.808 . . . . 62.22 111.648 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.99 -56.09 5.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.561 0.744 . . . . 71.32 111.633 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -86.66 -49.02 7.8 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.287 0.635 . . . . 74.52 111.486 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.49 -3.16 27.88 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.858 -0.61 . . . . 74.03 113.453 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.09 153.12 23.94 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.297 0.639 . . . . 74.34 111.044 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 23' ' ' GLU . 95.4 mt -68.01 135.61 52.58 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.006 0.522 . . . . 60.53 110.502 174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' A' ' 54' ' ' TYR . 50.2 mtpt -68.26 -26.16 65.54 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.069 0.548 . . . . 73.4 112.092 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.41 38.72 8.78 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.598 -0.601 . . . . 73.31 111.598 -168.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.1 mt-10 -134.8 158.02 45.27 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.735 0.814 . . . . 72.22 110.245 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.69 160.33 28.43 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 54.33 112.017 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 p -117.41 114.31 23.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.939 0.496 . . . . 73.35 110.296 167.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.29 104.56 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.966 0.906 . . . . 74.54 109.757 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 56.0 m -82.65 102.59 11.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.68 0.392 . . . . 71.12 111.708 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 57.9 m-85 -80.22 160.07 25.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.807 0.843 . . . . 72.24 109.736 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.53 -31.24 47.42 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.485 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -110.38 130.16 23.18 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.768 0.827 . . . . 61.23 110.719 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.08 -40.46 81.45 Favored 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.181 1.921 . . . . 74.12 115.164 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.58 -31.5 87.16 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 122.406 1.895 . . . . 62.34 113.973 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m -69.49 -43.12 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.167 0.587 . . . . 72.12 109.963 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.5 -49.34 75.76 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.983 -1.008 . . . . 75.21 111.107 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -60.21 -48.43 81.77 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.708 1.203 . . . . 62.04 111.19 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.09 -35.59 80.91 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.139 0.576 . . . . 73.34 112.192 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.42 -32.12 69.89 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.824 0.45 . . . . 61.41 111.913 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 95' ' ' VAL . 59.8 mt -64.45 -59.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.787 0.435 . . . . 75.33 110.102 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -55.83 -32.43 63.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.791 0.837 . . . . 75.25 112.924 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -78.47 -59.91 2.59 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.351 0.66 . . . . 64.32 111.173 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 93' ' ' ILE . 69.6 m-85 -84.41 -15.29 46.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.639 1.348 . . . . 71.45 114.639 -169.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.55 115.69 4.92 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 118.574 0.625 . . . . 53.42 110.444 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.45 58.34 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.768 -0.462 . . . . 62.04 114.193 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.451 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.1 mmtt -93.46 147.17 23.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.818 0.847 . . . . 73.21 110.674 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.09 124.4 31.07 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 122.232 -0.292 . . . . 63.32 111.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.426 ' HB2' HG21 ' A' ' 93' ' ' ILE . 54.3 t80 -84.35 -81.24 0.18 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.139 -0.689 . . . . 75.13 109.139 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.0 m -106.18 70.41 0.84 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.325 -0.62 . . . . 72.12 109.325 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.93 -3.76 34.69 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.963 0.745 . . . . 73.32 114.963 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -121.31 130.15 24.94 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 123.579 0.752 . . . . 75.53 110.89 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.62 120.01 7.09 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.868 2.379 . . . . 71.14 111.76 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.4 pt -88.57 146.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.232 0.539 . . . . 64.21 112.352 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -109.6 110.44 21.51 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.069 -1.086 . . . . 63.12 108.069 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 7.0 t -101.66 132.07 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.426 -0.583 . . . . 62.03 109.426 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -138.29 172.64 12.61 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.176 0.99 . . . . 50.25 109.438 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -71.97 142.95 49.38 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.146 0.43 . . . . 75.5 110.03 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 66.51 8.67 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.999 0.904 . . . . 40.04 110.659 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.557 1.244 0 CA-C-N 114.842 -1.072 . . . . 63.34 110.862 179.463 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.725 0.298 . . . . 73.11 111.556 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.4 m -97.58 126.05 42.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.819 0.448 . . . . 74.43 110.155 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 76' ' ' ALA . 34.7 pt -103.42 151.24 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.15 0.58 . . . . 73.04 111.202 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -110.06 119.78 40.36 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 74.2 109.508 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 95' ' ' VAL . 13.7 t -114.23 136.91 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.889 0.875 . . . . 73.23 110.44 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -117.48 162.18 18.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.265 1.026 . . . . 75.11 110.199 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.32 26.52 74.51 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 114.35 0.5 . . . . 73.12 114.35 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 93' ' ' ILE . 55.1 mt -71.7 -24.46 61.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.496 1.119 . . . . 72.31 111.981 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.36 161.42 36.57 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.447 -0.342 . . . . 44.15 112.811 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.69 -7.78 55.99 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.372 0.586 . . . . 70.34 111.595 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.19 11.94 17.29 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.001 0.921 . . . . 62.1 111.571 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.83 133.95 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 123.928 0.891 . . . . 54.24 112.476 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 p -133.73 155.2 50.18 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.671 0.788 . . . . 71.25 110.23 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.25 -39.54 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.217 0.607 . . . . 73.02 111.253 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.93 -49.91 74.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.834 0.854 . . . . 62.32 111.744 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 m -65.34 -43.44 90.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.088 0.555 . . . . 75.35 112.126 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.24 -40.84 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 122.901 0.48 . . . . 65.4 110.812 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.65 84.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.053 -0.521 . . . . 70.5 111.371 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.96 -27.94 67.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 70.41 111.92 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -77.18 -54.87 5.96 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.844 0.857 . . . . 74.41 111.978 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.85 -18.95 55.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.199 1.185 . . . . 71.3 114.199 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -57.24 -27.91 62.47 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 113.728 1.01 . . . . 74.25 113.728 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -58.2 -26.2 62.52 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.593 0.757 . . . . 74.12 112.758 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.24 -51.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 64.05 111.076 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.32 -177.01 46.72 Favored Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.861 -0.609 . . . . 70.53 113.259 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.04 118.31 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.253 0.621 . . . . 71.43 111.151 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.9 mt -87.95 123.08 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.177 -1.046 . . . . 53.3 108.177 169.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 54.3 mtpt -46.27 118.14 1.82 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.426 0.69 . . . . 72.12 112.423 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 80.7 m -103.96 115.56 30.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.335 0.654 . . . . 64.24 110.273 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -56.63 122.13 11.34 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.364 1.066 . . . . 74.1 110.592 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -80.75 -14.79 57.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.449 1.1 . . . . 72.42 112.583 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 10.0 mmpt? -84.83 -43.01 14.56 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.387 0.675 . . . . 73.41 111.249 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.8 p -85.98 -40.4 15.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.612 0.765 . . . . 75.22 111.553 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.76 64.92 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.086 -0.506 . . . . 70.51 112.025 -170.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -114.66 156.69 44.46 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 125.22 1.408 . . . . 62.13 110.824 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 65.2 Cg_endo -72.56 153.53 54.8 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.403 2.069 . . . . 40.22 112.852 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.524 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.5 mtt -83.7 95.73 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.99 0.916 . . . . 64.22 109.35 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -137.61 122.87 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 75.24 108.535 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -106.07 108.67 20.31 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.375 -0.602 . . . . 64.34 109.375 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.0 mt -89.37 129.52 35.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.728 0.811 . . . . 72.43 109.076 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' A' ' 63' ' ' LYS . 77.3 m-85 -89.19 124.44 34.36 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.574 0.35 . . . . 73.45 111.097 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.6 m -108.83 137.81 46.16 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.663 0.785 . . . . 73.33 110.201 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.54 136.05 47.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.777 0.831 . . . . 61.52 110.831 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -76.42 -24.3 53.98 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.13 0.789 . . . . 72.15 113.13 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -92.41 -55.4 3.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.842 0.457 . . . . 65.0 111.348 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -73.95 -30.63 62.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.771 0.828 . . . . 74.11 111.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.88 6.34 88.64 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.997 -0.547 . . . . 75.43 113.441 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -100.83 158.54 15.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.282 0.633 . . . . 70.5 111.511 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.62 130.91 44.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.168 0.587 . . . . 65.54 111.582 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' TYR . 97.2 mttt -66.43 -16.78 64.37 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.345 1.058 . . . . 61.05 112.697 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 29.07 56.22 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.267 -0.333 . . . . 63.42 112.267 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.67 146.23 52.07 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.416 1.086 . . . . 71.24 108.536 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.36 169.58 21.74 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.483 0.549 . . . . 62.52 112.483 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 p -123.56 130.82 53.24 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.982 -0.554 . . . . 54.11 111.089 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -110.1 109.52 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.669 0.788 . . . . 73.42 109.746 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -79.53 104.11 9.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.338 0.255 . . . . 64.03 111.143 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 48.9 m-85 -82.69 163.07 21.58 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 120.842 0.353 . . . . 74.43 110.187 169.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.31 -40.19 52.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.319 0.647 . . . . 74.43 110.836 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 11.7 m-20 -112.61 133.81 21.78 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.156 0.582 . . . . 75.31 111.706 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.17 -41.09 59.3 Favored 'Trans proline' 0 CA--C 1.584 3.015 0 C-N-CA 122.842 2.362 . . . . 63.24 116.028 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 69.8 Cg_endo -71.08 -20.92 28.12 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 122.526 1.938 . . . . 74.21 113.204 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 t -75.77 -39.5 56.92 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.574 0.702 . . . . 75.15 109.451 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.15 -45.17 95.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.056 -0.975 . . . . 70.14 110.623 173.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.1 -46.4 89.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.494 1.118 . . . . 73.34 110.882 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.79 97.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.172 0.589 . . . . 71.35 112.008 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.48 77.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 75.04 112.143 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 95' ' ' VAL . 83.7 mt -64.71 -57.91 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.216 0.607 . . . . 60.22 110.823 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.94 -32.92 68.28 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.11 0.964 . . . . 72.51 111.884 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.78 -54.45 5.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.236 0.615 . . . . 72.32 112.446 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 95' ' ' VAL . 58.8 m-85 -89.34 -6.52 56.61 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.872 1.064 . . . . 71.11 113.872 -171.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.6 124.45 22.39 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.266 0.485 . . . . 75.23 110.085 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.53 -0.84 89.22 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.041 -0.527 . . . . 71.24 114.017 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -97.57 170.5 8.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.537 0.735 . . . . 52.35 110.914 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.08 137.9 50.73 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.114 0.565 . . . . 53.21 111.78 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 93' ' ' ILE . 64.3 t80 -129.29 131.62 47.0 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.813 1.245 . . . . 75.25 108.526 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t 63.33 25.85 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.362 1.065 . . . . 70.31 111.537 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.01 88.1 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-N 116.049 -0.523 . . . . 34.05 113.706 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -115.02 117.24 41.88 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.341 1.056 . . . . 70.54 110.495 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.92 100.74 0.17 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.627 2.218 . . . . 62.43 113.066 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 HD23 ' A' ' 21' ' ' LEU . 40.3 pt -82.64 153.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.92 0.888 . . . . 74.03 113.368 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -114.91 110.25 19.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.076 1.351 . . . . 75.42 109.169 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 18' ' ' VAL . 23.8 t -103.87 131.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 122.151 -0.343 . . . . 63.44 110.096 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.1 p -142.79 179.29 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.608 1.163 . . . . 51.03 109.748 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -77.06 150.07 35.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.487 0.585 . . . . 64.54 110.772 169.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.82 87.94 7.48 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.094 0.473 . . . . 72.32 110.936 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.471 1.108 . . . . 64.3 110.822 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.972 0.415 . . . . 52.32 111.26 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -100.96 128.95 46.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 61.31 110.218 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.1 pt -110.85 151.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.423 0.689 . . . . 73.44 110.892 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -108.0 116.19 31.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.158 0.583 . . . . 72.34 109.724 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.3 t -107.76 142.1 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.251 1.02 . . . . 73.2 110.16 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -122.07 158.88 28.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.851 1.26 . . . . 74.32 110.171 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.55 38.98 95.29 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 114.509 0.563 . . . . 74.22 114.509 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.86 -31.86 27.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.648 1.179 . . . . 61.22 111.691 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.0 159.6 11.98 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 122.748 0.213 . . . . 63.51 113.489 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.71 -14.73 57.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.219 0.608 . . . . 75.41 111.302 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -88.92 3.89 49.87 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.728 0.811 . . . . 60.23 110.995 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.05 136.25 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.631 0.772 . . . . 71.45 111.585 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.7 p -129.05 151.92 49.21 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.945 -0.472 . . . . 62.0 110.194 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 51' ' ' ILE . 75.9 mt -52.8 -45.01 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.239 1.015 . . . . 74.35 112.032 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.82 -31.73 68.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.427 0.691 . . . . 53.24 112.528 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -75.37 -36.77 60.87 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.57 0.348 . . . . 64.24 111.684 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 26' ' ' THR . 63.6 t -65.88 -39.85 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.427 0.632 . . . . 72.11 109.599 172.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.92 99.52 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.913 -1.039 . . . . 73.55 111.65 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.84 -34.86 69.62 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.309 0.644 . . . . 73.34 111.679 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.27 -54.15 9.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.775 0.83 . . . . 75.23 111.508 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 38.6 m-85 -77.29 -18.28 57.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.635 1.346 . . . . 71.03 114.635 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.79 -21.47 64.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.511 1.3 . . . . 73.3 114.511 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -57.64 -26.09 61.11 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.413 0.685 . . . . 54.3 112.388 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 mm -85.65 -45.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 75.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.83 44.3 Favored Glycine 0 C--O 1.241 0.576 0 CA-C-N 116.077 -0.51 . . . . 33.04 113.302 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 122.84 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.555 0.742 . . . . 65.52 110.185 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.8 mt -92.51 124.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.071 -1.085 . . . . 71.11 108.071 173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -50.62 154.81 1.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.068 0.947 . . . . 75.0 112.902 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 87.2 m -137.5 127.25 25.42 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.559 -0.746 . . . . 52.21 110.824 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.34 113.94 4.42 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.686 -0.688 . . . . 63.25 109.417 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -78.01 -13.29 59.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.932 0.893 . . . . 63.35 112.172 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -80.67 -29.38 36.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.039 0.535 . . . . 75.41 112.289 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -103.21 -50.83 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.131 0.573 . . . . 64.3 110.893 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.58 10.64 28.6 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.563 -0.744 . . . . 73.2 112.364 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.63 145.31 30.38 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 64.21 111.637 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.27 145.74 93.31 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.842 2.361 . . . . 51.12 112.47 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 52.3 mtt -73.65 94.0 2.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.799 0.809 . . . . 73.22 109.739 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 27' ' ' ILE . 84.7 mt -145.78 120.93 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.507 -1.224 . . . . 60.34 108.369 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -101.29 110.33 22.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.496 -0.557 . . . . 61.32 109.496 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -78.71 136.09 37.33 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.098 -0.704 . . . . 63.41 109.098 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.2 111.03 22.72 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.253 0.621 . . . . 75.03 110.144 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -86.65 151.65 23.25 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.037 0.535 . . . . 64.13 110.087 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.98 142.19 28.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.914 0.886 . . . . 72.55 110.896 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -37.62 59.71 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.485 -0.779 . . . . 60.14 112.672 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -94.24 -43.85 8.25 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.705 0.402 . . . . 72.2 111.713 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -81.92 -33.71 30.25 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 118.008 0.367 . . . . 63.11 111.864 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.59 13.17 83.21 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 116.239 -0.437 . . . . 73.24 114.167 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -104.1 173.57 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.598 0.759 . . . . 74.15 110.286 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.28 123.31 22.71 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.792 0.33 . . . . 64.01 110.226 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.63 -21.68 66.5 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.125 0.97 . . . . 74.21 113.18 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 23.26 35.66 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 123.178 0.299 . . . . 65.53 112.412 -171.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -121.34 151.05 40.55 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.043 -0.681 . . . . 74.44 109.692 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.78 154.85 24.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 40.32 111.713 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.9 p -109.86 120.59 42.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.62 0.368 . . . . 63.53 110.08 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.67 111.65 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.696 0.798 . . . . 71.22 110.449 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 70.7 m -85.55 105.12 15.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.682 0.393 . . . . 75.2 111.166 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 52.1 m-85 -81.25 153.45 27.13 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.261 0.624 . . . . 64.42 110.074 168.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.29 -28.79 62.29 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.138 0.575 . . . . 74.44 111.233 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.61 127.97 26.35 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 123.72 0.808 . . . . 74.13 111.194 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.92 -34.31 85.63 Favored 'Trans proline' 0 CA--C 1.583 2.973 0 C-N-CA 123.008 2.472 . . . . 63.22 116.277 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.48 -28.06 62.14 Favored 'Trans proline' 0 C--N 1.4 3.284 0 CA-C-N 122.62 1.972 . . . . 64.14 113.39 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 m -75.1 -35.04 61.78 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.114 0.566 . . . . 62.15 110.004 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.33 -53.64 54.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.679 -0.691 . . . . 62.14 111.121 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -59.37 -44.43 92.74 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.936 0.895 . . . . 73.11 110.77 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.88 90.89 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.002 -0.545 . . . . 74.4 111.775 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.42 72.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.245 0.618 . . . . 74.32 112.327 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.45 HG12 HG12 ' A' ' 95' ' ' VAL . 83.0 mt -66.0 -58.37 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.992 0.517 . . . . 71.31 110.398 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.1 -26.21 68.44 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 115.327 -0.851 . . . . 71.53 111.919 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -81.0 -60.42 2.3 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.931 0.492 . . . . 75.24 111.754 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.52 -6.72 58.61 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.87 1.063 . . . . 72.44 113.87 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.39 106.27 0.73 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 118.118 0.417 . . . . 64.54 110.374 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.05 55.33 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.055 0.782 . . . . 72.51 115.055 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.41 -174.35 4.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.03 0.915 . . . . 71.21 110.616 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.6 127.42 37.04 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 122.922 0.489 . . . . 74.12 111.3 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -92.46 -87.91 0.21 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.861 0.464 . . . . 64.41 110.146 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.1 m -89.64 50.58 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.389 0.614 . . . . 72.01 109.907 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.17 4.9 69.64 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.883 -0.599 . . . . 63.53 113.915 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.68 134.09 21.01 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.725 0.81 . . . . 70.54 110.679 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.91 107.07 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.658 2.905 . . . . 53.2 112.672 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.73 143.53 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 N-CA-C 113.164 0.802 . . . . 74.21 113.164 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -118.65 114.86 23.4 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.951 1.301 . . . . 71.51 108.681 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 15.0 t -107.92 141.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.639 0.376 . . . . 61.42 110.584 -174.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 t -148.68 -178.21 6.22 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.329 1.051 . . . . 41.32 110.0 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -76.25 140.62 41.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.849 0.46 . . . . 61.1 110.252 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.24 5.25 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.173 0.511 . . . . 63.21 109.737 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 124.497 1.119 . . . . 71.21 110.857 -171.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.081 0.467 . . . . 63.22 109.924 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -98.64 129.87 45.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.584 0.753 . . . . 72.42 110.463 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.0 pt -110.33 151.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.6 0.76 . . . . 74.12 111.123 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -106.37 119.32 38.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.253 0.621 . . . . 62.02 109.67 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.2 t -112.61 140.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.249 1.02 . . . . 72.24 110.606 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.38 157.06 30.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.362 1.065 . . . . 64.24 110.486 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.64 34.88 42.63 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 115.135 0.814 . . . . 65.45 115.135 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.53 -21.69 28.47 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.269 1.028 . . . . 71.4 112.129 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.25 158.86 30.09 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 116.816 -0.174 . . . . 32.51 112.885 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.158 0.583 . . . . 74.31 112.297 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.96 11.8 23.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.95 0.5 . . . . 64.22 111.491 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.98 138.58 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 123.788 0.835 . . . . 73.54 112.414 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 39.0 p -124.91 153.86 42.01 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.213 0.605 . . . . 74.14 110.461 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 51' ' ' ILE . 79.8 mt -55.67 -42.84 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.741 0.817 . . . . 51.41 111.598 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -33.1 72.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.379 0.672 . . . . 74.42 112.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.3 t -69.9 -42.22 73.68 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.387 0.275 . . . . 62.15 111.025 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 59.8 t -63.89 -42.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.326 0.584 . . . . 72.53 110.072 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.32 82.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.13 -0.941 . . . . 73.01 111.895 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.88 -38.71 92.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 73.54 111.299 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -67.89 -56.36 9.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.356 1.063 . . . . 72.12 111.515 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 85.2 m-85 -78.87 -20.46 49.46 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.212 1.19 . . . . 74.12 114.212 -174.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.77 -23.24 67.28 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.824 1.046 . . . . 74.21 113.824 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -60.49 -24.91 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.181 0.592 . . . . 72.02 112.291 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 mm -82.85 -43.65 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.102 0.961 . . . . 41.51 111.018 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.79 169.17 42.29 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.793 -0.639 . . . . 61.32 112.612 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.39 131.52 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.045 0.538 . . . . 62.11 110.9 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.4 mt -97.69 131.09 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.814 0.846 . . . . 64.33 108.804 173.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 60.1 mtpt -53.65 151.2 6.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.288 0.635 . . . . 65.35 112.194 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.0 m -142.48 127.6 18.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.728 0.811 . . . . 64.31 110.262 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.78 127.8 34.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.711 0.804 . . . . 74.33 110.384 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -31.54 56.64 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.432 0.693 . . . . 72.2 112.287 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -51.45 43.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.966 0.506 . . . . 65.15 111.806 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -82.28 -51.37 7.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.569 0.748 . . . . 74.23 110.899 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.14 10.6 29.58 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.872 -0.603 . . . . 64.41 113.822 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -109.2 147.74 36.58 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 117.724 0.762 . . . . 54.12 112.721 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.7 Cg_endo -68.64 142.72 54.07 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.947 2.431 . . . . 75.1 112.371 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.1 mtt -74.08 95.25 2.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.595 0.712 . . . . 75.31 110.257 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -143.91 120.09 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.687 1.195 . . . . 74.24 108.902 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.74 111.28 23.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.146 0.578 . . . . 74.22 110.005 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.0 mt -86.5 114.37 23.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.643 0.777 . . . . 51.05 110.072 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.9 126.72 31.55 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.528 0.731 . . . . 64.32 111.433 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -99.72 145.3 27.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.604 0.762 . . . . 64.33 110.561 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.67 138.91 36.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.417 0.687 . . . . 74.44 112.334 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.42 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 11.4 ptp180 -64.94 -35.86 82.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.25 1.02 . . . . 75.44 112.64 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 19.5 mm-40 -87.86 -57.02 3.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.263 0.625 . . . . 63.14 111.462 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 p -73.11 -28.54 62.33 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.248 0.833 . . . . 74.03 113.248 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.0 73.32 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 123.358 0.411 . . . . 35.13 113.084 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -122.27 159.42 27.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.921 1.288 . . . . 72.42 109.167 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.52 133.07 55.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.645 0.378 . . . . 70.01 111.736 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -67.12 -14.19 62.66 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.853 0.861 . . . . 74.42 113.048 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.67 35.14 32.98 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.103 -0.799 . . . . 73.22 111.103 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -139.36 138.46 36.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.089 0.956 . . . . 74.25 109.016 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.58 159.11 40.68 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.02 0.438 . . . . 61.14 112.143 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 24.3 p -111.46 123.69 50.74 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.267 -0.424 . . . . 74.3 110.698 172.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.0 110.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.68 0.792 . . . . 74.04 110.371 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 30.9 m -88.6 102.27 14.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.852 0.461 . . . . 62.34 111.276 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 70.5 m-85 -79.3 158.25 27.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.217 0.607 . . . . 75.05 111.363 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.56 -32.08 70.66 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.853 0.861 . . . . 61.32 111.048 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.99 136.77 26.55 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.667 0.787 . . . . 71.41 112.006 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.0 -36.33 95.83 Favored 'Trans proline' 0 CA--C 1.58 2.795 0 C-N-CA 122.768 2.312 . . . . 75.0 116.208 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.09 -26.72 65.43 Favored 'Trans proline' 0 C--N 1.393 2.912 0 CA-C-N 122.816 2.041 . . . . 71.42 113.403 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -71.53 -40.45 70.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 53.14 109.712 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -61.49 -53.62 53.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.125 -0.943 . . . . 63.55 111.296 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.46 -46.51 88.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.752 1.221 . . . . 72.33 111.166 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.74 99.27 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.804 -0.634 . . . . 63.44 111.691 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.57 74.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.923 0.489 . . . . 73.03 112.183 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 95' ' ' VAL . 86.8 mt -62.12 -62.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.892 0.477 . . . . 71.11 110.449 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.59 -31.59 70.73 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.877 0.871 . . . . 74.21 112.578 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -77.54 -53.23 7.85 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.231 0.612 . . . . 71.31 111.964 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.583 ' HB3' HD11 ' A' ' 93' ' ' ILE . 64.7 m-85 -88.41 -7.66 56.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.838 1.051 . . . . 64.13 113.838 -172.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 19.3 t70 -62.21 115.35 4.07 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.126 0.421 . . . . 63.01 110.519 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.68 10.7 72.47 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.592 0.597 . . . . 65.22 114.592 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -101.52 153.43 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.701 0.75 . . . . 54.21 111.698 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.35 127.04 34.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.088 0.555 . . . . 75.32 112.163 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -92.47 -52.75 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.189 0.595 . . . . 73.03 110.852 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -126.01 40.65 3.69 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.963 0.905 . . . . 65.24 110.015 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.6 15.85 80.89 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 115.815 -0.63 . . . . 51.55 112.8 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -136.7 129.28 17.34 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.304 1.042 . . . . 73.52 110.758 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.33 135.26 36.16 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.185 2.59 . . . . 74.01 113.243 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.583 HD11 ' HB3' ' A' ' 83' ' ' PHE . 27.1 pt -104.7 150.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 72.34 112.215 -173.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -114.76 109.9 18.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.764 0.826 . . . . 74.11 108.807 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 7.8 t -108.64 137.59 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 122.813 0.445 . . . . 74.44 110.432 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.9 m -146.07 179.55 7.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.325 1.05 . . . . 71.44 109.458 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -74.62 143.05 44.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.725 -0.472 . . . . 72.2 109.725 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.33 91.89 1.37 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.37 0.605 . . . . 74.02 111.175 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 124.165 0.986 . . . . 71.13 111.102 178.915 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 111.808 0.299 . . . . 74.43 111.808 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.3 m -97.88 125.6 42.85 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.295 0.638 . . . . 71.11 109.819 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.69 140.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.066 0.547 . . . . 71.44 111.175 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -94.79 125.36 39.4 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.939 -0.393 . . . . 43.34 109.939 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 95' ' ' VAL . 23.0 t -118.05 139.64 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.099 0.959 . . . . 72.21 109.82 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -127.58 162.06 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.97 0.908 . . . . 74.14 110.973 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.75 66.93 Favored Glycine 0 N--CA 1.479 1.502 0 O-C-N 123.46 0.475 . . . . 61.14 114.192 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 93' ' ' ILE . 34.3 mt -75.46 -26.5 58.29 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.098 0.959 . . . . 55.43 111.789 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.16 152.15 21.11 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.964 -0.454 . . . . 63.11 111.964 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.99 -3.45 35.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.355 0.872 . . . . 70.53 113.355 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -101.43 18.85 19.07 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.393 0.677 . . . . 72.12 110.522 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 21' ' ' LEU . 11.2 p -71.51 135.59 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 123.264 0.626 . . . . 73.11 112.135 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -127.28 150.73 49.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.573 -0.705 . . . . 72.11 110.901 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.1 mt -52.93 -45.83 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.456 1.102 . . . . 75.2 111.978 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.62 -31.14 67.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.655 0.782 . . . . 72.22 111.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.5 m -71.54 -40.11 70.27 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.759 0.424 . . . . 72.23 111.606 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 26' ' ' THR . 52.3 t -66.45 -36.94 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.896 0.478 . . . . 73.12 110.151 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.27 75.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.605 -0.725 . . . . 64.2 111.344 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.44 -30.97 71.82 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.601 0.76 . . . . 72.11 111.68 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -74.18 -56.46 4.87 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.528 0.731 . . . . 74.34 111.195 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.412 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 23.0 m-85 -77.17 -18.55 57.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.404 1.261 . . . . 54.23 114.404 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -63.42 -20.57 65.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 113.89 1.07 . . . . 55.1 113.89 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.21 -25.32 65.51 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.23 0.612 . . . . 65.14 112.138 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.4 mm -88.36 -48.45 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.241 1.016 . . . . 73.23 111.367 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.0 169.7 39.0 Favored Glycine 0 C--O 1.238 0.353 0 C-N-CA 121.435 -0.412 . . . . 61.21 113.414 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.32 117.21 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.492 0.717 . . . . 61.24 110.329 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.7 mt -86.22 127.86 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -53.26 154.54 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.059 0.944 . . . . 72.15 112.833 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.3 m -132.01 127.0 35.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.953 0.901 . . . . 73.13 110.334 -175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -64.0 119.99 11.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.727 0.811 . . . . 65.32 109.986 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.72 -21.23 64.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.338 1.055 . . . . 74.25 112.529 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -86.53 -43.36 12.79 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.447 0.699 . . . . 62.52 112.037 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 p -89.46 -36.27 15.52 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.924 0.713 . . . . 44.03 112.924 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.43 77.09 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 112.712 -0.155 . . . . 51.44 112.712 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -99.46 151.18 37.34 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.631 1.172 . . . . 73.35 110.919 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.4 145.22 76.62 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.571 2.181 . . . . 52.4 111.436 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 59.3 mtt -74.47 92.26 2.34 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.234 -0.654 . . . . 72.42 109.234 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.621 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.72 117.66 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.781 1.232 . . . . 73.44 108.172 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 30.4 m-80 -104.5 111.58 24.3 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 109.94 -0.393 . . . . 75.11 109.94 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -80.37 128.65 33.81 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.413 0.685 . . . . 74.44 110.053 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 70.4 m-85 -86.1 136.09 33.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.183 0.593 . . . . 74.33 110.708 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -128.82 138.73 52.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.516 1.126 . . . . 62.42 109.614 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.09 110.55 3.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.695 -0.854 . . . . 65.4 108.695 170.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -67.64 -22.52 65.32 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.986 0.515 . . . . 73.35 111.695 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 59' ' ' THR . 8.9 pt-20 -75.85 -48.43 21.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.614 0.766 . . . . 73.15 112.17 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 58' ' ' GLU . 60.5 p -91.61 -33.42 15.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.226 0.61 . . . . 74.51 112.075 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.26 3.1 76.09 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.728 -0.669 . . . . 33.3 113.54 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -93.01 161.28 14.51 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.436 0.618 . . . . 55.44 111.17 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.64 141.51 39.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.139 0.576 . . . . 24.34 111.217 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -78.45 -14.31 59.43 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 70.12 112.134 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.86 37.96 28.36 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.177 -0.369 . . . . 54.12 112.177 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 48.5 mt-10 -130.7 151.37 51.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.896 0.878 . . . . 70.31 109.627 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 141.76 14.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.915 0.486 . . . . 63.35 112.02 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.3 p -101.62 112.92 25.64 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.438 0.295 . . . . 73.34 110.836 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -103.5 110.52 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.014 0.926 . . . . 64.1 110.038 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 47.3 m -87.86 107.08 18.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.843 0.457 . . . . 41.15 111.012 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.412 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 46.1 m-85 -83.12 157.11 22.94 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.217 0.532 . . . . 74.52 110.352 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.68 -34.43 75.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.78 0.832 . . . . 74.31 110.684 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -118.51 134.12 23.49 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.399 0.68 . . . . 41.23 111.033 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.62 -36.56 89.79 Favored 'Trans proline' 0 CA--C 1.582 2.888 0 C-N-CA 122.517 2.144 . . . . 52.12 116.225 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.85 -32.81 77.2 Favored 'Trans proline' 0 C--N 1.397 3.125 0 CA-C-N 122.8 2.036 . . . . 53.13 114.107 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.7 p -78.13 -33.25 50.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.09 0.556 . . . . 73.4 110.394 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.27 74.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.171 0.588 . . . . 60.13 111.205 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -61.87 -40.52 95.64 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.287 1.035 . . . . 73.01 110.796 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.97 94.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.776 -0.647 . . . . 72.52 111.872 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.06 -27.11 68.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.133 0.573 . . . . 55.45 112.408 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.1 mt -64.36 -63.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.519 0.328 . . . . 73.33 110.615 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.0 -28.16 66.11 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.672 0.789 . . . . 42.44 112.005 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.52 -61.01 2.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.117 0.567 . . . . 74.2 111.63 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 93' ' ' ILE . 72.8 m-85 -82.72 -10.83 58.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.162 1.171 . . . . 74.24 114.162 -169.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.53 94.13 0.27 Allowed 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 109.025 -0.732 . . . . 71.43 109.025 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.76 -12.65 11.85 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.195 -0.911 . . . . 43.14 114.444 -174.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 93' ' ' ILE . 49.0 mmtm -81.56 140.54 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.941 0.871 . . . . 72.03 110.612 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.9 121.19 31.01 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.148 -0.345 . . . . 73.04 111.842 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -83.95 -80.96 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.109 0.564 . . . . 72.12 109.719 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -104.33 57.03 0.71 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.501 0.667 . . . . 60.32 110.126 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 9.29 84.88 Favored Glycine 0 N--CA 1.48 1.62 0 CA-C-N 115.682 -0.69 . . . . 72.13 114.201 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -126.03 126.47 24.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 123.984 0.914 . . . . 72.45 110.534 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.15 108.62 1.37 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.796 2.33 . . . . 65.2 112.018 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 83' ' ' PHE . 11.3 pt -77.89 152.51 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.411 0.685 . . . . 72.42 111.872 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -116.87 120.49 38.65 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.811 -0.811 . . . . 75.13 108.811 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 18' ' ' VAL . 21.6 t -116.0 136.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 122.751 0.42 . . . . 73.52 110.955 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 t -147.29 176.63 9.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.469 1.508 . . . . 62.32 108.703 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -71.98 145.54 48.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.389 0.54 . . . . 75.33 111.094 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.63 76.32 10.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 75.13 109.9 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.635 0.774 . . . . 64.43 111.317 -178.125 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.284 0.476 . . . . 73.55 112.284 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -95.28 137.89 33.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.054 0.541 . . . . 74.44 109.947 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 pt -113.89 148.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.842 -0.536 . . . . 52.14 111.184 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.5 113.95 27.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.614 -0.513 . . . . 72.32 109.614 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 95' ' ' VAL . 11.0 t -105.63 132.78 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.037 0.935 . . . . 73.15 109.639 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.58 162.39 18.07 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.855 0.862 . . . . 72.44 109.824 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.71 68.44 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 114.424 0.53 . . . . 74.22 114.424 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 18' ' ' VAL . 32.3 mt -80.24 -17.55 51.95 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.857 1.263 . . . . 74.55 112.459 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.65 173.5 46.93 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.967 0.747 . . . . 52.21 114.967 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.98 -13.4 60.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.28 1.032 . . . . 64.05 112.723 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -93.19 11.32 28.28 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.922 0.889 . . . . 72.35 111.545 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.07 129.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 O-C-N 121.429 -0.794 . . . . 61.43 112.801 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -132.87 158.86 41.49 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.326 0.65 . . . . 70.21 110.475 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -51.88 -51.21 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.967 0.907 . . . . 75.34 111.593 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.06 -32.13 68.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.598 0.759 . . . . 74.33 112.891 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -72.06 -42.25 66.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.109 0.163 . . . . 74.43 111.004 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.86 -43.08 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 120.853 0.358 . . . . 64.52 110.445 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.71 87.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.891 -0.595 . . . . 24.42 112.242 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.06 -27.69 66.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.753 0.421 . . . . 60.44 111.282 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.38 -50.36 27.13 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 63.45 110.43 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 18.7 m-85 -82.81 -19.68 37.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.339 1.236 . . . . 72.3 114.339 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -67.1 -18.31 65.26 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 113.385 0.883 . . . . 62.53 113.385 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.78 -25.97 65.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.538 0.735 . . . . 62.54 111.799 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.5 mm -83.2 -38.7 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.376 1.07 . . . . 73.15 111.381 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.12 -179.81 48.24 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.172 -0.467 . . . . 71.2 113.156 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.7 120.13 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.178 0.591 . . . . 63.05 110.878 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 79.3 mt -93.85 123.78 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.362 0.665 . . . . 72.52 109.692 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 48.3 mtpt -48.61 146.85 2.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.157 0.983 . . . . 73.31 112.446 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 89.5 m -140.0 123.55 17.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.546 0.738 . . . . 73.33 110.717 -170.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -63.25 126.06 26.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.677 0.791 . . . . 65.13 109.719 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.36 -37.54 37.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.283 0.633 . . . . 74.44 111.973 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.32 -50.16 71.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.183 0.593 . . . . 75.13 111.29 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.7 p -79.43 -37.21 37.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.736 0.415 . . . . 60.42 111.344 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.58 63.91 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 116.379 -0.373 . . . . 23.13 112.464 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -111.15 144.31 30.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 123.93 0.892 . . . . 74.44 112.173 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 21.6 Cg_endo -61.35 139.17 81.26 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.81 2.34 . . . . 71.14 112.291 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 48.6 mtt -71.75 96.4 1.61 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.238 0.542 . . . . 72.25 110.112 -170.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 67' ' ' THR . 60.7 mt -141.12 126.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.434 1.093 . . . . 65.13 109.173 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.0 m-20 -103.1 110.43 22.37 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.994 -0.743 . . . . 62.23 108.994 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -89.24 116.68 27.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 72.32 110.287 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -82.68 118.54 23.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.532 0.733 . . . . 62.3 110.744 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -106.65 148.92 27.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.368 1.067 . . . . 72.55 110.479 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.57 136.72 35.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.121 0.568 . . . . 64.34 110.949 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -72.66 -29.81 63.75 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.75 0.82 . . . . 63.14 112.627 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -84.89 -61.15 1.85 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.052 0.541 . . . . 64.2 111.023 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 p -76.77 -31.23 56.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.747 0.819 . . . . 71.11 112.092 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.58 2.03 90.58 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 116.376 -0.375 . . . . 74.1 113.458 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -84.75 151.78 24.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.696 0.799 . . . . 55.14 111.025 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 mt -67.2 129.86 41.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.92 -0.582 . . . . 71.02 109.679 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -72.78 -9.39 58.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.301 0.64 . . . . 75.02 112.281 -173.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.35 40.97 31.95 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.268 -0.733 . . . . 33.33 111.268 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -142.54 138.13 30.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.866 0.866 . . . . 64.11 109.099 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.0 152.62 24.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.846 0.458 . . . . 22.12 111.657 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -111.97 120.56 42.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 116.216 -0.447 . . . . 75.15 111.185 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.08 111.16 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.651 1.181 . . . . 61.45 110.295 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.3 t -83.96 108.94 17.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.462 0.305 . . . . 73.34 110.9 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 44.3 m-85 -85.5 160.04 19.78 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.131 0.491 . . . . 73.23 110.501 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.23 -37.87 57.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.291 0.636 . . . . 72.52 110.485 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -116.38 129.81 24.96 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.518 0.727 . . . . 63.14 110.606 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.55 -35.45 56.23 Favored 'Trans proline' 0 CA--C 1.579 2.765 0 C-N-CA 123.09 2.527 . . . . 73.24 116.668 169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.5 -32.94 97.08 Favored 'Trans proline' 0 C--N 1.395 3.017 0 CA-C-N 122.843 2.051 . . . . 70.12 113.313 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -71.84 -38.55 70.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.215 0.606 . . . . 65.43 110.297 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.77 53.82 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.391 -0.822 . . . . 63.24 110.969 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.46 -40.48 97.24 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.474 1.11 . . . . 65.2 111.717 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.91 97.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 61.14 112.041 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.67 71.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.253 0.621 . . . . 74.25 111.993 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 95' ' ' VAL . 75.2 mt -63.43 -62.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.969 0.508 . . . . 71.02 110.464 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.65 -32.07 66.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.672 0.789 . . . . 50.01 112.321 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -77.77 -55.3 5.45 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.033 0.533 . . . . 74.04 112.228 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HB3' HD11 ' A' ' 93' ' ' ILE . 73.9 m-85 -88.57 -15.67 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.47 118.45 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.347 0.521 . . . . 73.1 110.271 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.09 -1.79 78.04 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.824 0.69 . . . . 74.0 114.824 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.97 173.57 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.45 0.625 . . . . 71.42 111.139 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -107.61 106.74 17.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.088 0.555 . . . . 75.23 111.268 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -86.0 113.57 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.235 -1.024 . . . . 72.14 108.235 168.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t 61.01 24.5 14.6 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.303 0.641 . . . . 65.42 111.872 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.19 76.89 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 123.169 0.414 . . . . 70.54 113.969 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.51 126.01 45.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.84 0.856 . . . . 64.14 111.024 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.81 100.95 1.4 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.411 2.074 . . . . 74.45 112.226 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.5 pt -85.49 154.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 113.557 0.947 . . . . 72.32 113.557 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -126.13 113.83 17.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.746 1.218 . . . . 72.33 109.075 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.605 HG22 HG13 ' A' ' 18' ' ' VAL . 15.5 t -104.53 138.88 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.571 0.348 . . . . 71.21 110.615 -172.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.4 m -144.25 -178.7 6.09 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 72.31 109.48 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.52 147.88 37.47 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.436 0.562 . . . . 75.11 110.734 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.11 83.63 4.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.022 -0.732 . . . . 70.54 109.022 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.527 0 C-N-CA 124.001 0.92 . . . . 72.4 111.563 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.717 0.294 . . . . 71.22 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 m -104.01 127.77 51.58 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.696 0.798 . . . . 41.24 109.698 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.1 pt -109.43 154.26 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.775 0.83 . . . . 74.22 111.279 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -109.08 121.97 46.27 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.858 0.863 . . . . 71.35 109.954 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 95' ' ' VAL . 19.8 t -118.03 140.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.535 1.134 . . . . 73.0 110.253 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.01 158.03 34.69 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.983 0.913 . . . . 73.11 110.525 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.17 35.43 43.48 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 114.602 0.601 . . . . 44.1 114.602 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 93' ' ' ILE . 65.3 mt -80.57 -34.16 35.55 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.074 0.95 . . . . 73.24 112.321 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 153.06 8.58 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.087 -0.405 . . . . 72.53 112.087 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.33 -1.93 43.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.989 0.737 . . . . 62.22 112.989 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -120.82 29.93 7.14 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.332 0.653 . . . . 74.33 110.142 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.41 136.95 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 123.44 0.696 . . . . 62.22 111.682 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 30' ' ' VAL . 42.7 p -122.48 151.13 41.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 74.24 110.521 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.7 mt -53.43 -41.16 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.663 0.785 . . . . 74.34 111.091 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.42 -40.42 93.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.341 0.656 . . . . 74.1 112.404 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.5 p -72.31 -38.27 68.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.288 0.235 . . . . 71.01 111.52 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 41.3 t -65.41 -40.52 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.163 0.506 . . . . 54.32 110.195 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.273 -0.876 . . . . 74.22 112.371 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.78 -32.25 72.7 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.374 0.669 . . . . 61.24 111.207 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -76.65 -49.83 15.23 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.013 -0.54 . . . . 73.15 111.158 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 18.4 m-85 -80.48 -17.91 50.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.147 1.166 . . . . 71.04 114.147 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.99 -21.69 66.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.269 0.841 . . . . 74.43 113.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.22 -28.72 59.36 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.581 0.752 . . . . 73.43 112.153 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -82.32 -42.67 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 72.23 111.445 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.94 -178.92 47.06 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.392 -0.367 . . . . 70.35 113.326 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.49 119.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.068 0.547 . . . . 60.33 110.747 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.5 mt -87.2 125.29 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.888 -0.782 . . . . 63.11 108.888 173.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 53.7 mtpt -48.41 131.9 16.83 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.661 0.784 . . . . 71.21 112.184 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 53.5 m -116.17 123.17 47.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 72.41 110.709 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -63.68 119.0 9.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.72 0.808 . . . . 61.33 109.132 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -76.37 -27.16 56.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 73.02 111.586 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -72.97 -43.44 62.25 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.427 0.691 . . . . 64.15 111.615 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -84.52 -36.54 22.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.019 0.527 . . . . 74.15 111.411 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.6 66.41 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 115.799 -0.637 . . . . 73.05 112.415 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.05 157.74 47.89 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.41 1.084 . . . . 74.5 111.665 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 60.6 Cg_endo -69.83 155.33 65.97 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.489 2.126 . . . . 74.2 113.002 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.441 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.1 mtt -83.41 94.85 8.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.718 0.807 . . . . 75.41 109.186 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 89.3 mt -142.18 117.95 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.765 -1.107 . . . . 61.22 108.799 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.12 107.5 20.04 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.758 -0.83 . . . . 64.41 108.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.1 mt -77.03 150.29 35.8 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.914 -0.772 . . . . 73.1 108.914 172.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.83 128.61 55.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.805 0.442 . . . . 71.41 110.654 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -115.08 139.63 49.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.252 1.021 . . . . 73.03 110.259 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -66.45 128.19 35.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.767 0.827 . . . . 71.14 110.798 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -62.98 -34.66 77.99 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.52 0.328 . . . . 73.14 110.744 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -76.72 -58.08 3.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.454 0.702 . . . . 71.51 111.809 -172.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.4 p -81.37 -29.24 34.09 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.498 0.555 . . . . 62.42 112.498 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.39 5.96 86.09 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 116.57 -0.286 . . . . 64.42 113.208 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -96.77 167.9 10.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.109 0.963 . . . . 64.21 109.721 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.1 mt -75.3 137.7 41.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.71 0.291 . . . . 71.3 110.512 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 6.6 mtpm? -67.82 -28.37 67.51 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.807 -0.633 . . . . 74.2 112.269 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.0 23.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.919 -0.582 . . . . 74.51 113.736 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -116.98 156.38 27.56 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.734 0.767 . . . . 71.4 110.228 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.14 149.81 14.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.429 0.692 . . . . 73.03 111.489 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 39.4 p -106.71 126.04 51.78 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.866 0.466 . . . . 53.53 110.498 172.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.56 110.99 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.526 0.73 . . . . 45.02 110.428 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 25.2 m -85.41 103.23 14.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.338 0.255 . . . . 54.52 111.071 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 63.7 m-85 -82.69 162.15 21.9 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.1 110.742 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.1 -40.19 62.88 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.62 -0.718 . . . . 61.34 110.929 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 26.7 m-20 -109.92 134.37 20.69 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.923 0.489 . . . . 75.24 112.049 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.09 -42.75 51.8 Favored 'Trans proline' 0 CA--C 1.581 2.837 0 C-N-CA 122.932 2.421 . . . . 72.23 116.199 168.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 59.6 Cg_endo -68.38 -24.12 37.33 Favored 'Trans proline' 0 C--N 1.398 3.157 0 CA-C-N 122.237 1.835 . . . . 73.24 112.713 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -71.3 -43.27 67.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.487 0.66 . . . . 55.4 109.787 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.93 -42.37 90.19 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.334 -0.848 . . . . 34.52 111.342 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -62.82 -43.36 99.0 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.78 0.832 . . . . 70.32 110.707 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.99 89.43 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.847 -0.615 . . . . 73.1 111.492 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.45 70.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.075 0.55 . . . . 73.51 112.003 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 95' ' ' VAL . 62.4 mt -68.4 -60.07 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.207 0.203 . . . . 72.02 110.478 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.37 -25.95 64.69 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.198 0.599 . . . . 73.51 111.871 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -82.68 -62.48 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.567 0.347 . . . . 74.41 111.811 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 95' ' ' VAL . 79.0 m-85 -80.52 -15.52 56.48 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.955 1.095 . . . . 73.01 113.955 -168.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.14 106.72 3.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.48 -0.563 . . . . 55.24 109.48 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.56 35.39 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 115.338 -0.847 . . . . 73.42 114.218 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -83.29 -177.04 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.466 0.633 . . . . 65.34 111.743 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -121.03 120.44 35.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.857 . . . . 73.43 109.843 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 93' ' ' ILE . 86.2 t80 -68.52 -69.5 0.32 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.097 0.559 . . . . 74.52 111.082 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.9 t -133.62 69.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.939 0.896 . . . . 70.35 109.167 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.87 -2.95 38.95 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.122 -0.945 . . . . 51.35 114.193 -172.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -115.87 125.89 28.22 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 124.262 1.025 . . . . 65.01 111.03 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.4 130.18 29.3 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.096 2.531 . . . . 74.45 112.742 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' PHE . 30.5 pt -116.4 144.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 121.908 0.861 . . . . 75.45 112.702 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -114.2 121.36 43.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.947 -1.501 . . . . 73.45 106.947 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 80' ' ' ILE . 25.8 t -113.85 138.71 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.258 0.551 . . . . 71.51 110.692 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.5 p -148.88 179.41 7.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.03 1.332 . . . . 64.05 109.481 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -78.37 145.1 35.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 118.526 0.603 . . . . 73.54 111.592 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.37 113.48 24.79 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.563 1.467 0 C-N-CA 123.153 0.581 . . . . 64.45 111.724 -176.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 120.713 0.292 . . . . 73.02 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -102.98 130.51 50.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.391 0.676 . . . . 64.41 109.509 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.22 138.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.23 0.612 . . . . 72.22 111.958 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -94.56 117.21 29.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.106 0.479 . . . . 75.03 110.469 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 95' ' ' VAL . 12.5 t -113.39 138.81 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.466 1.106 . . . . 75.3 110.279 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.95 162.57 22.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.343 1.057 . . . . 72.32 110.11 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.14 65.51 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 114.506 0.562 . . . . 70.23 114.506 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 25' ' ' VAL . 81.9 mt -72.34 -36.03 68.72 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.067 0.947 . . . . 73.43 111.879 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.27 158.07 11.68 Favored Glycine 0 N--CA 1.476 1.352 0 C-N-CA 123.219 0.438 . . . . 64.51 112.556 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.86 -19.43 61.96 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.015 0.908 . . . . 62.32 112.719 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -89.53 7.29 37.03 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.029 0.932 . . . . 75.43 111.323 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 21' ' ' LEU . 9.9 p -69.72 134.32 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.354 0.662 . . . . 62.14 112.444 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.0 p -120.4 163.05 18.48 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.016 -0.427 . . . . 65.23 110.007 171.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 51' ' ' ILE . 80.5 mt -57.83 -42.4 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 123.917 0.887 . . . . 74.54 111.5 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.41 -30.04 65.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.474 0.71 . . . . 74.41 111.776 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -45.85 81.53 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.783 0.433 . . . . 55.34 110.877 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' THR . 21.5 t -64.88 -40.84 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 121.19 0.519 . . . . 50.04 110.225 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.58 88.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.34 -0.846 . . . . 53.43 111.744 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.88 -40.33 97.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.027 0.931 . . . . 71.22 111.582 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.31 -48.19 44.03 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.379 -0.828 . . . . 75.1 110.89 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.38 -19.57 35.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.548 1.314 . . . . 72.52 114.548 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.44 -16.61 63.81 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.835 1.05 . . . . 72.34 113.835 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -61.41 -29.18 69.77 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.089 0.555 . . . . 74.44 111.772 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.17 -42.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.057 0.943 . . . . 74.32 111.189 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.62 171.67 42.81 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 116.358 -0.383 . . . . 45.45 113.04 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.84 123.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.826 -0.435 . . . . 73.25 109.826 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.4 mt -93.97 129.76 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.99 0.916 . . . . 61.42 108.796 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.0 mtpt -51.04 140.51 15.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 64.14 112.311 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 56.0 m -128.45 121.81 29.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.181 -0.918 . . . . 62.04 109.829 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -57.63 119.57 6.83 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.208 1.003 . . . . 65.44 110.565 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -76.09 -16.94 59.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.704 0.802 . . . . 72.31 112.839 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -82.08 -52.29 7.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.649 0.379 . . . . 64.43 110.803 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -80.46 -46.62 15.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.25 0.62 . . . . 64.52 111.587 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.31 15.65 40.44 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.979 -0.555 . . . . 71.52 112.633 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -107.87 148.84 38.16 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.24 1.016 . . . . 54.4 111.827 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -67.75 149.88 78.82 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.409 2.073 . . . . 73.52 112.182 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.504 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 49.4 mtt -81.94 94.34 7.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.619 0.723 . . . . 75.43 109.67 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.7 mt -145.88 117.56 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.501 1.121 . . . . 62.34 108.693 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 78.9 m-20 -96.88 109.38 22.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.67 -0.493 . . . . 73.43 109.67 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.01 150.19 39.04 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.554 0.534 . . . . 74.22 109.856 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 46.9 m-85 -107.65 132.28 53.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.275 0.63 . . . . 75.14 109.952 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -133.99 142.88 47.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.725 0.81 . . . . 73.21 110.042 -174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -76.67 114.83 15.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.798 0.439 . . . . 74.14 109.827 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -71.72 -8.03 51.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.293 0.637 . . . . 64.22 112.471 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.35 -56.27 4.46 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.392 0.677 . . . . 54.05 110.888 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 p -96.93 -21.13 17.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.733 0.813 . . . . 53.21 112.556 -173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 12.64 83.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 120.056 -0.302 . . . . 71.33 113.751 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -97.22 147.89 23.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.47 0.708 . . . . 75.2 111.588 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.81 138.32 56.05 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.103 0.561 . . . . 70.21 111.541 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -77.47 -17.23 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.342 0.657 . . . . 72.32 111.579 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.08 24.34 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.333 0.396 . . . . 62.21 112.33 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 46.8 mt-10 -135.25 153.05 52.05 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.916 0.886 . . . . 50.1 109.74 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.33 156.27 23.69 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.471 0.545 . . . . 55.01 112.471 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 69.5 p -113.87 118.57 34.57 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 122.745 0.418 . . . . 61.32 110.676 171.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.52 107.96 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.888 0.875 . . . . 75.11 111.025 -170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -83.82 102.65 12.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.716 0.407 . . . . 75.31 111.521 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 53.3 m-85 -79.81 149.86 30.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.403 0.681 . . . . 71.52 110.686 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.03 -32.75 57.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.395 0.678 . . . . 73.21 110.573 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.77 127.39 37.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.15 0.58 . . . . 72.31 110.473 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.31 -48.36 18.92 Favored 'Trans proline' 0 CA--C 1.581 2.874 0 C-N-CA 122.602 2.201 . . . . 73.12 115.532 170.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.85 -19.32 27.34 Favored 'Trans proline' 0 C--N 1.398 3.149 0 CA-C-N 122.2 1.821 . . . . 75.31 113.609 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -69.37 -33.67 73.41 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.222 0.609 . . . . 72.21 111.211 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.29 56.01 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.925 -0.579 . . . . 64.33 111.466 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.585 0.754 . . . . 71.31 111.092 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.78 94.21 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.102 0.561 . . . . 71.2 111.796 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.53 67.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 74.1 112.699 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.491 HG12 HG12 ' A' ' 95' ' ' VAL . 82.2 mt -66.86 -58.38 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 120.899 0.381 . . . . 74.24 110.054 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.99 -27.79 69.11 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.434 -0.803 . . . . 72.4 112.166 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -81.5 -62.3 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.612 0.365 . . . . 71.42 111.344 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' HD11 ' A' ' 93' ' ' ILE . 66.8 m-85 -79.51 -11.73 59.89 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.282 1.215 . . . . 70.25 114.282 -168.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.42 111.06 1.86 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 118.508 0.595 . . . . 74.32 110.362 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.57 60.0 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 115.128 0.811 . . . . 53.15 115.128 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.3 mmtt -86.74 161.56 18.33 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 118.43 1.115 . . . . 71.21 111.105 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -99.23 119.92 38.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 75.24 111.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -84.21 -77.69 0.26 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.903 0.481 . . . . 72.53 110.222 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -118.13 75.48 1.01 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.46 0.704 . . . . 73.4 110.078 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.21 1.03 59.21 Favored Glycine 0 CA--C 1.54 1.652 0 N-CA-C 115.061 0.784 . . . . 75.21 115.061 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -132.9 138.01 30.92 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.483 0.713 . . . . 74.51 110.983 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.96 140.6 55.33 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.695 2.264 . . . . 70.01 111.975 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 83' ' ' PHE . 19.6 pt -110.38 152.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.223 0.609 . . . . 71.21 111.707 -171.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -118.18 114.76 23.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.461 0.704 . . . . 62.33 109.567 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 18' ' ' VAL . 15.9 t -109.22 133.45 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.606 0.362 . . . . 75.03 110.244 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.2 t -145.42 -178.67 6.2 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.455 1.102 . . . . 53.2 109.494 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.84 134.9 38.91 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.858 -0.526 . . . . 72.34 110.815 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 86.53 6.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.852 0.461 . . . . 72.12 110.548 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.221 1.008 . . . . 73.31 110.951 -178.884 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.488 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.533 0.568 . . . . 72.0 112.533 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -93.87 132.08 38.64 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.051 0.54 . . . . 65.03 110.774 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 29.1 pt -113.23 147.92 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.64 . . . . 71.53 111.263 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -108.84 115.63 30.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.56 0.744 . . . . 75.54 110.426 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 t -111.75 143.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.831 0.852 . . . . 71.24 110.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.79 155.11 47.24 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.011 0.925 . . . . 72.41 111.484 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.72 24.64 37.93 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 114.367 0.507 . . . . 53.23 114.367 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.7 -16.28 51.75 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.934 0.894 . . . . 74.2 112.837 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.99 158.65 29.35 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 120.947 0.193 . . . . 73.04 113.444 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.91 -5.25 55.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.482 0.713 . . . . 74.21 112.857 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.18 18.74 19.05 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.818 0.847 . . . . 74.15 111.257 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.24 144.61 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.276 0.631 . . . . 71.25 112.318 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -124.09 154.62 39.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.196 0.598 . . . . 65.31 111.103 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.3 mt -55.45 -39.26 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.893 0.877 . . . . 74.34 110.881 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.055 0.942 . . . . 74.0 111.843 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -72.22 -40.91 67.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.513 0.325 . . . . 73.23 111.223 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.07 -42.08 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.082 0.468 . . . . 62.33 110.171 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.47 91.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.521 0.729 . . . . 73.32 111.808 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.96 -33.03 74.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.5 0.72 . . . . 72.35 110.764 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -71.04 -55.48 8.18 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.052 0.941 . . . . 74.12 111.085 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -81.51 -19.3 42.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.477 1.288 . . . . 73.12 114.477 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -61.35 -26.21 67.66 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.695 0.998 . . . . 74.12 113.695 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -61.72 -24.34 66.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.374 0.669 . . . . 72.01 112.323 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.9 mm -83.13 -50.95 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.992 0.917 . . . . 75.15 111.344 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 75' ' ' SER . . . -161.73 168.61 36.93 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.683 -0.69 . . . . 45.55 113.674 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.65 110.41 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.384 0.674 . . . . 74.55 110.669 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.1 mt -80.9 131.84 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 108.444 -0.947 . . . . 73.44 108.444 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.46 124.96 14.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.261 0.624 . . . . 73.21 111.085 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 30.6 m -113.43 120.15 40.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.643 -0.708 . . . . 74.44 110.487 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -60.93 108.77 0.91 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.59 -27.59 62.27 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.398 0.679 . . . . 71.33 111.994 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -62.16 -50.17 72.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.716 0.806 . . . . 65.2 111.48 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -86.51 -40.27 15.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.383 0.673 . . . . 72.53 111.077 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 1.62 50.12 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.861 -0.609 . . . . 54.03 112.718 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -104.89 151.52 39.42 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 124.134 0.974 . . . . 64.32 112.444 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 72.9 Cg_endo -72.18 155.48 56.46 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.761 2.307 . . . . 51.33 112.712 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.7 mtt -83.77 95.17 8.34 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.47 0.652 . . . . 73.14 109.962 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.6 mt -142.59 124.49 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.442 1.097 . . . . 70.23 109.117 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 15.3 m120 -106.18 109.84 21.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.883 0.473 . . . . 74.51 110.085 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 66' ' ' ALA . 88.5 mt -83.63 124.92 31.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.684 0.794 . . . . 60.25 109.601 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 94.0 m-85 -83.02 125.77 31.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.917 0.487 . . . . 75.23 111.149 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 9.9 m -112.23 142.16 45.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.783 0.833 . . . . 75.42 109.845 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.7 129.7 37.52 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.924 0.489 . . . . 75.31 110.454 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -70.59 -27.86 64.43 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.3 1.04 . . . . 73.31 112.384 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -85.86 -50.57 7.02 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.318 0.647 . . . . 63.42 112.025 -175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.5 p -83.16 -30.8 27.54 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.566 0.746 . . . . 72.4 112.111 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.28 9.69 85.66 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 116.229 -0.441 . . . . 70.12 113.872 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -109.41 154.75 22.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.224 0.61 . . . . 54.12 110.966 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 mt -62.18 136.47 57.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.421 0.688 . . . . 73.51 111.921 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -73.34 -12.74 60.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.797 0.839 . . . . 74.3 111.918 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.65 42.44 21.58 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.827 -0.509 . . . . 44.24 111.827 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 50.6 mt-10 -131.81 147.93 52.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.915 0.886 . . . . 74.21 109.722 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -153.18 139.46 18.48 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.196 0.443 . . . . 73.11 112.196 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.8 p -101.25 119.5 38.85 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.844 -0.428 . . . . 75.24 109.844 169.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.3 t -109.24 108.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.631 0.772 . . . . 74.52 110.383 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 66.2 m -81.02 104.93 11.85 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.6 0.36 . . . . 65.41 111.117 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -82.1 157.56 24.04 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.94 0.496 . . . . 73.33 110.463 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.44 -37.66 60.21 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.999 0.52 . . . . 75.4 110.027 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -111.91 122.25 37.49 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.918 0.887 . . . . 63.45 110.261 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.53 -34.63 73.34 Favored 'Trans proline' 0 CA--C 1.583 2.939 0 C-N-CA 122.554 2.17 . . . . 75.31 116.565 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.61 -30.41 79.06 Favored 'Trans proline' 0 C--N 1.397 3.114 0 CA-C-N 122.687 1.995 . . . . 74.02 113.209 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.404 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 36.7 m -73.77 -35.74 65.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.038 0.446 . . . . 64.32 110.503 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.29 -50.09 74.42 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.434 -0.803 . . . . 62.02 111.285 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.25 -40.94 98.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.503 0.721 . . . . 61.14 111.161 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.34 98.99 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.965 -0.562 . . . . 64.24 111.813 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.44 75.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.447 0.699 . . . . 55.1 112.145 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 95' ' ' VAL . 69.7 mt -66.81 -56.95 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.599 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.44 -31.01 67.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.644 0.778 . . . . 73.13 111.876 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -80.55 -58.21 3.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.78 0.832 . . . . 72.45 111.993 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -85.24 -10.19 56.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.382 1.253 . . . . 73.23 114.382 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.08 119.28 11.75 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 118.575 0.625 . . . . 75.2 110.45 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.02 1.85 84.34 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.456 -0.793 . . . . 54.21 114.45 -175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.94 173.26 8.59 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 117.623 0.711 . . . . 71.11 110.793 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.33 122.95 48.03 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.105 -0.372 . . . . 71.22 111.718 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -92.99 -67.44 0.86 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.621 0.769 . . . . 74.33 110.028 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -112.95 50.09 0.9 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.695 0.798 . . . . 63.03 109.886 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 115.456 -0.793 . . . . 73.21 113.678 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -122.32 130.23 24.77 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.355 1.062 . . . . 63.23 110.387 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.2 94.0 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.53 2.153 . . . . 74.22 111.804 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.2 pt -71.33 155.34 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.977 0.911 . . . . 75.33 112.506 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -118.82 122.16 41.73 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.188 -1.042 . . . . 71.51 108.188 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.587 HG12 HG12 ' A' ' 80' ' ' ILE . 11.2 t -109.29 133.08 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.196 0.522 . . . . 73.45 110.002 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -133.05 -178.03 4.78 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.148 1.379 . . . . 44.0 109.019 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 32.7 m-85 -90.67 151.2 21.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 122.097 -0.377 . . . . 70.22 110.736 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.18 82.87 2.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.554 0.741 . . . . 51.53 109.216 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 115.695 -0.684 . . . . 53.34 112.34 -172.188 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.988 0 CA-C-O 120.508 0.194 . . . . 72.34 111.229 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -108.65 126.21 52.73 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.615 0.766 . . . . 73.33 110.142 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.8 pt -105.5 157.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.681 0.792 . . . . 74.01 110.842 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -116.72 115.11 25.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.447 0.699 . . . . 74.43 110.095 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -104.98 145.02 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 124.401 1.08 . . . . 75.02 110.184 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.44 157.57 36.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.361 1.064 . . . . 73.35 110.056 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.12 41.7 92.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 115.233 0.853 . . . . 74.32 115.233 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.408 HD23 HG21 ' A' ' 93' ' ' ILE . 41.4 mt -81.82 -32.51 31.21 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.162 0.985 . . . . 61.21 111.639 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.76 161.26 11.7 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-N 116.182 -0.463 . . . . 65.54 112.619 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.48 -5.86 57.98 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.296 0.638 . . . . 73.2 112.064 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -94.54 14.0 22.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.506 0.723 . . . . 63.22 111.381 173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 p -75.42 138.53 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.421 0.688 . . . . 53.15 112.444 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.6 p -131.33 148.76 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.531 0.732 . . . . 54.44 110.947 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 51' ' ' ILE . 69.7 mt -51.66 -49.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.942 1.297 . . . . 65.24 112.893 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.91 -32.27 73.68 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 122.904 0.482 . . . . 71.41 111.935 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -74.37 -39.13 62.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.413 0.685 . . . . 73.24 111.536 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 42.7 t -63.97 -43.04 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 73.33 109.86 173.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.9 95.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.874 -1.057 . . . . 54.41 111.616 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 -34.17 77.67 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.634 0.773 . . . . 74.44 111.883 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.16 -53.51 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.881 0.472 . . . . 62.54 111.189 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 35.7 m-85 -77.87 -16.19 58.45 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.222 1.193 . . . . 75.3 114.222 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.19 -18.64 65.48 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.054 1.131 . . . . 61.41 114.054 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.02 -30.99 68.42 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.324 0.65 . . . . 75.22 111.914 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.59 -48.78 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.022 0.929 . . . . 70.42 110.896 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.7 173.18 40.59 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.426 -0.806 . . . . 50.14 112.695 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.88 127.83 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 122.989 0.516 . . . . 62.42 110.735 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.0 mt -97.54 134.79 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.637 0.775 . . . . 73.35 109.089 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 59.2 mtpt -62.22 155.64 24.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.457 0.703 . . . . 73.12 112.02 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 84.8 m -137.15 122.12 18.94 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.328 -0.851 . . . . 64.22 110.467 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -61.21 114.7 3.3 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.575 1.15 . . . . 43.25 109.47 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.26 -11.24 59.8 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.835 0.854 . . . . 72.24 112.878 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -83.4 -52.2 6.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.103 0.561 . . . . 73.41 110.598 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -79.67 -31.88 41.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.443 0.697 . . . . 71.22 111.691 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.2 81.58 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 116.008 -0.542 . . . . 42.55 112.964 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -104.92 149.86 38.04 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.42 1.088 . . . . 71.41 111.304 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.0 Cg_endo -63.65 146.73 92.72 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.369 2.046 . . . . 61.1 111.534 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 61.0 mtt -75.65 94.0 3.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.54 0.686 . . . . 60.4 109.471 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 27' ' ' ILE . 77.7 mt -144.08 127.89 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.85 1.26 . . . . 72.02 108.533 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 41.9 m-80 -108.02 110.31 21.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.715 -0.476 . . . . 71.31 109.715 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.951 0.782 . . . . 41.43 109.343 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 67' ' ' THR . 79.7 m-85 -74.99 120.44 20.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.232 0.613 . . . . 73.4 111.134 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 m -100.57 140.02 35.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.693 0.797 . . . . 65.33 108.956 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.59 124.36 23.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.593 0.757 . . . . 60.43 110.848 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -64.72 -24.9 67.71 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.633 0.773 . . . . 63.43 112.978 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.44 -53.65 3.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.404 0.682 . . . . 74.2 111.604 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.1 p -84.18 -22.86 30.8 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.366 0.667 . . . . 74.42 112.65 -173.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 8.12 74.1 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.262 0.465 . . . . 64.42 114.262 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.61 149.53 21.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.073 0.949 . . . . 64.41 111.233 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.25 125.72 24.44 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 117.94 0.336 . . . . 72.03 110.485 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -72.51 -21.97 61.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.994 0.518 . . . . 71.3 112.31 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 22.05 66.54 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.183 -0.367 . . . . 74.44 112.183 -170.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -115.08 143.13 45.68 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.24 -1.022 . . . . 53.51 108.24 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -151.73 159.3 44.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.705 0.402 . . . . 61.35 111.915 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 p -114.65 120.72 41.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.606 0.362 . . . . 64.42 111.24 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.29 111.84 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.099 0.559 . . . . 61.32 110.534 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -88.86 105.62 17.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.413 0.685 . . . . 75.12 111.413 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 51.5 m-85 -80.81 161.14 24.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.863 0.865 . . . . 62.11 110.765 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.32 -33.93 65.41 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.592 0.757 . . . . 75.53 110.943 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.18 132.07 22.92 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.776 0.83 . . . . 64.25 111.189 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.46 -43.29 45.29 Favored 'Trans proline' 0 CA--C 1.584 2.991 0 C-N-CA 122.779 2.319 . . . . 74.23 115.288 165.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.99 -27.72 66.2 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 122.311 1.861 . . . . 71.22 113.563 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 m -69.57 -38.72 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.545 0.688 . . . . 74.01 109.838 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -60.03 -54.78 41.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.628 -1.169 . . . . 65.3 110.861 175.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -59.22 -45.39 91.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.836 0.854 . . . . 75.4 111.404 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.94 99.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.946 -0.57 . . . . 64.12 111.686 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.05 -32.82 73.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.539 0.525 . . . . 72.23 111.992 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 95' ' ' VAL . 79.0 mt -65.33 -62.21 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.545 0.338 . . . . 64.5 111.049 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.65 -25.09 66.06 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 112.443 0.534 . . . . 75.31 112.443 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -78.26 -59.04 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.729 0.412 . . . . 74.12 110.945 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -86.62 -9.34 56.26 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.602 1.334 . . . . 71.32 114.602 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.87 106.28 1.85 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.732 0.696 . . . . 74.12 110.39 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.45 56.29 Favored Glycine 0 CA--C 1.546 1.985 0 CA-C-N 116.122 -0.49 . . . . 74.04 114.232 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 29.4 mmmt -80.71 175.9 10.27 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 123.761 0.824 . . . . 74.24 112.219 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.64 115.8 26.36 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.654 0.382 . . . . 74.21 111.383 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -82.55 -75.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.186 0.595 . . . . 75.21 111.042 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 t -98.93 37.31 1.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.324 0.65 . . . . 73.52 110.03 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.64 11.66 85.09 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 115.986 -0.552 . . . . 71.24 112.139 -164.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.1 121.6 41.24 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.433 1.093 . . . . 62.34 110.608 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.8 Cg_exo -66.21 96.2 0.33 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.937 2.425 . . . . 73.21 112.561 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.408 HG21 HD23 ' A' ' 21' ' ' LEU . 29.5 pt -74.86 153.58 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.181 0.992 . . . . 74.43 113.32 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -119.75 114.77 22.66 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.965 -1.124 . . . . 71.2 107.965 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 18' ' ' VAL . 19.2 t -109.39 137.28 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 120.974 0.416 . . . . 54.4 110.297 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -142.51 -174.52 4.16 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.336 1.454 . . . . 61.3 109.042 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -79.96 146.4 32.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.907 -0.495 . . . . 70.14 110.69 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.4 107.97 18.26 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.939 -0.393 . . . . 74.13 109.939 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.489 1.486 0 C-N-CA 123.385 0.674 . . . . 75.41 112.068 -176.744 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 120.475 0.179 . . . . 64.51 110.681 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 m -97.83 126.59 43.28 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.277 0.56 . . . . 71.35 110.059 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.2 pt -105.72 153.93 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.789 0.836 . . . . 73.33 111.13 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -109.41 125.19 52.14 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.144 0.578 . . . . 74.12 109.903 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 HG22 ' A' ' 95' ' ' VAL . 18.7 t -121.31 141.75 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.081 0.952 . . . . 71.44 109.901 -175.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -127.87 159.87 33.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.902 0.881 . . . . 74.24 110.539 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.5 32.12 35.1 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 114.303 0.481 . . . . 53.34 114.303 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.81 -28.38 24.53 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.888 0.875 . . . . 63.4 112.225 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.96 161.49 18.71 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 123.068 0.366 . . . . 70.01 113.496 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -83.78 -2.0 55.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.712 1.004 . . . . 54.53 113.712 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -121.19 21.6 11.15 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.395 0.678 . . . . 53.33 111.902 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.77 142.77 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.291 0.636 . . . . 62.15 111.528 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 30' ' ' VAL . 44.0 p -122.62 153.83 38.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.451 -0.78 . . . . 74.55 110.618 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 93.4 mt -53.46 -40.29 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.146 0.978 . . . . 70.11 111.43 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.29 -44.18 95.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.787 0.835 . . . . 63.23 111.53 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -68.94 -41.26 78.31 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.182 0.593 . . . . 71.05 111.844 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 26' ' ' THR . 56.9 t -64.6 -43.42 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.119 0.568 . . . . 75.42 110.021 176.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.95 88.75 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.368 -0.833 . . . . 61.33 111.753 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.42 -30.46 70.22 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.268 0.627 . . . . 62.14 111.6 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -72.61 -55.07 7.43 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.792 0.837 . . . . 73.33 111.64 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 77.2 m-85 -81.1 -20.01 42.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.413 1.264 . . . . 73.41 114.413 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -58.0 -29.93 65.66 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.659 0.985 . . . . 75.22 113.659 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.01 -26.49 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.815 0.846 . . . . 50.04 112.598 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 mm -79.27 -47.6 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.751 0.821 . . . . 55.32 110.758 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 173.99 43.03 Favored Glycine 0 N--CA 1.463 0.497 0 CA-C-N 116.211 -0.449 . . . . 62.52 113.295 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.28 124.3 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.379 0.671 . . . . 52.24 110.837 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 65.3 mt -94.37 131.86 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.062 0.945 . . . . 44.45 109.625 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.1 mtpt -54.91 144.99 21.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.464 0.706 . . . . 71.31 111.743 173.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.4 m -126.19 128.21 46.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.265 -0.879 . . . . 71.03 109.794 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -69.56 114.36 7.71 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.797 0.839 . . . . 74.31 108.942 172.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.96 -15.27 60.19 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.42 0.688 . . . . 74.21 112.254 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.73 -36.19 65.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.985 0.514 . . . . 73.51 111.371 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -98.67 -41.77 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.485 0.714 . . . . 73.1 111.761 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.58 8.07 54.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 115.754 -0.657 . . . . 33.13 112.812 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.9 150.16 52.43 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 123.931 0.892 . . . . 72.2 112.377 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.4 Cg_endo -61.48 145.03 98.34 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.434 2.756 . . . . 72.34 112.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.518 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 60.8 mtt -74.81 97.11 3.21 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.384 0.612 . . . . 74.21 109.789 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 99.2 mt -142.0 124.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.545 1.138 . . . . 75.34 109.043 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.9 m-20 -101.85 107.43 18.61 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.031 -0.729 . . . . 65.4 109.031 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.22 134.93 36.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.722 -0.844 . . . . 54.14 108.722 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HE2' HG23 ' A' ' 67' ' ' THR . 96.5 m-85 -100.01 122.15 42.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.008 0.523 . . . . 71.2 110.379 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 m -102.54 141.44 35.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.261 1.024 . . . . 74.4 110.218 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.8 133.82 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.165 0.586 . . . . 74.35 109.584 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -87.31 -24.86 24.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.554 0.742 . . . . 72.22 112.798 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.09 -34.98 14.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.271 0.471 . . . . 74.21 112.271 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -90.75 -53.52 4.37 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.074 0.398 . . . . 71.43 112.074 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.63 -0.88 34.33 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 116.025 -0.534 . . . . 51.32 113.587 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.06 152.93 19.72 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.451 0.7 . . . . 64.15 109.75 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 84.3 mt -62.66 140.55 58.7 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.097 0.475 . . . . 70.21 111.788 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -74.11 -13.08 60.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.969 0.908 . . . . 54.32 112.186 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 29.53 39.69 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.453 -0.34 . . . . 55.31 112.531 -174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.5 145.07 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.971 0.909 . . . . 73.22 109.631 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 147.0 18.41 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.963 0.411 . . . . 73.12 111.919 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 75.0 p -102.01 133.6 46.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.9 -0.591 . . . . 44.11 110.159 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -115.1 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 123.139 0.576 . . . . 64.42 110.339 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 43.9 m -85.14 102.3 13.16 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.849 0.46 . . . . 64.53 110.961 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.7 m-85 -79.45 155.51 28.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.116 0.566 . . . . 71.34 110.747 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.71 -35.76 72.89 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.216 0.606 . . . . 74.24 110.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -114.38 129.01 25.27 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.379 0.671 . . . . 52.14 111.337 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.51 -37.99 83.02 Favored 'Trans proline' 0 CA--C 1.587 3.15 0 C-N-CA 123.108 2.538 . . . . 70.21 116.42 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.64 -24.87 40.98 Favored 'Trans proline' 0 C--N 1.396 3.047 0 CA-C-N 122.611 1.968 . . . . 72.32 112.857 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -74.59 -38.12 62.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.647 0.779 . . . . 63.2 110.21 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.42 -51.34 70.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.779 -1.1 . . . . 44.12 110.692 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -65.17 -39.15 92.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.32 -0.854 . . . . 75.15 111.299 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.0 94.71 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.396 0.278 . . . . 70.23 111.285 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.404 0.682 . . . . 70.0 112.222 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 77' ' ' LYS . 89.6 mt -65.61 -63.46 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.018 0.527 . . . . 65.1 110.674 173.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.05 -25.59 67.77 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.403 -0.817 . . . . 74.14 111.698 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -82.12 -60.23 2.29 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.871 0.469 . . . . 74.14 111.691 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.728 1.381 . . . . 73.34 114.728 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.33 119.87 12.31 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.678 0.672 . . . . 71.34 109.74 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 5.35 75.97 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 114.86 0.704 . . . . 42.22 114.86 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 74.9 mmtt -88.29 -167.8 2.0 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 117.939 0.869 . . . . 75.22 111.525 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.13 118.06 23.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.098 0.959 . . . . 72.24 109.981 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 93' ' ' ILE . 67.9 t80 -78.8 -75.11 0.25 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.67 0.271 . . . . 72.44 110.578 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.4 t -122.84 61.21 1.01 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.778 0.799 . . . . 64.34 110.077 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.41 2.49 84.39 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.011 -0.995 . . . . 73.04 114.076 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -117.18 136.51 23.41 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.998 0.919 . . . . 74.31 110.186 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 73.5 Cg_endo -73.07 116.7 4.81 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.555 2.17 . . . . 74.41 112.153 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' A' ' 88' ' ' PHE . 41.1 pt -92.56 153.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.574 0.749 . . . . 73.53 113.005 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -123.95 119.09 28.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.215 1.006 . . . . 74.3 108.869 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG13 ' A' ' 18' ' ' VAL . 32.6 t -112.85 134.12 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.598 0.759 . . . . 71.11 110.136 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.7 p -146.42 -176.33 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.742 1.217 . . . . 72.43 109.182 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -76.46 145.33 39.31 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.01 0.823 . . . . 73.44 110.778 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.25 93.28 8.16 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.04 0.448 . . . . 54.2 110.793 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 124.036 0.935 . . . . 70.05 111.261 178.586 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.552 1.027 0 CA-C-O 121.025 0.44 . . . . 62.05 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -96.44 132.48 41.94 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.579 0.752 . . . . 75.11 110.625 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 76' ' ' ALA . 35.7 pt -114.96 152.87 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.879 0.872 . . . . 40.03 111.061 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -107.7 116.45 31.96 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.158 0.583 . . . . 72.41 110.175 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 95' ' ' VAL . 19.1 t -109.6 134.15 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.212 1.005 . . . . 75.33 110.436 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -120.12 157.19 29.53 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.063 0.945 . . . . 43.22 110.562 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.88 29.55 28.58 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-O 121.241 0.356 . . . . 70.54 113.941 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.28 -13.46 46.62 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.153 0.981 . . . . 72.2 112.957 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.0 54.25 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 114.878 0.711 . . . . 71.21 114.878 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.88 -24.61 48.43 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.813 0.845 . . . . 65.12 112.34 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.67 20.02 9.16 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.416 0.686 . . . . 62.11 111.787 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG13 HD13 ' A' ' 62' ' ' LEU . 5.0 p -80.14 131.73 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.056 0.543 . . . . 52.31 112.0 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.4 p -129.39 154.67 46.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.406 0.682 . . . . 75.14 110.292 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB ' ' A' ' 51' ' ' ILE . 90.4 mt -50.24 -52.51 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 124.283 1.033 . . . . 65.12 111.815 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.42 -37.03 84.28 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.568 -0.742 . . . . 73.31 111.462 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -69.9 -36.89 75.77 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.107 0.41 . . . . 62.33 112.107 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.5 -37.9 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 120.977 0.417 . . . . 55.23 110.052 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.74 66.06 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.924 0.49 . . . . 54.12 111.594 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.34 -32.52 58.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.101 0.96 . . . . 74.31 111.434 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.14 -49.69 41.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.659 0.784 . . . . 74.01 110.392 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.458 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 14.2 m-85 -82.89 -16.96 45.45 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.556 1.317 . . . . 54.15 114.556 -173.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -66.98 -17.36 64.88 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.471 0.915 . . . . 73.35 113.471 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.55 -24.75 63.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.039 0.536 . . . . 73.42 111.99 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.06 -41.08 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.304 1.042 . . . . 75.02 111.375 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.11 176.45 47.19 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.454 -0.403 . . . . 74.23 113.993 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.4 126.18 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.899 0.479 . . . . 55.14 109.911 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 81.0 mt -94.64 141.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.712 0.805 . . . . 75.42 109.038 173.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 26.4 mtpp -59.78 144.67 47.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.366 0.666 . . . . 72.12 111.658 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.3 m -128.4 120.27 26.62 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.489 -0.778 . . . . 71.53 109.569 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.16 114.72 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.017 -0.734 . . . . 73.22 109.017 171.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.35 -28.28 66.08 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.277 1.031 . . . . 73.42 111.777 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 11.5 mmpt? -71.61 -45.87 60.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.29 0.636 . . . . 75.24 111.74 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 p -82.98 -35.17 26.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.134 0.574 . . . . 74.15 111.453 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.17 17.79 64.15 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.78 -0.645 . . . . 72.22 112.404 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -120.98 152.07 55.94 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.407 1.083 . . . . 74.44 111.79 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HG2' HG22 ' A' ' 27' ' ' ILE . 18.8 Cg_endo -61.42 146.77 96.83 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.739 2.292 . . . . 74.22 113.141 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.539 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 52.7 mtt -82.75 97.1 8.41 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.016 0.526 . . . . 73.23 110.646 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 27' ' ' ILE . 70.2 mt -144.27 117.48 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.183 0.993 . . . . 71.44 109.132 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.56 110.37 22.19 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.589 -0.523 . . . . 74.45 109.589 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.7 mt -82.31 115.35 21.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.46 0.704 . . . . 74.41 110.196 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -69.89 117.33 11.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.061 0.545 . . . . 60.43 110.247 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 m -122.39 139.13 54.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.02 0.928 . . . . 62.01 109.59 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -73.32 135.63 44.38 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.175 0.59 . . . . 61.13 111.62 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 15.4 ptm180 -64.64 -38.33 90.65 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.459 1.103 . . . . 75.22 112.674 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 45.4 mt-10 -80.77 -55.52 4.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.252 0.621 . . . . 75.21 111.839 -171.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.2 p -84.07 -31.19 25.47 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.3 0.64 . . . . 45.1 111.794 -174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 8.71 86.26 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 116.438 -0.346 . . . . 64.0 113.22 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -92.8 152.32 19.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.213 0.605 . . . . 73.34 111.937 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 25' ' ' VAL . 82.8 mt -65.76 126.46 28.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.767 0.827 . . . . 44.14 110.784 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -71.27 -12.97 61.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.051 0.94 . . . . 62.24 112.201 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.97 37.73 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 112.014 -0.435 . . . . 72.24 112.014 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.47 149.27 49.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.998 . . . . 73.22 109.552 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.32 159.13 25.1 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.492 0.553 . . . . 72.11 112.492 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.5 p -115.24 114.08 24.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.132 0.573 . . . . 71.42 111.323 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 51' ' ' ILE . 21.6 t -99.81 108.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.432 1.093 . . . . 75.51 110.608 -173.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 42.2 m -84.98 101.76 12.63 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.686 0.394 . . . . 72.5 111.28 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 38.0 m-85 -77.37 156.13 31.44 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.097 0.559 . . . . 73.21 111.18 171.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.08 -27.41 54.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.298 0.639 . . . . 63.15 111.296 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 22.8 m-20 -120.0 131.38 24.43 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 122.942 0.497 . . . . 70.44 111.743 171.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.37 -38.3 82.37 Favored 'Trans proline' 0 CA--C 1.583 2.93 0 C-N-CA 122.879 2.386 . . . . 64.13 115.68 168.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 37.7 Cg_endo -64.98 -25.42 59.35 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 123.03 2.118 . . . . 62.04 113.404 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.9 m -76.17 -37.24 58.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.072 0.549 . . . . 73.01 110.19 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.69 -48.29 81.46 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.324 0.649 . . . . 71.3 111.015 174.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.42 -47.5 85.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.279 1.032 . . . . 75.21 110.799 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.34 93.88 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.604 -0.725 . . . . 64.44 111.738 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -31.76 73.07 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.321 0.648 . . . . 63.21 112.507 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' VAL . 72.5 mt -63.62 -61.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.264 0.226 . . . . 74.45 110.599 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.19 -24.7 65.0 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.421 0.688 . . . . 62.42 112.643 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -80.21 -59.38 2.73 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.44 0.696 . . . . 74.15 111.617 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB3' HD11 ' A' ' 93' ' ' ILE . 77.1 m-85 -85.84 -10.83 54.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.194 1.183 . . . . 74.12 114.194 -170.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.68 115.14 4.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.376 0.534 . . . . 61.31 110.258 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.53 68.58 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 114.921 0.728 . . . . 71.15 114.921 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.5 mmtt -94.08 141.46 28.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.111 0.956 . . . . 73.33 111.935 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.04 116.13 19.14 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.599 0.759 . . . . 74.32 112.179 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -90.9 -78.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.582 0.753 . . . . 54.33 110.949 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -109.26 54.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.968 0.889 . . . . 73.51 110.248 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.64 8.48 87.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.983 -1.008 . . . . 74.21 113.83 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -133.59 136.82 27.54 Favored Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 123.811 0.845 . . . . 74.01 109.878 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.73 116.55 4.76 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.739 2.293 . . . . 75.53 110.893 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 83' ' ' PHE . 16.0 pt -80.45 154.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.735 0.642 . . . . 72.51 112.735 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -119.22 112.3 19.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.369 -0.975 . . . . 72.23 108.369 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 18' ' ' VAL . 14.2 t -107.0 137.02 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.019 0.528 . . . . 72.05 110.876 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.6 m -141.51 179.86 6.56 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.997 1.319 . . . . 63.41 109.207 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.31 149.59 31.72 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.807 0.731 . . . . 73.23 110.399 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.89 85.92 7.03 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.024 0.44 . . . . 73.42 110.117 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.571 1.752 0 C-N-CA 123.209 0.604 . . . . 71.43 112.135 -176.114 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.47 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.461 0.172 . . . . 62.05 111.067 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -106.18 125.67 51.28 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.843 0.857 . . . . 71.21 110.747 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 76' ' ' ALA . 30.3 pt -114.9 148.28 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.906 0.882 . . . . 64.23 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -102.14 120.05 39.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.433 0.693 . . . . 73.11 109.607 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 95' ' ' VAL . 14.4 t -114.9 136.13 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.186 0.994 . . . . 72.23 110.388 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -124.37 162.69 23.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.131 0.973 . . . . 72.23 110.234 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.92 25.93 61.33 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 114.203 0.441 . . . . 61.04 114.203 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 93' ' ' ILE . 77.0 mt -79.03 -22.38 45.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.352 1.061 . . . . 54.21 112.013 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.87 167.66 42.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.083 0.373 . . . . 63.22 113.227 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.62 -19.56 59.13 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 112.84 0.682 . . . . 72.44 112.84 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -86.91 6.93 29.51 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.145 0.578 . . . . 74.52 111.934 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.2 138.03 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 124.198 0.999 . . . . 42.42 112.242 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -129.44 151.15 50.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.756 -0.59 . . . . 73.4 110.061 171.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 51' ' ' ILE . 67.9 mt -49.19 -51.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.631 1.172 . . . . 64.44 112.773 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.68 -21.1 55.85 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.788 0.662 . . . . 72.53 112.788 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -73.85 -37.55 64.75 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 117.962 0.346 . . . . 65.53 111.099 171.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.23 -41.48 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 121.309 0.576 . . . . 70.31 109.7 171.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.5 92.42 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.341 -0.845 . . . . 75.2 111.596 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.93 -38.11 89.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.273 0.629 . . . . 72.24 111.047 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -67.27 -55.9 12.06 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.816 0.846 . . . . 63.44 111.385 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.446 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 49.0 m-85 -77.94 -21.64 50.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.584 1.327 . . . . 64.31 114.584 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.87 -20.04 66.09 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.983 1.105 . . . . 74.5 113.983 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -60.56 -22.28 63.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 122.985 0.514 . . . . 73.22 112.15 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.08 -42.45 14.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 124.507 1.123 . . . . 73.14 111.424 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 172.67 45.12 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.981 -0.554 . . . . 73.3 113.229 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.96 125.47 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.557 0.743 . . . . 60.14 110.719 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 73.2 mt -95.56 130.5 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.943 0.897 . . . . 54.22 109.388 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.596 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.5 mtpt -51.04 153.99 1.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.743 0.817 . . . . 71.24 112.91 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 52.4 m -140.07 125.46 18.97 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.613 0.765 . . . . 71.23 110.508 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.13 123.87 20.19 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.448 0.699 . . . . 72.13 111.038 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -71.78 -24.02 61.67 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.109 0.563 . . . . 63.1 112.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.8 -54.36 13.99 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.807 0.443 . . . . 65.1 111.577 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -84.57 -45.3 12.7 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.196 0.598 . . . . 74.44 111.668 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.97 37.8 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.973 -0.558 . . . . 65.02 112.523 -170.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -106.13 148.94 37.52 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.128 0.971 . . . . 75.53 111.28 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 51.0 Cg_endo -68.14 145.97 68.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.598 2.198 . . . . 72.14 111.922 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.596 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 58.2 mtt -77.16 94.79 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.563 0.697 . . . . 71.2 110.026 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.587 ' HB ' HG23 ' A' ' 27' ' ' ILE . 86.7 mt -144.54 116.44 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.053 1.341 . . . . 74.51 108.49 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -99.03 109.43 22.18 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.155 -0.683 . . . . 51.34 109.155 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.84 120.8 26.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.138 0.575 . . . . 73.11 110.06 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.568 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 57.0 m-85 -73.12 104.35 4.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.011 0.524 . . . . 74.34 110.994 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -86.76 160.0 18.95 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.953 0.901 . . . . 62.14 110.065 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -93.45 155.1 17.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.953 0.901 . . . . 73.35 111.962 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.16 -35.64 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.658 0.783 . . . . 73.44 112.834 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.431 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.4 pt-20 -88.97 -37.99 14.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.93 -0.482 . . . . 63.23 111.952 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 58' ' ' GLU . 31.5 p -94.01 -33.38 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 112.522 0.564 . . . . 73.42 112.522 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.86 6.26 89.16 Favored Glycine 0 CA--C 1.541 1.656 0 N-CA-C 114.223 0.449 . . . . 33.14 114.223 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -102.1 171.72 7.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.689 0.796 . . . . 62.15 110.78 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.37 130.26 39.33 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.972 -0.455 . . . . 61.2 111.71 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -74.78 -18.96 60.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.432 0.693 . . . . 61.31 112.548 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 35.1 12.61 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 116.362 -0.381 . . . . 50.43 113.064 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 41.3 mt-10 -127.94 154.06 45.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.2 1.0 . . . . 70.42 109.042 173.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.57 164.08 24.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.093 0.557 . . . . 71.14 111.822 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.0 p -120.26 128.92 53.77 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.998 -0.546 . . . . 71.4 109.98 168.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.42 111.8 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.575 0.75 . . . . 63.44 110.809 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 m -89.21 102.71 15.37 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.936 0.494 . . . . 72.03 111.724 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 34.7 m-85 -78.09 156.85 29.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.707 0.803 . . . . 71.41 110.625 168.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.1 -32.31 44.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.045 0.538 . . . . 72.21 110.434 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 4.0 m-20 -106.08 122.58 41.82 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.59 0.756 . . . . 62.23 110.453 174.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 72' ' ' ASP . 5.3 Cg_endo -49.94 -42.45 44.97 Favored 'Trans proline' 0 CA--C 1.586 3.108 0 C-N-CA 122.918 2.412 . . . . 61.53 115.789 167.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.32 -25.5 71.57 Favored 'Trans proline' 0 C--N 1.406 3.564 0 CA-C-N 122.602 1.965 . . . . 52.43 113.117 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.8 m -76.59 -37.22 56.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.436 0.694 . . . . 73.14 110.917 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.07 -47.21 78.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.082 0.553 . . . . 53.51 111.151 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.58 -42.96 95.29 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.562 0.745 . . . . 75.21 111.282 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.42 89.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.285 -0.416 . . . . 71.41 111.847 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.65 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.398 0.679 . . . . 73.35 112.385 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 95' ' ' VAL . 72.4 mt -64.24 -63.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.528 0.331 . . . . 53.44 110.326 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.3 -31.76 63.97 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.556 0.742 . . . . 74.14 112.45 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -78.49 -56.98 4.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.499 0.72 . . . . 74.21 111.921 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 93' ' ' ILE . 62.7 m-85 -88.13 -4.1 58.8 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.242 1.201 . . . . 63.35 114.242 -171.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.7 110.81 1.4 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.634 0.374 . . . . 61.41 111.097 173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.33 80.16 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.049 0.779 . . . . 24.15 115.049 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.44 144.01 26.64 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 117.811 0.805 . . . . 64.4 112.023 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.64 116.91 19.33 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.983 0.513 . . . . 74.22 112.335 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.11 -66.88 0.82 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.485 0.714 . . . . 75.43 109.996 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.3 t -107.44 38.76 2.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.295 1.038 . . . . 74.44 110.001 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.56 23.86 74.22 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.003 -0.544 . . . . 74.22 113.253 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 28.0 p-10 -138.71 123.69 11.9 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 124.06 0.944 . . . . 73.23 110.53 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 21.9 Cg_exo -64.31 112.52 1.93 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.156 2.571 . . . . 53.32 112.771 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.44 HG21 HD23 ' A' ' 21' ' ' LEU . 18.6 pt -83.55 161.24 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 72.35 112.031 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -113.85 123.06 48.88 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.259 1.023 . . . . 71.25 108.298 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 18' ' ' VAL . 14.6 t -115.06 134.72 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 121.042 0.449 . . . . 75.43 110.508 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -142.72 179.77 6.8 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.173 1.389 . . . . 61.32 109.227 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -76.79 151.9 35.78 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.206 0.457 . . . . 52.23 110.488 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.72 95.89 8.62 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.69 0.396 . . . . 64.51 110.2 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 123.49 0.716 . . . . 72.44 111.275 -178.271 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 112.195 0.442 . . . . 74.34 112.195 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.7 m -126.82 129.56 48.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.889 0.876 . . . . 70.34 109.647 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.419 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.7 pt -116.21 146.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.823 0.849 . . . . 74.14 111.335 -175.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -102.28 123.92 46.94 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.457 0.703 . . . . 74.22 109.871 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 21.6 t -119.12 138.85 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.667 1.187 . . . . 71.4 110.073 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -126.1 155.41 41.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.03 0.932 . . . . 72.3 110.808 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.84 1.36 70.68 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 114.184 0.434 . . . . 74.31 114.184 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 93' ' ' ILE . 85.3 mt -61.36 -12.32 13.6 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.123 1.157 . . . . 65.51 114.123 -178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.25 173.28 49.57 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.389 0.515 . . . . 54.13 114.389 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 8.3 pt-20 -71.68 -22.46 61.66 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.286 -0.538 . . . . 74.33 111.27 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.52 8.93 22.76 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.714 0.806 . . . . 71.21 112.305 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.72 137.1 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.275 0 C-N-CA 122.722 0.409 . . . . 75.3 111.965 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' VAL . 57.9 p -131.22 148.01 52.66 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.428 0.691 . . . . 75.5 109.81 171.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.67 HG23 ' HB ' ' A' ' 51' ' ' ILE . 83.7 mt -51.5 -47.08 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.463 1.105 . . . . 75.51 112.983 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -69.7 -29.31 66.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.18 0.592 . . . . 73.45 111.916 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -74.1 -36.11 64.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.688 0.395 . . . . 73.14 111.369 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 26' ' ' THR . 44.4 t -65.36 -40.68 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.366 0.603 . . . . 65.01 109.663 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.98 85.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.017 -0.992 . . . . 63.12 111.735 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.74 -26.39 63.35 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.073 0.549 . . . . 75.33 111.664 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -75.29 -57.08 4.11 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.399 0.68 . . . . 72.44 111.578 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.432 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 30.9 m-85 -75.25 -19.47 59.71 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.593 1.331 . . . . 72.14 114.593 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.73 -21.51 66.44 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.69 0.996 . . . . 75.42 113.69 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -57.26 -25.03 58.54 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.112 0.565 . . . . 73.35 112.353 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.8 mm -84.57 -56.33 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.945 0.898 . . . . 71.03 110.72 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.33 166.99 33.87 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 116.024 -0.535 . . . . 73.21 113.38 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.23 114.16 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.019 0.528 . . . . 73.32 110.051 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 76.5 mt -79.7 136.31 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 109.186 -0.672 . . . . 60.44 109.186 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.6 mtpt -53.51 142.11 23.29 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.151 0.58 . . . . 61.15 112.0 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.7 m -132.88 119.84 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.629 -0.714 . . . . 71.04 110.079 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.73 123.33 16.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.335 1.054 . . . . 75.01 110.222 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -73.94 -30.75 62.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.656 0.782 . . . . 72.44 111.791 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.53 -51.54 49.67 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.151 0.581 . . . . 71.13 111.546 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 p -83.67 -45.67 13.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.469 0.708 . . . . 65.11 111.359 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.21 17.04 35.74 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 115.623 -0.717 . . . . 70.12 112.421 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -104.9 156.9 35.31 Favored Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 124.235 1.014 . . . . 74.4 112.801 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.78 142.2 19.98 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.956 2.437 . . . . 72.41 112.8 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.617 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.0 mtt -79.04 94.32 5.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.263 0.554 . . . . 74.34 110.305 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 27' ' ' ILE . 72.1 mt -146.77 115.88 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.525 1.13 . . . . 65.22 108.906 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.17 111.15 23.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 74.45 110.116 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.61 143.36 34.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.147 0.579 . . . . 72.13 110.164 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -100.38 126.09 46.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 73.34 109.848 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -115.2 142.45 46.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.065 0.946 . . . . 74.15 110.276 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -67.7 96.55 0.56 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.06 -0.718 . . . . 75.31 109.06 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -61.88 -24.1 66.72 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.593 0.757 . . . . 50.4 112.065 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.522 ' HG3' HG23 ' A' ' 59' ' ' THR . 10.9 pt-20 -71.69 -39.49 70.18 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.461 0.705 . . . . 71.11 111.903 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -103.49 -62.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.308 0.643 . . . . 75.24 111.478 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 -7.84 5.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.37 -0.377 . . . . 20.14 113.701 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -90.19 161.88 15.51 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.546 0.673 . . . . 62.44 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 59.6 mt -76.49 138.46 40.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.254 0.622 . . . . 74.32 111.649 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -73.32 -20.15 60.87 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.744 0.818 . . . . 74.45 111.787 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.79 33.85 20.4 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.739 -0.664 . . . . 71.3 112.719 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.88 148.97 52.29 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.917 0.887 . . . . 63.55 109.74 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.11 159.57 31.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.567 0.58 . . . . 70.21 112.567 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.6 p -114.9 117.57 31.05 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.068 0.547 . . . . 60.14 110.629 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.36 109.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.68 0.792 . . . . 73.21 110.385 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -86.94 101.61 13.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.021 0.528 . . . . 70.31 111.116 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 58.3 m-85 -77.59 157.28 30.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.722 0.809 . . . . 74.42 110.76 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.38 -35.99 58.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.225 0.61 . . . . 73.51 110.579 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -106.49 128.01 27.07 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.541 0.737 . . . . 65.13 110.821 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -52.29 -39.94 71.31 Favored 'Trans proline' 0 CA--C 1.582 2.883 0 C-N-CA 122.697 2.265 . . . . 61.23 115.764 166.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.25 -24.01 65.69 Favored 'Trans proline' 0 C--N 1.401 3.317 0 CA-C-N 122.297 1.856 . . . . 73.22 113.715 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.8 m -77.12 -38.06 52.88 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.109 0.564 . . . . 71.44 110.782 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -64.55 -43.8 92.81 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.428 0.632 . . . . 70.25 110.318 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -60.64 -48.02 83.64 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.146 1.378 . . . . 72.42 111.37 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.16 94.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.81 -0.632 . . . . 53.23 112.479 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.482 0.713 . . . . 74.23 112.387 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.484 HG12 HG12 ' A' ' 95' ' ' VAL . 92.2 mt -63.9 -60.53 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.115 0.566 . . . . 70.45 110.574 172.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.48 -31.68 66.23 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.409 -0.814 . . . . 75.44 111.576 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -80.06 -61.87 1.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.809 0.444 . . . . 70.22 111.933 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' HB2' HG21 ' A' ' 95' ' ' VAL . 71.3 m-85 -80.02 -10.46 59.77 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.618 0.97 . . . . 75.22 113.618 -170.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.4 104.26 2.23 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 109.541 -0.54 . . . . 72.01 109.541 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.55 42.41 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 115.546 -0.752 . . . . 62.32 114.017 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.2 mmtt -82.69 152.1 25.95 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.882 0.841 . . . . 75.01 110.073 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.95 124.1 35.81 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.429 0.529 . . . . 52.44 112.429 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -126.83 136.32 52.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.253 -1.018 . . . . 60.42 108.253 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 t 61.49 30.32 18.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.189 0.996 . . . . 71.4 111.609 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.26 29.0 54.83 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.478 -0.783 . . . . 53.0 115.041 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -161.41 145.29 9.8 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 117.305 0.553 . . . . 64.25 111.383 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.64 110.67 1.93 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.018 2.479 . . . . 74.15 113.438 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.431 HG21 HD23 ' A' ' 21' ' ' LEU . 34.4 pt -78.88 160.6 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.861 0.865 . . . . 74.21 112.223 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -118.18 128.19 54.47 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.463 1.105 . . . . 71.33 109.457 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 23.6 t -121.91 135.34 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 74.32 111.107 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.5 p -146.4 179.36 7.58 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.708 1.203 . . . . 60.14 109.022 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.27 154.4 37.47 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.969 0.804 . . . . 74.41 111.713 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.12 88.3 6.46 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.241 -0.652 . . . . 71.32 109.241 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.57 1.715 0 C-N-CA 123.451 0.7 . . . . 61.45 111.551 -174.712 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 14' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.117 0 N-CA-C 111.88 0.326 . . . . 75.2 111.88 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -94.77 126.75 40.29 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.915 0.486 . . . . 74.43 110.187 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.5 pt -113.36 156.0 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.584 0.754 . . . . 63.55 111.291 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -116.3 125.42 52.13 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.329 0.651 . . . . 72.42 110.146 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.621 HG13 HG22 ' A' ' 95' ' ' VAL . 18.5 t -117.41 146.33 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.191 0.996 . . . . 74.14 110.363 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 27.6 mt-30 -124.7 163.62 21.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.684 1.193 . . . . 74.0 110.184 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.97 23.57 74.29 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 114.953 0.741 . . . . 60.21 114.953 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 18' ' ' VAL . 57.5 mt -76.19 -17.92 59.31 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.328 1.051 . . . . 74.34 111.958 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 177.29 49.54 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 114.71 0.644 . . . . 74.14 114.71 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 34.0 mt-10 -75.29 -14.66 60.52 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.664 0.786 . . . . 75.05 112.797 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -84.09 -8.97 58.96 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.336 0.654 . . . . 60.44 112.191 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.7 128.36 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 113.716 1.006 . . . . 74.12 113.716 -169.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.3 p -125.61 152.86 44.57 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.517 0.727 . . . . 72.52 110.289 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 51' ' ' ILE . 88.0 mt -52.91 -45.55 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.379 0.672 . . . . 70.04 111.593 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.64 -38.74 92.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.58 0.752 . . . . 74.43 111.777 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.3 t -71.5 -39.46 70.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.756 0.422 . . . . 72.34 111.707 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' THR . 61.9 t -65.32 -40.4 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.256 0.55 . . . . 65.54 110.014 176.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.22 -42.63 99.29 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.141 -0.936 . . . . 72.24 111.286 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.52 -30.65 67.46 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.143 0.577 . . . . 74.5 111.379 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.43 -53.7 7.76 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.692 0.797 . . . . 73.23 111.418 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.445 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.2 m-85 -79.04 -16.26 57.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.784 1.031 . . . . 64.35 113.784 -174.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.07 -29.77 67.57 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 113.09 0.774 . . . . 70.4 113.09 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -58.85 -25.09 62.94 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.796 0.838 . . . . 51.13 112.275 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.35 -45.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.253 1.021 . . . . 74.43 111.649 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -178.7 45.62 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 116.343 -0.39 . . . . 65.5 113.315 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.92 126.97 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.7 0.4 . . . . 71.11 110.123 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 80.4 mt -95.06 143.2 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.785 0.834 . . . . 51.3 108.852 170.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.611 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.7 mtpt -62.42 145.62 53.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.092 0.557 . . . . 74.12 111.504 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 41.5 m -125.67 123.91 39.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.106 0.962 . . . . 73.31 108.809 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -71.69 123.74 23.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.071 0.549 . . . . 71.21 109.664 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -18.28 45.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.209 0.604 . . . . 72.44 111.722 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.26 -52.73 44.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.932 0.493 . . . . 72.25 110.801 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -83.38 -41.53 18.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.388 0.675 . . . . 70.42 111.022 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.63 16.0 44.27 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 115.881 -0.599 . . . . 70.41 112.512 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -121.91 153.33 60.48 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.184 0.994 . . . . 61.31 111.972 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 41.1 Cg_endo -64.22 140.92 73.43 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.256 2.637 . . . . 55.42 112.855 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.611 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.8 mtt -73.98 95.51 2.51 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.359 0.6 . . . . 74.02 109.809 -174.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 27' ' ' ILE . 80.4 mt -144.67 120.73 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.833 1.253 . . . . 73.33 108.614 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 m120 -101.45 110.15 22.1 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.902 -0.407 . . . . 71.41 109.902 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.86 141.52 32.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.524 0.73 . . . . 64.32 109.748 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.49 112.41 25.31 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.474 0.71 . . . . 75.3 110.267 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -97.52 141.61 30.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.614 0.766 . . . . 75.54 110.17 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.41 123.63 25.02 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.69 1.196 . . . . 73.33 109.995 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.38 -20.05 59.19 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.307 1.225 . . . . 73.41 114.307 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.1 pt-20 -93.76 -44.5 8.11 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.946 0.793 . . . . 60.13 112.199 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 58' ' ' GLU . 46.1 p -92.22 -35.35 13.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.896 0.478 . . . . 51.21 112.124 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.89 0.94 68.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 116.168 -0.469 . . . . 70.33 113.945 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.5 162.31 27.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.39 0.595 . . . . 74.41 110.532 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 78.3 mt -81.08 132.67 35.38 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.811 -0.555 . . . . 50.1 111.053 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.21 -19.35 64.75 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.799 0.84 . . . . 72.42 111.866 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.57 21.49 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.007 -0.542 . . . . 62.31 112.147 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.45 145.11 46.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.789 0.835 . . . . 71.44 109.405 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.22 150.63 22.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.783 0.66 . . . . 64.35 112.783 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 35.6 p -108.19 114.46 28.36 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.828 0.451 . . . . 70.34 111.045 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -102.66 108.96 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.953 0.901 . . . . 74.21 109.853 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.1 m -85.47 105.29 15.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.615 0.366 . . . . 73.41 110.52 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 49.4 m-85 -79.26 156.63 28.02 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.357 0.663 . . . . 54.13 111.161 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.04 57.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.36 0.664 . . . . 55.42 110.737 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.27 129.52 23.81 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.276 0.63 . . . . 61.2 110.712 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.59 -42.02 43.57 Favored 'Trans proline' 0 CA--C 1.58 2.778 0 C-N-CA 123.005 2.47 . . . . 65.54 116.55 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.63 -21.17 52.52 Favored 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 122.301 1.857 . . . . 74.55 113.362 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 m -72.64 -38.17 67.78 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.309 0.644 . . . . 72.51 109.669 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.48 -53.24 57.66 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 51.14 111.276 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -61.99 -41.75 98.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.64 0.776 . . . . 62.44 111.151 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.49 98.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.892 0.477 . . . . 72.2 111.778 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.151 0.58 . . . . 63.21 112.457 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 77' ' ' LYS . 86.0 mt -66.64 -56.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.074 0.55 . . . . 70.44 110.928 174.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.5 -27.33 69.2 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.524 0.729 . . . . 64.14 112.043 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -82.36 -60.39 2.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.057 0.543 . . . . 74.33 111.553 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -82.69 -13.57 56.16 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.23 1.196 . . . . 65.43 114.23 -168.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.57 104.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 119.194 0.906 . . . . 73.43 110.203 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.05 6.04 49.24 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.514 -0.766 . . . . 62.35 114.56 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.25 -176.45 5.11 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 117.856 0.828 . . . . 75.5 111.556 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.81 122.36 42.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.121 0.569 . . . . 61.22 110.664 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -75.32 -70.9 0.39 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.842 -0.429 . . . . 70.33 109.842 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.8 t -115.17 50.06 1.01 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.783 0.833 . . . . 74.51 109.391 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.53 73.59 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 115.408 -0.815 . . . . 64.5 113.501 -174.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -131.37 128.76 22.1 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.904 0.881 . . . . 72.43 111.806 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 113.82 2.3 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.369 2.713 . . . . 74.53 113.551 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.1 pt -97.19 151.86 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.552 0.741 . . . . 73.5 112.777 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 75.1 mmtt -113.6 112.09 22.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.326 1.05 . . . . 75.15 109.384 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG13 ' A' ' 18' ' ' VAL . 21.7 t -112.5 128.3 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.99 -0.444 . . . . 74.44 110.809 -174.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.0 m -140.48 -179.66 6.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.161 1.384 . . . . 63.13 109.495 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -73.87 151.49 40.46 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.179 0.445 . . . . 73.44 110.63 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 91.1 6.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.214 0.531 . . . . 64.04 109.939 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.567 1.611 0 C-N-CA 123.931 0.892 . . . . 74.44 110.782 -177.283 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 70' ' ' PHE . 35.5 p30 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 112.274 0.472 . . . . 51.41 112.274 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -103.19 130.0 50.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.282 0.633 . . . . 72.22 110.672 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.9 pt -119.26 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.64 0.776 . . . . 62.42 112.13 -176.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -95.81 119.63 34.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.25 0.548 . . . . 70.34 110.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -112.83 141.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.782 1.233 . . . . 75.41 109.814 -177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -126.44 155.22 42.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.229 1.011 . . . . 62.4 110.439 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.88 32.3 50.24 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.222 0.849 . . . . 75.45 115.222 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 93' ' ' ILE . 69.8 mt -74.89 -33.33 62.03 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.214 1.006 . . . . 74.11 112.114 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.64 153.86 10.34 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-N 116.185 -0.461 . . . . 72.3 112.868 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.43 -8.36 54.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.992 0.917 . . . . 64.42 112.191 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -117.22 81.8 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.032 0.933 . . . . 71.51 109.302 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 21' ' ' LEU . 7.3 p -134.17 131.75 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.2 1.0 . . . . 71.04 110.525 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 12.8 p -116.26 155.71 27.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.655 -0.653 . . . . 73.05 109.992 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 68.1 mt -52.19 -47.67 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.118 0.967 . . . . 74.34 112.187 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.88 -21.45 54.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.995 0.518 . . . . 74.2 112.374 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -68.83 -44.34 73.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.842 0.457 . . . . 74.42 110.144 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 24.6 t -67.14 -38.97 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 115.912 -0.586 . . . . 72.04 110.364 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.71 79.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.756 -0.656 . . . . 72.54 111.738 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.55 -31.57 72.84 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.222 0.609 . . . . 63.22 111.358 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -73.58 -54.29 8.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.035 0.534 . . . . 74.43 111.152 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -78.02 -22.92 48.5 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.087 1.143 . . . . 74.44 114.087 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.52 -22.61 66.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.055 0.761 . . . . 72.42 113.055 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.46 -27.32 65.98 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.796 0.438 . . . . 73.21 111.628 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.06 -45.07 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 75.52 110.988 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.22 44.3 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 116.094 -0.503 . . . . 62.42 113.625 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.23 127.39 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.71 0.804 . . . . 74.53 110.683 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.3 mt -98.85 132.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 73.14 109.904 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.0 mtpp -55.03 142.75 29.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 64.24 111.501 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 67.7 m -139.85 131.32 26.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.811 -0.632 . . . . 73.02 111.07 -176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -68.86 114.68 7.4 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.261 1.025 . . . . 73.3 109.357 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -74.37 -21.57 59.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.391 0.676 . . . . 70.3 112.184 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -73.52 -49.13 28.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.653 0.381 . . . . 74.53 111.499 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -86.16 -45.19 11.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.039 0.536 . . . . 65.21 111.867 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.84 -4.34 39.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.893 -0.594 . . . . 63.51 112.802 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -93.19 140.15 23.22 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.33 0.652 . . . . 73.23 112.471 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 53.8 Cg_endo -70.44 149.67 62.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.745 2.297 . . . . 54.14 111.842 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.421 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.6 mtt -75.57 94.35 3.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.351 0.596 . . . . 71.11 109.52 -176.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.1 mt -145.06 121.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 70.12 107.713 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.7 m-80 -104.57 107.85 19.0 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 110.019 -0.363 . . . . 72.23 110.019 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.7 mt -81.04 126.17 31.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.057 0.943 . . . . 51.31 110.002 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 96.4 m-85 -86.43 134.73 33.67 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.251 0.62 . . . . 74.53 111.085 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -129.78 144.91 51.53 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.64 1.176 . . . . 72.2 109.746 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -68.97 113.02 5.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.116 0.566 . . . . 72.04 110.12 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -65.88 -24.61 66.9 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.994 0.917 . . . . 72.31 111.44 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.54 ' HG3' HG23 ' A' ' 59' ' ' THR . 11.6 pt-20 -77.37 -45.34 26.3 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.546 0.738 . . . . 64.43 112.011 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 58' ' ' GLU . 37.4 p -94.28 -56.74 2.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.068 0.461 . . . . 73.33 111.698 -176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.24 4.7 23.67 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-N 116.053 -0.521 . . . . 41.34 113.574 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.87 151.38 20.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.293 0.637 . . . . 73.12 111.577 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.76 135.2 52.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.452 0.701 . . . . 65.32 111.158 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.67 -16.17 60.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.374 0.67 . . . . 75.4 111.708 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.62 39.65 24.79 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.766 -0.534 . . . . 75.23 111.766 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 57.9 mt-10 -133.56 148.97 51.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.427 0.691 . . . . 72.45 109.33 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -157.86 151.53 23.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.791 0.436 . . . . 72.31 111.688 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 54' ' ' TYR . 32.6 p -112.44 113.43 25.61 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.649 0.38 . . . . 74.23 110.65 172.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.0 t -101.5 110.62 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.571 1.148 . . . . 60.04 110.174 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 20.0 m -89.95 101.39 14.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.245 0.618 . . . . 74.23 111.216 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 41.9 m-85 -76.56 157.42 32.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.383 0.673 . . . . 63.1 110.557 170.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.06 -32.37 67.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.777 0.431 . . . . 53.32 110.017 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -113.79 123.67 32.5 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.548 0.739 . . . . 72.33 111.474 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.74 -33.53 80.86 Favored 'Trans proline' 0 CA--C 1.583 2.941 0 C-N-CA 122.841 2.36 . . . . 62.51 116.497 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.2 -26.41 42.32 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 122.871 2.061 . . . . 64.4 113.209 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.5 m -77.69 -35.44 52.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.531 0.733 . . . . 53.33 110.485 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.63 -49.89 73.4 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 121.4 0.619 . . . . 65.21 110.594 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -65.58 -37.52 86.88 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.676 1.191 . . . . 71.25 111.426 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.82 90.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.1 0.56 . . . . 51.31 112.045 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.64 68.46 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.303 0.641 . . . . 75.25 112.444 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 95' ' ' VAL . 81.4 mt -64.47 -64.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.883 0.473 . . . . 71.24 110.464 171.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.06 -25.01 65.02 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.355 0.662 . . . . 75.23 112.389 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -82.32 -62.14 1.7 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.993 0.517 . . . . 73.24 111.67 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.12 -9.76 59.42 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.032 1.123 . . . . 74.22 114.032 -170.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -66.13 118.13 9.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 120.943 0.401 . . . . 61.32 110.389 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.88 79.66 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.335 -0.703 . . . . 44.2 114.511 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.4 mmtt -93.95 167.89 11.31 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 118.44 1.12 . . . . 73.31 111.386 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -96.89 118.92 34.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.214 0.605 . . . . 70.02 111.487 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 89.7 t80 -72.47 -74.17 0.17 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.001 0.521 . . . . 64.03 110.414 172.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -116.95 60.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.039 0.936 . . . . 73.45 108.847 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.22 13.27 67.11 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 115.272 -0.876 . . . . 60.45 113.46 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -118.19 120.48 32.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.247 1.019 . . . . 65.21 111.017 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.28 96.0 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.953 2.435 . . . . 73.14 113.158 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 21' ' ' LEU . 28.1 pt -76.04 156.07 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.78 0.832 . . . . 45.02 113.225 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -122.98 116.56 23.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.366 1.066 . . . . 74.5 108.942 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 18' ' ' VAL . 20.0 t -110.92 136.36 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.67 0.388 . . . . 73.33 110.731 -174.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.8 p -148.67 -176.52 5.36 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.982 1.313 . . . . 75.42 109.657 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -76.6 146.67 38.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.741 0.701 . . . . 72.3 111.758 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.84 100.15 11.5 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.984 0.514 . . . . 34.23 110.242 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.811 0.844 . . . . 43.23 111.416 -174.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.409 0.147 . . . . 73.03 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.94 -171.31 27.88 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 116.614 -0.267 . . . . 74.12 113.242 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -68.4 -40.58 81.25 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.659 0.784 . . . . 73.34 111.462 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -100.45 135.75 41.41 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.838 0.855 . . . . 73.33 109.487 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -117.35 140.32 49.72 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.654 0.782 . . . . 62.31 110.665 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -69.88 -41.01 75.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.541 0.736 . . . . 74.03 112.683 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -80.52 77.07 7.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.285 -0.635 . . . . 73.11 109.285 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.06 -31.08 71.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.956 0.902 . . . . 71.3 112.153 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -64.47 144.14 57.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.57 0.348 . . . . 73.53 110.535 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -84.98 121.37 27.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 122.573 0.349 . . . . 64.52 110.644 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.7 t -79.63 91.91 5.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.319 0.648 . . . . 71.12 111.009 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.4 98.81 6.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.782 -0.644 . . . . 64.0 109.467 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.465 HD21 ' HB3' ' A' ' 97' ' ' PHE . 8.5 p30 -90.28 174.35 7.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.909 0.484 . . . . 71.24 111.146 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -99.46 12.35 36.63 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.452 0.538 . . . . 53.23 112.452 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.2 m -130.83 128.63 41.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.884 0.474 . . . . 62.12 110.099 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 80' ' ' ILE . 22.4 pt -115.39 147.31 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.423 . . . . 71.44 111.551 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -105.71 108.86 20.6 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.256 0.622 . . . . 73.54 110.045 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 95' ' ' VAL . 17.5 t -101.19 138.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.064 0.946 . . . . 73.14 110.09 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 74.4 mt-30 -119.44 155.11 32.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.728 0.811 . . . . 55.23 111.34 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.04 44.74 76.41 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.511 0.965 . . . . 52.34 115.511 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 93' ' ' ILE . 49.3 mt -81.22 -30.75 34.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.462 1.105 . . . . 65.52 110.781 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.07 160.53 11.39 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.138 -0.483 . . . . 44.41 113.815 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.55 -23.01 64.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.492 0.717 . . . . 73.42 110.364 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -107.15 88.44 2.74 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.646 0.778 . . . . 52.34 108.995 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.37 136.7 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.888 0.875 . . . . 75.52 111.038 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.38 161.81 20.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.689 . . . . 64.35 110.43 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.57 HG23 ' HB ' ' A' ' 51' ' ' ILE . 76.1 mt -50.85 -47.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.173 0.989 . . . . 55.32 111.32 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -75.99 -23.99 55.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.333 0.653 . . . . 72.22 111.823 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -67.94 -46.4 71.56 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.658 0.383 . . . . 44.21 110.541 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 30.8 t -64.6 -42.73 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.092 0.473 . . . . 54.31 110.27 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.62 96.16 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.542 -0.754 . . . . 74.21 112.637 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.19 -22.07 55.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.96 0.504 . . . . 71.33 111.449 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -79.58 -44.95 20.1 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.236 0.614 . . . . 75.24 111.364 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -83.14 -13.71 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.852 1.056 . . . . 64.43 113.852 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.71 -30.08 60.53 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.009 1.114 . . . . 65.01 114.009 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.28 -24.41 67.27 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.623 0.769 . . . . 63.51 112.606 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 79' ' ' ALA . 19.5 mm -82.41 -44.37 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.836 0.854 . . . . 72.53 111.372 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.88 179.64 48.66 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 116.406 -0.361 . . . . 63.43 113.67 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.64 125.09 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.497 0.719 . . . . 74.23 111.549 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.7 mt -94.0 138.38 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 70.13 108.781 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.591 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 27.1 mtpp -57.73 155.02 10.73 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.068 0.547 . . . . 41.22 111.73 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.8 m -145.5 125.38 13.5 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.273 0.629 . . . . 70.02 111.155 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.33 125.85 30.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.778 -0.823 . . . . 62.13 108.778 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.3 -21.66 25.62 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.643 0.608 . . . . 74.44 112.643 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.26 -43.21 95.56 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.305 0.642 . . . . 74.3 111.713 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -82.72 -42.93 17.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.576 0.75 . . . . 70.04 110.117 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.51 56.02 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.392 -0.822 . . . . 71.32 111.893 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -110.44 147.09 35.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.105 0.962 . . . . 62.33 111.63 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 33.7 Cg_endo -64.99 142.19 73.82 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.594 2.196 . . . . 73.13 110.835 173.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.591 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 61.3 mtt -72.79 94.31 1.78 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.716 0.77 . . . . 71.44 110.34 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 27' ' ' ILE . 66.4 mt -144.93 119.81 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.042 1.337 . . . . 72.1 108.264 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 24.5 m-80 -102.7 110.77 22.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.114 -0.699 . . . . 74.13 109.114 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.69 124.35 28.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.903 0.881 . . . . 74.23 109.92 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.2 m-85 -80.33 110.43 15.76 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.647 0.779 . . . . 72.23 110.814 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -96.86 143.02 28.16 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 43.3 109.864 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.08 144.44 40.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 73.45 111.266 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.87 -46.47 30.04 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.447 0.699 . . . . 74.23 112.175 -171.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.11 -42.69 15.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.539 0.57 . . . . 74.25 112.539 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.5 p -81.95 -30.03 31.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.06 84.57 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 114.015 0.366 . . . . 55.21 114.015 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -99.19 164.89 11.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.014 0.926 . . . . 74.14 110.531 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.02 131.47 45.11 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.973 0.509 . . . . 72.33 111.622 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -75.66 -21.71 57.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.194 0.598 . . . . 52.25 111.82 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.77 26.66 31.46 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 116.073 -0.512 . . . . 60.31 112.902 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 3.6 mp0 -116.72 154.47 30.56 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.543 -0.975 . . . . 75.34 109.755 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -160.14 146.94 16.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.877 0.471 . . . . 61.15 111.513 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.9 p -104.16 117.89 35.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.973 -0.38 . . . . 63.41 109.973 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.93 108.08 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.621 0.769 . . . . 74.31 110.36 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 m -85.18 104.19 14.83 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.889 0.476 . . . . 72.12 110.821 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.4 m-85 -79.67 158.2 27.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.49 0.716 . . . . 74.12 110.788 169.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.64 -31.23 63.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.065 0.546 . . . . 71.35 111.349 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -118.73 134.17 23.56 Favored Pre-proline 0 N--CA 1.48 1.067 0 C-N-CA 123.053 0.541 . . . . 64.34 111.564 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.2 -34.9 99.02 Favored 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 122.523 2.149 . . . . 74.13 116.197 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.72 -29.35 77.19 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 122.867 2.059 . . . . 53.55 113.079 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -74.68 -40.85 61.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.223 0.609 . . . . 52.4 110.396 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.86 84.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.541 -0.754 . . . . 72.05 111.098 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.34 -44.85 90.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.11 111.296 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.891 0.476 . . . . 61.11 111.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 37' ' ' ILE . . . -60.76 -34.21 74.11 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.407 0.683 . . . . 53.35 112.232 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 95' ' ' VAL . 71.9 mt -69.19 -54.98 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.831 0.452 . . . . 74.04 110.49 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.42 -33.1 69.3 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.768 0.827 . . . . 63.12 111.921 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -80.57 -56.46 4.15 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.691 0.796 . . . . 64.23 112.17 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' ILE . 61.7 m-85 -86.65 -11.64 50.73 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 114.457 1.28 . . . . 74.34 114.457 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -63.87 116.12 5.5 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.578 0.626 . . . . 72.33 110.322 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.73 5.55 74.23 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 114.871 0.708 . . . . 50.04 114.871 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.84 159.59 14.9 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 117.949 0.874 . . . . 70.5 111.767 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.41 115.79 27.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.64 0.376 . . . . 62.03 111.651 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 91.2 t80 -70.28 -56.34 7.0 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.997 0.919 . . . . 73.32 110.925 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -147.18 63.01 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.908 0.861 . . . . 62.43 109.151 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.37 0.28 66.25 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 115.093 -0.958 . . . . 75.4 113.692 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.13 121.28 36.9 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 51.42 110.7 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.8 98.98 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.736 2.291 . . . . 70.11 112.666 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.438 HG21 HD23 ' A' ' 21' ' ' LEU . 28.0 pt -71.22 148.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.591 0.96 . . . . 70.23 113.591 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -115.39 104.94 12.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.67 1.188 . . . . 54.32 108.416 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 18' ' ' VAL . 15.1 t -102.16 131.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.671 0.388 . . . . 73.13 110.137 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.3 p -136.55 178.65 6.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.503 1.121 . . . . 40.23 109.779 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.465 ' HB3' HD21 ' A' ' 13' ' ' ASN . 78.1 m-85 -80.9 145.13 31.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.681 0.392 . . . . 65.22 110.076 169.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.19 7.7 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.031 0.443 . . . . 74.34 109.983 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.573 1.84 0 C-N-CA 123.733 0.813 . . . . 65.34 110.835 -178.785 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 111.433 0.16 . . . . 61.2 111.433 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.58 76.01 0.53 Allowed Glycine 0 C--N 1.354 1.58 0 C-N-CA 122.895 0.283 . . . . 55.22 113.142 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -81.0 131.17 35.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.149 0.98 . . . . 74.41 111.383 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.15 -27.77 65.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.622 0.601 . . . . 74.34 112.622 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -73.89 141.73 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.38 0.511 . . . . 74.05 112.38 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -81.0 -19.7 43.42 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.568 0.747 . . . . 73.25 111.486 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -145.02 140.52 28.21 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 53.31 110.334 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -84.26 83.51 7.95 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.289 0.636 . . . . 61.11 110.785 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -89.49 130.94 35.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.739 0.816 . . . . 62.43 111.176 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.37 -33.82 76.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.748 0.419 . . . . 62.12 111.583 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 p -76.64 91.97 3.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.357 0.663 . . . . 64.25 110.869 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.42 110.46 4.15 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.045 -0.724 . . . . 75.12 109.045 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -58.86 121.85 12.15 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.455 0.702 . . . . 71.3 112.31 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -97.17 -6.67 34.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.592 0.757 . . . . 53.34 111.767 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -101.25 130.18 47.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 64.55 109.917 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 43.4 pt -110.71 153.07 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.517 0.727 . . . . 70.22 110.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -111.08 128.46 55.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.147 0.579 . . . . 71.54 109.49 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 95' ' ' VAL . 10.7 t -121.11 141.34 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.775 0.83 . . . . 54.33 110.324 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -123.8 155.42 38.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.413 1.085 . . . . 73.21 110.169 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 23.19 63.23 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 114.713 0.645 . . . . 74.34 114.713 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 93' ' ' ILE . 77.1 mt -64.52 -34.56 78.52 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.169 0.988 . . . . 73.04 111.885 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.25 21.9 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.154 -0.93 . . . . 53.31 111.119 -168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.92 -4.78 56.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 117.827 0.814 . . . . 75.22 112.636 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -94.01 17.56 12.14 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.233 0.613 . . . . 72.33 110.711 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 88' ' ' PHE . 8.2 p -75.83 140.49 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 124.159 0.984 . . . . 73.12 112.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' VAL . 50.1 p -125.05 158.46 33.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.357 0.663 . . . . 72.34 110.214 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.2 mt -59.57 -35.09 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.834 0.454 . . . . 72.12 110.777 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.27 -46.78 88.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.605 0.762 . . . . 73.34 111.388 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -61.83 -43.28 99.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.581 0.752 . . . . 62.02 111.767 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' THR . 48.1 t -66.13 -45.68 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 121.047 0.451 . . . . 75.25 110.64 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -64.65 -33.98 77.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.677 -0.692 . . . . 43.05 111.996 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.23 -33.77 59.21 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.292 0.637 . . . . 71.53 111.644 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -74.56 -53.33 9.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 74.34 111.424 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 48.3 m-85 -78.68 -17.56 55.74 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 113.729 1.011 . . . . 72.31 113.729 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 64.9 pttt -58.29 -28.71 65.24 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.528 0.936 . . . . 74.42 113.528 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.35 -22.88 63.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.552 0.741 . . . . 63.23 112.357 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mm -81.38 -41.13 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.097 0.959 . . . . 73.25 111.094 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.28 -171.64 44.75 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.014 -0.539 . . . . 71.52 113.184 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.97 127.11 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.063 0.545 . . . . 44.53 110.257 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.2 mt -94.56 137.02 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.148 0.979 . . . . 61.32 108.954 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.4 mtpt -59.03 146.37 38.57 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.548 0.69 . . . . 70.11 111.707 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 50.5 m -129.29 125.27 36.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.728 -1.124 . . . . 74.52 109.583 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -57.22 107.51 0.43 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 109.082 -0.71 . . . . 53.34 109.082 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.64 -19.4 65.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.018 0.927 . . . . 73.52 112.827 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -78.59 -48.6 14.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.449 0.699 . . . . 74.33 111.65 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -85.13 -38.54 18.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.229 0.612 . . . . 75.14 111.821 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.77 2.67 61.19 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 115.927 -0.579 . . . . 42.11 112.636 -172.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -99.1 144.2 27.79 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.053 0.941 . . . . 65.41 111.777 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 38.2 Cg_endo -66.11 139.64 56.53 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.852 2.368 . . . . 65.52 111.811 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.0 mtt -72.73 93.37 1.65 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.669 0.747 . . . . 73.25 109.586 -175.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.555 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -147.0 120.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.948 1.299 . . . . 74.51 108.602 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.55 110.55 22.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 110.027 -0.36 . . . . 71.22 110.027 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.34 129.22 34.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.854 0.862 . . . . 65.32 109.835 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 92.6 m-85 -89.13 117.32 28.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.487 0.715 . . . . 72.01 110.244 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 m -99.14 150.62 21.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.17 0.988 . . . . 74.34 110.196 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.25 132.27 35.82 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.585 0.754 . . . . 64.24 109.842 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -70.17 -32.67 70.73 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.662 0.785 . . . . 71.41 112.249 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.8 -52.68 5.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.64 0.776 . . . . 71.34 111.557 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 p -82.11 -30.31 31.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.53 0.732 . . . . 72.21 112.323 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.76 89.43 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.501 -0.318 . . . . 71.14 113.498 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -102.17 155.7 18.04 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.767 0.827 . . . . 72.1 109.808 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.42 136.57 57.97 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.914 0.486 . . . . 72.11 111.776 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -72.09 -15.28 62.0 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.278 0.631 . . . . 55.1 112.284 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.77 31.06 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.689 -0.564 . . . . 73.24 111.689 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 52.0 mt-10 -130.9 149.13 52.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.064 0.946 . . . . 75.33 109.566 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.71 154.25 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.748 0.647 . . . . 65.21 112.748 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 25.1 p -109.43 116.12 31.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.851 -0.613 . . . . 71.24 111.007 173.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.66 109.71 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.466 0.706 . . . . 75.5 110.113 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 69.2 m -83.52 102.84 12.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.693 0.397 . . . . 65.12 110.772 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 56.3 m-85 -78.89 153.78 30.26 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.903 0.481 . . . . 72.04 110.842 170.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.05 -34.38 61.84 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.828 -0.624 . . . . 65.55 111.143 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -111.91 130.2 23.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.054 0.542 . . . . 63.31 111.032 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -49.84 -38.11 46.82 Favored 'Trans proline' 0 CA--C 1.583 2.936 0 C-N-CA 123.334 2.69 . . . . 72.5 116.305 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.37 -28.68 78.62 Favored 'Trans proline' 0 C--N 1.403 3.434 0 CA-C-N 122.477 1.92 . . . . 33.45 113.934 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 m -73.42 -39.45 65.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 74.34 110.038 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.87 79.94 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.474 0.71 . . . . 62.5 111.052 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -59.96 -51.42 69.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.242 1.017 . . . . 62.35 111.149 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.75 90.7 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.005 -0.543 . . . . 61.54 112.156 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.24 72.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.45 0.7 . . . . 61.32 112.506 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 95' ' ' VAL . 70.2 mt -63.29 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.03 0.532 . . . . 74.5 111.05 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.34 -30.05 69.28 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.347 -0.842 . . . . 65.44 111.985 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -79.06 -59.53 2.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.954 0.501 . . . . 73.04 111.675 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.606 ' HB3' HD11 ' A' ' 93' ' ' ILE . 27.4 m-85 -80.78 -10.55 59.72 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.965 1.098 . . . . 75.13 113.965 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -65.76 111.19 3.11 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.548 0.613 . . . . 72.1 109.992 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.27 1.4 60.95 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.794 -0.639 . . . . 63.21 114.307 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.7 mmtt -96.37 149.29 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.261 0.624 . . . . 74.32 111.036 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -87.52 128.06 35.24 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.083 -0.386 . . . . 71.1 111.376 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' HG21 ' A' ' 93' ' ' ILE . 53.8 t80 -81.75 -73.63 0.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.399 0.68 . . . . 60.12 110.603 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 t -119.96 53.11 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.75 0.786 . . . . 65.11 109.814 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.73 90.11 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 115.37 -0.832 . . . . 50.35 113.322 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -122.57 126.73 26.06 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.048 0.939 . . . . 62.4 109.895 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 132.04 25.65 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.089 2.526 . . . . 62.11 112.52 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.3 pt -107.56 153.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.219 0.608 . . . . 73.22 111.857 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -121.8 126.82 49.69 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.003 0.921 . . . . 44.31 108.575 172.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 18' ' ' VAL . 16.2 t -114.55 143.89 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 122.943 0.497 . . . . 63.54 111.156 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 m -147.12 -177.08 5.48 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.807 1.643 . . . . 73.14 109.057 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 53.7 m-85 -87.38 147.82 25.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.699 0.681 . . . . 65.53 110.603 168.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.92 85.69 6.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.584 0.753 . . . . 73.21 109.752 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 123.658 0.783 . . . . 73.25 111.405 -175.015 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.568 -0.16 . . . . 75.0 110.568 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.6 -77.15 0.28 Allowed Glycine 0 C--N 1.344 1.01 0 O-C-N 122.375 -0.203 . . . . 70.41 112.636 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -73.32 162.26 29.55 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.245 0.618 . . . . 72.03 111.178 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 59.7 27.27 16.49 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.271 1.029 . . . . 74.41 112.562 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -76.25 129.82 37.25 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.036 0.534 . . . . 65.31 111.372 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -81.17 136.68 35.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.363 0.505 . . . . 74.04 112.363 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -46.28 109.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.879 1.272 . . . . 60.21 112.919 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -73.72 -29.14 62.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.612 0.597 . . . . 75.23 112.612 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -109.34 152.34 25.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.47 0.708 . . . . 64.23 112.197 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -121.81 16.0 10.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.378 1.071 . . . . 71.43 111.458 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -146.94 -49.21 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.574 0.75 . . . . 71.33 110.055 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.55 84.75 2.61 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.791 0.805 . . . . 74.54 110.377 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' ' 97' ' ' PHE . 36.4 t30 -159.75 131.57 6.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.606 1.162 . . . . 73.31 108.305 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -97.05 -24.12 15.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.974 0.51 . . . . 51.33 111.641 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -95.45 125.18 39.89 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.989 0.516 . . . . 72.31 109.944 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.531 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.4 pt -120.95 140.61 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.156 0.583 . . . . 75.43 112.23 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -95.32 127.62 41.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.132 0.491 . . . . 75.12 110.554 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 95' ' ' VAL . 14.9 t -120.57 137.26 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.458 1.103 . . . . 64.25 109.985 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.42 156.26 31.79 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.046 0.938 . . . . 74.32 110.778 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 2.28 82.98 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 114.468 0.547 . . . . 64.53 114.468 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB3' HG21 ' A' ' 25' ' ' VAL . 96.0 mt -57.21 -20.87 29.65 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.834 1.05 . . . . 61.22 113.834 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.32 162.0 35.15 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.055 0.382 . . . . 73.11 114.055 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.21 -21.34 61.42 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.211 0.604 . . . . 75.44 111.787 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -92.45 2.58 56.58 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.004 0.922 . . . . 74.43 111.18 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 21' ' ' LEU . 11.1 p -66.54 147.53 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.53 0.732 . . . . 74.34 112.242 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.6 p -128.19 157.4 40.93 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.381 0.672 . . . . 72.44 110.367 172.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' A' ' 51' ' ' ILE . 71.5 mt -54.14 -41.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.156 0.982 . . . . 74.32 111.381 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.95 -29.27 62.96 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.367 0.667 . . . . 74.52 112.28 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 m -70.94 -43.56 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.567 0.347 . . . . 73.01 111.199 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.07 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 120.946 0.403 . . . . 63.54 110.022 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.08 96.36 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.498 0.719 . . . . 64.43 112.254 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -34.5 75.12 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.63 0.772 . . . . 72.41 111.071 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.13 -51.86 19.43 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.524 0.73 . . . . 74.11 110.882 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -80.9 -14.61 57.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.86 1.059 . . . . 73.01 113.86 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -54.89 -33.34 61.91 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.8 0.666 . . . . 63.44 112.8 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.97 -23.34 66.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.88 0.872 . . . . 73.42 112.67 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.31 -50.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.712 0.805 . . . . 53.22 111.277 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.35 -178.73 43.54 Favored Glycine 0 C--O 1.24 0.514 0 CA-C-N 115.35 -0.841 . . . . 53.41 113.012 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.3 mt -69.29 122.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 123.332 0.653 . . . . 74.22 110.317 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.1 mt -92.81 135.42 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.809 0.844 . . . . 51.41 108.835 171.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 29.3 mtpp -56.26 154.47 8.02 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.96 0.504 . . . . 64.24 111.591 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.0 m -138.64 122.35 17.53 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.169 0.588 . . . . 62.33 111.007 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -65.93 112.25 3.71 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.25 -1.019 . . . . 63.41 108.25 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -82.8 -12.23 57.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.942 0.497 . . . . 73.13 112.289 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -74.6 -47.77 30.47 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.605 0.762 . . . . 74.41 110.514 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -83.3 -39.37 20.9 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.63 0.772 . . . . 73.41 111.127 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.7 16.13 52.85 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.305 -0.861 . . . . 63.52 112.742 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -114.75 149.88 43.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.051 0.94 . . . . 61.52 111.299 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.49 151.32 85.54 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.584 2.189 . . . . 70.22 112.74 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.508 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.1 mtt -78.3 93.1 4.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.666 0.745 . . . . 63.3 109.147 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.0 mt -141.42 114.35 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.576 -1.268 . . . . 74.41 107.576 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 109.57 21.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.398 -0.593 . . . . 73.32 109.398 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 66' ' ' ALA . 87.6 mt -79.11 125.16 29.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.538 0.735 . . . . 73.43 110.324 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 9.6 m-85 -78.12 126.31 30.62 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 72.55 110.429 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -116.91 143.45 45.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.847 0.859 . . . . 75.41 110.061 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -71.14 112.16 7.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.319 0.648 . . . . 63.35 109.971 168.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.926 0.49 . . . . 74.14 111.819 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 59' ' ' THR . 12.9 pt-20 -73.71 -43.82 58.14 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.871 0.868 . . . . 71.52 111.907 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.56 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -99.39 -50.08 4.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.466 0.706 . . . . 71.24 111.612 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.1 -1.37 28.4 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.521 -0.763 . . . . 53.42 112.652 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -98.12 160.06 14.54 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.635 0.774 . . . . 72.01 111.271 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.69 136.58 51.22 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.203 0.601 . . . . 65.33 111.901 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.85 -17.99 65.16 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.729 0.812 . . . . 61.22 112.398 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.38 33.86 21.59 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 121.318 0.399 . . . . 52.31 112.446 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.8 mt-10 -135.16 155.9 49.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.169 0.988 . . . . 70.22 109.948 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -164.03 152.56 13.27 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.219 0.533 . . . . 73.31 112.14 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 21.7 p -104.59 123.95 48.45 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.576 -0.738 . . . . 72.23 110.186 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 t -104.6 109.16 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.709 0.804 . . . . 70.14 109.816 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.1 m -86.76 100.47 12.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.53 0.332 . . . . 64.41 110.816 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 56.2 m-85 -75.55 160.57 30.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.372 0.669 . . . . 55.25 111.134 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.0 -30.31 39.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.514 0.726 . . . . 72.32 111.188 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -114.49 132.76 22.68 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.381 0.672 . . . . 63.15 110.866 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.98 -36.14 95.47 Favored 'Trans proline' 0 CA--C 1.586 3.116 0 C-N-CA 122.547 2.165 . . . . 72.14 115.956 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.1 -28.0 65.35 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 122.701 2.0 . . . . 73.11 113.356 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -69.77 -39.85 76.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.573 0.701 . . . . 22.24 110.211 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.86 -49.27 76.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.865 -1.061 . . . . 63.4 111.413 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -60.24 -45.44 93.22 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.208 1.003 . . . . 62.43 111.17 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.42 97.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.838 -0.619 . . . . 64.53 111.797 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.88 72.25 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.203 0.601 . . . . 74.43 112.482 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.34 -63.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.047 0.539 . . . . 73.32 110.684 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.12 -31.19 66.92 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.747 0.819 . . . . 73.42 112.105 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -78.75 -59.76 2.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.656 0.783 . . . . 74.14 111.668 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 95' ' ' VAL . 39.2 m-85 -87.45 -11.48 48.93 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.449 1.277 . . . . 71.32 114.449 -170.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.28 119.48 10.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.289 -0.634 . . . . 63.41 109.289 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.44 87.74 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.977 0.751 . . . . 64.34 114.977 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.9 150.14 21.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.714 0.806 . . . . 74.41 112.061 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.11 123.87 27.37 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.054 0.761 . . . . 72.03 113.054 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -125.13 133.04 52.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 74.33 108.373 167.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 t 62.58 11.43 4.75 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.531 1.132 . . . . 74.43 113.362 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.62 20.03 10.55 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 114.94 0.736 . . . . 61.32 114.94 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -154.04 146.33 17.3 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 118.22 1.01 . . . . 71.23 111.193 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.82 104.06 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.332 2.021 . . . . 74.22 112.733 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.31 165.21 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.356 0.662 . . . . 71.43 112.418 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 94' ' ' LYS . 9.3 mmpt? -121.01 117.72 27.99 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.28 1.032 . . . . 62.13 109.79 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 18' ' ' VAL . 21.9 t -114.53 136.71 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.062 0.545 . . . . 71.43 110.546 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -153.6 175.68 12.94 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.538 1.135 . . . . 75.15 109.997 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' HB3' HD22 ' A' ' 13' ' ' ASN . 44.7 m-85 -67.62 146.14 54.15 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 118.562 0.619 . . . . 73.11 111.828 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.72 97.22 5.09 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.514 -0.551 . . . . 63.23 109.514 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 CA--C 1.556 1.182 0 C-N-CA 124.112 0.965 . . . . 73.44 110.869 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.342 -0.244 . . . . 74.33 110.342 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.53 100.92 1.29 Allowed Glycine 0 C--N 1.354 1.564 0 N-CA-C 111.904 -0.479 . . . . 73.44 111.904 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -62.26 -55.06 32.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.622 0.769 . . . . 73.13 111.482 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -98.41 78.24 2.41 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.829 0.452 . . . . 63.13 110.118 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -92.26 103.48 15.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.937 0.495 . . . . 71.11 110.009 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -126.48 145.16 50.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.206 1.002 . . . . 74.54 111.218 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -84.87 79.41 9.64 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.587 0.755 . . . . 72.32 110.768 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -89.95 137.51 32.28 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.118 -0.697 . . . . 72.43 109.118 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -75.97 140.01 41.82 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.411 0.684 . . . . 44.13 111.903 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -73.34 -26.56 61.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.161 0.584 . . . . 74.51 111.846 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -97.7 153.64 18.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.79 0.836 . . . . 11.4 111.168 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.28 176.72 7.1 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.442 0.697 . . . . 53.5 110.905 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -141.55 115.02 8.92 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.084 0.469 . . . . 73.12 110.633 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -101.18 -4.83 26.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.208 1.003 . . . . 71.24 111.512 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -99.47 125.93 45.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.007 0.523 . . . . 65.43 110.765 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.433 HG23 ' HB1' ' A' ' 76' ' ' ALA . 42.0 pt -110.11 152.27 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.847 0.859 . . . . 72.23 110.983 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -107.31 130.51 54.76 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 123.431 0.693 . . . . 75.12 109.827 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 95' ' ' VAL . 14.7 t -122.6 140.82 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.228 1.011 . . . . 43.43 110.259 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -118.66 164.35 15.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.925 1.29 . . . . 64.43 110.217 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.48 79.24 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 114.639 0.616 . . . . 72.21 114.639 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.1 -17.97 60.87 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.496 1.119 . . . . 65.24 112.705 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.95 173.03 48.7 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.151 0.42 . . . . 43.14 114.151 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.32 -19.67 61.62 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.594 0.757 . . . . 75.35 112.604 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.64 10.58 36.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.639 0.607 . . . . 71.01 112.639 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.32 128.92 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 122.997 0.519 . . . . 60.4 111.803 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 7.6 p -122.72 150.77 42.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.857 -0.527 . . . . 73.22 109.657 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.6 mt -54.38 -42.38 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.145 0.978 . . . . 72.3 111.706 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -39.42 80.58 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.181 0.592 . . . . 74.34 112.333 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.3 m -64.26 -41.7 96.82 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.914 0.486 . . . . 73.33 111.396 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' THR . 63.5 t -65.49 -43.27 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.022 0.529 . . . . 64.44 110.723 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.0 96.46 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.831 -0.622 . . . . 73.21 112.186 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.93 -30.72 62.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.371 0.669 . . . . 60.14 111.46 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -74.17 -53.86 8.98 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.693 0.797 . . . . 74.21 112.007 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 62.1 m-85 -77.46 -14.51 59.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.983 1.105 . . . . 62.34 113.983 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.14 -30.84 62.72 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.767 1.025 . . . . 71.31 113.767 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.58 -25.02 65.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.691 0.797 . . . . 43.12 113.037 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.2 mm -83.9 -52.76 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.461 0.704 . . . . 71.25 110.59 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.51 167.79 35.81 Favored Glycine 0 C--O 1.241 0.568 0 CA-C-N 116.08 -0.509 . . . . 64.15 113.391 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.18 128.04 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 51.4 109.538 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 83.3 mt -97.12 136.61 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.501 0.721 . . . . 54.44 109.09 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.5 mtpt -57.15 142.27 43.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.254 0.622 . . . . 74.43 111.951 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 75.3 m -132.73 127.16 34.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.696 0.798 . . . . 75.43 110.489 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -70.81 118.33 13.45 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.699 0.8 . . . . 70.12 109.154 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -77.06 -23.01 52.01 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.517 0.727 . . . . 71.23 111.796 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.95 -51.57 53.59 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.336 0.654 . . . . 73.42 110.72 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -84.74 -37.11 21.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.153 0.581 . . . . 71.32 111.838 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.11 -2.86 59.9 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 116.025 -0.534 . . . . 72.11 113.076 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -99.74 147.77 33.86 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.262 1.025 . . . . 75.35 112.355 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 39.7 Cg_endo -67.6 149.27 79.42 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.655 2.236 . . . . 71.03 112.775 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 53.1 mtt -78.33 94.74 4.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 64.01 109.973 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.96 123.86 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.992 1.317 . . . . 61.31 108.027 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -106.4 108.66 20.28 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.577 -0.527 . . . . 74.33 109.577 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.8 mt -83.08 117.71 23.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.239 0.616 . . . . 74.44 109.677 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HE1' HG23 ' A' ' 67' ' ' THR . 30.5 m-85 -70.29 105.36 2.96 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.089 0.556 . . . . 74.32 111.106 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -89.82 147.37 23.83 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.596 -0.729 . . . . 53.54 109.233 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.85 125.89 30.28 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.54 0.736 . . . . 62.02 109.907 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -70.15 -21.8 63.04 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.976 0.732 . . . . 70.35 112.976 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.71 -57.94 2.42 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.28 0.632 . . . . 71.14 111.128 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.2 p -82.67 -20.25 36.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.048 0.539 . . . . 72.05 112.279 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.75 -1.19 74.29 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 114.937 0.735 . . . . 63.32 114.937 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -101.81 160.73 14.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.26 0.624 . . . . 73.21 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.78 126.37 28.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.792 0.437 . . . . 40.55 111.133 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.89 -16.52 64.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.07 0.948 . . . . 71.43 112.242 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.33 25.23 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.991 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -133.24 150.54 51.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.09 0.956 . . . . 73.2 109.164 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.76 157.38 18.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.58 0.585 . . . . 74.34 112.58 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.404 HG23 ' HE1' ' A' ' 54' ' ' TYR . 27.2 p -117.24 117.2 28.89 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.093 0.557 . . . . 73.32 111.074 173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.47 111.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.32 1.048 . . . . 75.41 110.353 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m -85.85 103.18 14.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.509 0.323 . . . . 53.3 111.004 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 33.5 m-85 -76.4 164.55 25.89 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.024 0.53 . . . . 74.02 110.499 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.73 -40.4 61.3 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.023 0.529 . . . . 75.12 109.934 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.89 129.39 24.22 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.49 0.716 . . . . 62.21 110.916 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.17 -37.65 87.62 Favored 'Trans proline' 0 CA--C 1.587 3.144 0 C-N-CA 122.669 2.246 . . . . 65.31 115.471 165.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.51 -27.62 61.96 Favored 'Trans proline' 0 C--N 1.406 3.59 0 CA-C-N 122.386 1.888 . . . . 71.0 113.426 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.9 m -72.84 -39.0 66.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.284 0.564 . . . . 73.45 110.363 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -59.43 -52.14 66.89 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.227 -0.897 . . . . 60.42 110.898 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tmtp? -64.26 -42.55 96.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.77 0.828 . . . . 72.03 111.841 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.17 96.7 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.698 0.399 . . . . 70.33 111.68 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.53 71.64 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.397 0.679 . . . . 43.43 112.257 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 77' ' ' LYS . 81.6 mt -62.26 -61.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 122.684 0.394 . . . . 73.4 110.282 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 -33.8 67.63 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.742 0.817 . . . . 72.2 112.299 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -77.91 -54.55 6.19 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.722 0.809 . . . . 75.14 112.151 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.62 -12.78 30.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.246 1.202 . . . . 75.21 114.246 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.41 126.87 29.19 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.739 0.7 . . . . 72.24 110.452 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.29 1.71 90.45 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.044 0.778 . . . . 63.35 115.044 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 75.3 mmtt -92.0 -167.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.91 0.855 . . . . 74.44 111.775 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.17 125.86 44.33 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.138 0.575 . . . . 71.25 112.104 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 93' ' ' ILE . 66.6 t80 -77.32 -69.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.244 0.618 . . . . 53.11 111.455 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 m -133.83 75.29 1.59 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.666 0.786 . . . . 62.13 109.486 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.4 0.04 44.14 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 115.379 -0.828 . . . . 51.33 114.638 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.2 135.06 26.95 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.081 0.953 . . . . 54.12 111.895 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.4 Cg_exo -67.85 140.06 49.53 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.109 2.539 . . . . 72.23 113.357 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 88' ' ' PHE . 37.7 pt -123.36 151.83 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.32 1.048 . . . . 74.43 112.068 -173.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -118.72 122.48 42.59 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.086 -1.079 . . . . 74.31 108.086 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 18' ' ' VAL . 18.9 t -112.29 141.17 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.506 . . . . 73.02 110.655 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.0 p -152.3 -179.78 7.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.289 1.436 . . . . 70.13 109.041 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -73.81 150.42 41.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.772 0.714 . . . . 62.33 110.944 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.68 88.87 7.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.026 0.53 . . . . 54.43 110.293 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.498 0 C-N-CA 123.953 0.901 . . . . 75.41 110.945 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 110.21 -0.293 . . . . 64.14 110.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.77 -146.07 50.16 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 122.893 0.282 . . . . 70.33 113.392 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -107.98 -20.61 13.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.668 . . . . 52.42 111.503 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -156.39 84.37 0.98 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-O 121.856 0.836 . . . . 73.24 111.455 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -132.07 120.22 22.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.548 0.739 . . . . 71.55 110.139 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -153.28 153.42 32.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 73.24 109.966 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.65 122.14 30.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.18 0.592 . . . . 74.3 110.481 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -70.67 112.85 7.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.669 0.388 . . . . 72.01 110.092 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -122.53 125.58 46.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.173 0.589 . . . . 73.03 111.826 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -78.57 70.61 4.95 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.812 0.815 . . . . 70.43 109.087 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.1 m -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.157 0.983 . . . . 53.23 112.079 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.47 80.1 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.374 1.07 . . . . 75.14 111.063 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -94.57 168.42 10.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.197 0.599 . . . . 74.14 110.393 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -95.18 11.75 31.24 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 111.747 0.277 . . . . 74.44 111.747 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.8 m -138.16 125.83 22.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.788 -0.449 . . . . 74.3 109.788 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.0 pt -109.6 143.12 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 122.779 0.432 . . . . 60.01 112.101 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -96.8 110.66 23.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.468 -0.567 . . . . 75.12 109.468 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 5.9 t -104.96 138.37 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.611 0.764 . . . . 71.45 110.103 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -120.71 166.48 13.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.282 1.033 . . . . 74.45 110.218 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.15 31.72 72.22 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 114.519 0.568 . . . . 73.2 114.519 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -81.91 -17.11 48.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.205 1.002 . . . . 74.33 112.355 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.99 168.61 40.69 Favored Glycine 0 N--CA 1.475 1.271 0 N-CA-C 114.133 0.413 . . . . 53.45 114.133 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 62' ' ' LEU . 13.5 pt-20 -74.69 -13.38 60.61 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.426 0.69 . . . . 75.23 112.599 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.61 -3.55 58.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.621 0.768 . . . . 73.24 111.895 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.72 127.53 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 N-CA-C 113.161 0.801 . . . . 73.24 113.161 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -122.93 154.22 38.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.385 0.674 . . . . 74.43 110.042 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.7 mt -57.25 -42.72 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.533 0.733 . . . . 74.41 111.736 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.35 -40.39 95.77 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.634 0.774 . . . . 74.3 111.463 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.2 t -65.82 -45.02 83.82 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.88 0.472 . . . . 74.24 111.282 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 26' ' ' THR . 60.2 t -62.83 -42.08 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.27 0.557 . . . . 62.4 110.278 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.519 -0.764 . . . . 74.52 112.172 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.79 -35.7 80.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.758 0.823 . . . . 55.34 111.271 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -71.92 -55.98 6.51 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.93 0.892 . . . . 73.45 111.031 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.0 m-85 -79.71 -16.59 55.38 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.147 1.166 . . . . 71.43 114.147 -172.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.71 -24.17 66.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.729 1.011 . . . . 75.13 113.729 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.96 -23.94 65.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.335 0.654 . . . . 64.23 112.686 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.7 mm -86.86 -45.99 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 51.52 111.812 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.63 174.67 45.72 Favored Glycine 0 C--O 1.24 0.505 0 CA-C-N 115.709 -0.678 . . . . 64.04 113.123 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.0 mt -67.54 123.62 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.499 0.72 . . . . 74.14 111.339 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 74.2 mt -94.08 130.8 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.446 1.098 . . . . 64.33 108.41 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.8 mtpp -54.64 146.57 16.35 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.498 0.719 . . . . 60.04 112.193 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 99.6 m -126.93 138.53 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.196 0.998 . . . . 73.31 109.352 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -78.27 128.68 34.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.651 0.781 . . . . 55.54 109.68 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -67.48 -40.13 85.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.789 0.836 . . . . 73.24 111.856 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.93 -49.6 75.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.718 0.807 . . . . 63.3 112.029 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -87.11 -47.04 9.23 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.158 0.583 . . . . 73.42 111.753 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.6 14.6 49.65 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 116.276 -0.42 . . . . 74.13 112.624 -171.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -117.56 151.92 48.92 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 124.338 1.055 . . . . 73.33 111.447 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.0 Cg_endo -67.22 146.65 76.71 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.743 2.295 . . . . 73.43 112.633 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.537 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.2 mtt -77.95 96.57 5.07 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.319 0.58 . . . . 71.34 110.014 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' A' ' 27' ' ' ILE . 83.4 mt -143.07 118.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.61 1.164 . . . . 74.23 108.363 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.5 m-20 -98.7 108.27 20.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.285 -0.635 . . . . 71.1 109.285 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -80.04 130.15 35.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.524 -0.547 . . . . 65.15 109.524 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 84.1 m-85 -89.78 121.85 32.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.994 0.518 . . . . 63.45 110.438 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -115.56 145.95 42.18 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.381 1.072 . . . . 72.33 110.167 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.53 104.81 1.66 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.95 0.5 . . . . 73.42 110.063 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -64.15 -22.65 67.02 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.72 0.808 . . . . 62.22 111.648 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.99 -56.09 5.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.561 0.744 . . . . 71.32 111.633 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -86.66 -49.02 7.8 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.287 0.635 . . . . 74.52 111.486 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.49 -3.16 27.88 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.858 -0.61 . . . . 74.03 113.453 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.09 153.12 23.94 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.297 0.639 . . . . 74.34 111.044 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 23' ' ' GLU . 95.4 mt -68.01 135.61 52.58 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.006 0.522 . . . . 60.53 110.502 174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' A' ' 54' ' ' TYR . 50.2 mtpt -68.26 -26.16 65.54 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.069 0.548 . . . . 73.4 112.092 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.41 38.72 8.78 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.598 -0.601 . . . . 73.31 111.598 -168.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.1 mt-10 -134.8 158.02 45.27 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.735 0.814 . . . . 72.22 110.245 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.69 160.33 28.43 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 54.33 112.017 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 p -117.41 114.31 23.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.939 0.496 . . . . 73.35 110.296 167.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.29 104.56 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.966 0.906 . . . . 74.54 109.757 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 56.0 m -82.65 102.59 11.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.68 0.392 . . . . 71.12 111.708 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 57.9 m-85 -80.22 160.07 25.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.807 0.843 . . . . 72.24 109.736 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.53 -31.24 47.42 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.485 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -110.38 130.16 23.18 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.768 0.827 . . . . 61.23 110.719 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.08 -40.46 81.45 Favored 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.181 1.921 . . . . 74.12 115.164 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.58 -31.5 87.16 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 122.406 1.895 . . . . 62.34 113.973 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m -69.49 -43.12 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.167 0.587 . . . . 72.12 109.963 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.5 -49.34 75.76 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.983 -1.008 . . . . 75.21 111.107 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -60.21 -48.43 81.77 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.708 1.203 . . . . 62.04 111.19 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.09 -35.59 80.91 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.139 0.576 . . . . 73.34 112.192 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.42 -32.12 69.89 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.824 0.45 . . . . 61.41 111.913 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 95' ' ' VAL . 59.8 mt -64.45 -59.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.787 0.435 . . . . 75.33 110.102 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -55.83 -32.43 63.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.791 0.837 . . . . 75.25 112.924 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -78.47 -59.91 2.59 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.351 0.66 . . . . 64.32 111.173 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 93' ' ' ILE . 69.6 m-85 -84.41 -15.29 46.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.639 1.348 . . . . 71.45 114.639 -169.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.55 115.69 4.92 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 118.574 0.625 . . . . 53.42 110.444 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.45 58.34 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.768 -0.462 . . . . 62.04 114.193 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.451 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.1 mmtt -93.46 147.17 23.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.818 0.847 . . . . 73.21 110.674 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.09 124.4 31.07 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 122.232 -0.292 . . . . 63.32 111.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.426 ' HB2' HG21 ' A' ' 93' ' ' ILE . 54.3 t80 -84.35 -81.24 0.18 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.139 -0.689 . . . . 75.13 109.139 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.0 m -106.18 70.41 0.84 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.325 -0.62 . . . . 72.12 109.325 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.93 -3.76 34.69 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.963 0.745 . . . . 73.32 114.963 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -121.31 130.15 24.94 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 123.579 0.752 . . . . 75.53 110.89 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.62 120.01 7.09 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.868 2.379 . . . . 71.14 111.76 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.4 pt -88.57 146.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.232 0.539 . . . . 64.21 112.352 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -109.6 110.44 21.51 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.069 -1.086 . . . . 63.12 108.069 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 7.0 t -101.66 132.07 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.426 -0.583 . . . . 62.03 109.426 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -138.29 172.64 12.61 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.176 0.99 . . . . 50.25 109.438 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -71.97 142.95 49.38 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.146 0.43 . . . . 75.5 110.03 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 66.51 8.67 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.999 0.904 . . . . 40.04 110.659 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.557 1.244 0 CA-C-N 114.842 -1.072 . . . . 63.34 110.862 179.463 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.752 0.31 . . . . 73.12 110.65 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.02 -53.65 4.86 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 116.182 -0.463 . . . . 70.01 113.72 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -80.25 129.07 34.24 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.374 0.67 . . . . 72.23 110.967 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -63.8 137.54 58.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.402 0.681 . . . . 62.53 111.058 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -72.19 102.29 3.02 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 120.66 0.267 . . . . 62.12 111.408 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -62.69 -42.39 99.61 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.063 0.459 . . . . 53.03 110.353 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -73.08 130.03 39.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.352 0.661 . . . . 74.2 109.315 170.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -89.39 133.4 34.53 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.026 0.53 . . . . 73.33 111.355 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m -79.92 74.9 6.66 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.367 -0.975 . . . . 74.03 108.367 164.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -136.37 112.52 9.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.404 -0.816 . . . . 75.43 110.343 -168.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -140.55 97.32 3.18 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.377 -0.972 . . . . 73.31 108.377 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -54.38 125.84 20.97 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.066 1.135 . . . . 55.15 114.066 -167.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.18 132.41 35.91 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.944 0.898 . . . . 72.13 110.188 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -93.15 -23.57 18.54 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.685 0.794 . . . . 73.11 111.556 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.4 m -97.58 126.05 42.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.819 0.448 . . . . 74.43 110.155 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 76' ' ' ALA . 34.7 pt -103.42 151.24 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.15 0.58 . . . . 73.04 111.202 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -110.06 119.78 40.36 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 74.2 109.508 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 95' ' ' VAL . 13.7 t -114.23 136.91 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.889 0.875 . . . . 73.23 110.44 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -117.48 162.18 18.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.265 1.026 . . . . 75.11 110.199 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.32 26.52 74.51 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 114.35 0.5 . . . . 73.12 114.35 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 93' ' ' ILE . 55.1 mt -71.7 -24.46 61.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.496 1.119 . . . . 72.31 111.981 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.36 161.42 36.57 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.447 -0.342 . . . . 44.15 112.811 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.69 -7.78 55.99 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.372 0.586 . . . . 70.34 111.595 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.19 11.94 17.29 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.001 0.921 . . . . 62.1 111.571 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.83 133.95 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 123.928 0.891 . . . . 54.24 112.476 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 p -133.73 155.2 50.18 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.671 0.788 . . . . 71.25 110.23 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.25 -39.54 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.217 0.607 . . . . 73.02 111.253 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.93 -49.91 74.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.834 0.854 . . . . 62.32 111.744 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 m -65.34 -43.44 90.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.088 0.555 . . . . 75.35 112.126 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.24 -40.84 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 122.901 0.48 . . . . 65.4 110.812 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.65 84.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.053 -0.521 . . . . 70.5 111.371 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.96 -27.94 67.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 70.41 111.92 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -77.18 -54.87 5.96 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.844 0.857 . . . . 74.41 111.978 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.85 -18.95 55.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.199 1.185 . . . . 71.3 114.199 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -57.24 -27.91 62.47 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 113.728 1.01 . . . . 74.25 113.728 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -58.2 -26.2 62.52 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.593 0.757 . . . . 74.12 112.758 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.24 -51.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 64.05 111.076 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.32 -177.01 46.72 Favored Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.861 -0.609 . . . . 70.53 113.259 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.04 118.31 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.253 0.621 . . . . 71.43 111.151 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.9 mt -87.95 123.08 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.177 -1.046 . . . . 53.3 108.177 169.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 54.3 mtpt -46.27 118.14 1.82 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.426 0.69 . . . . 72.12 112.423 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 80.7 m -103.96 115.56 30.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.335 0.654 . . . . 64.24 110.273 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -56.63 122.13 11.34 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.364 1.066 . . . . 74.1 110.592 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -80.75 -14.79 57.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.449 1.1 . . . . 72.42 112.583 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 10.0 mmpt? -84.83 -43.01 14.56 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.387 0.675 . . . . 73.41 111.249 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.8 p -85.98 -40.4 15.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.612 0.765 . . . . 75.22 111.553 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.76 64.92 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.086 -0.506 . . . . 70.51 112.025 -170.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -114.66 156.69 44.46 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 125.22 1.408 . . . . 62.13 110.824 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 65.2 Cg_endo -72.56 153.53 54.8 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.403 2.069 . . . . 40.22 112.852 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.524 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.5 mtt -83.7 95.73 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.99 0.916 . . . . 64.22 109.35 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -137.61 122.87 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 75.24 108.535 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -106.07 108.67 20.31 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.375 -0.602 . . . . 64.34 109.375 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.0 mt -89.37 129.52 35.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.728 0.811 . . . . 72.43 109.076 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' A' ' 63' ' ' LYS . 77.3 m-85 -89.19 124.44 34.36 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.574 0.35 . . . . 73.45 111.097 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.6 m -108.83 137.81 46.16 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.663 0.785 . . . . 73.33 110.201 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.54 136.05 47.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.777 0.831 . . . . 61.52 110.831 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -76.42 -24.3 53.98 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.13 0.789 . . . . 72.15 113.13 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -92.41 -55.4 3.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.842 0.457 . . . . 65.0 111.348 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -73.95 -30.63 62.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.771 0.828 . . . . 74.11 111.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.88 6.34 88.64 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.997 -0.547 . . . . 75.43 113.441 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -100.83 158.54 15.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.282 0.633 . . . . 70.5 111.511 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.62 130.91 44.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.168 0.587 . . . . 65.54 111.582 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' TYR . 97.2 mttt -66.43 -16.78 64.37 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.345 1.058 . . . . 61.05 112.697 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 29.07 56.22 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.267 -0.333 . . . . 63.42 112.267 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.67 146.23 52.07 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.416 1.086 . . . . 71.24 108.536 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.36 169.58 21.74 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.483 0.549 . . . . 62.52 112.483 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 p -123.56 130.82 53.24 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.982 -0.554 . . . . 54.11 111.089 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -110.1 109.52 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.669 0.788 . . . . 73.42 109.746 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -79.53 104.11 9.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.338 0.255 . . . . 64.03 111.143 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 48.9 m-85 -82.69 163.07 21.58 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 120.842 0.353 . . . . 74.43 110.187 169.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.31 -40.19 52.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.319 0.647 . . . . 74.43 110.836 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 11.7 m-20 -112.61 133.81 21.78 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.156 0.582 . . . . 75.31 111.706 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.17 -41.09 59.3 Favored 'Trans proline' 0 CA--C 1.584 3.015 0 C-N-CA 122.842 2.362 . . . . 63.24 116.028 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 69.8 Cg_endo -71.08 -20.92 28.12 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 122.526 1.938 . . . . 74.21 113.204 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 t -75.77 -39.5 56.92 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.574 0.702 . . . . 75.15 109.451 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.15 -45.17 95.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.056 -0.975 . . . . 70.14 110.623 173.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.1 -46.4 89.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.494 1.118 . . . . 73.34 110.882 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.79 97.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.172 0.589 . . . . 71.35 112.008 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.48 77.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 75.04 112.143 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 95' ' ' VAL . 83.7 mt -64.71 -57.91 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.216 0.607 . . . . 60.22 110.823 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.94 -32.92 68.28 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.11 0.964 . . . . 72.51 111.884 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.78 -54.45 5.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.236 0.615 . . . . 72.32 112.446 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 95' ' ' VAL . 58.8 m-85 -89.34 -6.52 56.61 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.872 1.064 . . . . 71.11 113.872 -171.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.6 124.45 22.39 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.266 0.485 . . . . 75.23 110.085 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.53 -0.84 89.22 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.041 -0.527 . . . . 71.24 114.017 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -97.57 170.5 8.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.537 0.735 . . . . 52.35 110.914 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.08 137.9 50.73 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.114 0.565 . . . . 53.21 111.78 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 93' ' ' ILE . 64.3 t80 -129.29 131.62 47.0 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.813 1.245 . . . . 75.25 108.526 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t 63.33 25.85 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.362 1.065 . . . . 70.31 111.537 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.01 88.1 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-N 116.049 -0.523 . . . . 34.05 113.706 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -115.02 117.24 41.88 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.341 1.056 . . . . 70.54 110.495 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.92 100.74 0.17 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.627 2.218 . . . . 62.43 113.066 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 HD23 ' A' ' 21' ' ' LEU . 40.3 pt -82.64 153.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.92 0.888 . . . . 74.03 113.368 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -114.91 110.25 19.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.076 1.351 . . . . 75.42 109.169 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 18' ' ' VAL . 23.8 t -103.87 131.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 122.151 -0.343 . . . . 63.44 110.096 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.1 p -142.79 179.29 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.608 1.163 . . . . 51.03 109.748 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -77.06 150.07 35.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.487 0.585 . . . . 64.54 110.772 169.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.82 87.94 7.48 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.094 0.473 . . . . 72.32 110.936 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.471 1.108 . . . . 64.3 110.822 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.65 0.262 . . . . 75.11 111.65 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.28 -60.21 0.24 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.313 -0.403 . . . . 74.4 112.754 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -81.65 99.77 9.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.945 0.498 . . . . 52.21 111.0 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -79.74 95.34 5.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.309 0.643 . . . . 70.22 110.543 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -139.87 116.93 11.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.89 0.876 . . . . 74.43 110.57 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -74.39 112.43 10.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.117 0.567 . . . . 74.54 109.693 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -75.95 122.53 24.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.88 0.472 . . . . 55.33 110.932 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -71.71 105.43 3.71 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.524 0.678 . . . . 73.21 110.796 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -154.41 28.35 0.45 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.442 0.697 . . . . 75.23 110.697 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -65.32 -60.55 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.848 -0.797 . . . . 75.22 108.848 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.3 t -85.97 124.04 31.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.423 0.689 . . . . 75.11 109.835 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.4 103.82 2.11 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.818 0.847 . . . . 71.3 111.087 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -90.13 122.72 33.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.639 0.376 . . . . 73.32 110.882 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -94.45 -13.14 26.5 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.773 0.829 . . . . 52.32 111.26 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -100.96 128.95 46.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 61.31 110.218 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.1 pt -110.85 151.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.423 0.689 . . . . 73.44 110.892 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -108.0 116.19 31.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.158 0.583 . . . . 72.34 109.724 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.3 t -107.76 142.1 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.251 1.02 . . . . 73.2 110.16 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -122.07 158.88 28.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.851 1.26 . . . . 74.32 110.171 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.55 38.98 95.29 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 114.509 0.563 . . . . 74.22 114.509 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.86 -31.86 27.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.648 1.179 . . . . 61.22 111.691 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.0 159.6 11.98 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 122.748 0.213 . . . . 63.51 113.489 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.71 -14.73 57.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.219 0.608 . . . . 75.41 111.302 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -88.92 3.89 49.87 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.728 0.811 . . . . 60.23 110.995 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.05 136.25 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.631 0.772 . . . . 71.45 111.585 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.7 p -129.05 151.92 49.21 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.945 -0.472 . . . . 62.0 110.194 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 51' ' ' ILE . 75.9 mt -52.8 -45.01 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.239 1.015 . . . . 74.35 112.032 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.82 -31.73 68.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.427 0.691 . . . . 53.24 112.528 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -75.37 -36.77 60.87 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.57 0.348 . . . . 64.24 111.684 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 26' ' ' THR . 63.6 t -65.88 -39.85 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.427 0.632 . . . . 72.11 109.599 172.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.92 99.52 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.913 -1.039 . . . . 73.55 111.65 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.84 -34.86 69.62 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.309 0.644 . . . . 73.34 111.679 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.27 -54.15 9.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.775 0.83 . . . . 75.23 111.508 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 38.6 m-85 -77.29 -18.28 57.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.635 1.346 . . . . 71.03 114.635 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.79 -21.47 64.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.511 1.3 . . . . 73.3 114.511 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -57.64 -26.09 61.11 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.413 0.685 . . . . 54.3 112.388 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 mm -85.65 -45.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 75.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.83 44.3 Favored Glycine 0 C--O 1.241 0.576 0 CA-C-N 116.077 -0.51 . . . . 33.04 113.302 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 122.84 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.555 0.742 . . . . 65.52 110.185 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.8 mt -92.51 124.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.071 -1.085 . . . . 71.11 108.071 173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -50.62 154.81 1.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.068 0.947 . . . . 75.0 112.902 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 87.2 m -137.5 127.25 25.42 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.559 -0.746 . . . . 52.21 110.824 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.34 113.94 4.42 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.686 -0.688 . . . . 63.25 109.417 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -78.01 -13.29 59.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.932 0.893 . . . . 63.35 112.172 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -80.67 -29.38 36.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.039 0.535 . . . . 75.41 112.289 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -103.21 -50.83 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.131 0.573 . . . . 64.3 110.893 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.58 10.64 28.6 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.563 -0.744 . . . . 73.2 112.364 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.63 145.31 30.38 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 64.21 111.637 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.27 145.74 93.31 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.842 2.361 . . . . 51.12 112.47 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 52.3 mtt -73.65 94.0 2.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.799 0.809 . . . . 73.22 109.739 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 27' ' ' ILE . 84.7 mt -145.78 120.93 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.507 -1.224 . . . . 60.34 108.369 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -101.29 110.33 22.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.496 -0.557 . . . . 61.32 109.496 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -78.71 136.09 37.33 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.098 -0.704 . . . . 63.41 109.098 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.2 111.03 22.72 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.253 0.621 . . . . 75.03 110.144 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -86.65 151.65 23.25 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.037 0.535 . . . . 64.13 110.087 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.98 142.19 28.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.914 0.886 . . . . 72.55 110.896 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -37.62 59.71 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.485 -0.779 . . . . 60.14 112.672 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -94.24 -43.85 8.25 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.705 0.402 . . . . 72.2 111.713 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -81.92 -33.71 30.25 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 118.008 0.367 . . . . 63.11 111.864 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.59 13.17 83.21 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 116.239 -0.437 . . . . 73.24 114.167 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -104.1 173.57 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.598 0.759 . . . . 74.15 110.286 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.28 123.31 22.71 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.792 0.33 . . . . 64.01 110.226 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.63 -21.68 66.5 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.125 0.97 . . . . 74.21 113.18 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 23.26 35.66 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 123.178 0.299 . . . . 65.53 112.412 -171.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -121.34 151.05 40.55 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.043 -0.681 . . . . 74.44 109.692 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.78 154.85 24.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 40.32 111.713 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.9 p -109.86 120.59 42.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.62 0.368 . . . . 63.53 110.08 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.67 111.65 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.696 0.798 . . . . 71.22 110.449 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 70.7 m -85.55 105.12 15.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.682 0.393 . . . . 75.2 111.166 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 52.1 m-85 -81.25 153.45 27.13 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.261 0.624 . . . . 64.42 110.074 168.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.29 -28.79 62.29 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.138 0.575 . . . . 74.44 111.233 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.61 127.97 26.35 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 123.72 0.808 . . . . 74.13 111.194 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.92 -34.31 85.63 Favored 'Trans proline' 0 CA--C 1.583 2.973 0 C-N-CA 123.008 2.472 . . . . 63.22 116.277 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.48 -28.06 62.14 Favored 'Trans proline' 0 C--N 1.4 3.284 0 CA-C-N 122.62 1.972 . . . . 64.14 113.39 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 m -75.1 -35.04 61.78 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.114 0.566 . . . . 62.15 110.004 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.33 -53.64 54.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.679 -0.691 . . . . 62.14 111.121 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -59.37 -44.43 92.74 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.936 0.895 . . . . 73.11 110.77 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.88 90.89 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.002 -0.545 . . . . 74.4 111.775 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.42 72.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.245 0.618 . . . . 74.32 112.327 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.45 HG12 HG12 ' A' ' 95' ' ' VAL . 83.0 mt -66.0 -58.37 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.992 0.517 . . . . 71.31 110.398 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.1 -26.21 68.44 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 115.327 -0.851 . . . . 71.53 111.919 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -81.0 -60.42 2.3 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.931 0.492 . . . . 75.24 111.754 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.52 -6.72 58.61 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.87 1.063 . . . . 72.44 113.87 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.39 106.27 0.73 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 118.118 0.417 . . . . 64.54 110.374 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.05 55.33 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.055 0.782 . . . . 72.51 115.055 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.41 -174.35 4.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.03 0.915 . . . . 71.21 110.616 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.6 127.42 37.04 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 122.922 0.489 . . . . 74.12 111.3 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -92.46 -87.91 0.21 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.861 0.464 . . . . 64.41 110.146 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.1 m -89.64 50.58 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.389 0.614 . . . . 72.01 109.907 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.17 4.9 69.64 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.883 -0.599 . . . . 63.53 113.915 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.68 134.09 21.01 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.725 0.81 . . . . 70.54 110.679 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.91 107.07 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.658 2.905 . . . . 53.2 112.672 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.73 143.53 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 N-CA-C 113.164 0.802 . . . . 74.21 113.164 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -118.65 114.86 23.4 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.951 1.301 . . . . 71.51 108.681 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 15.0 t -107.92 141.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.639 0.376 . . . . 61.42 110.584 -174.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 t -148.68 -178.21 6.22 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.329 1.051 . . . . 41.32 110.0 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -76.25 140.62 41.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.849 0.46 . . . . 61.1 110.252 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.24 5.25 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.173 0.511 . . . . 63.21 109.737 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 124.497 1.119 . . . . 71.21 110.857 -171.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 110.053 -0.351 . . . . 55.13 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 112.19 3.65 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.019 -0.323 . . . . 62.12 113.083 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -76.97 127.11 32.11 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.318 0.559 . . . . 75.21 110.989 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -161.62 114.46 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.22 0.608 . . . . 75.51 110.293 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -127.85 124.98 38.84 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.982 0.513 . . . . 75.54 110.264 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -95.2 137.24 34.52 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.503 0.321 . . . . 75.54 110.622 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -65.13 116.42 6.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.709 0.804 . . . . 72.43 110.921 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -74.93 123.76 25.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.785 0.834 . . . . 73.33 110.744 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.0 t -95.99 97.02 9.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.259 0.624 . . . . 73.34 111.613 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -82.89 3.69 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.353 0.661 . . . . 73.32 111.946 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 t -138.11 131.58 30.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.121 0.969 . . . . 70.21 109.906 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.1 79.44 5.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.761 0.791 . . . . 54.33 111.023 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.07 129.17 35.7 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.345 -0.847 . . . . 72.24 110.442 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -90.4 -19.35 24.05 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.081 0.467 . . . . 63.22 109.924 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -98.64 129.87 45.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.584 0.753 . . . . 72.42 110.463 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.0 pt -110.33 151.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.6 0.76 . . . . 74.12 111.123 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -106.37 119.32 38.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.253 0.621 . . . . 62.02 109.67 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.2 t -112.61 140.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.249 1.02 . . . . 72.24 110.606 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.38 157.06 30.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.362 1.065 . . . . 64.24 110.486 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.64 34.88 42.63 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 115.135 0.814 . . . . 65.45 115.135 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.53 -21.69 28.47 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.269 1.028 . . . . 71.4 112.129 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.25 158.86 30.09 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 116.816 -0.174 . . . . 32.51 112.885 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.158 0.583 . . . . 74.31 112.297 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.96 11.8 23.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.95 0.5 . . . . 64.22 111.491 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.98 138.58 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 123.788 0.835 . . . . 73.54 112.414 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 39.0 p -124.91 153.86 42.01 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.213 0.605 . . . . 74.14 110.461 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 51' ' ' ILE . 79.8 mt -55.67 -42.84 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.741 0.817 . . . . 51.41 111.598 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -33.1 72.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.379 0.672 . . . . 74.42 112.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.3 t -69.9 -42.22 73.68 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.387 0.275 . . . . 62.15 111.025 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 59.8 t -63.89 -42.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.326 0.584 . . . . 72.53 110.072 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.32 82.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.13 -0.941 . . . . 73.01 111.895 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.88 -38.71 92.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 73.54 111.299 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -67.89 -56.36 9.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.356 1.063 . . . . 72.12 111.515 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 85.2 m-85 -78.87 -20.46 49.46 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.212 1.19 . . . . 74.12 114.212 -174.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.77 -23.24 67.28 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.824 1.046 . . . . 74.21 113.824 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -60.49 -24.91 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.181 0.592 . . . . 72.02 112.291 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 mm -82.85 -43.65 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.102 0.961 . . . . 41.51 111.018 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.79 169.17 42.29 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.793 -0.639 . . . . 61.32 112.612 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.39 131.52 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.045 0.538 . . . . 62.11 110.9 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.4 mt -97.69 131.09 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.814 0.846 . . . . 64.33 108.804 173.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 60.1 mtpt -53.65 151.2 6.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.288 0.635 . . . . 65.35 112.194 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.0 m -142.48 127.6 18.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.728 0.811 . . . . 64.31 110.262 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.78 127.8 34.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.711 0.804 . . . . 74.33 110.384 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -31.54 56.64 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.432 0.693 . . . . 72.2 112.287 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -51.45 43.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.966 0.506 . . . . 65.15 111.806 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -82.28 -51.37 7.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.569 0.748 . . . . 74.23 110.899 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.14 10.6 29.58 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.872 -0.603 . . . . 64.41 113.822 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -109.2 147.74 36.58 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 117.724 0.762 . . . . 54.12 112.721 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.7 Cg_endo -68.64 142.72 54.07 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.947 2.431 . . . . 75.1 112.371 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.1 mtt -74.08 95.25 2.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.595 0.712 . . . . 75.31 110.257 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -143.91 120.09 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.687 1.195 . . . . 74.24 108.902 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.74 111.28 23.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.146 0.578 . . . . 74.22 110.005 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.0 mt -86.5 114.37 23.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.643 0.777 . . . . 51.05 110.072 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.9 126.72 31.55 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.528 0.731 . . . . 64.32 111.433 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -99.72 145.3 27.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.604 0.762 . . . . 64.33 110.561 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.67 138.91 36.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.417 0.687 . . . . 74.44 112.334 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.42 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 11.4 ptp180 -64.94 -35.86 82.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.25 1.02 . . . . 75.44 112.64 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 19.5 mm-40 -87.86 -57.02 3.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.263 0.625 . . . . 63.14 111.462 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 p -73.11 -28.54 62.33 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.248 0.833 . . . . 74.03 113.248 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.0 73.32 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 123.358 0.411 . . . . 35.13 113.084 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -122.27 159.42 27.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.921 1.288 . . . . 72.42 109.167 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.52 133.07 55.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.645 0.378 . . . . 70.01 111.736 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -67.12 -14.19 62.66 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.853 0.861 . . . . 74.42 113.048 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.67 35.14 32.98 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.103 -0.799 . . . . 73.22 111.103 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -139.36 138.46 36.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.089 0.956 . . . . 74.25 109.016 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.58 159.11 40.68 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.02 0.438 . . . . 61.14 112.143 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 24.3 p -111.46 123.69 50.74 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.267 -0.424 . . . . 74.3 110.698 172.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.0 110.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.68 0.792 . . . . 74.04 110.371 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 30.9 m -88.6 102.27 14.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.852 0.461 . . . . 62.34 111.276 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 70.5 m-85 -79.3 158.25 27.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.217 0.607 . . . . 75.05 111.363 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.56 -32.08 70.66 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.853 0.861 . . . . 61.32 111.048 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.99 136.77 26.55 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.667 0.787 . . . . 71.41 112.006 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.0 -36.33 95.83 Favored 'Trans proline' 0 CA--C 1.58 2.795 0 C-N-CA 122.768 2.312 . . . . 75.0 116.208 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.09 -26.72 65.43 Favored 'Trans proline' 0 C--N 1.393 2.912 0 CA-C-N 122.816 2.041 . . . . 71.42 113.403 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -71.53 -40.45 70.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 53.14 109.712 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -61.49 -53.62 53.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.125 -0.943 . . . . 63.55 111.296 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.46 -46.51 88.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.752 1.221 . . . . 72.33 111.166 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.74 99.27 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.804 -0.634 . . . . 63.44 111.691 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.57 74.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.923 0.489 . . . . 73.03 112.183 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 95' ' ' VAL . 86.8 mt -62.12 -62.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.892 0.477 . . . . 71.11 110.449 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.59 -31.59 70.73 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.877 0.871 . . . . 74.21 112.578 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -77.54 -53.23 7.85 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.231 0.612 . . . . 71.31 111.964 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.583 ' HB3' HD11 ' A' ' 93' ' ' ILE . 64.7 m-85 -88.41 -7.66 56.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.838 1.051 . . . . 64.13 113.838 -172.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 19.3 t70 -62.21 115.35 4.07 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.126 0.421 . . . . 63.01 110.519 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.68 10.7 72.47 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.592 0.597 . . . . 65.22 114.592 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -101.52 153.43 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.701 0.75 . . . . 54.21 111.698 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.35 127.04 34.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.088 0.555 . . . . 75.32 112.163 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -92.47 -52.75 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.189 0.595 . . . . 73.03 110.852 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -126.01 40.65 3.69 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.963 0.905 . . . . 65.24 110.015 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.6 15.85 80.89 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 115.815 -0.63 . . . . 51.55 112.8 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -136.7 129.28 17.34 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.304 1.042 . . . . 73.52 110.758 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.33 135.26 36.16 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.185 2.59 . . . . 74.01 113.243 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.583 HD11 ' HB3' ' A' ' 83' ' ' PHE . 27.1 pt -104.7 150.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 72.34 112.215 -173.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -114.76 109.9 18.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.764 0.826 . . . . 74.11 108.807 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 7.8 t -108.64 137.59 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 122.813 0.445 . . . . 74.44 110.432 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.9 m -146.07 179.55 7.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.325 1.05 . . . . 71.44 109.458 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -74.62 143.05 44.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.725 -0.472 . . . . 72.2 109.725 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.33 91.89 1.37 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.37 0.605 . . . . 74.02 111.175 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 124.165 0.986 . . . . 71.13 111.102 178.915 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.529 0.204 . . . . 72.42 110.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.13 133.53 13.04 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 119.754 -0.47 . . . . 44.13 112.99 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -59.34 127.67 33.25 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.801 0.84 . . . . 70.51 111.616 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -68.5 90.48 0.38 Allowed 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.249 0.833 . . . . 60.14 113.249 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 t60 61.46 111.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.491 1.516 . . . . 74.43 112.975 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.01 137.73 55.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.848 0.459 . . . . 73.35 111.461 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -120.15 -173.92 2.66 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.442 1.097 . . . . 63.33 110.771 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.39 147.6 30.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.083 0.553 . . . . 70.22 110.819 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.1 t -60.23 110.59 1.27 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.851 0.46 . . . . 61.33 111.772 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -157.47 152.51 25.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.436 1.094 . . . . 72.52 109.792 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t 62.31 15.12 7.35 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.981 0.913 . . . . 70.31 113.291 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.32 150.38 41.93 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.712 0.805 . . . . 65.32 111.79 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.519 HD22 ' HB3' ' A' ' 97' ' ' PHE . 48.1 t30 -83.61 129.44 34.96 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.41 0.684 . . . . 70.33 110.562 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -102.26 -11.05 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.284 0.633 . . . . 74.43 111.808 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.3 m -97.88 125.6 42.85 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.295 0.638 . . . . 71.11 109.819 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.69 140.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.066 0.547 . . . . 71.44 111.175 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -94.79 125.36 39.4 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.939 -0.393 . . . . 43.34 109.939 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 95' ' ' VAL . 23.0 t -118.05 139.64 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.099 0.959 . . . . 72.21 109.82 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -127.58 162.06 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.97 0.908 . . . . 74.14 110.973 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.75 66.93 Favored Glycine 0 N--CA 1.479 1.502 0 O-C-N 123.46 0.475 . . . . 61.14 114.192 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 93' ' ' ILE . 34.3 mt -75.46 -26.5 58.29 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.098 0.959 . . . . 55.43 111.789 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.16 152.15 21.11 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.964 -0.454 . . . . 63.11 111.964 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.99 -3.45 35.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.355 0.872 . . . . 70.53 113.355 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -101.43 18.85 19.07 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.393 0.677 . . . . 72.12 110.522 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 21' ' ' LEU . 11.2 p -71.51 135.59 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 123.264 0.626 . . . . 73.11 112.135 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -127.28 150.73 49.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.573 -0.705 . . . . 72.11 110.901 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.1 mt -52.93 -45.83 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.456 1.102 . . . . 75.2 111.978 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.62 -31.14 67.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.655 0.782 . . . . 72.22 111.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.5 m -71.54 -40.11 70.27 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.759 0.424 . . . . 72.23 111.606 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 26' ' ' THR . 52.3 t -66.45 -36.94 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.896 0.478 . . . . 73.12 110.151 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.27 75.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.605 -0.725 . . . . 64.2 111.344 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.44 -30.97 71.82 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.601 0.76 . . . . 72.11 111.68 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -74.18 -56.46 4.87 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.528 0.731 . . . . 74.34 111.195 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.412 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 23.0 m-85 -77.17 -18.55 57.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.404 1.261 . . . . 54.23 114.404 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -63.42 -20.57 65.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 113.89 1.07 . . . . 55.1 113.89 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.21 -25.32 65.51 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.23 0.612 . . . . 65.14 112.138 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.4 mm -88.36 -48.45 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.241 1.016 . . . . 73.23 111.367 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.0 169.7 39.0 Favored Glycine 0 C--O 1.238 0.353 0 C-N-CA 121.435 -0.412 . . . . 61.21 113.414 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.32 117.21 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.492 0.717 . . . . 61.24 110.329 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.7 mt -86.22 127.86 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -53.26 154.54 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.059 0.944 . . . . 72.15 112.833 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.3 m -132.01 127.0 35.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.953 0.901 . . . . 73.13 110.334 -175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -64.0 119.99 11.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.727 0.811 . . . . 65.32 109.986 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.72 -21.23 64.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.338 1.055 . . . . 74.25 112.529 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -86.53 -43.36 12.79 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.447 0.699 . . . . 62.52 112.037 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 p -89.46 -36.27 15.52 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.924 0.713 . . . . 44.03 112.924 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.43 77.09 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 112.712 -0.155 . . . . 51.44 112.712 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -99.46 151.18 37.34 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.631 1.172 . . . . 73.35 110.919 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.4 145.22 76.62 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.571 2.181 . . . . 52.4 111.436 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 59.3 mtt -74.47 92.26 2.34 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.234 -0.654 . . . . 72.42 109.234 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.621 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.72 117.66 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.781 1.232 . . . . 73.44 108.172 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 30.4 m-80 -104.5 111.58 24.3 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 109.94 -0.393 . . . . 75.11 109.94 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -80.37 128.65 33.81 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.413 0.685 . . . . 74.44 110.053 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 70.4 m-85 -86.1 136.09 33.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.183 0.593 . . . . 74.33 110.708 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -128.82 138.73 52.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.516 1.126 . . . . 62.42 109.614 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.09 110.55 3.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.695 -0.854 . . . . 65.4 108.695 170.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -67.64 -22.52 65.32 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.986 0.515 . . . . 73.35 111.695 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 59' ' ' THR . 8.9 pt-20 -75.85 -48.43 21.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.614 0.766 . . . . 73.15 112.17 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 58' ' ' GLU . 60.5 p -91.61 -33.42 15.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.226 0.61 . . . . 74.51 112.075 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.26 3.1 76.09 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.728 -0.669 . . . . 33.3 113.54 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -93.01 161.28 14.51 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.436 0.618 . . . . 55.44 111.17 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.64 141.51 39.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.139 0.576 . . . . 24.34 111.217 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -78.45 -14.31 59.43 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 70.12 112.134 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.86 37.96 28.36 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.177 -0.369 . . . . 54.12 112.177 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 48.5 mt-10 -130.7 151.37 51.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.896 0.878 . . . . 70.31 109.627 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 141.76 14.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.915 0.486 . . . . 63.35 112.02 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.3 p -101.62 112.92 25.64 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.438 0.295 . . . . 73.34 110.836 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -103.5 110.52 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.014 0.926 . . . . 64.1 110.038 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 47.3 m -87.86 107.08 18.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.843 0.457 . . . . 41.15 111.012 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.412 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 46.1 m-85 -83.12 157.11 22.94 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.217 0.532 . . . . 74.52 110.352 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.68 -34.43 75.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.78 0.832 . . . . 74.31 110.684 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -118.51 134.12 23.49 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.399 0.68 . . . . 41.23 111.033 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.62 -36.56 89.79 Favored 'Trans proline' 0 CA--C 1.582 2.888 0 C-N-CA 122.517 2.144 . . . . 52.12 116.225 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.85 -32.81 77.2 Favored 'Trans proline' 0 C--N 1.397 3.125 0 CA-C-N 122.8 2.036 . . . . 53.13 114.107 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.7 p -78.13 -33.25 50.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.09 0.556 . . . . 73.4 110.394 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.27 74.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.171 0.588 . . . . 60.13 111.205 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -61.87 -40.52 95.64 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.287 1.035 . . . . 73.01 110.796 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.97 94.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.776 -0.647 . . . . 72.52 111.872 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.06 -27.11 68.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.133 0.573 . . . . 55.45 112.408 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.1 mt -64.36 -63.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.519 0.328 . . . . 73.33 110.615 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.0 -28.16 66.11 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.672 0.789 . . . . 42.44 112.005 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.52 -61.01 2.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.117 0.567 . . . . 74.2 111.63 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 93' ' ' ILE . 72.8 m-85 -82.72 -10.83 58.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.162 1.171 . . . . 74.24 114.162 -169.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.53 94.13 0.27 Allowed 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 109.025 -0.732 . . . . 71.43 109.025 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.76 -12.65 11.85 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.195 -0.911 . . . . 43.14 114.444 -174.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 93' ' ' ILE . 49.0 mmtm -81.56 140.54 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.941 0.871 . . . . 72.03 110.612 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.9 121.19 31.01 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.148 -0.345 . . . . 73.04 111.842 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -83.95 -80.96 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.109 0.564 . . . . 72.12 109.719 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -104.33 57.03 0.71 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.501 0.667 . . . . 60.32 110.126 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 9.29 84.88 Favored Glycine 0 N--CA 1.48 1.62 0 CA-C-N 115.682 -0.69 . . . . 72.13 114.201 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -126.03 126.47 24.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 123.984 0.914 . . . . 72.45 110.534 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.15 108.62 1.37 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.796 2.33 . . . . 65.2 112.018 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 83' ' ' PHE . 11.3 pt -77.89 152.51 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.411 0.685 . . . . 72.42 111.872 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -116.87 120.49 38.65 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.811 -0.811 . . . . 75.13 108.811 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 18' ' ' VAL . 21.6 t -116.0 136.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 122.751 0.42 . . . . 73.52 110.955 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 t -147.29 176.63 9.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.469 1.508 . . . . 62.32 108.703 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' HB3' HD22 ' A' ' 13' ' ' ASN . 39.9 m-85 -71.98 145.54 48.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.389 0.54 . . . . 75.33 111.094 169.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.63 76.32 10.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 75.13 109.9 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.635 0.774 . . . . 64.43 111.317 -178.125 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.137 -0.32 . . . . 73.33 110.137 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.48 -14.7 15.82 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.398 0.919 . . . . 74.02 115.398 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -86.15 98.88 11.14 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 117.574 0.687 . . . . 74.55 111.474 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -170.07 142.91 2.39 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.537 1.135 . . . . 74.34 109.175 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -62.18 111.28 1.9 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.979 0.511 . . . . 74.44 111.541 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -76.72 -30.75 56.77 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.7 0.8 . . . . 71.25 111.241 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -76.22 134.99 39.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.733 0.813 . . . . 74.32 110.16 173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -64.84 123.97 20.78 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.198 0.599 . . . . 63.31 111.393 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.8 t -170.17 130.91 0.96 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.908 0.883 . . . . 42.12 110.815 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -79.01 -0.18 30.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 122.833 0.453 . . . . 71.11 111.178 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t 60.47 64.01 1.27 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.531 1.133 . . . . 73.43 110.709 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.8 27.0 1.64 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.773 -1.103 . . . . 74.33 112.121 -172.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 115.24 15.23 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.873 0.869 . . . . 75.14 109.806 176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -86.9 -17.47 33.17 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.915 0.486 . . . . 73.55 112.284 -168.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -95.28 137.89 33.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.054 0.541 . . . . 74.44 109.947 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 pt -113.89 148.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.842 -0.536 . . . . 52.14 111.184 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.5 113.95 27.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.614 -0.513 . . . . 72.32 109.614 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 95' ' ' VAL . 11.0 t -105.63 132.78 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.037 0.935 . . . . 73.15 109.639 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.58 162.39 18.07 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.855 0.862 . . . . 72.44 109.824 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.71 68.44 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 114.424 0.53 . . . . 74.22 114.424 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 18' ' ' VAL . 32.3 mt -80.24 -17.55 51.95 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.857 1.263 . . . . 74.55 112.459 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.65 173.5 46.93 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.967 0.747 . . . . 52.21 114.967 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.98 -13.4 60.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.28 1.032 . . . . 64.05 112.723 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -93.19 11.32 28.28 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.922 0.889 . . . . 72.35 111.545 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.07 129.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 O-C-N 121.429 -0.794 . . . . 61.43 112.801 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -132.87 158.86 41.49 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.326 0.65 . . . . 70.21 110.475 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -51.88 -51.21 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.967 0.907 . . . . 75.34 111.593 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.06 -32.13 68.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.598 0.759 . . . . 74.33 112.891 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -72.06 -42.25 66.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.109 0.163 . . . . 74.43 111.004 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.86 -43.08 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 120.853 0.358 . . . . 64.52 110.445 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.71 87.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.891 -0.595 . . . . 24.42 112.242 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.06 -27.69 66.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.753 0.421 . . . . 60.44 111.282 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.38 -50.36 27.13 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 63.45 110.43 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 18.7 m-85 -82.81 -19.68 37.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.339 1.236 . . . . 72.3 114.339 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -67.1 -18.31 65.26 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 113.385 0.883 . . . . 62.53 113.385 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.78 -25.97 65.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.538 0.735 . . . . 62.54 111.799 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.5 mm -83.2 -38.7 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.376 1.07 . . . . 73.15 111.381 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.12 -179.81 48.24 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.172 -0.467 . . . . 71.2 113.156 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.7 120.13 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.178 0.591 . . . . 63.05 110.878 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 79.3 mt -93.85 123.78 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.362 0.665 . . . . 72.52 109.692 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 48.3 mtpt -48.61 146.85 2.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.157 0.983 . . . . 73.31 112.446 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 89.5 m -140.0 123.55 17.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.546 0.738 . . . . 73.33 110.717 -170.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -63.25 126.06 26.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.677 0.791 . . . . 65.13 109.719 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.36 -37.54 37.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.283 0.633 . . . . 74.44 111.973 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.32 -50.16 71.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.183 0.593 . . . . 75.13 111.29 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.7 p -79.43 -37.21 37.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.736 0.415 . . . . 60.42 111.344 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.58 63.91 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 116.379 -0.373 . . . . 23.13 112.464 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -111.15 144.31 30.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 123.93 0.892 . . . . 74.44 112.173 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 21.6 Cg_endo -61.35 139.17 81.26 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.81 2.34 . . . . 71.14 112.291 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 48.6 mtt -71.75 96.4 1.61 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.238 0.542 . . . . 72.25 110.112 -170.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 67' ' ' THR . 60.7 mt -141.12 126.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.434 1.093 . . . . 65.13 109.173 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.0 m-20 -103.1 110.43 22.37 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.994 -0.743 . . . . 62.23 108.994 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -89.24 116.68 27.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 72.32 110.287 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -82.68 118.54 23.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.532 0.733 . . . . 62.3 110.744 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -106.65 148.92 27.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.368 1.067 . . . . 72.55 110.479 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.57 136.72 35.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.121 0.568 . . . . 64.34 110.949 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -72.66 -29.81 63.75 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.75 0.82 . . . . 63.14 112.627 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -84.89 -61.15 1.85 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.052 0.541 . . . . 64.2 111.023 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 p -76.77 -31.23 56.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.747 0.819 . . . . 71.11 112.092 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.58 2.03 90.58 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 116.376 -0.375 . . . . 74.1 113.458 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -84.75 151.78 24.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.696 0.799 . . . . 55.14 111.025 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 mt -67.2 129.86 41.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.92 -0.582 . . . . 71.02 109.679 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -72.78 -9.39 58.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.301 0.64 . . . . 75.02 112.281 -173.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.35 40.97 31.95 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.268 -0.733 . . . . 33.33 111.268 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -142.54 138.13 30.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.866 0.866 . . . . 64.11 109.099 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.0 152.62 24.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.846 0.458 . . . . 22.12 111.657 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -111.97 120.56 42.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 116.216 -0.447 . . . . 75.15 111.185 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.08 111.16 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.651 1.181 . . . . 61.45 110.295 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.3 t -83.96 108.94 17.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.462 0.305 . . . . 73.34 110.9 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 44.3 m-85 -85.5 160.04 19.78 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.131 0.491 . . . . 73.23 110.501 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.23 -37.87 57.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.291 0.636 . . . . 72.52 110.485 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -116.38 129.81 24.96 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.518 0.727 . . . . 63.14 110.606 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.55 -35.45 56.23 Favored 'Trans proline' 0 CA--C 1.579 2.765 0 C-N-CA 123.09 2.527 . . . . 73.24 116.668 169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.5 -32.94 97.08 Favored 'Trans proline' 0 C--N 1.395 3.017 0 CA-C-N 122.843 2.051 . . . . 70.12 113.313 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -71.84 -38.55 70.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.215 0.606 . . . . 65.43 110.297 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.77 53.82 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.391 -0.822 . . . . 63.24 110.969 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.46 -40.48 97.24 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.474 1.11 . . . . 65.2 111.717 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.91 97.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 61.14 112.041 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.67 71.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.253 0.621 . . . . 74.25 111.993 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 95' ' ' VAL . 75.2 mt -63.43 -62.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.969 0.508 . . . . 71.02 110.464 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.65 -32.07 66.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.672 0.789 . . . . 50.01 112.321 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -77.77 -55.3 5.45 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.033 0.533 . . . . 74.04 112.228 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HB3' HD11 ' A' ' 93' ' ' ILE . 73.9 m-85 -88.57 -15.67 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.47 118.45 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.347 0.521 . . . . 73.1 110.271 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.09 -1.79 78.04 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.824 0.69 . . . . 74.0 114.824 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.97 173.57 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.45 0.625 . . . . 71.42 111.139 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -107.61 106.74 17.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.088 0.555 . . . . 75.23 111.268 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -86.0 113.57 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.235 -1.024 . . . . 72.14 108.235 168.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t 61.01 24.5 14.6 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.303 0.641 . . . . 65.42 111.872 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.19 76.89 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 123.169 0.414 . . . . 70.54 113.969 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.51 126.01 45.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.84 0.856 . . . . 64.14 111.024 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.81 100.95 1.4 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.411 2.074 . . . . 74.45 112.226 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.5 pt -85.49 154.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 113.557 0.947 . . . . 72.32 113.557 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -126.13 113.83 17.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.746 1.218 . . . . 72.33 109.075 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.605 HG22 HG13 ' A' ' 18' ' ' VAL . 15.5 t -104.53 138.88 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.571 0.348 . . . . 71.21 110.615 -172.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.4 m -144.25 -178.7 6.09 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 72.31 109.48 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.52 147.88 37.47 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.436 0.562 . . . . 75.11 110.734 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.11 83.63 4.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.022 -0.732 . . . . 70.54 109.022 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.527 0 C-N-CA 124.001 0.92 . . . . 72.4 111.563 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mmm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 110.179 -0.304 . . . . 74.22 110.179 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.86 47.9 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 113.524 0.17 . . . . 54.51 113.524 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -70.25 93.43 0.84 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.606 0.762 . . . . 72.11 110.207 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -90.6 -31.61 16.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.263 0.625 . . . . 74.44 111.97 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -120.62 130.15 54.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.223 0.609 . . . . 75.52 110.883 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -77.39 -40.97 41.9 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.124 0.569 . . . . 72.34 111.915 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -138.6 122.73 18.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.023 0.929 . . . . 75.11 110.429 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -87.86 -52.67 5.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.709 0.804 . . . . 63.42 111.378 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -76.07 105.19 6.98 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.144 0.578 . . . . 54.52 111.46 -175.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -78.51 100.01 6.72 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.075 0.55 . . . . 74.31 110.025 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p -122.28 117.12 25.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.229 0.612 . . . . 53.33 109.869 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -79.48 -170.92 2.53 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.068 0.947 . . . . 64.04 111.895 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 2.2 m-20 -77.04 135.56 38.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.24 -0.652 . . . . 75.25 109.24 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.59 -19.86 30.41 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.758 0.423 . . . . 71.22 110.323 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 m -104.01 127.77 51.58 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.696 0.798 . . . . 41.24 109.698 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.1 pt -109.43 154.26 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.775 0.83 . . . . 74.22 111.279 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -109.08 121.97 46.27 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.858 0.863 . . . . 71.35 109.954 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 95' ' ' VAL . 19.8 t -118.03 140.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.535 1.134 . . . . 73.0 110.253 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.01 158.03 34.69 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.983 0.913 . . . . 73.11 110.525 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.17 35.43 43.48 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 114.602 0.601 . . . . 44.1 114.602 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 93' ' ' ILE . 65.3 mt -80.57 -34.16 35.55 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.074 0.95 . . . . 73.24 112.321 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 153.06 8.58 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.087 -0.405 . . . . 72.53 112.087 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.33 -1.93 43.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.989 0.737 . . . . 62.22 112.989 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -120.82 29.93 7.14 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.332 0.653 . . . . 74.33 110.142 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.41 136.95 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 123.44 0.696 . . . . 62.22 111.682 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 30' ' ' VAL . 42.7 p -122.48 151.13 41.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 74.24 110.521 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.7 mt -53.43 -41.16 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.663 0.785 . . . . 74.34 111.091 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.42 -40.42 93.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.341 0.656 . . . . 74.1 112.404 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.5 p -72.31 -38.27 68.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.288 0.235 . . . . 71.01 111.52 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 41.3 t -65.41 -40.52 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.163 0.506 . . . . 54.32 110.195 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.273 -0.876 . . . . 74.22 112.371 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.78 -32.25 72.7 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.374 0.669 . . . . 61.24 111.207 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -76.65 -49.83 15.23 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.013 -0.54 . . . . 73.15 111.158 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 18.4 m-85 -80.48 -17.91 50.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.147 1.166 . . . . 71.04 114.147 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.99 -21.69 66.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.269 0.841 . . . . 74.43 113.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.22 -28.72 59.36 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.581 0.752 . . . . 73.43 112.153 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -82.32 -42.67 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 72.23 111.445 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.94 -178.92 47.06 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.392 -0.367 . . . . 70.35 113.326 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.49 119.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.068 0.547 . . . . 60.33 110.747 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.5 mt -87.2 125.29 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.888 -0.782 . . . . 63.11 108.888 173.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 53.7 mtpt -48.41 131.9 16.83 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.661 0.784 . . . . 71.21 112.184 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 53.5 m -116.17 123.17 47.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 72.41 110.709 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -63.68 119.0 9.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.72 0.808 . . . . 61.33 109.132 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -76.37 -27.16 56.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 73.02 111.586 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -72.97 -43.44 62.25 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.427 0.691 . . . . 64.15 111.615 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -84.52 -36.54 22.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.019 0.527 . . . . 74.15 111.411 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.6 66.41 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 115.799 -0.637 . . . . 73.05 112.415 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.05 157.74 47.89 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.41 1.084 . . . . 74.5 111.665 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 60.6 Cg_endo -69.83 155.33 65.97 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.489 2.126 . . . . 74.2 113.002 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.441 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.1 mtt -83.41 94.85 8.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.718 0.807 . . . . 75.41 109.186 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 89.3 mt -142.18 117.95 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.765 -1.107 . . . . 61.22 108.799 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.12 107.5 20.04 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.758 -0.83 . . . . 64.41 108.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.1 mt -77.03 150.29 35.8 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.914 -0.772 . . . . 73.1 108.914 172.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.83 128.61 55.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.805 0.442 . . . . 71.41 110.654 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -115.08 139.63 49.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.252 1.021 . . . . 73.03 110.259 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -66.45 128.19 35.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.767 0.827 . . . . 71.14 110.798 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -62.98 -34.66 77.99 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.52 0.328 . . . . 73.14 110.744 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -76.72 -58.08 3.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.454 0.702 . . . . 71.51 111.809 -172.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.4 p -81.37 -29.24 34.09 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.498 0.555 . . . . 62.42 112.498 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.39 5.96 86.09 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 116.57 -0.286 . . . . 64.42 113.208 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -96.77 167.9 10.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.109 0.963 . . . . 64.21 109.721 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.1 mt -75.3 137.7 41.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.71 0.291 . . . . 71.3 110.512 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 6.6 mtpm? -67.82 -28.37 67.51 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.807 -0.633 . . . . 74.2 112.269 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.0 23.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.919 -0.582 . . . . 74.51 113.736 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -116.98 156.38 27.56 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.734 0.767 . . . . 71.4 110.228 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.14 149.81 14.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.429 0.692 . . . . 73.03 111.489 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 39.4 p -106.71 126.04 51.78 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.866 0.466 . . . . 53.53 110.498 172.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.56 110.99 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.526 0.73 . . . . 45.02 110.428 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 25.2 m -85.41 103.23 14.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.338 0.255 . . . . 54.52 111.071 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 63.7 m-85 -82.69 162.15 21.9 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.1 110.742 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.1 -40.19 62.88 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.62 -0.718 . . . . 61.34 110.929 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 26.7 m-20 -109.92 134.37 20.69 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.923 0.489 . . . . 75.24 112.049 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.09 -42.75 51.8 Favored 'Trans proline' 0 CA--C 1.581 2.837 0 C-N-CA 122.932 2.421 . . . . 72.23 116.199 168.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 59.6 Cg_endo -68.38 -24.12 37.33 Favored 'Trans proline' 0 C--N 1.398 3.157 0 CA-C-N 122.237 1.835 . . . . 73.24 112.713 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -71.3 -43.27 67.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.487 0.66 . . . . 55.4 109.787 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.93 -42.37 90.19 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.334 -0.848 . . . . 34.52 111.342 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -62.82 -43.36 99.0 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.78 0.832 . . . . 70.32 110.707 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.99 89.43 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.847 -0.615 . . . . 73.1 111.492 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.45 70.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.075 0.55 . . . . 73.51 112.003 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 95' ' ' VAL . 62.4 mt -68.4 -60.07 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.207 0.203 . . . . 72.02 110.478 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.37 -25.95 64.69 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.198 0.599 . . . . 73.51 111.871 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -82.68 -62.48 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.567 0.347 . . . . 74.41 111.811 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 95' ' ' VAL . 79.0 m-85 -80.52 -15.52 56.48 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.955 1.095 . . . . 73.01 113.955 -168.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.14 106.72 3.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.48 -0.563 . . . . 55.24 109.48 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.56 35.39 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 115.338 -0.847 . . . . 73.42 114.218 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -83.29 -177.04 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.466 0.633 . . . . 65.34 111.743 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -121.03 120.44 35.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.857 . . . . 73.43 109.843 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 93' ' ' ILE . 86.2 t80 -68.52 -69.5 0.32 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.097 0.559 . . . . 74.52 111.082 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.9 t -133.62 69.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.939 0.896 . . . . 70.35 109.167 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.87 -2.95 38.95 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.122 -0.945 . . . . 51.35 114.193 -172.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -115.87 125.89 28.22 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 124.262 1.025 . . . . 65.01 111.03 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.4 130.18 29.3 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.096 2.531 . . . . 74.45 112.742 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' PHE . 30.5 pt -116.4 144.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 121.908 0.861 . . . . 75.45 112.702 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -114.2 121.36 43.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.947 -1.501 . . . . 73.45 106.947 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 80' ' ' ILE . 25.8 t -113.85 138.71 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.258 0.551 . . . . 71.51 110.692 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.5 p -148.88 179.41 7.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.03 1.332 . . . . 64.05 109.481 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 13' ' ' ASN . 51.7 m-85 -78.37 145.1 35.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 118.526 0.603 . . . . 73.54 111.592 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.37 113.48 24.79 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.563 1.467 0 C-N-CA 123.153 0.581 . . . . 64.45 111.724 -176.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.556 1.192 0 CA-C-O 120.724 0.297 . . . . 70.22 111.168 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.54 2.16 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 114.603 0.601 . . . . 32.14 114.603 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -79.16 -13.95 59.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.597 0.759 . . . . 73.02 111.873 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.51 94.17 7.22 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.269 0.628 . . . . 71.1 109.959 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -66.57 -30.34 70.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.921 0.489 . . . . 75.14 110.619 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -96.85 137.75 35.45 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.142 0.977 . . . . 73.12 110.004 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -66.52 -47.75 71.94 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.254 0.622 . . . . 71.12 111.119 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -92.83 110.84 22.3 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.224 -0.658 . . . . 64.43 109.224 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.3 t -69.76 141.27 53.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.948 0.499 . . . . 64.4 111.103 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -98.7 -7.77 27.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.038 0.535 . . . . 73.51 111.677 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.6 p -145.52 114.64 7.01 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.159 0.584 . . . . 73.12 110.812 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -130.69 113.07 13.7 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.769 0.828 . . . . 53.23 108.845 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.28 108.97 1.74 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.213 0.605 . . . . 54.13 111.187 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -98.74 1.58 46.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.867 0.867 . . . . 73.02 111.334 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -102.98 130.51 50.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.391 0.676 . . . . 64.41 109.509 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.22 138.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.23 0.612 . . . . 72.22 111.958 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -94.56 117.21 29.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.106 0.479 . . . . 75.03 110.469 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 95' ' ' VAL . 12.5 t -113.39 138.81 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.466 1.106 . . . . 75.3 110.279 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.95 162.57 22.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.343 1.057 . . . . 72.32 110.11 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.14 65.51 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 114.506 0.562 . . . . 70.23 114.506 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 25' ' ' VAL . 81.9 mt -72.34 -36.03 68.72 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.067 0.947 . . . . 73.43 111.879 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.27 158.07 11.68 Favored Glycine 0 N--CA 1.476 1.352 0 C-N-CA 123.219 0.438 . . . . 64.51 112.556 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.86 -19.43 61.96 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.015 0.908 . . . . 62.32 112.719 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -89.53 7.29 37.03 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.029 0.932 . . . . 75.43 111.323 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 21' ' ' LEU . 9.9 p -69.72 134.32 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.354 0.662 . . . . 62.14 112.444 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.0 p -120.4 163.05 18.48 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.016 -0.427 . . . . 65.23 110.007 171.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 51' ' ' ILE . 80.5 mt -57.83 -42.4 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 123.917 0.887 . . . . 74.54 111.5 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.41 -30.04 65.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.474 0.71 . . . . 74.41 111.776 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -45.85 81.53 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.783 0.433 . . . . 55.34 110.877 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' THR . 21.5 t -64.88 -40.84 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 121.19 0.519 . . . . 50.04 110.225 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.58 88.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.34 -0.846 . . . . 53.43 111.744 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.88 -40.33 97.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.027 0.931 . . . . 71.22 111.582 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.31 -48.19 44.03 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.379 -0.828 . . . . 75.1 110.89 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.38 -19.57 35.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.548 1.314 . . . . 72.52 114.548 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.44 -16.61 63.81 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.835 1.05 . . . . 72.34 113.835 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -61.41 -29.18 69.77 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.089 0.555 . . . . 74.44 111.772 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.17 -42.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.057 0.943 . . . . 74.32 111.189 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.62 171.67 42.81 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 116.358 -0.383 . . . . 45.45 113.04 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.84 123.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.826 -0.435 . . . . 73.25 109.826 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.4 mt -93.97 129.76 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.99 0.916 . . . . 61.42 108.796 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.0 mtpt -51.04 140.51 15.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 64.14 112.311 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 56.0 m -128.45 121.81 29.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.181 -0.918 . . . . 62.04 109.829 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -57.63 119.57 6.83 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.208 1.003 . . . . 65.44 110.565 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -76.09 -16.94 59.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.704 0.802 . . . . 72.31 112.839 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -82.08 -52.29 7.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.649 0.379 . . . . 64.43 110.803 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -80.46 -46.62 15.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.25 0.62 . . . . 64.52 111.587 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.31 15.65 40.44 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.979 -0.555 . . . . 71.52 112.633 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -107.87 148.84 38.16 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.24 1.016 . . . . 54.4 111.827 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -67.75 149.88 78.82 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.409 2.073 . . . . 73.52 112.182 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.504 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 49.4 mtt -81.94 94.34 7.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.619 0.723 . . . . 75.43 109.67 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.7 mt -145.88 117.56 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.501 1.121 . . . . 62.34 108.693 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 78.9 m-20 -96.88 109.38 22.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.67 -0.493 . . . . 73.43 109.67 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.01 150.19 39.04 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.554 0.534 . . . . 74.22 109.856 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 46.9 m-85 -107.65 132.28 53.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.275 0.63 . . . . 75.14 109.952 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -133.99 142.88 47.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.725 0.81 . . . . 73.21 110.042 -174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -76.67 114.83 15.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.798 0.439 . . . . 74.14 109.827 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -71.72 -8.03 51.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.293 0.637 . . . . 64.22 112.471 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.35 -56.27 4.46 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.392 0.677 . . . . 54.05 110.888 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 p -96.93 -21.13 17.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.733 0.813 . . . . 53.21 112.556 -173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 12.64 83.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 120.056 -0.302 . . . . 71.33 113.751 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -97.22 147.89 23.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.47 0.708 . . . . 75.2 111.588 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.81 138.32 56.05 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.103 0.561 . . . . 70.21 111.541 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -77.47 -17.23 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.342 0.657 . . . . 72.32 111.579 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.08 24.34 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.333 0.396 . . . . 62.21 112.33 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 46.8 mt-10 -135.25 153.05 52.05 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.916 0.886 . . . . 50.1 109.74 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.33 156.27 23.69 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.471 0.545 . . . . 55.01 112.471 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 69.5 p -113.87 118.57 34.57 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 122.745 0.418 . . . . 61.32 110.676 171.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.52 107.96 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.888 0.875 . . . . 75.11 111.025 -170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -83.82 102.65 12.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.716 0.407 . . . . 75.31 111.521 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 53.3 m-85 -79.81 149.86 30.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.403 0.681 . . . . 71.52 110.686 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.03 -32.75 57.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.395 0.678 . . . . 73.21 110.573 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.77 127.39 37.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.15 0.58 . . . . 72.31 110.473 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.31 -48.36 18.92 Favored 'Trans proline' 0 CA--C 1.581 2.874 0 C-N-CA 122.602 2.201 . . . . 73.12 115.532 170.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.85 -19.32 27.34 Favored 'Trans proline' 0 C--N 1.398 3.149 0 CA-C-N 122.2 1.821 . . . . 75.31 113.609 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -69.37 -33.67 73.41 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.222 0.609 . . . . 72.21 111.211 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.29 56.01 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.925 -0.579 . . . . 64.33 111.466 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.585 0.754 . . . . 71.31 111.092 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.78 94.21 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.102 0.561 . . . . 71.2 111.796 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.53 67.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 74.1 112.699 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.491 HG12 HG12 ' A' ' 95' ' ' VAL . 82.2 mt -66.86 -58.38 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 120.899 0.381 . . . . 74.24 110.054 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.99 -27.79 69.11 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.434 -0.803 . . . . 72.4 112.166 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -81.5 -62.3 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.612 0.365 . . . . 71.42 111.344 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' HD11 ' A' ' 93' ' ' ILE . 66.8 m-85 -79.51 -11.73 59.89 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.282 1.215 . . . . 70.25 114.282 -168.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.42 111.06 1.86 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 118.508 0.595 . . . . 74.32 110.362 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.57 60.0 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 115.128 0.811 . . . . 53.15 115.128 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.3 mmtt -86.74 161.56 18.33 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 118.43 1.115 . . . . 71.21 111.105 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -99.23 119.92 38.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 75.24 111.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -84.21 -77.69 0.26 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.903 0.481 . . . . 72.53 110.222 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -118.13 75.48 1.01 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.46 0.704 . . . . 73.4 110.078 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.21 1.03 59.21 Favored Glycine 0 CA--C 1.54 1.652 0 N-CA-C 115.061 0.784 . . . . 75.21 115.061 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -132.9 138.01 30.92 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.483 0.713 . . . . 74.51 110.983 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.96 140.6 55.33 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.695 2.264 . . . . 70.01 111.975 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 83' ' ' PHE . 19.6 pt -110.38 152.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.223 0.609 . . . . 71.21 111.707 -171.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -118.18 114.76 23.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.461 0.704 . . . . 62.33 109.567 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 18' ' ' VAL . 15.9 t -109.22 133.45 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.606 0.362 . . . . 75.03 110.244 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.2 t -145.42 -178.67 6.2 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.455 1.102 . . . . 53.2 109.494 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.84 134.9 38.91 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.858 -0.526 . . . . 72.34 110.815 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 86.53 6.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.852 0.461 . . . . 72.12 110.548 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.221 1.008 . . . . 73.31 110.951 -178.884 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.61 0.243 . . . . 72.53 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.04 -157.0 33.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.678 -0.237 . . . . 51.22 113.609 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.5 140.36 29.94 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.927 0.891 . . . . 72.44 110.373 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -60.01 117.93 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.41 0.684 . . . . 63.43 111.527 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -53.87 -67.64 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.497 1.119 . . . . 74.42 113.005 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -82.54 123.81 29.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.024 0.44 . . . . 74.24 110.055 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -149.12 130.47 14.7 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.585 0.754 . . . . 72.33 110.392 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -95.79 28.73 2.94 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.484 0.714 . . . . 63.31 110.201 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 63.1 p -70.53 83.38 0.59 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.153 0.981 . . . . 74.41 113.097 -171.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.17 -68.17 0.92 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.804 -1.184 . . . . 72.24 107.804 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -65.89 -29.49 69.93 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 122.597 0.359 . . . . 71.31 111.013 168.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 9' ' ' SER . 38.9 t70 -81.31 2.05 29.87 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.838 0.855 . . . . 63.33 112.1 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -80.23 135.29 36.23 Favored 'General case' 0 CA--C 1.556 1.187 0 O-C-N 121.107 -0.996 . . . . 71.3 110.076 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -92.0 -26.74 18.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.533 0.568 . . . . 72.0 112.533 -175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -93.87 132.08 38.64 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.051 0.54 . . . . 65.03 110.774 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 29.1 pt -113.23 147.92 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.64 . . . . 71.53 111.263 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -108.84 115.63 30.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.56 0.744 . . . . 75.54 110.426 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 t -111.75 143.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.831 0.852 . . . . 71.24 110.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.79 155.11 47.24 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.011 0.925 . . . . 72.41 111.484 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.72 24.64 37.93 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 114.367 0.507 . . . . 53.23 114.367 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.7 -16.28 51.75 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.934 0.894 . . . . 74.2 112.837 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.99 158.65 29.35 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 120.947 0.193 . . . . 73.04 113.444 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.91 -5.25 55.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.482 0.713 . . . . 74.21 112.857 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.18 18.74 19.05 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.818 0.847 . . . . 74.15 111.257 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.24 144.61 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.276 0.631 . . . . 71.25 112.318 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -124.09 154.62 39.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.196 0.598 . . . . 65.31 111.103 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.3 mt -55.45 -39.26 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.893 0.877 . . . . 74.34 110.881 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.055 0.942 . . . . 74.0 111.843 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -72.22 -40.91 67.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.513 0.325 . . . . 73.23 111.223 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.07 -42.08 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.082 0.468 . . . . 62.33 110.171 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.47 91.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.521 0.729 . . . . 73.32 111.808 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.96 -33.03 74.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.5 0.72 . . . . 72.35 110.764 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -71.04 -55.48 8.18 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.052 0.941 . . . . 74.12 111.085 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -81.51 -19.3 42.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.477 1.288 . . . . 73.12 114.477 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -61.35 -26.21 67.66 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.695 0.998 . . . . 74.12 113.695 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -61.72 -24.34 66.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.374 0.669 . . . . 72.01 112.323 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.9 mm -83.13 -50.95 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.992 0.917 . . . . 75.15 111.344 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 75' ' ' SER . . . -161.73 168.61 36.93 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.683 -0.69 . . . . 45.55 113.674 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.65 110.41 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.384 0.674 . . . . 74.55 110.669 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.1 mt -80.9 131.84 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 108.444 -0.947 . . . . 73.44 108.444 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.46 124.96 14.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.261 0.624 . . . . 73.21 111.085 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 30.6 m -113.43 120.15 40.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.643 -0.708 . . . . 74.44 110.487 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -60.93 108.77 0.91 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.59 -27.59 62.27 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.398 0.679 . . . . 71.33 111.994 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -62.16 -50.17 72.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.716 0.806 . . . . 65.2 111.48 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -86.51 -40.27 15.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.383 0.673 . . . . 72.53 111.077 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 1.62 50.12 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.861 -0.609 . . . . 54.03 112.718 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -104.89 151.52 39.42 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 124.134 0.974 . . . . 64.32 112.444 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 72.9 Cg_endo -72.18 155.48 56.46 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.761 2.307 . . . . 51.33 112.712 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.7 mtt -83.77 95.17 8.34 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.47 0.652 . . . . 73.14 109.962 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.6 mt -142.59 124.49 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.442 1.097 . . . . 70.23 109.117 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 15.3 m120 -106.18 109.84 21.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.883 0.473 . . . . 74.51 110.085 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 66' ' ' ALA . 88.5 mt -83.63 124.92 31.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.684 0.794 . . . . 60.25 109.601 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 94.0 m-85 -83.02 125.77 31.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.917 0.487 . . . . 75.23 111.149 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 9.9 m -112.23 142.16 45.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.783 0.833 . . . . 75.42 109.845 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.7 129.7 37.52 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.924 0.489 . . . . 75.31 110.454 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -70.59 -27.86 64.43 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.3 1.04 . . . . 73.31 112.384 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -85.86 -50.57 7.02 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.318 0.647 . . . . 63.42 112.025 -175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.5 p -83.16 -30.8 27.54 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.566 0.746 . . . . 72.4 112.111 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.28 9.69 85.66 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 116.229 -0.441 . . . . 70.12 113.872 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -109.41 154.75 22.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.224 0.61 . . . . 54.12 110.966 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 mt -62.18 136.47 57.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.421 0.688 . . . . 73.51 111.921 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -73.34 -12.74 60.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.797 0.839 . . . . 74.3 111.918 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.65 42.44 21.58 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.827 -0.509 . . . . 44.24 111.827 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 50.6 mt-10 -131.81 147.93 52.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.915 0.886 . . . . 74.21 109.722 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -153.18 139.46 18.48 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.196 0.443 . . . . 73.11 112.196 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.8 p -101.25 119.5 38.85 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.844 -0.428 . . . . 75.24 109.844 169.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.3 t -109.24 108.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.631 0.772 . . . . 74.52 110.383 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 66.2 m -81.02 104.93 11.85 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.6 0.36 . . . . 65.41 111.117 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -82.1 157.56 24.04 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.94 0.496 . . . . 73.33 110.463 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.44 -37.66 60.21 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.999 0.52 . . . . 75.4 110.027 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -111.91 122.25 37.49 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.918 0.887 . . . . 63.45 110.261 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.53 -34.63 73.34 Favored 'Trans proline' 0 CA--C 1.583 2.939 0 C-N-CA 122.554 2.17 . . . . 75.31 116.565 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.61 -30.41 79.06 Favored 'Trans proline' 0 C--N 1.397 3.114 0 CA-C-N 122.687 1.995 . . . . 74.02 113.209 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.404 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 36.7 m -73.77 -35.74 65.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.038 0.446 . . . . 64.32 110.503 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.29 -50.09 74.42 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.434 -0.803 . . . . 62.02 111.285 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.25 -40.94 98.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.503 0.721 . . . . 61.14 111.161 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.34 98.99 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.965 -0.562 . . . . 64.24 111.813 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.44 75.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.447 0.699 . . . . 55.1 112.145 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 95' ' ' VAL . 69.7 mt -66.81 -56.95 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.599 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.44 -31.01 67.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.644 0.778 . . . . 73.13 111.876 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -80.55 -58.21 3.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.78 0.832 . . . . 72.45 111.993 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -85.24 -10.19 56.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.382 1.253 . . . . 73.23 114.382 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.08 119.28 11.75 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 118.575 0.625 . . . . 75.2 110.45 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.02 1.85 84.34 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.456 -0.793 . . . . 54.21 114.45 -175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.94 173.26 8.59 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 117.623 0.711 . . . . 71.11 110.793 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.33 122.95 48.03 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.105 -0.372 . . . . 71.22 111.718 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -92.99 -67.44 0.86 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.621 0.769 . . . . 74.33 110.028 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -112.95 50.09 0.9 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.695 0.798 . . . . 63.03 109.886 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 115.456 -0.793 . . . . 73.21 113.678 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -122.32 130.23 24.77 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.355 1.062 . . . . 63.23 110.387 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.2 94.0 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.53 2.153 . . . . 74.22 111.804 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.2 pt -71.33 155.34 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.977 0.911 . . . . 75.33 112.506 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -118.82 122.16 41.73 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.188 -1.042 . . . . 71.51 108.188 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.587 HG12 HG12 ' A' ' 80' ' ' ILE . 11.2 t -109.29 133.08 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.196 0.522 . . . . 73.45 110.002 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -133.05 -178.03 4.78 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.148 1.379 . . . . 44.0 109.019 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 32.7 m-85 -90.67 151.2 21.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 122.097 -0.377 . . . . 70.22 110.736 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.18 82.87 2.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.554 0.741 . . . . 51.53 109.216 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 115.695 -0.684 . . . . 53.34 112.34 -172.188 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.64 0.257 . . . . 73.01 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.72 -65.57 3.52 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 114.31 0.484 . . . . 71.11 114.31 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -70.08 89.74 0.63 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.321 0.649 . . . . 73.34 112.248 -175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -156.96 104.15 2.09 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 70.11 109.842 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -65.72 125.95 26.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.515 0.726 . . . . 74.41 110.522 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -75.06 81.05 2.23 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 120.923 0.392 . . . . 75.42 111.167 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -151.91 130.13 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 63.54 109.742 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -96.97 121.18 38.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.145 -0.687 . . . . 72.12 109.145 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -52.1 -46.5 65.29 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.497 1.119 . . . . 40.54 113.081 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -102.77 110.86 22.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.945 0.498 . . . . 73.2 110.03 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 t -127.13 109.62 12.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.384 0.674 . . . . 44.25 109.351 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.74 172.69 10.26 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.699 0.8 . . . . 75.42 110.443 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -51.31 107.05 0.16 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.17 0.988 . . . . 73.41 112.742 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -100.28 6.68 44.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.538 0.735 . . . . 72.34 111.229 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -108.65 126.21 52.73 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.615 0.766 . . . . 73.33 110.142 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.8 pt -105.5 157.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.681 0.792 . . . . 74.01 110.842 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -116.72 115.11 25.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.447 0.699 . . . . 74.43 110.095 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -104.98 145.02 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 124.401 1.08 . . . . 75.02 110.184 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.44 157.57 36.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.361 1.064 . . . . 73.35 110.056 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.12 41.7 92.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 115.233 0.853 . . . . 74.32 115.233 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.408 HD23 HG21 ' A' ' 93' ' ' ILE . 41.4 mt -81.82 -32.51 31.21 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.162 0.985 . . . . 61.21 111.639 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.76 161.26 11.7 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-N 116.182 -0.463 . . . . 65.54 112.619 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.48 -5.86 57.98 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.296 0.638 . . . . 73.2 112.064 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -94.54 14.0 22.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.506 0.723 . . . . 63.22 111.381 173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 p -75.42 138.53 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.421 0.688 . . . . 53.15 112.444 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.6 p -131.33 148.76 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.531 0.732 . . . . 54.44 110.947 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 51' ' ' ILE . 69.7 mt -51.66 -49.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.942 1.297 . . . . 65.24 112.893 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.91 -32.27 73.68 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 122.904 0.482 . . . . 71.41 111.935 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -74.37 -39.13 62.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.413 0.685 . . . . 73.24 111.536 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 42.7 t -63.97 -43.04 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 73.33 109.86 173.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.9 95.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.874 -1.057 . . . . 54.41 111.616 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 -34.17 77.67 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.634 0.773 . . . . 74.44 111.883 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.16 -53.51 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.881 0.472 . . . . 62.54 111.189 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 35.7 m-85 -77.87 -16.19 58.45 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.222 1.193 . . . . 75.3 114.222 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.19 -18.64 65.48 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.054 1.131 . . . . 61.41 114.054 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.02 -30.99 68.42 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.324 0.65 . . . . 75.22 111.914 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.59 -48.78 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.022 0.929 . . . . 70.42 110.896 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.7 173.18 40.59 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.426 -0.806 . . . . 50.14 112.695 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.88 127.83 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 122.989 0.516 . . . . 62.42 110.735 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.0 mt -97.54 134.79 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.637 0.775 . . . . 73.35 109.089 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 59.2 mtpt -62.22 155.64 24.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.457 0.703 . . . . 73.12 112.02 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 84.8 m -137.15 122.12 18.94 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.328 -0.851 . . . . 64.22 110.467 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -61.21 114.7 3.3 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.575 1.15 . . . . 43.25 109.47 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.26 -11.24 59.8 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.835 0.854 . . . . 72.24 112.878 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -83.4 -52.2 6.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.103 0.561 . . . . 73.41 110.598 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -79.67 -31.88 41.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.443 0.697 . . . . 71.22 111.691 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.2 81.58 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 116.008 -0.542 . . . . 42.55 112.964 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -104.92 149.86 38.04 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.42 1.088 . . . . 71.41 111.304 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.0 Cg_endo -63.65 146.73 92.72 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.369 2.046 . . . . 61.1 111.534 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 61.0 mtt -75.65 94.0 3.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.54 0.686 . . . . 60.4 109.471 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 27' ' ' ILE . 77.7 mt -144.08 127.89 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.85 1.26 . . . . 72.02 108.533 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 41.9 m-80 -108.02 110.31 21.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.715 -0.476 . . . . 71.31 109.715 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.951 0.782 . . . . 41.43 109.343 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 67' ' ' THR . 79.7 m-85 -74.99 120.44 20.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.232 0.613 . . . . 73.4 111.134 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 m -100.57 140.02 35.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.693 0.797 . . . . 65.33 108.956 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.59 124.36 23.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.593 0.757 . . . . 60.43 110.848 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -64.72 -24.9 67.71 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.633 0.773 . . . . 63.43 112.978 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.44 -53.65 3.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.404 0.682 . . . . 74.2 111.604 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.1 p -84.18 -22.86 30.8 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.366 0.667 . . . . 74.42 112.65 -173.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 8.12 74.1 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.262 0.465 . . . . 64.42 114.262 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.61 149.53 21.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.073 0.949 . . . . 64.41 111.233 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.25 125.72 24.44 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 117.94 0.336 . . . . 72.03 110.485 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -72.51 -21.97 61.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.994 0.518 . . . . 71.3 112.31 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 22.05 66.54 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.183 -0.367 . . . . 74.44 112.183 -170.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -115.08 143.13 45.68 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.24 -1.022 . . . . 53.51 108.24 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -151.73 159.3 44.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.705 0.402 . . . . 61.35 111.915 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 p -114.65 120.72 41.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.606 0.362 . . . . 64.42 111.24 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.29 111.84 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.099 0.559 . . . . 61.32 110.534 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -88.86 105.62 17.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.413 0.685 . . . . 75.12 111.413 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 51.5 m-85 -80.81 161.14 24.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.863 0.865 . . . . 62.11 110.765 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.32 -33.93 65.41 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.592 0.757 . . . . 75.53 110.943 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.18 132.07 22.92 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.776 0.83 . . . . 64.25 111.189 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.46 -43.29 45.29 Favored 'Trans proline' 0 CA--C 1.584 2.991 0 C-N-CA 122.779 2.319 . . . . 74.23 115.288 165.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.99 -27.72 66.2 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 122.311 1.861 . . . . 71.22 113.563 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 m -69.57 -38.72 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.545 0.688 . . . . 74.01 109.838 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -60.03 -54.78 41.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.628 -1.169 . . . . 65.3 110.861 175.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -59.22 -45.39 91.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.836 0.854 . . . . 75.4 111.404 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.94 99.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.946 -0.57 . . . . 64.12 111.686 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.05 -32.82 73.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.539 0.525 . . . . 72.23 111.992 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 95' ' ' VAL . 79.0 mt -65.33 -62.21 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.545 0.338 . . . . 64.5 111.049 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.65 -25.09 66.06 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 112.443 0.534 . . . . 75.31 112.443 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -78.26 -59.04 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.729 0.412 . . . . 74.12 110.945 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -86.62 -9.34 56.26 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.602 1.334 . . . . 71.32 114.602 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.87 106.28 1.85 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.732 0.696 . . . . 74.12 110.39 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.45 56.29 Favored Glycine 0 CA--C 1.546 1.985 0 CA-C-N 116.122 -0.49 . . . . 74.04 114.232 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 29.4 mmmt -80.71 175.9 10.27 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 123.761 0.824 . . . . 74.24 112.219 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.64 115.8 26.36 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.654 0.382 . . . . 74.21 111.383 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -82.55 -75.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.186 0.595 . . . . 75.21 111.042 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 t -98.93 37.31 1.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.324 0.65 . . . . 73.52 110.03 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.64 11.66 85.09 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 115.986 -0.552 . . . . 71.24 112.139 -164.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.1 121.6 41.24 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.433 1.093 . . . . 62.34 110.608 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.8 Cg_exo -66.21 96.2 0.33 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.937 2.425 . . . . 73.21 112.561 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.408 HG21 HD23 ' A' ' 21' ' ' LEU . 29.5 pt -74.86 153.58 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.181 0.992 . . . . 74.43 113.32 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -119.75 114.77 22.66 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.965 -1.124 . . . . 71.2 107.965 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 18' ' ' VAL . 19.2 t -109.39 137.28 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 120.974 0.416 . . . . 54.4 110.297 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -142.51 -174.52 4.16 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.336 1.454 . . . . 61.3 109.042 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -79.96 146.4 32.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.907 -0.495 . . . . 70.14 110.69 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.4 107.97 18.26 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.939 -0.393 . . . . 74.13 109.939 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.489 1.486 0 C-N-CA 123.385 0.674 . . . . 75.41 112.068 -176.744 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 110.311 -0.255 . . . . 71.52 110.311 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.03 118.62 13.71 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 123.091 0.377 . . . . 33.41 113.508 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -77.2 101.19 6.08 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.657 0.783 . . . . 72.1 110.474 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -104.49 92.82 4.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.526 0.731 . . . . 62.12 112.167 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.74 117.71 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.934 1.294 . . . . 72.11 108.531 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -73.28 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.103 -0.373 . . . . 74.15 111.882 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 57.04 29.78 17.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.351 1.061 . . . . 62.03 111.006 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -94.93 103.37 15.23 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.665 0.786 . . . . 73.3 110.46 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -153.69 116.14 4.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.364 0.666 . . . . 71.31 110.24 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -67.17 -43.47 82.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.689 0.795 . . . . 70.11 110.573 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -101.52 82.11 2.26 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.95 0.9 . . . . 72.01 109.692 170.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.27 90.51 7.14 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.648 0.737 . . . . 71.24 109.18 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.17 138.34 56.93 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.779 0.831 . . . . 63.44 113.127 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -98.13 -17.34 19.1 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.348 -0.842 . . . . 64.51 110.681 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 m -97.83 126.59 43.28 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.277 0.56 . . . . 71.35 110.059 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.2 pt -105.72 153.93 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.789 0.836 . . . . 73.33 111.13 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -109.41 125.19 52.14 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.144 0.578 . . . . 74.12 109.903 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 HG22 ' A' ' 95' ' ' VAL . 18.7 t -121.31 141.75 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.081 0.952 . . . . 71.44 109.901 -175.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -127.87 159.87 33.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.902 0.881 . . . . 74.24 110.539 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.5 32.12 35.1 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 114.303 0.481 . . . . 53.34 114.303 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.81 -28.38 24.53 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.888 0.875 . . . . 63.4 112.225 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.96 161.49 18.71 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 123.068 0.366 . . . . 70.01 113.496 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -83.78 -2.0 55.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.712 1.004 . . . . 54.53 113.712 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -121.19 21.6 11.15 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.395 0.678 . . . . 53.33 111.902 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.77 142.77 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.291 0.636 . . . . 62.15 111.528 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 30' ' ' VAL . 44.0 p -122.62 153.83 38.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.451 -0.78 . . . . 74.55 110.618 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 93.4 mt -53.46 -40.29 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.146 0.978 . . . . 70.11 111.43 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.29 -44.18 95.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.787 0.835 . . . . 63.23 111.53 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -68.94 -41.26 78.31 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.182 0.593 . . . . 71.05 111.844 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 26' ' ' THR . 56.9 t -64.6 -43.42 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.119 0.568 . . . . 75.42 110.021 176.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.95 88.75 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.368 -0.833 . . . . 61.33 111.753 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.42 -30.46 70.22 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.268 0.627 . . . . 62.14 111.6 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -72.61 -55.07 7.43 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.792 0.837 . . . . 73.33 111.64 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 77.2 m-85 -81.1 -20.01 42.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.413 1.264 . . . . 73.41 114.413 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -58.0 -29.93 65.66 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.659 0.985 . . . . 75.22 113.659 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.01 -26.49 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.815 0.846 . . . . 50.04 112.598 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 mm -79.27 -47.6 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.751 0.821 . . . . 55.32 110.758 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 173.99 43.03 Favored Glycine 0 N--CA 1.463 0.497 0 CA-C-N 116.211 -0.449 . . . . 62.52 113.295 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.28 124.3 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.379 0.671 . . . . 52.24 110.837 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 65.3 mt -94.37 131.86 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.062 0.945 . . . . 44.45 109.625 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.1 mtpt -54.91 144.99 21.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.464 0.706 . . . . 71.31 111.743 173.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.4 m -126.19 128.21 46.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.265 -0.879 . . . . 71.03 109.794 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -69.56 114.36 7.71 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.797 0.839 . . . . 74.31 108.942 172.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.96 -15.27 60.19 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.42 0.688 . . . . 74.21 112.254 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.73 -36.19 65.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.985 0.514 . . . . 73.51 111.371 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -98.67 -41.77 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.485 0.714 . . . . 73.1 111.761 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.58 8.07 54.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 115.754 -0.657 . . . . 33.13 112.812 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.9 150.16 52.43 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 123.931 0.892 . . . . 72.2 112.377 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.4 Cg_endo -61.48 145.03 98.34 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.434 2.756 . . . . 72.34 112.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.518 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 60.8 mtt -74.81 97.11 3.21 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.384 0.612 . . . . 74.21 109.789 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 99.2 mt -142.0 124.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.545 1.138 . . . . 75.34 109.043 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.9 m-20 -101.85 107.43 18.61 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.031 -0.729 . . . . 65.4 109.031 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.22 134.93 36.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.722 -0.844 . . . . 54.14 108.722 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HE2' HG23 ' A' ' 67' ' ' THR . 96.5 m-85 -100.01 122.15 42.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.008 0.523 . . . . 71.2 110.379 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 m -102.54 141.44 35.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.261 1.024 . . . . 74.4 110.218 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.8 133.82 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.165 0.586 . . . . 74.35 109.584 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -87.31 -24.86 24.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.554 0.742 . . . . 72.22 112.798 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.09 -34.98 14.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.271 0.471 . . . . 74.21 112.271 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -90.75 -53.52 4.37 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.074 0.398 . . . . 71.43 112.074 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.63 -0.88 34.33 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 116.025 -0.534 . . . . 51.32 113.587 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.06 152.93 19.72 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.451 0.7 . . . . 64.15 109.75 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 84.3 mt -62.66 140.55 58.7 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.097 0.475 . . . . 70.21 111.788 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -74.11 -13.08 60.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.969 0.908 . . . . 54.32 112.186 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 29.53 39.69 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.453 -0.34 . . . . 55.31 112.531 -174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.5 145.07 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.971 0.909 . . . . 73.22 109.631 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 147.0 18.41 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.963 0.411 . . . . 73.12 111.919 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 75.0 p -102.01 133.6 46.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.9 -0.591 . . . . 44.11 110.159 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -115.1 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 123.139 0.576 . . . . 64.42 110.339 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 43.9 m -85.14 102.3 13.16 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.849 0.46 . . . . 64.53 110.961 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.7 m-85 -79.45 155.51 28.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.116 0.566 . . . . 71.34 110.747 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.71 -35.76 72.89 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.216 0.606 . . . . 74.24 110.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -114.38 129.01 25.27 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.379 0.671 . . . . 52.14 111.337 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.51 -37.99 83.02 Favored 'Trans proline' 0 CA--C 1.587 3.15 0 C-N-CA 123.108 2.538 . . . . 70.21 116.42 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.64 -24.87 40.98 Favored 'Trans proline' 0 C--N 1.396 3.047 0 CA-C-N 122.611 1.968 . . . . 72.32 112.857 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -74.59 -38.12 62.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.647 0.779 . . . . 63.2 110.21 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.42 -51.34 70.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.779 -1.1 . . . . 44.12 110.692 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -65.17 -39.15 92.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.32 -0.854 . . . . 75.15 111.299 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.0 94.71 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.396 0.278 . . . . 70.23 111.285 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.404 0.682 . . . . 70.0 112.222 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 77' ' ' LYS . 89.6 mt -65.61 -63.46 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.018 0.527 . . . . 65.1 110.674 173.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.05 -25.59 67.77 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.403 -0.817 . . . . 74.14 111.698 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -82.12 -60.23 2.29 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.871 0.469 . . . . 74.14 111.691 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.728 1.381 . . . . 73.34 114.728 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.33 119.87 12.31 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.678 0.672 . . . . 71.34 109.74 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 5.35 75.97 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 114.86 0.704 . . . . 42.22 114.86 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 74.9 mmtt -88.29 -167.8 2.0 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 117.939 0.869 . . . . 75.22 111.525 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.13 118.06 23.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.098 0.959 . . . . 72.24 109.981 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 93' ' ' ILE . 67.9 t80 -78.8 -75.11 0.25 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.67 0.271 . . . . 72.44 110.578 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.4 t -122.84 61.21 1.01 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.778 0.799 . . . . 64.34 110.077 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.41 2.49 84.39 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.011 -0.995 . . . . 73.04 114.076 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -117.18 136.51 23.41 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.998 0.919 . . . . 74.31 110.186 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 73.5 Cg_endo -73.07 116.7 4.81 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.555 2.17 . . . . 74.41 112.153 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' A' ' 88' ' ' PHE . 41.1 pt -92.56 153.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.574 0.749 . . . . 73.53 113.005 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -123.95 119.09 28.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.215 1.006 . . . . 74.3 108.869 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG13 ' A' ' 18' ' ' VAL . 32.6 t -112.85 134.12 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.598 0.759 . . . . 71.11 110.136 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.7 p -146.42 -176.33 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.742 1.217 . . . . 72.43 109.182 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -76.46 145.33 39.31 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.01 0.823 . . . . 73.44 110.778 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.25 93.28 8.16 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.04 0.448 . . . . 54.2 110.793 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 124.036 0.935 . . . . 70.05 111.261 178.586 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.112 0.006 . . . . 73.54 111.007 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.61 23.8 69.08 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 115.23 0.852 . . . . 72.44 115.23 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -86.43 -48.55 8.34 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.055 0.542 . . . . 74.04 111.164 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -90.66 92.25 8.75 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.031 -0.729 . . . . 73.1 109.031 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -72.08 74.79 0.94 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.968 0.907 . . . . 71.35 111.734 -172.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 58.25 21.02 7.7 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.596 1.158 . . . . 74.21 112.622 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -86.6 -29.92 22.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.106 0.562 . . . . 63.32 109.638 173.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.53 113.12 22.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.964 -0.754 . . . . 63.53 108.964 168.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -72.7 111.2 7.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.614 0.366 . . . . 62.44 111.539 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -69.24 -55.77 9.57 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.398 0.679 . . . . 72.05 109.309 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -179.34 50.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.929 1.292 . . . . 52.3 108.149 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.96 25.8 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.02 1.489 . . . . 74.31 115.02 -163.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -65.49 129.76 40.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.78 0.432 . . . . 74.01 110.735 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -87.44 -22.03 25.21 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.146 -0.479 . . . . 62.05 110.328 174.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -96.44 132.48 41.94 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.579 0.752 . . . . 75.11 110.625 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 76' ' ' ALA . 35.7 pt -114.96 152.87 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.879 0.872 . . . . 40.03 111.061 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -107.7 116.45 31.96 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.158 0.583 . . . . 72.41 110.175 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 95' ' ' VAL . 19.1 t -109.6 134.15 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.212 1.005 . . . . 75.33 110.436 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -120.12 157.19 29.53 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.063 0.945 . . . . 43.22 110.562 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.88 29.55 28.58 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-O 121.241 0.356 . . . . 70.54 113.941 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.28 -13.46 46.62 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.153 0.981 . . . . 72.2 112.957 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.0 54.25 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 114.878 0.711 . . . . 71.21 114.878 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.88 -24.61 48.43 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.813 0.845 . . . . 65.12 112.34 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.67 20.02 9.16 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.416 0.686 . . . . 62.11 111.787 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG13 HD13 ' A' ' 62' ' ' LEU . 5.0 p -80.14 131.73 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.056 0.543 . . . . 52.31 112.0 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.4 p -129.39 154.67 46.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.406 0.682 . . . . 75.14 110.292 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB ' ' A' ' 51' ' ' ILE . 90.4 mt -50.24 -52.51 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 124.283 1.033 . . . . 65.12 111.815 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.42 -37.03 84.28 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.568 -0.742 . . . . 73.31 111.462 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -69.9 -36.89 75.77 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.107 0.41 . . . . 62.33 112.107 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.5 -37.9 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 120.977 0.417 . . . . 55.23 110.052 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.74 66.06 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.924 0.49 . . . . 54.12 111.594 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.34 -32.52 58.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.101 0.96 . . . . 74.31 111.434 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.14 -49.69 41.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.659 0.784 . . . . 74.01 110.392 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.458 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 14.2 m-85 -82.89 -16.96 45.45 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.556 1.317 . . . . 54.15 114.556 -173.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -66.98 -17.36 64.88 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.471 0.915 . . . . 73.35 113.471 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.55 -24.75 63.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.039 0.536 . . . . 73.42 111.99 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.06 -41.08 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.304 1.042 . . . . 75.02 111.375 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.11 176.45 47.19 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.454 -0.403 . . . . 74.23 113.993 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.4 126.18 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.899 0.479 . . . . 55.14 109.911 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 81.0 mt -94.64 141.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.712 0.805 . . . . 75.42 109.038 173.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 26.4 mtpp -59.78 144.67 47.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.366 0.666 . . . . 72.12 111.658 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.3 m -128.4 120.27 26.62 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.489 -0.778 . . . . 71.53 109.569 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.16 114.72 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.017 -0.734 . . . . 73.22 109.017 171.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.35 -28.28 66.08 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.277 1.031 . . . . 73.42 111.777 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 11.5 mmpt? -71.61 -45.87 60.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.29 0.636 . . . . 75.24 111.74 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 p -82.98 -35.17 26.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.134 0.574 . . . . 74.15 111.453 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.17 17.79 64.15 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.78 -0.645 . . . . 72.22 112.404 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -120.98 152.07 55.94 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.407 1.083 . . . . 74.44 111.79 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HG2' HG22 ' A' ' 27' ' ' ILE . 18.8 Cg_endo -61.42 146.77 96.83 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.739 2.292 . . . . 74.22 113.141 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.539 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 52.7 mtt -82.75 97.1 8.41 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.016 0.526 . . . . 73.23 110.646 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 27' ' ' ILE . 70.2 mt -144.27 117.48 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.183 0.993 . . . . 71.44 109.132 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.56 110.37 22.19 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.589 -0.523 . . . . 74.45 109.589 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.7 mt -82.31 115.35 21.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.46 0.704 . . . . 74.41 110.196 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -69.89 117.33 11.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.061 0.545 . . . . 60.43 110.247 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 m -122.39 139.13 54.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.02 0.928 . . . . 62.01 109.59 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -73.32 135.63 44.38 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.175 0.59 . . . . 61.13 111.62 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 15.4 ptm180 -64.64 -38.33 90.65 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.459 1.103 . . . . 75.22 112.674 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 45.4 mt-10 -80.77 -55.52 4.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.252 0.621 . . . . 75.21 111.839 -171.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.2 p -84.07 -31.19 25.47 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.3 0.64 . . . . 45.1 111.794 -174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 8.71 86.26 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 116.438 -0.346 . . . . 64.0 113.22 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -92.8 152.32 19.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.213 0.605 . . . . 73.34 111.937 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 25' ' ' VAL . 82.8 mt -65.76 126.46 28.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.767 0.827 . . . . 44.14 110.784 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -71.27 -12.97 61.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.051 0.94 . . . . 62.24 112.201 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.97 37.73 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 112.014 -0.435 . . . . 72.24 112.014 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.47 149.27 49.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.998 . . . . 73.22 109.552 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.32 159.13 25.1 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.492 0.553 . . . . 72.11 112.492 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.5 p -115.24 114.08 24.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.132 0.573 . . . . 71.42 111.323 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 51' ' ' ILE . 21.6 t -99.81 108.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.432 1.093 . . . . 75.51 110.608 -173.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 42.2 m -84.98 101.76 12.63 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.686 0.394 . . . . 72.5 111.28 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 38.0 m-85 -77.37 156.13 31.44 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.097 0.559 . . . . 73.21 111.18 171.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.08 -27.41 54.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.298 0.639 . . . . 63.15 111.296 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 22.8 m-20 -120.0 131.38 24.43 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 122.942 0.497 . . . . 70.44 111.743 171.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.37 -38.3 82.37 Favored 'Trans proline' 0 CA--C 1.583 2.93 0 C-N-CA 122.879 2.386 . . . . 64.13 115.68 168.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 37.7 Cg_endo -64.98 -25.42 59.35 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 123.03 2.118 . . . . 62.04 113.404 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.9 m -76.17 -37.24 58.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.072 0.549 . . . . 73.01 110.19 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.69 -48.29 81.46 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.324 0.649 . . . . 71.3 111.015 174.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.42 -47.5 85.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.279 1.032 . . . . 75.21 110.799 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.34 93.88 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.604 -0.725 . . . . 64.44 111.738 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -31.76 73.07 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.321 0.648 . . . . 63.21 112.507 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' VAL . 72.5 mt -63.62 -61.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.264 0.226 . . . . 74.45 110.599 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.19 -24.7 65.0 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.421 0.688 . . . . 62.42 112.643 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -80.21 -59.38 2.73 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.44 0.696 . . . . 74.15 111.617 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB3' HD11 ' A' ' 93' ' ' ILE . 77.1 m-85 -85.84 -10.83 54.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.194 1.183 . . . . 74.12 114.194 -170.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.68 115.14 4.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.376 0.534 . . . . 61.31 110.258 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.53 68.58 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 114.921 0.728 . . . . 71.15 114.921 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.5 mmtt -94.08 141.46 28.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.111 0.956 . . . . 73.33 111.935 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.04 116.13 19.14 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.599 0.759 . . . . 74.32 112.179 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -90.9 -78.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.582 0.753 . . . . 54.33 110.949 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -109.26 54.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.968 0.889 . . . . 73.51 110.248 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.64 8.48 87.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.983 -1.008 . . . . 74.21 113.83 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -133.59 136.82 27.54 Favored Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 123.811 0.845 . . . . 74.01 109.878 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.73 116.55 4.76 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.739 2.293 . . . . 75.53 110.893 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 83' ' ' PHE . 16.0 pt -80.45 154.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.735 0.642 . . . . 72.51 112.735 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -119.22 112.3 19.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.369 -0.975 . . . . 72.23 108.369 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 18' ' ' VAL . 14.2 t -107.0 137.02 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.019 0.528 . . . . 72.05 110.876 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.6 m -141.51 179.86 6.56 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.997 1.319 . . . . 63.41 109.207 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.31 149.59 31.72 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.807 0.731 . . . . 73.23 110.399 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.89 85.92 7.03 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.024 0.44 . . . . 73.42 110.117 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.571 1.752 0 C-N-CA 123.209 0.604 . . . . 71.43 112.135 -176.114 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 111.642 0.238 . . . . 73.33 111.642 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.5 -158.01 28.81 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.356 -0.383 . . . . 73.32 113.106 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -101.33 85.9 2.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.887 0.875 . . . . 74.33 111.918 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 64.44 -2.75 0.59 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.841 1.793 . . . . 65.35 115.841 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -91.04 -7.73 51.03 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.059 0.845 . . . . 73.12 111.832 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -114.03 125.71 54.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.681 0.793 . . . . 75.35 109.703 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -76.1 127.63 33.34 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 72.32 111.361 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -89.36 40.54 0.99 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.29 0.567 . . . . 74.51 111.826 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -62.72 156.62 23.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.655 0.782 . . . . 61.4 111.712 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 62.12 74.08 0.45 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.206 1.002 . . . . 71.35 111.596 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.7 t -100.8 -11.64 19.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.754 0.822 . . . . 62.33 111.737 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -78.95 102.0 8.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.964 0.506 . . . . 70.13 111.931 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 16.9 m-80 -105.8 138.78 41.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.689 0.795 . . . . 74.11 110.39 173.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -93.43 -22.84 18.66 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.976 0.511 . . . . 62.05 111.067 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -106.18 125.67 51.28 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.843 0.857 . . . . 71.21 110.747 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 76' ' ' ALA . 30.3 pt -114.9 148.28 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.906 0.882 . . . . 64.23 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -102.14 120.05 39.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.433 0.693 . . . . 73.11 109.607 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 95' ' ' VAL . 14.4 t -114.9 136.13 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.186 0.994 . . . . 72.23 110.388 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -124.37 162.69 23.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.131 0.973 . . . . 72.23 110.234 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.92 25.93 61.33 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 114.203 0.441 . . . . 61.04 114.203 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 93' ' ' ILE . 77.0 mt -79.03 -22.38 45.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.352 1.061 . . . . 54.21 112.013 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.87 167.66 42.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.083 0.373 . . . . 63.22 113.227 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.62 -19.56 59.13 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 112.84 0.682 . . . . 72.44 112.84 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -86.91 6.93 29.51 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.145 0.578 . . . . 74.52 111.934 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.2 138.03 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 124.198 0.999 . . . . 42.42 112.242 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -129.44 151.15 50.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.756 -0.59 . . . . 73.4 110.061 171.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 51' ' ' ILE . 67.9 mt -49.19 -51.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.631 1.172 . . . . 64.44 112.773 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.68 -21.1 55.85 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.788 0.662 . . . . 72.53 112.788 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -73.85 -37.55 64.75 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 117.962 0.346 . . . . 65.53 111.099 171.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.23 -41.48 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 121.309 0.576 . . . . 70.31 109.7 171.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.5 92.42 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.341 -0.845 . . . . 75.2 111.596 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.93 -38.11 89.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.273 0.629 . . . . 72.24 111.047 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -67.27 -55.9 12.06 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.816 0.846 . . . . 63.44 111.385 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.446 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 49.0 m-85 -77.94 -21.64 50.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.584 1.327 . . . . 64.31 114.584 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.87 -20.04 66.09 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.983 1.105 . . . . 74.5 113.983 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -60.56 -22.28 63.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 122.985 0.514 . . . . 73.22 112.15 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.08 -42.45 14.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 124.507 1.123 . . . . 73.14 111.424 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 172.67 45.12 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.981 -0.554 . . . . 73.3 113.229 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.96 125.47 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.557 0.743 . . . . 60.14 110.719 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 73.2 mt -95.56 130.5 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.943 0.897 . . . . 54.22 109.388 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.596 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.5 mtpt -51.04 153.99 1.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.743 0.817 . . . . 71.24 112.91 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 52.4 m -140.07 125.46 18.97 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.613 0.765 . . . . 71.23 110.508 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -64.13 123.87 20.19 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.448 0.699 . . . . 72.13 111.038 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -71.78 -24.02 61.67 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.109 0.563 . . . . 63.1 112.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.8 -54.36 13.99 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.807 0.443 . . . . 65.1 111.577 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -84.57 -45.3 12.7 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.196 0.598 . . . . 74.44 111.668 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.97 37.8 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.973 -0.558 . . . . 65.02 112.523 -170.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -106.13 148.94 37.52 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.128 0.971 . . . . 75.53 111.28 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 51.0 Cg_endo -68.14 145.97 68.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.598 2.198 . . . . 72.14 111.922 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.596 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 58.2 mtt -77.16 94.79 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.563 0.697 . . . . 71.2 110.026 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.587 ' HB ' HG23 ' A' ' 27' ' ' ILE . 86.7 mt -144.54 116.44 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.053 1.341 . . . . 74.51 108.49 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -99.03 109.43 22.18 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.155 -0.683 . . . . 51.34 109.155 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.84 120.8 26.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.138 0.575 . . . . 73.11 110.06 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.568 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 57.0 m-85 -73.12 104.35 4.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.011 0.524 . . . . 74.34 110.994 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -86.76 160.0 18.95 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.953 0.901 . . . . 62.14 110.065 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -93.45 155.1 17.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.953 0.901 . . . . 73.35 111.962 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.16 -35.64 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.658 0.783 . . . . 73.44 112.834 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.431 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.4 pt-20 -88.97 -37.99 14.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.93 -0.482 . . . . 63.23 111.952 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 58' ' ' GLU . 31.5 p -94.01 -33.38 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 112.522 0.564 . . . . 73.42 112.522 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.86 6.26 89.16 Favored Glycine 0 CA--C 1.541 1.656 0 N-CA-C 114.223 0.449 . . . . 33.14 114.223 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -102.1 171.72 7.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.689 0.796 . . . . 62.15 110.78 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.37 130.26 39.33 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.972 -0.455 . . . . 61.2 111.71 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -74.78 -18.96 60.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.432 0.693 . . . . 61.31 112.548 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 35.1 12.61 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 116.362 -0.381 . . . . 50.43 113.064 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 41.3 mt-10 -127.94 154.06 45.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.2 1.0 . . . . 70.42 109.042 173.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.57 164.08 24.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.093 0.557 . . . . 71.14 111.822 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.0 p -120.26 128.92 53.77 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.998 -0.546 . . . . 71.4 109.98 168.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.42 111.8 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.575 0.75 . . . . 63.44 110.809 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 m -89.21 102.71 15.37 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.936 0.494 . . . . 72.03 111.724 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 34.7 m-85 -78.09 156.85 29.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.707 0.803 . . . . 71.41 110.625 168.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.1 -32.31 44.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.045 0.538 . . . . 72.21 110.434 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 4.0 m-20 -106.08 122.58 41.82 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.59 0.756 . . . . 62.23 110.453 174.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 72' ' ' ASP . 5.3 Cg_endo -49.94 -42.45 44.97 Favored 'Trans proline' 0 CA--C 1.586 3.108 0 C-N-CA 122.918 2.412 . . . . 61.53 115.789 167.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.32 -25.5 71.57 Favored 'Trans proline' 0 C--N 1.406 3.564 0 CA-C-N 122.602 1.965 . . . . 52.43 113.117 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.8 m -76.59 -37.22 56.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.436 0.694 . . . . 73.14 110.917 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.07 -47.21 78.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.082 0.553 . . . . 53.51 111.151 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.58 -42.96 95.29 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.562 0.745 . . . . 75.21 111.282 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.42 89.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.285 -0.416 . . . . 71.41 111.847 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.65 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.398 0.679 . . . . 73.35 112.385 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 95' ' ' VAL . 72.4 mt -64.24 -63.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.528 0.331 . . . . 53.44 110.326 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.3 -31.76 63.97 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.556 0.742 . . . . 74.14 112.45 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -78.49 -56.98 4.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.499 0.72 . . . . 74.21 111.921 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 93' ' ' ILE . 62.7 m-85 -88.13 -4.1 58.8 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.242 1.201 . . . . 63.35 114.242 -171.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.7 110.81 1.4 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.634 0.374 . . . . 61.41 111.097 173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.33 80.16 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.049 0.779 . . . . 24.15 115.049 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.44 144.01 26.64 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 117.811 0.805 . . . . 64.4 112.023 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.64 116.91 19.33 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.983 0.513 . . . . 74.22 112.335 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.11 -66.88 0.82 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.485 0.714 . . . . 75.43 109.996 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.3 t -107.44 38.76 2.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.295 1.038 . . . . 74.44 110.001 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.56 23.86 74.22 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.003 -0.544 . . . . 74.22 113.253 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 28.0 p-10 -138.71 123.69 11.9 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 124.06 0.944 . . . . 73.23 110.53 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 21.9 Cg_exo -64.31 112.52 1.93 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.156 2.571 . . . . 53.32 112.771 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.44 HG21 HD23 ' A' ' 21' ' ' LEU . 18.6 pt -83.55 161.24 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 72.35 112.031 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -113.85 123.06 48.88 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.259 1.023 . . . . 71.25 108.298 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 18' ' ' VAL . 14.6 t -115.06 134.72 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 121.042 0.449 . . . . 75.43 110.508 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -142.72 179.77 6.8 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.173 1.389 . . . . 61.32 109.227 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 13' ' ' ASN . 94.5 m-85 -76.79 151.9 35.78 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.206 0.457 . . . . 52.23 110.488 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.72 95.89 8.62 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.69 0.396 . . . . 64.51 110.2 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 123.49 0.716 . . . . 72.44 111.275 -178.271 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.917 0.389 . . . . 74.04 111.483 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.4 -121.94 5.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.147 -0.479 . . . . 71.51 111.937 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -84.9 108.09 17.37 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.119 0.568 . . . . 64.43 110.612 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.9 114.42 26.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.491 0.716 . . . . 73.22 110.813 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -71.42 93.73 1.19 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.518 0.727 . . . . 74.31 109.826 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -74.93 85.68 2.26 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.834 0.826 . . . . 75.54 112.825 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -132.97 -69.72 0.56 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.081 0.953 . . . . 73.45 108.795 170.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.88 -42.33 11.92 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.426 -0.583 . . . . 71.45 109.426 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 m -68.32 91.99 0.41 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.565 -0.743 . . . . 71.13 110.626 176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -119.76 165.99 13.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.615 0.766 . . . . 74.31 111.349 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 p -92.88 107.13 18.98 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.348 0.659 . . . . 42.35 111.491 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -109.99 10.42 24.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.814 0.846 . . . . 72.1 112.264 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -75.45 131.83 40.41 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.212 0.605 . . . . 65.02 109.986 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.25 11.04 25.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.05 0.54 . . . . 74.34 112.195 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.7 m -126.82 129.56 48.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.889 0.876 . . . . 70.34 109.647 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.419 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.7 pt -116.21 146.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.823 0.849 . . . . 74.14 111.335 -175.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -102.28 123.92 46.94 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.457 0.703 . . . . 74.22 109.871 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 21.6 t -119.12 138.85 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.667 1.187 . . . . 71.4 110.073 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -126.1 155.41 41.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.03 0.932 . . . . 72.3 110.808 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.84 1.36 70.68 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 114.184 0.434 . . . . 74.31 114.184 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 93' ' ' ILE . 85.3 mt -61.36 -12.32 13.6 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.123 1.157 . . . . 65.51 114.123 -178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.25 173.28 49.57 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.389 0.515 . . . . 54.13 114.389 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 8.3 pt-20 -71.68 -22.46 61.66 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.286 -0.538 . . . . 74.33 111.27 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.52 8.93 22.76 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.714 0.806 . . . . 71.21 112.305 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.72 137.1 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.275 0 C-N-CA 122.722 0.409 . . . . 75.3 111.965 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' VAL . 57.9 p -131.22 148.01 52.66 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.428 0.691 . . . . 75.5 109.81 171.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG23 ' HB ' ' A' ' 51' ' ' ILE . 83.7 mt -51.5 -47.08 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.463 1.105 . . . . 75.51 112.983 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -69.7 -29.31 66.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.18 0.592 . . . . 73.45 111.916 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -74.1 -36.11 64.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.688 0.395 . . . . 73.14 111.369 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 26' ' ' THR . 44.4 t -65.36 -40.68 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.366 0.603 . . . . 65.01 109.663 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.98 85.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.017 -0.992 . . . . 63.12 111.735 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.74 -26.39 63.35 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.073 0.549 . . . . 75.33 111.664 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -75.29 -57.08 4.11 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.399 0.68 . . . . 72.44 111.578 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.432 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 30.9 m-85 -75.25 -19.47 59.71 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.593 1.331 . . . . 72.14 114.593 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.73 -21.51 66.44 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.69 0.996 . . . . 75.42 113.69 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -57.26 -25.03 58.54 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.112 0.565 . . . . 73.35 112.353 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.8 mm -84.57 -56.33 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.945 0.898 . . . . 71.03 110.72 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.33 166.99 33.87 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 116.024 -0.535 . . . . 73.21 113.38 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.23 114.16 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.019 0.528 . . . . 73.32 110.051 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 76.5 mt -79.7 136.31 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 109.186 -0.672 . . . . 60.44 109.186 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.6 mtpt -53.51 142.11 23.29 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.151 0.58 . . . . 61.15 112.0 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.7 m -132.88 119.84 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.629 -0.714 . . . . 71.04 110.079 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.73 123.33 16.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.335 1.054 . . . . 75.01 110.222 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -73.94 -30.75 62.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.656 0.782 . . . . 72.44 111.791 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.53 -51.54 49.67 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.151 0.581 . . . . 71.13 111.546 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 p -83.67 -45.67 13.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.469 0.708 . . . . 65.11 111.359 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.21 17.04 35.74 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 115.623 -0.717 . . . . 70.12 112.421 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -104.9 156.9 35.31 Favored Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 124.235 1.014 . . . . 74.4 112.801 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.78 142.2 19.98 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.956 2.437 . . . . 72.41 112.8 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.617 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.0 mtt -79.04 94.32 5.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.263 0.554 . . . . 74.34 110.305 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 27' ' ' ILE . 72.1 mt -146.77 115.88 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.525 1.13 . . . . 65.22 108.906 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.17 111.15 23.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 74.45 110.116 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.61 143.36 34.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.147 0.579 . . . . 72.13 110.164 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -100.38 126.09 46.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 73.34 109.848 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -115.2 142.45 46.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.065 0.946 . . . . 74.15 110.276 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -67.7 96.55 0.56 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.06 -0.718 . . . . 75.31 109.06 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -61.88 -24.1 66.72 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.593 0.757 . . . . 50.4 112.065 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.522 ' HG3' HG23 ' A' ' 59' ' ' THR . 10.9 pt-20 -71.69 -39.49 70.18 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.461 0.705 . . . . 71.11 111.903 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -103.49 -62.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.308 0.643 . . . . 75.24 111.478 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 -7.84 5.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.37 -0.377 . . . . 20.14 113.701 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -90.19 161.88 15.51 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.546 0.673 . . . . 62.44 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 59.6 mt -76.49 138.46 40.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.254 0.622 . . . . 74.32 111.649 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -73.32 -20.15 60.87 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.744 0.818 . . . . 74.45 111.787 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.79 33.85 20.4 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.739 -0.664 . . . . 71.3 112.719 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.88 148.97 52.29 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.917 0.887 . . . . 63.55 109.74 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.11 159.57 31.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.567 0.58 . . . . 70.21 112.567 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.6 p -114.9 117.57 31.05 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.068 0.547 . . . . 60.14 110.629 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.36 109.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.68 0.792 . . . . 73.21 110.385 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -86.94 101.61 13.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.021 0.528 . . . . 70.31 111.116 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 58.3 m-85 -77.59 157.28 30.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.722 0.809 . . . . 74.42 110.76 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.38 -35.99 58.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.225 0.61 . . . . 73.51 110.579 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -106.49 128.01 27.07 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.541 0.737 . . . . 65.13 110.821 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -52.29 -39.94 71.31 Favored 'Trans proline' 0 CA--C 1.582 2.883 0 C-N-CA 122.697 2.265 . . . . 61.23 115.764 166.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.25 -24.01 65.69 Favored 'Trans proline' 0 C--N 1.401 3.317 0 CA-C-N 122.297 1.856 . . . . 73.22 113.715 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.8 m -77.12 -38.06 52.88 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.109 0.564 . . . . 71.44 110.782 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -64.55 -43.8 92.81 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.428 0.632 . . . . 70.25 110.318 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -60.64 -48.02 83.64 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.146 1.378 . . . . 72.42 111.37 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.16 94.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.81 -0.632 . . . . 53.23 112.479 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.482 0.713 . . . . 74.23 112.387 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.484 HG12 HG12 ' A' ' 95' ' ' VAL . 92.2 mt -63.9 -60.53 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.115 0.566 . . . . 70.45 110.574 172.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.48 -31.68 66.23 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.409 -0.814 . . . . 75.44 111.576 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -80.06 -61.87 1.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.809 0.444 . . . . 70.22 111.933 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' HB2' HG21 ' A' ' 95' ' ' VAL . 71.3 m-85 -80.02 -10.46 59.77 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.618 0.97 . . . . 75.22 113.618 -170.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.4 104.26 2.23 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 109.541 -0.54 . . . . 72.01 109.541 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.55 42.41 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 115.546 -0.752 . . . . 62.32 114.017 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.2 mmtt -82.69 152.1 25.95 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.882 0.841 . . . . 75.01 110.073 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.95 124.1 35.81 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.429 0.529 . . . . 52.44 112.429 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -126.83 136.32 52.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.253 -1.018 . . . . 60.42 108.253 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 t 61.49 30.32 18.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.189 0.996 . . . . 71.4 111.609 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.26 29.0 54.83 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.478 -0.783 . . . . 53.0 115.041 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -161.41 145.29 9.8 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 117.305 0.553 . . . . 64.25 111.383 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.64 110.67 1.93 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.018 2.479 . . . . 74.15 113.438 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.431 HG21 HD23 ' A' ' 21' ' ' LEU . 34.4 pt -78.88 160.6 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.861 0.865 . . . . 74.21 112.223 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -118.18 128.19 54.47 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.463 1.105 . . . . 71.33 109.457 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 23.6 t -121.91 135.34 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 74.32 111.107 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.5 p -146.4 179.36 7.58 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.708 1.203 . . . . 60.14 109.022 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.27 154.4 37.47 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.969 0.804 . . . . 74.41 111.713 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.12 88.3 6.46 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.241 -0.652 . . . . 71.32 109.241 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.57 1.715 0 C-N-CA 123.451 0.7 . . . . 61.45 111.551 -174.712 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.339 0.114 . . . . 65.42 111.172 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.27 138.72 28.22 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 114.195 0.438 . . . . 53.04 114.195 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -75.26 88.75 2.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.897 0.855 . . . . 71.12 110.981 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.41 -29.54 70.81 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.368 -1.287 . . . . 71.33 112.716 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -67.88 135.69 52.89 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.203 0.601 . . . . 73.21 110.067 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -76.16 158.33 31.82 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.185 0.594 . . . . 70.12 112.026 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -104.62 6.67 34.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.678 0.791 . . . . 73.12 111.842 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -71.51 87.55 0.9 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.319 0.648 . . . . 64.3 111.06 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -158.46 -174.86 5.0 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.873 0.869 . . . . 74.53 110.654 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -66.64 99.96 0.64 Allowed 'General case' 0 CA--C 1.562 1.433 0 CA-C-O 121.488 0.661 . . . . 71.22 112.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.3 t -99.79 171.69 7.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.168 0.587 . . . . 72.32 110.239 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.44 35.21 0.49 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.542 0.737 . . . . 74.01 111.506 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -80.39 137.9 36.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.132 0.973 . . . . 71.12 110.575 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -98.64 -20.4 17.01 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.615 0.766 . . . . 75.2 111.88 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -94.77 126.75 40.29 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.915 0.486 . . . . 74.43 110.187 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.5 pt -113.36 156.0 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.584 0.754 . . . . 63.55 111.291 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -116.3 125.42 52.13 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.329 0.651 . . . . 72.42 110.146 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.621 HG13 HG22 ' A' ' 95' ' ' VAL . 18.5 t -117.41 146.33 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.191 0.996 . . . . 74.14 110.363 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 27.6 mt-30 -124.7 163.62 21.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.684 1.193 . . . . 74.0 110.184 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.97 23.57 74.29 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 114.953 0.741 . . . . 60.21 114.953 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 18' ' ' VAL . 57.5 mt -76.19 -17.92 59.31 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.328 1.051 . . . . 74.34 111.958 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 177.29 49.54 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 114.71 0.644 . . . . 74.14 114.71 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 34.0 mt-10 -75.29 -14.66 60.52 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.664 0.786 . . . . 75.05 112.797 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -84.09 -8.97 58.96 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.336 0.654 . . . . 60.44 112.191 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.7 128.36 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 113.716 1.006 . . . . 74.12 113.716 -169.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.3 p -125.61 152.86 44.57 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.517 0.727 . . . . 72.52 110.289 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 51' ' ' ILE . 88.0 mt -52.91 -45.55 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.379 0.672 . . . . 70.04 111.593 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.64 -38.74 92.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.58 0.752 . . . . 74.43 111.777 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.3 t -71.5 -39.46 70.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.756 0.422 . . . . 72.34 111.707 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' THR . 61.9 t -65.32 -40.4 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.256 0.55 . . . . 65.54 110.014 176.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.22 -42.63 99.29 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.141 -0.936 . . . . 72.24 111.286 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.52 -30.65 67.46 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.143 0.577 . . . . 74.5 111.379 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.43 -53.7 7.76 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.692 0.797 . . . . 73.23 111.418 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.445 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.2 m-85 -79.04 -16.26 57.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.784 1.031 . . . . 64.35 113.784 -174.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.07 -29.77 67.57 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 113.09 0.774 . . . . 70.4 113.09 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -58.85 -25.09 62.94 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.796 0.838 . . . . 51.13 112.275 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.35 -45.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.253 1.021 . . . . 74.43 111.649 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -178.7 45.62 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 116.343 -0.39 . . . . 65.5 113.315 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.92 126.97 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.7 0.4 . . . . 71.11 110.123 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 80.4 mt -95.06 143.2 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.785 0.834 . . . . 51.3 108.852 170.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.611 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.7 mtpt -62.42 145.62 53.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.092 0.557 . . . . 74.12 111.504 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 41.5 m -125.67 123.91 39.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.106 0.962 . . . . 73.31 108.809 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -71.69 123.74 23.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.071 0.549 . . . . 71.21 109.664 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -18.28 45.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.209 0.604 . . . . 72.44 111.722 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.26 -52.73 44.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.932 0.493 . . . . 72.25 110.801 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -83.38 -41.53 18.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.388 0.675 . . . . 70.42 111.022 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.63 16.0 44.27 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 115.881 -0.599 . . . . 70.41 112.512 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -121.91 153.33 60.48 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.184 0.994 . . . . 61.31 111.972 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 41.1 Cg_endo -64.22 140.92 73.43 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.256 2.637 . . . . 55.42 112.855 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.611 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.8 mtt -73.98 95.51 2.51 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.359 0.6 . . . . 74.02 109.809 -174.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 27' ' ' ILE . 80.4 mt -144.67 120.73 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.833 1.253 . . . . 73.33 108.614 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 m120 -101.45 110.15 22.1 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.902 -0.407 . . . . 71.41 109.902 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.86 141.52 32.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.524 0.73 . . . . 64.32 109.748 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.49 112.41 25.31 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.474 0.71 . . . . 75.3 110.267 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -97.52 141.61 30.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.614 0.766 . . . . 75.54 110.17 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.41 123.63 25.02 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.69 1.196 . . . . 73.33 109.995 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.38 -20.05 59.19 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.307 1.225 . . . . 73.41 114.307 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.1 pt-20 -93.76 -44.5 8.11 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.946 0.793 . . . . 60.13 112.199 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 58' ' ' GLU . 46.1 p -92.22 -35.35 13.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.896 0.478 . . . . 51.21 112.124 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.89 0.94 68.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 116.168 -0.469 . . . . 70.33 113.945 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.5 162.31 27.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.39 0.595 . . . . 74.41 110.532 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 78.3 mt -81.08 132.67 35.38 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.811 -0.555 . . . . 50.1 111.053 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.21 -19.35 64.75 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.799 0.84 . . . . 72.42 111.866 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.57 21.49 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.007 -0.542 . . . . 62.31 112.147 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.45 145.11 46.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.789 0.835 . . . . 71.44 109.405 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.22 150.63 22.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.783 0.66 . . . . 64.35 112.783 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 35.6 p -108.19 114.46 28.36 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.828 0.451 . . . . 70.34 111.045 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -102.66 108.96 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.953 0.901 . . . . 74.21 109.853 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.1 m -85.47 105.29 15.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.615 0.366 . . . . 73.41 110.52 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 49.4 m-85 -79.26 156.63 28.02 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.357 0.663 . . . . 54.13 111.161 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.04 57.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.36 0.664 . . . . 55.42 110.737 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.27 129.52 23.81 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.276 0.63 . . . . 61.2 110.712 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.59 -42.02 43.57 Favored 'Trans proline' 0 CA--C 1.58 2.778 0 C-N-CA 123.005 2.47 . . . . 65.54 116.55 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.63 -21.17 52.52 Favored 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 122.301 1.857 . . . . 74.55 113.362 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 m -72.64 -38.17 67.78 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.309 0.644 . . . . 72.51 109.669 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.48 -53.24 57.66 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 51.14 111.276 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -61.99 -41.75 98.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.64 0.776 . . . . 62.44 111.151 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.49 98.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.892 0.477 . . . . 72.2 111.778 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.151 0.58 . . . . 63.21 112.457 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 77' ' ' LYS . 86.0 mt -66.64 -56.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.074 0.55 . . . . 70.44 110.928 174.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.5 -27.33 69.2 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.524 0.729 . . . . 64.14 112.043 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -82.36 -60.39 2.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.057 0.543 . . . . 74.33 111.553 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -82.69 -13.57 56.16 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.23 1.196 . . . . 65.43 114.23 -168.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.57 104.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 119.194 0.906 . . . . 73.43 110.203 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.05 6.04 49.24 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.514 -0.766 . . . . 62.35 114.56 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.25 -176.45 5.11 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 117.856 0.828 . . . . 75.5 111.556 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.81 122.36 42.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.121 0.569 . . . . 61.22 110.664 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -75.32 -70.9 0.39 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.842 -0.429 . . . . 70.33 109.842 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.8 t -115.17 50.06 1.01 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.783 0.833 . . . . 74.51 109.391 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.53 73.59 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 115.408 -0.815 . . . . 64.5 113.501 -174.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -131.37 128.76 22.1 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.904 0.881 . . . . 72.43 111.806 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 113.82 2.3 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.369 2.713 . . . . 74.53 113.551 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.1 pt -97.19 151.86 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.552 0.741 . . . . 73.5 112.777 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 75.1 mmtt -113.6 112.09 22.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.326 1.05 . . . . 75.15 109.384 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG13 ' A' ' 18' ' ' VAL . 21.7 t -112.5 128.3 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.99 -0.444 . . . . 74.44 110.809 -174.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.0 m -140.48 -179.66 6.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.161 1.384 . . . . 63.13 109.495 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -73.87 151.49 40.46 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.179 0.445 . . . . 73.44 110.63 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 91.1 6.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.214 0.531 . . . . 64.04 109.939 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.567 1.611 0 C-N-CA 123.931 0.892 . . . . 74.44 110.782 -177.283 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HB3' ' HB3' ' A' ' 4' ' ' HIS . 56.8 mtt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 110.742 -0.096 . . . . 75.11 110.742 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.84 -88.68 0.3 Allowed Glycine 0 C--N 1.355 1.626 0 O-C-N 123.335 0.397 . . . . 74.22 113.609 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -65.06 -32.24 73.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.679 0.792 . . . . 75.14 112.103 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 39.6 t-80 -91.79 86.35 5.9 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.36 0.6 . . . . 75.03 110.087 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -78.41 106.29 10.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.845 -0.616 . . . . 75.42 111.369 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.24 18.99 1.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.562 0.745 . . . . 71.13 112.635 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -117.74 155.59 29.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.657 0.783 . . . . 74.51 110.463 169.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -148.51 123.0 9.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.715 0.806 . . . . 74.04 109.605 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 t -83.16 138.47 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.921 0.488 . . . . 32.42 110.792 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -67.18 125.13 25.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.447 0.699 . . . . 75.14 111.383 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.7 t -70.64 121.06 17.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.876 0.87 . . . . 52.05 111.577 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.51 133.94 52.33 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 120.994 0.426 . . . . 75.41 111.102 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -124.55 120.35 31.69 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 64.13 109.787 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 70' ' ' PHE . 35.5 p30 -92.46 -12.06 33.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.323 0.649 . . . . 51.41 112.274 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -103.19 130.0 50.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.282 0.633 . . . . 72.22 110.672 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.9 pt -119.26 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.64 0.776 . . . . 62.42 112.13 -176.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -95.81 119.63 34.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.25 0.548 . . . . 70.34 110.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -112.83 141.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.782 1.233 . . . . 75.41 109.814 -177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -126.44 155.22 42.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.229 1.011 . . . . 62.4 110.439 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.88 32.3 50.24 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.222 0.849 . . . . 75.45 115.222 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 93' ' ' ILE . 69.8 mt -74.89 -33.33 62.03 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.214 1.006 . . . . 74.11 112.114 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.64 153.86 10.34 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-N 116.185 -0.461 . . . . 72.3 112.868 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.43 -8.36 54.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.992 0.917 . . . . 64.42 112.191 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -117.22 81.8 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.032 0.933 . . . . 71.51 109.302 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 21' ' ' LEU . 7.3 p -134.17 131.75 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.2 1.0 . . . . 71.04 110.525 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 12.8 p -116.26 155.71 27.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.655 -0.653 . . . . 73.05 109.992 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 68.1 mt -52.19 -47.67 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.118 0.967 . . . . 74.34 112.187 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.88 -21.45 54.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.995 0.518 . . . . 74.2 112.374 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -68.83 -44.34 73.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.842 0.457 . . . . 74.42 110.144 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 24.6 t -67.14 -38.97 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 115.912 -0.586 . . . . 72.04 110.364 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.71 79.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.756 -0.656 . . . . 72.54 111.738 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.55 -31.57 72.84 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.222 0.609 . . . . 63.22 111.358 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -73.58 -54.29 8.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.035 0.534 . . . . 74.43 111.152 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -78.02 -22.92 48.5 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.087 1.143 . . . . 74.44 114.087 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.52 -22.61 66.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.055 0.761 . . . . 72.42 113.055 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.46 -27.32 65.98 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.796 0.438 . . . . 73.21 111.628 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.06 -45.07 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 75.52 110.988 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.22 44.3 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 116.094 -0.503 . . . . 62.42 113.625 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.23 127.39 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.71 0.804 . . . . 74.53 110.683 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.3 mt -98.85 132.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 73.14 109.904 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.0 mtpp -55.03 142.75 29.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 64.24 111.501 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 67.7 m -139.85 131.32 26.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.811 -0.632 . . . . 73.02 111.07 -176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -68.86 114.68 7.4 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.261 1.025 . . . . 73.3 109.357 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -74.37 -21.57 59.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.391 0.676 . . . . 70.3 112.184 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -73.52 -49.13 28.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.653 0.381 . . . . 74.53 111.499 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -86.16 -45.19 11.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.039 0.536 . . . . 65.21 111.867 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.84 -4.34 39.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.893 -0.594 . . . . 63.51 112.802 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -93.19 140.15 23.22 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.33 0.652 . . . . 73.23 112.471 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 53.8 Cg_endo -70.44 149.67 62.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.745 2.297 . . . . 54.14 111.842 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.421 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.6 mtt -75.57 94.35 3.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.351 0.596 . . . . 71.11 109.52 -176.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.1 mt -145.06 121.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 70.12 107.713 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.7 m-80 -104.57 107.85 19.0 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 110.019 -0.363 . . . . 72.23 110.019 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.7 mt -81.04 126.17 31.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.057 0.943 . . . . 51.31 110.002 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 96.4 m-85 -86.43 134.73 33.67 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.251 0.62 . . . . 74.53 111.085 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -129.78 144.91 51.53 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.64 1.176 . . . . 72.2 109.746 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -68.97 113.02 5.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.116 0.566 . . . . 72.04 110.12 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -65.88 -24.61 66.9 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.994 0.917 . . . . 72.31 111.44 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.54 ' HG3' HG23 ' A' ' 59' ' ' THR . 11.6 pt-20 -77.37 -45.34 26.3 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.546 0.738 . . . . 64.43 112.011 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 58' ' ' GLU . 37.4 p -94.28 -56.74 2.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.068 0.461 . . . . 73.33 111.698 -176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.24 4.7 23.67 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-N 116.053 -0.521 . . . . 41.34 113.574 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.87 151.38 20.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.293 0.637 . . . . 73.12 111.577 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.76 135.2 52.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.452 0.701 . . . . 65.32 111.158 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.67 -16.17 60.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.374 0.67 . . . . 75.4 111.708 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.62 39.65 24.79 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.766 -0.534 . . . . 75.23 111.766 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 57.9 mt-10 -133.56 148.97 51.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.427 0.691 . . . . 72.45 109.33 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -157.86 151.53 23.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.791 0.436 . . . . 72.31 111.688 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 54' ' ' TYR . 32.6 p -112.44 113.43 25.61 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.649 0.38 . . . . 74.23 110.65 172.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.0 t -101.5 110.62 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.571 1.148 . . . . 60.04 110.174 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 20.0 m -89.95 101.39 14.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.245 0.618 . . . . 74.23 111.216 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 41.9 m-85 -76.56 157.42 32.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.383 0.673 . . . . 63.1 110.557 170.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.06 -32.37 67.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.777 0.431 . . . . 53.32 110.017 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -113.79 123.67 32.5 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.548 0.739 . . . . 72.33 111.474 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.74 -33.53 80.86 Favored 'Trans proline' 0 CA--C 1.583 2.941 0 C-N-CA 122.841 2.36 . . . . 62.51 116.497 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.2 -26.41 42.32 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 122.871 2.061 . . . . 64.4 113.209 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.5 m -77.69 -35.44 52.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.531 0.733 . . . . 53.33 110.485 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.63 -49.89 73.4 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 121.4 0.619 . . . . 65.21 110.594 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -65.58 -37.52 86.88 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.676 1.191 . . . . 71.25 111.426 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.82 90.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.1 0.56 . . . . 51.31 112.045 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.64 68.46 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.303 0.641 . . . . 75.25 112.444 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 95' ' ' VAL . 81.4 mt -64.47 -64.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.883 0.473 . . . . 71.24 110.464 171.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.06 -25.01 65.02 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.355 0.662 . . . . 75.23 112.389 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -82.32 -62.14 1.7 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.993 0.517 . . . . 73.24 111.67 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.12 -9.76 59.42 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.032 1.123 . . . . 74.22 114.032 -170.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -66.13 118.13 9.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 120.943 0.401 . . . . 61.32 110.389 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.88 79.66 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.335 -0.703 . . . . 44.2 114.511 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.4 mmtt -93.95 167.89 11.31 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 118.44 1.12 . . . . 73.31 111.386 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -96.89 118.92 34.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.214 0.605 . . . . 70.02 111.487 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 89.7 t80 -72.47 -74.17 0.17 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.001 0.521 . . . . 64.03 110.414 172.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -116.95 60.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.039 0.936 . . . . 73.45 108.847 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.22 13.27 67.11 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 115.272 -0.876 . . . . 60.45 113.46 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -118.19 120.48 32.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.247 1.019 . . . . 65.21 111.017 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.28 96.0 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.953 2.435 . . . . 73.14 113.158 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 21' ' ' LEU . 28.1 pt -76.04 156.07 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.78 0.832 . . . . 45.02 113.225 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -122.98 116.56 23.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.366 1.066 . . . . 74.5 108.942 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 18' ' ' VAL . 20.0 t -110.92 136.36 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.67 0.388 . . . . 73.33 110.731 -174.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.8 p -148.67 -176.52 5.36 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.982 1.313 . . . . 75.42 109.657 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -76.6 146.67 38.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.741 0.701 . . . . 72.3 111.758 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.84 100.15 11.5 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.984 0.514 . . . . 34.23 110.242 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.811 0.844 . . . . 43.23 111.416 -174.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 112.452 0.538 . . . . 53.23 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.2 m -130.83 128.63 41.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.884 0.474 . . . . 62.12 110.099 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 80' ' ' ILE . 22.4 pt -115.39 147.31 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.423 . . . . 71.44 111.551 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -105.71 108.86 20.6 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.256 0.622 . . . . 73.54 110.045 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 95' ' ' VAL . 17.5 t -101.19 138.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.064 0.946 . . . . 73.14 110.09 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 23.4 mt-30 -119.44 155.11 32.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.728 0.811 . . . . 55.23 111.34 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.04 44.74 76.41 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.511 0.965 . . . . 52.34 115.511 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 93' ' ' ILE . 49.3 mt -81.22 -30.75 34.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.462 1.105 . . . . 65.52 110.781 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.07 160.53 11.39 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.138 -0.483 . . . . 44.41 113.815 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.55 -23.01 64.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.492 0.717 . . . . 73.42 110.364 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -107.15 88.44 2.74 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.646 0.778 . . . . 52.34 108.995 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.37 136.7 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.888 0.875 . . . . 75.52 111.038 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.38 161.81 20.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.689 . . . . 64.35 110.43 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.57 HG23 ' HB ' ' A' ' 51' ' ' ILE . 76.1 mt -50.85 -47.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.173 0.989 . . . . 55.32 111.32 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -75.99 -23.99 55.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.333 0.653 . . . . 72.22 111.823 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -67.94 -46.4 71.56 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.658 0.383 . . . . 44.21 110.541 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 30.8 t -64.6 -42.73 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.092 0.473 . . . . 54.31 110.27 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.62 96.16 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.542 -0.754 . . . . 74.21 112.637 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.19 -22.07 55.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.96 0.504 . . . . 71.33 111.449 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -79.58 -44.95 20.1 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.236 0.614 . . . . 75.24 111.364 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -83.14 -13.71 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.852 1.056 . . . . 64.43 113.852 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.71 -30.08 60.53 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.009 1.114 . . . . 65.01 114.009 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.28 -24.41 67.27 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.623 0.769 . . . . 63.51 112.606 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 79' ' ' ALA . 19.5 mm -82.41 -44.37 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.836 0.854 . . . . 72.53 111.372 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.88 179.64 48.66 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 116.406 -0.361 . . . . 63.43 113.67 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.64 125.09 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.497 0.719 . . . . 74.23 111.549 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.7 mt -94.0 138.38 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 70.13 108.781 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.591 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 27.1 mtpp -57.73 155.02 10.73 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.068 0.547 . . . . 41.22 111.73 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.8 m -145.5 125.38 13.5 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.273 0.629 . . . . 70.02 111.155 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.33 125.85 30.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.778 -0.823 . . . . 62.13 108.778 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.3 -21.66 25.62 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.643 0.608 . . . . 74.44 112.643 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.26 -43.21 95.56 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.305 0.642 . . . . 74.3 111.713 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -82.72 -42.93 17.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.576 0.75 . . . . 70.04 110.117 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.51 56.02 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.392 -0.822 . . . . 71.32 111.893 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -110.44 147.09 35.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.105 0.962 . . . . 62.33 111.63 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 33.7 Cg_endo -64.99 142.19 73.82 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.594 2.196 . . . . 73.13 110.835 173.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.591 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 61.3 mtt -72.79 94.31 1.78 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.716 0.77 . . . . 71.44 110.34 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 27' ' ' ILE . 66.4 mt -144.93 119.81 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.042 1.337 . . . . 72.1 108.264 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 24.5 m-80 -102.7 110.77 22.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.114 -0.699 . . . . 74.13 109.114 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.69 124.35 28.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.903 0.881 . . . . 74.23 109.92 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.2 m-85 -80.33 110.43 15.76 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.647 0.779 . . . . 72.23 110.814 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -96.86 143.02 28.16 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 43.3 109.864 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.08 144.44 40.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 73.45 111.266 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.87 -46.47 30.04 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.447 0.699 . . . . 74.23 112.175 -171.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.11 -42.69 15.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.539 0.57 . . . . 74.25 112.539 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.5 p -81.95 -30.03 31.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.06 84.57 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 114.015 0.366 . . . . 55.21 114.015 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -99.19 164.89 11.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.014 0.926 . . . . 74.14 110.531 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.02 131.47 45.11 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.973 0.509 . . . . 72.33 111.622 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -75.66 -21.71 57.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.194 0.598 . . . . 52.25 111.82 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.77 26.66 31.46 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 116.073 -0.512 . . . . 60.31 112.902 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 3.6 mp0 -116.72 154.47 30.56 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.543 -0.975 . . . . 75.34 109.755 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -160.14 146.94 16.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.877 0.471 . . . . 61.15 111.513 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.9 p -104.16 117.89 35.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.973 -0.38 . . . . 63.41 109.973 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.93 108.08 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.621 0.769 . . . . 74.31 110.36 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 m -85.18 104.19 14.83 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.889 0.476 . . . . 72.12 110.821 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.4 m-85 -79.67 158.2 27.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.49 0.716 . . . . 74.12 110.788 169.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.64 -31.23 63.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.065 0.546 . . . . 71.35 111.349 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -118.73 134.17 23.56 Favored Pre-proline 0 N--CA 1.48 1.067 0 C-N-CA 123.053 0.541 . . . . 64.34 111.564 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.2 -34.9 99.02 Favored 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 122.523 2.149 . . . . 74.13 116.197 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.72 -29.35 77.19 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 122.867 2.059 . . . . 53.55 113.079 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -74.68 -40.85 61.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.223 0.609 . . . . 52.4 110.396 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.86 84.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.541 -0.754 . . . . 72.05 111.098 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.34 -44.85 90.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.11 111.296 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.891 0.476 . . . . 61.11 111.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 37' ' ' ILE . . . -60.76 -34.21 74.11 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.407 0.683 . . . . 53.35 112.232 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 95' ' ' VAL . 71.9 mt -69.19 -54.98 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.831 0.452 . . . . 74.04 110.49 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.42 -33.1 69.3 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.768 0.827 . . . . 63.12 111.921 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -80.57 -56.46 4.15 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.691 0.796 . . . . 64.23 112.17 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' ILE . 61.7 m-85 -86.65 -11.64 50.73 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 114.457 1.28 . . . . 74.34 114.457 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -63.87 116.12 5.5 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.578 0.626 . . . . 72.33 110.322 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.73 5.55 74.23 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 114.871 0.708 . . . . 50.04 114.871 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.84 159.59 14.9 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 117.949 0.874 . . . . 70.5 111.767 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.41 115.79 27.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.64 0.376 . . . . 62.03 111.651 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 91.2 t80 -70.28 -56.34 7.0 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.997 0.919 . . . . 73.32 110.925 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -147.18 63.01 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.908 0.861 . . . . 62.43 109.151 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.37 0.28 66.25 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 115.093 -0.958 . . . . 75.4 113.692 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.13 121.28 36.9 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 51.42 110.7 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.8 98.98 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.736 2.291 . . . . 70.11 112.666 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.438 HG21 HD23 ' A' ' 21' ' ' LEU . 28.0 pt -71.22 148.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.591 0.96 . . . . 70.23 113.591 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -115.39 104.94 12.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.67 1.188 . . . . 54.32 108.416 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 18' ' ' VAL . 15.1 t -102.16 131.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.671 0.388 . . . . 73.13 110.137 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.3 p -136.55 178.65 6.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.503 1.121 . . . . 40.23 109.779 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.9 145.13 31.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.681 0.392 . . . . 65.22 110.076 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.19 7.7 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.031 0.443 . . . . 74.34 109.983 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.573 1.84 0 C-N-CA 123.733 0.813 . . . . 65.34 110.835 -178.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 111.767 0.284 . . . . 53.34 111.767 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -101.25 130.18 47.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 64.55 109.917 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 43.4 pt -110.71 153.07 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.517 0.727 . . . . 70.22 110.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -111.08 128.46 55.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.147 0.579 . . . . 71.54 109.49 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 95' ' ' VAL . 10.7 t -121.11 141.34 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.775 0.83 . . . . 54.33 110.324 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -123.8 155.42 38.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.413 1.085 . . . . 73.21 110.169 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 23.19 63.23 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 114.713 0.645 . . . . 74.34 114.713 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 93' ' ' ILE . 77.1 mt -64.52 -34.56 78.52 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.169 0.988 . . . . 73.04 111.885 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.25 21.9 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.154 -0.93 . . . . 53.31 111.119 -168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.92 -4.78 56.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 117.827 0.814 . . . . 75.22 112.636 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -94.01 17.56 12.14 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.233 0.613 . . . . 72.33 110.711 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 88' ' ' PHE . 8.2 p -75.83 140.49 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 124.159 0.984 . . . . 73.12 112.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' VAL . 50.1 p -125.05 158.46 33.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.357 0.663 . . . . 72.34 110.214 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.2 mt -59.57 -35.09 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.834 0.454 . . . . 72.12 110.777 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.27 -46.78 88.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.605 0.762 . . . . 73.34 111.388 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -61.83 -43.28 99.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.581 0.752 . . . . 62.02 111.767 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' THR . 48.1 t -66.13 -45.68 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 121.047 0.451 . . . . 75.25 110.64 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -64.65 -33.98 77.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.677 -0.692 . . . . 43.05 111.996 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.23 -33.77 59.21 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.292 0.637 . . . . 71.53 111.644 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -74.56 -53.33 9.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 74.34 111.424 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 48.3 m-85 -78.68 -17.56 55.74 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 113.729 1.011 . . . . 72.31 113.729 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 64.9 pttt -58.29 -28.71 65.24 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.528 0.936 . . . . 74.42 113.528 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.35 -22.88 63.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.552 0.741 . . . . 63.23 112.357 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mm -81.38 -41.13 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.097 0.959 . . . . 73.25 111.094 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.28 -171.64 44.75 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.014 -0.539 . . . . 71.52 113.184 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.97 127.11 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.063 0.545 . . . . 44.53 110.257 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.2 mt -94.56 137.02 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.148 0.979 . . . . 61.32 108.954 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.4 mtpt -59.03 146.37 38.57 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.548 0.69 . . . . 70.11 111.707 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 50.5 m -129.29 125.27 36.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.728 -1.124 . . . . 74.52 109.583 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -57.22 107.51 0.43 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 109.082 -0.71 . . . . 53.34 109.082 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.64 -19.4 65.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.018 0.927 . . . . 73.52 112.827 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -78.59 -48.6 14.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.449 0.699 . . . . 74.33 111.65 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -85.13 -38.54 18.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.229 0.612 . . . . 75.14 111.821 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.77 2.67 61.19 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 115.927 -0.579 . . . . 42.11 112.636 -172.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -99.1 144.2 27.79 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.053 0.941 . . . . 65.41 111.777 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 38.2 Cg_endo -66.11 139.64 56.53 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.852 2.368 . . . . 65.52 111.811 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.0 mtt -72.73 93.37 1.65 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.669 0.747 . . . . 73.25 109.586 -175.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.555 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -147.0 120.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.948 1.299 . . . . 74.51 108.602 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.55 110.55 22.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 110.027 -0.36 . . . . 71.22 110.027 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.34 129.22 34.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.854 0.862 . . . . 65.32 109.835 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 92.6 m-85 -89.13 117.32 28.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.487 0.715 . . . . 72.01 110.244 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 m -99.14 150.62 21.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.17 0.988 . . . . 74.34 110.196 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.25 132.27 35.82 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.585 0.754 . . . . 64.24 109.842 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -70.17 -32.67 70.73 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.662 0.785 . . . . 71.41 112.249 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.8 -52.68 5.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.64 0.776 . . . . 71.34 111.557 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 p -82.11 -30.31 31.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.53 0.732 . . . . 72.21 112.323 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.76 89.43 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.501 -0.318 . . . . 71.14 113.498 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -102.17 155.7 18.04 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.767 0.827 . . . . 72.1 109.808 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.42 136.57 57.97 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.914 0.486 . . . . 72.11 111.776 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -72.09 -15.28 62.0 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.278 0.631 . . . . 55.1 112.284 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.77 31.06 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.689 -0.564 . . . . 73.24 111.689 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 52.0 mt-10 -130.9 149.13 52.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.064 0.946 . . . . 75.33 109.566 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.71 154.25 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.748 0.647 . . . . 65.21 112.748 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 25.1 p -109.43 116.12 31.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.851 -0.613 . . . . 71.24 111.007 173.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.66 109.71 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.466 0.706 . . . . 75.5 110.113 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 69.2 m -83.52 102.84 12.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.693 0.397 . . . . 65.12 110.772 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 56.3 m-85 -78.89 153.78 30.26 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.903 0.481 . . . . 72.04 110.842 170.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.05 -34.38 61.84 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.828 -0.624 . . . . 65.55 111.143 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -111.91 130.2 23.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.054 0.542 . . . . 63.31 111.032 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -49.84 -38.11 46.82 Favored 'Trans proline' 0 CA--C 1.583 2.936 0 C-N-CA 123.334 2.69 . . . . 72.5 116.305 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.37 -28.68 78.62 Favored 'Trans proline' 0 C--N 1.403 3.434 0 CA-C-N 122.477 1.92 . . . . 33.45 113.934 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 m -73.42 -39.45 65.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 74.34 110.038 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.87 79.94 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.474 0.71 . . . . 62.5 111.052 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -59.96 -51.42 69.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.242 1.017 . . . . 62.35 111.149 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.75 90.7 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.005 -0.543 . . . . 61.54 112.156 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.24 72.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.45 0.7 . . . . 61.32 112.506 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 95' ' ' VAL . 70.2 mt -63.29 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.03 0.532 . . . . 74.5 111.05 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.34 -30.05 69.28 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.347 -0.842 . . . . 65.44 111.985 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -79.06 -59.53 2.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.954 0.501 . . . . 73.04 111.675 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.606 ' HB3' HD11 ' A' ' 93' ' ' ILE . 27.4 m-85 -80.78 -10.55 59.72 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.965 1.098 . . . . 75.13 113.965 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -65.76 111.19 3.11 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.548 0.613 . . . . 72.1 109.992 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.27 1.4 60.95 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.794 -0.639 . . . . 63.21 114.307 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.7 mmtt -96.37 149.29 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.261 0.624 . . . . 74.32 111.036 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -87.52 128.06 35.24 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.083 -0.386 . . . . 71.1 111.376 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' HG21 ' A' ' 93' ' ' ILE . 53.8 t80 -81.75 -73.63 0.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.399 0.68 . . . . 60.12 110.603 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 t -119.96 53.11 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.75 0.786 . . . . 65.11 109.814 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.73 90.11 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 115.37 -0.832 . . . . 50.35 113.322 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -122.57 126.73 26.06 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.048 0.939 . . . . 62.4 109.895 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 132.04 25.65 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.089 2.526 . . . . 62.11 112.52 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.3 pt -107.56 153.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.219 0.608 . . . . 73.22 111.857 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -121.8 126.82 49.69 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.003 0.921 . . . . 44.31 108.575 172.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 18' ' ' VAL . 16.2 t -114.55 143.89 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 122.943 0.497 . . . . 63.54 111.156 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 m -147.12 -177.08 5.48 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.807 1.643 . . . . 73.14 109.057 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 53.7 m-85 -87.38 147.82 25.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.699 0.681 . . . . 65.53 110.603 168.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.92 85.69 6.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.584 0.753 . . . . 73.21 109.752 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 123.658 0.783 . . . . 73.25 111.405 -175.015 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 111.641 0.237 . . . . 51.33 111.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -95.45 125.18 39.89 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.989 0.516 . . . . 72.31 109.944 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.531 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.4 pt -120.95 140.61 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.156 0.583 . . . . 75.43 112.23 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -95.32 127.62 41.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.132 0.491 . . . . 75.12 110.554 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 95' ' ' VAL . 14.9 t -120.57 137.26 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.458 1.103 . . . . 64.25 109.985 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.42 156.26 31.79 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.046 0.938 . . . . 74.32 110.778 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 2.28 82.98 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 114.468 0.547 . . . . 64.53 114.468 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB3' HG21 ' A' ' 25' ' ' VAL . 96.0 mt -57.21 -20.87 29.65 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.834 1.05 . . . . 61.22 113.834 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.32 162.0 35.15 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.055 0.382 . . . . 73.11 114.055 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.21 -21.34 61.42 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.211 0.604 . . . . 75.44 111.787 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -92.45 2.58 56.58 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.004 0.922 . . . . 74.43 111.18 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 21' ' ' LEU . 11.1 p -66.54 147.53 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.53 0.732 . . . . 74.34 112.242 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.6 p -128.19 157.4 40.93 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.381 0.672 . . . . 72.44 110.367 172.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' A' ' 51' ' ' ILE . 71.5 mt -54.14 -41.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.156 0.982 . . . . 74.32 111.381 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.95 -29.27 62.96 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.367 0.667 . . . . 74.52 112.28 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 m -70.94 -43.56 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.567 0.347 . . . . 73.01 111.199 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.07 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 120.946 0.403 . . . . 63.54 110.022 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.08 96.36 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.498 0.719 . . . . 64.43 112.254 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -34.5 75.12 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.63 0.772 . . . . 72.41 111.071 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.13 -51.86 19.43 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.524 0.73 . . . . 74.11 110.882 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -80.9 -14.61 57.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.86 1.059 . . . . 73.01 113.86 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -54.89 -33.34 61.91 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.8 0.666 . . . . 63.44 112.8 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.97 -23.34 66.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.88 0.872 . . . . 73.42 112.67 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.31 -50.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.712 0.805 . . . . 53.22 111.277 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.35 -178.73 43.54 Favored Glycine 0 C--O 1.24 0.514 0 CA-C-N 115.35 -0.841 . . . . 53.41 113.012 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.3 mt -69.29 122.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 123.332 0.653 . . . . 74.22 110.317 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.1 mt -92.81 135.42 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.809 0.844 . . . . 51.41 108.835 171.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 29.3 mtpp -56.26 154.47 8.02 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.96 0.504 . . . . 64.24 111.591 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.0 m -138.64 122.35 17.53 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.169 0.588 . . . . 62.33 111.007 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -65.93 112.25 3.71 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.25 -1.019 . . . . 63.41 108.25 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -82.8 -12.23 57.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.942 0.497 . . . . 73.13 112.289 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -74.6 -47.77 30.47 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.605 0.762 . . . . 74.41 110.514 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -83.3 -39.37 20.9 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.63 0.772 . . . . 73.41 111.127 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.7 16.13 52.85 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.305 -0.861 . . . . 63.52 112.742 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -114.75 149.88 43.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.051 0.94 . . . . 61.52 111.299 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.49 151.32 85.54 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.584 2.189 . . . . 70.22 112.74 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.508 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.1 mtt -78.3 93.1 4.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.666 0.745 . . . . 63.3 109.147 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.0 mt -141.42 114.35 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.576 -1.268 . . . . 74.41 107.576 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' N ' HD22 ' A' ' 52' ' ' ASN . 0.8 OUTLIER -99.86 109.57 21.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.398 -0.593 . . . . 73.32 109.398 -170.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 66' ' ' ALA . 87.6 mt -79.11 125.16 29.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.538 0.735 . . . . 73.43 110.324 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 9.6 m-85 -78.12 126.31 30.62 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 72.55 110.429 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -116.91 143.45 45.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.847 0.859 . . . . 75.41 110.061 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -71.14 112.16 7.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.319 0.648 . . . . 63.35 109.971 168.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.926 0.49 . . . . 74.14 111.819 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 59' ' ' THR . 12.9 pt-20 -73.71 -43.82 58.14 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.871 0.868 . . . . 71.52 111.907 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.56 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -99.39 -50.08 4.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.466 0.706 . . . . 71.24 111.612 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.1 -1.37 28.4 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.521 -0.763 . . . . 53.42 112.652 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -98.12 160.06 14.54 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.635 0.774 . . . . 72.01 111.271 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.69 136.58 51.22 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.203 0.601 . . . . 65.33 111.901 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.85 -17.99 65.16 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.729 0.812 . . . . 61.22 112.398 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.38 33.86 21.59 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 121.318 0.399 . . . . 52.31 112.446 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.8 mt-10 -135.16 155.9 49.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.169 0.988 . . . . 70.22 109.948 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -164.03 152.56 13.27 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.219 0.533 . . . . 73.31 112.14 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 21.7 p -104.59 123.95 48.45 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.576 -0.738 . . . . 72.23 110.186 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 t -104.6 109.16 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.709 0.804 . . . . 70.14 109.816 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.1 m -86.76 100.47 12.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.53 0.332 . . . . 64.41 110.816 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 56.2 m-85 -75.55 160.57 30.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.372 0.669 . . . . 55.25 111.134 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.0 -30.31 39.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.514 0.726 . . . . 72.32 111.188 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -114.49 132.76 22.68 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.381 0.672 . . . . 63.15 110.866 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.98 -36.14 95.47 Favored 'Trans proline' 0 CA--C 1.586 3.116 0 C-N-CA 122.547 2.165 . . . . 72.14 115.956 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.1 -28.0 65.35 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 122.701 2.0 . . . . 73.11 113.356 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -69.77 -39.85 76.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.573 0.701 . . . . 22.24 110.211 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.86 -49.27 76.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.865 -1.061 . . . . 63.4 111.413 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -60.24 -45.44 93.22 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.208 1.003 . . . . 62.43 111.17 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.42 97.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.838 -0.619 . . . . 64.53 111.797 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.88 72.25 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.203 0.601 . . . . 74.43 112.482 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.34 -63.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.047 0.539 . . . . 73.32 110.684 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.12 -31.19 66.92 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.747 0.819 . . . . 73.42 112.105 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -78.75 -59.76 2.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.656 0.783 . . . . 74.14 111.668 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 95' ' ' VAL . 39.2 m-85 -87.45 -11.48 48.93 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.449 1.277 . . . . 71.32 114.449 -170.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.28 119.48 10.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.289 -0.634 . . . . 63.41 109.289 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.44 87.74 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.977 0.751 . . . . 64.34 114.977 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.9 150.14 21.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.714 0.806 . . . . 74.41 112.061 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.11 123.87 27.37 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.054 0.761 . . . . 72.03 113.054 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -125.13 133.04 52.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 74.33 108.373 167.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 t 62.58 11.43 4.75 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.531 1.132 . . . . 74.43 113.362 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.62 20.03 10.55 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 114.94 0.736 . . . . 61.32 114.94 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -154.04 146.33 17.3 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 118.22 1.01 . . . . 71.23 111.193 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.82 104.06 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.332 2.021 . . . . 74.22 112.733 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.31 165.21 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.356 0.662 . . . . 71.43 112.418 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 94' ' ' LYS . 9.3 mmpt? -121.01 117.72 27.99 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.28 1.032 . . . . 62.13 109.79 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 18' ' ' VAL . 21.9 t -114.53 136.71 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.062 0.545 . . . . 71.43 110.546 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -153.6 175.68 12.94 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.538 1.135 . . . . 75.15 109.997 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -67.62 146.14 54.15 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 118.562 0.619 . . . . 73.11 111.828 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.72 97.22 5.09 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.514 -0.551 . . . . 63.23 109.514 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 CA--C 1.556 1.182 0 C-N-CA 124.112 0.965 . . . . 73.44 110.869 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.524 0.202 . . . . 71.24 111.512 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -99.47 125.93 45.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.007 0.523 . . . . 65.43 110.765 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.433 HG23 ' HB1' ' A' ' 76' ' ' ALA . 42.0 pt -110.11 152.27 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.847 0.859 . . . . 72.23 110.983 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -107.31 130.51 54.76 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 123.431 0.693 . . . . 75.12 109.827 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 95' ' ' VAL . 14.7 t -122.6 140.82 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.228 1.011 . . . . 43.43 110.259 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -118.66 164.35 15.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.925 1.29 . . . . 64.43 110.217 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.48 79.24 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 114.639 0.616 . . . . 72.21 114.639 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.1 -17.97 60.87 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.496 1.119 . . . . 65.24 112.705 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.95 173.03 48.7 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.151 0.42 . . . . 43.14 114.151 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.32 -19.67 61.62 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.594 0.757 . . . . 75.35 112.604 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.64 10.58 36.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.639 0.607 . . . . 71.01 112.639 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.32 128.92 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 122.997 0.519 . . . . 60.4 111.803 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 7.6 p -122.72 150.77 42.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.857 -0.527 . . . . 73.22 109.657 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.6 mt -54.38 -42.38 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.145 0.978 . . . . 72.3 111.706 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -39.42 80.58 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.181 0.592 . . . . 74.34 112.333 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.3 m -64.26 -41.7 96.82 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.914 0.486 . . . . 73.33 111.396 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' THR . 63.5 t -65.49 -43.27 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.022 0.529 . . . . 64.44 110.723 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.0 96.46 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.831 -0.622 . . . . 73.21 112.186 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.93 -30.72 62.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.371 0.669 . . . . 60.14 111.46 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -74.17 -53.86 8.98 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.693 0.797 . . . . 74.21 112.007 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 62.1 m-85 -77.46 -14.51 59.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.983 1.105 . . . . 62.34 113.983 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.14 -30.84 62.72 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.767 1.025 . . . . 71.31 113.767 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.58 -25.02 65.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.691 0.797 . . . . 43.12 113.037 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.2 mm -83.9 -52.76 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.461 0.704 . . . . 71.25 110.59 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.51 167.79 35.81 Favored Glycine 0 C--O 1.241 0.568 0 CA-C-N 116.08 -0.509 . . . . 64.15 113.391 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.18 128.04 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 51.4 109.538 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 83.3 mt -97.12 136.61 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.501 0.721 . . . . 54.44 109.09 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.5 mtpt -57.15 142.27 43.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.254 0.622 . . . . 74.43 111.951 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 75.3 m -132.73 127.16 34.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.696 0.798 . . . . 75.43 110.489 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -70.81 118.33 13.45 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.699 0.8 . . . . 70.12 109.154 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -77.06 -23.01 52.01 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.517 0.727 . . . . 71.23 111.796 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.95 -51.57 53.59 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.336 0.654 . . . . 73.42 110.72 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -84.74 -37.11 21.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.153 0.581 . . . . 71.32 111.838 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.11 -2.86 59.9 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 116.025 -0.534 . . . . 72.11 113.076 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -99.74 147.77 33.86 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.262 1.025 . . . . 75.35 112.355 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 39.7 Cg_endo -67.6 149.27 79.42 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.655 2.236 . . . . 71.03 112.775 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 53.1 mtt -78.33 94.74 4.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 64.01 109.973 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.96 123.86 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.992 1.317 . . . . 61.31 108.027 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -106.4 108.66 20.28 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.577 -0.527 . . . . 74.33 109.577 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.8 mt -83.08 117.71 23.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.239 0.616 . . . . 74.44 109.677 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HE1' HG23 ' A' ' 67' ' ' THR . 30.5 m-85 -70.29 105.36 2.96 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.089 0.556 . . . . 74.32 111.106 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -89.82 147.37 23.83 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.596 -0.729 . . . . 53.54 109.233 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.85 125.89 30.28 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.54 0.736 . . . . 62.02 109.907 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -70.15 -21.8 63.04 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.976 0.732 . . . . 70.35 112.976 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.71 -57.94 2.42 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.28 0.632 . . . . 71.14 111.128 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.2 p -82.67 -20.25 36.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.048 0.539 . . . . 72.05 112.279 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.75 -1.19 74.29 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 114.937 0.735 . . . . 63.32 114.937 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -101.81 160.73 14.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.26 0.624 . . . . 73.21 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.78 126.37 28.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.792 0.437 . . . . 40.55 111.133 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.89 -16.52 64.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.07 0.948 . . . . 71.43 112.242 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.33 25.23 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.991 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -133.24 150.54 51.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.09 0.956 . . . . 73.2 109.164 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.76 157.38 18.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.58 0.585 . . . . 74.34 112.58 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.404 HG23 ' HE1' ' A' ' 54' ' ' TYR . 27.2 p -117.24 117.2 28.89 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.093 0.557 . . . . 73.32 111.074 173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.47 111.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.32 1.048 . . . . 75.41 110.353 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m -85.85 103.18 14.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.509 0.323 . . . . 53.3 111.004 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 33.5 m-85 -76.4 164.55 25.89 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.024 0.53 . . . . 74.02 110.499 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.73 -40.4 61.3 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.023 0.529 . . . . 75.12 109.934 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.89 129.39 24.22 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.49 0.716 . . . . 62.21 110.916 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.17 -37.65 87.62 Favored 'Trans proline' 0 CA--C 1.587 3.144 0 C-N-CA 122.669 2.246 . . . . 65.31 115.471 165.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.51 -27.62 61.96 Favored 'Trans proline' 0 C--N 1.406 3.59 0 CA-C-N 122.386 1.888 . . . . 71.0 113.426 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.9 m -72.84 -39.0 66.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.284 0.564 . . . . 73.45 110.363 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -59.43 -52.14 66.89 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.227 -0.897 . . . . 60.42 110.898 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tmtp? -64.26 -42.55 96.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.77 0.828 . . . . 72.03 111.841 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.17 96.7 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.698 0.399 . . . . 70.33 111.68 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.53 71.64 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.397 0.679 . . . . 43.43 112.257 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 77' ' ' LYS . 81.6 mt -62.26 -61.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 122.684 0.394 . . . . 73.4 110.282 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 -33.8 67.63 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.742 0.817 . . . . 72.2 112.299 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -77.91 -54.55 6.19 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.722 0.809 . . . . 75.14 112.151 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.62 -12.78 30.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.246 1.202 . . . . 75.21 114.246 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.41 126.87 29.19 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.739 0.7 . . . . 72.24 110.452 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.29 1.71 90.45 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.044 0.778 . . . . 63.35 115.044 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 75.3 mmtt -92.0 -167.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.91 0.855 . . . . 74.44 111.775 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.17 125.86 44.33 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.138 0.575 . . . . 71.25 112.104 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 93' ' ' ILE . 66.6 t80 -77.32 -69.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.244 0.618 . . . . 53.11 111.455 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 m -133.83 75.29 1.59 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.666 0.786 . . . . 62.13 109.486 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.4 0.04 44.14 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 115.379 -0.828 . . . . 51.33 114.638 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.2 135.06 26.95 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.081 0.953 . . . . 54.12 111.895 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.4 Cg_exo -67.85 140.06 49.53 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.109 2.539 . . . . 72.23 113.357 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 88' ' ' PHE . 37.7 pt -123.36 151.83 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.32 1.048 . . . . 74.43 112.068 -173.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -118.72 122.48 42.59 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.086 -1.079 . . . . 74.31 108.086 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 18' ' ' VAL . 18.9 t -112.29 141.17 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.506 . . . . 73.02 110.655 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.0 p -152.3 -179.78 7.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.289 1.436 . . . . 70.13 109.041 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -73.81 150.42 41.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.772 0.714 . . . . 62.33 110.944 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.68 88.87 7.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.026 0.53 . . . . 54.43 110.293 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.498 0 C-N-CA 123.953 0.901 . . . . 75.41 110.945 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 111.747 0.277 . . . . 74.44 111.747 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.8 m -138.16 125.83 22.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.788 -0.449 . . . . 74.3 109.788 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.0 pt -109.6 143.12 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 122.779 0.432 . . . . 60.01 112.101 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -96.8 110.66 23.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.468 -0.567 . . . . 75.12 109.468 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 5.9 t -104.96 138.37 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.611 0.764 . . . . 71.45 110.103 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -120.71 166.48 13.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.282 1.033 . . . . 74.45 110.218 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.15 31.72 72.22 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 114.519 0.568 . . . . 73.2 114.519 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -81.91 -17.11 48.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.205 1.002 . . . . 74.33 112.355 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.99 168.61 40.69 Favored Glycine 0 N--CA 1.475 1.271 0 N-CA-C 114.133 0.413 . . . . 53.45 114.133 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 62' ' ' LEU . 13.5 pt-20 -74.69 -13.38 60.61 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.426 0.69 . . . . 75.23 112.599 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.61 -3.55 58.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.621 0.768 . . . . 73.24 111.895 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.72 127.53 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 N-CA-C 113.161 0.801 . . . . 73.24 113.161 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -122.93 154.22 38.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.385 0.674 . . . . 74.43 110.042 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.7 mt -57.25 -42.72 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.533 0.733 . . . . 74.41 111.736 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.35 -40.39 95.77 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.634 0.774 . . . . 74.3 111.463 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.2 t -65.82 -45.02 83.82 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.88 0.472 . . . . 74.24 111.282 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 26' ' ' THR . 60.2 t -62.83 -42.08 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.27 0.557 . . . . 62.4 110.278 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.519 -0.764 . . . . 74.52 112.172 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.79 -35.7 80.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.758 0.823 . . . . 55.34 111.271 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -71.92 -55.98 6.51 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.93 0.892 . . . . 73.45 111.031 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.0 m-85 -79.71 -16.59 55.38 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.147 1.166 . . . . 71.43 114.147 -172.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.71 -24.17 66.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.729 1.011 . . . . 75.13 113.729 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.96 -23.94 65.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.335 0.654 . . . . 64.23 112.686 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.7 mm -86.86 -45.99 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 51.52 111.812 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.63 174.67 45.72 Favored Glycine 0 C--O 1.24 0.505 0 CA-C-N 115.709 -0.678 . . . . 64.04 113.123 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.0 mt -67.54 123.62 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.499 0.72 . . . . 74.14 111.339 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 74.2 mt -94.08 130.8 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.446 1.098 . . . . 64.33 108.41 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.8 mtpp -54.64 146.57 16.35 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.498 0.719 . . . . 60.04 112.193 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 99.6 m -126.93 138.53 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.196 0.998 . . . . 73.31 109.352 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -78.27 128.68 34.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.651 0.781 . . . . 55.54 109.68 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -67.48 -40.13 85.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.789 0.836 . . . . 73.24 111.856 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.93 -49.6 75.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.718 0.807 . . . . 63.3 112.029 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -87.11 -47.04 9.23 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.158 0.583 . . . . 73.42 111.753 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.6 14.6 49.65 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 116.276 -0.42 . . . . 74.13 112.624 -171.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -117.56 151.92 48.92 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 124.338 1.055 . . . . 73.33 111.447 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.0 Cg_endo -67.22 146.65 76.71 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.743 2.295 . . . . 73.43 112.633 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.537 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.2 mtt -77.95 96.57 5.07 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.319 0.58 . . . . 71.34 110.014 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' A' ' 27' ' ' ILE . 83.4 mt -143.07 118.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.61 1.164 . . . . 74.23 108.363 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.5 m-20 -98.7 108.27 20.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.285 -0.635 . . . . 71.1 109.285 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -80.04 130.15 35.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.524 -0.547 . . . . 65.15 109.524 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 84.1 m-85 -89.78 121.85 32.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.994 0.518 . . . . 63.45 110.438 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -115.56 145.95 42.18 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.381 1.072 . . . . 72.33 110.167 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.53 104.81 1.66 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.95 0.5 . . . . 73.42 110.063 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -64.15 -22.65 67.02 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.72 0.808 . . . . 62.22 111.648 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.99 -56.09 5.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.561 0.744 . . . . 71.32 111.633 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -86.66 -49.02 7.8 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.287 0.635 . . . . 74.52 111.486 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.49 -3.16 27.88 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.858 -0.61 . . . . 74.03 113.453 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.09 153.12 23.94 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.297 0.639 . . . . 74.34 111.044 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 23' ' ' GLU . 95.4 mt -68.01 135.61 52.58 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.006 0.522 . . . . 60.53 110.502 174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' A' ' 54' ' ' TYR . 50.2 mtpt -68.26 -26.16 65.54 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.069 0.548 . . . . 73.4 112.092 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.41 38.72 8.78 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.598 -0.601 . . . . 73.31 111.598 -168.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.1 mt-10 -134.8 158.02 45.27 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.735 0.814 . . . . 72.22 110.245 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.69 160.33 28.43 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 54.33 112.017 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 p -117.41 114.31 23.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.939 0.496 . . . . 73.35 110.296 167.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.29 104.56 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.966 0.906 . . . . 74.54 109.757 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 56.0 m -82.65 102.59 11.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.68 0.392 . . . . 71.12 111.708 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 57.9 m-85 -80.22 160.07 25.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.807 0.843 . . . . 72.24 109.736 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.53 -31.24 47.42 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.485 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -110.38 130.16 23.18 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.768 0.827 . . . . 61.23 110.719 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.08 -40.46 81.45 Favored 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.181 1.921 . . . . 74.12 115.164 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.58 -31.5 87.16 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 122.406 1.895 . . . . 62.34 113.973 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m -69.49 -43.12 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.167 0.587 . . . . 72.12 109.963 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.5 -49.34 75.76 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.983 -1.008 . . . . 75.21 111.107 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -60.21 -48.43 81.77 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.708 1.203 . . . . 62.04 111.19 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.09 -35.59 80.91 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.139 0.576 . . . . 73.34 112.192 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.42 -32.12 69.89 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.824 0.45 . . . . 61.41 111.913 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 95' ' ' VAL . 59.8 mt -64.45 -59.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.787 0.435 . . . . 75.33 110.102 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -55.83 -32.43 63.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.791 0.837 . . . . 75.25 112.924 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -78.47 -59.91 2.59 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.351 0.66 . . . . 64.32 111.173 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 93' ' ' ILE . 69.6 m-85 -84.41 -15.29 46.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.639 1.348 . . . . 71.45 114.639 -169.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.55 115.69 4.92 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 118.574 0.625 . . . . 53.42 110.444 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.45 58.34 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.768 -0.462 . . . . 62.04 114.193 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.451 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.1 mmtt -93.46 147.17 23.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.818 0.847 . . . . 73.21 110.674 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.09 124.4 31.07 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 122.232 -0.292 . . . . 63.32 111.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.426 ' HB2' HG21 ' A' ' 93' ' ' ILE . 54.3 t80 -84.35 -81.24 0.18 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.139 -0.689 . . . . 75.13 109.139 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.0 m -106.18 70.41 0.84 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.325 -0.62 . . . . 72.12 109.325 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.93 -3.76 34.69 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.963 0.745 . . . . 73.32 114.963 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -121.31 130.15 24.94 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 123.579 0.752 . . . . 75.53 110.89 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.62 120.01 7.09 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.868 2.379 . . . . 71.14 111.76 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.4 pt -88.57 146.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.232 0.539 . . . . 64.21 112.352 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -109.6 110.44 21.51 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.069 -1.086 . . . . 63.12 108.069 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 7.0 t -101.66 132.07 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.426 -0.583 . . . . 62.03 109.426 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -138.29 172.64 12.61 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.176 0.99 . . . . 50.25 109.438 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -71.97 142.95 49.38 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.146 0.43 . . . . 75.5 110.03 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 66.51 8.67 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.999 0.904 . . . . 40.04 110.659 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.557 1.244 0 CA-C-N 114.842 -1.072 . . . . 63.34 110.862 179.463 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.725 0.298 . . . . 73.11 111.556 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.4 m -97.58 126.05 42.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.819 0.448 . . . . 74.43 110.155 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 76' ' ' ALA . 34.7 pt -103.42 151.24 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.15 0.58 . . . . 73.04 111.202 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -110.06 119.78 40.36 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 74.2 109.508 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 95' ' ' VAL . 13.7 t -114.23 136.91 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.889 0.875 . . . . 73.23 110.44 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -117.48 162.18 18.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.265 1.026 . . . . 75.11 110.199 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.32 26.52 74.51 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 114.35 0.5 . . . . 73.12 114.35 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 93' ' ' ILE . 55.1 mt -71.7 -24.46 61.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.496 1.119 . . . . 72.31 111.981 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.36 161.42 36.57 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.447 -0.342 . . . . 44.15 112.811 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.69 -7.78 55.99 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.372 0.586 . . . . 70.34 111.595 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.19 11.94 17.29 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.001 0.921 . . . . 62.1 111.571 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.83 133.95 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 123.928 0.891 . . . . 54.24 112.476 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 p -133.73 155.2 50.18 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.671 0.788 . . . . 71.25 110.23 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.25 -39.54 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.217 0.607 . . . . 73.02 111.253 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.93 -49.91 74.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.834 0.854 . . . . 62.32 111.744 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 m -65.34 -43.44 90.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.088 0.555 . . . . 75.35 112.126 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.24 -40.84 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 122.901 0.48 . . . . 65.4 110.812 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.65 84.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.053 -0.521 . . . . 70.5 111.371 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.96 -27.94 67.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 70.41 111.92 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -77.18 -54.87 5.96 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.844 0.857 . . . . 74.41 111.978 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.85 -18.95 55.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.199 1.185 . . . . 71.3 114.199 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -57.24 -27.91 62.47 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 113.728 1.01 . . . . 74.25 113.728 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -58.2 -26.2 62.52 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.593 0.757 . . . . 74.12 112.758 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.24 -51.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 64.05 111.076 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.32 -177.01 46.72 Favored Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.861 -0.609 . . . . 70.53 113.259 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.04 118.31 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.253 0.621 . . . . 71.43 111.151 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.9 mt -87.95 123.08 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.177 -1.046 . . . . 53.3 108.177 169.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 54.3 mtpt -46.27 118.14 1.82 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.426 0.69 . . . . 72.12 112.423 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 80.7 m -103.96 115.56 30.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.335 0.654 . . . . 64.24 110.273 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -56.63 122.13 11.34 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.364 1.066 . . . . 74.1 110.592 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -80.75 -14.79 57.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.449 1.1 . . . . 72.42 112.583 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 10.0 mmpt? -84.83 -43.01 14.56 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.387 0.675 . . . . 73.41 111.249 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.8 p -85.98 -40.4 15.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.612 0.765 . . . . 75.22 111.553 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.76 64.92 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.086 -0.506 . . . . 70.51 112.025 -170.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -114.66 156.69 44.46 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 125.22 1.408 . . . . 62.13 110.824 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 65.2 Cg_endo -72.56 153.53 54.8 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.403 2.069 . . . . 40.22 112.852 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.524 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.5 mtt -83.7 95.73 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.99 0.916 . . . . 64.22 109.35 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -137.61 122.87 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 75.24 108.535 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -106.07 108.67 20.31 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.375 -0.602 . . . . 64.34 109.375 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.0 mt -89.37 129.52 35.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.728 0.811 . . . . 72.43 109.076 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' A' ' 63' ' ' LYS . 77.3 m-85 -89.19 124.44 34.36 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.574 0.35 . . . . 73.45 111.097 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.6 m -108.83 137.81 46.16 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.663 0.785 . . . . 73.33 110.201 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.54 136.05 47.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.777 0.831 . . . . 61.52 110.831 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -76.42 -24.3 53.98 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.13 0.789 . . . . 72.15 113.13 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -92.41 -55.4 3.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.842 0.457 . . . . 65.0 111.348 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -73.95 -30.63 62.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.771 0.828 . . . . 74.11 111.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.88 6.34 88.64 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.997 -0.547 . . . . 75.43 113.441 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -100.83 158.54 15.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.282 0.633 . . . . 70.5 111.511 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.62 130.91 44.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.168 0.587 . . . . 65.54 111.582 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' TYR . 97.2 mttt -66.43 -16.78 64.37 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.345 1.058 . . . . 61.05 112.697 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 29.07 56.22 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.267 -0.333 . . . . 63.42 112.267 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.67 146.23 52.07 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.416 1.086 . . . . 71.24 108.536 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.36 169.58 21.74 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.483 0.549 . . . . 62.52 112.483 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 p -123.56 130.82 53.24 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.982 -0.554 . . . . 54.11 111.089 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -110.1 109.52 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.669 0.788 . . . . 73.42 109.746 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -79.53 104.11 9.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.338 0.255 . . . . 64.03 111.143 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 48.9 m-85 -82.69 163.07 21.58 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 120.842 0.353 . . . . 74.43 110.187 169.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.31 -40.19 52.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.319 0.647 . . . . 74.43 110.836 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 11.7 m-20 -112.61 133.81 21.78 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.156 0.582 . . . . 75.31 111.706 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.17 -41.09 59.3 Favored 'Trans proline' 0 CA--C 1.584 3.015 0 C-N-CA 122.842 2.362 . . . . 63.24 116.028 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 69.8 Cg_endo -71.08 -20.92 28.12 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 122.526 1.938 . . . . 74.21 113.204 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 t -75.77 -39.5 56.92 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.574 0.702 . . . . 75.15 109.451 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.15 -45.17 95.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.056 -0.975 . . . . 70.14 110.623 173.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.1 -46.4 89.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.494 1.118 . . . . 73.34 110.882 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.79 97.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.172 0.589 . . . . 71.35 112.008 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.48 77.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 75.04 112.143 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 95' ' ' VAL . 83.7 mt -64.71 -57.91 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.216 0.607 . . . . 60.22 110.823 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.94 -32.92 68.28 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.11 0.964 . . . . 72.51 111.884 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.78 -54.45 5.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.236 0.615 . . . . 72.32 112.446 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 95' ' ' VAL . 58.8 m-85 -89.34 -6.52 56.61 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.872 1.064 . . . . 71.11 113.872 -171.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.6 124.45 22.39 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.266 0.485 . . . . 75.23 110.085 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.53 -0.84 89.22 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.041 -0.527 . . . . 71.24 114.017 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -97.57 170.5 8.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.537 0.735 . . . . 52.35 110.914 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.08 137.9 50.73 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.114 0.565 . . . . 53.21 111.78 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 93' ' ' ILE . 64.3 t80 -129.29 131.62 47.0 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.813 1.245 . . . . 75.25 108.526 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t 63.33 25.85 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.362 1.065 . . . . 70.31 111.537 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.01 88.1 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-N 116.049 -0.523 . . . . 34.05 113.706 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -115.02 117.24 41.88 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.341 1.056 . . . . 70.54 110.495 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.92 100.74 0.17 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.627 2.218 . . . . 62.43 113.066 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 HD23 ' A' ' 21' ' ' LEU . 40.3 pt -82.64 153.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.92 0.888 . . . . 74.03 113.368 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -114.91 110.25 19.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.076 1.351 . . . . 75.42 109.169 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 18' ' ' VAL . 23.8 t -103.87 131.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 122.151 -0.343 . . . . 63.44 110.096 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.1 p -142.79 179.29 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.608 1.163 . . . . 51.03 109.748 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -77.06 150.07 35.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.487 0.585 . . . . 64.54 110.772 169.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.82 87.94 7.48 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.094 0.473 . . . . 72.32 110.936 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.471 1.108 . . . . 64.3 110.822 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.972 0.415 . . . . 52.32 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -100.96 128.95 46.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 61.31 110.218 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.1 pt -110.85 151.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.423 0.689 . . . . 73.44 110.892 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -108.0 116.19 31.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.158 0.583 . . . . 72.34 109.724 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.3 t -107.76 142.1 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.251 1.02 . . . . 73.2 110.16 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -122.07 158.88 28.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.851 1.26 . . . . 74.32 110.171 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.55 38.98 95.29 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 114.509 0.563 . . . . 74.22 114.509 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.86 -31.86 27.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.648 1.179 . . . . 61.22 111.691 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.0 159.6 11.98 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 122.748 0.213 . . . . 63.51 113.489 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.71 -14.73 57.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.219 0.608 . . . . 75.41 111.302 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -88.92 3.89 49.87 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.728 0.811 . . . . 60.23 110.995 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.05 136.25 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.631 0.772 . . . . 71.45 111.585 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.7 p -129.05 151.92 49.21 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.945 -0.472 . . . . 62.0 110.194 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 51' ' ' ILE . 75.9 mt -52.8 -45.01 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.239 1.015 . . . . 74.35 112.032 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.82 -31.73 68.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.427 0.691 . . . . 53.24 112.528 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -75.37 -36.77 60.87 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.57 0.348 . . . . 64.24 111.684 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 26' ' ' THR . 63.6 t -65.88 -39.85 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.427 0.632 . . . . 72.11 109.599 172.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.92 99.52 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.913 -1.039 . . . . 73.55 111.65 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.84 -34.86 69.62 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.309 0.644 . . . . 73.34 111.679 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.27 -54.15 9.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.775 0.83 . . . . 75.23 111.508 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.434 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 38.6 m-85 -77.29 -18.28 57.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.635 1.346 . . . . 71.03 114.635 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.79 -21.47 64.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.511 1.3 . . . . 73.3 114.511 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -57.64 -26.09 61.11 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.413 0.685 . . . . 54.3 112.388 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 mm -85.65 -45.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 75.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.83 44.3 Favored Glycine 0 C--O 1.241 0.576 0 CA-C-N 116.077 -0.51 . . . . 33.04 113.302 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 122.84 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.555 0.742 . . . . 65.52 110.185 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.8 mt -92.51 124.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.071 -1.085 . . . . 71.11 108.071 173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -50.62 154.81 1.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.068 0.947 . . . . 75.0 112.902 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 87.2 m -137.5 127.25 25.42 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.559 -0.746 . . . . 52.21 110.824 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.34 113.94 4.42 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.686 -0.688 . . . . 63.25 109.417 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -78.01 -13.29 59.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.932 0.893 . . . . 63.35 112.172 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -80.67 -29.38 36.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.039 0.535 . . . . 75.41 112.289 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -103.21 -50.83 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.131 0.573 . . . . 64.3 110.893 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.58 10.64 28.6 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.563 -0.744 . . . . 73.2 112.364 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.63 145.31 30.38 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 64.21 111.637 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.27 145.74 93.31 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.842 2.361 . . . . 51.12 112.47 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 52.3 mtt -73.65 94.0 2.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.799 0.809 . . . . 73.22 109.739 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 27' ' ' ILE . 84.7 mt -145.78 120.93 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.507 -1.224 . . . . 60.34 108.369 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -101.29 110.33 22.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.496 -0.557 . . . . 61.32 109.496 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -78.71 136.09 37.33 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.098 -0.704 . . . . 63.41 109.098 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.2 111.03 22.72 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.253 0.621 . . . . 75.03 110.144 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -86.65 151.65 23.25 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.037 0.535 . . . . 64.13 110.087 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.98 142.19 28.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.914 0.886 . . . . 72.55 110.896 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -37.62 59.71 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.485 -0.779 . . . . 60.14 112.672 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -94.24 -43.85 8.25 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.705 0.402 . . . . 72.2 111.713 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -81.92 -33.71 30.25 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 118.008 0.367 . . . . 63.11 111.864 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.59 13.17 83.21 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 116.239 -0.437 . . . . 73.24 114.167 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -104.1 173.57 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.598 0.759 . . . . 74.15 110.286 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.28 123.31 22.71 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.792 0.33 . . . . 64.01 110.226 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.63 -21.68 66.5 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.125 0.97 . . . . 74.21 113.18 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 23.26 35.66 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 123.178 0.299 . . . . 65.53 112.412 -171.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -121.34 151.05 40.55 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.043 -0.681 . . . . 74.44 109.692 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.78 154.85 24.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 40.32 111.713 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.9 p -109.86 120.59 42.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.62 0.368 . . . . 63.53 110.08 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.67 111.65 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.696 0.798 . . . . 71.22 110.449 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 70.7 m -85.55 105.12 15.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.682 0.393 . . . . 75.2 111.166 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 52.1 m-85 -81.25 153.45 27.13 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.261 0.624 . . . . 64.42 110.074 168.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.29 -28.79 62.29 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.138 0.575 . . . . 74.44 111.233 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.61 127.97 26.35 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 123.72 0.808 . . . . 74.13 111.194 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.92 -34.31 85.63 Favored 'Trans proline' 0 CA--C 1.583 2.973 0 C-N-CA 123.008 2.472 . . . . 63.22 116.277 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.48 -28.06 62.14 Favored 'Trans proline' 0 C--N 1.4 3.284 0 CA-C-N 122.62 1.972 . . . . 64.14 113.39 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 m -75.1 -35.04 61.78 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.114 0.566 . . . . 62.15 110.004 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.33 -53.64 54.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.679 -0.691 . . . . 62.14 111.121 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -59.37 -44.43 92.74 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.936 0.895 . . . . 73.11 110.77 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.88 90.89 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.002 -0.545 . . . . 74.4 111.775 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.42 72.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.245 0.618 . . . . 74.32 112.327 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.45 HG12 HG12 ' A' ' 95' ' ' VAL . 83.0 mt -66.0 -58.37 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.992 0.517 . . . . 71.31 110.398 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.1 -26.21 68.44 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 115.327 -0.851 . . . . 71.53 111.919 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -81.0 -60.42 2.3 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.931 0.492 . . . . 75.24 111.754 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.52 -6.72 58.61 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.87 1.063 . . . . 72.44 113.87 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.39 106.27 0.73 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 118.118 0.417 . . . . 64.54 110.374 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.05 55.33 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.055 0.782 . . . . 72.51 115.055 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.41 -174.35 4.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.03 0.915 . . . . 71.21 110.616 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.6 127.42 37.04 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 122.922 0.489 . . . . 74.12 111.3 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -92.46 -87.91 0.21 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.861 0.464 . . . . 64.41 110.146 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.1 m -89.64 50.58 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.389 0.614 . . . . 72.01 109.907 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.17 4.9 69.64 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.883 -0.599 . . . . 63.53 113.915 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.68 134.09 21.01 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.725 0.81 . . . . 70.54 110.679 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.91 107.07 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.658 2.905 . . . . 53.2 112.672 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.73 143.53 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 N-CA-C 113.164 0.802 . . . . 74.21 113.164 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -118.65 114.86 23.4 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.951 1.301 . . . . 71.51 108.681 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 15.0 t -107.92 141.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.639 0.376 . . . . 61.42 110.584 -174.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 t -148.68 -178.21 6.22 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.329 1.051 . . . . 41.32 110.0 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -76.25 140.62 41.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.849 0.46 . . . . 61.1 110.252 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.24 5.25 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.173 0.511 . . . . 63.21 109.737 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 124.497 1.119 . . . . 71.21 110.857 -171.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.081 0.467 . . . . 63.22 109.924 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -98.64 129.87 45.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.584 0.753 . . . . 72.42 110.463 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.0 pt -110.33 151.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.6 0.76 . . . . 74.12 111.123 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -106.37 119.32 38.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.253 0.621 . . . . 62.02 109.67 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.2 t -112.61 140.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.249 1.02 . . . . 72.24 110.606 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.38 157.06 30.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.362 1.065 . . . . 64.24 110.486 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.64 34.88 42.63 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 115.135 0.814 . . . . 65.45 115.135 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.53 -21.69 28.47 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.269 1.028 . . . . 71.4 112.129 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.25 158.86 30.09 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 116.816 -0.174 . . . . 32.51 112.885 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.158 0.583 . . . . 74.31 112.297 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.96 11.8 23.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.95 0.5 . . . . 64.22 111.491 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.98 138.58 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 123.788 0.835 . . . . 73.54 112.414 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 39.0 p -124.91 153.86 42.01 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.213 0.605 . . . . 74.14 110.461 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 51' ' ' ILE . 79.8 mt -55.67 -42.84 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.741 0.817 . . . . 51.41 111.598 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -33.1 72.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.379 0.672 . . . . 74.42 112.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.3 t -69.9 -42.22 73.68 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.387 0.275 . . . . 62.15 111.025 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 59.8 t -63.89 -42.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.326 0.584 . . . . 72.53 110.072 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.32 82.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.13 -0.941 . . . . 73.01 111.895 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.88 -38.71 92.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 73.54 111.299 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -67.89 -56.36 9.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.356 1.063 . . . . 72.12 111.515 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 85.2 m-85 -78.87 -20.46 49.46 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.212 1.19 . . . . 74.12 114.212 -174.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.77 -23.24 67.28 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.824 1.046 . . . . 74.21 113.824 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -60.49 -24.91 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.181 0.592 . . . . 72.02 112.291 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 mm -82.85 -43.65 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.102 0.961 . . . . 41.51 111.018 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.79 169.17 42.29 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.793 -0.639 . . . . 61.32 112.612 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.39 131.52 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.045 0.538 . . . . 62.11 110.9 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.4 mt -97.69 131.09 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.814 0.846 . . . . 64.33 108.804 173.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 60.1 mtpt -53.65 151.2 6.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.288 0.635 . . . . 65.35 112.194 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.0 m -142.48 127.6 18.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.728 0.811 . . . . 64.31 110.262 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.78 127.8 34.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.711 0.804 . . . . 74.33 110.384 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -31.54 56.64 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.432 0.693 . . . . 72.2 112.287 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -51.45 43.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.966 0.506 . . . . 65.15 111.806 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -82.28 -51.37 7.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.569 0.748 . . . . 74.23 110.899 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.14 10.6 29.58 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.872 -0.603 . . . . 64.41 113.822 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -109.2 147.74 36.58 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 117.724 0.762 . . . . 54.12 112.721 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.7 Cg_endo -68.64 142.72 54.07 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.947 2.431 . . . . 75.1 112.371 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.1 mtt -74.08 95.25 2.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.595 0.712 . . . . 75.31 110.257 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -143.91 120.09 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.687 1.195 . . . . 74.24 108.902 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.74 111.28 23.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.146 0.578 . . . . 74.22 110.005 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.0 mt -86.5 114.37 23.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.643 0.777 . . . . 51.05 110.072 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.9 126.72 31.55 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.528 0.731 . . . . 64.32 111.433 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -99.72 145.3 27.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.604 0.762 . . . . 64.33 110.561 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.67 138.91 36.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.417 0.687 . . . . 74.44 112.334 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.42 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 11.4 ptp180 -64.94 -35.86 82.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.25 1.02 . . . . 75.44 112.64 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 19.5 mm-40 -87.86 -57.02 3.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.263 0.625 . . . . 63.14 111.462 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 p -73.11 -28.54 62.33 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.248 0.833 . . . . 74.03 113.248 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.0 73.32 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 123.358 0.411 . . . . 35.13 113.084 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -122.27 159.42 27.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.921 1.288 . . . . 72.42 109.167 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.52 133.07 55.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.645 0.378 . . . . 70.01 111.736 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -67.12 -14.19 62.66 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.853 0.861 . . . . 74.42 113.048 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.67 35.14 32.98 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.103 -0.799 . . . . 73.22 111.103 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -139.36 138.46 36.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.089 0.956 . . . . 74.25 109.016 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.58 159.11 40.68 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.02 0.438 . . . . 61.14 112.143 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 24.3 p -111.46 123.69 50.74 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.267 -0.424 . . . . 74.3 110.698 172.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.0 110.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.68 0.792 . . . . 74.04 110.371 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 30.9 m -88.6 102.27 14.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.852 0.461 . . . . 62.34 111.276 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 70.5 m-85 -79.3 158.25 27.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.217 0.607 . . . . 75.05 111.363 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.56 -32.08 70.66 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.853 0.861 . . . . 61.32 111.048 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.99 136.77 26.55 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.667 0.787 . . . . 71.41 112.006 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.0 -36.33 95.83 Favored 'Trans proline' 0 CA--C 1.58 2.795 0 C-N-CA 122.768 2.312 . . . . 75.0 116.208 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.09 -26.72 65.43 Favored 'Trans proline' 0 C--N 1.393 2.912 0 CA-C-N 122.816 2.041 . . . . 71.42 113.403 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -71.53 -40.45 70.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 53.14 109.712 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -61.49 -53.62 53.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.125 -0.943 . . . . 63.55 111.296 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.46 -46.51 88.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.752 1.221 . . . . 72.33 111.166 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.74 99.27 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.804 -0.634 . . . . 63.44 111.691 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.57 74.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.923 0.489 . . . . 73.03 112.183 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 95' ' ' VAL . 86.8 mt -62.12 -62.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.892 0.477 . . . . 71.11 110.449 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.59 -31.59 70.73 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.877 0.871 . . . . 74.21 112.578 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -77.54 -53.23 7.85 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.231 0.612 . . . . 71.31 111.964 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.583 ' HB3' HD11 ' A' ' 93' ' ' ILE . 64.7 m-85 -88.41 -7.66 56.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.838 1.051 . . . . 64.13 113.838 -172.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 19.3 t70 -62.21 115.35 4.07 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.126 0.421 . . . . 63.01 110.519 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.68 10.7 72.47 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.592 0.597 . . . . 65.22 114.592 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -101.52 153.43 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.701 0.75 . . . . 54.21 111.698 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.35 127.04 34.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.088 0.555 . . . . 75.32 112.163 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -92.47 -52.75 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.189 0.595 . . . . 73.03 110.852 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -126.01 40.65 3.69 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.963 0.905 . . . . 65.24 110.015 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.6 15.85 80.89 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 115.815 -0.63 . . . . 51.55 112.8 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -136.7 129.28 17.34 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.304 1.042 . . . . 73.52 110.758 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.33 135.26 36.16 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.185 2.59 . . . . 74.01 113.243 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.583 HD11 ' HB3' ' A' ' 83' ' ' PHE . 27.1 pt -104.7 150.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 72.34 112.215 -173.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -114.76 109.9 18.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.764 0.826 . . . . 74.11 108.807 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 7.8 t -108.64 137.59 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 122.813 0.445 . . . . 74.44 110.432 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.9 m -146.07 179.55 7.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.325 1.05 . . . . 71.44 109.458 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -74.62 143.05 44.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.725 -0.472 . . . . 72.2 109.725 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.33 91.89 1.37 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.37 0.605 . . . . 74.02 111.175 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 124.165 0.986 . . . . 71.13 111.102 178.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 111.808 0.299 . . . . 74.43 111.808 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.3 m -97.88 125.6 42.85 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.295 0.638 . . . . 71.11 109.819 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.69 140.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.066 0.547 . . . . 71.44 111.175 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -94.79 125.36 39.4 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.939 -0.393 . . . . 43.34 109.939 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 95' ' ' VAL . 23.0 t -118.05 139.64 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.099 0.959 . . . . 72.21 109.82 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -127.58 162.06 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.97 0.908 . . . . 74.14 110.973 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.75 66.93 Favored Glycine 0 N--CA 1.479 1.502 0 O-C-N 123.46 0.475 . . . . 61.14 114.192 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 93' ' ' ILE . 34.3 mt -75.46 -26.5 58.29 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.098 0.959 . . . . 55.43 111.789 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.16 152.15 21.11 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.964 -0.454 . . . . 63.11 111.964 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.99 -3.45 35.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.355 0.872 . . . . 70.53 113.355 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -101.43 18.85 19.07 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.393 0.677 . . . . 72.12 110.522 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 21' ' ' LEU . 11.2 p -71.51 135.59 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 123.264 0.626 . . . . 73.11 112.135 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -127.28 150.73 49.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.573 -0.705 . . . . 72.11 110.901 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.1 mt -52.93 -45.83 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.456 1.102 . . . . 75.2 111.978 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.62 -31.14 67.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.655 0.782 . . . . 72.22 111.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.5 m -71.54 -40.11 70.27 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.759 0.424 . . . . 72.23 111.606 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 26' ' ' THR . 52.3 t -66.45 -36.94 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.896 0.478 . . . . 73.12 110.151 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.27 75.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.605 -0.725 . . . . 64.2 111.344 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.44 -30.97 71.82 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.601 0.76 . . . . 72.11 111.68 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -74.18 -56.46 4.87 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.528 0.731 . . . . 74.34 111.195 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.412 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 23.0 m-85 -77.17 -18.55 57.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.404 1.261 . . . . 54.23 114.404 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -63.42 -20.57 65.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 113.89 1.07 . . . . 55.1 113.89 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.21 -25.32 65.51 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.23 0.612 . . . . 65.14 112.138 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.4 mm -88.36 -48.45 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.241 1.016 . . . . 73.23 111.367 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.0 169.7 39.0 Favored Glycine 0 C--O 1.238 0.353 0 C-N-CA 121.435 -0.412 . . . . 61.21 113.414 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.32 117.21 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.492 0.717 . . . . 61.24 110.329 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.7 mt -86.22 127.86 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -53.26 154.54 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.059 0.944 . . . . 72.15 112.833 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.3 m -132.01 127.0 35.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.953 0.901 . . . . 73.13 110.334 -175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -64.0 119.99 11.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.727 0.811 . . . . 65.32 109.986 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.72 -21.23 64.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.338 1.055 . . . . 74.25 112.529 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -86.53 -43.36 12.79 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.447 0.699 . . . . 62.52 112.037 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 p -89.46 -36.27 15.52 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.924 0.713 . . . . 44.03 112.924 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.43 77.09 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 112.712 -0.155 . . . . 51.44 112.712 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -99.46 151.18 37.34 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.631 1.172 . . . . 73.35 110.919 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.4 145.22 76.62 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.571 2.181 . . . . 52.4 111.436 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 59.3 mtt -74.47 92.26 2.34 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.234 -0.654 . . . . 72.42 109.234 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.621 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.72 117.66 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.781 1.232 . . . . 73.44 108.172 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 30.4 m-80 -104.5 111.58 24.3 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 109.94 -0.393 . . . . 75.11 109.94 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -80.37 128.65 33.81 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.413 0.685 . . . . 74.44 110.053 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 70.4 m-85 -86.1 136.09 33.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.183 0.593 . . . . 74.33 110.708 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -128.82 138.73 52.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.516 1.126 . . . . 62.42 109.614 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.09 110.55 3.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.695 -0.854 . . . . 65.4 108.695 170.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -67.64 -22.52 65.32 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.986 0.515 . . . . 73.35 111.695 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 59' ' ' THR . 8.9 pt-20 -75.85 -48.43 21.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.614 0.766 . . . . 73.15 112.17 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 58' ' ' GLU . 60.5 p -91.61 -33.42 15.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.226 0.61 . . . . 74.51 112.075 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.26 3.1 76.09 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.728 -0.669 . . . . 33.3 113.54 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -93.01 161.28 14.51 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.436 0.618 . . . . 55.44 111.17 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.64 141.51 39.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.139 0.576 . . . . 24.34 111.217 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -78.45 -14.31 59.43 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 70.12 112.134 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.86 37.96 28.36 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.177 -0.369 . . . . 54.12 112.177 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 48.5 mt-10 -130.7 151.37 51.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.896 0.878 . . . . 70.31 109.627 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 141.76 14.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.915 0.486 . . . . 63.35 112.02 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.3 p -101.62 112.92 25.64 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.438 0.295 . . . . 73.34 110.836 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -103.5 110.52 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.014 0.926 . . . . 64.1 110.038 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 47.3 m -87.86 107.08 18.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.843 0.457 . . . . 41.15 111.012 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.412 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 46.1 m-85 -83.12 157.11 22.94 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.217 0.532 . . . . 74.52 110.352 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.68 -34.43 75.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.78 0.832 . . . . 74.31 110.684 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -118.51 134.12 23.49 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.399 0.68 . . . . 41.23 111.033 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.62 -36.56 89.79 Favored 'Trans proline' 0 CA--C 1.582 2.888 0 C-N-CA 122.517 2.144 . . . . 52.12 116.225 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.85 -32.81 77.2 Favored 'Trans proline' 0 C--N 1.397 3.125 0 CA-C-N 122.8 2.036 . . . . 53.13 114.107 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.7 p -78.13 -33.25 50.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.09 0.556 . . . . 73.4 110.394 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.27 74.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.171 0.588 . . . . 60.13 111.205 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -61.87 -40.52 95.64 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.287 1.035 . . . . 73.01 110.796 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.97 94.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.776 -0.647 . . . . 72.52 111.872 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.06 -27.11 68.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.133 0.573 . . . . 55.45 112.408 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.1 mt -64.36 -63.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.519 0.328 . . . . 73.33 110.615 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.0 -28.16 66.11 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.672 0.789 . . . . 42.44 112.005 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.52 -61.01 2.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.117 0.567 . . . . 74.2 111.63 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 93' ' ' ILE . 72.8 m-85 -82.72 -10.83 58.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.162 1.171 . . . . 74.24 114.162 -169.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.53 94.13 0.27 Allowed 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 109.025 -0.732 . . . . 71.43 109.025 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.76 -12.65 11.85 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.195 -0.911 . . . . 43.14 114.444 -174.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 93' ' ' ILE . 49.0 mmtm -81.56 140.54 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.941 0.871 . . . . 72.03 110.612 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.9 121.19 31.01 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.148 -0.345 . . . . 73.04 111.842 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -83.95 -80.96 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.109 0.564 . . . . 72.12 109.719 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -104.33 57.03 0.71 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.501 0.667 . . . . 60.32 110.126 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 9.29 84.88 Favored Glycine 0 N--CA 1.48 1.62 0 CA-C-N 115.682 -0.69 . . . . 72.13 114.201 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -126.03 126.47 24.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 123.984 0.914 . . . . 72.45 110.534 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.15 108.62 1.37 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.796 2.33 . . . . 65.2 112.018 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 83' ' ' PHE . 11.3 pt -77.89 152.51 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.411 0.685 . . . . 72.42 111.872 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -116.87 120.49 38.65 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.811 -0.811 . . . . 75.13 108.811 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 18' ' ' VAL . 21.6 t -116.0 136.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 122.751 0.42 . . . . 73.52 110.955 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 t -147.29 176.63 9.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.469 1.508 . . . . 62.32 108.703 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -71.98 145.54 48.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.389 0.54 . . . . 75.33 111.094 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.63 76.32 10.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 75.13 109.9 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.635 0.774 . . . . 64.43 111.317 -178.125 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.284 0.476 . . . . 73.55 112.284 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -95.28 137.89 33.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.054 0.541 . . . . 74.44 109.947 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 pt -113.89 148.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.842 -0.536 . . . . 52.14 111.184 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.5 113.95 27.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.614 -0.513 . . . . 72.32 109.614 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 95' ' ' VAL . 11.0 t -105.63 132.78 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.037 0.935 . . . . 73.15 109.639 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.58 162.39 18.07 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.855 0.862 . . . . 72.44 109.824 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.71 68.44 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 114.424 0.53 . . . . 74.22 114.424 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 18' ' ' VAL . 32.3 mt -80.24 -17.55 51.95 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.857 1.263 . . . . 74.55 112.459 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.65 173.5 46.93 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.967 0.747 . . . . 52.21 114.967 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.98 -13.4 60.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.28 1.032 . . . . 64.05 112.723 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -93.19 11.32 28.28 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.922 0.889 . . . . 72.35 111.545 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.07 129.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 O-C-N 121.429 -0.794 . . . . 61.43 112.801 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -132.87 158.86 41.49 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.326 0.65 . . . . 70.21 110.475 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -51.88 -51.21 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.967 0.907 . . . . 75.34 111.593 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.06 -32.13 68.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.598 0.759 . . . . 74.33 112.891 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -72.06 -42.25 66.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.109 0.163 . . . . 74.43 111.004 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.86 -43.08 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 120.853 0.358 . . . . 64.52 110.445 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.71 87.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.891 -0.595 . . . . 24.42 112.242 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.06 -27.69 66.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.753 0.421 . . . . 60.44 111.282 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.38 -50.36 27.13 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 63.45 110.43 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 18.7 m-85 -82.81 -19.68 37.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.339 1.236 . . . . 72.3 114.339 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -67.1 -18.31 65.26 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 113.385 0.883 . . . . 62.53 113.385 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.78 -25.97 65.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.538 0.735 . . . . 62.54 111.799 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.5 mm -83.2 -38.7 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.376 1.07 . . . . 73.15 111.381 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.12 -179.81 48.24 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.172 -0.467 . . . . 71.2 113.156 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.7 120.13 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.178 0.591 . . . . 63.05 110.878 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 79.3 mt -93.85 123.78 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.362 0.665 . . . . 72.52 109.692 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 48.3 mtpt -48.61 146.85 2.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.157 0.983 . . . . 73.31 112.446 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 89.5 m -140.0 123.55 17.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.546 0.738 . . . . 73.33 110.717 -170.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -63.25 126.06 26.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.677 0.791 . . . . 65.13 109.719 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.36 -37.54 37.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.283 0.633 . . . . 74.44 111.973 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.32 -50.16 71.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.183 0.593 . . . . 75.13 111.29 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.7 p -79.43 -37.21 37.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.736 0.415 . . . . 60.42 111.344 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.58 63.91 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 116.379 -0.373 . . . . 23.13 112.464 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -111.15 144.31 30.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 123.93 0.892 . . . . 74.44 112.173 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 21.6 Cg_endo -61.35 139.17 81.26 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.81 2.34 . . . . 71.14 112.291 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 48.6 mtt -71.75 96.4 1.61 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.238 0.542 . . . . 72.25 110.112 -170.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 67' ' ' THR . 60.7 mt -141.12 126.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.434 1.093 . . . . 65.13 109.173 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.0 m-20 -103.1 110.43 22.37 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.994 -0.743 . . . . 62.23 108.994 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -89.24 116.68 27.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 72.32 110.287 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -82.68 118.54 23.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.532 0.733 . . . . 62.3 110.744 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -106.65 148.92 27.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.368 1.067 . . . . 72.55 110.479 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.57 136.72 35.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.121 0.568 . . . . 64.34 110.949 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -72.66 -29.81 63.75 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.75 0.82 . . . . 63.14 112.627 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -84.89 -61.15 1.85 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.052 0.541 . . . . 64.2 111.023 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 p -76.77 -31.23 56.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.747 0.819 . . . . 71.11 112.092 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.58 2.03 90.58 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 116.376 -0.375 . . . . 74.1 113.458 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -84.75 151.78 24.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.696 0.799 . . . . 55.14 111.025 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 mt -67.2 129.86 41.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.92 -0.582 . . . . 71.02 109.679 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -72.78 -9.39 58.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.301 0.64 . . . . 75.02 112.281 -173.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.35 40.97 31.95 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.268 -0.733 . . . . 33.33 111.268 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -142.54 138.13 30.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.866 0.866 . . . . 64.11 109.099 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.0 152.62 24.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.846 0.458 . . . . 22.12 111.657 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -111.97 120.56 42.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 116.216 -0.447 . . . . 75.15 111.185 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.08 111.16 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.651 1.181 . . . . 61.45 110.295 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.3 t -83.96 108.94 17.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.462 0.305 . . . . 73.34 110.9 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 44.3 m-85 -85.5 160.04 19.78 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.131 0.491 . . . . 73.23 110.501 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.23 -37.87 57.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.291 0.636 . . . . 72.52 110.485 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -116.38 129.81 24.96 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.518 0.727 . . . . 63.14 110.606 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.55 -35.45 56.23 Favored 'Trans proline' 0 CA--C 1.579 2.765 0 C-N-CA 123.09 2.527 . . . . 73.24 116.668 169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.5 -32.94 97.08 Favored 'Trans proline' 0 C--N 1.395 3.017 0 CA-C-N 122.843 2.051 . . . . 70.12 113.313 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -71.84 -38.55 70.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.215 0.606 . . . . 65.43 110.297 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.77 53.82 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.391 -0.822 . . . . 63.24 110.969 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.46 -40.48 97.24 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.474 1.11 . . . . 65.2 111.717 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.91 97.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 61.14 112.041 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.67 71.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.253 0.621 . . . . 74.25 111.993 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 95' ' ' VAL . 75.2 mt -63.43 -62.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.969 0.508 . . . . 71.02 110.464 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.65 -32.07 66.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.672 0.789 . . . . 50.01 112.321 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -77.77 -55.3 5.45 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.033 0.533 . . . . 74.04 112.228 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HB3' HD11 ' A' ' 93' ' ' ILE . 73.9 m-85 -88.57 -15.67 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.47 118.45 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.347 0.521 . . . . 73.1 110.271 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.09 -1.79 78.04 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.824 0.69 . . . . 74.0 114.824 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.97 173.57 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.45 0.625 . . . . 71.42 111.139 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -107.61 106.74 17.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.088 0.555 . . . . 75.23 111.268 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -86.0 113.57 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.235 -1.024 . . . . 72.14 108.235 168.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t 61.01 24.5 14.6 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.303 0.641 . . . . 65.42 111.872 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.19 76.89 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 123.169 0.414 . . . . 70.54 113.969 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.51 126.01 45.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.84 0.856 . . . . 64.14 111.024 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.81 100.95 1.4 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.411 2.074 . . . . 74.45 112.226 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.5 pt -85.49 154.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 113.557 0.947 . . . . 72.32 113.557 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -126.13 113.83 17.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.746 1.218 . . . . 72.33 109.075 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.605 HG22 HG13 ' A' ' 18' ' ' VAL . 15.5 t -104.53 138.88 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.571 0.348 . . . . 71.21 110.615 -172.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.4 m -144.25 -178.7 6.09 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 72.31 109.48 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.52 147.88 37.47 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.436 0.562 . . . . 75.11 110.734 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.11 83.63 4.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.022 -0.732 . . . . 70.54 109.022 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.527 0 C-N-CA 124.001 0.92 . . . . 72.4 111.563 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.717 0.294 . . . . 71.22 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 m -104.01 127.77 51.58 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.696 0.798 . . . . 41.24 109.698 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.1 pt -109.43 154.26 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.775 0.83 . . . . 74.22 111.279 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -109.08 121.97 46.27 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.858 0.863 . . . . 71.35 109.954 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 95' ' ' VAL . 19.8 t -118.03 140.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.535 1.134 . . . . 73.0 110.253 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.01 158.03 34.69 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.983 0.913 . . . . 73.11 110.525 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.17 35.43 43.48 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 114.602 0.601 . . . . 44.1 114.602 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 93' ' ' ILE . 65.3 mt -80.57 -34.16 35.55 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.074 0.95 . . . . 73.24 112.321 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 153.06 8.58 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.087 -0.405 . . . . 72.53 112.087 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.33 -1.93 43.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.989 0.737 . . . . 62.22 112.989 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -120.82 29.93 7.14 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.332 0.653 . . . . 74.33 110.142 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.41 136.95 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 123.44 0.696 . . . . 62.22 111.682 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 30' ' ' VAL . 42.7 p -122.48 151.13 41.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 74.24 110.521 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.7 mt -53.43 -41.16 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.663 0.785 . . . . 74.34 111.091 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.42 -40.42 93.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.341 0.656 . . . . 74.1 112.404 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.5 p -72.31 -38.27 68.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.288 0.235 . . . . 71.01 111.52 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 41.3 t -65.41 -40.52 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.163 0.506 . . . . 54.32 110.195 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.273 -0.876 . . . . 74.22 112.371 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.78 -32.25 72.7 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.374 0.669 . . . . 61.24 111.207 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -76.65 -49.83 15.23 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.013 -0.54 . . . . 73.15 111.158 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 18.4 m-85 -80.48 -17.91 50.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.147 1.166 . . . . 71.04 114.147 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.99 -21.69 66.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.269 0.841 . . . . 74.43 113.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.22 -28.72 59.36 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.581 0.752 . . . . 73.43 112.153 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -82.32 -42.67 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 72.23 111.445 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.94 -178.92 47.06 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.392 -0.367 . . . . 70.35 113.326 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.49 119.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.068 0.547 . . . . 60.33 110.747 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.5 mt -87.2 125.29 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.888 -0.782 . . . . 63.11 108.888 173.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 53.7 mtpt -48.41 131.9 16.83 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.661 0.784 . . . . 71.21 112.184 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 53.5 m -116.17 123.17 47.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 72.41 110.709 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -63.68 119.0 9.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.72 0.808 . . . . 61.33 109.132 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -76.37 -27.16 56.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 73.02 111.586 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -72.97 -43.44 62.25 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.427 0.691 . . . . 64.15 111.615 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -84.52 -36.54 22.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.019 0.527 . . . . 74.15 111.411 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.6 66.41 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 115.799 -0.637 . . . . 73.05 112.415 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.05 157.74 47.89 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.41 1.084 . . . . 74.5 111.665 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 60.6 Cg_endo -69.83 155.33 65.97 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.489 2.126 . . . . 74.2 113.002 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.441 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.1 mtt -83.41 94.85 8.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.718 0.807 . . . . 75.41 109.186 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 89.3 mt -142.18 117.95 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.765 -1.107 . . . . 61.22 108.799 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -97.12 107.5 20.04 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.758 -0.83 . . . . 64.41 108.758 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.1 mt -77.03 150.29 35.8 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.914 -0.772 . . . . 73.1 108.914 172.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.83 128.61 55.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.805 0.442 . . . . 71.41 110.654 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -115.08 139.63 49.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.252 1.021 . . . . 73.03 110.259 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -66.45 128.19 35.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.767 0.827 . . . . 71.14 110.798 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -62.98 -34.66 77.99 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.52 0.328 . . . . 73.14 110.744 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -76.72 -58.08 3.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.454 0.702 . . . . 71.51 111.809 -172.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.4 p -81.37 -29.24 34.09 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.498 0.555 . . . . 62.42 112.498 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.39 5.96 86.09 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 116.57 -0.286 . . . . 64.42 113.208 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -96.77 167.9 10.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.109 0.963 . . . . 64.21 109.721 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.1 mt -75.3 137.7 41.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.71 0.291 . . . . 71.3 110.512 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 6.6 mtpm? -67.82 -28.37 67.51 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.807 -0.633 . . . . 74.2 112.269 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.0 23.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.919 -0.582 . . . . 74.51 113.736 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -116.98 156.38 27.56 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.734 0.767 . . . . 71.4 110.228 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.14 149.81 14.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.429 0.692 . . . . 73.03 111.489 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 39.4 p -106.71 126.04 51.78 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.866 0.466 . . . . 53.53 110.498 172.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.56 110.99 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.526 0.73 . . . . 45.02 110.428 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 25.2 m -85.41 103.23 14.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.338 0.255 . . . . 54.52 111.071 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 63.7 m-85 -82.69 162.15 21.9 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.1 110.742 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.1 -40.19 62.88 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.62 -0.718 . . . . 61.34 110.929 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 26.7 m-20 -109.92 134.37 20.69 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.923 0.489 . . . . 75.24 112.049 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.09 -42.75 51.8 Favored 'Trans proline' 0 CA--C 1.581 2.837 0 C-N-CA 122.932 2.421 . . . . 72.23 116.199 168.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 59.6 Cg_endo -68.38 -24.12 37.33 Favored 'Trans proline' 0 C--N 1.398 3.157 0 CA-C-N 122.237 1.835 . . . . 73.24 112.713 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -71.3 -43.27 67.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.487 0.66 . . . . 55.4 109.787 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.93 -42.37 90.19 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.334 -0.848 . . . . 34.52 111.342 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -62.82 -43.36 99.0 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.78 0.832 . . . . 70.32 110.707 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.99 89.43 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.847 -0.615 . . . . 73.1 111.492 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.45 70.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.075 0.55 . . . . 73.51 112.003 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 95' ' ' VAL . 62.4 mt -68.4 -60.07 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.207 0.203 . . . . 72.02 110.478 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.37 -25.95 64.69 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.198 0.599 . . . . 73.51 111.871 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -82.68 -62.48 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.567 0.347 . . . . 74.41 111.811 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 95' ' ' VAL . 79.0 m-85 -80.52 -15.52 56.48 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.955 1.095 . . . . 73.01 113.955 -168.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.14 106.72 3.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.48 -0.563 . . . . 55.24 109.48 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.56 35.39 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 115.338 -0.847 . . . . 73.42 114.218 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -83.29 -177.04 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.466 0.633 . . . . 65.34 111.743 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -121.03 120.44 35.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.857 . . . . 73.43 109.843 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 93' ' ' ILE . 86.2 t80 -68.52 -69.5 0.32 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.097 0.559 . . . . 74.52 111.082 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.9 t -133.62 69.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.939 0.896 . . . . 70.35 109.167 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.87 -2.95 38.95 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.122 -0.945 . . . . 51.35 114.193 -172.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -115.87 125.89 28.22 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 124.262 1.025 . . . . 65.01 111.03 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.4 130.18 29.3 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.096 2.531 . . . . 74.45 112.742 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' PHE . 30.5 pt -116.4 144.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 121.908 0.861 . . . . 75.45 112.702 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -114.2 121.36 43.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.947 -1.501 . . . . 73.45 106.947 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 80' ' ' ILE . 25.8 t -113.85 138.71 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.258 0.551 . . . . 71.51 110.692 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.5 p -148.88 179.41 7.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.03 1.332 . . . . 64.05 109.481 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -78.37 145.1 35.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 118.526 0.603 . . . . 73.54 111.592 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.37 113.48 24.79 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.563 1.467 0 C-N-CA 123.153 0.581 . . . . 64.45 111.724 -176.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 120.713 0.292 . . . . 73.02 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -102.98 130.51 50.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.391 0.676 . . . . 64.41 109.509 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.22 138.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.23 0.612 . . . . 72.22 111.958 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -94.56 117.21 29.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.106 0.479 . . . . 75.03 110.469 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 95' ' ' VAL . 12.5 t -113.39 138.81 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.466 1.106 . . . . 75.3 110.279 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.95 162.57 22.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.343 1.057 . . . . 72.32 110.11 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.14 65.51 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 114.506 0.562 . . . . 70.23 114.506 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 25' ' ' VAL . 81.9 mt -72.34 -36.03 68.72 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.067 0.947 . . . . 73.43 111.879 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.27 158.07 11.68 Favored Glycine 0 N--CA 1.476 1.352 0 C-N-CA 123.219 0.438 . . . . 64.51 112.556 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.86 -19.43 61.96 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.015 0.908 . . . . 62.32 112.719 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -89.53 7.29 37.03 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.029 0.932 . . . . 75.43 111.323 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 21' ' ' LEU . 9.9 p -69.72 134.32 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.354 0.662 . . . . 62.14 112.444 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.0 p -120.4 163.05 18.48 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.016 -0.427 . . . . 65.23 110.007 171.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 51' ' ' ILE . 80.5 mt -57.83 -42.4 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 123.917 0.887 . . . . 74.54 111.5 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.41 -30.04 65.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.474 0.71 . . . . 74.41 111.776 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -45.85 81.53 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.783 0.433 . . . . 55.34 110.877 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' THR . 21.5 t -64.88 -40.84 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 121.19 0.519 . . . . 50.04 110.225 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.58 88.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.34 -0.846 . . . . 53.43 111.744 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.88 -40.33 97.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.027 0.931 . . . . 71.22 111.582 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.31 -48.19 44.03 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.379 -0.828 . . . . 75.1 110.89 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.38 -19.57 35.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.548 1.314 . . . . 72.52 114.548 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.44 -16.61 63.81 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.835 1.05 . . . . 72.34 113.835 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -61.41 -29.18 69.77 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.089 0.555 . . . . 74.44 111.772 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.17 -42.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.057 0.943 . . . . 74.32 111.189 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.62 171.67 42.81 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 116.358 -0.383 . . . . 45.45 113.04 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.84 123.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.826 -0.435 . . . . 73.25 109.826 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.4 mt -93.97 129.76 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.99 0.916 . . . . 61.42 108.796 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.0 mtpt -51.04 140.51 15.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 64.14 112.311 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 56.0 m -128.45 121.81 29.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.181 -0.918 . . . . 62.04 109.829 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -57.63 119.57 6.83 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.208 1.003 . . . . 65.44 110.565 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -76.09 -16.94 59.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.704 0.802 . . . . 72.31 112.839 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -82.08 -52.29 7.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.649 0.379 . . . . 64.43 110.803 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -80.46 -46.62 15.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.25 0.62 . . . . 64.52 111.587 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.31 15.65 40.44 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.979 -0.555 . . . . 71.52 112.633 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -107.87 148.84 38.16 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.24 1.016 . . . . 54.4 111.827 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -67.75 149.88 78.82 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.409 2.073 . . . . 73.52 112.182 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.504 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 49.4 mtt -81.94 94.34 7.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.619 0.723 . . . . 75.43 109.67 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.7 mt -145.88 117.56 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.501 1.121 . . . . 62.34 108.693 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 78.9 m-20 -96.88 109.38 22.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.67 -0.493 . . . . 73.43 109.67 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.01 150.19 39.04 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.554 0.534 . . . . 74.22 109.856 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 46.9 m-85 -107.65 132.28 53.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.275 0.63 . . . . 75.14 109.952 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -133.99 142.88 47.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.725 0.81 . . . . 73.21 110.042 -174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -76.67 114.83 15.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.798 0.439 . . . . 74.14 109.827 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -71.72 -8.03 51.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.293 0.637 . . . . 64.22 112.471 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.35 -56.27 4.46 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.392 0.677 . . . . 54.05 110.888 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 p -96.93 -21.13 17.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.733 0.813 . . . . 53.21 112.556 -173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 12.64 83.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 120.056 -0.302 . . . . 71.33 113.751 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -97.22 147.89 23.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.47 0.708 . . . . 75.2 111.588 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.81 138.32 56.05 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.103 0.561 . . . . 70.21 111.541 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -77.47 -17.23 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.342 0.657 . . . . 72.32 111.579 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.08 24.34 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.333 0.396 . . . . 62.21 112.33 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 46.8 mt-10 -135.25 153.05 52.05 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.916 0.886 . . . . 50.1 109.74 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.33 156.27 23.69 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.471 0.545 . . . . 55.01 112.471 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 69.5 p -113.87 118.57 34.57 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 122.745 0.418 . . . . 61.32 110.676 171.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.52 107.96 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.888 0.875 . . . . 75.11 111.025 -170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -83.82 102.65 12.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.716 0.407 . . . . 75.31 111.521 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 53.3 m-85 -79.81 149.86 30.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.403 0.681 . . . . 71.52 110.686 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.03 -32.75 57.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.395 0.678 . . . . 73.21 110.573 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.77 127.39 37.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.15 0.58 . . . . 72.31 110.473 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.31 -48.36 18.92 Favored 'Trans proline' 0 CA--C 1.581 2.874 0 C-N-CA 122.602 2.201 . . . . 73.12 115.532 170.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.85 -19.32 27.34 Favored 'Trans proline' 0 C--N 1.398 3.149 0 CA-C-N 122.2 1.821 . . . . 75.31 113.609 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -69.37 -33.67 73.41 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.222 0.609 . . . . 72.21 111.211 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.29 56.01 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.925 -0.579 . . . . 64.33 111.466 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.585 0.754 . . . . 71.31 111.092 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.78 94.21 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.102 0.561 . . . . 71.2 111.796 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.53 67.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 74.1 112.699 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.491 HG12 HG12 ' A' ' 95' ' ' VAL . 82.2 mt -66.86 -58.38 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 120.899 0.381 . . . . 74.24 110.054 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.99 -27.79 69.11 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.434 -0.803 . . . . 72.4 112.166 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -81.5 -62.3 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.612 0.365 . . . . 71.42 111.344 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' HD11 ' A' ' 93' ' ' ILE . 66.8 m-85 -79.51 -11.73 59.89 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.282 1.215 . . . . 70.25 114.282 -168.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.42 111.06 1.86 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 118.508 0.595 . . . . 74.32 110.362 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.57 60.0 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 115.128 0.811 . . . . 53.15 115.128 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.3 mmtt -86.74 161.56 18.33 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 118.43 1.115 . . . . 71.21 111.105 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -99.23 119.92 38.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 75.24 111.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -84.21 -77.69 0.26 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.903 0.481 . . . . 72.53 110.222 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -118.13 75.48 1.01 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.46 0.704 . . . . 73.4 110.078 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.21 1.03 59.21 Favored Glycine 0 CA--C 1.54 1.652 0 N-CA-C 115.061 0.784 . . . . 75.21 115.061 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -132.9 138.01 30.92 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.483 0.713 . . . . 74.51 110.983 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.96 140.6 55.33 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.695 2.264 . . . . 70.01 111.975 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 83' ' ' PHE . 19.6 pt -110.38 152.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.223 0.609 . . . . 71.21 111.707 -171.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -118.18 114.76 23.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.461 0.704 . . . . 62.33 109.567 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 18' ' ' VAL . 15.9 t -109.22 133.45 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.606 0.362 . . . . 75.03 110.244 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.2 t -145.42 -178.67 6.2 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.455 1.102 . . . . 53.2 109.494 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -76.84 134.9 38.91 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.858 -0.526 . . . . 72.34 110.815 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 86.53 6.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.852 0.461 . . . . 72.12 110.548 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.221 1.008 . . . . 73.31 110.951 -178.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.533 0.568 . . . . 72.0 112.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -93.87 132.08 38.64 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.051 0.54 . . . . 65.03 110.774 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 29.1 pt -113.23 147.92 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.64 . . . . 71.53 111.263 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -108.84 115.63 30.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.56 0.744 . . . . 75.54 110.426 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 t -111.75 143.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.831 0.852 . . . . 71.24 110.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.79 155.11 47.24 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.011 0.925 . . . . 72.41 111.484 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.72 24.64 37.93 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 114.367 0.507 . . . . 53.23 114.367 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.7 -16.28 51.75 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.934 0.894 . . . . 74.2 112.837 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.99 158.65 29.35 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 120.947 0.193 . . . . 73.04 113.444 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.91 -5.25 55.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.482 0.713 . . . . 74.21 112.857 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.18 18.74 19.05 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.818 0.847 . . . . 74.15 111.257 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.24 144.61 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.276 0.631 . . . . 71.25 112.318 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -124.09 154.62 39.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.196 0.598 . . . . 65.31 111.103 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.3 mt -55.45 -39.26 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.893 0.877 . . . . 74.34 110.881 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.055 0.942 . . . . 74.0 111.843 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -72.22 -40.91 67.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.513 0.325 . . . . 73.23 111.223 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.07 -42.08 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.082 0.468 . . . . 62.33 110.171 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.47 91.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.521 0.729 . . . . 73.32 111.808 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.96 -33.03 74.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.5 0.72 . . . . 72.35 110.764 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -71.04 -55.48 8.18 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.052 0.941 . . . . 74.12 111.085 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -81.51 -19.3 42.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.477 1.288 . . . . 73.12 114.477 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -61.35 -26.21 67.66 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.695 0.998 . . . . 74.12 113.695 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -61.72 -24.34 66.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.374 0.669 . . . . 72.01 112.323 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.9 mm -83.13 -50.95 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.992 0.917 . . . . 75.15 111.344 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 75' ' ' SER . . . -161.73 168.61 36.93 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.683 -0.69 . . . . 45.55 113.674 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.65 110.41 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.384 0.674 . . . . 74.55 110.669 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.1 mt -80.9 131.84 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 108.444 -0.947 . . . . 73.44 108.444 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.46 124.96 14.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.261 0.624 . . . . 73.21 111.085 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 30.6 m -113.43 120.15 40.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.643 -0.708 . . . . 74.44 110.487 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -60.93 108.77 0.91 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.59 -27.59 62.27 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.398 0.679 . . . . 71.33 111.994 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -62.16 -50.17 72.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.716 0.806 . . . . 65.2 111.48 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -86.51 -40.27 15.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.383 0.673 . . . . 72.53 111.077 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 1.62 50.12 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.861 -0.609 . . . . 54.03 112.718 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -104.89 151.52 39.42 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 124.134 0.974 . . . . 64.32 112.444 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 72.9 Cg_endo -72.18 155.48 56.46 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.761 2.307 . . . . 51.33 112.712 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.7 mtt -83.77 95.17 8.34 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.47 0.652 . . . . 73.14 109.962 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.6 mt -142.59 124.49 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.442 1.097 . . . . 70.23 109.117 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 15.3 m120 -106.18 109.84 21.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.883 0.473 . . . . 74.51 110.085 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 66' ' ' ALA . 88.5 mt -83.63 124.92 31.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.684 0.794 . . . . 60.25 109.601 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 94.0 m-85 -83.02 125.77 31.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.917 0.487 . . . . 75.23 111.149 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 9.9 m -112.23 142.16 45.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.783 0.833 . . . . 75.42 109.845 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.7 129.7 37.52 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.924 0.489 . . . . 75.31 110.454 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -70.59 -27.86 64.43 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.3 1.04 . . . . 73.31 112.384 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -85.86 -50.57 7.02 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.318 0.647 . . . . 63.42 112.025 -175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.5 p -83.16 -30.8 27.54 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.566 0.746 . . . . 72.4 112.111 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.28 9.69 85.66 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 116.229 -0.441 . . . . 70.12 113.872 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -109.41 154.75 22.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.224 0.61 . . . . 54.12 110.966 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 mt -62.18 136.47 57.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.421 0.688 . . . . 73.51 111.921 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -73.34 -12.74 60.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.797 0.839 . . . . 74.3 111.918 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.65 42.44 21.58 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.827 -0.509 . . . . 44.24 111.827 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 50.6 mt-10 -131.81 147.93 52.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.915 0.886 . . . . 74.21 109.722 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -153.18 139.46 18.48 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.196 0.443 . . . . 73.11 112.196 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.8 p -101.25 119.5 38.85 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.844 -0.428 . . . . 75.24 109.844 169.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.3 t -109.24 108.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.631 0.772 . . . . 74.52 110.383 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 66.2 m -81.02 104.93 11.85 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.6 0.36 . . . . 65.41 111.117 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -82.1 157.56 24.04 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.94 0.496 . . . . 73.33 110.463 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.44 -37.66 60.21 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.999 0.52 . . . . 75.4 110.027 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -111.91 122.25 37.49 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.918 0.887 . . . . 63.45 110.261 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.53 -34.63 73.34 Favored 'Trans proline' 0 CA--C 1.583 2.939 0 C-N-CA 122.554 2.17 . . . . 75.31 116.565 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.61 -30.41 79.06 Favored 'Trans proline' 0 C--N 1.397 3.114 0 CA-C-N 122.687 1.995 . . . . 74.02 113.209 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.404 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 36.7 m -73.77 -35.74 65.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.038 0.446 . . . . 64.32 110.503 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.29 -50.09 74.42 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.434 -0.803 . . . . 62.02 111.285 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.25 -40.94 98.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.503 0.721 . . . . 61.14 111.161 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.34 98.99 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.965 -0.562 . . . . 64.24 111.813 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.44 75.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.447 0.699 . . . . 55.1 112.145 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 95' ' ' VAL . 69.7 mt -66.81 -56.95 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.599 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.44 -31.01 67.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.644 0.778 . . . . 73.13 111.876 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -80.55 -58.21 3.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.78 0.832 . . . . 72.45 111.993 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -85.24 -10.19 56.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.382 1.253 . . . . 73.23 114.382 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.08 119.28 11.75 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 118.575 0.625 . . . . 75.2 110.45 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.02 1.85 84.34 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.456 -0.793 . . . . 54.21 114.45 -175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.94 173.26 8.59 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 117.623 0.711 . . . . 71.11 110.793 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.33 122.95 48.03 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.105 -0.372 . . . . 71.22 111.718 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -92.99 -67.44 0.86 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.621 0.769 . . . . 74.33 110.028 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -112.95 50.09 0.9 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.695 0.798 . . . . 63.03 109.886 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 115.456 -0.793 . . . . 73.21 113.678 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -122.32 130.23 24.77 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.355 1.062 . . . . 63.23 110.387 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.2 94.0 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.53 2.153 . . . . 74.22 111.804 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.2 pt -71.33 155.34 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.977 0.911 . . . . 75.33 112.506 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -118.82 122.16 41.73 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.188 -1.042 . . . . 71.51 108.188 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.587 HG12 HG12 ' A' ' 80' ' ' ILE . 11.2 t -109.29 133.08 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.196 0.522 . . . . 73.45 110.002 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -133.05 -178.03 4.78 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.148 1.379 . . . . 44.0 109.019 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 32.7 m-85 -90.67 151.2 21.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 122.097 -0.377 . . . . 70.22 110.736 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.18 82.87 2.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.554 0.741 . . . . 51.53 109.216 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 115.695 -0.684 . . . . 53.34 112.34 -172.188 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 CA--C 1.551 0.988 0 CA-C-O 120.508 0.194 . . . . 72.34 111.229 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -108.65 126.21 52.73 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.615 0.766 . . . . 73.33 110.142 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.8 pt -105.5 157.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.681 0.792 . . . . 74.01 110.842 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -116.72 115.11 25.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.447 0.699 . . . . 74.43 110.095 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -104.98 145.02 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 124.401 1.08 . . . . 75.02 110.184 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.44 157.57 36.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.361 1.064 . . . . 73.35 110.056 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.12 41.7 92.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 115.233 0.853 . . . . 74.32 115.233 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.408 HD23 HG21 ' A' ' 93' ' ' ILE . 41.4 mt -81.82 -32.51 31.21 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.162 0.985 . . . . 61.21 111.639 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.76 161.26 11.7 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-N 116.182 -0.463 . . . . 65.54 112.619 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.48 -5.86 57.98 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.296 0.638 . . . . 73.2 112.064 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -94.54 14.0 22.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.506 0.723 . . . . 63.22 111.381 173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 p -75.42 138.53 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.421 0.688 . . . . 53.15 112.444 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.6 p -131.33 148.76 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.531 0.732 . . . . 54.44 110.947 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 51' ' ' ILE . 69.7 mt -51.66 -49.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.942 1.297 . . . . 65.24 112.893 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.91 -32.27 73.68 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 122.904 0.482 . . . . 71.41 111.935 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -74.37 -39.13 62.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.413 0.685 . . . . 73.24 111.536 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 42.7 t -63.97 -43.04 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 73.33 109.86 173.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.9 95.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.874 -1.057 . . . . 54.41 111.616 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 -34.17 77.67 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.634 0.773 . . . . 74.44 111.883 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.16 -53.51 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.881 0.472 . . . . 62.54 111.189 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 35.7 m-85 -77.87 -16.19 58.45 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.222 1.193 . . . . 75.3 114.222 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.19 -18.64 65.48 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.054 1.131 . . . . 61.41 114.054 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.02 -30.99 68.42 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.324 0.65 . . . . 75.22 111.914 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.59 -48.78 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.022 0.929 . . . . 70.42 110.896 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.7 173.18 40.59 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.426 -0.806 . . . . 50.14 112.695 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.88 127.83 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 122.989 0.516 . . . . 62.42 110.735 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.0 mt -97.54 134.79 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.637 0.775 . . . . 73.35 109.089 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 59.2 mtpt -62.22 155.64 24.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.457 0.703 . . . . 73.12 112.02 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 84.8 m -137.15 122.12 18.94 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.328 -0.851 . . . . 64.22 110.467 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -61.21 114.7 3.3 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.575 1.15 . . . . 43.25 109.47 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.26 -11.24 59.8 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.835 0.854 . . . . 72.24 112.878 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -83.4 -52.2 6.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.103 0.561 . . . . 73.41 110.598 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -79.67 -31.88 41.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.443 0.697 . . . . 71.22 111.691 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.2 81.58 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 116.008 -0.542 . . . . 42.55 112.964 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -104.92 149.86 38.04 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.42 1.088 . . . . 71.41 111.304 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.0 Cg_endo -63.65 146.73 92.72 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.369 2.046 . . . . 61.1 111.534 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 61.0 mtt -75.65 94.0 3.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.54 0.686 . . . . 60.4 109.471 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 27' ' ' ILE . 77.7 mt -144.08 127.89 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.85 1.26 . . . . 72.02 108.533 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 19.2 m120 -108.02 110.31 21.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.715 -0.476 . . . . 71.31 109.715 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.951 0.782 . . . . 41.43 109.343 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 67' ' ' THR . 79.7 m-85 -74.99 120.44 20.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.232 0.613 . . . . 73.4 111.134 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 m -100.57 140.02 35.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.693 0.797 . . . . 65.33 108.956 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.59 124.36 23.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.593 0.757 . . . . 60.43 110.848 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -64.72 -24.9 67.71 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.633 0.773 . . . . 63.43 112.978 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.44 -53.65 3.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.404 0.682 . . . . 74.2 111.604 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.1 p -84.18 -22.86 30.8 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.366 0.667 . . . . 74.42 112.65 -173.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 8.12 74.1 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.262 0.465 . . . . 64.42 114.262 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.61 149.53 21.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.073 0.949 . . . . 64.41 111.233 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.25 125.72 24.44 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 117.94 0.336 . . . . 72.03 110.485 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -72.51 -21.97 61.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.994 0.518 . . . . 71.3 112.31 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 22.05 66.54 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.183 -0.367 . . . . 74.44 112.183 -170.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -115.08 143.13 45.68 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.24 -1.022 . . . . 53.51 108.24 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -151.73 159.3 44.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.705 0.402 . . . . 61.35 111.915 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 p -114.65 120.72 41.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.606 0.362 . . . . 64.42 111.24 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.29 111.84 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.099 0.559 . . . . 61.32 110.534 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -88.86 105.62 17.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.413 0.685 . . . . 75.12 111.413 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 51.5 m-85 -80.81 161.14 24.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.863 0.865 . . . . 62.11 110.765 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.32 -33.93 65.41 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.592 0.757 . . . . 75.53 110.943 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.18 132.07 22.92 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.776 0.83 . . . . 64.25 111.189 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.46 -43.29 45.29 Favored 'Trans proline' 0 CA--C 1.584 2.991 0 C-N-CA 122.779 2.319 . . . . 74.23 115.288 165.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.99 -27.72 66.2 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 122.311 1.861 . . . . 71.22 113.563 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 m -69.57 -38.72 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.545 0.688 . . . . 74.01 109.838 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -60.03 -54.78 41.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.628 -1.169 . . . . 65.3 110.861 175.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -59.22 -45.39 91.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.836 0.854 . . . . 75.4 111.404 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.94 99.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.946 -0.57 . . . . 64.12 111.686 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.05 -32.82 73.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.539 0.525 . . . . 72.23 111.992 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 95' ' ' VAL . 79.0 mt -65.33 -62.21 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.545 0.338 . . . . 64.5 111.049 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.65 -25.09 66.06 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 112.443 0.534 . . . . 75.31 112.443 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -78.26 -59.04 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.729 0.412 . . . . 74.12 110.945 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -86.62 -9.34 56.26 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.602 1.334 . . . . 71.32 114.602 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.87 106.28 1.85 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.732 0.696 . . . . 74.12 110.39 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.45 56.29 Favored Glycine 0 CA--C 1.546 1.985 0 CA-C-N 116.122 -0.49 . . . . 74.04 114.232 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 29.4 mmmt -80.71 175.9 10.27 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 123.761 0.824 . . . . 74.24 112.219 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.64 115.8 26.36 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.654 0.382 . . . . 74.21 111.383 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -82.55 -75.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.186 0.595 . . . . 75.21 111.042 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 t -98.93 37.31 1.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.324 0.65 . . . . 73.52 110.03 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.64 11.66 85.09 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 115.986 -0.552 . . . . 71.24 112.139 -164.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.1 121.6 41.24 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.433 1.093 . . . . 62.34 110.608 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.8 Cg_exo -66.21 96.2 0.33 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.937 2.425 . . . . 73.21 112.561 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.408 HG21 HD23 ' A' ' 21' ' ' LEU . 29.5 pt -74.86 153.58 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.181 0.992 . . . . 74.43 113.32 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -119.75 114.77 22.66 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.965 -1.124 . . . . 71.2 107.965 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 18' ' ' VAL . 19.2 t -109.39 137.28 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 120.974 0.416 . . . . 54.4 110.297 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -142.51 -174.52 4.16 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.336 1.454 . . . . 61.3 109.042 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -79.96 146.4 32.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.907 -0.495 . . . . 70.14 110.69 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.4 107.97 18.26 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.939 -0.393 . . . . 74.13 109.939 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.489 1.486 0 C-N-CA 123.385 0.674 . . . . 75.41 112.068 -176.744 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 120.475 0.179 . . . . 64.51 110.681 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 m -97.83 126.59 43.28 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.277 0.56 . . . . 71.35 110.059 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.2 pt -105.72 153.93 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.789 0.836 . . . . 73.33 111.13 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -109.41 125.19 52.14 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.144 0.578 . . . . 74.12 109.903 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 HG22 ' A' ' 95' ' ' VAL . 18.7 t -121.31 141.75 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.081 0.952 . . . . 71.44 109.901 -175.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -127.87 159.87 33.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.902 0.881 . . . . 74.24 110.539 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.5 32.12 35.1 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 114.303 0.481 . . . . 53.34 114.303 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.81 -28.38 24.53 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.888 0.875 . . . . 63.4 112.225 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.96 161.49 18.71 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 123.068 0.366 . . . . 70.01 113.496 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -83.78 -2.0 55.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.712 1.004 . . . . 54.53 113.712 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -121.19 21.6 11.15 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.395 0.678 . . . . 53.33 111.902 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.77 142.77 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.291 0.636 . . . . 62.15 111.528 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 30' ' ' VAL . 44.0 p -122.62 153.83 38.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.451 -0.78 . . . . 74.55 110.618 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 93.4 mt -53.46 -40.29 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.146 0.978 . . . . 70.11 111.43 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.29 -44.18 95.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.787 0.835 . . . . 63.23 111.53 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -68.94 -41.26 78.31 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.182 0.593 . . . . 71.05 111.844 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 26' ' ' THR . 56.9 t -64.6 -43.42 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.119 0.568 . . . . 75.42 110.021 176.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.95 88.75 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.368 -0.833 . . . . 61.33 111.753 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.42 -30.46 70.22 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.268 0.627 . . . . 62.14 111.6 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -72.61 -55.07 7.43 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.792 0.837 . . . . 73.33 111.64 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 77.2 m-85 -81.1 -20.01 42.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.413 1.264 . . . . 73.41 114.413 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -58.0 -29.93 65.66 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.659 0.985 . . . . 75.22 113.659 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.01 -26.49 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.815 0.846 . . . . 50.04 112.598 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 mm -79.27 -47.6 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.751 0.821 . . . . 55.32 110.758 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 173.99 43.03 Favored Glycine 0 N--CA 1.463 0.497 0 CA-C-N 116.211 -0.449 . . . . 62.52 113.295 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.28 124.3 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.379 0.671 . . . . 52.24 110.837 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 65.3 mt -94.37 131.86 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.062 0.945 . . . . 44.45 109.625 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.1 mtpt -54.91 144.99 21.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.464 0.706 . . . . 71.31 111.743 173.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.4 m -126.19 128.21 46.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.265 -0.879 . . . . 71.03 109.794 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -69.56 114.36 7.71 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.797 0.839 . . . . 74.31 108.942 172.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.96 -15.27 60.19 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.42 0.688 . . . . 74.21 112.254 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.73 -36.19 65.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.985 0.514 . . . . 73.51 111.371 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -98.67 -41.77 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.485 0.714 . . . . 73.1 111.761 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.58 8.07 54.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 115.754 -0.657 . . . . 33.13 112.812 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.9 150.16 52.43 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 123.931 0.892 . . . . 72.2 112.377 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.4 Cg_endo -61.48 145.03 98.34 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.434 2.756 . . . . 72.34 112.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.518 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 60.8 mtt -74.81 97.11 3.21 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.384 0.612 . . . . 74.21 109.789 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 99.2 mt -142.0 124.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.545 1.138 . . . . 75.34 109.043 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.9 m-20 -101.85 107.43 18.61 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.031 -0.729 . . . . 65.4 109.031 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.22 134.93 36.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.722 -0.844 . . . . 54.14 108.722 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HE2' HG23 ' A' ' 67' ' ' THR . 96.5 m-85 -100.01 122.15 42.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.008 0.523 . . . . 71.2 110.379 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 m -102.54 141.44 35.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.261 1.024 . . . . 74.4 110.218 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.8 133.82 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.165 0.586 . . . . 74.35 109.584 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -87.31 -24.86 24.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.554 0.742 . . . . 72.22 112.798 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.09 -34.98 14.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.271 0.471 . . . . 74.21 112.271 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -90.75 -53.52 4.37 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.074 0.398 . . . . 71.43 112.074 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.63 -0.88 34.33 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 116.025 -0.534 . . . . 51.32 113.587 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.06 152.93 19.72 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.451 0.7 . . . . 64.15 109.75 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 84.3 mt -62.66 140.55 58.7 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.097 0.475 . . . . 70.21 111.788 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -74.11 -13.08 60.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.969 0.908 . . . . 54.32 112.186 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 29.53 39.69 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.453 -0.34 . . . . 55.31 112.531 -174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.5 145.07 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.971 0.909 . . . . 73.22 109.631 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 147.0 18.41 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.963 0.411 . . . . 73.12 111.919 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 75.0 p -102.01 133.6 46.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.9 -0.591 . . . . 44.11 110.159 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -115.1 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 123.139 0.576 . . . . 64.42 110.339 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 43.9 m -85.14 102.3 13.16 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.849 0.46 . . . . 64.53 110.961 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.7 m-85 -79.45 155.51 28.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.116 0.566 . . . . 71.34 110.747 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.71 -35.76 72.89 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.216 0.606 . . . . 74.24 110.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -114.38 129.01 25.27 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.379 0.671 . . . . 52.14 111.337 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.51 -37.99 83.02 Favored 'Trans proline' 0 CA--C 1.587 3.15 0 C-N-CA 123.108 2.538 . . . . 70.21 116.42 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.64 -24.87 40.98 Favored 'Trans proline' 0 C--N 1.396 3.047 0 CA-C-N 122.611 1.968 . . . . 72.32 112.857 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -74.59 -38.12 62.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.647 0.779 . . . . 63.2 110.21 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.42 -51.34 70.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.779 -1.1 . . . . 44.12 110.692 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -65.17 -39.15 92.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.32 -0.854 . . . . 75.15 111.299 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.0 94.71 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.396 0.278 . . . . 70.23 111.285 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.404 0.682 . . . . 70.0 112.222 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 77' ' ' LYS . 89.6 mt -65.61 -63.46 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.018 0.527 . . . . 65.1 110.674 173.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.05 -25.59 67.77 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.403 -0.817 . . . . 74.14 111.698 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -82.12 -60.23 2.29 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.871 0.469 . . . . 74.14 111.691 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.728 1.381 . . . . 73.34 114.728 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.33 119.87 12.31 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.678 0.672 . . . . 71.34 109.74 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 5.35 75.97 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 114.86 0.704 . . . . 42.22 114.86 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 74.9 mmtt -88.29 -167.8 2.0 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 117.939 0.869 . . . . 75.22 111.525 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.13 118.06 23.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.098 0.959 . . . . 72.24 109.981 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 93' ' ' ILE . 67.9 t80 -78.8 -75.11 0.25 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.67 0.271 . . . . 72.44 110.578 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.4 t -122.84 61.21 1.01 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.778 0.799 . . . . 64.34 110.077 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.41 2.49 84.39 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.011 -0.995 . . . . 73.04 114.076 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -117.18 136.51 23.41 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.998 0.919 . . . . 74.31 110.186 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 73.5 Cg_endo -73.07 116.7 4.81 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.555 2.17 . . . . 74.41 112.153 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' A' ' 88' ' ' PHE . 41.1 pt -92.56 153.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.574 0.749 . . . . 73.53 113.005 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -123.95 119.09 28.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.215 1.006 . . . . 74.3 108.869 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG13 ' A' ' 18' ' ' VAL . 32.6 t -112.85 134.12 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.598 0.759 . . . . 71.11 110.136 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.7 p -146.42 -176.33 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.742 1.217 . . . . 72.43 109.182 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -76.46 145.33 39.31 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.01 0.823 . . . . 73.44 110.778 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.25 93.28 8.16 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.04 0.448 . . . . 54.2 110.793 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 124.036 0.935 . . . . 70.05 111.261 178.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.552 1.027 0 CA-C-O 121.025 0.44 . . . . 62.05 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -96.44 132.48 41.94 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.579 0.752 . . . . 75.11 110.625 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 76' ' ' ALA . 35.7 pt -114.96 152.87 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.879 0.872 . . . . 40.03 111.061 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -107.7 116.45 31.96 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.158 0.583 . . . . 72.41 110.175 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 95' ' ' VAL . 19.1 t -109.6 134.15 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.212 1.005 . . . . 75.33 110.436 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -120.12 157.19 29.53 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.063 0.945 . . . . 43.22 110.562 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.88 29.55 28.58 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-O 121.241 0.356 . . . . 70.54 113.941 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.28 -13.46 46.62 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.153 0.981 . . . . 72.2 112.957 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.0 54.25 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 114.878 0.711 . . . . 71.21 114.878 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.88 -24.61 48.43 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.813 0.845 . . . . 65.12 112.34 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.67 20.02 9.16 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.416 0.686 . . . . 62.11 111.787 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG13 HD13 ' A' ' 62' ' ' LEU . 5.0 p -80.14 131.73 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.056 0.543 . . . . 52.31 112.0 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.4 p -129.39 154.67 46.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.406 0.682 . . . . 75.14 110.292 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB ' ' A' ' 51' ' ' ILE . 90.4 mt -50.24 -52.51 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 124.283 1.033 . . . . 65.12 111.815 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.42 -37.03 84.28 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.568 -0.742 . . . . 73.31 111.462 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -69.9 -36.89 75.77 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.107 0.41 . . . . 62.33 112.107 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.5 -37.9 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 120.977 0.417 . . . . 55.23 110.052 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.74 66.06 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.924 0.49 . . . . 54.12 111.594 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.34 -32.52 58.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.101 0.96 . . . . 74.31 111.434 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.14 -49.69 41.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.659 0.784 . . . . 74.01 110.392 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.458 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 14.2 m-85 -82.89 -16.96 45.45 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.556 1.317 . . . . 54.15 114.556 -173.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -66.98 -17.36 64.88 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.471 0.915 . . . . 73.35 113.471 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.55 -24.75 63.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.039 0.536 . . . . 73.42 111.99 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.06 -41.08 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.304 1.042 . . . . 75.02 111.375 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.11 176.45 47.19 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.454 -0.403 . . . . 74.23 113.993 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.4 126.18 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.899 0.479 . . . . 55.14 109.911 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 81.0 mt -94.64 141.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.712 0.805 . . . . 75.42 109.038 173.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 26.4 mtpp -59.78 144.67 47.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.366 0.666 . . . . 72.12 111.658 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.3 m -128.4 120.27 26.62 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.489 -0.778 . . . . 71.53 109.569 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.16 114.72 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.017 -0.734 . . . . 73.22 109.017 171.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.35 -28.28 66.08 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.277 1.031 . . . . 73.42 111.777 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 11.5 mmpt? -71.61 -45.87 60.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.29 0.636 . . . . 75.24 111.74 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 p -82.98 -35.17 26.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.134 0.574 . . . . 74.15 111.453 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.17 17.79 64.15 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.78 -0.645 . . . . 72.22 112.404 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -120.98 152.07 55.94 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.407 1.083 . . . . 74.44 111.79 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HG2' HG22 ' A' ' 27' ' ' ILE . 18.8 Cg_endo -61.42 146.77 96.83 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.739 2.292 . . . . 74.22 113.141 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.539 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 52.7 mtt -82.75 97.1 8.41 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.016 0.526 . . . . 73.23 110.646 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 27' ' ' ILE . 70.2 mt -144.27 117.48 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.183 0.993 . . . . 71.44 109.132 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.56 110.37 22.19 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.589 -0.523 . . . . 74.45 109.589 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.7 mt -82.31 115.35 21.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.46 0.704 . . . . 74.41 110.196 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -69.89 117.33 11.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.061 0.545 . . . . 60.43 110.247 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 m -122.39 139.13 54.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.02 0.928 . . . . 62.01 109.59 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -73.32 135.63 44.38 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.175 0.59 . . . . 61.13 111.62 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 15.4 ptm180 -64.64 -38.33 90.65 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.459 1.103 . . . . 75.22 112.674 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 45.4 mt-10 -80.77 -55.52 4.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.252 0.621 . . . . 75.21 111.839 -171.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.2 p -84.07 -31.19 25.47 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.3 0.64 . . . . 45.1 111.794 -174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 8.71 86.26 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 116.438 -0.346 . . . . 64.0 113.22 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -92.8 152.32 19.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.213 0.605 . . . . 73.34 111.937 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 25' ' ' VAL . 82.8 mt -65.76 126.46 28.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.767 0.827 . . . . 44.14 110.784 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -71.27 -12.97 61.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.051 0.94 . . . . 62.24 112.201 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.97 37.73 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 112.014 -0.435 . . . . 72.24 112.014 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.47 149.27 49.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.998 . . . . 73.22 109.552 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.32 159.13 25.1 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.492 0.553 . . . . 72.11 112.492 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.5 p -115.24 114.08 24.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.132 0.573 . . . . 71.42 111.323 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 51' ' ' ILE . 21.6 t -99.81 108.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.432 1.093 . . . . 75.51 110.608 -173.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 42.2 m -84.98 101.76 12.63 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.686 0.394 . . . . 72.5 111.28 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 38.0 m-85 -77.37 156.13 31.44 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.097 0.559 . . . . 73.21 111.18 171.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.08 -27.41 54.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.298 0.639 . . . . 63.15 111.296 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 22.8 m-20 -120.0 131.38 24.43 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 122.942 0.497 . . . . 70.44 111.743 171.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.37 -38.3 82.37 Favored 'Trans proline' 0 CA--C 1.583 2.93 0 C-N-CA 122.879 2.386 . . . . 64.13 115.68 168.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 37.7 Cg_endo -64.98 -25.42 59.35 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 123.03 2.118 . . . . 62.04 113.404 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.9 m -76.17 -37.24 58.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.072 0.549 . . . . 73.01 110.19 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.69 -48.29 81.46 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.324 0.649 . . . . 71.3 111.015 174.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.42 -47.5 85.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.279 1.032 . . . . 75.21 110.799 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.34 93.88 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.604 -0.725 . . . . 64.44 111.738 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -31.76 73.07 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.321 0.648 . . . . 63.21 112.507 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' VAL . 72.5 mt -63.62 -61.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.264 0.226 . . . . 74.45 110.599 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.19 -24.7 65.0 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.421 0.688 . . . . 62.42 112.643 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -80.21 -59.38 2.73 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.44 0.696 . . . . 74.15 111.617 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB3' HD11 ' A' ' 93' ' ' ILE . 77.1 m-85 -85.84 -10.83 54.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.194 1.183 . . . . 74.12 114.194 -170.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.68 115.14 4.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.376 0.534 . . . . 61.31 110.258 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.53 68.58 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 114.921 0.728 . . . . 71.15 114.921 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.5 mmtt -94.08 141.46 28.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.111 0.956 . . . . 73.33 111.935 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.04 116.13 19.14 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.599 0.759 . . . . 74.32 112.179 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -90.9 -78.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.582 0.753 . . . . 54.33 110.949 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -109.26 54.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.968 0.889 . . . . 73.51 110.248 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.64 8.48 87.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.983 -1.008 . . . . 74.21 113.83 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -133.59 136.82 27.54 Favored Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 123.811 0.845 . . . . 74.01 109.878 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.73 116.55 4.76 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.739 2.293 . . . . 75.53 110.893 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 83' ' ' PHE . 16.0 pt -80.45 154.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.735 0.642 . . . . 72.51 112.735 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -119.22 112.3 19.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.369 -0.975 . . . . 72.23 108.369 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 18' ' ' VAL . 14.2 t -107.0 137.02 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.019 0.528 . . . . 72.05 110.876 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.6 m -141.51 179.86 6.56 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.997 1.319 . . . . 63.41 109.207 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.31 149.59 31.72 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.807 0.731 . . . . 73.23 110.399 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.89 85.92 7.03 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.024 0.44 . . . . 73.42 110.117 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.571 1.752 0 C-N-CA 123.209 0.604 . . . . 71.43 112.135 -176.114 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.461 0.172 . . . . 62.05 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -106.18 125.67 51.28 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.843 0.857 . . . . 71.21 110.747 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 76' ' ' ALA . 30.3 pt -114.9 148.28 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.906 0.882 . . . . 64.23 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -102.14 120.05 39.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.433 0.693 . . . . 73.11 109.607 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 95' ' ' VAL . 14.4 t -114.9 136.13 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.186 0.994 . . . . 72.23 110.388 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -124.37 162.69 23.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.131 0.973 . . . . 72.23 110.234 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.92 25.93 61.33 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 114.203 0.441 . . . . 61.04 114.203 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 93' ' ' ILE . 77.0 mt -79.03 -22.38 45.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.352 1.061 . . . . 54.21 112.013 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.87 167.66 42.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.083 0.373 . . . . 63.22 113.227 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.62 -19.56 59.13 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 112.84 0.682 . . . . 72.44 112.84 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -86.91 6.93 29.51 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.145 0.578 . . . . 74.52 111.934 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.2 138.03 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 124.198 0.999 . . . . 42.42 112.242 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -129.44 151.15 50.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.756 -0.59 . . . . 73.4 110.061 171.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 51' ' ' ILE . 67.9 mt -49.19 -51.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.631 1.172 . . . . 64.44 112.773 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.68 -21.1 55.85 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.788 0.662 . . . . 72.53 112.788 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -73.85 -37.55 64.75 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 117.962 0.346 . . . . 65.53 111.099 171.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.23 -41.48 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 121.309 0.576 . . . . 70.31 109.7 171.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.5 92.42 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.341 -0.845 . . . . 75.2 111.596 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.93 -38.11 89.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.273 0.629 . . . . 72.24 111.047 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -67.27 -55.9 12.06 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.816 0.846 . . . . 63.44 111.385 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.446 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 49.0 m-85 -77.94 -21.64 50.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.584 1.327 . . . . 64.31 114.584 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.87 -20.04 66.09 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.983 1.105 . . . . 74.5 113.983 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -60.56 -22.28 63.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 122.985 0.514 . . . . 73.22 112.15 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.08 -42.45 14.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 124.507 1.123 . . . . 73.14 111.424 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 172.67 45.12 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.981 -0.554 . . . . 73.3 113.229 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.96 125.47 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.557 0.743 . . . . 60.14 110.719 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 73.2 mt -95.56 130.5 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.943 0.897 . . . . 54.22 109.388 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.596 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.5 mtpt -51.04 153.99 1.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.743 0.817 . . . . 71.24 112.91 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 52.4 m -140.07 125.46 18.97 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.613 0.765 . . . . 71.23 110.508 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.414 HD21 ' HB2' ' A' ' 45' ' ' LYS . 40.1 t30 -64.13 123.87 20.19 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.448 0.699 . . . . 72.13 111.038 174.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -71.78 -24.02 61.67 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.109 0.563 . . . . 63.1 112.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HB2' HD21 ' A' ' 43' ' ' ASN . 34.0 mmtp -69.8 -54.36 13.99 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.807 0.443 . . . . 65.1 111.577 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -84.57 -45.3 12.7 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.196 0.598 . . . . 74.44 111.668 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.97 37.8 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.973 -0.558 . . . . 65.02 112.523 -170.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -106.13 148.94 37.52 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.128 0.971 . . . . 75.53 111.28 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 51.0 Cg_endo -68.14 145.97 68.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.598 2.198 . . . . 72.14 111.922 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.596 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 58.2 mtt -77.16 94.79 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.563 0.697 . . . . 71.2 110.026 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.587 ' HB ' HG23 ' A' ' 27' ' ' ILE . 86.7 mt -144.54 116.44 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.053 1.341 . . . . 74.51 108.49 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -99.03 109.43 22.18 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.155 -0.683 . . . . 51.34 109.155 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.84 120.8 26.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.138 0.575 . . . . 73.11 110.06 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.568 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 57.0 m-85 -73.12 104.35 4.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.011 0.524 . . . . 74.34 110.994 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -86.76 160.0 18.95 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.953 0.901 . . . . 62.14 110.065 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -93.45 155.1 17.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.953 0.901 . . . . 73.35 111.962 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.16 -35.64 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.658 0.783 . . . . 73.44 112.834 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.431 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.4 pt-20 -88.97 -37.99 14.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.93 -0.482 . . . . 63.23 111.952 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 58' ' ' GLU . 31.5 p -94.01 -33.38 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 112.522 0.564 . . . . 73.42 112.522 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.86 6.26 89.16 Favored Glycine 0 CA--C 1.541 1.656 0 N-CA-C 114.223 0.449 . . . . 33.14 114.223 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -102.1 171.72 7.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.689 0.796 . . . . 62.15 110.78 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.37 130.26 39.33 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.972 -0.455 . . . . 61.2 111.71 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -74.78 -18.96 60.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.432 0.693 . . . . 61.31 112.548 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 35.1 12.61 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 116.362 -0.381 . . . . 50.43 113.064 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 41.3 mt-10 -127.94 154.06 45.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.2 1.0 . . . . 70.42 109.042 173.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.57 164.08 24.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.093 0.557 . . . . 71.14 111.822 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.0 p -120.26 128.92 53.77 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.998 -0.546 . . . . 71.4 109.98 168.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.42 111.8 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.575 0.75 . . . . 63.44 110.809 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 m -89.21 102.71 15.37 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.936 0.494 . . . . 72.03 111.724 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 34.7 m-85 -78.09 156.85 29.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.707 0.803 . . . . 71.41 110.625 168.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.1 -32.31 44.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.045 0.538 . . . . 72.21 110.434 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 4.0 m-20 -106.08 122.58 41.82 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.59 0.756 . . . . 62.23 110.453 174.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 72' ' ' ASP . 5.3 Cg_endo -49.94 -42.45 44.97 Favored 'Trans proline' 0 CA--C 1.586 3.108 0 C-N-CA 122.918 2.412 . . . . 61.53 115.789 167.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.32 -25.5 71.57 Favored 'Trans proline' 0 C--N 1.406 3.564 0 CA-C-N 122.602 1.965 . . . . 52.43 113.117 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.8 m -76.59 -37.22 56.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.436 0.694 . . . . 73.14 110.917 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.07 -47.21 78.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.082 0.553 . . . . 53.51 111.151 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.58 -42.96 95.29 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.562 0.745 . . . . 75.21 111.282 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.42 89.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.285 -0.416 . . . . 71.41 111.847 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.65 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.398 0.679 . . . . 73.35 112.385 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 95' ' ' VAL . 72.4 mt -64.24 -63.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.528 0.331 . . . . 53.44 110.326 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.3 -31.76 63.97 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.556 0.742 . . . . 74.14 112.45 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -78.49 -56.98 4.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.499 0.72 . . . . 74.21 111.921 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 93' ' ' ILE . 62.7 m-85 -88.13 -4.1 58.8 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.242 1.201 . . . . 63.35 114.242 -171.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.7 110.81 1.4 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.634 0.374 . . . . 61.41 111.097 173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.33 80.16 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.049 0.779 . . . . 24.15 115.049 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.44 144.01 26.64 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 117.811 0.805 . . . . 64.4 112.023 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.64 116.91 19.33 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.983 0.513 . . . . 74.22 112.335 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.11 -66.88 0.82 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.485 0.714 . . . . 75.43 109.996 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.3 t -107.44 38.76 2.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.295 1.038 . . . . 74.44 110.001 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.56 23.86 74.22 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.003 -0.544 . . . . 74.22 113.253 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 28.0 p-10 -138.71 123.69 11.9 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 124.06 0.944 . . . . 73.23 110.53 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 21.9 Cg_exo -64.31 112.52 1.93 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.156 2.571 . . . . 53.32 112.771 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.44 HG21 HD23 ' A' ' 21' ' ' LEU . 18.6 pt -83.55 161.24 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 72.35 112.031 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -113.85 123.06 48.88 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.259 1.023 . . . . 71.25 108.298 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 18' ' ' VAL . 14.6 t -115.06 134.72 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 121.042 0.449 . . . . 75.43 110.508 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -142.72 179.77 6.8 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.173 1.389 . . . . 61.32 109.227 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -76.79 151.9 35.78 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.206 0.457 . . . . 52.23 110.488 172.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.72 95.89 8.62 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.69 0.396 . . . . 64.51 110.2 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 123.49 0.716 . . . . 72.44 111.275 -178.271 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 112.195 0.442 . . . . 74.34 112.195 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.7 m -126.82 129.56 48.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.889 0.876 . . . . 70.34 109.647 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.419 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.7 pt -116.21 146.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.823 0.849 . . . . 74.14 111.335 -175.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -102.28 123.92 46.94 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.457 0.703 . . . . 74.22 109.871 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 21.6 t -119.12 138.85 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.667 1.187 . . . . 71.4 110.073 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -126.1 155.41 41.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.03 0.932 . . . . 72.3 110.808 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.84 1.36 70.68 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 114.184 0.434 . . . . 74.31 114.184 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 93' ' ' ILE . 85.3 mt -61.36 -12.32 13.6 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.123 1.157 . . . . 65.51 114.123 -178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.25 173.28 49.57 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.389 0.515 . . . . 54.13 114.389 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 8.3 pt-20 -71.68 -22.46 61.66 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.286 -0.538 . . . . 74.33 111.27 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.52 8.93 22.76 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.714 0.806 . . . . 71.21 112.305 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.72 137.1 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.275 0 C-N-CA 122.722 0.409 . . . . 75.3 111.965 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' VAL . 57.9 p -131.22 148.01 52.66 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.428 0.691 . . . . 75.5 109.81 171.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.67 HG23 ' HB ' ' A' ' 51' ' ' ILE . 83.7 mt -51.5 -47.08 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.463 1.105 . . . . 75.51 112.983 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -69.7 -29.31 66.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.18 0.592 . . . . 73.45 111.916 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -74.1 -36.11 64.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.688 0.395 . . . . 73.14 111.369 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 26' ' ' THR . 44.4 t -65.36 -40.68 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.366 0.603 . . . . 65.01 109.663 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.98 85.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.017 -0.992 . . . . 63.12 111.735 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.74 -26.39 63.35 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.073 0.549 . . . . 75.33 111.664 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -75.29 -57.08 4.11 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.399 0.68 . . . . 72.44 111.578 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.432 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 30.9 m-85 -75.25 -19.47 59.71 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.593 1.331 . . . . 72.14 114.593 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.73 -21.51 66.44 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.69 0.996 . . . . 75.42 113.69 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -57.26 -25.03 58.54 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.112 0.565 . . . . 73.35 112.353 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.8 mm -84.57 -56.33 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.945 0.898 . . . . 71.03 110.72 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.33 166.99 33.87 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 116.024 -0.535 . . . . 73.21 113.38 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.23 114.16 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.019 0.528 . . . . 73.32 110.051 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 76.5 mt -79.7 136.31 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 109.186 -0.672 . . . . 60.44 109.186 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.6 mtpt -53.51 142.11 23.29 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.151 0.58 . . . . 61.15 112.0 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.7 m -132.88 119.84 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.629 -0.714 . . . . 71.04 110.079 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.73 123.33 16.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.335 1.054 . . . . 75.01 110.222 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -73.94 -30.75 62.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.656 0.782 . . . . 72.44 111.791 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.53 -51.54 49.67 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.151 0.581 . . . . 71.13 111.546 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 p -83.67 -45.67 13.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.469 0.708 . . . . 65.11 111.359 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.21 17.04 35.74 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 115.623 -0.717 . . . . 70.12 112.421 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -104.9 156.9 35.31 Favored Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 124.235 1.014 . . . . 74.4 112.801 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.78 142.2 19.98 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.956 2.437 . . . . 72.41 112.8 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.617 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.0 mtt -79.04 94.32 5.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.263 0.554 . . . . 74.34 110.305 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 27' ' ' ILE . 72.1 mt -146.77 115.88 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.525 1.13 . . . . 65.22 108.906 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.17 111.15 23.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 74.45 110.116 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.61 143.36 34.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.147 0.579 . . . . 72.13 110.164 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -100.38 126.09 46.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 73.34 109.848 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -115.2 142.45 46.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.065 0.946 . . . . 74.15 110.276 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -67.7 96.55 0.56 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.06 -0.718 . . . . 75.31 109.06 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -61.88 -24.1 66.72 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.593 0.757 . . . . 50.4 112.065 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.522 ' HG3' HG23 ' A' ' 59' ' ' THR . 10.9 pt-20 -71.69 -39.49 70.18 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.461 0.705 . . . . 71.11 111.903 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -103.49 -62.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.308 0.643 . . . . 75.24 111.478 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 -7.84 5.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.37 -0.377 . . . . 20.14 113.701 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -90.19 161.88 15.51 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.546 0.673 . . . . 62.44 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 59.6 mt -76.49 138.46 40.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.254 0.622 . . . . 74.32 111.649 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -73.32 -20.15 60.87 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.744 0.818 . . . . 74.45 111.787 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.79 33.85 20.4 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.739 -0.664 . . . . 71.3 112.719 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.88 148.97 52.29 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.917 0.887 . . . . 63.55 109.74 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.11 159.57 31.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.567 0.58 . . . . 70.21 112.567 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.6 p -114.9 117.57 31.05 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.068 0.547 . . . . 60.14 110.629 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.36 109.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.68 0.792 . . . . 73.21 110.385 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -86.94 101.61 13.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.021 0.528 . . . . 70.31 111.116 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 58.3 m-85 -77.59 157.28 30.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.722 0.809 . . . . 74.42 110.76 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.38 -35.99 58.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.225 0.61 . . . . 73.51 110.579 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -106.49 128.01 27.07 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.541 0.737 . . . . 65.13 110.821 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -52.29 -39.94 71.31 Favored 'Trans proline' 0 CA--C 1.582 2.883 0 C-N-CA 122.697 2.265 . . . . 61.23 115.764 166.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.25 -24.01 65.69 Favored 'Trans proline' 0 C--N 1.401 3.317 0 CA-C-N 122.297 1.856 . . . . 73.22 113.715 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.8 m -77.12 -38.06 52.88 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.109 0.564 . . . . 71.44 110.782 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -64.55 -43.8 92.81 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.428 0.632 . . . . 70.25 110.318 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -60.64 -48.02 83.64 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.146 1.378 . . . . 72.42 111.37 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.16 94.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.81 -0.632 . . . . 53.23 112.479 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.482 0.713 . . . . 74.23 112.387 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.484 HG12 HG12 ' A' ' 95' ' ' VAL . 92.2 mt -63.9 -60.53 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.115 0.566 . . . . 70.45 110.574 172.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.48 -31.68 66.23 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.409 -0.814 . . . . 75.44 111.576 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -80.06 -61.87 1.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.809 0.444 . . . . 70.22 111.933 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' HB2' HG21 ' A' ' 95' ' ' VAL . 71.3 m-85 -80.02 -10.46 59.77 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.618 0.97 . . . . 75.22 113.618 -170.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.4 104.26 2.23 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 109.541 -0.54 . . . . 72.01 109.541 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.55 42.41 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 115.546 -0.752 . . . . 62.32 114.017 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.2 mmtt -82.69 152.1 25.95 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.882 0.841 . . . . 75.01 110.073 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.95 124.1 35.81 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.429 0.529 . . . . 52.44 112.429 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -126.83 136.32 52.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.253 -1.018 . . . . 60.42 108.253 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 t 61.49 30.32 18.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.189 0.996 . . . . 71.4 111.609 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.26 29.0 54.83 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.478 -0.783 . . . . 53.0 115.041 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -161.41 145.29 9.8 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 117.305 0.553 . . . . 64.25 111.383 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.64 110.67 1.93 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.018 2.479 . . . . 74.15 113.438 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.431 HG21 HD23 ' A' ' 21' ' ' LEU . 34.4 pt -78.88 160.6 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.861 0.865 . . . . 74.21 112.223 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -118.18 128.19 54.47 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.463 1.105 . . . . 71.33 109.457 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 23.6 t -121.91 135.34 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 74.32 111.107 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.5 p -146.4 179.36 7.58 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.708 1.203 . . . . 60.14 109.022 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.27 154.4 37.47 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.969 0.804 . . . . 74.41 111.713 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.12 88.3 6.46 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.241 -0.652 . . . . 71.32 109.241 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.57 1.715 0 C-N-CA 123.451 0.7 . . . . 61.45 111.551 -174.712 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 CA--C 1.554 1.117 0 N-CA-C 111.88 0.326 . . . . 75.2 111.88 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -94.77 126.75 40.29 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.915 0.486 . . . . 74.43 110.187 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.5 pt -113.36 156.0 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.584 0.754 . . . . 63.55 111.291 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -116.3 125.42 52.13 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.329 0.651 . . . . 72.42 110.146 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.621 HG13 HG22 ' A' ' 95' ' ' VAL . 18.5 t -117.41 146.33 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.191 0.996 . . . . 74.14 110.363 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 27.6 mt-30 -124.7 163.62 21.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.684 1.193 . . . . 74.0 110.184 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.97 23.57 74.29 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 114.953 0.741 . . . . 60.21 114.953 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 18' ' ' VAL . 57.5 mt -76.19 -17.92 59.31 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.328 1.051 . . . . 74.34 111.958 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 177.29 49.54 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 114.71 0.644 . . . . 74.14 114.71 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 34.0 mt-10 -75.29 -14.66 60.52 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.664 0.786 . . . . 75.05 112.797 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -84.09 -8.97 58.96 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.336 0.654 . . . . 60.44 112.191 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.7 128.36 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 113.716 1.006 . . . . 74.12 113.716 -169.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.3 p -125.61 152.86 44.57 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.517 0.727 . . . . 72.52 110.289 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 51' ' ' ILE . 88.0 mt -52.91 -45.55 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.379 0.672 . . . . 70.04 111.593 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.64 -38.74 92.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.58 0.752 . . . . 74.43 111.777 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.3 t -71.5 -39.46 70.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.756 0.422 . . . . 72.34 111.707 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' THR . 61.9 t -65.32 -40.4 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.256 0.55 . . . . 65.54 110.014 176.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.22 -42.63 99.29 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.141 -0.936 . . . . 72.24 111.286 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.52 -30.65 67.46 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.143 0.577 . . . . 74.5 111.379 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.43 -53.7 7.76 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.692 0.797 . . . . 73.23 111.418 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.445 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.2 m-85 -79.04 -16.26 57.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.784 1.031 . . . . 64.35 113.784 -174.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.07 -29.77 67.57 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 113.09 0.774 . . . . 70.4 113.09 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -58.85 -25.09 62.94 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.796 0.838 . . . . 51.13 112.275 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.35 -45.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.253 1.021 . . . . 74.43 111.649 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -178.7 45.62 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 116.343 -0.39 . . . . 65.5 113.315 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.92 126.97 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.7 0.4 . . . . 71.11 110.123 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 80.4 mt -95.06 143.2 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.785 0.834 . . . . 51.3 108.852 170.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.611 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.7 mtpt -62.42 145.62 53.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.092 0.557 . . . . 74.12 111.504 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 41.5 m -125.67 123.91 39.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.106 0.962 . . . . 73.31 108.809 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -71.69 123.74 23.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.071 0.549 . . . . 71.21 109.664 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -18.28 45.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.209 0.604 . . . . 72.44 111.722 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.26 -52.73 44.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.932 0.493 . . . . 72.25 110.801 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -83.38 -41.53 18.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.388 0.675 . . . . 70.42 111.022 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.63 16.0 44.27 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 115.881 -0.599 . . . . 70.41 112.512 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -121.91 153.33 60.48 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.184 0.994 . . . . 61.31 111.972 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 41.1 Cg_endo -64.22 140.92 73.43 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.256 2.637 . . . . 55.42 112.855 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.611 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.8 mtt -73.98 95.51 2.51 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.359 0.6 . . . . 74.02 109.809 -174.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 27' ' ' ILE . 80.4 mt -144.67 120.73 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.833 1.253 . . . . 73.33 108.614 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 m120 -101.45 110.15 22.1 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.902 -0.407 . . . . 71.41 109.902 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.86 141.52 32.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.524 0.73 . . . . 64.32 109.748 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.49 112.41 25.31 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.474 0.71 . . . . 75.3 110.267 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -97.52 141.61 30.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.614 0.766 . . . . 75.54 110.17 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.41 123.63 25.02 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.69 1.196 . . . . 73.33 109.995 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.38 -20.05 59.19 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.307 1.225 . . . . 73.41 114.307 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.1 pt-20 -93.76 -44.5 8.11 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.946 0.793 . . . . 60.13 112.199 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 58' ' ' GLU . 46.1 p -92.22 -35.35 13.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.896 0.478 . . . . 51.21 112.124 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.89 0.94 68.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 116.168 -0.469 . . . . 70.33 113.945 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.5 162.31 27.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.39 0.595 . . . . 74.41 110.532 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 78.3 mt -81.08 132.67 35.38 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.811 -0.555 . . . . 50.1 111.053 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.21 -19.35 64.75 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.799 0.84 . . . . 72.42 111.866 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.57 21.49 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.007 -0.542 . . . . 62.31 112.147 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.45 145.11 46.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.789 0.835 . . . . 71.44 109.405 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.22 150.63 22.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.783 0.66 . . . . 64.35 112.783 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 35.6 p -108.19 114.46 28.36 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.828 0.451 . . . . 70.34 111.045 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -102.66 108.96 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.953 0.901 . . . . 74.21 109.853 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.1 m -85.47 105.29 15.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.615 0.366 . . . . 73.41 110.52 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 49.4 m-85 -79.26 156.63 28.02 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.357 0.663 . . . . 54.13 111.161 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.04 57.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.36 0.664 . . . . 55.42 110.737 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.27 129.52 23.81 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.276 0.63 . . . . 61.2 110.712 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.59 -42.02 43.57 Favored 'Trans proline' 0 CA--C 1.58 2.778 0 C-N-CA 123.005 2.47 . . . . 65.54 116.55 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.63 -21.17 52.52 Favored 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 122.301 1.857 . . . . 74.55 113.362 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 m -72.64 -38.17 67.78 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.309 0.644 . . . . 72.51 109.669 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.48 -53.24 57.66 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 51.14 111.276 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -61.99 -41.75 98.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.64 0.776 . . . . 62.44 111.151 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.49 98.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.892 0.477 . . . . 72.2 111.778 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.151 0.58 . . . . 63.21 112.457 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 77' ' ' LYS . 86.0 mt -66.64 -56.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.074 0.55 . . . . 70.44 110.928 174.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.5 -27.33 69.2 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.524 0.729 . . . . 64.14 112.043 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -82.36 -60.39 2.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.057 0.543 . . . . 74.33 111.553 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -82.69 -13.57 56.16 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.23 1.196 . . . . 65.43 114.23 -168.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.57 104.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 119.194 0.906 . . . . 73.43 110.203 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.05 6.04 49.24 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.514 -0.766 . . . . 62.35 114.56 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.25 -176.45 5.11 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 117.856 0.828 . . . . 75.5 111.556 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.81 122.36 42.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.121 0.569 . . . . 61.22 110.664 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -75.32 -70.9 0.39 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.842 -0.429 . . . . 70.33 109.842 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.8 t -115.17 50.06 1.01 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.783 0.833 . . . . 74.51 109.391 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.53 73.59 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 115.408 -0.815 . . . . 64.5 113.501 -174.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -131.37 128.76 22.1 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.904 0.881 . . . . 72.43 111.806 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 113.82 2.3 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.369 2.713 . . . . 74.53 113.551 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.1 pt -97.19 151.86 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.552 0.741 . . . . 73.5 112.777 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 75.1 mmtt -113.6 112.09 22.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.326 1.05 . . . . 75.15 109.384 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG13 ' A' ' 18' ' ' VAL . 21.7 t -112.5 128.3 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.99 -0.444 . . . . 74.44 110.809 -174.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.0 m -140.48 -179.66 6.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.161 1.384 . . . . 63.13 109.495 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -73.87 151.49 40.46 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.179 0.445 . . . . 73.44 110.63 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 91.1 6.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.214 0.531 . . . . 64.04 109.939 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.567 1.611 0 C-N-CA 123.931 0.892 . . . . 74.44 110.782 -177.283 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 70' ' ' PHE . 35.5 p30 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 112.274 0.472 . . . . 51.41 112.274 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -103.19 130.0 50.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.282 0.633 . . . . 72.22 110.672 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.9 pt -119.26 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.64 0.776 . . . . 62.42 112.13 -176.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -95.81 119.63 34.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.25 0.548 . . . . 70.34 110.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -112.83 141.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.782 1.233 . . . . 75.41 109.814 -177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -126.44 155.22 42.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.229 1.011 . . . . 62.4 110.439 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.88 32.3 50.24 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.222 0.849 . . . . 75.45 115.222 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 93' ' ' ILE . 69.8 mt -74.89 -33.33 62.03 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.214 1.006 . . . . 74.11 112.114 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.64 153.86 10.34 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-N 116.185 -0.461 . . . . 72.3 112.868 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.43 -8.36 54.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.992 0.917 . . . . 64.42 112.191 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -117.22 81.8 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.032 0.933 . . . . 71.51 109.302 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 21' ' ' LEU . 7.3 p -134.17 131.75 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.2 1.0 . . . . 71.04 110.525 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 12.8 p -116.26 155.71 27.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.655 -0.653 . . . . 73.05 109.992 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 68.1 mt -52.19 -47.67 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.118 0.967 . . . . 74.34 112.187 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.88 -21.45 54.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.995 0.518 . . . . 74.2 112.374 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -68.83 -44.34 73.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.842 0.457 . . . . 74.42 110.144 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 24.6 t -67.14 -38.97 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 115.912 -0.586 . . . . 72.04 110.364 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.71 79.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.756 -0.656 . . . . 72.54 111.738 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.55 -31.57 72.84 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.222 0.609 . . . . 63.22 111.358 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -73.58 -54.29 8.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.035 0.534 . . . . 74.43 111.152 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -78.02 -22.92 48.5 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.087 1.143 . . . . 74.44 114.087 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.52 -22.61 66.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.055 0.761 . . . . 72.42 113.055 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.46 -27.32 65.98 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.796 0.438 . . . . 73.21 111.628 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.06 -45.07 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 75.52 110.988 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.22 44.3 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 116.094 -0.503 . . . . 62.42 113.625 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.23 127.39 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.71 0.804 . . . . 74.53 110.683 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.3 mt -98.85 132.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 73.14 109.904 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.0 mtpp -55.03 142.75 29.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 64.24 111.501 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 67.7 m -139.85 131.32 26.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.811 -0.632 . . . . 73.02 111.07 -176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -68.86 114.68 7.4 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.261 1.025 . . . . 73.3 109.357 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -74.37 -21.57 59.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.391 0.676 . . . . 70.3 112.184 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -73.52 -49.13 28.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.653 0.381 . . . . 74.53 111.499 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -86.16 -45.19 11.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.039 0.536 . . . . 65.21 111.867 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.84 -4.34 39.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.893 -0.594 . . . . 63.51 112.802 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -93.19 140.15 23.22 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.33 0.652 . . . . 73.23 112.471 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 53.8 Cg_endo -70.44 149.67 62.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.745 2.297 . . . . 54.14 111.842 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.421 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.6 mtt -75.57 94.35 3.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.351 0.596 . . . . 71.11 109.52 -176.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.1 mt -145.06 121.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 70.12 107.713 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.7 m-80 -104.57 107.85 19.0 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 110.019 -0.363 . . . . 72.23 110.019 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.7 mt -81.04 126.17 31.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.057 0.943 . . . . 51.31 110.002 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 96.4 m-85 -86.43 134.73 33.67 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.251 0.62 . . . . 74.53 111.085 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -129.78 144.91 51.53 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.64 1.176 . . . . 72.2 109.746 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -68.97 113.02 5.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.116 0.566 . . . . 72.04 110.12 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -65.88 -24.61 66.9 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.994 0.917 . . . . 72.31 111.44 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.54 ' HG3' HG23 ' A' ' 59' ' ' THR . 11.6 pt-20 -77.37 -45.34 26.3 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.546 0.738 . . . . 64.43 112.011 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 58' ' ' GLU . 37.4 p -94.28 -56.74 2.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.068 0.461 . . . . 73.33 111.698 -176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.24 4.7 23.67 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-N 116.053 -0.521 . . . . 41.34 113.574 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.87 151.38 20.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.293 0.637 . . . . 73.12 111.577 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.76 135.2 52.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.452 0.701 . . . . 65.32 111.158 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.67 -16.17 60.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.374 0.67 . . . . 75.4 111.708 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.62 39.65 24.79 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.766 -0.534 . . . . 75.23 111.766 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 57.9 mt-10 -133.56 148.97 51.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.427 0.691 . . . . 72.45 109.33 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -157.86 151.53 23.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.791 0.436 . . . . 72.31 111.688 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 54' ' ' TYR . 32.6 p -112.44 113.43 25.61 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.649 0.38 . . . . 74.23 110.65 172.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.0 t -101.5 110.62 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.571 1.148 . . . . 60.04 110.174 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 20.0 m -89.95 101.39 14.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.245 0.618 . . . . 74.23 111.216 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 41.9 m-85 -76.56 157.42 32.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.383 0.673 . . . . 63.1 110.557 170.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.06 -32.37 67.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.777 0.431 . . . . 53.32 110.017 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -113.79 123.67 32.5 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.548 0.739 . . . . 72.33 111.474 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.74 -33.53 80.86 Favored 'Trans proline' 0 CA--C 1.583 2.941 0 C-N-CA 122.841 2.36 . . . . 62.51 116.497 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.2 -26.41 42.32 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 122.871 2.061 . . . . 64.4 113.209 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.5 m -77.69 -35.44 52.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.531 0.733 . . . . 53.33 110.485 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.63 -49.89 73.4 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 121.4 0.619 . . . . 65.21 110.594 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -65.58 -37.52 86.88 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.676 1.191 . . . . 71.25 111.426 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.82 90.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.1 0.56 . . . . 51.31 112.045 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.64 68.46 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.303 0.641 . . . . 75.25 112.444 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 95' ' ' VAL . 81.4 mt -64.47 -64.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.883 0.473 . . . . 71.24 110.464 171.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.06 -25.01 65.02 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.355 0.662 . . . . 75.23 112.389 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -82.32 -62.14 1.7 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.993 0.517 . . . . 73.24 111.67 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.12 -9.76 59.42 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.032 1.123 . . . . 74.22 114.032 -170.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -66.13 118.13 9.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 120.943 0.401 . . . . 61.32 110.389 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.88 79.66 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.335 -0.703 . . . . 44.2 114.511 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.4 mmtt -93.95 167.89 11.31 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 118.44 1.12 . . . . 73.31 111.386 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -96.89 118.92 34.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.214 0.605 . . . . 70.02 111.487 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 89.7 t80 -72.47 -74.17 0.17 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.001 0.521 . . . . 64.03 110.414 172.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -116.95 60.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.039 0.936 . . . . 73.45 108.847 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.22 13.27 67.11 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 115.272 -0.876 . . . . 60.45 113.46 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -118.19 120.48 32.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.247 1.019 . . . . 65.21 111.017 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.28 96.0 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.953 2.435 . . . . 73.14 113.158 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 21' ' ' LEU . 28.1 pt -76.04 156.07 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.78 0.832 . . . . 45.02 113.225 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -122.98 116.56 23.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.366 1.066 . . . . 74.5 108.942 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 18' ' ' VAL . 20.0 t -110.92 136.36 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.67 0.388 . . . . 73.33 110.731 -174.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.8 p -148.67 -176.52 5.36 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.982 1.313 . . . . 75.42 109.657 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -76.6 146.67 38.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.741 0.701 . . . . 72.3 111.758 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.84 100.15 11.5 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.984 0.514 . . . . 34.23 110.242 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.811 0.844 . . . . 43.23 111.416 -174.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.409 0.147 . . . . 73.03 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.94 -171.31 27.88 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 116.614 -0.267 . . . . 74.12 113.242 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -68.4 -40.58 81.25 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.659 0.784 . . . . 73.34 111.462 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -100.45 135.75 41.41 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.838 0.855 . . . . 73.33 109.487 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -117.35 140.32 49.72 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.654 0.782 . . . . 62.31 110.665 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -69.88 -41.01 75.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.541 0.736 . . . . 74.03 112.683 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -80.52 77.07 7.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.285 -0.635 . . . . 73.11 109.285 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.06 -31.08 71.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.956 0.902 . . . . 71.3 112.153 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -64.47 144.14 57.4 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.57 0.348 . . . . 73.53 110.535 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -84.98 121.37 27.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 122.573 0.349 . . . . 64.52 110.644 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.7 t -79.63 91.91 5.29 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.319 0.648 . . . . 71.12 111.009 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.4 98.81 6.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.782 -0.644 . . . . 64.0 109.467 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.465 HD21 ' HB3' ' A' ' 97' ' ' PHE . 8.5 p30 -90.28 174.35 7.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.909 0.484 . . . . 71.24 111.146 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -99.46 12.35 36.63 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.452 0.538 . . . . 53.23 112.452 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.2 m -130.83 128.63 41.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.884 0.474 . . . . 62.12 110.099 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 80' ' ' ILE . 22.4 pt -115.39 147.31 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.423 . . . . 71.44 111.551 -174.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -105.71 108.86 20.6 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.256 0.622 . . . . 73.54 110.045 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 95' ' ' VAL . 17.5 t -101.19 138.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.064 0.946 . . . . 73.14 110.09 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 65' ' ' GLU . 23.4 mt-30 -119.44 155.11 32.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.728 0.811 . . . . 55.23 111.34 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.04 44.74 76.41 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.511 0.965 . . . . 52.34 115.511 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 93' ' ' ILE . 49.3 mt -81.22 -30.75 34.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.462 1.105 . . . . 65.52 110.781 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.07 160.53 11.39 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.138 -0.483 . . . . 44.41 113.815 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.55 -23.01 64.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.492 0.717 . . . . 73.42 110.364 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -107.15 88.44 2.74 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.646 0.778 . . . . 52.34 108.995 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.37 136.7 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.888 0.875 . . . . 75.52 111.038 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.38 161.81 20.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.689 . . . . 64.35 110.43 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.57 HG23 ' HB ' ' A' ' 51' ' ' ILE . 76.1 mt -50.85 -47.35 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.173 0.989 . . . . 55.32 111.32 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -75.99 -23.99 55.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.333 0.653 . . . . 72.22 111.823 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -67.94 -46.4 71.56 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.658 0.383 . . . . 44.21 110.541 172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 30.8 t -64.6 -42.73 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.092 0.473 . . . . 54.31 110.27 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.62 96.16 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.542 -0.754 . . . . 74.21 112.637 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.19 -22.07 55.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.96 0.504 . . . . 71.33 111.449 -176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -79.58 -44.95 20.1 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.236 0.614 . . . . 75.24 111.364 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -83.14 -13.71 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.852 1.056 . . . . 64.43 113.852 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.71 -30.08 60.53 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.009 1.114 . . . . 65.01 114.009 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.28 -24.41 67.27 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.623 0.769 . . . . 63.51 112.606 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 79' ' ' ALA . 19.5 mm -82.41 -44.37 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.836 0.854 . . . . 72.53 111.372 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.88 179.64 48.66 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 116.406 -0.361 . . . . 63.43 113.67 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.64 125.09 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.497 0.719 . . . . 74.23 111.549 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.7 mt -94.0 138.38 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 70.13 108.781 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.591 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 27.1 mtpp -57.73 155.02 10.73 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.068 0.547 . . . . 41.22 111.73 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.8 m -145.5 125.38 13.5 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.273 0.629 . . . . 70.02 111.155 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.33 125.85 30.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.778 -0.823 . . . . 62.13 108.778 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.3 -21.66 25.62 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.643 0.608 . . . . 74.44 112.643 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -64.26 -43.21 95.56 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.305 0.642 . . . . 74.3 111.713 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -82.72 -42.93 17.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.576 0.75 . . . . 70.04 110.117 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.51 56.02 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.392 -0.822 . . . . 71.32 111.893 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -110.44 147.09 35.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.105 0.962 . . . . 62.33 111.63 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 33.7 Cg_endo -64.99 142.19 73.82 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.594 2.196 . . . . 73.13 110.835 173.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.591 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 61.3 mtt -72.79 94.31 1.78 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.716 0.77 . . . . 71.44 110.34 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 27' ' ' ILE . 66.4 mt -144.93 119.81 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.042 1.337 . . . . 72.1 108.264 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 24.5 m-80 -102.7 110.77 22.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.114 -0.699 . . . . 74.13 109.114 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.69 124.35 28.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.903 0.881 . . . . 74.23 109.92 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.2 m-85 -80.33 110.43 15.76 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.647 0.779 . . . . 72.23 110.814 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -96.86 143.02 28.16 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 43.3 109.864 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.08 144.44 40.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 73.45 111.266 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.87 -46.47 30.04 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.447 0.699 . . . . 74.23 112.175 -171.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.11 -42.69 15.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.539 0.57 . . . . 74.25 112.539 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.5 p -81.95 -30.03 31.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.06 5.06 84.57 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 114.015 0.366 . . . . 55.21 114.015 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -99.19 164.89 11.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.014 0.926 . . . . 74.14 110.531 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.02 131.47 45.11 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.973 0.509 . . . . 72.33 111.622 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -75.66 -21.71 57.42 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.194 0.598 . . . . 52.25 111.82 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.77 26.66 31.46 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 116.073 -0.512 . . . . 60.31 112.902 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 3.6 mp0 -116.72 154.47 30.56 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.543 -0.975 . . . . 75.34 109.755 172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -160.14 146.94 16.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.877 0.471 . . . . 61.15 111.513 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.9 p -104.16 117.89 35.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.973 -0.38 . . . . 63.41 109.973 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.93 108.08 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.621 0.769 . . . . 74.31 110.36 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 m -85.18 104.19 14.83 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.889 0.476 . . . . 72.12 110.821 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.4 m-85 -79.67 158.2 27.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.49 0.716 . . . . 74.12 110.788 169.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.64 -31.23 63.4 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.065 0.546 . . . . 71.35 111.349 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -118.73 134.17 23.56 Favored Pre-proline 0 N--CA 1.48 1.067 0 C-N-CA 123.053 0.541 . . . . 64.34 111.564 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.2 -34.9 99.02 Favored 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 122.523 2.149 . . . . 74.13 116.197 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.72 -29.35 77.19 Favored 'Trans proline' 0 C--N 1.399 3.187 0 CA-C-N 122.867 2.059 . . . . 53.55 113.079 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -74.68 -40.85 61.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.223 0.609 . . . . 52.4 110.396 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.86 84.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.541 -0.754 . . . . 72.05 111.098 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -64.34 -44.85 90.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.11 111.296 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.891 0.476 . . . . 61.11 111.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 37' ' ' ILE . . . -60.76 -34.21 74.11 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.407 0.683 . . . . 53.35 112.232 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 95' ' ' VAL . 71.9 mt -69.19 -54.98 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.831 0.452 . . . . 74.04 110.49 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.42 -33.1 69.3 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.768 0.827 . . . . 63.12 111.921 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -80.57 -56.46 4.15 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.691 0.796 . . . . 64.23 112.17 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' ILE . 61.7 m-85 -86.65 -11.64 50.73 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 114.457 1.28 . . . . 74.34 114.457 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -63.87 116.12 5.5 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.578 0.626 . . . . 72.33 110.322 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.73 5.55 74.23 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 114.871 0.708 . . . . 50.04 114.871 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.84 159.59 14.9 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 117.949 0.874 . . . . 70.5 111.767 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.41 115.79 27.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.64 0.376 . . . . 62.03 111.651 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 91.2 t80 -70.28 -56.34 7.0 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.997 0.919 . . . . 73.32 110.925 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -147.18 63.01 1.17 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.908 0.861 . . . . 62.43 109.151 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.37 0.28 66.25 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 115.093 -0.958 . . . . 75.4 113.692 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.13 121.28 36.9 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 51.42 110.7 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.8 98.98 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.736 2.291 . . . . 70.11 112.666 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.438 HG21 HD23 ' A' ' 21' ' ' LEU . 28.0 pt -71.22 148.19 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.591 0.96 . . . . 70.23 113.591 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -115.39 104.94 12.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.67 1.188 . . . . 54.32 108.416 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 18' ' ' VAL . 15.1 t -102.16 131.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.671 0.388 . . . . 73.13 110.137 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.3 p -136.55 178.65 6.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.503 1.121 . . . . 40.23 109.779 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.465 ' HB3' HD21 ' A' ' 13' ' ' ASN . 78.1 m-85 -80.9 145.13 31.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.681 0.392 . . . . 65.22 110.076 169.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.19 7.7 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.031 0.443 . . . . 74.34 109.983 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.573 1.84 0 C-N-CA 123.733 0.813 . . . . 65.34 110.835 -178.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 111.433 0.16 . . . . 61.2 111.433 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.58 76.01 0.53 Allowed Glycine 0 C--N 1.354 1.58 0 C-N-CA 122.895 0.283 . . . . 55.22 113.142 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -81.0 131.17 35.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.149 0.98 . . . . 74.41 111.383 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.15 -27.77 65.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.622 0.601 . . . . 74.34 112.622 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -73.89 141.73 46.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.38 0.511 . . . . 74.05 112.38 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -81.0 -19.7 43.42 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.568 0.747 . . . . 73.25 111.486 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -145.02 140.52 28.21 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 53.31 110.334 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -84.26 83.51 7.95 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.289 0.636 . . . . 61.11 110.785 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -89.49 130.94 35.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.739 0.816 . . . . 62.43 111.176 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.37 -33.82 76.58 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.748 0.419 . . . . 62.12 111.583 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 p -76.64 91.97 3.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.357 0.663 . . . . 64.25 110.869 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.42 110.46 4.15 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.045 -0.724 . . . . 75.12 109.045 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' A' ' 97' ' ' PHE . 57.0 t30 -58.86 121.85 12.15 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.455 0.702 . . . . 71.3 112.31 -170.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -97.17 -6.67 34.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.592 0.757 . . . . 53.34 111.767 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -101.25 130.18 47.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 64.55 109.917 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 43.4 pt -110.71 153.07 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.517 0.727 . . . . 70.22 110.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -111.08 128.46 55.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.147 0.579 . . . . 71.54 109.49 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 95' ' ' VAL . 10.7 t -121.11 141.34 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.775 0.83 . . . . 54.33 110.324 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -123.8 155.42 38.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.413 1.085 . . . . 73.21 110.169 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 23.19 63.23 Favored Glycine 0 N--CA 1.482 1.747 0 N-CA-C 114.713 0.645 . . . . 74.34 114.713 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 HG21 ' A' ' 93' ' ' ILE . 77.1 mt -64.52 -34.56 78.52 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.169 0.988 . . . . 73.04 111.885 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.25 21.9 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.154 -0.93 . . . . 53.31 111.119 -168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.92 -4.78 56.1 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 117.827 0.814 . . . . 75.22 112.636 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -94.01 17.56 12.14 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.233 0.613 . . . . 72.33 110.711 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 88' ' ' PHE . 8.2 p -75.83 140.49 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 124.159 0.984 . . . . 73.12 112.272 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' VAL . 50.1 p -125.05 158.46 33.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.357 0.663 . . . . 72.34 110.214 170.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.555 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.2 mt -59.57 -35.09 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.834 0.454 . . . . 72.12 110.777 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.27 -46.78 88.62 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.605 0.762 . . . . 73.34 111.388 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -61.83 -43.28 99.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.581 0.752 . . . . 62.02 111.767 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' THR . 48.1 t -66.13 -45.68 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 121.047 0.451 . . . . 75.25 110.64 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 35' ' ' LYS . . . -64.65 -33.98 77.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.677 -0.692 . . . . 43.05 111.996 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.23 -33.77 59.21 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.292 0.637 . . . . 71.53 111.644 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -74.56 -53.33 9.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 74.34 111.424 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 48.3 m-85 -78.68 -17.56 55.74 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 113.729 1.011 . . . . 72.31 113.729 -174.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 64.9 pttt -58.29 -28.71 65.24 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.528 0.936 . . . . 74.42 113.528 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.35 -22.88 63.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.552 0.741 . . . . 63.23 112.357 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mm -81.38 -41.13 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.097 0.959 . . . . 73.25 111.094 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.28 -171.64 44.75 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 116.014 -0.539 . . . . 71.52 113.184 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.97 127.11 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.063 0.545 . . . . 44.53 110.257 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.2 mt -94.56 137.02 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.148 0.979 . . . . 61.32 108.954 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.4 mtpt -59.03 146.37 38.57 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.548 0.69 . . . . 70.11 111.707 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 50.5 m -129.29 125.27 36.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.728 -1.124 . . . . 74.52 109.583 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -57.22 107.51 0.43 Allowed 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 109.082 -0.71 . . . . 53.34 109.082 170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.64 -19.4 65.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.018 0.927 . . . . 73.52 112.827 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -78.59 -48.6 14.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.449 0.699 . . . . 74.33 111.65 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -85.13 -38.54 18.93 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.229 0.612 . . . . 75.14 111.821 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.77 2.67 61.19 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 115.927 -0.579 . . . . 42.11 112.636 -172.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -99.1 144.2 27.79 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.053 0.941 . . . . 65.41 111.777 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 38.2 Cg_endo -66.11 139.64 56.53 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.852 2.368 . . . . 65.52 111.811 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.0 mtt -72.73 93.37 1.65 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.669 0.747 . . . . 73.25 109.586 -175.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.555 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -147.0 120.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.948 1.299 . . . . 74.51 108.602 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.55 110.55 22.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 110.027 -0.36 . . . . 71.22 110.027 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.34 129.22 34.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.854 0.862 . . . . 65.32 109.835 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 92.6 m-85 -89.13 117.32 28.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.487 0.715 . . . . 72.01 110.244 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 m -99.14 150.62 21.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.17 0.988 . . . . 74.34 110.196 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.25 132.27 35.82 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.585 0.754 . . . . 64.24 109.842 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -70.17 -32.67 70.73 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.662 0.785 . . . . 71.41 112.249 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.8 -52.68 5.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.64 0.776 . . . . 71.34 111.557 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.7 p -82.11 -30.31 31.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.53 0.732 . . . . 72.21 112.323 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.76 89.43 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.501 -0.318 . . . . 71.14 113.498 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -102.17 155.7 18.04 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.767 0.827 . . . . 72.1 109.808 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.42 136.57 57.97 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.914 0.486 . . . . 72.11 111.776 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -72.09 -15.28 62.0 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.278 0.631 . . . . 55.1 112.284 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.77 31.06 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.689 -0.564 . . . . 73.24 111.689 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 52.0 mt-10 -130.9 149.13 52.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.064 0.946 . . . . 75.33 109.566 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.71 154.25 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.748 0.647 . . . . 65.21 112.748 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 25.1 p -109.43 116.12 31.23 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.851 -0.613 . . . . 71.24 111.007 173.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.66 109.71 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 123.466 0.706 . . . . 75.5 110.113 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 69.2 m -83.52 102.84 12.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.693 0.397 . . . . 65.12 110.772 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 34' ' ' PHE . 56.3 m-85 -78.89 153.78 30.26 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.903 0.481 . . . . 72.04 110.842 170.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.05 -34.38 61.84 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.828 -0.624 . . . . 65.55 111.143 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -111.91 130.2 23.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.054 0.542 . . . . 63.31 111.032 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -49.84 -38.11 46.82 Favored 'Trans proline' 0 CA--C 1.583 2.936 0 C-N-CA 123.334 2.69 . . . . 72.5 116.305 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.37 -28.68 78.62 Favored 'Trans proline' 0 C--N 1.403 3.434 0 CA-C-N 122.477 1.92 . . . . 33.45 113.934 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 m -73.42 -39.45 65.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 74.34 110.038 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.87 79.94 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.474 0.71 . . . . 62.5 111.052 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -59.96 -51.42 69.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.242 1.017 . . . . 62.35 111.149 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.75 90.7 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.005 -0.543 . . . . 61.54 112.156 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.24 72.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.45 0.7 . . . . 61.32 112.506 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 95' ' ' VAL . 70.2 mt -63.29 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.03 0.532 . . . . 74.5 111.05 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.34 -30.05 69.28 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.347 -0.842 . . . . 65.44 111.985 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -79.06 -59.53 2.74 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.954 0.501 . . . . 73.04 111.675 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.606 ' HB3' HD11 ' A' ' 93' ' ' ILE . 27.4 m-85 -80.78 -10.55 59.72 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.965 1.098 . . . . 75.13 113.965 -171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -65.76 111.19 3.11 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.548 0.613 . . . . 72.1 109.992 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.27 1.4 60.95 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.794 -0.639 . . . . 63.21 114.307 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.7 mmtt -96.37 149.29 21.87 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.261 0.624 . . . . 74.32 111.036 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -87.52 128.06 35.24 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.083 -0.386 . . . . 71.1 111.376 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' HG21 ' A' ' 93' ' ' ILE . 53.8 t80 -81.75 -73.63 0.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.399 0.68 . . . . 60.12 110.603 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 t -119.96 53.11 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.75 0.786 . . . . 65.11 109.814 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.73 90.11 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 115.37 -0.832 . . . . 50.35 113.322 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -122.57 126.73 26.06 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.048 0.939 . . . . 62.4 109.895 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 132.04 25.65 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.089 2.526 . . . . 62.11 112.52 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.3 pt -107.56 153.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.219 0.608 . . . . 73.22 111.857 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -121.8 126.82 49.69 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.003 0.921 . . . . 44.31 108.575 172.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 18' ' ' VAL . 16.2 t -114.55 143.89 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 122.943 0.497 . . . . 63.54 111.156 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 m -147.12 -177.08 5.48 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.807 1.643 . . . . 73.14 109.057 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 53.7 m-85 -87.38 147.82 25.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.699 0.681 . . . . 65.53 110.603 168.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.92 85.69 6.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.584 0.753 . . . . 73.21 109.752 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 123.658 0.783 . . . . 73.25 111.405 -175.015 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.568 -0.16 . . . . 75.0 110.568 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.6 -77.15 0.28 Allowed Glycine 0 C--N 1.344 1.01 0 O-C-N 122.375 -0.203 . . . . 70.41 112.636 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -73.32 162.26 29.55 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.245 0.618 . . . . 72.03 111.178 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 59.7 27.27 16.49 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.271 1.029 . . . . 74.41 112.562 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -76.25 129.82 37.25 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.036 0.534 . . . . 65.31 111.372 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -81.17 136.68 35.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.363 0.505 . . . . 74.04 112.363 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -46.28 109.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.879 1.272 . . . . 60.21 112.919 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -73.72 -29.14 62.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.612 0.597 . . . . 75.23 112.612 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -109.34 152.34 25.41 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.47 0.708 . . . . 64.23 112.197 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -121.81 16.0 10.98 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.378 1.071 . . . . 71.43 111.458 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -146.94 -49.21 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.574 0.75 . . . . 71.33 110.055 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.55 84.75 2.61 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.791 0.805 . . . . 74.54 110.377 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' ' 97' ' ' PHE . 36.4 t30 -159.75 131.57 6.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.606 1.162 . . . . 73.31 108.305 171.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -97.05 -24.12 15.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.974 0.51 . . . . 51.33 111.641 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.5 m -95.45 125.18 39.89 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.989 0.516 . . . . 72.31 109.944 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.531 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.4 pt -120.95 140.61 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.156 0.583 . . . . 75.43 112.23 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -95.32 127.62 41.51 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.132 0.491 . . . . 75.12 110.554 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 95' ' ' VAL . 14.9 t -120.57 137.26 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.458 1.103 . . . . 64.25 109.985 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.42 156.26 31.79 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.046 0.938 . . . . 74.32 110.778 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 2.28 82.98 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 114.468 0.547 . . . . 64.53 114.468 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB3' HG21 ' A' ' 25' ' ' VAL . 96.0 mt -57.21 -20.87 29.65 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.834 1.05 . . . . 61.22 113.834 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.32 162.0 35.15 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.055 0.382 . . . . 73.11 114.055 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.21 -21.34 61.42 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.211 0.604 . . . . 75.44 111.787 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -92.45 2.58 56.58 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.004 0.922 . . . . 74.43 111.18 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 21' ' ' LEU . 11.1 p -66.54 147.53 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.53 0.732 . . . . 74.34 112.242 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.6 p -128.19 157.4 40.93 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.381 0.672 . . . . 72.44 110.367 172.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' A' ' 51' ' ' ILE . 71.5 mt -54.14 -41.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.156 0.982 . . . . 74.32 111.381 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.95 -29.27 62.96 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.367 0.667 . . . . 74.52 112.28 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.3 m -70.94 -43.56 67.95 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.567 0.347 . . . . 73.01 111.199 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.07 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 120.946 0.403 . . . . 63.54 110.022 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.08 96.36 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.498 0.719 . . . . 64.43 112.254 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -34.5 75.12 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.63 0.772 . . . . 72.41 111.071 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.13 -51.86 19.43 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.524 0.73 . . . . 74.11 110.882 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -80.9 -14.61 57.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.86 1.059 . . . . 73.01 113.86 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -54.89 -33.34 61.91 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.8 0.666 . . . . 63.44 112.8 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.97 -23.34 66.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.88 0.872 . . . . 73.42 112.67 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.31 -50.38 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.712 0.805 . . . . 53.22 111.277 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.35 -178.73 43.54 Favored Glycine 0 C--O 1.24 0.514 0 CA-C-N 115.35 -0.841 . . . . 53.41 113.012 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.3 mt -69.29 122.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 123.332 0.653 . . . . 74.22 110.317 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.1 mt -92.81 135.42 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.809 0.844 . . . . 51.41 108.835 171.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 29.3 mtpp -56.26 154.47 8.02 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.96 0.504 . . . . 64.24 111.591 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.0 m -138.64 122.35 17.53 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.169 0.588 . . . . 62.33 111.007 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -65.93 112.25 3.71 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.25 -1.019 . . . . 63.41 108.25 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -82.8 -12.23 57.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.942 0.497 . . . . 73.13 112.289 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -74.6 -47.77 30.47 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.605 0.762 . . . . 74.41 110.514 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -83.3 -39.37 20.9 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.63 0.772 . . . . 73.41 111.127 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.7 16.13 52.85 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.305 -0.861 . . . . 63.52 112.742 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -114.75 149.88 43.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.051 0.94 . . . . 61.52 111.299 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.49 151.32 85.54 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.584 2.189 . . . . 70.22 112.74 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.508 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.1 mtt -78.3 93.1 4.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.666 0.745 . . . . 63.3 109.147 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.0 mt -141.42 114.35 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.576 -1.268 . . . . 74.41 107.576 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' N ' HD22 ' A' ' 52' ' ' ASN . 0.8 OUTLIER -99.86 109.57 21.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.398 -0.593 . . . . 73.32 109.398 -170.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD23 ' HB2' ' A' ' 66' ' ' ALA . 87.6 mt -79.11 125.16 29.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.538 0.735 . . . . 73.43 110.324 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 9.6 m-85 -78.12 126.31 30.62 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.487 0.715 . . . . 72.55 110.429 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 m -116.91 143.45 45.69 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.847 0.859 . . . . 75.41 110.061 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -71.14 112.16 7.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.319 0.648 . . . . 63.35 109.971 168.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.926 0.49 . . . . 74.14 111.819 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 59' ' ' THR . 12.9 pt-20 -73.71 -43.82 58.14 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.871 0.868 . . . . 71.52 111.907 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.56 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -99.39 -50.08 4.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.466 0.706 . . . . 71.24 111.612 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.1 -1.37 28.4 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.521 -0.763 . . . . 53.42 112.652 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -98.12 160.06 14.54 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.635 0.774 . . . . 72.01 111.271 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.69 136.58 51.22 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.203 0.601 . . . . 65.33 111.901 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.85 -17.99 65.16 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.729 0.812 . . . . 61.22 112.398 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.38 33.86 21.59 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 121.318 0.399 . . . . 52.31 112.446 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.8 mt-10 -135.16 155.9 49.91 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.169 0.988 . . . . 70.22 109.948 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -164.03 152.56 13.27 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.219 0.533 . . . . 73.31 112.14 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 21.7 p -104.59 123.95 48.45 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.576 -0.738 . . . . 72.23 110.186 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.1 t -104.6 109.16 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.709 0.804 . . . . 70.14 109.816 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.1 m -86.76 100.47 12.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.53 0.332 . . . . 64.41 110.816 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 56.2 m-85 -75.55 160.57 30.01 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.372 0.669 . . . . 55.25 111.134 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.0 -30.31 39.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.514 0.726 . . . . 72.32 111.188 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -114.49 132.76 22.68 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.381 0.672 . . . . 63.15 110.866 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.98 -36.14 95.47 Favored 'Trans proline' 0 CA--C 1.586 3.116 0 C-N-CA 122.547 2.165 . . . . 72.14 115.956 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.1 -28.0 65.35 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 122.701 2.0 . . . . 73.11 113.356 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.2 m -69.77 -39.85 76.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.573 0.701 . . . . 22.24 110.211 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.86 -49.27 76.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 114.865 -1.061 . . . . 63.4 111.413 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -60.24 -45.44 93.22 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.208 1.003 . . . . 62.43 111.17 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.42 97.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.838 -0.619 . . . . 64.53 111.797 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.88 72.25 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.203 0.601 . . . . 74.43 112.482 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.34 -63.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.047 0.539 . . . . 73.32 110.684 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.12 -31.19 66.92 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.747 0.819 . . . . 73.42 112.105 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -78.75 -59.76 2.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.656 0.783 . . . . 74.14 111.668 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 95' ' ' VAL . 39.2 m-85 -87.45 -11.48 48.93 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.449 1.277 . . . . 71.32 114.449 -170.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.28 119.48 10.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.289 -0.634 . . . . 63.41 109.289 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.44 87.74 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.977 0.751 . . . . 64.34 114.977 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.9 150.14 21.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.714 0.806 . . . . 74.41 112.061 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.11 123.87 27.37 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.054 0.761 . . . . 72.03 113.054 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -125.13 133.04 52.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 74.33 108.373 167.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 t 62.58 11.43 4.75 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.531 1.132 . . . . 74.43 113.362 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.62 20.03 10.55 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 114.94 0.736 . . . . 61.32 114.94 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -154.04 146.33 17.3 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 118.22 1.01 . . . . 71.23 111.193 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.82 104.06 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.332 2.021 . . . . 74.22 112.733 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.31 165.21 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.356 0.662 . . . . 71.43 112.418 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 94' ' ' LYS . 9.3 mmpt? -121.01 117.72 27.99 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.28 1.032 . . . . 62.13 109.79 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 18' ' ' VAL . 21.9 t -114.53 136.71 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.062 0.545 . . . . 71.43 110.546 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.8 p -153.6 175.68 12.94 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.538 1.135 . . . . 75.15 109.997 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' HB3' HD22 ' A' ' 13' ' ' ASN . 44.7 m-85 -67.62 146.14 54.15 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 118.562 0.619 . . . . 73.11 111.828 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.72 97.22 5.09 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.514 -0.551 . . . . 63.23 109.514 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 CA--C 1.556 1.182 0 C-N-CA 124.112 0.965 . . . . 73.44 110.869 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.342 -0.244 . . . . 74.33 110.342 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.53 100.92 1.29 Allowed Glycine 0 C--N 1.354 1.564 0 N-CA-C 111.904 -0.479 . . . . 73.44 111.904 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -62.26 -55.06 32.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.622 0.769 . . . . 73.13 111.482 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -98.41 78.24 2.41 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.829 0.452 . . . . 63.13 110.118 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -92.26 103.48 15.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.937 0.495 . . . . 71.11 110.009 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -126.48 145.16 50.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.206 1.002 . . . . 74.54 111.218 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -84.87 79.41 9.64 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.587 0.755 . . . . 72.32 110.768 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -89.95 137.51 32.28 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.118 -0.697 . . . . 72.43 109.118 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -75.97 140.01 41.82 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.411 0.684 . . . . 44.13 111.903 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -73.34 -26.56 61.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.161 0.584 . . . . 74.51 111.846 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -97.7 153.64 18.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.79 0.836 . . . . 11.4 111.168 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.28 176.72 7.1 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.442 0.697 . . . . 53.5 110.905 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -141.55 115.02 8.92 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.084 0.469 . . . . 73.12 110.633 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -101.18 -4.83 26.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.208 1.003 . . . . 71.24 111.512 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -99.47 125.93 45.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.007 0.523 . . . . 65.43 110.765 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.433 HG23 ' HB1' ' A' ' 76' ' ' ALA . 42.0 pt -110.11 152.27 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.847 0.859 . . . . 72.23 110.983 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -107.31 130.51 54.76 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 123.431 0.693 . . . . 75.12 109.827 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 95' ' ' VAL . 14.7 t -122.6 140.82 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.228 1.011 . . . . 43.43 110.259 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -118.66 164.35 15.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.925 1.29 . . . . 64.43 110.217 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.48 79.24 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 114.639 0.616 . . . . 72.21 114.639 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.1 -17.97 60.87 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.496 1.119 . . . . 65.24 112.705 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.95 173.03 48.7 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.151 0.42 . . . . 43.14 114.151 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.32 -19.67 61.62 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.594 0.757 . . . . 75.35 112.604 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.64 10.58 36.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.639 0.607 . . . . 71.01 112.639 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.32 128.92 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 122.997 0.519 . . . . 60.4 111.803 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 7.6 p -122.72 150.77 42.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.857 -0.527 . . . . 73.22 109.657 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.6 mt -54.38 -42.38 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.145 0.978 . . . . 72.3 111.706 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.68 -39.42 80.58 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.181 0.592 . . . . 74.34 112.333 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.3 m -64.26 -41.7 96.82 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.914 0.486 . . . . 73.33 111.396 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' THR . 63.5 t -65.49 -43.27 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.022 0.529 . . . . 64.44 110.723 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.0 96.46 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.831 -0.622 . . . . 73.21 112.186 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.93 -30.72 62.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.371 0.669 . . . . 60.14 111.46 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -74.17 -53.86 8.98 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.693 0.797 . . . . 74.21 112.007 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 62.1 m-85 -77.46 -14.51 59.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.983 1.105 . . . . 62.34 113.983 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -56.14 -30.84 62.72 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.767 1.025 . . . . 71.31 113.767 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.58 -25.02 65.9 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.691 0.797 . . . . 43.12 113.037 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.2 mm -83.9 -52.76 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.461 0.704 . . . . 71.25 110.59 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.51 167.79 35.81 Favored Glycine 0 C--O 1.241 0.568 0 CA-C-N 116.08 -0.509 . . . . 64.15 113.391 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.18 128.04 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.881 0.872 . . . . 51.4 109.538 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 83.3 mt -97.12 136.61 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.501 0.721 . . . . 54.44 109.09 175.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.5 mtpt -57.15 142.27 43.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.254 0.622 . . . . 74.43 111.951 177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 75.3 m -132.73 127.16 34.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.696 0.798 . . . . 75.43 110.489 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -70.81 118.33 13.45 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.699 0.8 . . . . 70.12 109.154 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -77.06 -23.01 52.01 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.517 0.727 . . . . 71.23 111.796 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -66.95 -51.57 53.59 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.336 0.654 . . . . 73.42 110.72 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -84.74 -37.11 21.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.153 0.581 . . . . 71.32 111.838 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.11 -2.86 59.9 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 116.025 -0.534 . . . . 72.11 113.076 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -99.74 147.77 33.86 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.262 1.025 . . . . 75.35 112.355 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 39.7 Cg_endo -67.6 149.27 79.42 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.655 2.236 . . . . 71.03 112.775 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 53.1 mtt -78.33 94.74 4.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 64.01 109.973 -177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.96 123.86 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.992 1.317 . . . . 61.31 108.027 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -106.4 108.66 20.28 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.577 -0.527 . . . . 74.33 109.577 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.8 mt -83.08 117.71 23.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.239 0.616 . . . . 74.44 109.677 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HE1' HG23 ' A' ' 67' ' ' THR . 30.5 m-85 -70.29 105.36 2.96 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.089 0.556 . . . . 74.32 111.106 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -89.82 147.37 23.83 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.596 -0.729 . . . . 53.54 109.233 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -79.85 125.89 30.28 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.54 0.736 . . . . 62.02 109.907 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -70.15 -21.8 63.04 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.976 0.732 . . . . 70.35 112.976 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.71 -57.94 2.42 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.28 0.632 . . . . 71.14 111.128 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.2 p -82.67 -20.25 36.59 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.048 0.539 . . . . 72.05 112.279 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.75 -1.19 74.29 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 114.937 0.735 . . . . 63.32 114.937 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -101.81 160.73 14.22 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.26 0.624 . . . . 73.21 110.853 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.78 126.37 28.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.792 0.437 . . . . 40.55 111.133 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.89 -16.52 64.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.07 0.948 . . . . 71.43 112.242 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.33 25.23 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.991 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -133.24 150.54 51.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.09 0.956 . . . . 73.2 109.164 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.76 157.38 18.96 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 112.58 0.585 . . . . 74.34 112.58 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.404 HG23 ' HE1' ' A' ' 54' ' ' TYR . 27.2 p -117.24 117.2 28.89 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.093 0.557 . . . . 73.32 111.074 173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.47 111.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.32 1.048 . . . . 75.41 110.353 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m -85.85 103.18 14.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.509 0.323 . . . . 53.3 111.004 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 33.5 m-85 -76.4 164.55 25.89 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.024 0.53 . . . . 74.02 110.499 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -74.73 -40.4 61.3 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.023 0.529 . . . . 75.12 109.934 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.89 129.39 24.22 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.49 0.716 . . . . 62.21 110.916 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -54.17 -37.65 87.62 Favored 'Trans proline' 0 CA--C 1.587 3.144 0 C-N-CA 122.669 2.246 . . . . 65.31 115.471 165.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.51 -27.62 61.96 Favored 'Trans proline' 0 C--N 1.406 3.59 0 CA-C-N 122.386 1.888 . . . . 71.0 113.426 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.9 m -72.84 -39.0 66.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.284 0.564 . . . . 73.45 110.363 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -59.43 -52.14 66.89 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.227 -0.897 . . . . 60.42 110.898 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tmtp? -64.26 -42.55 96.43 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.77 0.828 . . . . 72.03 111.841 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.17 96.7 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.698 0.399 . . . . 70.33 111.68 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.53 71.64 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.397 0.679 . . . . 43.43 112.257 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 77' ' ' LYS . 81.6 mt -62.26 -61.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 122.684 0.394 . . . . 73.4 110.282 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.07 -33.8 67.63 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.742 0.817 . . . . 72.2 112.299 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -77.91 -54.55 6.19 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.722 0.809 . . . . 75.14 112.151 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.62 -12.78 30.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.246 1.202 . . . . 75.21 114.246 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.41 126.87 29.19 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.739 0.7 . . . . 72.24 110.452 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.29 1.71 90.45 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.044 0.778 . . . . 63.35 115.044 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 75.3 mmtt -92.0 -167.17 1.71 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.91 0.855 . . . . 74.44 111.775 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.17 125.86 44.33 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.138 0.575 . . . . 71.25 112.104 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 93' ' ' ILE . 66.6 t80 -77.32 -69.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.244 0.618 . . . . 53.11 111.455 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.3 m -133.83 75.29 1.59 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.666 0.786 . . . . 62.13 109.486 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.4 0.04 44.14 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 115.379 -0.828 . . . . 51.33 114.638 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.2 135.06 26.95 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.081 0.953 . . . . 54.12 111.895 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.4 Cg_exo -67.85 140.06 49.53 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.109 2.539 . . . . 72.23 113.357 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 88' ' ' PHE . 37.7 pt -123.36 151.83 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.32 1.048 . . . . 74.43 112.068 -173.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -118.72 122.48 42.59 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.086 -1.079 . . . . 74.31 108.086 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 18' ' ' VAL . 18.9 t -112.29 141.17 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.506 . . . . 73.02 110.655 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.0 p -152.3 -179.78 7.84 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.289 1.436 . . . . 70.13 109.041 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -73.81 150.42 41.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.772 0.714 . . . . 62.33 110.944 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.68 88.87 7.06 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.026 0.53 . . . . 54.43 110.293 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.498 0 C-N-CA 123.953 0.901 . . . . 75.41 110.945 -179.467 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 110.21 -0.293 . . . . 64.14 110.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.77 -146.07 50.16 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 122.893 0.282 . . . . 70.33 113.392 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -107.98 -20.61 13.12 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.668 . . . . 52.42 111.503 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -156.39 84.37 0.98 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-O 121.856 0.836 . . . . 73.24 111.455 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -132.07 120.22 22.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.548 0.739 . . . . 71.55 110.139 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -153.28 153.42 32.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 73.24 109.966 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.65 122.14 30.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.18 0.592 . . . . 74.3 110.481 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -70.67 112.85 7.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.669 0.388 . . . . 72.01 110.092 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -122.53 125.58 46.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.173 0.589 . . . . 73.03 111.826 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -78.57 70.61 4.95 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.812 0.815 . . . . 70.43 109.087 169.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.1 m -61.0 116.21 4.32 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.157 0.983 . . . . 53.23 112.079 -170.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.47 80.1 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.374 1.07 . . . . 75.14 111.063 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -94.57 168.42 10.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.197 0.599 . . . . 74.14 110.393 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -95.18 11.75 31.24 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 111.747 0.277 . . . . 74.44 111.747 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.8 m -138.16 125.83 22.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.788 -0.449 . . . . 74.3 109.788 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.0 pt -109.6 143.12 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 122.779 0.432 . . . . 60.01 112.101 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -96.8 110.66 23.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.468 -0.567 . . . . 75.12 109.468 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 5.9 t -104.96 138.37 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.611 0.764 . . . . 71.45 110.103 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -120.71 166.48 13.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.282 1.033 . . . . 74.45 110.218 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.15 31.72 72.22 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 114.519 0.568 . . . . 73.2 114.519 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -81.91 -17.11 48.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.205 1.002 . . . . 74.33 112.355 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.99 168.61 40.69 Favored Glycine 0 N--CA 1.475 1.271 0 N-CA-C 114.133 0.413 . . . . 53.45 114.133 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 62' ' ' LEU . 13.5 pt-20 -74.69 -13.38 60.61 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.426 0.69 . . . . 75.23 112.599 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -89.61 -3.55 58.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.621 0.768 . . . . 73.24 111.895 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.72 127.53 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 N-CA-C 113.161 0.801 . . . . 73.24 113.161 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -122.93 154.22 38.66 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.385 0.674 . . . . 74.43 110.042 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.7 mt -57.25 -42.72 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.533 0.733 . . . . 74.41 111.736 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.35 -40.39 95.77 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.634 0.774 . . . . 74.3 111.463 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.2 t -65.82 -45.02 83.82 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.88 0.472 . . . . 74.24 111.282 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 26' ' ' THR . 60.2 t -62.83 -42.08 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.27 0.557 . . . . 62.4 110.278 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.519 -0.764 . . . . 74.52 112.172 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.79 -35.7 80.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.758 0.823 . . . . 55.34 111.271 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -71.92 -55.98 6.51 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.93 0.892 . . . . 73.45 111.031 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.0 m-85 -79.71 -16.59 55.38 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.147 1.166 . . . . 71.43 114.147 -172.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.71 -24.17 66.61 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.729 1.011 . . . . 75.13 113.729 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -60.96 -23.94 65.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.335 0.654 . . . . 64.23 112.686 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.7 mm -86.86 -45.99 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 51.52 111.812 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.63 174.67 45.72 Favored Glycine 0 C--O 1.24 0.505 0 CA-C-N 115.709 -0.678 . . . . 64.04 113.123 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.0 mt -67.54 123.62 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.499 0.72 . . . . 74.14 111.339 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 74.2 mt -94.08 130.8 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.446 1.098 . . . . 64.33 108.41 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.8 mtpp -54.64 146.57 16.35 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.498 0.719 . . . . 60.04 112.193 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 99.6 m -126.93 138.53 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.196 0.998 . . . . 73.31 109.352 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -78.27 128.68 34.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.651 0.781 . . . . 55.54 109.68 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -67.48 -40.13 85.26 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.789 0.836 . . . . 73.24 111.856 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -61.93 -49.6 75.51 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.718 0.807 . . . . 63.3 112.029 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -87.11 -47.04 9.23 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.158 0.583 . . . . 73.42 111.753 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.6 14.6 49.65 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 116.276 -0.42 . . . . 74.13 112.624 -171.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -117.56 151.92 48.92 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 124.338 1.055 . . . . 73.33 111.447 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.0 Cg_endo -67.22 146.65 76.71 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.743 2.295 . . . . 73.43 112.633 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.537 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 56.2 mtt -77.95 96.57 5.07 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.319 0.58 . . . . 71.34 110.014 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' A' ' 27' ' ' ILE . 83.4 mt -143.07 118.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.61 1.164 . . . . 74.23 108.363 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.5 m-20 -98.7 108.27 20.92 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.285 -0.635 . . . . 71.1 109.285 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -80.04 130.15 35.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.524 -0.547 . . . . 65.15 109.524 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 84.1 m-85 -89.78 121.85 32.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.994 0.518 . . . . 63.45 110.438 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -115.56 145.95 42.18 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.381 1.072 . . . . 72.33 110.167 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.53 104.81 1.66 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.95 0.5 . . . . 73.42 110.063 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -64.15 -22.65 67.02 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 123.72 0.808 . . . . 62.22 111.648 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.99 -56.09 5.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.561 0.744 . . . . 71.32 111.633 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -86.66 -49.02 7.8 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.287 0.635 . . . . 74.52 111.486 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.49 -3.16 27.88 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.858 -0.61 . . . . 74.03 113.453 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.09 153.12 23.94 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.297 0.639 . . . . 74.34 111.044 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 23' ' ' GLU . 95.4 mt -68.01 135.61 52.58 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.006 0.522 . . . . 60.53 110.502 174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' A' ' 54' ' ' TYR . 50.2 mtpt -68.26 -26.16 65.54 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.069 0.548 . . . . 73.4 112.092 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.41 38.72 8.78 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.598 -0.601 . . . . 73.31 111.598 -168.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 62.1 mt-10 -134.8 158.02 45.27 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.735 0.814 . . . . 72.22 110.245 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.69 160.33 28.43 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 54.33 112.017 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 p -117.41 114.31 23.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.939 0.496 . . . . 73.35 110.296 167.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.29 104.56 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.966 0.906 . . . . 74.54 109.757 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 56.0 m -82.65 102.59 11.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.68 0.392 . . . . 71.12 111.708 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 57.9 m-85 -80.22 160.07 25.73 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.807 0.843 . . . . 72.24 109.736 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.53 -31.24 47.42 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.485 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -110.38 130.16 23.18 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.768 0.827 . . . . 61.23 110.719 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -54.08 -40.46 81.45 Favored 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.181 1.921 . . . . 74.12 115.164 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.58 -31.5 87.16 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 122.406 1.895 . . . . 62.34 113.973 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m -69.49 -43.12 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.167 0.587 . . . . 72.12 109.963 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.5 -49.34 75.76 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.983 -1.008 . . . . 75.21 111.107 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -60.21 -48.43 81.77 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.708 1.203 . . . . 62.04 111.19 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.09 -35.59 80.91 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.139 0.576 . . . . 73.34 112.192 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.42 -32.12 69.89 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.824 0.45 . . . . 61.41 111.913 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 95' ' ' VAL . 59.8 mt -64.45 -59.77 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 122.787 0.435 . . . . 75.33 110.102 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -55.83 -32.43 63.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.791 0.837 . . . . 75.25 112.924 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -78.47 -59.91 2.59 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.351 0.66 . . . . 64.32 111.173 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 93' ' ' ILE . 69.6 m-85 -84.41 -15.29 46.8 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.639 1.348 . . . . 71.45 114.639 -169.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.55 115.69 4.92 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 118.574 0.625 . . . . 53.42 110.444 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.45 58.34 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.768 -0.462 . . . . 62.04 114.193 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.451 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.1 mmtt -93.46 147.17 23.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.818 0.847 . . . . 73.21 110.674 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.09 124.4 31.07 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 122.232 -0.292 . . . . 63.32 111.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.426 ' HB2' HG21 ' A' ' 93' ' ' ILE . 54.3 t80 -84.35 -81.24 0.18 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.139 -0.689 . . . . 75.13 109.139 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.0 m -106.18 70.41 0.84 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.325 -0.62 . . . . 72.12 109.325 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.93 -3.76 34.69 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.963 0.745 . . . . 73.32 114.963 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -121.31 130.15 24.94 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 123.579 0.752 . . . . 75.53 110.89 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.62 120.01 7.09 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.868 2.379 . . . . 71.14 111.76 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 83' ' ' PHE . 13.4 pt -88.57 146.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.232 0.539 . . . . 64.21 112.352 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -109.6 110.44 21.51 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.069 -1.086 . . . . 63.12 108.069 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 7.0 t -101.66 132.07 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.426 -0.583 . . . . 62.03 109.426 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -138.29 172.64 12.61 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.176 0.99 . . . . 50.25 109.438 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -71.97 142.95 49.38 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.146 0.43 . . . . 75.5 110.03 168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 66.51 8.67 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.999 0.904 . . . . 40.04 110.659 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.557 1.244 0 CA-C-N 114.842 -1.072 . . . . 63.34 110.862 179.463 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.752 0.31 . . . . 73.12 110.65 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.02 -53.65 4.86 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 116.182 -0.463 . . . . 70.01 113.72 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -80.25 129.07 34.24 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.374 0.67 . . . . 72.23 110.967 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -63.8 137.54 58.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.402 0.681 . . . . 62.53 111.058 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -72.19 102.29 3.02 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 120.66 0.267 . . . . 62.12 111.408 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -62.69 -42.39 99.61 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.063 0.459 . . . . 53.03 110.353 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -73.08 130.03 39.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.352 0.661 . . . . 74.2 109.315 170.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -89.39 133.4 34.53 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.026 0.53 . . . . 73.33 111.355 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.0 m -79.92 74.9 6.66 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.367 -0.975 . . . . 74.03 108.367 164.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -136.37 112.52 9.75 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.404 -0.816 . . . . 75.43 110.343 -168.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -140.55 97.32 3.18 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.377 -0.972 . . . . 73.31 108.377 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -54.38 125.84 20.97 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.066 1.135 . . . . 55.15 114.066 -167.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.491 HD22 ' HB3' ' A' ' 97' ' ' PHE . 47.7 t30 -136.18 132.41 35.91 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.944 0.898 . . . . 72.13 110.188 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -93.15 -23.57 18.54 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.685 0.794 . . . . 73.11 111.556 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.4 m -97.58 126.05 42.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.819 0.448 . . . . 74.43 110.155 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 76' ' ' ALA . 34.7 pt -103.42 151.24 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.15 0.58 . . . . 73.04 111.202 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -110.06 119.78 40.36 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 74.2 109.508 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 95' ' ' VAL . 13.7 t -114.23 136.91 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.889 0.875 . . . . 73.23 110.44 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -117.48 162.18 18.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.265 1.026 . . . . 75.11 110.199 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.32 26.52 74.51 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 114.35 0.5 . . . . 73.12 114.35 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 93' ' ' ILE . 55.1 mt -71.7 -24.46 61.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.496 1.119 . . . . 72.31 111.981 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.36 161.42 36.57 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 116.447 -0.342 . . . . 44.15 112.811 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.69 -7.78 55.99 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.372 0.586 . . . . 70.34 111.595 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.19 11.94 17.29 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.001 0.921 . . . . 62.1 111.571 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.83 133.95 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 123.928 0.891 . . . . 54.24 112.476 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 p -133.73 155.2 50.18 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.671 0.788 . . . . 71.25 110.23 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.25 -39.54 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.217 0.607 . . . . 73.02 111.253 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.93 -49.91 74.24 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.834 0.854 . . . . 62.32 111.744 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.6 m -65.34 -43.44 90.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.088 0.555 . . . . 75.35 112.126 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.24 -40.84 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 122.901 0.48 . . . . 65.4 110.812 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.65 84.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.053 -0.521 . . . . 70.5 111.371 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.96 -27.94 67.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 70.41 111.92 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -77.18 -54.87 5.96 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.844 0.857 . . . . 74.41 111.978 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.85 -18.95 55.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.199 1.185 . . . . 71.3 114.199 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -57.24 -27.91 62.47 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 113.728 1.01 . . . . 74.25 113.728 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -58.2 -26.2 62.52 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.593 0.757 . . . . 74.12 112.758 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.24 -51.38 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.948 0.899 . . . . 64.05 111.076 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.32 -177.01 46.72 Favored Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.861 -0.609 . . . . 70.53 113.259 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.04 118.31 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.253 0.621 . . . . 71.43 111.151 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 66.9 mt -87.95 123.08 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.177 -1.046 . . . . 53.3 108.177 169.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 54.3 mtpt -46.27 118.14 1.82 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.426 0.69 . . . . 72.12 112.423 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 80.7 m -103.96 115.56 30.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.335 0.654 . . . . 64.24 110.273 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -56.63 122.13 11.34 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.364 1.066 . . . . 74.1 110.592 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -80.75 -14.79 57.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.449 1.1 . . . . 72.42 112.583 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 10.0 mmpt? -84.83 -43.01 14.56 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.387 0.675 . . . . 73.41 111.249 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.8 p -85.98 -40.4 15.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.612 0.765 . . . . 75.22 111.553 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.6 10.76 64.92 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.086 -0.506 . . . . 70.51 112.025 -170.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -114.66 156.69 44.46 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 125.22 1.408 . . . . 62.13 110.824 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 65.2 Cg_endo -72.56 153.53 54.8 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.403 2.069 . . . . 40.22 112.852 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.524 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.5 mtt -83.7 95.73 8.48 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.99 0.916 . . . . 64.22 109.35 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -137.61 122.87 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 75.24 108.535 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -106.07 108.67 20.31 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.375 -0.602 . . . . 64.34 109.375 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.0 mt -89.37 129.52 35.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.728 0.811 . . . . 72.43 109.076 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' A' ' 63' ' ' LYS . 77.3 m-85 -89.19 124.44 34.36 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.574 0.35 . . . . 73.45 111.097 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.6 m -108.83 137.81 46.16 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.663 0.785 . . . . 73.33 110.201 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.54 136.05 47.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.777 0.831 . . . . 61.52 110.831 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -76.42 -24.3 53.98 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.13 0.789 . . . . 72.15 113.13 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -92.41 -55.4 3.42 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.842 0.457 . . . . 65.0 111.348 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -73.95 -30.63 62.64 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.771 0.828 . . . . 74.11 111.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.88 6.34 88.64 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.997 -0.547 . . . . 75.43 113.441 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -100.83 158.54 15.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.282 0.633 . . . . 70.5 111.511 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.62 130.91 44.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.168 0.587 . . . . 65.54 111.582 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' TYR . 97.2 mttt -66.43 -16.78 64.37 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.345 1.058 . . . . 61.05 112.697 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 29.07 56.22 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.267 -0.333 . . . . 63.42 112.267 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.67 146.23 52.07 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.416 1.086 . . . . 71.24 108.536 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.36 169.58 21.74 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.483 0.549 . . . . 62.52 112.483 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 p -123.56 130.82 53.24 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.982 -0.554 . . . . 54.11 111.089 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -110.1 109.52 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.669 0.788 . . . . 73.42 109.746 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -79.53 104.11 9.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.338 0.255 . . . . 64.03 111.143 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 48.9 m-85 -82.69 163.07 21.58 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 120.842 0.353 . . . . 74.43 110.187 169.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.31 -40.19 52.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.319 0.647 . . . . 74.43 110.836 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 11.7 m-20 -112.61 133.81 21.78 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.156 0.582 . . . . 75.31 111.706 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.17 -41.09 59.3 Favored 'Trans proline' 0 CA--C 1.584 3.015 0 C-N-CA 122.842 2.362 . . . . 63.24 116.028 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 69.8 Cg_endo -71.08 -20.92 28.12 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 122.526 1.938 . . . . 74.21 113.204 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 t -75.77 -39.5 56.92 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.574 0.702 . . . . 75.15 109.451 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.15 -45.17 95.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.056 -0.975 . . . . 70.14 110.623 173.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.1 -46.4 89.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.494 1.118 . . . . 73.34 110.882 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.79 97.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.172 0.589 . . . . 71.35 112.008 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.48 77.21 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 75.04 112.143 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 95' ' ' VAL . 83.7 mt -64.71 -57.91 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.216 0.607 . . . . 60.22 110.823 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.94 -32.92 68.28 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.11 0.964 . . . . 72.51 111.884 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.78 -54.45 5.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.236 0.615 . . . . 72.32 112.446 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HB2' HG21 ' A' ' 95' ' ' VAL . 58.8 m-85 -89.34 -6.52 56.61 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.872 1.064 . . . . 71.11 113.872 -171.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.6 124.45 22.39 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 118.266 0.485 . . . . 75.23 110.085 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.53 -0.84 89.22 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.041 -0.527 . . . . 71.24 114.017 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -97.57 170.5 8.98 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.537 0.735 . . . . 52.35 110.914 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.08 137.9 50.73 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.114 0.565 . . . . 53.21 111.78 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 93' ' ' ILE . 64.3 t80 -129.29 131.62 47.0 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.813 1.245 . . . . 75.25 108.526 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t 63.33 25.85 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.362 1.065 . . . . 70.31 111.537 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.01 88.1 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-N 116.049 -0.523 . . . . 34.05 113.706 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -115.02 117.24 41.88 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.341 1.056 . . . . 70.54 110.495 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.92 100.74 0.17 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.627 2.218 . . . . 62.43 113.066 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 HD23 ' A' ' 21' ' ' LEU . 40.3 pt -82.64 153.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.92 0.888 . . . . 74.03 113.368 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -114.91 110.25 19.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.076 1.351 . . . . 75.42 109.169 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 18' ' ' VAL . 23.8 t -103.87 131.16 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 122.151 -0.343 . . . . 63.44 110.096 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.1 p -142.79 179.29 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.608 1.163 . . . . 51.03 109.748 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HB3' HD22 ' A' ' 13' ' ' ASN . 63.6 m-85 -77.06 150.07 35.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.487 0.585 . . . . 64.54 110.772 169.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.82 87.94 7.48 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.094 0.473 . . . . 72.32 110.936 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.471 1.108 . . . . 64.3 110.822 179.057 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.65 0.262 . . . . 75.11 111.65 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.28 -60.21 0.24 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.313 -0.403 . . . . 74.4 112.754 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -81.65 99.77 9.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.945 0.498 . . . . 52.21 111.0 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -79.74 95.34 5.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.309 0.643 . . . . 70.22 110.543 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -139.87 116.93 11.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.89 0.876 . . . . 74.43 110.57 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -74.39 112.43 10.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.117 0.567 . . . . 74.54 109.693 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -75.95 122.53 24.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.88 0.472 . . . . 55.33 110.932 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -71.71 105.43 3.71 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.524 0.678 . . . . 73.21 110.796 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -154.41 28.35 0.45 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.442 0.697 . . . . 75.23 110.697 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -65.32 -60.55 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.848 -0.797 . . . . 75.22 108.848 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.3 t -85.97 124.04 31.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.423 0.689 . . . . 75.11 109.835 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.4 103.82 2.11 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.818 0.847 . . . . 71.3 111.087 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.44 HD22 ' HB3' ' A' ' 97' ' ' PHE . 57.7 t30 -90.13 122.72 33.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.639 0.376 . . . . 73.32 110.882 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -94.45 -13.14 26.5 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.773 0.829 . . . . 52.32 111.26 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -100.96 128.95 46.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.555 0.742 . . . . 61.31 110.218 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.1 pt -110.85 151.19 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.423 0.689 . . . . 73.44 110.892 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -108.0 116.19 31.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.158 0.583 . . . . 72.34 109.724 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.3 t -107.76 142.1 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.251 1.02 . . . . 73.2 110.16 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -122.07 158.88 28.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.851 1.26 . . . . 74.32 110.171 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.55 38.98 95.29 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 114.509 0.563 . . . . 74.22 114.509 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.86 -31.86 27.77 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.648 1.179 . . . . 61.22 111.691 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.0 159.6 11.98 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 122.748 0.213 . . . . 63.51 113.489 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.71 -14.73 57.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.219 0.608 . . . . 75.41 111.302 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -88.92 3.89 49.87 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.728 0.811 . . . . 60.23 110.995 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.05 136.25 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.631 0.772 . . . . 71.45 111.585 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.7 p -129.05 151.92 49.21 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.945 -0.472 . . . . 62.0 110.194 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 51' ' ' ILE . 75.9 mt -52.8 -45.01 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.239 1.015 . . . . 74.35 112.032 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -70.82 -31.73 68.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.427 0.691 . . . . 53.24 112.528 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.1 m -75.37 -36.77 60.87 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.57 0.348 . . . . 64.24 111.684 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 26' ' ' THR . 63.6 t -65.88 -39.85 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.427 0.632 . . . . 72.11 109.599 172.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.92 99.52 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.913 -1.039 . . . . 73.55 111.65 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.84 -34.86 69.62 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.309 0.644 . . . . 73.34 111.679 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.27 -54.15 9.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.775 0.83 . . . . 75.23 111.508 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.434 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 38.6 m-85 -77.29 -18.28 57.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.635 1.346 . . . . 71.03 114.635 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -61.79 -21.47 64.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.511 1.3 . . . . 73.3 114.511 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -57.64 -26.09 61.11 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.413 0.685 . . . . 54.3 112.388 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 mm -85.65 -45.34 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 75.43 111.214 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.83 44.3 Favored Glycine 0 C--O 1.241 0.576 0 CA-C-N 116.077 -0.51 . . . . 33.04 113.302 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.19 122.84 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.555 0.742 . . . . 65.52 110.185 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.8 mt -92.51 124.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.071 -1.085 . . . . 71.11 108.071 173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -50.62 154.81 1.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.068 0.947 . . . . 75.0 112.902 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 87.2 m -137.5 127.25 25.42 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.559 -0.746 . . . . 52.21 110.824 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.34 113.94 4.42 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.686 -0.688 . . . . 63.25 109.417 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -78.01 -13.29 59.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.932 0.893 . . . . 63.35 112.172 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -80.67 -29.38 36.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.039 0.535 . . . . 75.41 112.289 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -103.21 -50.83 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.131 0.573 . . . . 64.3 110.893 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.58 10.64 28.6 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.563 -0.744 . . . . 73.2 112.364 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.63 145.31 30.38 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 64.21 111.637 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 29.1 Cg_endo -63.27 145.74 93.31 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.842 2.361 . . . . 51.12 112.47 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 52.3 mtt -73.65 94.0 2.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.799 0.809 . . . . 73.22 109.739 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 27' ' ' ILE . 84.7 mt -145.78 120.93 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.507 -1.224 . . . . 60.34 108.369 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -101.29 110.33 22.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.496 -0.557 . . . . 61.32 109.496 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -78.71 136.09 37.33 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.098 -0.704 . . . . 63.41 109.098 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.2 111.03 22.72 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.253 0.621 . . . . 75.03 110.144 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 m -86.65 151.65 23.25 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.037 0.535 . . . . 64.13 110.087 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.98 142.19 28.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.914 0.886 . . . . 72.55 110.896 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -37.62 59.71 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.485 -0.779 . . . . 60.14 112.672 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -94.24 -43.85 8.25 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.705 0.402 . . . . 72.2 111.713 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -81.92 -33.71 30.25 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 118.008 0.367 . . . . 63.11 111.864 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.59 13.17 83.21 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 116.239 -0.437 . . . . 73.24 114.167 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -104.1 173.57 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.598 0.759 . . . . 74.15 110.286 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.28 123.31 22.71 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.792 0.33 . . . . 64.01 110.226 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.63 -21.68 66.5 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.125 0.97 . . . . 74.21 113.18 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 23.26 35.66 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 123.178 0.299 . . . . 65.53 112.412 -171.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -121.34 151.05 40.55 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.043 -0.681 . . . . 74.44 109.692 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.78 154.85 24.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 40.32 111.713 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.9 p -109.86 120.59 42.95 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.62 0.368 . . . . 63.53 110.08 171.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.67 111.65 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.696 0.798 . . . . 71.22 110.449 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 70.7 m -85.55 105.12 15.91 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.682 0.393 . . . . 75.2 111.166 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 52.1 m-85 -81.25 153.45 27.13 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.261 0.624 . . . . 64.42 110.074 168.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.29 -28.79 62.29 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.138 0.575 . . . . 74.44 111.233 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.61 127.97 26.35 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 123.72 0.808 . . . . 74.13 111.194 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.92 -34.31 85.63 Favored 'Trans proline' 0 CA--C 1.583 2.973 0 C-N-CA 123.008 2.472 . . . . 63.22 116.277 170.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.48 -28.06 62.14 Favored 'Trans proline' 0 C--N 1.4 3.284 0 CA-C-N 122.62 1.972 . . . . 64.14 113.39 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 m -75.1 -35.04 61.78 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.114 0.566 . . . . 62.15 110.004 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.33 -53.64 54.08 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.679 -0.691 . . . . 62.14 111.121 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -59.37 -44.43 92.74 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.936 0.895 . . . . 73.11 110.77 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.88 90.89 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.002 -0.545 . . . . 74.4 111.775 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.87 -31.42 72.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.245 0.618 . . . . 74.32 112.327 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.45 HG12 HG12 ' A' ' 95' ' ' VAL . 83.0 mt -66.0 -58.37 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.992 0.517 . . . . 71.31 110.398 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.1 -26.21 68.44 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 115.327 -0.851 . . . . 71.53 111.919 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -81.0 -60.42 2.3 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.931 0.492 . . . . 75.24 111.754 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.52 -6.72 58.61 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.87 1.063 . . . . 72.44 113.87 -169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.39 106.27 0.73 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 118.118 0.417 . . . . 64.54 110.374 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.05 55.33 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 115.055 0.782 . . . . 72.51 115.055 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -87.41 -174.35 4.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.03 0.915 . . . . 71.21 110.616 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.6 127.42 37.04 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 122.922 0.489 . . . . 74.12 111.3 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -92.46 -87.91 0.21 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.861 0.464 . . . . 64.41 110.146 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.1 m -89.64 50.58 1.93 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.389 0.614 . . . . 72.01 109.907 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.17 4.9 69.64 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.883 -0.599 . . . . 63.53 113.915 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.68 134.09 21.01 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.725 0.81 . . . . 70.54 110.679 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.91 107.07 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.658 2.905 . . . . 53.2 112.672 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.73 143.53 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 N-CA-C 113.164 0.802 . . . . 74.21 113.164 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -118.65 114.86 23.4 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.951 1.301 . . . . 71.51 108.681 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 15.0 t -107.92 141.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.639 0.376 . . . . 61.42 110.584 -174.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 t -148.68 -178.21 6.22 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.329 1.051 . . . . 41.32 110.0 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.44 ' HB3' HD22 ' A' ' 13' ' ' ASN . 97.9 m-85 -76.25 140.62 41.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.849 0.46 . . . . 61.1 110.252 171.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.24 5.25 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.173 0.511 . . . . 63.21 109.737 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 124.497 1.119 . . . . 71.21 110.857 -171.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 110.053 -0.351 . . . . 55.13 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 112.19 3.65 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.019 -0.323 . . . . 62.12 113.083 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -76.97 127.11 32.11 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.318 0.559 . . . . 75.21 110.989 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -161.62 114.46 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.22 0.608 . . . . 75.51 110.293 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -127.85 124.98 38.84 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.982 0.513 . . . . 75.54 110.264 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -95.2 137.24 34.52 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.503 0.321 . . . . 75.54 110.622 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -65.13 116.42 6.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.709 0.804 . . . . 72.43 110.921 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -74.93 123.76 25.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.785 0.834 . . . . 73.33 110.744 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.0 t -95.99 97.02 9.28 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.259 0.624 . . . . 73.34 111.613 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -82.89 3.69 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.353 0.661 . . . . 73.32 111.946 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 t -138.11 131.58 30.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.121 0.969 . . . . 70.21 109.906 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.1 79.44 5.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.761 0.791 . . . . 54.33 111.023 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.07 129.17 35.7 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.345 -0.847 . . . . 72.24 110.442 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -90.4 -19.35 24.05 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.081 0.467 . . . . 63.22 109.924 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.0 m -98.64 129.87 45.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.584 0.753 . . . . 72.42 110.463 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.0 pt -110.33 151.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.6 0.76 . . . . 74.12 111.123 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -106.37 119.32 38.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.253 0.621 . . . . 62.02 109.67 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.595 HG13 HG22 ' A' ' 95' ' ' VAL . 11.2 t -112.61 140.96 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.249 1.02 . . . . 72.24 110.606 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -120.38 157.06 30.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.362 1.065 . . . . 64.24 110.486 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.64 34.88 42.63 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 115.135 0.814 . . . . 65.45 115.135 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.53 -21.69 28.47 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.269 1.028 . . . . 71.4 112.129 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.25 158.86 30.09 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 116.816 -0.174 . . . . 32.51 112.885 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.82 -20.97 61.76 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.158 0.583 . . . . 74.31 112.297 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.96 11.8 23.9 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.95 0.5 . . . . 64.22 111.491 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.98 138.58 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 123.788 0.835 . . . . 73.54 112.414 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 39.0 p -124.91 153.86 42.01 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.213 0.605 . . . . 74.14 110.461 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' A' ' 51' ' ' ILE . 79.8 mt -55.67 -42.84 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.741 0.817 . . . . 51.41 111.598 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -33.1 72.6 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.379 0.672 . . . . 74.42 112.134 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.3 t -69.9 -42.22 73.68 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.387 0.275 . . . . 62.15 111.025 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 59.8 t -63.89 -42.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.326 0.584 . . . . 72.53 110.072 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.32 82.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.13 -0.941 . . . . 73.01 111.895 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.88 -38.71 92.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.3 0.64 . . . . 73.54 111.299 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -67.89 -56.36 9.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.356 1.063 . . . . 72.12 111.515 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 85.2 m-85 -78.87 -20.46 49.46 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.212 1.19 . . . . 74.12 114.212 -174.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.77 -23.24 67.28 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.824 1.046 . . . . 74.21 113.824 -174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -60.49 -24.91 65.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.181 0.592 . . . . 72.02 112.291 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.9 mm -82.85 -43.65 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.102 0.961 . . . . 41.51 111.018 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.79 169.17 42.29 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.793 -0.639 . . . . 61.32 112.612 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.4 mt -65.39 131.52 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.045 0.538 . . . . 62.11 110.9 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.4 mt -97.69 131.09 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.814 0.846 . . . . 64.33 108.804 173.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 60.1 mtpt -53.65 151.2 6.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.288 0.635 . . . . 65.35 112.194 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.0 m -142.48 127.6 18.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.728 0.811 . . . . 64.31 110.262 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.78 127.8 34.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.711 0.804 . . . . 74.33 110.384 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -31.54 56.64 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.432 0.693 . . . . 72.2 112.287 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -51.45 43.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.966 0.506 . . . . 65.15 111.806 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -82.28 -51.37 7.98 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.569 0.748 . . . . 74.23 110.899 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.14 10.6 29.58 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.872 -0.603 . . . . 64.41 113.822 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -109.2 147.74 36.58 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 117.724 0.762 . . . . 54.12 112.721 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 57.7 Cg_endo -68.64 142.72 54.07 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 122.947 2.431 . . . . 75.1 112.371 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.1 mtt -74.08 95.25 2.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.595 0.712 . . . . 75.31 110.257 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 27' ' ' ILE . 81.9 mt -143.91 120.09 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.687 1.195 . . . . 74.24 108.902 -178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -100.74 111.28 23.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.146 0.578 . . . . 74.22 110.005 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.0 mt -86.5 114.37 23.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.643 0.777 . . . . 51.05 110.072 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.9 126.72 31.55 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.528 0.731 . . . . 64.32 111.433 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -99.72 145.3 27.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.604 0.762 . . . . 64.33 110.561 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.67 138.91 36.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.417 0.687 . . . . 74.44 112.334 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.42 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 11.4 ptp180 -64.94 -35.86 82.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.25 1.02 . . . . 75.44 112.64 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 19.5 mm-40 -87.86 -57.02 3.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.263 0.625 . . . . 63.14 111.462 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 p -73.11 -28.54 62.33 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.248 0.833 . . . . 74.03 113.248 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.56 18.0 73.32 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 123.358 0.411 . . . . 35.13 113.084 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -122.27 159.42 27.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.921 1.288 . . . . 72.42 109.167 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.52 133.07 55.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.645 0.378 . . . . 70.01 111.736 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -67.12 -14.19 62.66 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.853 0.861 . . . . 74.42 113.048 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.67 35.14 32.98 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.103 -0.799 . . . . 73.22 111.103 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -139.36 138.46 36.63 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.089 0.956 . . . . 74.25 109.016 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.58 159.11 40.68 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.02 0.438 . . . . 61.14 112.143 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 24.3 p -111.46 123.69 50.74 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.267 -0.424 . . . . 74.3 110.698 172.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.0 110.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.68 0.792 . . . . 74.04 110.371 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 30.9 m -88.6 102.27 14.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.852 0.461 . . . . 62.34 111.276 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 70.5 m-85 -79.3 158.25 27.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.217 0.607 . . . . 75.05 111.363 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.56 -32.08 70.66 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.853 0.861 . . . . 61.32 111.048 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.99 136.77 26.55 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.667 0.787 . . . . 71.41 112.006 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.0 -36.33 95.83 Favored 'Trans proline' 0 CA--C 1.58 2.795 0 C-N-CA 122.768 2.312 . . . . 75.0 116.208 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.09 -26.72 65.43 Favored 'Trans proline' 0 C--N 1.393 2.912 0 CA-C-N 122.816 2.041 . . . . 71.42 113.403 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.1 m -71.53 -40.45 70.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 53.14 109.712 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -61.49 -53.62 53.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.125 -0.943 . . . . 63.55 111.296 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.46 -46.51 88.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.752 1.221 . . . . 72.33 111.166 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.74 99.27 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.804 -0.634 . . . . 63.44 111.691 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.57 74.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.923 0.489 . . . . 73.03 112.183 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 95' ' ' VAL . 86.8 mt -62.12 -62.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.892 0.477 . . . . 71.11 110.449 175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.59 -31.59 70.73 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.877 0.871 . . . . 74.21 112.578 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -77.54 -53.23 7.85 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.231 0.612 . . . . 71.31 111.964 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.583 ' HB3' HD11 ' A' ' 93' ' ' ILE . 64.7 m-85 -88.41 -7.66 56.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.838 1.051 . . . . 64.13 113.838 -172.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 19.3 t70 -62.21 115.35 4.07 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.126 0.421 . . . . 63.01 110.519 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.68 10.7 72.47 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.592 0.597 . . . . 65.22 114.592 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -101.52 153.43 19.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.701 0.75 . . . . 54.21 111.698 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.35 127.04 34.21 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.088 0.555 . . . . 75.32 112.163 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -92.47 -52.75 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.189 0.595 . . . . 73.03 110.852 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -126.01 40.65 3.69 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.963 0.905 . . . . 65.24 110.015 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.6 15.85 80.89 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 115.815 -0.63 . . . . 51.55 112.8 -170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -136.7 129.28 17.34 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.304 1.042 . . . . 73.52 110.758 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.33 135.26 36.16 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.185 2.59 . . . . 74.01 113.243 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.583 HD11 ' HB3' ' A' ' 83' ' ' PHE . 27.1 pt -104.7 150.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 72.34 112.215 -173.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -114.76 109.9 18.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.764 0.826 . . . . 74.11 108.807 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 HG13 ' A' ' 18' ' ' VAL . 7.8 t -108.64 137.59 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 122.813 0.445 . . . . 74.44 110.432 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.9 m -146.07 179.55 7.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.325 1.05 . . . . 71.44 109.458 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -74.62 143.05 44.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.725 -0.472 . . . . 72.2 109.725 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.33 91.89 1.37 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.37 0.605 . . . . 74.02 111.175 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.56 1.352 0 C-N-CA 124.165 0.986 . . . . 71.13 111.102 178.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.529 0.204 . . . . 72.42 110.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.13 133.53 13.04 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 119.754 -0.47 . . . . 44.13 112.99 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -59.34 127.67 33.25 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.801 0.84 . . . . 70.51 111.616 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -68.5 90.48 0.38 Allowed 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.249 0.833 . . . . 60.14 113.249 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 t60 61.46 111.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.491 1.516 . . . . 74.43 112.975 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -68.01 137.73 55.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.848 0.459 . . . . 73.35 111.461 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -120.15 -173.92 2.66 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.442 1.097 . . . . 63.33 110.771 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.39 147.6 30.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.083 0.553 . . . . 70.22 110.819 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.1 t -60.23 110.59 1.27 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.851 0.46 . . . . 61.33 111.772 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -157.47 152.51 25.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.436 1.094 . . . . 72.52 109.792 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t 62.31 15.12 7.35 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.981 0.913 . . . . 70.31 113.291 174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.32 150.38 41.93 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.712 0.805 . . . . 65.32 111.79 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.519 HD22 ' HB3' ' A' ' 97' ' ' PHE . 48.1 t30 -83.61 129.44 34.96 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.41 0.684 . . . . 70.33 110.562 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -102.26 -11.05 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.284 0.633 . . . . 74.43 111.808 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.3 m -97.88 125.6 42.85 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.295 0.638 . . . . 71.11 109.819 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 pt -112.69 140.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.066 0.547 . . . . 71.44 111.175 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -94.79 125.36 39.4 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.939 -0.393 . . . . 43.34 109.939 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 95' ' ' VAL . 23.0 t -118.05 139.64 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.099 0.959 . . . . 72.21 109.82 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -127.58 162.06 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.97 0.908 . . . . 74.14 110.973 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.75 66.93 Favored Glycine 0 N--CA 1.479 1.502 0 O-C-N 123.46 0.475 . . . . 61.14 114.192 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 93' ' ' ILE . 34.3 mt -75.46 -26.5 58.29 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.098 0.959 . . . . 55.43 111.789 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.16 152.15 21.11 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 111.964 -0.454 . . . . 63.11 111.964 -173.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.99 -3.45 35.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 113.355 0.872 . . . . 70.53 113.355 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -101.43 18.85 19.07 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.393 0.677 . . . . 72.12 110.522 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 21' ' ' LEU . 11.2 p -71.51 135.59 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 C-N-CA 123.264 0.626 . . . . 73.11 112.135 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.6 p -127.28 150.73 49.43 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.573 -0.705 . . . . 72.11 110.901 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 51' ' ' ILE . 85.1 mt -52.93 -45.83 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.456 1.102 . . . . 75.2 111.978 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.62 -31.14 67.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.655 0.782 . . . . 72.22 111.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.5 m -71.54 -40.11 70.27 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.759 0.424 . . . . 72.23 111.606 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 26' ' ' THR . 52.3 t -66.45 -36.94 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.896 0.478 . . . . 73.12 110.151 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.27 75.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.605 -0.725 . . . . 64.2 111.344 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.44 -30.97 71.82 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.601 0.76 . . . . 72.11 111.68 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -74.18 -56.46 4.87 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.528 0.731 . . . . 74.34 111.195 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.412 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 23.0 m-85 -77.17 -18.55 57.73 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.404 1.261 . . . . 54.23 114.404 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -63.42 -20.57 65.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 113.89 1.07 . . . . 55.1 113.89 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -60.21 -25.32 65.51 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.23 0.612 . . . . 65.14 112.138 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.4 mm -88.36 -48.45 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.241 1.016 . . . . 73.23 111.367 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.0 169.7 39.0 Favored Glycine 0 C--O 1.238 0.353 0 C-N-CA 121.435 -0.412 . . . . 61.21 113.414 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.32 117.21 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.492 0.717 . . . . 61.24 110.329 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.7 mt -86.22 127.86 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.828 -0.804 . . . . 72.45 108.828 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -53.26 154.54 3.18 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.059 0.944 . . . . 72.15 112.833 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.3 m -132.01 127.0 35.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.953 0.901 . . . . 73.13 110.334 -175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -64.0 119.99 11.15 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.727 0.811 . . . . 65.32 109.986 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.72 -21.23 64.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.338 1.055 . . . . 74.25 112.529 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -86.53 -43.36 12.79 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.447 0.699 . . . . 62.52 112.037 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.6 p -89.46 -36.27 15.52 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.924 0.713 . . . . 44.03 112.924 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.43 77.09 Favored Glycine 0 CA--C 1.543 1.783 0 N-CA-C 112.712 -0.155 . . . . 51.44 112.712 -171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -99.46 151.18 37.34 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 124.631 1.172 . . . . 73.35 110.919 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.4 145.22 76.62 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.571 2.181 . . . . 52.4 111.436 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 59.3 mtt -74.47 92.26 2.34 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 109.234 -0.654 . . . . 72.42 109.234 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.621 ' HB ' HG23 ' A' ' 27' ' ' ILE . 79.9 mt -145.72 117.66 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.781 1.232 . . . . 73.44 108.172 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 30.4 m-80 -104.5 111.58 24.3 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 109.94 -0.393 . . . . 75.11 109.94 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -80.37 128.65 33.81 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.413 0.685 . . . . 74.44 110.053 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 70.4 m-85 -86.1 136.09 33.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.183 0.593 . . . . 74.33 110.708 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.3 m -128.82 138.73 52.23 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.516 1.126 . . . . 62.42 109.614 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.09 110.55 3.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.695 -0.854 . . . . 65.4 108.695 170.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -67.64 -22.52 65.32 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.986 0.515 . . . . 73.35 111.695 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 59' ' ' THR . 8.9 pt-20 -75.85 -48.43 21.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.614 0.766 . . . . 73.15 112.17 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 58' ' ' GLU . 60.5 p -91.61 -33.42 15.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.226 0.61 . . . . 74.51 112.075 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.26 3.1 76.09 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.728 -0.669 . . . . 33.3 113.54 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -93.01 161.28 14.51 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.436 0.618 . . . . 55.44 111.17 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.64 141.51 39.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.139 0.576 . . . . 24.34 111.217 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -78.45 -14.31 59.43 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 70.12 112.134 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.86 37.96 28.36 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 112.177 -0.369 . . . . 54.12 112.177 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 48.5 mt-10 -130.7 151.37 51.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.896 0.878 . . . . 70.31 109.627 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 141.76 14.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.915 0.486 . . . . 63.35 112.02 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.3 p -101.62 112.92 25.64 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.438 0.295 . . . . 73.34 110.836 172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -103.5 110.52 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.014 0.926 . . . . 64.1 110.038 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 47.3 m -87.86 107.08 18.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.843 0.457 . . . . 41.15 111.012 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.412 ' HZ ' ' HB3' ' A' ' 34' ' ' PHE . 46.1 m-85 -83.12 157.11 22.94 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.217 0.532 . . . . 74.52 110.352 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.68 -34.43 75.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.78 0.832 . . . . 74.31 110.684 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -118.51 134.12 23.49 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.399 0.68 . . . . 41.23 111.033 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.62 -36.56 89.79 Favored 'Trans proline' 0 CA--C 1.582 2.888 0 C-N-CA 122.517 2.144 . . . . 52.12 116.225 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.85 -32.81 77.2 Favored 'Trans proline' 0 C--N 1.397 3.125 0 CA-C-N 122.8 2.036 . . . . 53.13 114.107 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.7 p -78.13 -33.25 50.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.09 0.556 . . . . 73.4 110.394 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.84 -50.27 74.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.171 0.588 . . . . 60.13 111.205 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -61.87 -40.52 95.64 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.287 1.035 . . . . 73.01 110.796 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.97 94.03 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.776 -0.647 . . . . 72.52 111.872 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.06 -27.11 68.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.133 0.573 . . . . 55.45 112.408 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.1 mt -64.36 -63.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.519 0.328 . . . . 73.33 110.615 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.0 -28.16 66.11 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.672 0.789 . . . . 42.44 112.005 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -80.52 -61.01 2.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.117 0.567 . . . . 74.2 111.63 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 93' ' ' ILE . 72.8 m-85 -82.72 -10.83 58.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.162 1.171 . . . . 74.24 114.162 -169.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.53 94.13 0.27 Allowed 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 109.025 -0.732 . . . . 71.43 109.025 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.76 -12.65 11.85 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.195 -0.911 . . . . 43.14 114.444 -174.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 93' ' ' ILE . 49.0 mmtm -81.56 140.54 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.941 0.871 . . . . 72.03 110.612 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.9 121.19 31.01 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.148 -0.345 . . . . 73.04 111.842 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -83.95 -80.96 0.18 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.109 0.564 . . . . 72.12 109.719 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -104.33 57.03 0.71 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.501 0.667 . . . . 60.32 110.126 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 9.29 84.88 Favored Glycine 0 N--CA 1.48 1.62 0 CA-C-N 115.682 -0.69 . . . . 72.13 114.201 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -126.03 126.47 24.79 Favored Pre-proline 0 N--CA 1.484 1.24 0 C-N-CA 123.984 0.914 . . . . 72.45 110.534 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.15 108.62 1.37 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.796 2.33 . . . . 65.2 112.018 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 83' ' ' PHE . 11.3 pt -77.89 152.51 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.411 0.685 . . . . 72.42 111.872 -174.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -116.87 120.49 38.65 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.811 -0.811 . . . . 75.13 108.811 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 18' ' ' VAL . 21.6 t -116.0 136.77 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 122.751 0.42 . . . . 73.52 110.955 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 t -147.29 176.63 9.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.469 1.508 . . . . 62.32 108.703 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' HB3' HD22 ' A' ' 13' ' ' ASN . 39.9 m-85 -71.98 145.54 48.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.389 0.54 . . . . 75.33 111.094 169.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.63 76.32 10.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.237 0.615 . . . . 75.13 109.9 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.635 0.774 . . . . 64.43 111.317 -178.125 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.137 -0.32 . . . . 73.33 110.137 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.48 -14.7 15.82 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.398 0.919 . . . . 74.02 115.398 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -86.15 98.88 11.14 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 117.574 0.687 . . . . 74.55 111.474 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -170.07 142.91 2.39 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.537 1.135 . . . . 74.34 109.175 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -62.18 111.28 1.9 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.979 0.511 . . . . 74.44 111.541 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -76.72 -30.75 56.77 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.7 0.8 . . . . 71.25 111.241 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -76.22 134.99 39.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.733 0.813 . . . . 74.32 110.16 173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -64.84 123.97 20.78 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.198 0.599 . . . . 63.31 111.393 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.8 t -170.17 130.91 0.96 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.908 0.883 . . . . 42.12 110.815 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -79.01 -0.18 30.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 122.833 0.453 . . . . 71.11 111.178 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t 60.47 64.01 1.27 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.531 1.133 . . . . 73.43 110.709 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.8 27.0 1.64 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.773 -1.103 . . . . 74.33 112.121 -172.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 115.24 15.23 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 123.873 0.869 . . . . 75.14 109.806 176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -86.9 -17.47 33.17 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.915 0.486 . . . . 73.55 112.284 -168.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -95.28 137.89 33.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.054 0.541 . . . . 74.44 109.947 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 pt -113.89 148.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.842 -0.536 . . . . 52.14 111.184 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -105.5 113.95 27.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.614 -0.513 . . . . 72.32 109.614 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 95' ' ' VAL . 11.0 t -105.63 132.78 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.037 0.935 . . . . 73.15 109.639 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.58 162.39 18.07 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.855 0.862 . . . . 72.44 109.824 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.71 68.44 Favored Glycine 0 CA--C 1.538 1.521 0 N-CA-C 114.424 0.53 . . . . 74.22 114.424 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 18' ' ' VAL . 32.3 mt -80.24 -17.55 51.95 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.857 1.263 . . . . 74.55 112.459 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.65 173.5 46.93 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.967 0.747 . . . . 52.21 114.967 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.98 -13.4 60.87 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.28 1.032 . . . . 64.05 112.723 176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -93.19 11.32 28.28 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.922 0.889 . . . . 72.35 111.545 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.07 129.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 O-C-N 121.429 -0.794 . . . . 61.43 112.801 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.5 p -132.87 158.86 41.49 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.326 0.65 . . . . 70.21 110.475 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -51.88 -51.21 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.967 0.907 . . . . 75.34 111.593 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -71.06 -32.13 68.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.598 0.759 . . . . 74.33 112.891 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -72.06 -42.25 66.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.109 0.163 . . . . 74.43 111.004 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.86 -43.08 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 120.853 0.358 . . . . 64.52 110.445 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.71 87.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.891 -0.595 . . . . 24.42 112.242 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.06 -27.69 66.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.753 0.421 . . . . 60.44 111.282 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.38 -50.36 27.13 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 63.45 110.43 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 18.7 m-85 -82.81 -19.68 37.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.339 1.236 . . . . 72.3 114.339 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -67.1 -18.31 65.26 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 113.385 0.883 . . . . 62.53 113.385 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.78 -25.97 65.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.538 0.735 . . . . 62.54 111.799 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.5 mm -83.2 -38.7 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.376 1.07 . . . . 73.15 111.381 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.12 -179.81 48.24 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 116.172 -0.467 . . . . 71.2 113.156 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.7 120.13 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.178 0.591 . . . . 63.05 110.878 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 79.3 mt -93.85 123.78 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.362 0.665 . . . . 72.52 109.692 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 48.3 mtpt -48.61 146.85 2.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.157 0.983 . . . . 73.31 112.446 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 89.5 m -140.0 123.55 17.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.546 0.738 . . . . 73.33 110.717 -170.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -63.25 126.06 26.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.677 0.791 . . . . 65.13 109.719 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -79.36 -37.54 37.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.283 0.633 . . . . 74.44 111.973 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.32 -50.16 71.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.183 0.593 . . . . 75.13 111.29 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.7 p -79.43 -37.21 37.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.736 0.415 . . . . 60.42 111.344 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.58 63.91 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 116.379 -0.373 . . . . 23.13 112.464 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -111.15 144.31 30.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 123.93 0.892 . . . . 74.44 112.173 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 21.6 Cg_endo -61.35 139.17 81.26 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.81 2.34 . . . . 71.14 112.291 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 48.6 mtt -71.75 96.4 1.61 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.238 0.542 . . . . 72.25 110.112 -170.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 67' ' ' THR . 60.7 mt -141.12 126.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.434 1.093 . . . . 65.13 109.173 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.0 m-20 -103.1 110.43 22.37 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.994 -0.743 . . . . 62.23 108.994 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.8 mt -89.24 116.68 27.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 72.32 110.287 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -82.68 118.54 23.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.532 0.733 . . . . 62.3 110.744 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -106.65 148.92 27.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.368 1.067 . . . . 72.55 110.479 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.57 136.72 35.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.121 0.568 . . . . 64.34 110.949 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -72.66 -29.81 63.75 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.75 0.82 . . . . 63.14 112.627 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -84.89 -61.15 1.85 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.052 0.541 . . . . 64.2 111.023 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.5 p -76.77 -31.23 56.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.747 0.819 . . . . 71.11 112.092 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.58 2.03 90.58 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 116.376 -0.375 . . . . 74.1 113.458 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -84.75 151.78 24.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.696 0.799 . . . . 55.14 111.025 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 mt -67.2 129.86 41.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.92 -0.582 . . . . 71.02 109.679 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -72.78 -9.39 58.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.301 0.64 . . . . 75.02 112.281 -173.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.35 40.97 31.95 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.268 -0.733 . . . . 33.33 111.268 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -142.54 138.13 30.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.866 0.866 . . . . 64.11 109.099 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.0 152.62 24.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.846 0.458 . . . . 22.12 111.657 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.6 p -111.97 120.56 42.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 116.216 -0.447 . . . . 75.15 111.185 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.08 111.16 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.651 1.181 . . . . 61.45 110.295 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.3 t -83.96 108.94 17.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.462 0.305 . . . . 73.34 110.9 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 44.3 m-85 -85.5 160.04 19.78 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.131 0.491 . . . . 73.23 110.501 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.23 -37.87 57.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.291 0.636 . . . . 72.52 110.485 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -116.38 129.81 24.96 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.518 0.727 . . . . 63.14 110.606 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.55 -35.45 56.23 Favored 'Trans proline' 0 CA--C 1.579 2.765 0 C-N-CA 123.09 2.527 . . . . 73.24 116.668 169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.5 -32.94 97.08 Favored 'Trans proline' 0 C--N 1.395 3.017 0 CA-C-N 122.843 2.051 . . . . 70.12 113.313 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 m -71.84 -38.55 70.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.215 0.606 . . . . 65.43 110.297 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.77 53.82 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.391 -0.822 . . . . 63.24 110.969 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.46 -40.48 97.24 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.474 1.11 . . . . 65.2 111.717 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.91 97.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 61.14 112.041 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.67 71.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.253 0.621 . . . . 74.25 111.993 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 95' ' ' VAL . 75.2 mt -63.43 -62.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.969 0.508 . . . . 71.02 110.464 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.65 -32.07 66.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.672 0.789 . . . . 50.01 112.321 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -77.77 -55.3 5.45 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.033 0.533 . . . . 74.04 112.228 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HB3' HD11 ' A' ' 93' ' ' ILE . 73.9 m-85 -88.57 -15.67 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.47 118.45 7.55 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.347 0.521 . . . . 73.1 110.271 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.09 -1.79 78.04 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.824 0.69 . . . . 74.0 114.824 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.97 173.57 7.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.45 0.625 . . . . 71.42 111.139 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -107.61 106.74 17.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.088 0.555 . . . . 75.23 111.268 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -86.0 113.57 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.235 -1.024 . . . . 72.14 108.235 168.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t 61.01 24.5 14.6 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.303 0.641 . . . . 65.42 111.872 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.19 76.89 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 123.169 0.414 . . . . 70.54 113.969 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.51 126.01 45.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.84 0.856 . . . . 64.14 111.024 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.81 100.95 1.4 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.411 2.074 . . . . 74.45 112.226 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.5 pt -85.49 154.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 113.557 0.947 . . . . 72.32 113.557 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -126.13 113.83 17.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.746 1.218 . . . . 72.33 109.075 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.605 HG22 HG13 ' A' ' 18' ' ' VAL . 15.5 t -104.53 138.88 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.571 0.348 . . . . 71.21 110.615 -172.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.4 m -144.25 -178.7 6.09 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.788 1.235 . . . . 72.31 109.48 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.52 147.88 37.47 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.436 0.562 . . . . 75.11 110.734 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.11 83.63 4.32 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.022 -0.732 . . . . 70.54 109.022 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.527 0 C-N-CA 124.001 0.92 . . . . 72.4 111.563 -175.153 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mmm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 110.179 -0.304 . . . . 74.22 110.179 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.86 47.9 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 113.524 0.17 . . . . 54.51 113.524 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -70.25 93.43 0.84 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.606 0.762 . . . . 72.11 110.207 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -90.6 -31.61 16.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.263 0.625 . . . . 74.44 111.97 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -120.62 130.15 54.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.223 0.609 . . . . 75.52 110.883 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -77.39 -40.97 41.9 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.124 0.569 . . . . 72.34 111.915 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -138.6 122.73 18.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.023 0.929 . . . . 75.11 110.429 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -87.86 -52.67 5.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.709 0.804 . . . . 63.42 111.378 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.2 t -76.07 105.19 6.98 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.144 0.578 . . . . 54.52 111.46 -175.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -78.51 100.01 6.72 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.075 0.55 . . . . 74.31 110.025 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p -122.28 117.12 25.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.229 0.612 . . . . 53.33 109.869 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -79.48 -170.92 2.53 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.068 0.947 . . . . 64.04 111.895 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 2.2 m-20 -77.04 135.56 38.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.24 -0.652 . . . . 75.25 109.24 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.59 -19.86 30.41 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.758 0.423 . . . . 71.22 110.323 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 m -104.01 127.77 51.58 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.696 0.798 . . . . 41.24 109.698 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 76' ' ' ALA . 32.1 pt -109.43 154.26 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.775 0.83 . . . . 74.22 111.279 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -109.08 121.97 46.27 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.858 0.863 . . . . 71.35 109.954 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 95' ' ' VAL . 19.8 t -118.03 140.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.535 1.134 . . . . 73.0 110.253 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.01 158.03 34.69 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.983 0.913 . . . . 73.11 110.525 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.17 35.43 43.48 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 114.602 0.601 . . . . 44.1 114.602 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 93' ' ' ILE . 65.3 mt -80.57 -34.16 35.55 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.074 0.95 . . . . 73.24 112.321 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 153.06 8.58 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.087 -0.405 . . . . 72.53 112.087 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -80.33 -1.93 43.17 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.989 0.737 . . . . 62.22 112.989 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -120.82 29.93 7.14 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.332 0.653 . . . . 74.33 110.142 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.41 136.95 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 123.44 0.696 . . . . 62.22 111.682 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 30' ' ' VAL . 42.7 p -122.48 151.13 41.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 74.24 110.521 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 70.7 mt -53.43 -41.16 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.663 0.785 . . . . 74.34 111.091 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.42 -40.42 93.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.341 0.656 . . . . 74.1 112.404 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.5 p -72.31 -38.27 68.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.288 0.235 . . . . 71.01 111.52 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 41.3 t -65.41 -40.52 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.163 0.506 . . . . 54.32 110.195 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.39 -47.61 81.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.273 -0.876 . . . . 74.22 112.371 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.78 -32.25 72.7 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.374 0.669 . . . . 61.24 111.207 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -76.65 -49.83 15.23 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.013 -0.54 . . . . 73.15 111.158 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 83' ' ' PHE . 18.4 m-85 -80.48 -17.91 50.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.147 1.166 . . . . 71.04 114.147 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.99 -21.69 66.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.269 0.841 . . . . 74.43 113.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.22 -28.72 59.36 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.581 0.752 . . . . 73.43 112.153 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -82.32 -42.67 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 72.23 111.445 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.94 -178.92 47.06 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 116.392 -0.367 . . . . 70.35 113.326 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -70.49 119.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.068 0.547 . . . . 60.33 110.747 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 68.5 mt -87.2 125.29 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.888 -0.782 . . . . 63.11 108.888 173.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 53.7 mtpt -48.41 131.9 16.83 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.661 0.784 . . . . 71.21 112.184 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 53.5 m -116.17 123.17 47.15 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.57 -0.741 . . . . 72.41 110.709 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -63.68 119.0 9.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.72 0.808 . . . . 61.33 109.132 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -76.37 -27.16 56.29 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 73.02 111.586 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -72.97 -43.44 62.25 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.427 0.691 . . . . 64.15 111.615 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -84.52 -36.54 22.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.019 0.527 . . . . 74.15 111.411 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.6 66.41 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 115.799 -0.637 . . . . 73.05 112.415 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.05 157.74 47.89 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.41 1.084 . . . . 74.5 111.665 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 60.6 Cg_endo -69.83 155.33 65.97 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.489 2.126 . . . . 74.2 113.002 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.441 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.1 mtt -83.41 94.85 8.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.718 0.807 . . . . 75.41 109.186 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 89.3 mt -142.18 117.95 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.765 -1.107 . . . . 61.22 108.799 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -97.12 107.5 20.04 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.758 -0.83 . . . . 64.41 108.758 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.1 mt -77.03 150.29 35.8 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.914 -0.772 . . . . 73.1 108.914 172.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.83 128.61 55.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.805 0.442 . . . . 71.41 110.654 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -115.08 139.63 49.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.252 1.021 . . . . 73.03 110.259 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -66.45 128.19 35.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.767 0.827 . . . . 71.14 110.798 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -62.98 -34.66 77.99 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.52 0.328 . . . . 73.14 110.744 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -76.72 -58.08 3.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.454 0.702 . . . . 71.51 111.809 -172.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.4 p -81.37 -29.24 34.09 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.498 0.555 . . . . 62.42 112.498 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.39 5.96 86.09 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 116.57 -0.286 . . . . 64.42 113.208 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -96.77 167.9 10.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.109 0.963 . . . . 64.21 109.721 173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.1 mt -75.3 137.7 41.32 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.71 0.291 . . . . 71.3 110.512 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 6.6 mtpm? -67.82 -28.37 67.51 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.807 -0.633 . . . . 74.2 112.269 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.0 23.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.919 -0.582 . . . . 74.51 113.736 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -116.98 156.38 27.56 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.734 0.767 . . . . 71.4 110.228 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.14 149.81 14.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.429 0.692 . . . . 73.03 111.489 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 39.4 p -106.71 126.04 51.78 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.866 0.466 . . . . 53.53 110.498 172.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.56 110.99 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.526 0.73 . . . . 45.02 110.428 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 25.2 m -85.41 103.23 14.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.338 0.255 . . . . 54.52 111.071 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 63.7 m-85 -82.69 162.15 21.9 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.1 110.742 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.1 -40.19 62.88 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.62 -0.718 . . . . 61.34 110.929 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 26.7 m-20 -109.92 134.37 20.69 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.923 0.489 . . . . 75.24 112.049 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.09 -42.75 51.8 Favored 'Trans proline' 0 CA--C 1.581 2.837 0 C-N-CA 122.932 2.421 . . . . 72.23 116.199 168.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 59.6 Cg_endo -68.38 -24.12 37.33 Favored 'Trans proline' 0 C--N 1.398 3.157 0 CA-C-N 122.237 1.835 . . . . 73.24 112.713 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.0 t -71.3 -43.27 67.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.487 0.66 . . . . 55.4 109.787 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.93 -42.37 90.19 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.334 -0.848 . . . . 34.52 111.342 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -62.82 -43.36 99.0 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.78 0.832 . . . . 70.32 110.707 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.99 89.43 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.847 -0.615 . . . . 73.1 111.492 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.45 70.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.075 0.55 . . . . 73.51 112.003 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 95' ' ' VAL . 62.4 mt -68.4 -60.07 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 122.207 0.203 . . . . 72.02 110.478 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -59.37 -25.95 64.69 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.198 0.599 . . . . 73.51 111.871 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -82.68 -62.48 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.567 0.347 . . . . 74.41 111.811 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 95' ' ' VAL . 79.0 m-85 -80.52 -15.52 56.48 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.955 1.095 . . . . 73.01 113.955 -168.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.14 106.72 3.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.48 -0.563 . . . . 55.24 109.48 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.56 35.39 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 115.338 -0.847 . . . . 73.42 114.218 -174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -83.29 -177.04 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.466 0.633 . . . . 65.34 111.743 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -121.03 120.44 35.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.857 . . . . 73.43 109.843 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 93' ' ' ILE . 86.2 t80 -68.52 -69.5 0.32 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.097 0.559 . . . . 74.52 111.082 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.9 t -133.62 69.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.939 0.896 . . . . 70.35 109.167 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.87 -2.95 38.95 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 115.122 -0.945 . . . . 51.35 114.193 -172.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -115.87 125.89 28.22 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 124.262 1.025 . . . . 65.01 111.03 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.4 130.18 29.3 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.096 2.531 . . . . 74.45 112.742 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 88' ' ' PHE . 30.5 pt -116.4 144.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 121.908 0.861 . . . . 75.45 112.702 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -114.2 121.36 43.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.947 -1.501 . . . . 73.45 106.947 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 80' ' ' ILE . 25.8 t -113.85 138.71 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.258 0.551 . . . . 71.51 110.692 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.5 p -148.88 179.41 7.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.03 1.332 . . . . 64.05 109.481 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 13' ' ' ASN . 51.7 m-85 -78.37 145.1 35.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 118.526 0.603 . . . . 73.54 111.592 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.37 113.48 24.79 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.563 1.467 0 C-N-CA 123.153 0.581 . . . . 64.45 111.724 -176.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.556 1.192 0 CA-C-O 120.724 0.297 . . . . 70.22 111.168 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.54 2.16 Favored Glycine 0 CA--C 1.538 1.525 0 N-CA-C 114.603 0.601 . . . . 32.14 114.603 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -79.16 -13.95 59.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.597 0.759 . . . . 73.02 111.873 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.51 94.17 7.22 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.269 0.628 . . . . 71.1 109.959 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -66.57 -30.34 70.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.921 0.489 . . . . 75.14 110.619 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -96.85 137.75 35.45 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.142 0.977 . . . . 73.12 110.004 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -66.52 -47.75 71.94 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.254 0.622 . . . . 71.12 111.119 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -92.83 110.84 22.3 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.224 -0.658 . . . . 64.43 109.224 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.3 t -69.76 141.27 53.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.948 0.499 . . . . 64.4 111.103 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -98.7 -7.77 27.25 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.038 0.535 . . . . 73.51 111.677 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.6 p -145.52 114.64 7.01 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.159 0.584 . . . . 73.12 110.812 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -130.69 113.07 13.7 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.769 0.828 . . . . 53.23 108.845 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 97' ' ' PHE . 49.9 t30 -64.28 108.97 1.74 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.213 0.605 . . . . 54.13 111.187 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -98.74 1.58 46.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.867 0.867 . . . . 73.02 111.334 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -102.98 130.51 50.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.391 0.676 . . . . 64.41 109.509 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.22 138.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.23 0.612 . . . . 72.22 111.958 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -94.56 117.21 29.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.106 0.479 . . . . 75.03 110.469 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 95' ' ' VAL . 12.5 t -113.39 138.81 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.466 1.106 . . . . 75.3 110.279 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.95 162.57 22.04 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.343 1.057 . . . . 72.32 110.11 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.14 65.51 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 114.506 0.562 . . . . 70.23 114.506 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 25' ' ' VAL . 81.9 mt -72.34 -36.03 68.72 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.067 0.947 . . . . 73.43 111.879 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.27 158.07 11.68 Favored Glycine 0 N--CA 1.476 1.352 0 C-N-CA 123.219 0.438 . . . . 64.51 112.556 -173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.86 -19.43 61.96 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.015 0.908 . . . . 62.32 112.719 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -89.53 7.29 37.03 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.029 0.932 . . . . 75.43 111.323 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 21' ' ' LEU . 9.9 p -69.72 134.32 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 123.354 0.662 . . . . 62.14 112.444 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.0 p -120.4 163.05 18.48 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.016 -0.427 . . . . 65.23 110.007 171.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 51' ' ' ILE . 80.5 mt -57.83 -42.4 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 123.917 0.887 . . . . 74.54 111.5 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.41 -30.04 65.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.474 0.71 . . . . 74.41 111.776 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -45.85 81.53 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.783 0.433 . . . . 55.34 110.877 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' THR . 21.5 t -64.88 -40.84 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 121.19 0.519 . . . . 50.04 110.225 177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.58 88.79 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.34 -0.846 . . . . 53.43 111.744 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.88 -40.33 97.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.027 0.931 . . . . 71.22 111.582 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -72.31 -48.19 44.03 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.379 -0.828 . . . . 75.1 110.89 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.38 -19.57 35.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 114.548 1.314 . . . . 72.52 114.548 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.44 -16.61 63.81 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.835 1.05 . . . . 72.34 113.835 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -61.41 -29.18 69.77 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.089 0.555 . . . . 74.44 111.772 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.17 -42.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.057 0.943 . . . . 74.32 111.189 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.62 171.67 42.81 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 116.358 -0.383 . . . . 45.45 113.04 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.84 123.56 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.826 -0.435 . . . . 73.25 109.826 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.4 mt -93.97 129.76 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.99 0.916 . . . . 61.42 108.796 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.0 mtpt -51.04 140.51 15.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 64.14 112.311 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 56.0 m -128.45 121.81 29.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.181 -0.918 . . . . 62.04 109.829 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -57.63 119.57 6.83 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.208 1.003 . . . . 65.44 110.565 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -76.09 -16.94 59.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.704 0.802 . . . . 72.31 112.839 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -82.08 -52.29 7.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.649 0.379 . . . . 64.43 110.803 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -80.46 -46.62 15.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.25 0.62 . . . . 64.52 111.587 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.31 15.65 40.44 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.979 -0.555 . . . . 71.52 112.633 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -107.87 148.84 38.16 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.24 1.016 . . . . 54.4 111.827 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -67.75 149.88 78.82 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.409 2.073 . . . . 73.52 112.182 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.504 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 49.4 mtt -81.94 94.34 7.11 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.619 0.723 . . . . 75.43 109.67 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 27' ' ' ILE . 78.7 mt -145.88 117.56 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.501 1.121 . . . . 62.34 108.693 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 78.9 m-20 -96.88 109.38 22.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.67 -0.493 . . . . 73.43 109.67 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.01 150.19 39.04 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.554 0.534 . . . . 74.22 109.856 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 46.9 m-85 -107.65 132.28 53.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.275 0.63 . . . . 75.14 109.952 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -133.99 142.88 47.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.725 0.81 . . . . 73.21 110.042 -174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -76.67 114.83 15.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.798 0.439 . . . . 74.14 109.827 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -71.72 -8.03 51.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.293 0.637 . . . . 64.22 112.471 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -79.35 -56.27 4.46 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.392 0.677 . . . . 54.05 110.888 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 p -96.93 -21.13 17.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.733 0.813 . . . . 53.21 112.556 -173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 12.64 83.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 120.056 -0.302 . . . . 71.33 113.751 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -97.22 147.89 23.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.47 0.708 . . . . 75.2 111.588 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.81 138.32 56.05 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.103 0.561 . . . . 70.21 111.541 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -77.47 -17.23 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.342 0.657 . . . . 72.32 111.579 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.16 39.08 24.34 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.333 0.396 . . . . 62.21 112.33 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 46.8 mt-10 -135.25 153.05 52.05 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.916 0.886 . . . . 50.1 109.74 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -161.33 156.27 23.69 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.471 0.545 . . . . 55.01 112.471 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 69.5 p -113.87 118.57 34.57 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 122.745 0.418 . . . . 61.32 110.676 171.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.52 107.96 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.888 0.875 . . . . 75.11 111.025 -170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -83.82 102.65 12.49 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.716 0.407 . . . . 75.31 111.521 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 53.3 m-85 -79.81 149.86 30.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.403 0.681 . . . . 71.52 110.686 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.03 -32.75 57.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.395 0.678 . . . . 73.21 110.573 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.77 127.39 37.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.15 0.58 . . . . 72.31 110.473 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.31 -48.36 18.92 Favored 'Trans proline' 0 CA--C 1.581 2.874 0 C-N-CA 122.602 2.201 . . . . 73.12 115.532 170.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.85 -19.32 27.34 Favored 'Trans proline' 0 C--N 1.398 3.149 0 CA-C-N 122.2 1.821 . . . . 75.31 113.609 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -69.37 -33.67 73.41 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.222 0.609 . . . . 72.21 111.211 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.11 -51.29 56.01 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.925 -0.579 . . . . 64.33 111.466 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -65.85 -36.85 84.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.585 0.754 . . . . 71.31 111.092 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.96 -44.78 94.21 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.102 0.561 . . . . 71.2 111.796 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.53 67.76 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 74.1 112.699 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.491 HG12 HG12 ' A' ' 95' ' ' VAL . 82.2 mt -66.86 -58.38 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 120.899 0.381 . . . . 74.24 110.054 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.99 -27.79 69.11 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.434 -0.803 . . . . 72.4 112.166 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -81.5 -62.3 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.612 0.365 . . . . 71.42 111.344 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' HD11 ' A' ' 93' ' ' ILE . 66.8 m-85 -79.51 -11.73 59.89 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.282 1.215 . . . . 70.25 114.282 -168.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.42 111.06 1.86 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 118.508 0.595 . . . . 74.32 110.362 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.03 0.57 60.0 Favored Glycine 0 CA--C 1.541 1.718 0 N-CA-C 115.128 0.811 . . . . 53.15 115.128 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 73.3 mmtt -86.74 161.56 18.33 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 118.43 1.115 . . . . 71.21 111.105 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -99.23 119.92 38.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 75.24 111.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -84.21 -77.69 0.26 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 122.903 0.481 . . . . 72.53 110.222 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -118.13 75.48 1.01 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.46 0.704 . . . . 73.4 110.078 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.21 1.03 59.21 Favored Glycine 0 CA--C 1.54 1.652 0 N-CA-C 115.061 0.784 . . . . 75.21 115.061 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -132.9 138.01 30.92 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.483 0.713 . . . . 74.51 110.983 -175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.96 140.6 55.33 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.695 2.264 . . . . 70.01 111.975 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 83' ' ' PHE . 19.6 pt -110.38 152.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.223 0.609 . . . . 71.21 111.707 -171.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -118.18 114.76 23.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.461 0.704 . . . . 62.33 109.567 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 18' ' ' VAL . 15.9 t -109.22 133.45 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.606 0.362 . . . . 75.03 110.244 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.2 t -145.42 -178.67 6.2 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.455 1.102 . . . . 53.2 109.494 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 13' ' ' ASN . 97.7 m-85 -76.84 134.9 38.91 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.858 -0.526 . . . . 72.34 110.815 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 86.53 6.96 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.852 0.461 . . . . 72.12 110.548 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 124.221 1.008 . . . . 73.31 110.951 -178.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.61 0.243 . . . . 72.53 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.04 -157.0 33.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.678 -0.237 . . . . 51.22 113.609 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -94.5 140.36 29.94 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.927 0.891 . . . . 72.44 110.373 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -60.01 117.93 5.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.41 0.684 . . . . 63.43 111.527 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -53.87 -67.64 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.497 1.119 . . . . 74.42 113.005 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -82.54 123.81 29.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.024 0.44 . . . . 74.24 110.055 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -149.12 130.47 14.7 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.585 0.754 . . . . 72.33 110.392 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -95.79 28.73 2.94 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.484 0.714 . . . . 63.31 110.201 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 63.1 p -70.53 83.38 0.59 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.153 0.981 . . . . 74.41 113.097 -171.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.17 -68.17 0.92 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.804 -1.184 . . . . 72.24 107.804 167.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -65.89 -29.49 69.93 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 122.597 0.359 . . . . 71.31 111.013 168.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 9' ' ' SER . 38.9 t70 -81.31 2.05 29.87 Favored 'General case' 0 CA--C 1.567 1.596 0 C-N-CA 123.838 0.855 . . . . 63.33 112.1 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.477 HD22 ' HB3' ' A' ' 97' ' ' PHE . 41.6 t30 -80.23 135.29 36.23 Favored 'General case' 0 CA--C 1.556 1.187 0 O-C-N 121.107 -0.996 . . . . 71.3 110.076 168.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -92.0 -26.74 18.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.533 0.568 . . . . 72.0 112.533 -175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -93.87 132.08 38.64 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.051 0.54 . . . . 65.03 110.774 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 29.1 pt -113.23 147.92 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.64 . . . . 71.53 111.263 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -108.84 115.63 30.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.56 0.744 . . . . 75.54 110.426 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 t -111.75 143.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.831 0.852 . . . . 71.24 110.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -130.79 155.11 47.24 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.011 0.925 . . . . 72.41 111.484 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.72 24.64 37.93 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 114.367 0.507 . . . . 53.23 114.367 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.7 -16.28 51.75 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.934 0.894 . . . . 74.2 112.837 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.99 158.65 29.35 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 120.947 0.193 . . . . 73.04 113.444 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.91 -5.25 55.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.482 0.713 . . . . 74.21 112.857 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -111.18 18.74 19.05 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.818 0.847 . . . . 74.15 111.257 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.24 144.61 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 123.276 0.631 . . . . 71.25 112.318 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -124.09 154.62 39.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.196 0.598 . . . . 65.31 111.103 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 73.3 mt -55.45 -39.26 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.893 0.877 . . . . 74.34 110.881 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.055 0.942 . . . . 74.0 111.843 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -72.22 -40.91 67.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.513 0.325 . . . . 73.23 111.223 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.07 -42.08 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 121.082 0.468 . . . . 62.33 110.171 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.47 91.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.521 0.729 . . . . 73.32 111.808 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.96 -33.03 74.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.5 0.72 . . . . 72.35 110.764 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -71.04 -55.48 8.18 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.052 0.941 . . . . 74.12 111.085 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -81.51 -19.3 42.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.477 1.288 . . . . 73.12 114.477 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -61.35 -26.21 67.66 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.695 0.998 . . . . 74.12 113.695 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -61.72 -24.34 66.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.374 0.669 . . . . 72.01 112.323 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.9 mm -83.13 -50.95 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.992 0.917 . . . . 75.15 111.344 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 75' ' ' SER . . . -161.73 168.61 36.93 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.683 -0.69 . . . . 45.55 113.674 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.65 110.41 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.384 0.674 . . . . 74.55 110.669 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.1 mt -80.9 131.84 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 108.444 -0.947 . . . . 73.44 108.444 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.46 124.96 14.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.261 0.624 . . . . 73.21 111.085 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 30.6 m -113.43 120.15 40.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.643 -0.708 . . . . 74.44 110.487 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -60.93 108.77 0.91 Allowed 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.551 -0.907 . . . . 74.11 108.551 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.59 -27.59 62.27 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.398 0.679 . . . . 71.33 111.994 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -62.16 -50.17 72.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.716 0.806 . . . . 65.2 111.48 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -86.51 -40.27 15.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.383 0.673 . . . . 72.53 111.077 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 1.62 50.12 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-N 115.861 -0.609 . . . . 54.03 112.718 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -104.89 151.52 39.42 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 124.134 0.974 . . . . 64.32 112.444 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 72.9 Cg_endo -72.18 155.48 56.46 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.761 2.307 . . . . 51.33 112.712 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 54.7 mtt -83.77 95.17 8.34 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.47 0.652 . . . . 73.14 109.962 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.6 mt -142.59 124.49 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.442 1.097 . . . . 70.23 109.117 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 15.3 m120 -106.18 109.84 21.9 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.883 0.473 . . . . 74.51 110.085 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 66' ' ' ALA . 88.5 mt -83.63 124.92 31.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.684 0.794 . . . . 60.25 109.601 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 94.0 m-85 -83.02 125.77 31.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.917 0.487 . . . . 75.23 111.149 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 9.9 m -112.23 142.16 45.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.783 0.833 . . . . 75.42 109.845 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.7 129.7 37.52 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.924 0.489 . . . . 75.31 110.454 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -70.59 -27.86 64.43 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.3 1.04 . . . . 73.31 112.384 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -85.86 -50.57 7.02 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.318 0.647 . . . . 63.42 112.025 -175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.5 p -83.16 -30.8 27.54 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.566 0.746 . . . . 72.4 112.111 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.28 9.69 85.66 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 116.229 -0.441 . . . . 70.12 113.872 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -109.41 154.75 22.15 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.224 0.61 . . . . 54.12 110.966 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 mt -62.18 136.47 57.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.421 0.688 . . . . 73.51 111.921 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -73.34 -12.74 60.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.797 0.839 . . . . 74.3 111.918 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.65 42.44 21.58 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.827 -0.509 . . . . 44.24 111.827 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 50.6 mt-10 -131.81 147.93 52.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.915 0.886 . . . . 74.21 109.722 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -153.18 139.46 18.48 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.196 0.443 . . . . 73.11 112.196 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 37.8 p -101.25 119.5 38.85 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.844 -0.428 . . . . 75.24 109.844 169.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.3 t -109.24 108.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.631 0.772 . . . . 74.52 110.383 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 66.2 m -81.02 104.93 11.85 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.6 0.36 . . . . 65.41 111.117 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -82.1 157.56 24.04 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.94 0.496 . . . . 73.33 110.463 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -75.44 -37.66 60.21 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.999 0.52 . . . . 75.4 110.027 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -111.91 122.25 37.49 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.918 0.887 . . . . 63.45 110.261 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -53.53 -34.63 73.34 Favored 'Trans proline' 0 CA--C 1.583 2.939 0 C-N-CA 122.554 2.17 . . . . 75.31 116.565 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.61 -30.41 79.06 Favored 'Trans proline' 0 C--N 1.397 3.114 0 CA-C-N 122.687 1.995 . . . . 74.02 113.209 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.404 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 36.7 m -73.77 -35.74 65.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.038 0.446 . . . . 64.32 110.503 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.29 -50.09 74.42 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.434 -0.803 . . . . 62.02 111.285 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.25 -40.94 98.85 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.503 0.721 . . . . 61.14 111.161 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.34 98.99 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.965 -0.562 . . . . 64.24 111.813 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.44 75.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.447 0.699 . . . . 55.1 112.145 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 95' ' ' VAL . 69.7 mt -66.81 -56.95 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.822 -0.626 . . . . 63.11 110.599 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.44 -31.01 67.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.644 0.778 . . . . 73.13 111.876 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -80.55 -58.21 3.22 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.78 0.832 . . . . 72.45 111.993 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -85.24 -10.19 56.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.382 1.253 . . . . 73.23 114.382 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.08 119.28 11.75 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 118.575 0.625 . . . . 75.2 110.45 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.02 1.85 84.34 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.456 -0.793 . . . . 54.21 114.45 -175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.94 173.26 8.59 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 117.623 0.711 . . . . 71.11 110.793 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.33 122.95 48.03 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 122.105 -0.372 . . . . 71.22 111.718 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -92.99 -67.44 0.86 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.621 0.769 . . . . 74.33 110.028 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -112.95 50.09 0.9 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.695 0.798 . . . . 63.03 109.886 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 115.456 -0.793 . . . . 73.21 113.678 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -122.32 130.23 24.77 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.355 1.062 . . . . 63.23 110.387 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.2 94.0 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.53 2.153 . . . . 74.22 111.804 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.2 pt -71.33 155.34 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.977 0.911 . . . . 75.33 112.506 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -118.82 122.16 41.73 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.188 -1.042 . . . . 71.51 108.188 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.587 HG12 HG12 ' A' ' 80' ' ' ILE . 11.2 t -109.29 133.08 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.196 0.522 . . . . 73.45 110.002 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -133.05 -178.03 4.78 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.148 1.379 . . . . 44.0 109.019 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.477 ' HB3' HD22 ' A' ' 13' ' ' ASN . 32.7 m-85 -90.67 151.2 21.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 122.097 -0.377 . . . . 70.22 110.736 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.18 82.87 2.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.554 0.741 . . . . 51.53 109.216 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.568 1.635 0 CA-C-N 115.695 -0.684 . . . . 53.34 112.34 -172.188 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.64 0.257 . . . . 73.01 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.72 -65.57 3.52 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 114.31 0.484 . . . . 71.11 114.31 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -70.08 89.74 0.63 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.321 0.649 . . . . 73.34 112.248 -175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -156.96 104.15 2.09 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.879 0.872 . . . . 70.11 109.842 172.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -65.72 125.95 26.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.515 0.726 . . . . 74.41 110.522 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -75.06 81.05 2.23 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 120.923 0.392 . . . . 75.42 111.167 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -151.91 130.13 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 63.54 109.742 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -96.97 121.18 38.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.145 -0.687 . . . . 72.12 109.145 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -52.1 -46.5 65.29 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.497 1.119 . . . . 40.54 113.081 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -102.77 110.86 22.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.945 0.498 . . . . 73.2 110.03 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 t -127.13 109.62 12.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.384 0.674 . . . . 44.25 109.351 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.74 172.69 10.26 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.699 0.8 . . . . 75.42 110.443 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -51.31 107.05 0.16 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.17 0.988 . . . . 73.41 112.742 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -100.28 6.68 44.66 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.538 0.735 . . . . 72.34 111.229 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -108.65 126.21 52.73 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.615 0.766 . . . . 73.33 110.142 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 67' ' ' THR . 22.8 pt -105.5 157.9 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.681 0.792 . . . . 74.01 110.842 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -116.72 115.11 25.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.447 0.699 . . . . 74.43 110.095 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -104.98 145.02 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 124.401 1.08 . . . . 75.02 110.184 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -125.44 157.57 36.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.361 1.064 . . . . 73.35 110.056 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.12 41.7 92.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 115.233 0.853 . . . . 74.32 115.233 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.408 HD23 HG21 ' A' ' 93' ' ' ILE . 41.4 mt -81.82 -32.51 31.21 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.162 0.985 . . . . 61.21 111.639 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.76 161.26 11.7 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-N 116.182 -0.463 . . . . 65.54 112.619 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.48 -5.86 57.98 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.296 0.638 . . . . 73.2 112.064 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -94.54 14.0 22.25 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.506 0.723 . . . . 63.22 111.381 173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 p -75.42 138.53 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.421 0.688 . . . . 53.15 112.444 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.6 p -131.33 148.76 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.531 0.732 . . . . 54.44 110.947 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 51' ' ' ILE . 69.7 mt -51.66 -49.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.942 1.297 . . . . 65.24 112.893 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.91 -32.27 73.68 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 122.904 0.482 . . . . 71.41 111.935 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.2 t -74.37 -39.13 62.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.413 0.685 . . . . 73.24 111.536 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 26' ' ' THR . 42.7 t -63.97 -43.04 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 73.33 109.86 173.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.9 95.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.874 -1.057 . . . . 54.41 111.616 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.38 -34.17 77.67 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.634 0.773 . . . . 74.44 111.883 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -74.16 -53.51 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.881 0.472 . . . . 62.54 111.189 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 35.7 m-85 -77.87 -16.19 58.45 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.222 1.193 . . . . 75.3 114.222 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.19 -18.64 65.48 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.054 1.131 . . . . 61.41 114.054 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.02 -30.99 68.42 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.324 0.65 . . . . 75.22 111.914 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.59 -48.78 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.022 0.929 . . . . 70.42 110.896 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.7 173.18 40.59 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.426 -0.806 . . . . 50.14 112.695 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.88 127.83 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 122.989 0.516 . . . . 62.42 110.735 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 71.0 mt -97.54 134.79 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.637 0.775 . . . . 73.35 109.089 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 59.2 mtpt -62.22 155.64 24.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.457 0.703 . . . . 73.12 112.02 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 84.8 m -137.15 122.12 18.94 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.328 -0.851 . . . . 64.22 110.467 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -61.21 114.7 3.3 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.575 1.15 . . . . 43.25 109.47 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.26 -11.24 59.8 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.835 0.854 . . . . 72.24 112.878 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -83.4 -52.2 6.74 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.103 0.561 . . . . 73.41 110.598 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -79.67 -31.88 41.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.443 0.697 . . . . 71.22 111.691 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.17 4.2 81.58 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 116.008 -0.542 . . . . 42.55 112.964 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -104.92 149.86 38.04 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.42 1.088 . . . . 71.41 111.304 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.0 Cg_endo -63.65 146.73 92.72 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.369 2.046 . . . . 61.1 111.534 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 61.0 mtt -75.65 94.0 3.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.54 0.686 . . . . 60.4 109.471 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 27' ' ' ILE . 77.7 mt -144.08 127.89 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.85 1.26 . . . . 72.02 108.533 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 19.2 m120 -108.02 110.31 21.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.715 -0.476 . . . . 71.31 109.715 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.951 0.782 . . . . 41.43 109.343 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 67' ' ' THR . 79.7 m-85 -74.99 120.44 20.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.232 0.613 . . . . 73.4 111.134 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.3 m -100.57 140.02 35.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.693 0.797 . . . . 65.33 108.956 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.59 124.36 23.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.593 0.757 . . . . 60.43 110.848 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -64.72 -24.9 67.71 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.633 0.773 . . . . 63.43 112.978 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.44 -53.65 3.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.404 0.682 . . . . 74.2 111.604 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.1 p -84.18 -22.86 30.8 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.366 0.667 . . . . 74.42 112.65 -173.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 8.12 74.1 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.262 0.465 . . . . 64.42 114.262 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.61 149.53 21.14 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.073 0.949 . . . . 64.41 111.233 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.25 125.72 24.44 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 117.94 0.336 . . . . 72.03 110.485 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -72.51 -21.97 61.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.994 0.518 . . . . 71.3 112.31 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 22.05 66.54 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.183 -0.367 . . . . 74.44 112.183 -170.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -115.08 143.13 45.68 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.24 -1.022 . . . . 53.51 108.24 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -151.73 159.3 44.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.705 0.402 . . . . 61.35 111.915 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 p -114.65 120.72 41.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.606 0.362 . . . . 64.42 111.24 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.29 111.84 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 123.099 0.559 . . . . 61.32 110.534 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 68.9 m -88.86 105.62 17.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.413 0.685 . . . . 75.12 111.413 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 51.5 m-85 -80.81 161.14 24.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.863 0.865 . . . . 62.11 110.765 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.32 -33.93 65.41 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.592 0.757 . . . . 75.53 110.943 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.18 132.07 22.92 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 123.776 0.83 . . . . 64.25 111.189 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.46 -43.29 45.29 Favored 'Trans proline' 0 CA--C 1.584 2.991 0 C-N-CA 122.779 2.319 . . . . 74.23 115.288 165.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.99 -27.72 66.2 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 122.311 1.861 . . . . 71.22 113.563 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 m -69.57 -38.72 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.545 0.688 . . . . 74.01 109.838 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 80' ' ' ILE . . . -60.03 -54.78 41.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.628 -1.169 . . . . 65.3 110.861 175.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -59.22 -45.39 91.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.836 0.854 . . . . 75.4 111.404 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.94 99.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.946 -0.57 . . . . 64.12 111.686 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.05 -32.82 73.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.539 0.525 . . . . 72.23 111.992 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 95' ' ' VAL . 79.0 mt -65.33 -62.21 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.545 0.338 . . . . 64.5 111.049 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.65 -25.09 66.06 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 112.443 0.534 . . . . 75.31 112.443 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -78.26 -59.04 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.729 0.412 . . . . 74.12 110.945 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -86.62 -9.34 56.26 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.602 1.334 . . . . 71.32 114.602 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.87 106.28 1.85 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 118.732 0.696 . . . . 74.12 110.39 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.45 56.29 Favored Glycine 0 CA--C 1.546 1.985 0 CA-C-N 116.122 -0.49 . . . . 74.04 114.232 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 29.4 mmmt -80.71 175.9 10.27 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 123.761 0.824 . . . . 74.24 112.219 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.64 115.8 26.36 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.654 0.382 . . . . 74.21 111.383 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -82.55 -75.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.186 0.595 . . . . 75.21 111.042 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 t -98.93 37.31 1.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.324 0.65 . . . . 73.52 110.03 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.64 11.66 85.09 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 115.986 -0.552 . . . . 71.24 112.139 -164.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.1 121.6 41.24 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.433 1.093 . . . . 62.34 110.608 -175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 16.8 Cg_exo -66.21 96.2 0.33 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.937 2.425 . . . . 73.21 112.561 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.408 HG21 HD23 ' A' ' 21' ' ' LEU . 29.5 pt -74.86 153.58 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.181 0.992 . . . . 74.43 113.32 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -119.75 114.77 22.66 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.965 -1.124 . . . . 71.2 107.965 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 18' ' ' VAL . 19.2 t -109.39 137.28 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 120.974 0.416 . . . . 54.4 110.297 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -142.51 -174.52 4.16 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.336 1.454 . . . . 61.3 109.042 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -79.96 146.4 32.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.907 -0.495 . . . . 70.14 110.69 169.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.4 107.97 18.26 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.939 -0.393 . . . . 74.13 109.939 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.489 1.486 0 C-N-CA 123.385 0.674 . . . . 75.41 112.068 -176.744 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 110.311 -0.255 . . . . 71.52 110.311 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.03 118.62 13.71 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 123.091 0.377 . . . . 33.41 113.508 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -77.2 101.19 6.08 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.657 0.783 . . . . 72.1 110.474 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -104.49 92.82 4.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.526 0.731 . . . . 62.12 112.167 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.74 117.71 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.934 1.294 . . . . 72.11 108.531 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -73.28 -86.29 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.103 -0.373 . . . . 74.15 111.882 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 57.04 29.78 17.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.351 1.061 . . . . 62.03 111.006 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -94.93 103.37 15.23 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.665 0.786 . . . . 73.3 110.46 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -153.69 116.14 4.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.364 0.666 . . . . 71.31 110.24 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -67.17 -43.47 82.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.689 0.795 . . . . 70.11 110.573 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -101.52 82.11 2.26 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.95 0.9 . . . . 72.01 109.692 170.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -83.27 90.51 7.14 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.648 0.737 . . . . 71.24 109.18 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -67.17 138.34 56.93 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.779 0.831 . . . . 63.44 113.127 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -98.13 -17.34 19.1 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.348 -0.842 . . . . 64.51 110.681 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 m -97.83 126.59 43.28 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.277 0.56 . . . . 71.35 110.059 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.2 pt -105.72 153.93 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.789 0.836 . . . . 73.33 111.13 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -109.41 125.19 52.14 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.144 0.578 . . . . 74.12 109.903 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 HG22 ' A' ' 95' ' ' VAL . 18.7 t -121.31 141.75 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.081 0.952 . . . . 71.44 109.901 -175.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -127.87 159.87 33.54 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.902 0.881 . . . . 74.24 110.539 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.5 32.12 35.1 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 114.303 0.481 . . . . 53.34 114.303 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.81 -28.38 24.53 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.888 0.875 . . . . 63.4 112.225 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.96 161.49 18.71 Favored Glycine 0 N--CA 1.479 1.521 0 C-N-CA 123.068 0.366 . . . . 70.01 113.496 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -83.78 -2.0 55.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.712 1.004 . . . . 54.53 113.712 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -121.19 21.6 11.15 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.395 0.678 . . . . 53.33 111.902 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.77 142.77 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 C-N-CA 123.291 0.636 . . . . 62.15 111.528 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 30' ' ' VAL . 44.0 p -122.62 153.83 38.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.451 -0.78 . . . . 74.55 110.618 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HG23 ' HB ' ' A' ' 51' ' ' ILE . 93.4 mt -53.46 -40.29 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.146 0.978 . . . . 70.11 111.43 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.29 -44.18 95.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.787 0.835 . . . . 63.23 111.53 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -68.94 -41.26 78.31 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.182 0.593 . . . . 71.05 111.844 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 26' ' ' THR . 56.9 t -64.6 -43.42 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.119 0.568 . . . . 75.42 110.021 176.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.95 88.75 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.368 -0.833 . . . . 61.33 111.753 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -67.42 -30.46 70.22 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.268 0.627 . . . . 62.14 111.6 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -72.61 -55.07 7.43 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.792 0.837 . . . . 73.33 111.64 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 77.2 m-85 -81.1 -20.01 42.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.413 1.264 . . . . 73.41 114.413 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -58.0 -29.93 65.66 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.659 0.985 . . . . 75.22 113.659 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.01 -26.49 67.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.815 0.846 . . . . 50.04 112.598 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 mm -79.27 -47.6 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.751 0.821 . . . . 55.32 110.758 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 173.99 43.03 Favored Glycine 0 N--CA 1.463 0.497 0 CA-C-N 116.211 -0.449 . . . . 62.52 113.295 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -67.28 124.3 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.379 0.671 . . . . 52.24 110.837 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 65.3 mt -94.37 131.86 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.062 0.945 . . . . 44.45 109.625 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 63.1 mtpt -54.91 144.99 21.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.464 0.706 . . . . 71.31 111.743 173.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 92.4 m -126.19 128.21 46.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.265 -0.879 . . . . 71.03 109.794 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -69.56 114.36 7.71 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.797 0.839 . . . . 74.31 108.942 172.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.96 -15.27 60.19 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.42 0.688 . . . . 74.21 112.254 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.73 -36.19 65.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.985 0.514 . . . . 73.51 111.371 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -98.67 -41.77 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.485 0.714 . . . . 73.1 111.761 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.58 8.07 54.99 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 115.754 -0.657 . . . . 33.13 112.812 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.9 150.16 52.43 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 123.931 0.892 . . . . 72.2 112.377 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 36.4 Cg_endo -61.48 145.03 98.34 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.434 2.756 . . . . 72.34 112.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.518 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 60.8 mtt -74.81 97.11 3.21 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.384 0.612 . . . . 74.21 109.789 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 27' ' ' ILE . 99.2 mt -142.0 124.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.545 1.138 . . . . 75.34 109.043 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.9 m-20 -101.85 107.43 18.61 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.031 -0.729 . . . . 65.4 109.031 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.22 134.93 36.17 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.722 -0.844 . . . . 54.14 108.722 171.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HE2' HG23 ' A' ' 67' ' ' THR . 96.5 m-85 -100.01 122.15 42.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.008 0.523 . . . . 71.2 110.379 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 m -102.54 141.44 35.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.261 1.024 . . . . 74.4 110.218 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.8 133.82 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.165 0.586 . . . . 74.35 109.584 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -87.31 -24.86 24.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.554 0.742 . . . . 72.22 112.798 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.09 -34.98 14.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.271 0.471 . . . . 74.21 112.271 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -90.75 -53.52 4.37 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 112.074 0.398 . . . . 71.43 112.074 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.63 -0.88 34.33 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 116.025 -0.534 . . . . 51.32 113.587 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.06 152.93 19.72 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.451 0.7 . . . . 64.15 109.75 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 84.3 mt -62.66 140.55 58.7 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.097 0.475 . . . . 70.21 111.788 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -74.11 -13.08 60.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.969 0.908 . . . . 54.32 112.186 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 29.53 39.69 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.453 -0.34 . . . . 55.31 112.531 -174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.5 145.07 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.971 0.909 . . . . 73.22 109.631 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.64 147.0 18.41 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.963 0.411 . . . . 73.12 111.919 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 75.0 p -102.01 133.6 46.56 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.9 -0.591 . . . . 44.11 110.159 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -115.1 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 123.139 0.576 . . . . 64.42 110.339 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 43.9 m -85.14 102.3 13.16 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.849 0.46 . . . . 64.53 110.961 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 50.7 m-85 -79.45 155.51 28.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.116 0.566 . . . . 71.34 110.747 170.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.71 -35.76 72.89 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.216 0.606 . . . . 74.24 110.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -114.38 129.01 25.27 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.379 0.671 . . . . 52.14 111.337 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.51 -37.99 83.02 Favored 'Trans proline' 0 CA--C 1.587 3.15 0 C-N-CA 123.108 2.538 . . . . 70.21 116.42 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.64 -24.87 40.98 Favored 'Trans proline' 0 C--N 1.396 3.047 0 CA-C-N 122.611 1.968 . . . . 72.32 112.857 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -74.59 -38.12 62.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.647 0.779 . . . . 63.2 110.21 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.42 -51.34 70.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.779 -1.1 . . . . 44.12 110.692 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -65.17 -39.15 92.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.32 -0.854 . . . . 75.15 111.299 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.0 94.71 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.396 0.278 . . . . 70.23 111.285 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -29.48 70.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.404 0.682 . . . . 70.0 112.222 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 77' ' ' LYS . 89.6 mt -65.61 -63.46 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.018 0.527 . . . . 65.1 110.674 173.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.05 -25.59 67.77 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.403 -0.817 . . . . 74.14 111.698 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -82.12 -60.23 2.29 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.871 0.469 . . . . 74.14 111.691 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.728 1.381 . . . . 73.34 114.728 -169.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.33 119.87 12.31 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.678 0.672 . . . . 71.34 109.74 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.35 5.35 75.97 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 114.86 0.704 . . . . 42.22 114.86 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 74.9 mmtt -88.29 -167.8 2.0 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 117.939 0.869 . . . . 75.22 111.525 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.13 118.06 23.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.098 0.959 . . . . 72.24 109.981 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 93' ' ' ILE . 67.9 t80 -78.8 -75.11 0.25 Allowed 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 120.67 0.271 . . . . 72.44 110.578 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.4 t -122.84 61.21 1.01 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.778 0.799 . . . . 64.34 110.077 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.41 2.49 84.39 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-N 115.011 -0.995 . . . . 73.04 114.076 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -117.18 136.51 23.41 Favored Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.998 0.919 . . . . 74.31 110.186 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 73.5 Cg_endo -73.07 116.7 4.81 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.555 2.17 . . . . 74.41 112.153 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' A' ' 88' ' ' PHE . 41.1 pt -92.56 153.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.574 0.749 . . . . 73.53 113.005 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -123.95 119.09 28.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.215 1.006 . . . . 74.3 108.869 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG13 ' A' ' 18' ' ' VAL . 32.6 t -112.85 134.12 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.598 0.759 . . . . 71.11 110.136 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.7 p -146.42 -176.33 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.742 1.217 . . . . 72.43 109.182 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -76.46 145.33 39.31 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.01 0.823 . . . . 73.44 110.778 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.25 93.28 8.16 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.04 0.448 . . . . 54.2 110.793 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 124.036 0.935 . . . . 70.05 111.261 178.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.112 0.006 . . . . 73.54 111.007 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.61 23.8 69.08 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 115.23 0.852 . . . . 72.44 115.23 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -86.43 -48.55 8.34 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.055 0.542 . . . . 74.04 111.164 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -90.66 92.25 8.75 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.031 -0.729 . . . . 73.1 109.031 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -72.08 74.79 0.94 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.968 0.907 . . . . 71.35 111.734 -172.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 58.25 21.02 7.7 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.596 1.158 . . . . 74.21 112.622 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -86.6 -29.92 22.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.106 0.562 . . . . 63.32 109.638 173.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.53 113.12 22.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.964 -0.754 . . . . 63.53 108.964 168.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -72.7 111.2 7.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.614 0.366 . . . . 62.44 111.539 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -69.24 -55.77 9.57 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.398 0.679 . . . . 72.05 109.309 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -179.34 50.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.929 1.292 . . . . 52.3 108.149 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.96 25.8 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.02 1.489 . . . . 74.31 115.02 -163.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -65.49 129.76 40.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.78 0.432 . . . . 74.01 110.735 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -87.44 -22.03 25.21 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.146 -0.479 . . . . 62.05 110.328 174.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -96.44 132.48 41.94 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.579 0.752 . . . . 75.11 110.625 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 76' ' ' ALA . 35.7 pt -114.96 152.87 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.879 0.872 . . . . 40.03 111.061 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -107.7 116.45 31.96 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.158 0.583 . . . . 72.41 110.175 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 95' ' ' VAL . 19.1 t -109.6 134.15 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.212 1.005 . . . . 75.33 110.436 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -120.12 157.19 29.53 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.063 0.945 . . . . 43.22 110.562 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.88 29.55 28.58 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-O 121.241 0.356 . . . . 70.54 113.941 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.8 mt -86.28 -13.46 46.62 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.153 0.981 . . . . 72.2 112.957 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.0 54.25 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 114.878 0.711 . . . . 71.21 114.878 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.88 -24.61 48.43 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.813 0.845 . . . . 65.12 112.34 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.67 20.02 9.16 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.416 0.686 . . . . 62.11 111.787 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG13 HD13 ' A' ' 62' ' ' LEU . 5.0 p -80.14 131.73 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.056 0.543 . . . . 52.31 112.0 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.4 p -129.39 154.67 46.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.406 0.682 . . . . 75.14 110.292 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB ' ' A' ' 51' ' ' ILE . 90.4 mt -50.24 -52.51 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 124.283 1.033 . . . . 65.12 111.815 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.42 -37.03 84.28 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.568 -0.742 . . . . 73.31 111.462 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.2 m -69.9 -36.89 75.77 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.107 0.41 . . . . 62.33 112.107 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -67.5 -37.9 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 120.977 0.417 . . . . 55.23 110.052 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.74 66.06 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.924 0.49 . . . . 54.12 111.594 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.34 -32.52 58.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.101 0.96 . . . . 74.31 111.434 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.14 -49.69 41.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.659 0.784 . . . . 74.01 110.392 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.458 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 14.2 m-85 -82.89 -16.96 45.45 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 114.556 1.317 . . . . 54.15 114.556 -173.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -66.98 -17.36 64.88 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.471 0.915 . . . . 73.35 113.471 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.55 -24.75 63.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.039 0.536 . . . . 73.42 111.99 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.06 -41.08 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.304 1.042 . . . . 75.02 111.375 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.11 176.45 47.19 Favored Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.454 -0.403 . . . . 74.23 113.993 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 61.5 mt -68.4 126.18 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.899 0.479 . . . . 55.14 109.911 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 81.0 mt -94.64 141.88 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.712 0.805 . . . . 75.42 109.038 173.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 26.4 mtpp -59.78 144.67 47.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.366 0.666 . . . . 72.12 111.658 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 91.3 m -128.4 120.27 26.62 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.489 -0.778 . . . . 71.53 109.569 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.16 114.72 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.017 -0.734 . . . . 73.22 109.017 171.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.35 -28.28 66.08 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.277 1.031 . . . . 73.42 111.777 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 11.5 mmpt? -71.61 -45.87 60.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.29 0.636 . . . . 75.24 111.74 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 p -82.98 -35.17 26.11 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.134 0.574 . . . . 74.15 111.453 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.17 17.79 64.15 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.78 -0.645 . . . . 72.22 112.404 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -120.98 152.07 55.94 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.407 1.083 . . . . 74.44 111.79 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HG2' HG22 ' A' ' 27' ' ' ILE . 18.8 Cg_endo -61.42 146.77 96.83 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.739 2.292 . . . . 74.22 113.141 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.539 ' SD ' ' HE3' ' A' ' 41' ' ' LYS . 52.7 mtt -82.75 97.1 8.41 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.016 0.526 . . . . 73.23 110.646 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 27' ' ' ILE . 70.2 mt -144.27 117.48 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.183 0.993 . . . . 71.44 109.132 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.56 110.37 22.19 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.589 -0.523 . . . . 74.45 109.589 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.7 mt -82.31 115.35 21.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.46 0.704 . . . . 74.41 110.196 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -69.89 117.33 11.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.061 0.545 . . . . 60.43 110.247 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 m -122.39 139.13 54.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.02 0.928 . . . . 62.01 109.59 -175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -73.32 135.63 44.38 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.175 0.59 . . . . 61.13 111.62 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 15.4 ptm180 -64.64 -38.33 90.65 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.459 1.103 . . . . 75.22 112.674 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 45.4 mt-10 -80.77 -55.52 4.76 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.252 0.621 . . . . 75.21 111.839 -171.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.2 p -84.07 -31.19 25.47 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.3 0.64 . . . . 45.1 111.794 -174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.99 8.71 86.26 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 116.438 -0.346 . . . . 64.0 113.22 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -92.8 152.32 19.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.213 0.605 . . . . 73.34 111.937 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 25' ' ' VAL . 82.8 mt -65.76 126.46 28.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.767 0.827 . . . . 44.14 110.784 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -71.27 -12.97 61.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.051 0.94 . . . . 62.24 112.201 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.97 37.73 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 112.014 -0.435 . . . . 72.24 112.014 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.47 149.27 49.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.998 . . . . 73.22 109.552 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.32 159.13 25.1 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.492 0.553 . . . . 72.11 112.492 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 23.5 p -115.24 114.08 24.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.132 0.573 . . . . 71.42 111.323 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 51' ' ' ILE . 21.6 t -99.81 108.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 124.432 1.093 . . . . 75.51 110.608 -173.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 42.2 m -84.98 101.76 12.63 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.686 0.394 . . . . 72.5 111.28 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 38.0 m-85 -77.37 156.13 31.44 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.097 0.559 . . . . 73.21 111.18 171.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.08 -27.41 54.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.298 0.639 . . . . 63.15 111.296 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 22.8 m-20 -120.0 131.38 24.43 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 122.942 0.497 . . . . 70.44 111.743 171.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.37 -38.3 82.37 Favored 'Trans proline' 0 CA--C 1.583 2.93 0 C-N-CA 122.879 2.386 . . . . 64.13 115.68 168.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 72' ' ' ASP . 37.7 Cg_endo -64.98 -25.42 59.35 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 123.03 2.118 . . . . 62.04 113.404 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.9 m -76.17 -37.24 58.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.072 0.549 . . . . 73.01 110.19 174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -61.69 -48.29 81.46 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.324 0.649 . . . . 71.3 111.015 174.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.42 -47.5 85.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.279 1.032 . . . . 75.21 110.799 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.34 93.88 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.604 -0.725 . . . . 64.44 111.738 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -31.76 73.07 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.321 0.648 . . . . 63.21 112.507 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' VAL . 72.5 mt -63.62 -61.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.264 0.226 . . . . 74.45 110.599 172.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.19 -24.7 65.0 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.421 0.688 . . . . 62.42 112.643 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -80.21 -59.38 2.73 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.44 0.696 . . . . 74.15 111.617 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB3' HD11 ' A' ' 93' ' ' ILE . 77.1 m-85 -85.84 -10.83 54.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.194 1.183 . . . . 74.12 114.194 -170.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.68 115.14 4.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.376 0.534 . . . . 61.31 110.258 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.53 68.58 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 114.921 0.728 . . . . 71.15 114.921 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.5 mmtt -94.08 141.46 28.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.111 0.956 . . . . 73.33 111.935 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.04 116.13 19.14 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.599 0.759 . . . . 74.32 112.179 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -90.9 -78.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.582 0.753 . . . . 54.33 110.949 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.6 t -109.26 54.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.968 0.889 . . . . 73.51 110.248 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.64 8.48 87.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.983 -1.008 . . . . 74.21 113.83 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -133.59 136.82 27.54 Favored Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 123.811 0.845 . . . . 74.01 109.878 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.73 116.55 4.76 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.739 2.293 . . . . 75.53 110.893 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 83' ' ' PHE . 16.0 pt -80.45 154.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.735 0.642 . . . . 72.51 112.735 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -119.22 112.3 19.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.369 -0.975 . . . . 72.23 108.369 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 18' ' ' VAL . 14.2 t -107.0 137.02 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.019 0.528 . . . . 72.05 110.876 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.6 m -141.51 179.86 6.56 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.997 1.319 . . . . 63.41 109.207 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.31 149.59 31.72 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.807 0.731 . . . . 73.23 110.399 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.89 85.92 7.03 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.024 0.44 . . . . 73.42 110.117 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.571 1.752 0 C-N-CA 123.209 0.604 . . . . 71.43 112.135 -176.114 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 111.642 0.238 . . . . 73.33 111.642 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.5 -158.01 28.81 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.356 -0.383 . . . . 73.32 113.106 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -101.33 85.9 2.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.887 0.875 . . . . 74.33 111.918 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 64.44 -2.75 0.59 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.841 1.793 . . . . 65.35 115.841 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -91.04 -7.73 51.03 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 119.059 0.845 . . . . 73.12 111.832 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -114.03 125.71 54.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.681 0.793 . . . . 75.35 109.703 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -76.1 127.63 33.34 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 72.32 111.361 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -89.36 40.54 0.99 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.29 0.567 . . . . 74.51 111.826 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -62.72 156.62 23.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.655 0.782 . . . . 61.4 111.712 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 62.12 74.08 0.45 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.206 1.002 . . . . 71.35 111.596 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.7 t -100.8 -11.64 19.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.754 0.822 . . . . 62.33 111.737 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -78.95 102.0 8.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.964 0.506 . . . . 70.13 111.931 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 14.5 m120 -105.8 138.78 41.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.689 0.795 . . . . 74.11 110.39 173.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -93.43 -22.84 18.66 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.976 0.511 . . . . 62.05 111.067 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -106.18 125.67 51.28 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.843 0.857 . . . . 71.21 110.747 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 76' ' ' ALA . 30.3 pt -114.9 148.28 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.906 0.882 . . . . 64.23 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -102.14 120.05 39.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.433 0.693 . . . . 73.11 109.607 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 95' ' ' VAL . 14.4 t -114.9 136.13 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.186 0.994 . . . . 72.23 110.388 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -124.37 162.69 23.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.131 0.973 . . . . 72.23 110.234 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.92 25.93 61.33 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 114.203 0.441 . . . . 61.04 114.203 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 93' ' ' ILE . 77.0 mt -79.03 -22.38 45.51 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.352 1.061 . . . . 54.21 112.013 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.87 167.66 42.47 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.083 0.373 . . . . 63.22 113.227 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.62 -19.56 59.13 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 112.84 0.682 . . . . 72.44 112.84 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -86.91 6.93 29.51 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.145 0.578 . . . . 74.52 111.934 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.2 138.03 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 124.198 0.999 . . . . 42.42 112.242 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -129.44 151.15 50.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.756 -0.59 . . . . 73.4 110.061 171.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 51' ' ' ILE . 67.9 mt -49.19 -51.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.631 1.172 . . . . 64.44 112.773 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.68 -21.1 55.85 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.788 0.662 . . . . 72.53 112.788 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.6 m -73.85 -37.55 64.75 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 117.962 0.346 . . . . 65.53 111.099 171.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.23 -41.48 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 121.309 0.576 . . . . 70.31 109.7 171.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.5 92.42 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.341 -0.845 . . . . 75.2 111.596 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.93 -38.11 89.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.273 0.629 . . . . 72.24 111.047 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -67.27 -55.9 12.06 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.816 0.846 . . . . 63.44 111.385 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.446 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 49.0 m-85 -77.94 -21.64 50.75 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.584 1.327 . . . . 64.31 114.584 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.87 -20.04 66.09 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.983 1.105 . . . . 74.5 113.983 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -60.56 -22.28 63.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 122.985 0.514 . . . . 73.22 112.15 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.08 -42.45 14.95 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 124.507 1.123 . . . . 73.14 111.424 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 172.67 45.12 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.981 -0.554 . . . . 73.3 113.229 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.2 mt -70.96 125.47 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.557 0.743 . . . . 60.14 110.719 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 73.2 mt -95.56 130.5 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.943 0.897 . . . . 54.22 109.388 176.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.596 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 62.5 mtpt -51.04 153.99 1.68 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.743 0.817 . . . . 71.24 112.91 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 52.4 m -140.07 125.46 18.97 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.613 0.765 . . . . 71.23 110.508 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.414 HD21 ' HB2' ' A' ' 45' ' ' LYS . 40.1 t30 -64.13 123.87 20.19 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.448 0.699 . . . . 72.13 111.038 174.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -71.78 -24.02 61.67 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.109 0.563 . . . . 63.1 112.414 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HB2' HD21 ' A' ' 43' ' ' ASN . 34.0 mmtp -69.8 -54.36 13.99 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.807 0.443 . . . . 65.1 111.577 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 p -84.57 -45.3 12.7 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.196 0.598 . . . . 74.44 111.668 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.97 37.8 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.973 -0.558 . . . . 65.02 112.523 -170.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -106.13 148.94 37.52 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.128 0.971 . . . . 75.53 111.28 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 51.0 Cg_endo -68.14 145.97 68.62 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.598 2.198 . . . . 72.14 111.922 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.596 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 58.2 mtt -77.16 94.79 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.563 0.697 . . . . 71.2 110.026 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.587 ' HB ' HG23 ' A' ' 27' ' ' ILE . 86.7 mt -144.54 116.44 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.053 1.341 . . . . 74.51 108.49 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -99.03 109.43 22.18 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.155 -0.683 . . . . 51.34 109.155 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.84 120.8 26.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.138 0.575 . . . . 73.11 110.06 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.568 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 57.0 m-85 -73.12 104.35 4.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.011 0.524 . . . . 74.34 110.994 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -86.76 160.0 18.95 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.953 0.901 . . . . 62.14 110.065 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -93.45 155.1 17.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.953 0.901 . . . . 73.35 111.962 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -93.16 -35.64 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.658 0.783 . . . . 73.44 112.834 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.431 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.4 pt-20 -88.97 -37.99 14.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.93 -0.482 . . . . 63.23 111.952 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 58' ' ' GLU . 31.5 p -94.01 -33.38 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 112.522 0.564 . . . . 73.42 112.522 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.86 6.26 89.16 Favored Glycine 0 CA--C 1.541 1.656 0 N-CA-C 114.223 0.449 . . . . 33.14 114.223 -174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -102.1 171.72 7.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.689 0.796 . . . . 62.15 110.78 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.37 130.26 39.33 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.972 -0.455 . . . . 61.2 111.71 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -74.78 -18.96 60.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.432 0.693 . . . . 61.31 112.548 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 35.1 12.61 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 116.362 -0.381 . . . . 50.43 113.064 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 41.3 mt-10 -127.94 154.06 45.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.2 1.0 . . . . 70.42 109.042 173.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.57 164.08 24.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.093 0.557 . . . . 71.14 111.822 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.0 p -120.26 128.92 53.77 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.998 -0.546 . . . . 71.4 109.98 168.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.42 111.8 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.575 0.75 . . . . 63.44 110.809 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 m -89.21 102.71 15.37 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.936 0.494 . . . . 72.03 111.724 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 34.7 m-85 -78.09 156.85 29.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.707 0.803 . . . . 71.41 110.625 168.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.1 -32.31 44.55 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.045 0.538 . . . . 72.21 110.434 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 4.0 m-20 -106.08 122.58 41.82 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 123.59 0.756 . . . . 62.23 110.453 174.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 72' ' ' ASP . 5.3 Cg_endo -49.94 -42.45 44.97 Favored 'Trans proline' 0 CA--C 1.586 3.108 0 C-N-CA 122.918 2.412 . . . . 61.53 115.789 167.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.32 -25.5 71.57 Favored 'Trans proline' 0 C--N 1.406 3.564 0 CA-C-N 122.602 1.965 . . . . 52.43 113.117 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.8 m -76.59 -37.22 56.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.436 0.694 . . . . 73.14 110.917 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -65.07 -47.21 78.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.082 0.553 . . . . 53.51 111.151 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -64.58 -42.96 95.29 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.562 0.745 . . . . 75.21 111.282 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.42 89.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.285 -0.416 . . . . 71.41 111.847 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.65 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.398 0.679 . . . . 73.35 112.385 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.488 HG12 HG12 ' A' ' 95' ' ' VAL . 72.4 mt -64.24 -63.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.528 0.331 . . . . 53.44 110.326 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.3 -31.76 63.97 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.556 0.742 . . . . 74.14 112.45 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -78.49 -56.98 4.02 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.499 0.72 . . . . 74.21 111.921 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 93' ' ' ILE . 62.7 m-85 -88.13 -4.1 58.8 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.242 1.201 . . . . 63.35 114.242 -171.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.7 110.81 1.4 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.634 0.374 . . . . 61.41 111.097 173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.33 80.16 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.049 0.779 . . . . 24.15 115.049 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.44 144.01 26.64 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 117.811 0.805 . . . . 64.4 112.023 -175.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.64 116.91 19.33 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.983 0.513 . . . . 74.22 112.335 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.11 -66.88 0.82 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.485 0.714 . . . . 75.43 109.996 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.3 t -107.44 38.76 2.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.295 1.038 . . . . 74.44 110.001 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.56 23.86 74.22 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.003 -0.544 . . . . 74.22 113.253 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 28.0 p-10 -138.71 123.69 11.9 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 124.06 0.944 . . . . 73.23 110.53 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 21.9 Cg_exo -64.31 112.52 1.93 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.156 2.571 . . . . 53.32 112.771 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.44 HG21 HD23 ' A' ' 21' ' ' LEU . 18.6 pt -83.55 161.24 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 72.35 112.031 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -113.85 123.06 48.88 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.259 1.023 . . . . 71.25 108.298 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 18' ' ' VAL . 14.6 t -115.06 134.72 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 121.042 0.449 . . . . 75.43 110.508 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 82.4 p -142.72 179.77 6.8 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.173 1.389 . . . . 61.32 109.227 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 13' ' ' ASN . 94.5 m-85 -76.79 151.9 35.78 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.206 0.457 . . . . 52.23 110.488 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.72 95.89 8.62 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.69 0.396 . . . . 64.51 110.2 173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 123.49 0.716 . . . . 72.44 111.275 -178.271 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.917 0.389 . . . . 74.04 111.483 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.4 -121.94 5.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.147 -0.479 . . . . 71.51 111.937 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -84.9 108.09 17.37 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.119 0.568 . . . . 64.43 110.612 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.9 114.42 26.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.491 0.716 . . . . 73.22 110.813 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -71.42 93.73 1.19 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.518 0.727 . . . . 74.31 109.826 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -74.93 85.68 2.26 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.834 0.826 . . . . 75.54 112.825 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -132.97 -69.72 0.56 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.081 0.953 . . . . 73.45 108.795 170.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.88 -42.33 11.92 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.426 -0.583 . . . . 71.45 109.426 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 m -68.32 91.99 0.41 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.565 -0.743 . . . . 71.13 110.626 176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -119.76 165.99 13.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.615 0.766 . . . . 74.31 111.349 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 p -92.88 107.13 18.98 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.348 0.659 . . . . 42.35 111.491 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -109.99 10.42 24.21 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.814 0.846 . . . . 72.1 112.264 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -75.45 131.83 40.41 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.212 0.605 . . . . 65.02 109.986 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.25 11.04 25.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.05 0.54 . . . . 74.34 112.195 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.7 m -126.82 129.56 48.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.889 0.876 . . . . 70.34 109.647 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.419 HG23 ' HB1' ' A' ' 76' ' ' ALA . 29.7 pt -116.21 146.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.823 0.849 . . . . 74.14 111.335 -175.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -102.28 123.92 46.94 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.457 0.703 . . . . 74.22 109.871 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 95' ' ' VAL . 21.6 t -119.12 138.85 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.667 1.187 . . . . 71.4 110.073 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -126.1 155.41 41.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.03 0.932 . . . . 72.3 110.808 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.84 1.36 70.68 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 114.184 0.434 . . . . 74.31 114.184 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 93' ' ' ILE . 85.3 mt -61.36 -12.32 13.6 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.123 1.157 . . . . 65.51 114.123 -178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.25 173.28 49.57 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 114.389 0.515 . . . . 54.13 114.389 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 8.3 pt-20 -71.68 -22.46 61.66 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.286 -0.538 . . . . 74.33 111.27 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.52 8.93 22.76 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.714 0.806 . . . . 71.21 112.305 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -72.72 137.1 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.275 0 C-N-CA 122.722 0.409 . . . . 75.3 111.965 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' VAL . 57.9 p -131.22 148.01 52.66 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.428 0.691 . . . . 75.5 109.81 171.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG23 ' HB ' ' A' ' 51' ' ' ILE . 83.7 mt -51.5 -47.08 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.463 1.105 . . . . 75.51 112.983 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -69.7 -29.31 66.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.18 0.592 . . . . 73.45 111.916 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -74.1 -36.11 64.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.688 0.395 . . . . 73.14 111.369 175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 26' ' ' THR . 44.4 t -65.36 -40.68 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.366 0.603 . . . . 65.01 109.663 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.98 85.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.017 -0.992 . . . . 63.12 111.735 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.74 -26.39 63.35 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.073 0.549 . . . . 75.33 111.664 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -75.29 -57.08 4.11 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.399 0.68 . . . . 72.44 111.578 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.432 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 30.9 m-85 -75.25 -19.47 59.71 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.593 1.331 . . . . 72.14 114.593 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.73 -21.51 66.44 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.69 0.996 . . . . 75.42 113.69 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -57.26 -25.03 58.54 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.112 0.565 . . . . 73.35 112.353 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.8 mm -84.57 -56.33 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.945 0.898 . . . . 71.03 110.72 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.33 166.99 33.87 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 116.024 -0.535 . . . . 73.21 113.38 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.23 114.16 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.019 0.528 . . . . 73.32 110.051 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 76.5 mt -79.7 136.31 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 109.186 -0.672 . . . . 60.44 109.186 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.6 mtpt -53.51 142.11 23.29 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.151 0.58 . . . . 61.15 112.0 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.7 m -132.88 119.84 20.73 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.629 -0.714 . . . . 71.04 110.079 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -59.73 123.33 16.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.335 1.054 . . . . 75.01 110.222 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -73.94 -30.75 62.71 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.656 0.782 . . . . 72.44 111.791 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -67.53 -51.54 49.67 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.151 0.581 . . . . 71.13 111.546 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 p -83.67 -45.67 13.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.469 0.708 . . . . 65.11 111.359 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.21 17.04 35.74 Favored Glycine 0 CA--C 1.538 1.53 0 CA-C-N 115.623 -0.717 . . . . 70.12 112.421 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -104.9 156.9 35.31 Favored Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 124.235 1.014 . . . . 74.4 112.801 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.78 142.2 19.98 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.956 2.437 . . . . 72.41 112.8 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.617 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 45.0 mtt -79.04 94.32 5.28 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.263 0.554 . . . . 74.34 110.305 -176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 27' ' ' ILE . 72.1 mt -146.77 115.88 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.525 1.13 . . . . 65.22 108.906 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.17 111.15 23.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 74.45 110.116 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.61 143.36 34.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.147 0.579 . . . . 72.13 110.164 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -100.38 126.09 46.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.736 0.814 . . . . 73.34 109.848 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -115.2 142.45 46.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.065 0.946 . . . . 74.15 110.276 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -67.7 96.55 0.56 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.06 -0.718 . . . . 75.31 109.06 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -61.88 -24.1 66.72 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.593 0.757 . . . . 50.4 112.065 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.522 ' HG3' HG23 ' A' ' 59' ' ' THR . 10.9 pt-20 -71.69 -39.49 70.18 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.461 0.705 . . . . 71.11 111.903 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 58' ' ' GLU . 71.0 p -103.49 -62.31 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.308 0.643 . . . . 75.24 111.478 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 -7.84 5.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.37 -0.377 . . . . 20.14 113.701 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -90.19 161.88 15.51 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.546 0.673 . . . . 62.44 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 59.6 mt -76.49 138.46 40.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.254 0.622 . . . . 74.32 111.649 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -73.32 -20.15 60.87 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.744 0.818 . . . . 74.45 111.787 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.79 33.85 20.4 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.739 -0.664 . . . . 71.3 112.719 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -132.88 148.97 52.29 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.917 0.887 . . . . 63.55 109.74 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.11 159.57 31.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.567 0.58 . . . . 70.21 112.567 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.6 p -114.9 117.57 31.05 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.068 0.547 . . . . 60.14 110.629 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.36 109.32 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.68 0.792 . . . . 73.21 110.385 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -86.94 101.61 13.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.021 0.528 . . . . 70.31 111.116 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 58.3 m-85 -77.59 157.28 30.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.722 0.809 . . . . 74.42 110.76 168.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.38 -35.99 58.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.225 0.61 . . . . 73.51 110.579 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -106.49 128.01 27.07 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.541 0.737 . . . . 65.13 110.821 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -52.29 -39.94 71.31 Favored 'Trans proline' 0 CA--C 1.582 2.883 0 C-N-CA 122.697 2.265 . . . . 61.23 115.764 166.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.25 -24.01 65.69 Favored 'Trans proline' 0 C--N 1.401 3.317 0 CA-C-N 122.297 1.856 . . . . 73.22 113.715 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.8 m -77.12 -38.06 52.88 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.109 0.564 . . . . 71.44 110.782 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -64.55 -43.8 92.81 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.428 0.632 . . . . 70.25 110.318 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -60.64 -48.02 83.64 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.146 1.378 . . . . 72.42 111.37 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.16 94.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.81 -0.632 . . . . 53.23 112.479 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.482 0.713 . . . . 74.23 112.387 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.484 HG12 HG12 ' A' ' 95' ' ' VAL . 92.2 mt -63.9 -60.53 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.115 0.566 . . . . 70.45 110.574 172.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.48 -31.68 66.23 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.409 -0.814 . . . . 75.44 111.576 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -80.06 -61.87 1.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.809 0.444 . . . . 70.22 111.933 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' HB2' HG21 ' A' ' 95' ' ' VAL . 71.3 m-85 -80.02 -10.46 59.77 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.618 0.97 . . . . 75.22 113.618 -170.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.4 104.26 2.23 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 109.541 -0.54 . . . . 72.01 109.541 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.55 42.41 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 115.546 -0.752 . . . . 62.32 114.017 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 93' ' ' ILE . 75.2 mmtt -82.69 152.1 25.95 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.882 0.841 . . . . 75.01 110.073 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.95 124.1 35.81 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.429 0.529 . . . . 52.44 112.429 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -126.83 136.32 52.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.253 -1.018 . . . . 60.42 108.253 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 t 61.49 30.32 18.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.189 0.996 . . . . 71.4 111.609 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.26 29.0 54.83 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.478 -0.783 . . . . 53.0 115.041 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -161.41 145.29 9.8 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-N 117.305 0.553 . . . . 64.25 111.383 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.64 110.67 1.93 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.018 2.479 . . . . 74.15 113.438 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.431 HG21 HD23 ' A' ' 21' ' ' LEU . 34.4 pt -78.88 160.6 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 123.861 0.865 . . . . 74.21 112.223 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -118.18 128.19 54.47 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.463 1.105 . . . . 71.33 109.457 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 18' ' ' VAL . 23.6 t -121.91 135.34 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 74.32 111.107 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 94.5 p -146.4 179.36 7.58 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.708 1.203 . . . . 60.14 109.022 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -75.27 154.4 37.47 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.969 0.804 . . . . 74.41 111.713 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.12 88.3 6.46 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.241 -0.652 . . . . 71.32 109.241 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.57 1.715 0 C-N-CA 123.451 0.7 . . . . 61.45 111.551 -174.712 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.339 0.114 . . . . 65.42 111.172 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.27 138.72 28.22 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 114.195 0.438 . . . . 53.04 114.195 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -75.26 88.75 2.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.897 0.855 . . . . 71.12 110.981 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.41 -29.54 70.81 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.368 -1.287 . . . . 71.33 112.716 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -67.88 135.69 52.89 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.203 0.601 . . . . 73.21 110.067 177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -76.16 158.33 31.82 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.185 0.594 . . . . 70.12 112.026 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -104.62 6.67 34.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.678 0.791 . . . . 73.12 111.842 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -71.51 87.55 0.9 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.319 0.648 . . . . 64.3 111.06 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.2 t -158.46 -174.86 5.0 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.873 0.869 . . . . 74.53 110.654 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -66.64 99.96 0.64 Allowed 'General case' 0 CA--C 1.562 1.433 0 CA-C-O 121.488 0.661 . . . . 71.22 112.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.3 t -99.79 171.69 7.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.168 0.587 . . . . 72.32 110.239 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.44 35.21 0.49 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.542 0.737 . . . . 74.01 111.506 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -80.39 137.9 36.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.132 0.973 . . . . 71.12 110.575 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -98.64 -20.4 17.01 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.615 0.766 . . . . 75.2 111.88 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 m -94.77 126.75 40.29 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.915 0.486 . . . . 74.43 110.187 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 39.5 pt -113.36 156.0 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.584 0.754 . . . . 63.55 111.291 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -116.3 125.42 52.13 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.329 0.651 . . . . 72.42 110.146 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.621 HG13 HG22 ' A' ' 95' ' ' VAL . 18.5 t -117.41 146.33 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.191 0.996 . . . . 74.14 110.363 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 94' ' ' LYS . 27.6 mt-30 -124.7 163.62 21.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.684 1.193 . . . . 74.0 110.184 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.97 23.57 74.29 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 114.953 0.741 . . . . 60.21 114.953 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 18' ' ' VAL . 57.5 mt -76.19 -17.92 59.31 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.328 1.051 . . . . 74.34 111.958 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 177.29 49.54 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 114.71 0.644 . . . . 74.14 114.71 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 34.0 mt-10 -75.29 -14.66 60.52 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.664 0.786 . . . . 75.05 112.797 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -84.09 -8.97 58.96 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.336 0.654 . . . . 60.44 112.191 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.7 128.36 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 113.716 1.006 . . . . 74.12 113.716 -169.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.3 p -125.61 152.86 44.57 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.517 0.727 . . . . 72.52 110.289 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 51' ' ' ILE . 88.0 mt -52.91 -45.55 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.379 0.672 . . . . 70.04 111.593 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.64 -38.74 92.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.58 0.752 . . . . 74.43 111.777 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.3 t -71.5 -39.46 70.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.756 0.422 . . . . 72.34 111.707 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' THR . 61.9 t -65.32 -40.4 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.256 0.55 . . . . 65.54 110.014 176.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.22 -42.63 99.29 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.141 -0.936 . . . . 72.24 111.286 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.52 -30.65 67.46 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.143 0.577 . . . . 74.5 111.379 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -76.43 -53.7 7.76 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.692 0.797 . . . . 73.23 111.418 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.445 ' HB3' ' HZ ' ' A' ' 70' ' ' PHE . 36.2 m-85 -79.04 -16.26 57.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.784 1.031 . . . . 64.35 113.784 -174.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.07 -29.77 67.57 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 113.09 0.774 . . . . 70.4 113.09 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -58.85 -25.09 62.94 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.796 0.838 . . . . 51.13 112.275 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.35 -45.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.253 1.021 . . . . 74.43 111.649 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -178.7 45.62 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 116.343 -0.39 . . . . 65.5 113.315 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.92 126.97 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.7 0.4 . . . . 71.11 110.123 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 80.4 mt -95.06 143.2 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.785 0.834 . . . . 51.3 108.852 170.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.611 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 61.7 mtpt -62.42 145.62 53.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.092 0.557 . . . . 74.12 111.504 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 41.5 m -125.67 123.91 39.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.106 0.962 . . . . 73.31 108.809 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -71.69 123.74 23.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.071 0.549 . . . . 71.21 109.664 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -18.28 45.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.209 0.604 . . . . 72.44 111.722 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -66.26 -52.73 44.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.932 0.493 . . . . 72.25 110.801 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -83.38 -41.53 18.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.388 0.675 . . . . 70.42 111.022 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.63 16.0 44.27 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 115.881 -0.599 . . . . 70.41 112.512 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -121.91 153.33 60.48 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.184 0.994 . . . . 61.31 111.972 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 41.1 Cg_endo -64.22 140.92 73.43 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.256 2.637 . . . . 55.42 112.855 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.611 ' SD ' ' HE2' ' A' ' 41' ' ' LYS . 56.8 mtt -73.98 95.51 2.51 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.359 0.6 . . . . 74.02 109.809 -174.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 27' ' ' ILE . 80.4 mt -144.67 120.73 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.833 1.253 . . . . 73.33 108.614 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 m120 -101.45 110.15 22.1 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.902 -0.407 . . . . 71.41 109.902 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.86 141.52 32.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.524 0.73 . . . . 64.32 109.748 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.49 112.41 25.31 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.474 0.71 . . . . 75.3 110.267 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 m -97.52 141.61 30.36 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.614 0.766 . . . . 75.54 110.17 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.41 123.63 25.02 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.69 1.196 . . . . 73.33 109.995 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.38 -20.05 59.19 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 114.307 1.225 . . . . 73.41 114.307 -170.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 59' ' ' THR . 13.1 pt-20 -93.76 -44.5 8.11 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.946 0.793 . . . . 60.13 112.199 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 58' ' ' GLU . 46.1 p -92.22 -35.35 13.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 122.896 0.478 . . . . 51.21 112.124 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.89 0.94 68.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 116.168 -0.469 . . . . 70.33 113.945 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.5 162.31 27.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.39 0.595 . . . . 74.41 110.532 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 23' ' ' GLU . 78.3 mt -81.08 132.67 35.38 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.811 -0.555 . . . . 50.1 111.053 174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.21 -19.35 64.75 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.799 0.84 . . . . 72.42 111.866 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.57 21.49 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.007 -0.542 . . . . 62.31 112.147 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.45 145.11 46.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.789 0.835 . . . . 71.44 109.405 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -158.22 150.63 22.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.783 0.66 . . . . 64.35 112.783 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 35.6 p -108.19 114.46 28.36 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.828 0.451 . . . . 70.34 111.045 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -102.66 108.96 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.953 0.901 . . . . 74.21 109.853 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.1 m -85.47 105.29 15.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.615 0.366 . . . . 73.41 110.52 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 49.4 m-85 -79.26 156.63 28.02 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.357 0.663 . . . . 54.13 111.161 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.04 57.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.36 0.664 . . . . 55.42 110.737 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -109.27 129.52 23.81 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.276 0.63 . . . . 61.2 110.712 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -49.59 -42.02 43.57 Favored 'Trans proline' 0 CA--C 1.58 2.778 0 C-N-CA 123.005 2.47 . . . . 65.54 116.55 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.63 -21.17 52.52 Favored 'Trans proline' 0 C--N 1.396 3.036 0 CA-C-N 122.301 1.857 . . . . 74.55 113.362 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 m -72.64 -38.17 67.78 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.309 0.644 . . . . 72.51 109.669 174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.48 -53.24 57.66 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.211 -0.904 . . . . 51.14 111.276 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.3 tmtp? -61.99 -41.75 98.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.64 0.776 . . . . 62.44 111.151 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.11 -42.49 98.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.892 0.477 . . . . 72.2 111.778 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.151 0.58 . . . . 63.21 112.457 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 77' ' ' LYS . 86.0 mt -66.64 -56.35 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.074 0.55 . . . . 70.44 110.928 174.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.5 -27.33 69.2 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.524 0.729 . . . . 64.14 112.043 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -82.36 -60.39 2.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.057 0.543 . . . . 74.33 111.553 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -82.69 -13.57 56.16 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.23 1.196 . . . . 65.43 114.23 -168.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.57 104.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 119.194 0.906 . . . . 73.43 110.203 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.05 6.04 49.24 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 115.514 -0.766 . . . . 62.35 114.56 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.25 -176.45 5.11 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 117.856 0.828 . . . . 75.5 111.556 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.81 122.36 42.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.121 0.569 . . . . 61.22 110.664 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -75.32 -70.9 0.39 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.842 -0.429 . . . . 70.33 109.842 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.8 t -115.17 50.06 1.01 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.783 0.833 . . . . 74.51 109.391 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.27 23.53 73.59 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 115.408 -0.815 . . . . 64.5 113.501 -174.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -131.37 128.76 22.1 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.904 0.881 . . . . 72.43 111.806 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 113.82 2.3 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.369 2.713 . . . . 74.53 113.551 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.1 pt -97.19 151.86 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.552 0.741 . . . . 73.5 112.777 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 75.1 mmtt -113.6 112.09 22.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.326 1.05 . . . . 75.15 109.384 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG13 ' A' ' 18' ' ' VAL . 21.7 t -112.5 128.3 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.99 -0.444 . . . . 74.44 110.809 -174.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.0 m -140.48 -179.66 6.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.161 1.384 . . . . 63.13 109.495 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -73.87 151.49 40.46 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.179 0.445 . . . . 73.44 110.63 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 91.1 6.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.214 0.531 . . . . 64.04 109.939 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.567 1.611 0 C-N-CA 123.931 0.892 . . . . 74.44 110.782 -177.283 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HB3' ' HB3' ' A' ' 4' ' ' HIS . 56.8 mtt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 110.742 -0.096 . . . . 75.11 110.742 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.84 -88.68 0.3 Allowed Glycine 0 C--N 1.355 1.626 0 O-C-N 123.335 0.397 . . . . 74.22 113.609 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -65.06 -32.24 73.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.679 0.792 . . . . 75.14 112.103 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 39.6 t-80 -91.79 86.35 5.9 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.36 0.6 . . . . 75.03 110.087 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -78.41 106.29 10.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.845 -0.616 . . . . 75.42 111.369 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.24 18.99 1.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.562 0.745 . . . . 71.13 112.635 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -117.74 155.59 29.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.657 0.783 . . . . 74.51 110.463 169.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -148.51 123.0 9.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.715 0.806 . . . . 74.04 109.605 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.8 t -83.16 138.47 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.921 0.488 . . . . 32.42 110.792 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -67.18 125.13 25.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.447 0.699 . . . . 75.14 111.383 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.7 t -70.64 121.06 17.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.876 0.87 . . . . 52.05 111.577 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.51 133.94 52.33 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 120.994 0.426 . . . . 75.41 111.102 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -124.55 120.35 31.69 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 64.13 109.787 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 70' ' ' PHE . 35.5 p30 -92.46 -12.06 33.05 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.323 0.649 . . . . 51.41 112.274 -176.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -103.19 130.0 50.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.282 0.633 . . . . 72.22 110.672 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 36.9 pt -119.26 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.64 0.776 . . . . 62.42 112.13 -176.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -95.81 119.63 34.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.25 0.548 . . . . 70.34 110.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 95' ' ' VAL . 17.6 t -112.83 141.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.782 1.233 . . . . 75.41 109.814 -177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -126.44 155.22 42.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.229 1.011 . . . . 62.4 110.439 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.88 32.3 50.24 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.222 0.849 . . . . 75.45 115.222 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 93' ' ' ILE . 69.8 mt -74.89 -33.33 62.03 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.214 1.006 . . . . 74.11 112.114 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.64 153.86 10.34 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-N 116.185 -0.461 . . . . 72.3 112.868 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.43 -8.36 54.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.992 0.917 . . . . 64.42 112.191 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -117.22 81.8 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.032 0.933 . . . . 71.51 109.302 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 21' ' ' LEU . 7.3 p -134.17 131.75 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.2 1.0 . . . . 71.04 110.525 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 12.8 p -116.26 155.71 27.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.655 -0.653 . . . . 73.05 109.992 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG23 ' HB ' ' A' ' 51' ' ' ILE . 68.1 mt -52.19 -47.67 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.118 0.967 . . . . 74.34 112.187 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.88 -21.45 54.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.995 0.518 . . . . 74.2 112.374 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -68.83 -44.34 73.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.842 0.457 . . . . 74.42 110.144 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' HA ' ' HE1' ' A' ' 88' ' ' PHE . 24.6 t -67.14 -38.97 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 115.912 -0.586 . . . . 72.04 110.364 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.71 79.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.756 -0.656 . . . . 72.54 111.738 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.55 -31.57 72.84 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.222 0.609 . . . . 63.22 111.358 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -73.58 -54.29 8.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.035 0.534 . . . . 74.43 111.152 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -78.02 -22.92 48.5 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.087 1.143 . . . . 74.44 114.087 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.52 -22.61 66.99 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 113.055 0.761 . . . . 72.42 113.055 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.46 -27.32 65.98 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.796 0.438 . . . . 73.21 111.628 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.06 -45.07 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 75.52 110.988 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.22 44.3 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 116.094 -0.503 . . . . 62.42 113.625 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.23 127.39 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.71 0.804 . . . . 74.53 110.683 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 75.3 mt -98.85 132.76 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 73.14 109.904 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE3' ' SD ' ' A' ' 50' ' ' MET . 28.0 mtpp -55.03 142.75 29.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 64.24 111.501 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 67.7 m -139.85 131.32 26.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.811 -0.632 . . . . 73.02 111.07 -176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -68.86 114.68 7.4 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.261 1.025 . . . . 73.3 109.357 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -74.37 -21.57 59.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.391 0.676 . . . . 70.3 112.184 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -73.52 -49.13 28.13 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.653 0.381 . . . . 74.53 111.499 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -86.16 -45.19 11.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.039 0.536 . . . . 65.21 111.867 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.84 -4.34 39.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.893 -0.594 . . . . 63.51 112.802 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -93.19 140.15 23.22 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.33 0.652 . . . . 73.23 112.471 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 53.8 Cg_endo -70.44 149.67 62.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.745 2.297 . . . . 54.14 111.842 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.421 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 55.6 mtt -75.57 94.35 3.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.351 0.596 . . . . 71.11 109.52 -176.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' HB ' HG23 ' A' ' 27' ' ' ILE . 75.1 mt -145.06 121.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 70.12 107.713 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.7 m-80 -104.57 107.85 19.0 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 110.019 -0.363 . . . . 72.23 110.019 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.7 mt -81.04 126.17 31.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.057 0.943 . . . . 51.31 110.002 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 96.4 m-85 -86.43 134.73 33.67 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.251 0.62 . . . . 74.53 111.085 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -129.78 144.91 51.53 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.64 1.176 . . . . 72.2 109.746 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -68.97 113.02 5.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.116 0.566 . . . . 72.04 110.12 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -65.88 -24.61 66.9 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.994 0.917 . . . . 72.31 111.44 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.54 ' HG3' HG23 ' A' ' 59' ' ' THR . 11.6 pt-20 -77.37 -45.34 26.3 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.546 0.738 . . . . 64.43 112.011 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 58' ' ' GLU . 37.4 p -94.28 -56.74 2.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.068 0.461 . . . . 73.33 111.698 -176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.24 4.7 23.67 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-N 116.053 -0.521 . . . . 41.34 113.574 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.87 151.38 20.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.293 0.637 . . . . 73.12 111.577 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.76 135.2 52.3 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.452 0.701 . . . . 65.32 111.158 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.67 -16.17 60.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.374 0.67 . . . . 75.4 111.708 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.62 39.65 24.79 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.766 -0.534 . . . . 75.23 111.766 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 57.9 mt-10 -133.56 148.97 51.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.427 0.691 . . . . 72.45 109.33 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ASN . . . -157.86 151.53 23.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.791 0.436 . . . . 72.31 111.688 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 54' ' ' TYR . 32.6 p -112.44 113.43 25.61 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.649 0.38 . . . . 74.23 110.65 172.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.0 t -101.5 110.62 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.571 1.148 . . . . 60.04 110.174 -169.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' MET . 20.0 m -89.95 101.39 14.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.245 0.618 . . . . 74.23 111.216 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 40' ' ' ILE . 41.9 m-85 -76.56 157.42 32.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.383 0.673 . . . . 63.1 110.557 170.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.06 -32.37 67.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.777 0.431 . . . . 53.32 110.017 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -113.79 123.67 32.5 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.548 0.739 . . . . 72.33 111.474 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.74 -33.53 80.86 Favored 'Trans proline' 0 CA--C 1.583 2.941 0 C-N-CA 122.841 2.36 . . . . 62.51 116.497 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.2 -26.41 42.32 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 122.871 2.061 . . . . 64.4 113.209 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.5 m -77.69 -35.44 52.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.531 0.733 . . . . 53.33 110.485 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' HG23 ' A' ' 16' ' ' ILE . . . -62.63 -49.89 73.4 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 121.4 0.619 . . . . 65.21 110.594 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -65.58 -37.52 86.88 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.676 1.191 . . . . 71.25 111.426 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.82 90.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.1 0.56 . . . . 51.31 112.045 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.64 68.46 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.303 0.641 . . . . 75.25 112.444 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 95' ' ' VAL . 81.4 mt -64.47 -64.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.883 0.473 . . . . 71.24 110.464 171.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.06 -25.01 65.02 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.355 0.662 . . . . 75.23 112.389 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -82.32 -62.14 1.7 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.993 0.517 . . . . 73.24 111.67 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.12 -9.76 59.42 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.032 1.123 . . . . 74.22 114.032 -170.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -66.13 118.13 9.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 120.943 0.401 . . . . 61.32 110.389 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.88 79.66 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.335 -0.703 . . . . 44.2 114.511 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 93' ' ' ILE . 74.4 mmtt -93.95 167.89 11.31 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 118.44 1.12 . . . . 73.31 111.386 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -96.89 118.92 34.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.214 0.605 . . . . 70.02 111.487 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' HE1' ' HA ' ' A' ' 30' ' ' VAL . 89.7 t80 -72.47 -74.17 0.17 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.001 0.521 . . . . 64.03 110.414 172.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.2 t -116.95 60.37 0.75 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.039 0.936 . . . . 73.45 108.847 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.22 13.27 67.11 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 115.272 -0.876 . . . . 60.45 113.46 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -118.19 120.48 32.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.247 1.019 . . . . 65.21 111.017 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.28 96.0 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.953 2.435 . . . . 73.14 113.158 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 21' ' ' LEU . 28.1 pt -76.04 156.07 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.78 0.832 . . . . 45.02 113.225 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -122.98 116.56 23.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.366 1.066 . . . . 74.5 108.942 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 18' ' ' VAL . 20.0 t -110.92 136.36 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 122.67 0.388 . . . . 73.33 110.731 -174.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 88.8 p -148.67 -176.52 5.36 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.982 1.313 . . . . 75.42 109.657 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -76.6 146.67 38.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.741 0.701 . . . . 72.3 111.758 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.84 100.15 11.5 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.984 0.514 . . . . 34.23 110.242 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.811 0.844 . . . . 43.23 111.416 -174.946 . . . . . . . . 0 0 . 1 stop_ save_